P00001606T0076|14 33|alkaline phosphatases
P00001606T0076|37 50|5-nucleotidase
P00008997A0472|4 13|CSF [HCO3-]
P00008997A0472|34 40|CSF PCO2
P00013683A0210|40 58|CO2 production (VCO2)
P00015731A0090|44 52|anhydrase
P00015731A0090|214 215|pH
P00024600A0522|11 13|HMG
P00027739T0000|0 28|Serum gamma glutamyltransferase
P00027739T0000|45 56|liver disease
P00027967A0207|20 21|HI
P00029953T0045|17 22|lipase
P00030183T0000|0 16|Takayasu's disease
P00030183T0000|33 38|HLA-B5
P00030937A0119|0 3|SGPT
P00030937A0119|1 8|GPT, SGOT
P00030937A0119|13 31|alkaline phosphatase
P00033873T0001|0 32|Gamma glutamyl transpeptidase (GGTP)
P00034935A0545|12 29|Parkinson's disease
P00038408T0000|29 47|alpha-autoreceptors
P00038408T0000|70 85|alpha-methyldopa
P00038408T0000|89 91|FLA
P00050628A0202|2 4|IgG
P00050628A0202|59 70|Bence-Joanes
P00054900A0226|0 9|Peroxydase
P00054900A0226|50 57|esterase
P00055040A0000|70 91|immunofluorescence (IF)
P00055040A0000|116 125|fibrinogen
P00055040A0000|138 168|degradation products (FR-antigen)
P00055040A0000|209 241|heparin-precipitable fraction (HPF)
P00055040A0000|263 278|plasma fibrinogen
P00060529A0695|215 217|A.B
P00066874T0000|21 30|fluid alpha
P00073344A0367|14 25|phytomitogen
P00083846T0000|16 18|AMP
P00086313A0000|20 39|Legionnaires' disease
P00088391A0181|20 21|IX
P00088391A0181|70 71|IX
P00089778A0000|19 43|lpha 2-macroglobulin, alpha
P00089778A0000|20 68|pha 2-macroglobulin, alpha 1-antitrypsin, plasminogen
P00089778A0000|22 117|a 2-macroglobulin, alpha 1-antitrypsin, plasminogen, C3-complement, fibrinogen degradation products (FDP)
P00096241A0087|5 8|FT4I
P00096241A0087|128 138|34 weeks' EGA
P00096241A0087|156 157|(P
P00100540T0000|44 66|platelet cyclo-oxygenase
P00101300A0257|0 6|59 cases
P00101300A0257|36 38|(T1
P00105401A0635|11 13|CBZ
P00105401A0635|17 19|DPH
P00105401A0635|75 77|TBG
P00105401A0635|204 206|FT4
P00105401A0635|210 212|FT3
P00105903A0288|66 69|(PEG
P00112627A0542|126 143|g/kg), alphaprodine
P00114144A0189|134 135|IV
P00114144A0189|136 157|glycogen storage disease
P00114144A0189|158 168|(Andersen's
P00115974A0576|22 34|Hebb-Williams
P00118044A0000|115 117|EMG
P00119339A0400|142 153|degeneration
P00122718A0500|13 15|MRF
P00129659T0000|79 81|IQs
P00130573T0054|0 2|VII
P00133214T0064|40 43|USSR
P00136175A1137|153 158|ECA.20
P00137671A0896|50 59|VIII-ratio
P00139827A0000|21 90|egnenolone, progesterone, dehydroepiandrosterone (DHA) 16 alpha-hydroxy-DHA
P00142718A0156|68 77|metastases
P00142718A0156|93 102|99mTc-EHDP
P00150066A0100|11 20|fibrinogen
P00154430A0906|92 106|kb HindIII-EcoRI
P00159600A0871|0 1|SV
P00159600A0871|17 19|SHR
P00159600A0871|84 86|SHR
P00159600A0871|135 148|Frank-Starling
P00163384A0000|27 31|(Bubo
P00172199A0270|63 73|homogeneous
P00183063A0300|14 17|DNCB
P00183063A0300|51 52|II
P00183063A0300|100 102|III
P00183063A0300|177 179|III
P00188387A0975|75 76|FH
P00188387A0975|92 103|heart disease
P00193587T0000|0 2|EEG
P00196255A0000|0 2|REM
P00198510T0000|43 50|(Locusta
P00199012T0000|7 10|ACTH
P00201881A0487|63 68|PI ACTH
P00201881A0487|72 74|MSH
P00209664A0836|28 34|serum LH
P00211881A0602|126 128|PBB
P00216939T0001|45 61|acid dehydrogenase
P00219565A0172|40 50|transfusion
P00221725A0523|25 41|cytochrome oxidase
P00221725A0523|26 52|ytochrome oxidase, peroxidase
P00222102A0227|57 67|vitamin-D-3
P00222102A0227|71 99|1 alpha-Hydroxycholecalciferol
P00222827A0000|33 49|diisocyanate (TDI)
P00224013A0661|5 7|VO2
P00224013A0661|54 60|limb VO2
P00224013A0661|79 88|beta-block
P00224013A0661|80 104|eta-block group. beta-Block
P00224013A0661|325 359|2 pressure. beta-Vasodilator receptors
P00225352T0000|49 59|[3H]vitamin
P00227393T0000|12 45|25-hydroxyvitamin D3-24-hydroxylase
P00227393T0000|63 90|cytochrome P-450 monooxygenase
P00227610A1593|31 37|DBP mRNA
P00227610A1593|66 69|SV40
P00231555T0001|64 73|endogenous
P00231555T0001|74 77|ACTH
P00232354A0286|0 8|Serum ACTH
P00232456T0000|12 14|RNA
P00232456T0000|32 35|MC29
P00232456T0000|39 41|MH2
P00234206T0000|8 13|(Guama
P00234206T0000|30 40|(Bunyamwera
P00234264A0164|0 26|Gamma glutamyl transpeptidase
P00234626T0036|0 2|XXI
P00239014A0000|53 83|p-chlorophenoxyisobutyric (CPIB)
P00239169T0000|0 15|Dopamine receptor
P00264240A1843|50 56|5S genes
P00264240A1843|153 170|. laevis oocyte 5S DNA
P00294502T0001|12 37|treatment planning in Class II
P00304806A0760|12 24|serum alpha1AT
P00321261A0104|20 40|prostaglandin E2 (PGE2)
P00321261A0104|44 63|prostaglandin F2alpha
P00330364A0132|8 12|26 BCG
P00330364A0132|74 76|BCG
P00330364A0132|138 152|BCG-vaccination
P00330364A0132|183 198|BCG-vaccination)
P00331936T0000|44 59|immunoperoxidase
P00336354A0543|13 19|serum GH
P00336354A0543|22 37|arginine infusion
P00336547A0000|130 132|ICR
P00336547A0000|136 141|C3H/eB
P00336547A0000|233 241|C57/BL/6J
P00336547A0000|235 264|7/BL/6J, New Zealand Black, BALB/c
P00336547A0000|236 272|/BL/6J, New Zealand Black, BALB/c, CBA/LAC
P00336547A0000|237 283|BL/6J, New Zealand Black, BALB/c, CBA/LAC, and C3H/eB)
P00340692T0033|0 9|(Emeritus)
P00361059T0000|69 78|clobetasol
P00369397A0280|5 7|FSH
P00369397A0280|11 12|LH
P00369397A0280|56 59|GnRH
P00369397A0280|74 84|addicts' FSH
P00369397A0280|88 89|LH
P00377466A0188|30 40|hormone (LH)
P00377466A0188|31 72|ormone (LH), follicle stimulating hormone (FSH)
P00377466A0188|32 88|rmone (LH), follicle stimulating hormone (FSH), prolactin (HPRL)
P00377466A0188|33 103|mone (LH), follicle stimulating hormone (FSH), prolactin (HPRL), oestradiol (E2)
P00377466A0188|34 119|one (LH), follicle stimulating hormone (FSH), prolactin (HPRL), oestradiol (E2), progesterone (P)
P00377466A0188|123 137|testosterone (T)
P00377466A0188|155 166|healing phase
P00383169A0000|46 61|dopamine receptor
P00386251A0899|3 5|IDF
P00393598A0198|47 49|ALS
P00397806T0039|4 16|Algerian cases
P00413854A0958|9 18|tissue PCO2
P00414575T0000|0 9|Ultrasonic
P00420460A0291|111 112|SQ
P00425547A0000|69 90|beta-lactam-antibiotic
P00427715A0000|22 37|Hodgkin's disease
P00427715A0000|64 70|(Stages
P00427715A0000|75 76|II
P00429949A0000|161 198|International Reference Preparation (IRP)
P00431832T0001|42 53|beta receptor
P00432615A0541|167 170|RIST
P00435187T0000|0 3|"Let
P00445720A0263|11 31|pressure gradient (SPG)
P00445720A0263|46 58|ventricle (LV)
P00445720A0263|66 75|atrium (LA)
P00451192A0248|100 119|LV region-of-interest
P00453780A0430|15 22|serum IgA
P00453780A0430|155 157|IgA
P00463973A0000|95 123|small-for-gestational age (SGA)
P00464387A1185|25 32|serum IgE
P00464387A1185|75 78|ABPA
P00465223A0373|58 64|delta PU
P00465223A0373|68 74|delta PM
P00465223A0373|89 96|(SD) mmHg
P00465829T0000|0 13|Nernst--Planck
P00474064A0205|66 87|pethidine 20 mg.kg-1 I.V.
P00474064A0205|162 179|R 34 995 10 mg.kg-1 I.V
P00479222A0682|117 147|pseudo-extracellular fluid (PECF)
P00484177A0242|76 77|CT
P00484177A0242|97 98|VT
P00488534A0308|97 114|taurine-injected MR
P00488534A0308|132 148|saline-injected MR
P00497494A0112|32 36|PACO2
P00503336A0285|16 19|CAEC
P00503336A0285|29 30|CC
P00503336A0285|34 37|CIEC
P00503336A0285|81 99|alkaline phosphatase
P00503336A0285|103 115|transaminases
P00510341T0036|11 19|E.O.R.T.C
P00512215A0000|38 66|difference tone level [L(f2-f1)]
P00513284A0000|37 41|(DOTC
P00513284A0000|53 61|'Pfizer')
P00513284A0000|112 123|drip infusion
P00513284A0000|191 194|DOTC
P00513284A1255|23 34|DOTC infusion
P00521732T0000|19 43|estrone, oestradiol-17 beta
P00521732T0000|81 97|steroid sulphatase
P00534613A0000|36 39|UV-A
P00540707A0255|98 103|2 cases
P00540707A0255|215 217|PMK
P00541752A1032|125 130|+/- SD)
P00557559A0170|21 67|alpha-(3-methyl-2-quinoxalinyl)-N-methylnitrone
P00564943A0444|9 16|MCT-milk
P00564943A0444|71 78|SBO-milk
P00565136T0000|55 58|CH2O
P00565136T0000|56 65|H2O, SO2Cl2
P00569989A0239|28 53|flow pneumocardiogram (PnCG)
P00569989A0239|105 111|dPn/dt)
P00577440A0298|60 81|3H-alpha-acetyldigoxin
P00580106T0000|11 24|Graves' disease
P00580151A0706|83 86|se-T
P00583522T0001|0 15|Etiopathogenetic
P00589073A0000|15 29|plasma prolactin
P00593119T0001|42 44|IgE
P00593119T0001|90 92|IgE
P00594466T0001|24 29|"Papio
P00594617A0192|69 92|degradation products (FDP)
P00594617A0192|185 192|(Godal's
P00594617A0192|275 278|ESR)
P00597715A0256|79 81|FSH
P00598012A0174|2 15|girls prolactin
P00600943T0001|0 5|2 cases
P00601401A0181|96 114|delta log Po2/delta pH
P00602622A0362|36 49|Vikalin (Roter)
P00603783A0647|13 15|IgG
P00603783A0647|19 21|IgM
P00603783A0647|68 79|observers IgA
P00606849T0000|20 31|heart disease
P00616575A0000|100 103|(EMF
P00616575A0000|106 108|DW)
P00617815A0215|12 14|L-R
P00619782A0058|73 98|ultraviolet radiation (UV-A)
P00619948A0000|135 148|variation (CNV)
P00627129A0944|123 131|labetalol
P00627129A0944|165 191|alpha-and beta-adrenoceptors
P00633909A0000|35 59|Rotter's Internal-External
P00635194A0093|0 8|Kodak XV-2
P00641395A0441|80 82|ZPP
P00644539A0783|53 56|FEV1
P00656008T0000|41 59|superoxide dismutase
P00657551T0000|48 51|26Mg
P00663166A0000|150 176|patent ductus arteriosus (PDA)
P00665336A0908|43 57|EEG-information
P00685922A0451|66 74|tree (IHB)
P00686836A0000|170 173|40 IU
P00702773A0327|0 9|Althoug RBF
P00702773A0327|84 86|RBF
P00702773A0327|85 90|BF, GFR
P00703350A0418|0 4|99mTc
P00703350A0418|1 17|9mTc phytate, 198Au
P00703350A0418|29 33|99mTc
P00704675A0199|9 11|UO2
P00710372A0302|82 83|GH
P00712117A0521|71 87|A/Texas/1/77-like
P00712117A0521|107 121|A/Victoria/3/75
P00715753A0241|2 14|biopsies CK-MB
P00715753A0241|40 42|CPK
P00715753A0241|53 61|total-CPK
P00715753A0241|115 119|CK-MB
P00716366T0001|22 40|alkaline phosphatase
P00722652A0118|11 24|2nd-generation
P00725257A0452|13 15|pD2
P00725257A0452|40 42|DHE
P00725336T0000|0 15|Newcastle disease
P00725336T0000|61 67|poultry
P00725534A0888|66 68|IgA
P00725534A0888|137 141|to IgA
P00725752T0001|54 65|beta receptor
P00728718T0000|0 13|Thyroid disease
P00737422A0832|0 8|Pathogens
P00737422A0832|9 23|(Staphylococcus
P00740409A0000|20 33|ultrastructure
P00747722A0486|16 26|three-phase
P00747722A0486|41 56|1 injection : Phase
P00753237A0000|0 3|A--A
P00753237A0000|90 93|PAIN
P00753237A0000|109 139|utsentry (fig.--1) (5); B--Plantar
P00753237A0000|151 165|ulceration (PPU)
P00753237A0000|190 202|INSENSITIVITY
P00753237A0000|206 214|TRAUMATIS
P00753237A0000|207 224|RAUMATIS (1); C--The
P00753237A0000|322 339|D--PNEUMATIC INSOLE
P00753237A0000|481 483|PPU
P00759049A0185|60 87|bathophenanthroline chromogen
P00759049A0185|93 96|ICSH
P00759400T0000|0 22|Platelet serotonin (5-HT)
P00759400T0000|26 29|5-HT
P00762763A0253|21 24|SIDS
P00779272T0001|32 43|Epstein-Barr
P00780639X0000|16 27|antigen (CEA)
P00792847A0000|21 47|antilymphocyte globulin (ALG)
P00808898A0000|71 83|failure (IPRF)
P00821833A0000|63 71|(Alouatta
P00825571T0031|0 2|III
P00827364A0000|71 75|ultra
P00830568A0000|61 73|test meal (LTM)
P00830568A0000|141 166|gastroduodenostomy (STG-BI)
P00830568A0000|173 198|gastrojejunostomy (STG-BII)
P00830568A0000|235 251|pyloroplasty (V&P)
P00836637A0000|1 10|five-phase
P00836637A0000|134 136|EMR
P00837262A0000|25 34|cortex (VC)
P00837262A0000|46 59|colliculus (SC)
P00837262A0000|106 109|"ON"
P00837262A0000|112 116|"OFF"
P00837811A0675|12 13|MS
P00839378A0649|21 23|RDS
P00846559A0000|55 61|U.S.S.R
P00846559A0000|132 136|U.S.A
P00857024A0888|41 46|9 cases
P00866577A0579|14 31|eparin, plasminogen
P00866577A0579|45 60|fibrinogenolytic
P00871237A0601|14 16|III
P00872442T0000|44 46|LKB
P00875778T0000|18 30|Gravigard IUCD
P00877857A0763|0 11|Serum amylase
P00877857A0763|40 45|CU/100
P00877857A0763|58 65|serum FFA
P00877857A0763|72 81|mEq/liter)
P00879329A0176|79 91|pressure (Pci)
P00879329A0176|100 104|8 mmHg
P00879329A0176|141 151|plasma (IIp)
P00879829A0564|35 38|'IVH
P00881630A0000|90 104|Phospholipase-A
P00885562A0281|5 8|GAGs
P00885562A0281|121 123|GAG
P00898500A0246|56 57|HD
P00898500A0246|109 118|test (RAST)
P00898500A0246|143 153|IgE antibody
P00909114A0000|0 22|Diallylnitrosamine (DAN)
P00910823A0196|53 62|blood gases
P00910823A0196|54 65|lood gases, pH
P00913623A0242|43 72|diphosphonate 99mTc-labeled EHDP
P00913623A0242|75 87|99mTc-labeled
P00913623A0242|134 149|passive diffusion
P00915090A0536|34 36|mCi
P00917572T0001|14 26|TSH-Screening
P00918556A0000|15 45|hepatitis B surface antigen (HBsAg)
P00918556A0000|49 56|anti-HBs
P00918556A0000|82 96|double-antibody
P00918556A0000|153 165|liver diseases
P00918965A0728|171 174|PAO2
P00920381T0000|16 23|glycogen
P00921911A0159|12 14|PGF
P00921911A0159|18 21|PGFM
P00926604A0504|0 19|Propranolol (Inderal)
P00926604A0504|53 67|beta-adrenergic
P00929418T0001|9 26|infectious-disease
P00930947A0629|78 80|PZA
P00932738A0116|11 27|blood pressure (BP)
P00932738A0116|30 35|60 mmHg
P00932738A0116|99 100|BP
P00932817A0499|44 46|MEC
P00932817A0499|87 89|MTF
P00932817A0499|124 128|99mTc
P00935526A0000|24 41|prostaglandins (PG)
P00938594A0149|89 109|osteoarthropathy (HOA)
P00938594A0149|159 171|arthritis (RA)
P00947327A0000|121 158|sulfamethoxazole (SMZ) trimethoprim (TMP)
P00947327A0000|402 404|(CN
P00947327A0000|455 461|TMP/SMZ
P00947834X0000|0 6|RESULTS
P00947834X0000|13 15|IgE
P00951909X0001|135 145|Billroth-II
P00952734T0000|89 96|(PECL)'?
P00954819A1041|128 131|AChE
P00956364A0138|54 56|MSB
P00956554A0414|45 55|solid-phase
P00956554A0414|95 97|IgE
P00959656A0250|51 53|III
P00962222A0633|102 118|progesterone phase
P00970320A0000|64 66|SO2
P00970488A0105|3 29|neuroleptic-induced increase
P00970488A0105|39 40|DA
P00970488A0105|75 84|DA receptor
P00980255T0000|16 32|2-deoxy-D-glucose
P00984209A0614|115 117|V&P
P00984209A0614|130 132|V&A
P00985276A0000|105 111|(Skylab
P00986925A0002|70 89|glucagon on plasma 47Ca
P00986925A0002|133 136|47Ca
P00988572A0000|23 40|lymph vessels (PLO2)
P00989973A0000|16 31|plasma fibrinogen
P00993176A0066|133 141|(NH4)2SO4
P00999494A0000|68 82|beta-adrenergic
P01004298A0744|34 35|CA
P01009451A0728|23 24|UB
P01009451A0728|28 30|OCS
P01009739T0001|50 52|ECG
P01019207A0232|73 78|betaI%
P01019207A0232|87 89|lgC
P01019207A0232|106 125|0.5--10 mug ruscogenin
P01021091T0000|73 121|2--phenylalanine-8-lysine vasopressin (Octapressin)
P01047417T0000|7 15|'National
P01048020T0000|10 21|"Interactive
P01048020T0000|45 53|Credit/No
P01048020T0000|62 64|A-F
P01048968A0152|108 121|beta-lactamase
P01050144A0297|114 123|83A complex
P01078982A0227|69 95|antilymphocyte globulin (ALG)
P01078982A0227|109 111|ALG
P01080374A0709|92 104|Coats' disease
P01082726A0248|44 49|DC-ERG
P01082833A0000|83 98|indomethacin (IM)
P01082833A0000|128 138|ultraviolet
P01083784T0000|1 32|ymphocyte subpopulations, serum IgE
P01084413A0271|43 45|EMI
P01087288T0000|24 34|cytogenetic
P01090210A0417|157 158|IV
P01092248T0000|34 45|pathogenesis
P01093845A0208|27 37|Delta-9-THC
P01098179A0167|155 161|release
P01098592A0567|0 2|IgG
P01101272T0000|15 29|carcinogenicity
P01101272T0000|54 55|II
P01116466A0185|112 113|II
P01116466A0185|116 120|, VIII
P01116466A0185|122 123|IX
P01119586A0337|0 7|Glycogen
P01119586A0337|50 69|reatine phosphate, ATP
P01119658A0000|177 195|lymph node metastases
P01119658A0000|203 207|1, N2A
P01119658A0000|211 213|N2B
P01125117A0183|34 35|II
P01130186A0568|47 60|insulin release
P01130531A0224|71 73|CBF
P01138330A0204|52 55|N HC1
P01138330A0204|71 74|NaC1
P01140184A0342|48 61|epoxide hydrase
P01141114A0188|56 59|mmHg
P01141114A0188|76 79|PH-v
P01141114A0188|97 105|45 Pv-CO2)
P01141114A0188|169 172|[H+]
P01148868A0284|42 55|295 +/- 49 (S.E.)
P01150658A0683|62 68|(Sairam
P01156631A0658|46 51|(+/- SD
P01156631A0658|57 62|mEq/kg
P01156631A0658|134 139|(+/- SD
P01156631A0658|145 150|mEq/kg
P01156814T0000|49 69|thromboembolic disease
P01157191A0536|77 87|carcinogens
P01158512T0000|0 39|Glucose-6-phosphate dehydrogenase (G-6-PD)
P01159822A0353|71 84|ultrastructure
P01168908A0000|0 19|Prostaglandins F (PGF)
P01168956A0552|121 141|maximum weight decrease
P01171935A0313|134 149|dopamine receptor
P01172734T0035|15 18|HL-A
P01174873T0000|51 58|268 cases
P01185956A0722|23 32|ultrasonic
P01186344A0303|136 142|release
P01191964A0000|60 74|Graves's disease
P01191964A0000|162 180|serum thyroxine (T-4)
P01193458T0001|30 32|99M
P01215067A0000|89 95|14 cases
P01215067A0000|99 124|eningitis purulenta, 17 cases
P01215067A0000|128 150|eningitis serosa, 10 cases
P01224116A0576|35 54|serum immunoglobulins
P01224116A0576|63 65|IgG
P01224116A0576|115 129|French-Canadian
P01228258A0000|13 31|preparation (OK-432)
P01228258A0000|116 126|Mitomycin-C
P01228258A0000|117 131|itomycin-C, 5-FU
P01228882A0437|63 80|CSF immunoglobulins
P01237206A0199|87 92|(Stamp
P01241437A0152|42 46|NLA II
P01241588A1470|16 19|5-HT
P01241588A1470|23 28|5-HIAA
P01241588A1470|102 107|IDPN's
P01241588A1470|137 151|5-HT-containing
P01243628A0286|44 71|blood carboxyhemoglobin (COHb)
P01245162A0262|109 120|transaminase
P01246210A0648|49 53|TBCa)
P01249198A1097|3 10|serum FT3
P01249198A1097|80 82|GTD
P01256410T0001|22 23|II
P01265887T0001|8 17|factor VIII
P01267446A0210|0 15|Biohydrogenation
P01272816A0000|102 105|47Ca
P01275541A0405|21 23|CPK
P01278251A0000|109 133|tetraphenylbutadiene (TPB)
P01279197T0000|28 41|homology region
P01279197T0000|44 55|Mason-Pfizer
P01279197T0000|74 94|saturation mutagenesis
P01279352A0297|4 10|ite, PAL
P01279352A0297|27 48|10 bp sequence GGGGAGGAGG
P01279352A0473|124 127|PROX
P01279352A0473|131 133|PAL
P01279352A1197|16 28|NF(H) promoter
P01279352A1197|110 123|promoter region
P01279352A1197|133 162|beta-galactosidase reporter gene
P01279352A1197|167 175|generated
P01279374A0396|47 61|allele-specific
P01279374A0396|118 123|PET122
P01279696A0862|24 32|[Hisanaga
P01280807A0575|18 41|MetRS/CAU operator complex
P01280807A0575|80 103|ThrRS/CGU operator complex
P01281472T0000|14 29|muscle glycogenin
P01282014A0275|19 23|DSP-4
P01284032A0213|0 1|AP
P01284032A0213|83 87|(GDOC
P01284595A0102|77 79|CpG
P01284595A0102|93 96|(HTF
P01284828T0001|0 16|Tissue plasminogen
P01285009A0000|31 52|growth hormone (hGH) gene
P01285009A0000|61 79|promoter/regulatory
P01285009A0000|90 114|mouse metallothionein (mMT)
P01285009A0000|121 140|thymidine kinase (vTK)
P01285009A0000|122 165|hymidine kinase (vTK), rat cholecystokinin (rCCK)
P01285009A0000|169 194|chicken beta-actin (cBA) gene
P01285358A0396|15 17|AFP
P01285807A0365|3 17|mean (+/- SD) PaO2
P01285807A0365|42 45|mmHg
P01285807A0365|65 68|mmHg
P01285807A0365|85 86|(P
P01285807A0365|99 103|PaCO2
P01285807A0365|139 142|mmHg
P01285807A0365|143 144|(P
P01295373A0651|47 56|baseline RL
P01295373A0651|48 67|aseline RL; mean +/- SE)
P01296815A0059|31 34|LD78
P01296815A0059|42 45|LD78
P01296815A0059|88 109|5'-truncated pseudogene
P01297332T0000|21 23|DNA
P01297332A0983|44 47|SCBs
P01297332A0983|68 88|SWI4,6-dependent genes
P01298173A0153|25 43|esions, locoregional
P01299489A0788|128 131|RDIs
P01300914A1066|191 194|ACRV
P01300914A1066|320 321|VT
P01300914A1066|448 463|amplification ECG
P01300914A1066|611 612|RV
P01301171A0979|5 10|9 cases
P01302765A0999|102 104|EEG
P01309587A0715|31 43|BMRF1 promoter
P01309593A0095|3 5|UCR
P01309593A0095|4 27|CR core sequence, CGCCATTTT
P01309593A0095|89 100|MuLV promoter
P01309593A1092|20 24|UCRBP
P01309593A1092|39 50|target motifs
P01309593A1092|73 80|UCR motif
P01309593A1092|85 115|adeno-associated virus P5 promoter
P01309593A1092|155 170|heavy-chain genes
P01309593A1092|199 210|protein genes
P01309815A0972|130 132|AEP
P01309894A0807|31 33|AAV
P01309910A0428|38 48|TAR-binding
P01309910A0428|74 78|CREB2
P01310154A0879|89 91|FBR
P01310154A0879|203 205|FBR
P01310178A0876|3 6|JS78
P01310178A0876|39 48|amber codon
P01310178A0876|91 120|30-kDa gp0.7-related polypeptide
P01310178A0876|138 159|11-kDa C-terminal domain
P01310879A0000|21 59|heparin-associated thrombocytopenia (HAT)
P01310899A0339|89 107|transmembrane domain
P01310899A0339|133 160|serine/threonine kinase domain
P01310935T0000|10 14|UbcD1
P01312005A0600|49 52|MDP1
P01312005A0600|71 80|chick mtDNA
P01312005A0600|247 254|200 bases
P01312005A0600|270 287|H-strand origin (OH)
P01313715A0461|97 100|HL60
P01313715A0461|143 154|Epstein-Barr
P01313715A0461|171 199|B-lymphocyte cell line (EBV-BCL)
P01313715A0461|212 231|p47phox-deficient CGD
P01313846A0850|63 80|immunoglobulin gene
P01313846A0850|130 145|melanoma Ag MUC-18
P01313846A0850|187 204|poliovirus receptor
P01313894A1179|54 62|LMP2B mRNA
P01313909A0526|18 21|ICP0
P01313909A0526|104 114|ICP0-coding
P01314457T0000|49 76|herpesvirus saimiri (HVS) L-DNA
P01314457T0000|50 84|erpesvirus saimiri (HVS) L-DNA: general
P01314457T0000|125 127|HVS
P01314457T0000|131 142|Epstein-Barr
P01314841A0724|13 18|MK-801
P01314841A0724|48 50|EEG
P01314953A1266|60 63|HAP2
P01314953A1266|66 69|HAP3
P01315706A0000|0 7|Myogenic
P01316125A0176|37 39|1O2
P01316125A0176|52 63|radicals (O2-
P01316125A0176|65 67|.OH
P01316125A0176|71 77|YHPD-.)
P01316125A0176|99 102|YHPD
P01316125A0176|136 138|1O2
P01316125A0176|137 143|O2, YHPD
P01316125A0176|152 155|BHPD
P01316125A0176|165 174|generating
P01316125A0176|182 184|.OH
P01316125A0176|186 189|YHPD
P01316125A0176|201 204|BHPD
P01316125A0382|54 57|YHPD
P01316125A0382|81 83|1O2
P01316125A0382|96 107|radicals (O2-
P01316125A0382|109 111|.OH
P01316125A0382|115 121|YHPD-.)
P01316125A0382|164 167|YHPD
P01316125A0382|188 191|BHPD
P01316125A0382|254 256|1O2
P01316125A0382|296 297|OH
P01316461A1083|114 126|EIAV-infected
P01316476A0842|13 16|TATA
P01316476A0842|53 55|VZV
P01316476A1428|3 10|ORF 4 gene
P01316476A1428|40 48|ORF 62 gene
P01316680A0643|17 22|IR5 ORF
P01316680A0643|25 29|EHV-1
P01316680A0643|50 76|13 amino acids (CAYWCCLGHAFAC)
P01316680A0643|101 153|consensus zinc finger motif (C-X2-4-C-X2-15-C/H-X2-4-C/H)
P01316900A0000|3 5|DNA
P01316903A0296|25 37|RNA polymerase
P01316903A0296|38 39|II
P01316903A0296|52 54|IIA
P01316903A0296|96 98|IIO
P01316903A1040|0 15|RNA polymerase IIA
P01316903A1040|97 112|RNA polymerase IIA
P01317376A0981|0 11|Fructokinase
P01317376A0981|109 125|increase in frk mRNA
P01318310A0000|41 57|affinity receptors
P01318310A0000|65 87|density lipoprotein (HDL)
P01318739A0410|47 63|teniposide (VM-26)
P01320640A0336|38 59|neuron-specific enolase
P01320640A0336|80 82|VIP
P01321277A0342|52 54|SRC
P01321277A0342|56 58|ROS
P01321277A0342|71 99|chicken embryo fibroblasts (CEF)
P01321277A0342|141 143|UR2
P01321277A0664|0 2|ROS
P01321277A0664|4 9|SRC (R)
P01321280A0494|36 41|E7 gene
P01321280A0494|61 77|BPV-1-transformed
P01321280A0494|165 169|BPV-1
P01321280A0494|175 182|E7 fusion
P01321332A0970|69 85|RXR alpha-mediated
P01321332A0970|106 114|apoAI gene
P01321332A0970|135 147|hepatoma HepG2
P01321332A0970|168 169|RA
P01321332A0970|241 245|ARP-1
P01321336A0000|3 16|enhancer region
P01321336A0000|52 72|sequence motif ACAGATGG
P01321336A0731|19 26|ALF1 cDNA
P01321337A0318|43 51|mass 16 kDa
P01321337A0318|101 106|45Ca2+
P01321337A0318|144 153|(B) subunit
P01321337A1161|26 29|MATa
P01321337A1161|45 55|utants, MATa
P01321337A1161|107 126|alpha-factor-induced
P01324172A0880|44 47|RIM1
P01324385A0329|0 6|METHODS
P01324385A0329|1 10|ETHODS: IgG
P01324385A0329|23 43|HHV-6 (anti-HHV-6-IgG)
P01324385A0329|88 94|100 IVDA
P01324385A0329|130 134|HIV-1
P01324385A0329|155 156|II
P01324385A0329|164 168|IV-C1
P01324385A0329|171 174|CDC)
P01324404A0813|1 36|position-independent activation domain
P01324404A0813|67 68|II
P01324404A0813|72 74|III
P01324404A0813|114 122|HNF-3 beta
P01324404A1208|0 8|HNF-3 beta
P01324404A1208|56 57|IV
P01324404A1208|100 101|IV
P01324404A1208|139 156|region II-III domain
P01324406A1250|15 18|RAD5
P01324406A1250|27 44|ATPase/DNA helicase
P01324406A1250|55 57|DNA
P01324639T0000|53 78|moxicillin, amoxicillin-BRL
P01325221A0870|18 22|DU249
P01325221A0870|59 84|M-phase-activated MBP kinase
P01325221A0870|104 115|p41 MAP kinase
P01325221A0870|118 132|phenyl-Superose
P01325386A0766|44 48|74-kD
P01326329A0703|3 19|319 base pair region
P01326329A0703|44 46|CAP
P01326329A0703|86 89|TATA
P01326329A0703|127 128|GC
P01326329A0703|128 139|C boxes, CACCC
P01326329A0703|129 179|boxes, CACCC boxes, CCAAT boxes, activator protein 2 (Ap-2)
P01326329A0703|193 228|glucocorticoid response elements (GREs)
P01326329A0703|204 222|oid response elements
P01326329A0703|246 270|AMP response elements (CREs)
P01327280A0000|60 61|pH
P01327280A0000|105 106|pH
P01327758A0000|19 44|papillomavirus-1 (BPV-1) DNA
P01328197A0985|27 54|MAP kinase activator/MAP kinase
P01328219A1397|0 5|NSCL-1
P01328681A0149|6 16|LTR-binding
P01328681A0149|77 88|LTR-enhanced
P01328681A0149|120 130|LTR-binding
P01328681A0149|196 197|(A
P01328854T0000|7 11|MEF-2
P01328854T0000|78 99|muscle-specific subunit
P01328854T0000|110 135|phosphoglycerate mutase gene
P01328884T0000|40 42|MHC
P01328884T0000|48 49|II
P01328884T0000|66 79|sequence motifs
P01329039A0239|45 50|CANNTG
P01329039A0239|126 129|bHLH
P01329039A0951|47 58|TnI enhancers
P01329039A0951|90 92|MCK
P01330077A0000|0 17|T-cell receptor beta
P01330077A0000|18 21|(TCR
P01330077A0000|22 30|beta) gene
P01330077A0000|89 103|leukemias (ALLs)
P01330309A1134|3 14|CANNTG motifs
P01330309A1134|30 33|MyoD
P01330309A1134|37 50|myogenin fusion
P01331057A0000|24 28|COX12
P01331057A0000|47 56|subunit VIb
P01331057A0000|82 99|cytochrome c oxidase
P01331060A0768|17 32|calcineurin A gene
P01331060A0768|73 76|cDNA
P01331086T0000|8 23|promoter elements
P01331086T0000|32 56|cytochrome c oxidase subunit
P01331086T0000|57 58|IV
P01331086T0000|90 98|ets motifs
P01331086T0000|109 120|GABP-related
P01331292A1425|77 83|a region
P01331501A0397|49 59|pRB-binding
P01331501A0397|71 73|E1A
P01331516A0103|26 28|3T6
P01332589A0666|3 6|MICs
P01332964A0247|23 33|RII beta gene
P01333035T0000|10 21|cAMP receptor
P01333035T0000|45 56|alpha subunit
P01333035T0000|74 86|RNA polymerase
P01333053A0110|22 43|steroid hydroxylase gene
P01333053A0110|107 124|eptide hormone, ACTH
P01333053A0110|138 141|cAMP
P01333125A0000|96 112|structure elements
P01333125A0000|132 142|region (UTR)
P01333317A1008|3 15|-64/-37 region
P01333317A1008|97 103|(PRF-I)
P01334428A1102|16 43|ubstrates, src-related peptide
P01334428A1102|47 54|poly(Glu
P01334428A1102|73 74|mM
P01334428A1102|102 103|mM
P01334493A0289|20 30|HGFr (sHGFr)
P01334493A0289|36 38|HGF
P01334493A0289|81 107|membrane-associated receptor
P01337142A2043|13 45|glycoprotein alpha-subunit promoter
P01337142A2043|65 67|FSK
P01337142A2043|70 72|GH4
P01337142A2043|85 99|cells.(ABSTRACT
P01337142A2043|100 108|TRUNCATED
P01337142A2043|105 106|AT
P01337142A2043|111 119|400 WORDS)
P01339373T0000|77 93|SNF1 protein kinase
P01339391A0000|29 39|55-kb region
P01339391A0000|42 60|DNA surrounding HRAS1
P01339468A0272|3 6|ORF1
P01339468A0272|55 77|potexvirus RNA replicases
P01339468A0272|56 82|otexvirus RNA replicases; ORF2
P01339773A0778|116 136|ventilation-perfusion
P01339815A1545|27 33|peak VO2
P01340470A0000|2 23|RNA-binding protein gene
P01340470A0000|67 85|RNA recognition motif
P01340470A0000|91 97|Arg-Ser
P01340470A0000|102 111|(RS) domain
P01346262A0377|28 68|rotein profiles of wild-type S. entomophila UC9
P01346262A0377|78 81|UC21
P01346262A0377|124 129|44-kDa
P01346262A0377|168 173|20-kDa
P01347664A1026|50 56|CAD mRNA
P01347908T0000|62 79|Parkinson's disease
P01347944A0964|37 47|homeodomain
P01347944A0964|59 60|II
P01348504A0757|8 30|pol alpha-primase complex
P01348508A0313|153 160|TGM1 gene
P01348590A0000|34 40|35 cases
P01348590A0000|75 90|2017 HIV-infected
P01348590A0000|110 120|HIV-disease
P01348590A0000|125 127|CD4
P01349837T0000|0 3|cDNA
P01349837T0000|60 74|chaperonin HSP60
P01350780A0184|87 107|gamma-glutamyl kinases
P01350932A1123|59 92|N-glycosylation sequon -Asn-Cys-Ser-
P01352113A0002|52 56|(NO)2
P01352113A0231|62 64|NO2
P01352113A0231|98 110|00 ppm, 1 ppm NO2
P01352113A0231|116 124|mg m-3 NO2)
P01353478T0000|13 17|H-2Eb
P01353478T0000|24 26|IAP
P01353478T0000|47 52|A20/2J
P01354506T0000|67 78|cytogenetics
P01357190A0726|38 57|membrane anchor domain
P01357190A0726|119 129|CD4-bearing
P01357528A0084|63 68|SEF-17
P01358190A0654|17 23|DR1 beta
P01358190A0654|33 40|H-2E beta
P01358190A0654|63 78|ecognition; alpha
P01358758A0000|21 49|rat insulin I gene 5'-flanking DNA
P01358758A0000|61 76|sequence elements
P01358758A0000|87 98|FLAT elements
P01358758A0000|148 166|a beta-cell-specific
P01358880A0251|65 80|transglutaminase
P01359588A0375|62 80|neuron-like elements
P01360180A0513|59 73|wild-type kinase
P01360180A0513|124 129|kinase
P01360180A0513|150 151|II
P01360180A1568|82 86|dsRNA
P01360180A1568|109 121|dsRNA-binding
P01360180A1568|135 146|reporter gene
P01360180A1568|176 178|RNA
P01360294A0000|116 118|III
P01360294A0000|119 121|(AT
P01360294A0000|122 125|III)
P01363080A0710|143 151|anhydrase
P01363166T0001|17 26|H2 receptor
P01370281A0461|51 56|39-kDa
P01371181A0688|26 29|pLS1
P01371181A0688|36 41|(pE194
P01371181A0688|43 49|pADB201
P01371181A0688|54 58|pLB4)
P01371272A1167|14 17|dNTP
P01371272A1167|72 94|yeast DNA polymerase alpha
P01371275T0000|27 29|"B"
P01371275T0000|50 60|H(+)-ATPase
P01371413A0742|14 23|hGCSFR gene
P01371413A0742|104 125|rodent-human hybrid DNAs
P01371413A0742|146 149|cDNA
P01371863A0000|31 58|differentially-regulated gene
P01372365A1202|7 13|ites, %T
P01372365A1202|70 76|sites %T
P01372456A0426|22 31|TA infusion
P01372802A1481|107 111|C3(D)
P01372802A1481|191 201|fluid-phase
P01372802A1481|272 276|C3(D)
P01372900A1017|54 62|goat alpha
P01372900A1017|101 110|polymerase
P01373374A0735|52 61|G-box motif
P01373374A0735|67 70|GBF1
P01373374A0735|74 77|GBF3
P01374331A0636|62 69|nuclease
P01374392A0341|23 27|NHE-3
P01374392A0341|49 53|NHE-1
P01374392A0341|57 61|NHE-2
P01374398A0951|40 43|cDNA
P01374398A0951|52 54|kDa
P01375224A0152|41 45|v-Crk
P01375913A0484|32 34|DNA
P01375913A0484|53 64|U14 snRNA gene
P01375913A0484|94 116|T7 RNA polymerase promoter
P01376319T0000|7 16|pseudogene
P01376319T0000|22 68|mouse cation-dependent mannose 6-phosphate receptor
P01377818A0468|3 19|ddition, C/EBP beta
P01377818A0468|23 27|C/EBP
P01377818A0468|79 88|C/EBP alpha
P01377962A1012|3 21|ontrast, tobacco GS-2
P01378052A0594|7 10|acoR
P01378052A0594|14 20|acoXABC
P01378052A0594|68 84|symmetry [CAC-(N11
P01378052A0594|87 94|N18)-GTG
P01378052A0594|98 105|TGT-(N10
P01378052A0594|108 116|N14)-ACA]
P01378052A0594|153 156|NtrC
P01378052A0594|160 163|NifA
P01378431A0202|3 18|Sun, J., Hsu, M.-Y.
P01378431A0202|4 34|un, J., Hsu, M.-Y., Vallejo-Ramirez
P01378506A0884|55 66|virus release
P01378506A0884|82 83|NC
P01378526A0535|29 33|FK506
P01380062A0097|20 35|H-2Db-restricted
P01380062A0097|45 60|T lymphocyte (CTL)
P01380062A0097|97 99|CTL
P01380076A0165|18 31|reversed-phase
P01380454A0451|43 51|ref-1 gene
P01380454A0451|65 67|DNA
P01380454A0451|85 91|Fos-Jun
P01380454A0451|86 111|os-Jun heterodimers, Jun-Jun
P01380454A0451|125 136|Hela cell AP-1
P01380454A0451|200 207|NF-kappa
P01380454A0451|228 235|ATF/CREB
P01380825A0622|42 56|5-kilobase mRNAs
P01380825A0622|75 78|cDNA
P01383690A1023|3 14|ARG SH2 domain
P01383690A1023|49 51|BCR
P01383690A1023|105 116|ABL SH2 domain
P01383695A0100|12 14|EBV
P01383695A0100|79 81|IgM
P01384040A1043|110 123|wild-type pCF10
P01384165A0000|82 93|regeneration
P01384229A0175|44 53|chicken ICS
P01384229A0175|105 113|BF-IV gene
P01384229A0175|167 182|herpes TK promoter
P01384229A0175|197 246|chloramphenicol acetyl transferase (CAT) gene (pBLCAT2)
P01386210A0293|100 102|GM2
P01386897A0000|31 46|cell cycle (Start)
P01386897A0000|65 75|CDC28 kinase
P01386897A0000|121 124|CLN1
P01386897A0000|128 131|CLN2
P01387105A0933|29 31|DNA
P01387105A0933|48 54|cogenic
P01388160A1102|68 81|epsilon peptide
P01389573A1071|0 3|TBPf
P01389573A1071|62 76|easurement: TBPf
P01389573A1071|78 80|(P1
P01389573A1071|81 88|- P2)/(A1
P01391001A0583|67 69|ATB
P01392277A0000|113 115|KOK
P01392277A0000|162 166|[DIN]
P01394200A0592|124 140|subset markers CD25
P01394200A0592|153 162|2 receptor)
P01394200A0592|166 180|CD45RO (T-memory
P01394655A0615b|0 5|Urease
P01394655A0615b|88 91|(S/N
P01394655A0615b|101 118|Jack bean meal urease
P01396444A0934|72 73|AM
P01396572A0320|21 32|plasmid pUC19
P01396572A0320|74 89|plasmid pUC19(CG)
P01396572A0320|106 113|(dG-dC)7
P01396583A0204|1 4|cDNA
P01396583A0204|42 66|interleukin 2 gene-specific
P01396592A1113|28 34|SCL gene
P01396592A1113|62 86|transcription factor GATA-1
P01396592A1113|97 103|SCL gene
P01398068A0948|45 67|his273 mutant p53 proteins
P01398068A0948|98 103|RGC DNA
P01398071A0526|77 80|BRF1
P01398071A0526|130 143|RNA polymerases
P01398071A0526|146 147|II
P01398071A0526|152 154|III
P01398073A0986|42 53|multisubunit
P01398073A0986|54 58|TFIID
P01398073A0986|109 125|activation domains
P01398073A0986|133 150|a TATA-less promoter
P01398074A0697|30 46|340-nucleotide RNA
P01398074A0697|54 61|yeast RNA
P01398074A0697|75 82|RNase MRP
P01398074A1081|3 17|RNase MRP RNA gene
P01398074A1081|127 134|RNase MRP
P01398098A0770|0 11|Clone pSRc200
P01398098A0770|28 31|mRNA
P01398098A0770|67 83|38-kDa polypeptide
P01398104A0834|10 21|esults, CBF-A
P01398104A0834|30 33|CArG
P01398104A0834|31 44|ArG box-, ssDNA-
P01398104A0834|48 58|RNA-binding
P01398106A0754|13 40|intron-encoded enzyme (I-CreI)
P01398106A0754|88 95|3'-exon)
P01398106A0754|183 187|3'-OH
P01398140A0488|16 28|Xenopus U7 gene
P01398140A0488|48 68|octamer-binding motifs
P01398140A0488|104 106|PSE
P01399206A0375|35 45|collagenase
P01400217T0000|29 61|IncP alpha plasmid transfer genes traF
P01400217T0000|65 68|traG
P01400217T0000|85 88|traF
P01400396A1265|109 126|protein kinase C beta
P01400401A0065|13 24|AMP deaminase
P01400401A0854|25 39|anti-E-specific
P01400401A0854|128 136|AMPD3 cDNA
P01400775A0435|27 36|endogenous
P01402647A0114|0 2|DR1
P01403222A0391|101 111|transfusion
P01404401A0740|9 14|ATPase
P01404401A0740|85 99|chloroplast gene
P01404612A0303|53 55|HIV
P01406630A0545|126 136|DNA-protein
P01406630A0545|165 167|DNA
P01406630A0965|18 40|p65-selected kappa B motif
P01406630A0965|152 167|NF-kappa B complex
P01406656A1075|39 48|mouse alpha
P01406656A1075|49 52|1(I)
P01406656A1075|85 98|3'-flanking DNA
P01406656A1075|154 162|oncogenic
P01406677A0000|23 37|control elements
P01406677A0000|87 99|myoglobin gene
P01406677A0000|231 244|luciferase gene
P01406688A0898|34 44|rap1t allele
P01406703A1435|12 21|Y1 cell cDNA
P01406703A1435|36 52|DNA-binding region
P01406703A1435|58 65|H-2RIIBP
P01406703A1435|73 91|hormone receptor cDNA
P01406703A1435|88 91|cDNA
P01406703A1435|136 148|steroidogenic
P01407286A0427|146 164|tyrosine hydroxylase
P01408090A0572|17 19|TEE
P01408137A0974|32 34|G+C
P01408137A0974|102 105|mRNA
P01408137A0974|115 118|G+C)
P01408219A0670|32 42|generalized
P01408219A0670|43 63|lymph-adenopathy (PGL)
P01408474A0531|0 3|PaO2
P01409581A0206|45 77|myeloid/B-cell-specific factor PU.1
P01409643A0618|77 109|immunodeficiency virus 1 TATA element
P01409643A0618|184 189|123 kDa
P01409643A0618|205 215|TATA element
P01409643A0618|226 236|factor (TMF)
P01413984A0737|27 31|n-3 FA
P01413984A0737|30 170| FA supplementation on total cholesterol, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C, glucose, fibrinogen, factor VIII, antithrombin III, plasminogen
P01413984A0737|47 142|on total cholesterol, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C, glucose, fibrinogen, factor VIII
P01413984A0737|55 68|holesterol, HDL
P01413984A0737|56 83|olesterol, HDL cholesterol, LDL
P01413984A0737|59 112|sterol, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C
P01413984A0737|61 131|erol, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C, glucose, fibrinogen
P01413984A0737|62 142|rol, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C, glucose, fibrinogen, factor VIII
P01413984A0737|64 170|l, HDL cholesterol, LDL cholesterol, apo A1, Lp(a), HbA1C, glucose, fibrinogen, factor VIII, antithrombin III, plasminogen
P01414219A0319|55 57|AUC
P01414219A0319|112 114|OXC
P01414219A0319|149 151|ERY
P01418272A1072|5 10|5 ng/mL
P01418272A1072|39 41|CEA
P01418542A0000|11 41|sodium 18 beta-glycyrrhetate (SGA)
P01418834A0987|12 29|hematocrit decrease
P01420177A1065|81 94|protein kinases
P01420363T0000|13 15|AP1
P01420363T0000|19 22|PEA3
P01420363T0000|75 102|metalloproteinases-1 (TIMP-1)
P01420363A0818|3 18|TIMP(-59/ -53)AP1
P01420363A0818|51 64|c-Fos/c-Jun AP1
P01420363A0818|127 129|AP1
P01420363A0818|142 153|consensus TRE
P01420363A0818|207 218|consensus TRE
P01420579A0292|5 33|serum neutralizing (SN) antibody
P01420579A0292|84 93|SN antibody
P01421145A1190|79 84|PCAT-1
P01421609A1067|24 27|DMVA
P01421609A1067|64 66|CPB
P01422265A0263|3 5|IgG
P01422265A0263|32 45|coeliac disease
P01422265A0263|84 88|(IgG1
P01422265A0263|102 105|IgG2
P01422265A0263|107 110|IgG3
P01422265A0263|112 116|IgG4)
P01423454A0309|13 16|ANCA
P01425921A1286|130 158|complementary-determing region
P01425921A1286|161 164|V1J1
P01426635A0496|18 22|ZFH-2
P01426635A0496|34 36|CNS
P01426635A0496|63 65|DDC
P01427034A0440|42 53|protein genes
P01427034A0440|90 97|S13 genes
P01427034A0440|120 122|DNA
P01427457A0000|75 78|(SC)
P01427457A0000|127 130|(IV)
P01427457A0000|168 191|deep-vein thrombosis (DVT)
P01429596A1669|88 130|18K agglutination-aggregation factor (18K-LAF)
P01429624A0328|97 111|adenylylcyclase
P01429724A0664|67 79|Ile59-->Phe96
P01429724A0664|83 97|Gly451-->Leu455
P01429740A1065|56 75|lipoyl-bearing domain
P01429740A1065|105 106|IV
P01429740A1065|122 127|E2 gene
P01429836A1205|34 50|GTP-binding domain
P01431380A0244|140 176|anti-SF group rickettsiae (SFGR) antibody
P01431380A0244|296 299|JSFR
P01431380A0244|369 372|SFGR
P01431602A0229|86 108|100-500 microliters HClO4
P01431809T0000|49 62|polyhedrin gene
P01433502A1163|121 137|enhancer-specific
P01433524A0788|51 53|IE1
P01433524A0788|81 91|DNA-binding
P01435698A0000|43 52|autogenous
P01435698A0000|53 66|vein graft (AVG)
P01435698A0000|77 94|prostacyclin (PGI2)
P01437562A0462|0 7|Anti-CRK
P01437562A0462|25 29|53kDa
P01438224A0749|48 49|[J
P01443047A0773|79 84|Id-SCL
P01446828A1088|13 16|ADH5
P01446828A1088|79 92|oteins, Sp1, AP2
P01446828A1088|80 98|teins, Sp1, AP2, LF-A1
P01446828A1088|81 103|eins, Sp1, AP2, LF-A1, NF-1
P01446828A1088|82 109|ins, Sp1, AP2, LF-A1, NF-1, NF-A2
P01446828A1088|114 118|NF-E1
P01447189T0000|30 43|serine protease
P01447189T0000|31 53|erine protease, RNK-Met-1
P01447189A1546|21 29|RNK-Met-1
P01447189A1546|33 46|serine protease
P01448107A0361|24 27|GCN2
P01448107A0361|61 64|GCN4
P01448917A0775|81 87|CPMV RNA
P01448917A0775|123 142|clover mottle virus RNA
P01448917A0775|135 142|virus RNA
P01448917A0775|155 159|CPSMV
P01448917A0775|200 220|roteins: 32K proteinase
P01448917A0775|201 232|oteins: 32K proteinase cofactor, 58K
P01448917A0775|241 248|helicase
P01448917A0775|242 252|elicase, VPg
P01448917A0775|281 284|RNAs
P01448917A0775|282 298|NAs, 24K proteinase
P01448917A0775|303 305|87K
P01448917A0775|314 323|polymerase
P01450815A0337|29 32|IPRK
P01450815A0337|69 71|RPF
P01450815A0337|75 77|GFR
P01451771A0619|95 117|components analysis (PCA)
P01451771A0619|137 156|scaling analysis (MDS)
P01452037A0000|26 71|glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
P01452037A0000|27 101|lyceraldehyde-3-phosphate dehydrogenase (GAPDH), 3-phosphoglycerate kinase (PGK)
P01452037A0000|124 152|triosephosphate isomerase (TIM)
P01452037A0000|167 190|Bacillus megaterium DSM319
P01452037A0000|223 229|operon)
P01452703A0782|36 55|fluorescent-antibody
P01452703A0782|120 129|elementary
P01452703A0782|151 155|ELISA
P01452703A0782|181 193|600 elementary
P01454518A0336|191 199|ERCC3 cDNA
P01454819A0000|0 20|Mono-ADP-ribosylation
P01454819A0000|61 95|NAD:arginine ADP-ribosyltransferases
P01454819A0000|96 98|(EC
P01454819A0000|111 139|ADP-ribosylarginine hydrolases
P01454819A0000|140 142|(EC
P01454819A0000|186 201|ADP-ribosylation
P01456888A0074|58 62|HIV-1
P01457380A0000|3 20|tramtrack (ttk) gene
P01457380A0000|40 45|69-kDa
P01457380A0000|49 54|88-kDa
P01457695T0000b|45 58|hemofiltration
P01457695T0000a|45 58|hemofiltration
P01458170A0155|115 117|EEG
P01459447A0484|36 51|full-length genes
P01459451A0478|0 17|GAL4-VP16-mediated
P01459885A0705|103 111|a decrease
P01459921A0000|191 196|(C18:2
P01460054A0478|9 13|ICSBP
P01460054A0478|71 73|ICS
P01460054A0478|105 120|DNA binding domain
P01460054A0968|10 14|ICSBP
P01460054A0968|76 93|IFN-inducible genes
P01464329T0000|61 68|prophase
P01464606A0344|19 28|alpha 5 beta
P01464606A0344|161 164|EDTA
P01467828A0542|42 51|endogenous
P01467828A0542|52 65|opioid peptides
P01467828A0542|112 122|reperfusion
P01468625A0282|9 19|ibrary, LEU2
P01468625A0282|23 31|HIS3 cDNAs
P01468625A0282|84 90|13 cases
P01468625A1080|11 14|ACT1
P01468625A1080|39 42|NSR1
P01469042A0355|5 14|CENP-B gene
P01469042A0355|47 52|CENP-B
P01469042A0355|72 98|mouse centromere satellite DNA
P01469042A0355|120 147|sequence-specific DNA-protein
P01469047A1606|27 36|tail domain
P01469047A1606|140 156|acid decarboxylase
P01471602A0362|72 129|cids, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
P01474990A0000|9 18|lone, pTt21
P01474990A0000|30 32|DNA
P01474990A0000|172 187|epimastigote cDNA
P01476376T0000|24 29|urease
P01476376T0000|52 59|pH-meter
P01477021A0394|0 6|RESULTS
P01477021A0394|13 15|AGA
P01477021A0394|42 55|serum prolactin
P01477021A0394|104 105|(P
P01478672A0795|37 53|alpha satellite DNA
P01480183A0000|3 19|5'-flanking region
P01480183A0000|30 44|lactoferrin gene
P01480183A1689|37 44|estrogen
P01480183A1689|64 78|lactoferrin gene
P01480470A0323|0 5|BiP670
P01482912A0617|3 5|CEM
P01482912A0617|38 47|HL7 message
P01482912A0617|102 119|relational database
P01483755A0000|8 33|resonance spectroscopy (MRS)
P01483755A0000|37 48|imaging (MRI)
P01483771A1335|22 23|NA
P01485648A0000|46 61|est, Pharmacia CAP
P01485648A0000|68 77|(Pharmacia
P01485648A0000|78 90|Diagnostics AB
P01485648A0000|139 158|allergen-specific IgE
P01485648A0000|185 188|RAST
P01486836A0774|17 19|VPA
P01487144A0505|38 47|mu m poly(A)
P01493864A0619|37 42|6-OHDA
P01493864A0619|75 83|GBR-12909
P01495069A0392|0 3|DIBA
P01495069A0392|92 95|DFAT
P01497582A0593|86 94|pathogens
P01498607A0000|37 39|IV)
P01498607A0000|79 109|parsley chalcone synthase promoter
P01499213A0185|141 145|L2-L3
P01502157A0000|0 4|ME1a1
P01502157A0000|61 65|c-MYC
P01504178T0000|40 62|untry: visionary, complex
P01504853A0299|0 8|Exogenous
P01504853A0299|9 12|LHRH
P01505488A0231|41 43|EVL
P01506705A0282|6 8|V-A
P01509798A0520|2 8|rest AFF
P01509798A0520|33 34|UT
P01509798A0520|52 53|AT
P01509798A0520|62 64|UEA
P01512259A0867|61 73|cysteine motif
P01512654A0503|61 62|ES
P01512654A0503|73 75|KLH
P01512654A0503|91 92|ES
P01512941A0000|57 61|(LVFX
P01512941A0000|63 70|DR-3355)
P01512941A0000|116 134|ciprofloxacin (CPFX)
P01512941A0000|117 150|iprofloxacin (CPFX), ofloxacin (OFLX)
P01512941A0000|154 170|norfloxacin (NFLX)
P01513114A1133|48 51|(SPK
P01513114A1133|56 58|KTA
P01513114A1133|62 76|mg/d).(ABSTRACT
P01513114A1133|77 85|TRUNCATED
P01513114A1133|82 83|AT
P01513114A1133|88 96|250 WORDS)
P01513213A0231|74 76|HIP
P01513213A0231|128 130|HIP
P01516829A0113|23 26|SNF2
P01516829A0113|24 31|NF2, SNF5
P01516829A0113|36 39|SNF6
P01516829A0460|10 18|LexA-GAL4
P01516829A0460|22 38|LexA-Bicoid fusion
P01516829A0460|65 68|SNF2
P01516829A0460|66 73|NF2, SNF5
P01516829A0460|78 81|SNF6
P01516829A0460|97 107|target genes
P01516829A0460|131 134|lexA
P01518833A0397|1 14|lambda gt10 cDNA
P01518833A0397|40 50|poly(A)+ RNA
P01518849A0165|0 1|NE
P01518849A0165|5 7|PR3
P01518849A0165|150 184|alpha 1-proteinase inhibitor complexes
P01518849A0165|188 202|elastin peptides
P01518926T0000|25 45|ultrasonography--1992
P01524549A0241|4 5|GH
P01524549A0241|114 115|GH
P01524549A0241|152 153|GH
P01525153A0359|3 19|ontrast, d(T2AG3T)
P01525153A0359|23 30|d(T2G4T)
P01525153A0359|42 60|G-quadruplex monomer
P01525153A0359|124 127|[Sen
P01526658A0454|0 8|IFI 16 mRNA
P01527020A0511|0 10|Exon-intron
P01527020A0511|33 59|rat AdoMet decarboxylase genes
P01527020A0511|140 146|rat gene
P01529530T0000|0 27|Interferon-alpha-induced gene
P01529530T0000|92 116|ISGF3 transcription complex
P01531086A0127|3 6|cDNA
P01531086A0127|61 66|97-kDa
P01531214A0885|9 12|LD50
P01531214A0885|21 26|RP-170
P01531632A0000|76 107|teins, nucleolin, fibrillarin, SSB1
P01531632A0000|111 114|NSR1
P01531632A0000|149 157|GAR domain
P01532229A1264|51 63|factor (HF-1a)
P01532229A1264|67 92|a muscle factor (HF-1b/MEF-2)
P01532796A0107|78 89|beta subunits
P01532796A0107|136 144|(Ackerman
P01533760T0000|0 7|Estrogen
P01535242A0557|9 18|FDC-P1/MAC
P01535242A0557|36 40|M-CSF
P01535242A0557|43 48|GM-CSF
P01535242A0557|80 88|c-fms mRNA
P01536153A0574|195 197|IgE
P01536575A1213|152 180|cytochrome P450IA1 gene (CYPIA1)
P01537334A0507|15 19|TRP-2
P01537845A0571|51 59|c-myb gene
P01537845A0571|75 78|mRNA
P01538401A1244|59 67|5 S RNA gene
P01538401A1244|158 160|DNA
P01538403A1058|28 31|eUSF
P01538403A1058|35 70|TFIID-depleted transcription complexes
P01538403A1058|121 125|TFIID
P01538403A1058|133 136|eUSF
P01538403A1058|182 193|on H5 promoter
P01538403A1058|213 220|TATA-box
P01541577A0000|82 92|Scale (SHCS)
P01542565T0000|128 131|cDNA
P01542565A0220|59 71|protein L7/L12
P01542667A0125|15 23|IFN-gamma
P01542667A0125|53 60|intronic
P01542667A0125|61 75|enhancer element
P01542667A0125|156 177|IFN-gamma-encoding gene
P01542686A0000|21 31|polypeptide
P01542686A0000|62 84|p75 nucleoprotein complex
P01542686A0000|114 131|65-kDa (p65) subunit
P01542686A0000|134 141|NF-kappa
P01542730A1982|99 100|AV
P01542730A1982|109 111|DDD
P01542730A1982|172 202|rate-adaptive dual-chamber (DDDR)
P01542730A1982|247 264|patients.(ABSTRACT
P01542730A1982|265 273|TRUNCATED
P01542730A1982|270 271|AT
P01542730A1982|276 284|250 WORDS)
P01543909A0787|144 153|pseudogene
P01543909A0787|201 215|ferritin subunit
P01544854A0699|29 37|WR-168643
P01544854A0699|62 64|DMF
P01544918A1240|23 31|R subunits
P01544918A1240|39 50|8-azido-cAMP
P01544918A1240|143 205|sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
P01544918A1240|230 236|RII beta
P01544918A1240|240 243|kDa)
P01544918A1240|255 262|RII alpha
P01544918A1240|256 262|II alpha
P01544918A1240|279 282|kDa)
P01544928A1252|22 24|DNA
P01544928A1252|59 63|mRNAs
P01544928A1252|136 143|pre-mRNA
P01545787A0345|72 76|DNase
P01545787A0345|79 94|ootprints, NFAT-1
P01545787A0345|98 104|NFIL-2B
P01545792A0000|10 46|myosin light chain-2 (MLC-2) gene promoter
P01545792A0492|0 18|Deletion mutagenesis
P01545792A0492|87 95|MLC-2 gene
P01545797A0587|43 50|SLK1 gene
P01545806T0000|49 72|recombination genes REC102
P01545806T0000|76 86|REC107/MER2
P01545818A0696|48 56|complexed
P01545818A0696|57 64|v-Src SH2
P01545818A0696|90 94|v-Src
P01545818A0696|159 172|v-Src SH2 domain
P01546522A0000|29 52|leukoencephalopathy (PML)
P01546522A0000|161 173|non-Hodgkin's
P01547775A1024|122 124|RNA
P01547775A1024|150 162|PLRV replicase
P01547775A1024|168 178|ORF2a/ORF2b
P01547942A0120|1 25|32P-labeled LAP DNA-binding
P01547942A0120|29 46|dimerization domain
P01547942A0120|97 112|C/EBP-homologous
P01547942A0120|98 127|/EBP-homologous protein: CHOP-10
P01547957A1083|6 15|degenerate
P01547957A1083|143 146|CYP1
P01547957A1083|150 153|CYP2
P01547957A1083|185 200|CYP3-specific DNA
P01547957A1083|212 220|generated
P01547957A1083|226 253|polymerase chain reaction (PCR)
P01547957A1083|259 262|GL81
P01547957A1083|270 272|DNA
P01548756A1102|24 28|EHS-1
P01548756A1102|49 51|DNA
P01548756A1102|72 76|EHS-1
P01548756A1102|94 96|DNA
P01548756A1102|122 134|chimpanzee DNA
P01548756A1102|153 167|rhesus monkey DNA
P01548891A0635|131 132|(P
P01549118A0000|3 40|Caenorhabditis elegans vitellogenin genes
P01549123A0480|3 10|MET4 gene
P01549123A0480|86 89|bZIP
P01549125A0140|36 46|nsulin, IAPP
P01549125A0140|51 65|beta GK promoters
P01549125A0140|106 108|DNA
P01549346A0000|3 9|c-Ets-1
P01549346A0000|69 71|DNA
P01551176A0000|0 7|GR63178A
P01551568A1476|61 64|rpoB
P01551568A1476|79 87|Rif domain
P01551898A1084|116 125|LAPP/liter
P01551910A0313|69 79|DNA-protein
P01551910A0978|4 11|DNA motif
P01552052A0139|0 8|OBJECTIVE
P01552457T0000|52 69|controlled-release
P01552457T0000|86 101|ofloxacin (PT-01)
P01552662A0398|15 27|blood flow (BF)
P01552662A0398|70 80|artery (LAD)
P01552853A1377|19 22|virF
P01554334A0000|20 46|gamma-interferon (IFN-gamma)
P01555556A0565|62 64|(SD
P01556068A0000|3 29|Klebsiella aerogenes gene maoA
P01556068A0000|62 77|monoamine oxidase
P01557411A1282|13 19|D1A gene
P01557411A1282|80 105|housekeeping-type promoters
P01559209T0000|0 12|Preceptorship
P01559209T0000|15 17|CNS
P01560021A0379|63 70|brain AE3
P01560021A0379|109 115|rat gene
P01560774A0885|60 67|fliA gene
P01562659A0676|198 200|CNS
P01562659A0676|307 309|CNS
P01563343A0548|55 65|CAB promoter
P01563635T0000|48 71|M.HinfI methyltransferase
P01565093A0179|69 89|blood lead levels (BLLs)
P01565093A0179|195 212|Public Health (ADPH)
P01565882A0737|49 50|RD
P01565882A0737|54 56|ReI
P01565882A0737|119 120|RD
P01565882A0737|140 142|ReI
P01565882A0737|220 222|(Ia
P01565882A0737|238 240|(Ib
P01565882A0737|251 252|RD
P01566576A0605|1 7|eck, C.J
P01568960A1129|126 136|VA/Q regions
P01569015A0120|14 20|"FRAME"
P01569015A0120|53 71|reading frames (ORFs)
P01569102A0708|6 7|II
P01569102A0708|31 41|LDL receptor
P01569344A0404|7 21|ities, HTLV-I/II
P01569344A0404|85 105|sex-adjusted HTLV-I/II
P01569344A0404|157 158|(P
P01569581A0482|38 41|mRNA
P01569581A0482|92 101|start codon
P01569581A0482|104 106|21K
P01569581A0482|132 161|21K translation initiation region
P01569584A0672|29 33|6F6.2
P01569584A0672|73 80|m6F6 cDNA
P01569584A0672|93 97|6F6.1
P01569584A0672|101 105|6F6.3
P01569584A0672|113 117|6F6.2
P01569584A0672|132 146|alpha-type genes
P01569945A0529|3 10|SEN1 gene
P01569945A0529|93 103|ass, 239 kDa)
P01572549A0000|0 27|Protein tyrosine kinases (PTKs)
P01572549A0000|120 128|oncogenes
P01572549A0000|168 188|growth factor receptors
P01573270A0000|3 8|IA4 mAb
P01573270A0000|54 59|BALB/c
P01573270A0000|88 91|a HLA
P01573270A0000|89 156| HLA class I-deficient, lymphokine-activated killer (LAK)-susceptible EBV-B
P01577740A1111|29 38|S1 nuclease
P01577819A0709|10 29|PRP-precursor alleles
P01579472A1018|16 30|enhancer element
P01581409A0398|45 56|Pharmacia CAP
P01581409A0398|69 78|DPC AlaSTAT
P01581577A1186|0 4|PSI-G
P01581577A1186|8 12|PSI-K
P01581965A0388|85 111|breakpoint cluster region gene
P01581965A0388|134 139|rho GAP
P01581965A0388|182 184|GAP
P01581965A0388|200 206|GTPases
P01582413A0192|0 23|Site-directed mutagenesis
P01582413A0192|132 134|HLH
P01582413A0192|156 175|sequence-specific DNA
P01582413A0192|186 207|hetero-oligomerization
P01582413A0759|47 50|bHLH
P01582413A0759|91 93|DNA
P01582413A0759|141 143|DNA
P01583819A0377|0 2|SEA
P01583819A0377|40 47|25-250 HZ
P01584812T0000|89 124|zinc-finger transcription factor NGFI-C
P01585014A0000|78 91|micrograms GnRH
P01585014A0000|344 349|400 I.U
P01585014A0000|359 386|mare serum gonadotrophin (PMSG)
P01585014A0000|390 426|12 mg follicle stimulating hormone (FSH-P)
P01587267A1144|153 176|site-directed mutagenesis
P01588270A1029|103 106|mmHg
P01588270A1029|107 108|(P
P01588270A1029|124 127|DBP)
P01588315A0356|0 5|AgMNPV
P01588315A0356|9 39|Orgyia pseudotsugata MNPV (OpMNPV)
P01588315A0356|111 124|polyhedrin gene
P01588913A0000|1 14|gene homologous
P01588913A0000|35 42|dnaA gene
P01588961A0000|0 3|STP1
P01588961A0000|19 27|yeast gene
P01588961A0000|110 137|sequence-containing pre-tRNAs
P01588965A0000|0 7|GCR1 gene
P01594554A0845|41 43|CCK
P01596007A0908|40 41|II
P01596007A0908|46 48|REM
P01596007A0908|83 89|gamma OH
P01596007A0908|187 189|SWS
P01596007A0908|194 210|gamma OH.(ABSTRACT
P01596007A0908|211 219|TRUNCATED
P01596007A0908|216 217|AT
P01596007A0908|222 230|250 WORDS)
P01597170A0000|45 49|CoCl2
P01597170A0000|73 80|Cr(NO3)3
P01597462A0457|26 30|CDC14
P01601181A0842|3 5|60A
P01601869A1389|19 35|5'-flanking region
P01601869A1389|82 111|mammalian-specific 352-bp region
P01601869A1389|175 179|BC3H1
P01603088A1121|24 46|baculovirus-expressed TR
P01603088A1121|96 112|promoter-specific
P01605038T0001|53 56|GABA
P01607223A0000|45 51|release
P01607223A0000|96 102|release
P01611699A0000|64 89|Albizzia julibrissin DURAZZ.
P01612085A0624|3 26|serum erythropoietin (EPO)
P01615493A0408|3 4|HC
P01615493A0408|5 6|II
P01615493A0975|36 37|HC
P01615493A0975|38 39|II
P01616475A0756|42 45|NFPD
P01616475A0756|48 53|CP/NCA
P01617242T0000|0 2|FDA
P01617801A0088|0 5|DESIGN
P01618027A1108|81 89|generated
P01619114A0383|35 38|SMSP
P01619114A0383|67 90|Mini Speech Processor (MSP)
P01620129A0417|40 51|factor HiNF-D
P01620129A0417|71 85|promoter element
P01620129A0417|91 102|H4-FO108 gene
P01620129A0417|143 144|(J
P01620610A1070|31 44|TI region-based
P01620610A1070|141 158|periShine-Dalgarno
P01620610A1070|185 196|MTI subregion
P01620781A0611|89 114|A1----B2----A3----B4----A5
P01621584A0183|0 5|UF-021
P01621584A0183|83 99|dose-dependent IOP
P01621584A0183|118 122|mmHg)
P01621584A0183|140 142|IOP
P01623900A0670|314 315|dF
P01624425A0907|21 29|azido-ATP
P01624425A0907|102 110|azido-ATP
P01626430A1112|20 24|RAD16
P01626430A1112|21 30|AD16, RAD54
P01626430A1112|34 37|SNF2
P01626430A1112|95 109|Drosophila genes
P01627828A0475|37 44|mouse DNA
P01627828A0475|49 51|SmN
P01627828A0475|102 111|pseudogene
P01627828A0475|139 162|intron-containing SmN gene
P01627830A0000|3 7|cDNAs
P01627830A0000|51 59|yeast cDNA
P01627830A0000|76 79|CKI1
P01627830A0000|83 86|CKI2
P01628806A1347|44 46|ORF
P01628806A1347|76 78|ORF
P01628806A1347|99 112|helicase region
P01628904A0386|41 49|2 kilobase
P01629768A0131|53 55|SOC
P01630454A0635|1 22|38-bp poly(dA-dT) region
P01630454A0635|55 66|Act1 promoter
P01630455A0448|27 36|NFIL-1 beta
P01630455A0448|38 40|(NF
P01630455A0448|75 82|12-bp DNA
P01630455A0448|121 132|TATA box motif
P01630455A0448|156 168|IL-1 beta genes
P01630569A0605|7 24|amphotericin B (AmB)
P01633435A0743|3 7|DRF-2
P01633435A0743|85 95|actor, MEF-2
P01633435A0743|96 102|(Buskin
P01633816A0667|18 26|4-kb EcoRI
P01633816A0667|95 101|opn gene
P01633816A0667|183 192|S1 nuclease
P01634464A0163|26 34|factor VII
P01636339A0200|72 90|ucus, Charcot-Layden
P01636714A0845|48 50|MBF
P01636714A0845|110 113|MBF)
P01636714A0845|143 145|CLP
P01637758A0532|147 153|16%); OR
P01637758A0532|162 163|CI
P01639724A0452|45 71|contraceptives (Nordette-28)
P01640778A0485|34 37|MLPA
P01642060A0471|27 43|antibody-targeted
P01642060A0471|120 124|(FIGO
P01642060A0471|125 128|III)
P01643943A0300|38 41|67Ga
P01643943A0300|55 57|TFR
P01644751A0590|100 107|msgB gene
P01644814A0068|16 21|40-kDa
P01644821A1259|58 60|CAT
P01644821A1259|71 81|fusion genes
P01644821A1259|195 204|PSG1-I gene
P01644831A0824|55 60|NGFI-B
P01645902A1462|77 78|gH
P01645902A1462|114 115|TK
P01645902A1462|119 127|UL 24 genes
P01645902A1462|188 189|TK
P01645905A0341|0 15|Nucleoprotein (N)
P01645905A0341|58 61|TGEV
P01645905A0341|83 90|mass (Mr)
P01646157A0414|12 44|3.6-kb full-length alpha-GalNAc cDNA
P01646157A0414|110 126|amino acid homology
P01646157A0414|166 201|alpha-galactosidase A (alpha-Gal A) cDNA
P01646487A0874|73 75|IgA
P01646487A0874|74 79|gA, IgG
P01646487A0874|75 83|A, IgG, IgM
P01646753A0336|114 117|N2O-
P01646753A0336|167 178|EO (N2O/N2O-)
P01647070A0232|9 11|JCV
P01647070A0232|28 30|JCV
P01647070A0232|34 37|SV40
P01647070A0232|47 49|DNA
P01647656A0000|28 50|beta-adrenergic receptor
P01647656A0000|69 72|(LV)
P01647656A0000|135 136|LV
P01648142A1170|101 103|CAV
P01648142A1170|107 108|(P
P01648142A1170|133 134|PE
P01648142A1170|138 139|(P
P01648530A0000|13 14|"M
P01648530A0000|15 21|region"
P01648530A0000|56 72|actin gene promoter
P01648530A0000|133 161|actin-beta-globin reporter gene
P01649318A0734|0 5|EBNA-2
P01649318A0734|12 32|cis-acting CD23 element
P01649318A0734|42 56|TK-promoted mRNA
P01649318A0734|74 101|herpes simplex virus TK promoter
P01649318A1222|27 56|86-bp, EBNA-2-responsive cell DNA
P01649318A1222|91 96|EBNA-2
P01649318A1222|126 134|cell genes
P01649539T0000|29 43|myeloperoxidase
P01649835A0822|27 37|PBR/IBP cDNA
P01649835A0822|42 46|COS-7
P01649835A0822|64 78|11-fold increase
P01649835A0822|105 110|[3H]PK
P01650524A0837|70 73|LTB4
P01650524A0837|116 119|5-LO
P01650524A0837|117 144|-LO inhibitors phenidone, BW A4C
P01650524A0837|156 158|ICI
P01650557T0000|61 83|cytomegalovirus antibody
P01651232A0152|4 7|mRNA
P01651232A0152|85 87|UTP
P01651232A0152|91 98|thio-UTP
P01651918A0000|40 43|cDNA
P01651918A0000|99 164|rat testis fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase
P01652372A0153|16 21|SWI5's
P01652372A0153|29 51|localization signal (NLS)
P01652515A0379|119 120|DA
P01652755A1492|43 46|HeLa
P01652755A1492|79 110|retinoblastoma susceptibility gene
P01652755A1492|80 120|etinoblastoma susceptibility gene product, RB
P01652755A1492|142 158|serum-induced IL-6
P01652755A1492|191 200|beta-actin
P01652755A1492|232 246|PRV-induced IL-6
P01652755A1492|263 278|serum-induced MHC
P01652755A1492|286 298|-38) promoters
P01653173A0619|44 56|E2 DNA-binding
P01653173A0619|85 100|P105 promoter TATA
P01653173A0619|143 160|HPV-18 P105 promoter
P01653173A0619|215 234|preinitiation complex
P01653236A0895|40 61|glucocorticoid receptor
P01653236A0895|92 113|glucocorticoid receptor
P01653238A1062|11 68|12-O-tetradecanoyl-phorbol-13-acetate (TPA) response elements
P01653238A1062|104 126|transcription factor AP-1
P01653238A1062|163 188|growth factor beta 1 (TGF-beta
P01653238A1062|222 235|promoter region
P01653238A1715|0 2|TPA
P01653238A1715|6 13|TGF-beta
P01653238A1715|53 58|72-kDa
P01654349A0327|33 35|KCl
P01654349A0327|38 43|NaHCO3
P01654349A0327|131 136|NaHCO3
P01655126T0000|80 89|oluene, HBr
P01655713A0294|80 97|strain 388 exs1::Tn1
P01656220T0000|79 100|receptor tyrosine kinase
P01656221A1319|81 85|FGFRs
P01656221A1319|141 144|FGFR
P01656235A0946|33 69|inker-scanning analysis, is a 10-bp region
P01656235A0946|83 92|CCAAT motif
P01656675A0236|19 23|40 HVS
P01656675A0236|20 41|0 HVS patients, 40 non-HVS
P01657249A1019|3 8|anti-I
P01657249A1019|12 19|anti-i CA
P01657249A1019|38 40|VH4
P01657249A1019|60 63|17 CA
P01657249A1019|93 95|VH4
P01657249A1019|139 146|VH4-HV2a
P01658356T0000|54 63|endogenous
P01658356T0000|64 74|env elements
P01658356A1369|55 64|generation
P01658356A1369|67 70|FeLV
P01658356A1369|87 92|FeLV-C
P01658356A1369|117 121|3201B
P01658356A1369|169 178|endogenous
P01658356A1369|179 196|FeLV-specific mRNAs
P01658375A0854|103 123|protein-encoding genes
P01658375A0854|172 180|LAT intron
P01658375A0854|183 184|GC
P01658375A0854|197 215|consensus sequence GT
P01658741A1047|36 44|kilobases
P01658741A1047|93 95|ADE
P01660486A1756|41 52|ell type, gene
P01660486A1756|173 175|PKC
P01660925T0000|0 15|Transfer RNA genes
P01660925T0000|124 141|3'-flanking regions
P01661369A0825|13 16|strD
P01661369A0825|20 28|strE genes
P01662609A0398|18 29|polypeptides
P01662609A0398|32 53|420 amino acids (M.HgiCI)
P01662609A0398|57 78|345 amino acids (R.HgiCI)
P01662794A0640|15 21|wt1 gene
P01662794A0640|48 52|COS-1
P01662794A0640|67 71|52 kDa
P01662807A1182|24 33|TR promoter
P01662807A1182|51 54|SV40
P01664192A1577|42 45|ED90
P01671675A0483|12 21|clone pKB11
P01671675A0483|32 52|1369-base pair (bp) cDNA
P01671675A0483|71 77|pCAD142
P01671675A0483|166 169|cDNA
P01671675A0483|197 210|CAD polypeptide
P01671675A0905|57 73|5'-flanking region
P01671675A0905|76 82|CAD gene
P01673220A0578|32 35|cDNA
P01673220A0578|48 76|ight-independent Sn: bol3 allele
P01674242A0358|85 188|omycin, troleandomycin (triacetyloleandomycin), roxithromycin, enoxacin, ciprofloxacin, pefloxacin, norfloxacin
P01674242A0358|436 450|BCG-vaccination
P01674662A0000|10 24|253 HIV-antibody
P01674662A0000|53 70|HIV-related disease
P01674662A0000|93 103|generalized
P01674662A0000|176 179|AIDS
P01674662A0000|187 198|complex (ARC)
P01674817T0000|14 23|yeast RNA14
P01674817T0000|27 36|RNA15 genes
P01674817T0000|55 58|mRNA
P01674817T0000|92 110|an RNA-binding domain
P01674817T0000|116 120|RNA15
P01674817A0862|25 29|RNA14
P01674817A0862|33 37|RNA15
P01674817A0862|47 51|RNA14
P01675424A0991|35 44|NAD(P)H-NR
P01675424A0991|67 73|NADH-NR
P01675637T0033|31 46|C-terminal region
P01675763A1389|37 40|CD4+
P01678287A1308|15 23|Antp TATAA
P01678287A1308|101 112|homeobox gene
P01678392A0648|6 26|confidence values (2SD)
P01678392A0648|99 103|cmH2O
P01679124A1368|43 46|ChAT
P01679124A1368|128 145|norepinephrine (NE)
P01679124A1368|170 192|MS/HSI animals.(ABSTRACT
P01679124A1368|193 201|TRUNCATED
P01679124A1368|198 199|AT
P01679124A1368|204 212|250 WORDS)
P01679749A1171|77 81|RFLPs
P01679749A1171|136 156|HSPG2 proteoglycan gene
P01682484A0680|142 144|LCX
P01682509A0539|30 31|IE
P01682509A0539|32 43|proteins IE86
P01682509A0539|33 48|roteins IE86, IE72
P01682509A0539|53 56|IE55
P01682509A0539|88 93|HIV LTR
P01682509A0539|98 113|-cell line, HUT-78
P01682542A0690|22 24|HIV
P01684791A0000|3 19|cis-acting element
P01684791A0000|60 89|chicken glutamine synthetase gene
P01687050T0000|30 54|fluid immunoglobulin G (IgG)
P01688841A0430|16 24|enes, ipaB
P01688841A0430|17 29|nes, ipaB, ipaC
P01688841A0430|18 34|es, ipaB, ipaC, invE
P01688841A0430|19 39|s, ipaB, ipaC, invE, invG
P01688841A0430|20 44|, ipaB, ipaC, invE, invG, invJ
P01688841A0430|49 52|invK
P01688841A0430|89 101|regulator virF
P01688972A0803|9 10|VT
P01690728A1166|35 65|mRNA transcripts (3.2-3.5 kilobase
P01690728A1166|104 138|orthern blot hybridization, S1 nuclease
P01690728A1166|161 170|polymerase
P01690812A0000|30 38|DNA (rDNA)
P01690812A0000|96 101|28 S RNA
P01690812A0000|138 140|II)
P01691184A0995|18 28|polypeptide
P01691184A0995|35 37|(Mr
P01692135A0783|11 29|rtFc gamma R alpha cDNA
P01692135A0783|62 81|different-sized mRNAs
P01692135A0783|93 99|CRNK-16
P01692135A0783|126 145|Fc gamma R-related mRNA
P01692837A0390|56 76|3'-untranslated region
P01692837A0390|81 88|kilobase
P01692837A0390|109 112|mRNA
P01692837A0390|131 139|kilobases
P01692962A0980|41 51|polypeptide
P01692962A0980|61 77|hamster ovary (CHO)
P01692962A0980|110 113|cAMP
P01692962A0980|126 152|cAMP-dependent protein kinase
P01694009A0112|97 107|polypeptide
P01694014A0716|23 36|cell lines HL-60
P01694014A0716|48 81|phorbol 12-myristate 13-acetate (PMA)
P01694014A0716|118 120|RNA
P01694014A0716|135 142|LD78 cDNA
P01694525A0000|0 22|Isopenicillin N isomerase
P01695098A1116|0 7|Serum IgG
P01695116A0078|35 48|remission (CR1)
P01695314T0000|86 87|II
P01695314A0762|1 16|57 +/- 16 mg/dl; NS)
P01695322A0000|23 30|oncogene
P01695322A0000|66 68|DNA
P01695378A1406|98 105|FKBP mRNA
P01695905A0480|0 8|GLUT5 mRNA
P01697683T0000|52 65|cytotactin gene
P01697928A1214|22 37|sequence homology
P01697928A1214|57 61|Ly-6E
P01697928A1214|94 129|interferon-stimulated response element
P01697928A1214|197 235|alpha/beta interferon-inducible promoters
P01698761A1059|15 17|DNA
P01698761A1059|124 127|AlgP
P01699944A1538|59 62|CArG
P01699944A1538|117 131|promoter element
P01699944A1538|137 140|VLC1
P01699944A1538|149 159|alpha-actin
P01699944A1538|164 173|c-fos genes
P01700272A0838|17 21|B4 RNA
P01701088A1335|64 74|AP-2 element
P01701088A1335|77 81|CCAAT
P01702361A0621|86 97|angiogenesis
P01702426A0196|8 24|5'-flanking region
P01702426A0196|138 153|acid synthase gene
P01702426A1006|9 12|cDNA
P01702426A1006|61 84|lambda-ZAP goose liver cDNA
P01702426A1006|100 121|5'-most exon-containing
P01702426A1006|149 151|DNA
P01702972A0613|7 10|cDNA
P01702972A0613|33 35|DNA
P01702972A0613|67 76|G0S19 genes
P01702972A0613|112 119| most cDNA
P01702972A0613|116 120|cDNAs
P01702972A0613|131 135|G0S30
P01702972A0613|155 170|single-copy genes
P01703335T0000|61 62|FK
P01703632T0000|42 52|polypeptide
P01703632T0000|80 90|RNA-binding
P01707659A0458|40 58|'non-classical' gene
P01707659A0458|41 66|non-classical' gene, HLA-5.4
P01707659A0458|76 89|chimpanzee gene
P01707800A0354|11 17|N13-N20
P01708098A0922|5 27|avidin-biotin complex DNA
P01708098A0922|62 77|alpha promoter DNA
P01708098A0922|141 142|GR
P01708098A0922|152 161|control GRE
P01708774A0203|3 5|DNA
P01708774A0203|24 27|AP-1
P01708774A0203|59 72|promoter region
P01709486A0000|38 40|(W)
P01709486A0000|48 61|proto-oncogene
P01709933T0000|55 70|polypeptide (pS1)
P01710766A0349|109 123|initiation codon
P01710768A1172|123 132|HLA-B7 gene
P01710979T0000|3 5|SH2
P01710979T0000|9 18|SH3 domains
P01711041A0348|69 81|C5 alpha-chain
P01711041A0348|93 102|beta-chain
P01711041A0962|3 15|C5 alpha-chain
P01711041A0962|28 38|49 kilobases
P01711041A0962|49 55|26 exons
P01711041A0962|60 69|beta-chain
P01711041A0962|82 92|29 kilobases
P01711041A0962|103 109|16 exons
P01711048T0000|51 59|pro-alpha
P01711048T0000|60 63|2(I)
P01711048T0000|64 75|gene (COL1A2)
P01711048T0000|94 96|RNA
P01711048T0000|114 125|osteogenesis
P01713213A0000|42 60|pim-1 proto-oncogene
P01713213A0000|93 122|serine/threonine protein kinases
P01713213A0000|183 203|protein tyrosine kinase
P01713213A0488|17 25|pim-1 cDNA
P01713213A0488|54 66|vector pGEX-2T
P01713213A0488|123 151|glutathione S-transferase (GST)
P01714322A0969|42 46|18 kDa
P01714358A0990|3 18|10 kDa polypeptide
P01714358A0990|88 94|32P] ATP
P01714452A0559|47 58|repeat domain
P01714902A0221|39 82|Ti alpha-beta CD3 gamma delta epsilon TCR complexes
P01714902A0221|89 102|ell surface, CD3
P01714902A0221|158 160|TCR
P01714902A0221|189 213|histocompatibility complex
P01715975A0885|17 20|CYP1
P01716292A0000|35 41|HLA-DR1
P01716292A0000|155 168|DRB/H-2Eb genes
P01716292A0000|185 192|r DR alpha
P01716292A0000|186 192|DR alpha
P01716292A0000|195 198|H-2E
P01716629A0000|15 18|cDNA
P01717718A1255|31 45|Gag-Pol PR domain
P01717718A1255|67 68|RT
P01717718A1255|79 89|wild-type PR
P01717718A1255|132 148|PR domain in Gag-Pol
P01717718A1255|178 179|RT
P01717833T0000|15 30|alpha inhibin gene
P01717833A1223|3 22|alpha inhibin promoter
P01717833A1223|41 43|CRE
P01717833A1223|102 105|CREB
P01717925A0477|58 60|DNA
P01717994T0000|15 18|cDNA
P01717994T0000|28 45|CDC2-related kinase
P01718043A0384|48 58|PMN elastase
P01718983A1640|10 63|, C., Goff, D., Griffiths, B., Tizard, R., Newman, B., Chi-Rosso
P01719684A0494|36 60|alpha-adrenergic receptors
P01720555A1087|15 24|2-kilobase
P01720843A1506|117 126|endogenous
P01720843A1506|127 146|nitrovasodilator EDRF
P01721261T0000|18 19|FK
P01721884A0962|72 83|ribonuclease
P01721884A0962|85 90|(RNase
P01721884A0962|91 98|H) domain
P01721884A0962|186 190|RNase
P01721884A0962|255 259|RNase
P01722319A0849|49 54|CHIP28
P01722319A0849|73 95|bilayer-spanning domains
P01722479A0302|30 32|HCG
P01723962A0165|13 23|serum lipase
P01723962A0165|27 33|amylase
P01723962A0165|99 103|Na-Tc
P01724982A0237|18 38|anti-HCV (anti-C100-3)
P01724982A0237|43 48|HCV EIA
P01724982A0237|52 58|(Abbott
P01724982A0237|61 79|b., North Chicago, IL)
P01725547A0354|86 99|blood flow (CBF)
P01725622A0292|8 18|transfusion
P01725622A0292|56 59|(CCI
P01727488A1146|0 21|PRDII-BF1-derived cDNAs
P01727494A0000|0 16|Vaccinia virus (VV)
P01727494A0000|26 34|immunogen
P01727494A0000|50 51|VV
P01730412T0000|39 43|c-Myc
P01730747A0205|19 24|S phase
P01730747A0205|25 31|(Reilly
P01731107A0928|44 52|ICR2 motif
P01731107A0928|68 71|pRNA
P01731933T0000b|0 23|Zn(II) coordination domain
P01731933T0000a|0 23|Zn(II) coordination domain
P01731933T0000b|0 5|Zn(II)
P01731933T0000a|0 5|Zn(II)
P01731933T0000b|33 38|T4 gene
P01731933T0000a|33 38|T4 gene
P01731979A1408|79 107|CaMV 35S domain B enhancer element
P01732736A1076|22 35|POU-domain gene
P01732752A0156|33 67|leukemia virus-transformed pre-B-cell
P01732752A0156|34 79|eukemia virus-transformed pre-B-cell lines, LT mRNA
P01733105A0127|69 76|sense RNA
P01733358A0240|60 61|II
P01733358A0240|85 87|III
P01734020A1318|138 154|wild-type PKC alpha
P01734283A0817|27 31|RAP74
P01734283A0817|51 54|HeLa
P01734283A0817|83 85|DNA
P01734283A0817|134 138|RAP30
P01734570T0000|9 29|thromboxane synthetase
P01735347A0482|84 95|plasma lipase
P01735447A0271|64 91|precursor (pre-super-pro-PrB)
P01735447A0833|62 81|N-glycosylated 73-kDa
P01735447A0833|93 95|PrB
P01735447A0833|105 114|kDa pro-PrB
P01735721A0185|57 87|Bacillus stearothermophilus TyrTS
P01735721A0185|116 120|TyrTS
P01735721A0185|152 169|. subtilis TyrTS gene
P01735721A0185|181 184|tyrZ
P01736093A0731|0 16|Heat-inducible CAT
P01736093A0731|97 101|CCAAT
P01736093A0731|117 119|HSE
P01736651A0104|0 13|SETTING--Women
P01736844T0000|86 93|androgen
P01737741A0000|0 9|BACKGROUND
P01737741A0000|29 61|monoamine oxidase inhibitors (MAOIs)
P01737789A0800|11 21|delta-alpha
P01737789A0800|93 114|down-stream alpha-delta
P01738470A0441|20 24|PDDAT
P01738936A0292|14 28|plasma C-peptide
P01738936A0292|40 42|3 pM
P01739956A0638|23 27|beta-
P01739956A0638|60 65|type IC
P01740437A0851|8 13|49-kDa
P01740437A0851|30 38|liver HSPG
P01740448A1735|14 33|transmembrane regions
P01740448A1735|129 130|II
P01740682A0703|87 114|World Health Organization (WHO)
P01741249A0177|0 2|W.G
P01742606A0000|1 23|mouse brain beta-spectrin
P01742606A0000|26 29|cDNA
P01742606A0000|121 146|235 kDa spectrin beta-subunit
P01742879A0471|0 6|RESULTS
P01742879A0471|1 16|ESULTS: Plasma AVP
P01744039A0511|39 48|polymerase
P01744042A1355|3 12|csbA fusion
P01744119A0757|16 22|primase
P01744119A0757|141 153|the 63-kDa gene
P01748067A0000|151 162|degenerative
P01748194A0767|139 140|(N
P01748287T0000|5 15|SRF-related
P01748287T0000|6 35|RF-related proteins: DNA-binding
P01748292A0000|14 18|cDNAs
P01748292A0000|37 56|G protein alpha subunit
P01748292A0000|67 79|(Lycopersicon
P01748630A0125|59 63|c-Myc
P01748630A0125|79 94|activation domain
P01748630A0125|109 126|proline-rich region
P01748630A0125|174 181|(Alvarez
P01748630A0125|185 199|, Northwood, I.C.
P01751163A0000|100 119|device (Sarns/3M-VAD)
P01751255A0529|7 16|output (CO)
P01751255A0529|61 64|MBBF
P01752441A0000|30 34|HIV-1
P01752441A0000|118 123|TAR RNA
P01752792A0000|53 73|time differences (ITDs)
P01753317A0879|31 48|locally-applied TTC
P01753317A0879|66 69|FDBA
P01754381A0000|54 67|DNA polymerases
P01754381A0000|134 157|Trypanosoma (Trypanozoon)
P01754381A0000|188 205|DNA polymerase alpha
P01754381A0000|223 228|alpha)
P01757341A0591|3 20|volume fraction (Vv)
P01757341A0591|24 37|number/mm2 (Na)
P01757341A0591|127 145|alkaline phosphatase
P01760166A0963|0 9|CONCLUSION
P01760166A0963|21 24|SpO2
P01761736A0158|65 70|mL/min
P01761736A0158|71 72|(P
P01761736A0158|152 153|(P
P01762914A1218|9 19|uPA promoter
P01762914A1218|40 57|cis-acting elements
P01762917A0615|52 67|TGEK tetrapeptide
P01762917A0615|76 77|II
P01762917A0615|80 85|TFIIIA
P01762917A0615|105 107|DNA
P01765095A0680|0 24|12-O-Tetradecanoylphorbol
P01765095A0680|85 89|mRNAs
P01765095A0680|102 109|myogenic
P01765095A0680|110 123|regulators CMD1
P01765095A0680|127 134|myogenin
P01765266A0000|34 56|elongation factor 1-alpha
P01765266A0000|64 72|EF-1 alpha
P01765269A0308|37 51|pre-mRNA introns
P01765375A0290|3 6|mRNA
P01765375A0290|137 142|180 kDa
P01765386A0305|24 26|DNA
P01765386A0305|90 100|exon-intron
P01765407A0866|15 25|10 mg DMEA/m3
P01766666A0788|20 23|rE12
P01766666A0788|27 33|rNFIL-6
P01766666A0788|41 62|nucleoprotein complexes
P01766666A0788|72 82|DNA-binding
P01766876A0000|56 64|chain gene
P01766999A0000|20 53|allergen extract Ambrosia elatior (AE)
P01767060A0000|35 39|c-DDP
P01767592A0682|34 36|DNA
P01767592A0682|86 94|HAP2/HAP3
P01767592A0682|143 146|BAF1
P01767899A0136|34 48|serum fibrinogen
P01768648A0853|24 33|LexA fusion
P01768648A0853|67 87|DNA-contacting domains
P01768648A0853|90 93|cRel
P01769189A0000|67 69|(RU
P01769189A0000|108 144|raining distance 35 +/- 15 km week-1, VO2max
P01769189A0000|109 172|aining distance 35 +/- 15 km week-1, VO2max 36 +/- 4 ml kg-1 min-1, mean +/- SD)
P01769189A0000|201 203|(UT
P01769189A0000|237 242|VO2max
P01769919A0393|102 106|24 kHz
P01771593A1152|14 15|TA
P01771593A1152|41 43|AGD
P01771593A1152|42 43|GD
P01771593A1152|74 76|PCD
P01771593A1232|54 63|TA-exposed
P01771959A0442|5 8|PTCA
P01771959A0442|141 144|PTCA
P01771959A0442|220 223|PTCA
P01772341A0852|45 65|thromboxane synthetase
P01772341A0852|79 97|thromboxane receptor
P01774062A0257|1 9|330-kb YAC
P01774062A0257|2 16|30-kb YAC, A148A7
P01774062A0257|32 39|HLA-DQA1
P01774062A0257|55 61|Y3/Ring
P01774062A0257|104 111|YAC B1D12
P01774063A0161|35 41|progeny
P01774063A0161|62 70|(C57BL/6J
P01774063A0161|86 93|C57BL/6J
P01774063A0161|114 131|thrombospondin gene
P01774063A0161|170 172|B2M
P01774093T0000|30 32|IgM
P01774822A0289|8 39|mage-processing computer, regional
P01774822A0289|40 41|LV
P01776306A0572|19 20|VT
P01776715A0489|139 142|PCO2
P01776715A0489|147 149|kPa
P01779433A0694|19 27|monomeric
P01779433A0694|63 73|nonhomology
P01779433A0694|102 122|alpha 2 gene-containing
P01779433A0694|219 227|generated
P01779433A0694|242 250|monomeric
P01779769A0000|125 130|a 74 kDa
P01780235A0094|3 5|EPO
P01780235A0094|41 51|transfusion
P01780235A0094|91 101|transfusion
P01781923A0744|29 30|DB
P01781923A0744|65 66|DB
P01781923A0744|84 95|righting in LS
P01782982A0155|24 35|baseline FEV1
P01782982A0155|95 97|AMP
P01783088A1136|226 242|disease.(ABSTRACT
P01783088A1136|243 251|TRUNCATED
P01783088A1136|248 249|AT
P01783088A1136|254 262|250 WORDS)
P01784589A0000|41 53|5-HT2 receptor
P01787085A0331|38 62|5 control rats) 99mTc-sulfur
P01797467A0000|0 4|RU486
P01797467A0000|8 10|ONO
P01804671A1001|27 31|QS/QC
P01804671A1001|140 160|ventilation/perfusion
P01804671A1001|201 206|CDCSF6
P01804671A1001|217 231|ml.min-1.mmHg-1
P01808049A0262|0 1|CT
P01808136T0000|27 46|coagulation factor XII
P01808829A0510|0 3|TPTA
P01808829A0510|62 72|generalized
P01810108A0000|71 91|Listeria monocytogenes
P01811243A0000|16 30|blood flow (rCBF)
P01811243A0000|214 217|rCBF
P01811948A0289|45 65|cis-regulatory element
P01811948A0289|85 100|LpS1 beta promoter
P01811948A0289|116 119|(G)6
P01811948A0289|142 152|cis-element
P01812102A0101|54 75|pattern reversal (VEP-P)
P01812102A0101|129 138|NPN complex
P01812690A0475|8 10|SMF
P01814182A0000|16 34|15-methyl-PGF2 alpha
P01822995T0000|0 16|Maize rbcS promoter
P01822995T0000|34 49|sequence elements
P01822995T0000|60 77|dicot rbcS promoters
P01823520A0183|35 61|haematofluorometer Buchler ZF
P01824713A0964|3 8|12S E1A
P01824713A0964|32 34|TRE
P01824944A0988|68 85|18-kDa polypeptides
P01824944A0988|104 106|IgE
P01825027T0000|0 3|PAS1
P01825027T0000|6 14|yeast gene
P01825027T0000|26 45|peroxisome biogenesis
P01825027T0000|85 91|ATPases
P01826003A0694|57 59|SIG
P01826003A0694|70 79|beta TG gene
P01826003A0694|93 98|3 exons
P01826043A0431|3 23|pp90rsk-protein kinase
P01826043A0431|74 122|cofactor-dependent signal transducing protein kinases
P01826043A0431|138 164|AMP-dependent protein kinases
P01826043A0431|178 190|protein kinase
P01826043A0431|206 235|Ca2(+)-dependent protein kinases
P01827068T0000|5 10|GATA-3
P01827068T0000|81 102|T cell receptor alpha gene
P01827203A0136|58 60|DNA
P01828248A0189|15 18|UvrA
P01828248A0189|42 45|UvrB
P01828248A0189|111 113|DNA
P01828248A0189|123 134|UvrAB complex
P01828248A0189|145 152|helicase
P01829060A0649|3 6|ED30
P01829060A0649|74 76|(ED
P01829460A0329|68 80|kappa B element
P01830114A1587|24 26|NS1
P01830928A0361|81 96|force-generating
P01830928A0361|117 133|attachment domains
P01832152A0000|3 33|incompatibility group W plasmid pSa
P01832152A0000|44 79|Agrobacterium tumefaciens oncogenicity
P01832152A0000|80 81|(J
P01832152A0902|47 50|ORF1
P01832152A0902|54 57|ORF2
P01832197T0001|9 26|D2 dopamine receptor
P01833185A0547|3 11|Thr161Val
P01833637A0531|155 163|HSP82 gene
P01833716A0990|81 86|HTLV-1
P01837787T0000|9 18|Mov-34 gene
P01837787T0000|10 34|ov-34 gene: full-length cDNA
P01837842A1410|0 3|CREB
P01837842A1410|58 74|gel shift complexes
P01837842A1410|95 97|CRE
P01840513A1019|29 32|SL-2
P01840513A1019|30 42|L-2 cells, pCAT
P01840513A1019|69 85|5'-flanking region
P01840513A1019|98 147|3.5-fold increase in chloramphenicol acetyltransferase
P01840513A1019|192 203|8-bromo-cAMP
P01840607A0294|25 28|UTRs
P01840607A0294|52 53|II
P01840607A0294|105 107|PFP
P01840608A0823|52 55|nifA
P01840608A0823|82 85|nifB
P01840711A0000|3 5|RNA
P01840711A0000|31 48|disease virus (RHDV)
P01842498A0000|6 9|cDNA
P01842498A0000|62 66|a cDNA
P01842498A0000|94 106|(PHA)/phorbol
P01842498A0000|162 165|cDNA
P01842498A0000|175 188|PHA-stimulated
P01842867A0696|29 40|regeneration
P01844017A0410|48 81|glucose-6-phosphatase dehydrogenase
P01844878A0000|43 68|neomycin phosphotransferase
P01844878A0000|69 70|II
P01844878A0000|131 133|DNA
P01844982A0324|0 13|Chagas' disease
P01845829A0158|54 75|protein-binding domains
P01845885A1003|39 44|UL26.5
P01845885A1003|134 137|mRNA
P01845885A1003|187 190|UL26
P01845885A1003|240 264|methionine initiation codon
P01845885A1003|292 295|UL26
P01845899A0000|3 35|adeno-associated virus (AAV) rep gene
P01845899A0000|55 60|(Rep78
P01845899A0000|94 99|AAV DNA
P01845899A0000|114 120|AAV gene
P01846206A0665|28 30|CMV
P01846489A1119|27 47|3C-like protease domain
P01846489A1119|54 79|papain-like protease domains
P01846491A0459|33 39|VV genes
P01846491A0459|99 102|ORFs
P01846491A0459|105 107|SFV
P01846491A0459|163 165|DNA
P01846803A0688|63 75|p34cdc2 kinase
P01846803A0688|138 140|ATP
P01846803A0688|157 162|kinase
P01847464A0856|29 37|pFRTK-CAT
P01847464A0856|54 67|EBNA-1-binding
P01847464A0856|80 82|EBV
P01847464A0856|92 114|lasmid replication, ori-P
P01847464A0856|136 157|carboxy-terminal EBNA-1
P01847665A1079|55 67|PDGF receptors
P01848300A0910|33 36|cstA
P01848871A0392|134 158|signal-averaged QRS complex
P01849509T0000|37 75|Rhizobium meliloti insertion sequence ISRm3
P01849509T0000|105 115|transposase
P01849509T0000|125 129|ISRm3
P01849509T0000|167 171|IS256
P01849509T0000|175 202|Thiobacillus ferrooxidans IST2
P01849675A0167|52 54|DNA
P01849675A0167|65 66|KV
P01849734A1063|8 15|PR55 beta
P01849734A1063|86 99|cell line LA-N-1
P01849734A1063|114 117|mRNA
P01850096A0662|14 21|myogenin
P01850096A0662|31 34|MyoD
P01850096A0662|129 139|alpha-actin
P01850127A0000|19 25|U2 snRNP
P01850127A0000|63 71|pre-mRNAs
P01850127A0000|90 98|non-snRNP
P01851386T0092|10 37|Lung Cancer Task Force (FONICAP)
P01851527T0000|36 77|Alzheimer beta-amyloid precursor protein (APP)
P01851862A0273|29 35|env gene
P01851862A0273|42 44|LTR
P01851862A0273|47 51|SFV-1
P01851876A0129|28 32|EMBL3
P01852438A0928|3 11|MVV-value
P01852603A0000|3 13|rad9.192 DNA
P01852603A0000|88 89|UV
P01854339A0221|57 74|consensus promoters
P01855255T0000|42 45|RCC1
P01855255T0000|61 66|GTPase
P01857326A0160|57 62|IBM-AT
P01860846A0663|8 11|cDNA
P01860846A0663|36 60|tumor necrosis factor-alpha
P01860846A0663|82 91|MARCKS gene
P01860846A0663|128 147|leukemia cell line HL60
P01861188A0000|52 57|(PMMA)
P01861188A0000|280 283|ASIF
P01862027A0212|53 68|Rothmund-Thomson
P01863768A0649|19 24|ORF113
P01863887A0174|76 92|tissue plasminogen
P01864510A0946|0 7|Dd PK1 RNA
P01864821A0000|23 33|cell disease
P01864837A1029|100 113|43-46% homology
P01864837A1029|124 141|rat alpha 1-protease
P01865010A0000|104 122|tracers (Fluoro-Gold
P01867069A0000|5 8|CD-1
P01869565A1254|0 2|USF
P01869565A1254|72 82|ADH promoter
P01869565A1254|96 98|MLP
P01869907A2146|47 50|NaCl
P01869907A2146|103 115|H2O.(ABSTRACT
P01869907A2146|116 124|TRUNCATED
P01869907A2146|121 122|AT
P01869907A2146|127 135|400 WORDS)
P01869968A0000|63 67|HMPAO
P01869968A0673|69 84|clearance (HMPAO)
P01869968A0673|96 99| rCBF
P01870194A0302|5 37|immunodeficiency virus type 1 (HIV-1)
P01870194A0302|38 39|IN
P01870194A0302|85 95|homogeneity
P01870428A0677|34 36|HDL
P01870428A0677|40 45|HDL2-C
P01870428A0677|61 63|LDL
P01870500A0276|33 52|target volume elements
P01871135A0295|3 6|cDNA
P01871135A0295|97 101|52 kDa
P01871135A0295|130 148|rat liver glucokinase
P01871971A0836|47 57|NFIII/OCT-1
P01871971A0836|82 89|ATF motif
P01872856A0277|23 24|BA
P01874195A0139|25 34|GH receptor
P01874195A0139|151 180|ligand-activated tyrosine kinase
P01876836T0000|23 43|notch-related subunits
P01876836T0000|46 47|GA
P01878489A0959|80 91|NADPH oxidase
P01878755A0496|54 55|(P
P01878755A0496|97 98|(P
P01881595A0476|21 25|SNO NS
P01881595A0476|29 31|NnS
P01881595A0476|63 64|NS
P01881595A0476|116 118|NnS
P01882240A0526|84 87|AIDS
P01882386A0000|18 62|alpha-mercapto-beta-(2-furyl)acrylic acid (MFA)
P01882386A0000|66 106|N-benzyl-N-dithiocarboxy-D-glucamine (NaB)
P01883992A0922|23 28|beta-1
P01883992A0922|95 107|beta-zein gene
P01884435A0088|58 61|ptO2
P01884435A0088|65 67|ptH
P01884435A0088|188 191|ptO2
P01884435A0088|195 197|ptH
P01884998A1135|80 92|C/EBP-binding
P01885613A1298|77 84|pro alpha
P01885613A1298|85 89|1(II)
P01885613A1298|90 101|collagen gene
P01886043A0380|3 5|SMX
P01886043A0380|8 9|pH
P01886043A0380|39 40|pH
P01886043A0380|44 47|HPCD
P01886043A0380|96 98|SMX
P01886043A0380|145 162|inclusion complexes
P01886043A0380|170 173|HPCD
P01886368A0000|0 2|PO2
P01886774A0000|0 11|POU-specific
P01886774A0000|15 30|POU-homeo domains
P01886774A0000|86 88|DNA
P01889753A0441|32 47|xons, exon/intron
P01889753A0441|67 88|3'-untranslated regions
P01890989A1392|55 62|estrogen
P01893195A0000|75 84|pathogenic
P01893195A0000|101 114|virus Issyk-Kul
P01893927A0704|32 52|phenylephrine infusion
P01893927A0704|86 88|NMA
P01893927A0704|92 94|NNA
P01895370A0199|32 38|peak (S)
P01895370A0199|42 50|trough (D)
P01895384A0746|3 9|IE0 gene
P01895384A0746|38 48|IE1 promoter
P01895393A0745|29 32|TATA
P01895393A0745|82 86|a TATA
P01895393A0745|125 137|RNA polymerase
P01895393A0745|138 140|III
P01895555T0001|72 82|Tc-99m-MIBI
P01897515A0348|25 40|Hodgkin's disease
P01898113A0265|60 62|BCF
P01898113A0265|66 68|SWA
P01898928A0260|0 2|DNA
P01898928A0260|87 104|DNA locus homologous
P01898928A0260|125 131|fur gene
P01899209A0883|0 8|Increases
P01899209A0883|14 26|perfusate PCO2
P01899287A0726|37 51|steady-state RNA
P01899409T0000a|94 110|tissue plasminogen
P01899846A0862|13 21|rbcL-rbcS
P01900194T0000|32 55|NADH-ubiquinone reductase
P01900194T0000|69 91|NAD-reducing hydrogenase
P01901405A0694|10 13|mRNA
P01901405A0694|33 38|AT-BP1
P01901405A0694|42 47|AT-BP2
P01901664T0064|0 5|3 cases
P01901859A0000|0 59|UDP-Gal:Gal beta 1----4GlcNAc alpha 1----3-galactosyltransferase
P01901859A0000|71 89|glycosyltransferase
P01901946A0243|38 40|SRE
P01901946A0243|56 77|mouse c-fos gene promoter
P01901946A0243|153 177|Southwestern (DNA-protein)
P01901950T0000|76 89|mouse c-fos gene
P01903841A0125|97 102|eIF-5A
P01903841A1449|45 57|wild-type gene
P01904437A0000|18 25|metH gene
P01904437A0000|93 100|metR gene
P01904437A0000|110 112|DNA
P01904546A0671|26 33|AAR1 gene
P01904546A0671|44 50|a/alpha
P01904546A0671|93 99|a/alpha
P01905199A0210|11 18|ICRF-187
P01905199A0210|66 68|ADR
P01905199A0210|72 74|WBH
P01905517A1076|3 5|ORF
P01905517A1076|54 70|sequence data bases
P01906166A0119|0 10|Mitomycin-C
P01906166A0119|106 107|IV
P01906509A0072|27 43|5'-flanking region
P01906509A0072|54 64|nidogen gene
P01906692A0321|0 12|INTERVENTIONS
P01906692A0321|30 34|rt-PA
P01907265A0670|48 60|endonucleases
P01907265A0670|109 111|DNA
P01907941A0275|13 23|I kappa B beta
P01907941A0275|31 42|I kappa B alpha
P01909027A0922|30 45|DNA binding domain
P01909027A0922|48 50|ILF
P01909027A0922|90 113|fork head DNA binding domain
P01909027A0922|187 198|actors, HNF-3
P01909960A0134|52 68|noradrenaline (NA)
P01909960A0134|98 107|endogenous
P01909960A0134|123 142|normetanephrine (NMN)
P01909960A0134|160 161|NA
P01910505A0000|32 41|leukogenic
P01911767T0000|28 58|ribulosebisphosphate carboxylase
P01915580A0889|23 28|NZ-107
P01915580A0889|87 96|late-phase
P01916168A0969|45 48|ISO2
P01916168A0969|117 125|delta ISO2
P01916405A0242|93 94|PC
P01916405A0242|94 97|C, DB
P01916632A0431|0 7|Anti-HBc
P01916632A0431|20 23|PBMC
P01917943A0621b|21 25|sMtCK
P01917943A0621a|21 25|sMtCK
P01917943A0621a|65 69|TATAA
P01917943A0621b|65 69|TATAA
P01917943A0621a|82 87|80 base
P01917943A0621b|82 87|80 base
P01917943A0621a|185 224|chloramphenicol acetyltransferase reporter
P01917943A0621b|185 224|chloramphenicol acetyltransferase reporter
P01917943A0621a|185 216|chloramphenicol acetyltransferase
P01917943A0621b|185 216|chloramphenicol acetyltransferase
P01917943A0621a|185 216|chloramphenicol acetyltransferase
P01917962A0152|3 6|cDNA
P01917962A0152|28 45|immunoglobulin gene
P01917962A0152|83 86|cDNA
P01917962A0152|114 118|IL-2R
P01917962A0152|168 179|SV40 promoter
P01918010A0000|0 21|Lipoprotein lipase (LPL)
P01918010A0000|66 73|a complex
P01918010A1730|21 39|octanucleotide motif
P01918010A1730|84 94|LPL promoter
P01918010A1730|158 163|3T3-L1
P01918010A1730|177 181|HepG2
P01918070A0281|30 44|T3 receptor alpha
P01918070A0281|45 48|(T3R
P01918070A0281|49 54|alpha)
P01918070A0281|124 130|rGH T3RE
P01918070A0281|193 195|T3R
P01918073A0150|15 28|cDNA-predicted
P01918073A0150|34 43|TnIcardiac
P01918073A0150|71 73|TnI
P01918073A0150|153 165|protein kinase
P01918073A0150|260 262|TnI
P01918073A0150|333 369|near-N-terminal troponin C (TnC)-binding
P01918073A0150|389 404|isoform-specific
P01918073A0150|417 419|TnI
P01918073A0150|423 425|TnC
P01918073A0150|444 453|TnIcardiac
P01918073A0150|462 478|actin/TnC-binding
P01918073A0150|464 507|tin/TnC-binding, actomyosin-inhibitory, domain
P01918073A0150|555 564|TnIcardiac
P01918073A0150|597 609|protein kinase
P01918073A0150|654 656|TnI
P01921463T0000|2 10|ASSEMBLER
P01922082A0149|15 30|mouse TSH beta gene
P01922082A0149|61 65|mRNAs
P01922082A0149|82 102|5'-untranslated region
P01922739A0336|17 20|ROSP
P01922739A0336|206 209|ROSP
P01923628T0001|22 24|DNA
P01923628T0001|64 80|findings in 16 cases
P01923766A0485|70 73|mRNA
P01923766A0485|85 93|generated
P01923803A0609|37 42|SsoL12
P01923803A0609|68 75|AUA codon
P01924315A0158|76 79|SOD1
P01924920A0115|8 29|79 samples, Mobiluncus SP
P01924920A0115|113 119|agar RLK
P01925092A0304|86 102|tissue plasminogen
P01927845A0107|59 81|isorders, Bowen's disease
P01930470A0337|32 46|NANB-induced PTH
P01930470A0337|79 94|Blood Banks (AABB)
P01930470A0337|121 134|PTH-associated
P01930660T0000|0 31|Insulin-like growth factor 1 (IGF-1)
P01931966A0490|19 24|pADPRP
P01931966A0490|44 49|pADPRP
P01932650A0435|7 9|III
P01932650A0435|122 126|a MBRS
P01934378T0000|8 27|muscle metaboreceptor
P01934378A1219|8 27|muscle metaboreceptor
P01936348A0155|49 58|AmF/SnF2)-
P01936997A0795|0 2|RNA
P01936997A0795|51 57|TRP-185
P01936997A0795|89 94|TAR RNA
P01937790A0292|26 36|immunogenic
P01937989A0383|65 68|(R2)
P01939131A0871|29 34|BW2001
P01939199A0588|16 20|TFIID
P01939199A0588|106 110|TFIID
P01939199A0588|123 126|HeLa
P01939827A0150|118 151|ions containing 2 mmol/L CaCl2, 2 mmol/L
P01939827A0150|119 138|ons containing 2 mmol/L
P01939827A0150|132 143|2 mmol/L CaCl2
P01939827A0150|133 157| mmol/L CaCl2, 2 mmol/L KH2PO4
P01939827A0150|134 174|mol/L CaCl2, 2 mmol/L KH2PO4, 50 mmol/L Hepes, pH
P01939827A0150|225 244|s containing 1.2 mmol/L
P01939827A0150|239 249|mmol/L CaCl2
P01939827A0150|254 265|mmol/L KH2PO4
P01939827A0150|256 282|ol/L KH2PO4, 50 mmol/L Hepes, pH
P01939899A2043|107 128|perturbation.(ABSTRACT
P01939899A2043|129 137|TRUNCATED
P01939899A2043|134 135|AT
P01939899A2043|140 148|400 WORDS)
P01939906A0233|4 17|generalization
P01939906A0233|20 22|MFP
P01942033T0000|17 19|RNA
P01942033T0000|60 78|muscle-specific exon
P01947449A0191|11 19|diffusion
P01947449A0191|55 70|ratio O2 uptake/O2
P01947449A0191|196 198|PO2
P01947449A1082|0 11|(2) Diffusion
P01947449A1082|27 39|heterogeneous
P01947449A1082|153 163|homogeneous
P01952827A0215|47 56|test phrase
P01954355A0997|38 41|IL-1
P01954355A0997|45 47|TNF
P01956285A0000|56 63|bet genes
P01956285A0000|109 130|choline-glycine betaine
P01956491A0095|79 97|filtration rate (GFR)
P01961213A0150|11 14|DDT-
P01961213A0150|12 19|DT-, HCH-
P01961213A0150|23 32|HCB-levels
P01961747A0000|1 21|herpesvirus proteinase
P01961747A0000|97 110|substrate genes
P01963419A0501|45 49|17 MeV
P01963419A0501|94 96|13N
P01963419A0501|102 106|16O(p
P01963419A0501|103 116|6O(p, alpha)13N
P01963419A0501|127 139|[18F]fluoride
P01963419A0501|148 152|18O(p
P01963419A0501|149 158|8O(p, n)18F
P01963438T0000|0 12|Heterogeneous
P01964989A0145|30 47|phencyclidine (PCP)
P01964989A0145|50 112|11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (9-THC-COOH)
P01967130A0645|3 23|1489-base pair EFIA cDNA
P01967130A0645|103 105|DNA
P01968043A0908|20 23|cDNA
P01968043A0908|56 69|insert (pASB-1)
P01968224A0119|21 52|260-amino-acid residue polypeptide
P01968224A0119|89 94|60 base
P01968224A0119|160 163|PCNA
P01968224A0119|192 207|PCNA polypeptides
P01968224A0119|249 264|C-terminal region
P01970560A1024|25 28|aroF
P01970560A1024|48 51|lacZ
P01970560A1024|110 137|hromosome. beta-Galactosidase
P01970560A1024|147 159|tyrR-mediated
P01970560A1024|172 180|aroF-lacZ
P01970560A1024|212 215|TyrR
P01970801A0925|46 49|CD20
P01970801A0925|47 54|D20, OSBP
P01971191A1271|17 31|beta-adrenergic
P01972379T0042|0 2|DNA
P01972379T0042|28 36|CPS domain
P01972379T0042|70 79|protein CAD
P01974550A0362|5 16|base-line CBF
P01974876A1051|67 69|DNA
P01974876A1051|104 114|enzyme BglII
P01975157A0836|26 27|pH
P01975428A0151|16 32|end-to-end fusions
P01975428A0151|36 49|exonucleolytic
P01975428A0151|85 87|DNA
P01976638A1135|24 44|5'-untranslated region
P01977585A0222|27 62|protease-B-deficient URA2-transformed
P01977585A0222|121 147|cAMP-dependent protein kinase
P01977856A1036|21 25|BSPMs
P01977856A1036|52 54|AMI
P01978834A0076|7 28|abomasum lambda gt11 cDNA
P01978834A0076|86 112|rabbit H,K-ATPase beta subunit
P01978857A0504|53 55|CD4
P01982061T0000|53 66|hamster CAD gene
P01982061A0615|9 12|TATA
P01982997A1104|66 68|MDI
P01982997A1104|88 89|RA
P01982997A1104|130 138|c-Jun mRNA
P01982997A1104|174 178|c-Fos
P01982997A1104|182 191|Jun-B mRNAs
P01983026A0483|85 86|CA
P01985301T0000|19 24|MK-801
P01985920T0000|42 75|rat liver sterol carrier protein 2 cDNAs
P01985920A0156|19 30|rat liver cDNA
P01985920A0156|78 84|rat SCP2
P01985920A0156|110 125|825-base pair cDNA
P01985920A0156|151 154|SCP2
P01985924A0554|83 84|II
P01985924A0554|151 167|promoter-directed
P01985924A0554|191 192|II
P01986225A0250|31 33|HSF
P01986241A0117|20 27|ACE1 gene
P01986241A0117|66 79|promoter region
P01986241A0117|85 92|CUP1 gene
P01986254A0452|37 43|E6 motif
P01986254A0452|53 74|B-cell-specific complex
P01986254A0452|122 125|HeLa
P01986360A0000|19 43|interferon response element
P01986360A0000|79 107|mouse fibroblast lambda gt11 cDNA
P01986360A0000|122 125|a 32P
P01986360A0000|154 218|mouse (2'-5')oligoadenylate synthetase gene interferon response element
P01988041A0281|48 61|3018-bp BAL cDNA
P01989999A0000|16 52|synthetase (IMP:L-aspartate ligase (GDP)
P01989999A0000|17 55|ynthetase (IMP:L-aspartate ligase (GDP), EC
P01989999A0000|117 129|GTP-dependent
P01989999A0000|142 144|IMP
P01989999A0000|147 149|AMP
P01990254A0791|41 45|non-B
P01990254A0791|42 51|on-B, non-T
P01990254A0791|72 76|pre-B
P01990266A0678|0 12|DNA-protein UV
P01990266A0678|46 50|UHF-1
P01990266A0678|131 135|85 kDa
P01992459A0000|64 88|immunodeficiency virus mRNA
P01992459A0000|89 92|(RRE
P01992459A0000|97 115|Rev response element)
P01992459A0000|214 217|mRNA
P01992953T0000|0 22|Alanine aminotransferase
P01993181T0000|48 82|PpG7 salicylate hydroxylase gene (nahG)
P01993181T0000|89 105|3'-flanking region
P01993656A1860|6 13|ARF cDNAs
P01993656A1860|63 68|20-kDa
P01995951A0000|15 25|repeat (LTR)
P01995951A0000|36 61|immunodeficiency virus (HIV)
P01996312A0454|0 2|DNA
P01996312A0454|7 9|PCR
P01996312A0454|43 56|lambda gt11 cDNA
P01996312A0454|90 92|(Dd
P01999035A0383|98 100|IHD
P02000093A0794|0 14|Landsberg (La-O)
P02002051T0000|0 11|Isoform C beta
P02002051T0000|56 82|cAMP-dependent protein kinase
P02002051A0276|27 41|full-length cDNA
P02002051A0276|95 103|C-subunit
P02002511A0637|21 25|PB-PK
P02004521A0266|27 28|CT
P02008982A0463|0 4|ELISA
P02010912A0366|73 76|MalT
P02010912A0366|121 125|pulAp
P02010912A0366|129 142|pulCp promoters
P02011924A0729|74 79|MU/day
P02011924A0729|82 90|alpha-IFN
P02015921A0523|21 31|Category pN1
P02015921A0523|36 39|pN1a
P02015921A0523|67 70|pN1b
P02016053A0752|33 36|E74A
P02016053A0752|66 81|C-terminal region
P02016053A0752|148 167|sequence-specific DNA
P02017414A0307|5 7|POI
P02017414A0307|40 47|Line RBC2
P02019572A0000|13 15|DNA
P02019572A0000|59 91|rat liver pyruvate kinase (L-PK) genes
P02019572A0000|122 166|chloramphenicol acetyltransferase reporter genes
P02019572A0000|205 212|3200 base
P02019572A0000|235 242|L-PK gene
P02019572A0000|308 320|hepatoma HepG2
P02019572A0000|351 371|ulture, fibroblast LTK-
P02019572A0000|352 385|lture, fibroblast LTK- cells, myogenic
P02019572A0000|386 390|C2C12
P02019572A0000|400 402|CHO
P02020082A0356|63 67|AaDO2
P02020082A0356|113 117|AaDO2
P02020082A0356|239 241|PCW
P02020314A1290|11 34|6 micrograms/kg/day GM-CSF
P02021630A1104|31 46|hydrogen-bonding
P02021630A1104|79 81|DNA
P02021630A1104|124 126|DNA
P02022188A0112|38 40|BJ1
P02022188A0112|129 131|DNA
P02022188A0112|160 186|mobility group proteins (HMGs)
P02022920A0334|3 15|C4BP alpha gene
P02022920A0334|86 88|UTR
P02023097A0000|8 40|immunodeficiency virus type 1 (HIV-1)
P02023904A0120|3 10|CDC7 gene
P02023904A0120|17 33|in-frame AUG codons
P02023904A0120|89 94|56-kDa
P02024488A0506|0 3|HeLa
P02024488A0506|33 39|nef gene
P02024488A0506|51 61|CMV promoter
P02024488A0506|67 74|HIV-1 LTR
P02024791A0582|0 11|MEASUREMENTS
P02024791A0582|12 14|AND
P02024791A0582|15 25|MAIN RESULTS
P02024791A0582|83 86|FEV1
P02024816A0521|7 11|ELISA
P02024816A0521|34 47|protein A (SP-A)
P02026144A0741|17 19|GUS
P02026144A0741|69 81|equences, NRS1
P02026144A0741|97 100|NRS2
P02026144A0741|133 142|domain UAS1
P02026147A0000|11 53|Ca2+/calmodulin (CaM)-dependent protein kinase
P02026147A0000|54 57|(CaM
P02026147A0000|136 137|II
P02026147A0000|138 147|CaM kinases
P02026461A0760|7 25|ases, DR4-homozygous
P02026461A0760|8 43|ses, DR4-homozygous, DRB1-heterozygous
P02026491A0399|41 43|NMF
P02027839A0250|51 52|(P
P02028125A0101|51 54|AIDS
P02029468A0296|0 7|Serum TNF
P02030910A0000|33 40|ETS1 gene
P02030910A1070|0 9|Polymerase
P02030910A1070|33 40|ETS1 cDNA
P02033038A0309|23 36|E3 polypeptides
P02033062A1169|69 94|chicken IGF-I 5'-flanking DNA
P02033062A1169|98 109|promoterless
P02034655T0000|21 46|alpha 4 integrin gene promoter
P02034655A1224|3 12|alpha 4 gene
P02034676A0267|3 12|homologues
P02034676A0267|18 30|rhombotin gene
P02036066A0000|22 39|long-term perfusion
P02036066A0000|57 95|hemoglobin polyoxyethylene conjugate (PHP)
P02038293A0919|1 22|onclusion: inlet type VSD
P02038293A0919|40 46|type TOF
P02038293A0919|127 129|VSD
P02038326A0538|69 71|80S
P02038326A0538|141 189|translation initiation factor 2 (eIF-2 alpha) in 43S-48S
P02038784A0317|17 19|ARC
P02041088A1053|30 33|DR60
P02041088A1053|78 81|DR60
P02041088A1053|101 144|reporter chloramphenicol acetyltransferase gene
P02041088A1053|165 188|delayed-early 39K promoter
P02044785A0000|40 66|retroperitoneal enterogenous
P02044950A0258|8 17|polymerase
P02044950A0258|45 54|U6 RNA genes
P02044975A0380|51 52|(P
P02045366A1149|38 41|KlaA
P02045366A1149|45 60|KlaB polypeptides
P02045366A1149|92 106|KlaC polypeptide
P02045366A1149|138 161|membrane-spanning domains
P02045524A0000|69 91|Drug Administration (FDA)
P02045524A0000|173 184|end-of-phase
P02045524A0000|185 186|II
P02045809A0331|27 53| sphaericus products, ABG-6184
P02045809A0331|72 76|BSP-2
P02046202A0625|26 28|IgA
P02052544A0641|15 27|DNA polymerase
P02052544A0641|28 29|II
P02052544A0641|100 112|DNA polymerase
P02052544A0641|113 114|II
P02052544A0641|130 133|DPB2
P02052592A0000|193 200|estrogen
P02052592A0000|239 256|interleukin 1 (IL-1)
P02052592A0000|260 294|tumor necrosis factor alpha (TNF-alpha)
P02052592A0000|341 394|granulocyte-macrophage colony-stimulating factor (GM-CSF)
P02055484A0538|9 11|PCR
P02055484A0538|40 43|ATG1
P02055484A0538|50 53|ATG2
P02061282A0447|16 20|pMxL1
P02061282A0447|120 128|pilin gene
P02061333A0784|42 49|acvA gene
P02061333A1359|102 113|thioesterase
P02061333A1359|189 201|ACV tripeptide
P02062116A0688|11 26|monoamine oxidase
P02062933A0738|67 69|AOF
P02064119A1172|43 53|L/min/% SaO2
P02064119A1172|83 93|L/min/% SaO2
P02064119A1172|106 123|subjects.(ABSTRACT
P02064119A1172|124 132|TRUNCATED
P02064119A1172|129 130|AT
P02064119A1172|135 143|250 WORDS)
P02069873X0000|26 41|vav protooncogene
P02072238T0000|0 15|Menetrier disease
P02075876T0001|28 40|response (EER)
P02075876A0408|23 25|EER
P02076620A0548|12 27|plasma fibrinogen
P02076816T0000|2 17|RME1-independent
P02076816T0000|82 85|IME1
P02079811A0407|39 44|EMB AZS
P02081463A0110|28 35|Spec gene
P02081463A0110|118 128|protein-DNA
P02083199A1175|0 13|Phosphopeptide
P02083199A1175|70 76|EGFR-IC
P02083199A1175|96 108|wild-type EGFR
P02083230A0938|34 46|signal peptide
P02083230A0938|73 97|707 amino acid residue domain
P02083230A0938|128 143|nsmembrane domain
P02083253A1512|3 12|TCF-1 alpha
P02083253A1512|42 57|TCR alpha enhancer
P02083253A1512|115 118|HeLa
P02083253A1512|139 148|TCF-1 alpha
P02083546A0000|62 117|99m technetium-hexamethylpropylene amine oxime (99mTc-HMPAO)
P02083546A0000|196 213|Alzheimer's disease
P02083546A0000|282 300|motor neurone disease
P02089054A0121|0 2|IdB
P02089054A0121|89 102|reversed-phase
P02089054A0121|165 166|UV
P02093741A0211|108 118|ool, MAXITAB
P02093888A0293|0 4|ARPIA
P02093888A0293|41 44|DBMS
P02094257T0000|17 34|adenosine deaminase
P02094257T0000|56 64|effusions
P02102823A0492|36 53|beta-glucuronidase
P02102823A0492|57 82|neomycin phosphotransferase
P02102823A0492|83 84|II
P02102823A0492|85 96|reporter gene
P02102831A1282|22 38|soybean actin genes
P02102831A1282|74 77|(CT)
P02102831A1282|103 120|pyrimidine-rich DNA
P02103140A1088|92 107|ABO-incompatible
P02105497A1092|46 52|34 HSP70
P02105497A1092|86 93|BiP genes
P02105497A1092|137 146|HSP70 genes
P02107073A0584|31 34|STE4
P02107073A0584|38 42|STE18
P02107073A0584|111 114|STE4
P02107073A0584|147 151|STE18
P02107548A0727|7 23|transcription-PCR
P02107548A0727|51 61|poly(A)+ RNA
P02107548A0727|65 68|cDNA
P02107548A0727|105 110|psi ARF
P02107548A0727|130 132|ARF
P02109544A0000|132 148|leukocyte esterase
P02109544A0000|205 217|antibody (DFA)
P02110145T0000|22 63|imipenem-cefoxitin-hydrolyzing enzyme (CfiA)
P02110145T0000|87 93|TAL2480
P02110145T0000|124 127|CfiA
P02110145T0000|131 158|Bacillus cereus beta-lactamase
P02110145T0000|159 160|II
P02110148A0423|9 15|HindIII
P02110148A0423|40 42|DNA
P02110148A0423|90 101|. subtilis IF2
P02110148A0423|193 203|2.76-kb ClaI
P02110148A0423|242 244|IF2
P02111015A0574|47 63|DNA-binding domain
P02111015A0574|115 138|IFN response factors (IRF-1
P02111015A0574|142 147|IRF-2)
P02113699A0372|85 87|(N+
P02113699A0372|88 90|IM)
P02113699A0372|144 146|(N+
P02113699A0372|147 149|IS)
P02113699A0372|203 205|(N-
P02113699A0372|206 208|IS)
P02113901A0000|86 100|O2 tension (PaO2)
P02115111T0000|77 89|nif gene region
P02115111T0000|93 115|nabaena sp. strain PCC7120
P02115115A1053|46 60|sites homologous
P02115115A1053|66 72|CAR1 URS
P02115115A1053|91 108|5'-flanking regions
P02115115A1053|128 137|yeast genes
P02115116A1137|61 76|promoter elements
P02115118A0565|35 44|smg p25A GDI
P02115118A0565|112 152|sucrose density gradient ultracentrifugation
P02115121A0000|67 98|alpha-ketoglutarate dehydrogenase
P02115121A0000|132 165|dihydrolipoyl transsuccinylase (KE2)
P02115122A0562|80 84|c-Fos
P02115122A0562|91 95|v-Fos
P02115122A0562|122 126|c-Fos
P02115572A1323|17 33|V lambda pseudogene
P02115572A1323|69 82|U266 lambda gene
P02115889A0436|52 58|Gx alpha
P02115889A0436|78 88|60 kilobases
P02116071A0000|172 174|IgE
P02116071A0000|322 324|IgG
P02116537A1237|53 55|MIC
P02116537A1237|58 60|AMK
P02117799T0000a|6 19|orthoclone OKT3
P02117799T0000b|6 19|orthoclone OKT3
P02118519A0516|32 46|consensus motifs
P02118519A0516|104 128|nerve growth factor receptor
P02118519A0516|135 140|68-kDa
P02118525A0737|36 46|CCK promoter
P02118525A0737|117 157|herpes simplex virus thymidine kinase promoter
P02118612A0629|39 43|DOPAC
P02120707A0594|74 82|V elements
P02120707A0594|103 109|HLA-DRA
P02120833A0000|13 20|1-3 cases
P02120833A0000|23 67|transfusion-associated hepatitis NANB (TAH-NANB)
P02120833A0000|96 100|1 case
P02121371T0000|3 5|NF1
P02121371T0000|56 58|GAP
P02121371T0000|62 69|yeast IRA
P02123029A0478|39 48|chain genes
P02123029A0478|76 85|spleen cDNA
P02123029A0478|107 113|Raja VH-
P02123029A0478|117 128|CH1-specific
P02123295A0645|12 15|ARF2
P02123300T0000|16 26|DNA-derived
P02123300T0000|54 58|VIII)
P02123300T0000|98 107|Factor VIII
P02123466A0272|32 35|AP-4
P02123466A0272|36 38|HLH
P02123466A0272|102 117|site-specific DNA
P02123467A0811|81 85|MyoD1
P02123467A0811|159 169|exogenously
P02123467A0811|184 188|MyoD1
P02123820A0000|19 42|monoamine oxidase (MAO)--A
P02123820A0000|74 78|MAO-B
P02123820A0000|102 117|non-selective MAO
P02123820A0000|156 187|footshock-induced aggression (FIA)
P02123875A0223|49 56|c-region
P02123875A0223|96 110|signal peptidase
P02123875A0223|201 204|COOH
P02123875A0223|259 261|NH2
P02123875A0223|345 355|pro)apoA-II
P02123877A1452|29 38|egr-1 mRNAs
P02123877A1452|80 94|iver cells, fos-B
P02123877A1452|203 221|immediate-early gene
P02124433A0235|3 21|48 patients, 819 cases
P02124433A0235|95 97|MMC
P02124433A0235|99 124|5-FU:chemotherapy) 253 cases
P02124433A0235|141 143|MMC
P02124433A0235|145 148|5-FU
P02124433A0235|150 155|OK-432
P02124433A0235|158 180|PSK:immunochemotherapy)
P02124710A0193|38 56|c-jun protooncogenes
P02124710A1624|41 54|Fos-Jun complex
P02124710A1624|59 62|AP-1
P02124710A1624|72 80|type alpha
P02124710A1624|82 97|collagen promoter
P02124710A1624|140 143|VDRE
P02125016A0145|0 3|PBSX
P02125016A0145|35 37|SOS
P02126417A0408|93 95|VHF
P02131652A0883|93 115|gastrin release (AUC0-120
P02131652A0883|170 175|VTP-HM
P02131652A0883|185 191|VTP-Cas
P02131666A0483|31 50|61 examinees class II/2
P02131902A0000|76 80|(TEE)
P02131902A0000|130 144|ventricle (S-LV)
P02132636A0188|51 54|8 DST
P02133731A1572|6 9|(CBF
P02133731A1572|22 25|(CBF
P02133731A1572|28 37|9-0%), %WTh
P02133731A1572|29 43|-0%), %WTh, 1/TPC
P02133731A1572|39 41|1/T
P02135343A0131|169 174|ANGLE3
P02135536A0621|88 90|MPa
P02138707A0198|73 83|protein mXBP
P02138707A0198|143 144|II
P02138707A0198|150 184|histocompatibility complex A alpha gene
P02138707A0198|200 219|transcription element
P02138707A0198|243 244|II
P02138915A1060|3 9|p36 gene
P02138915A1060|96 109|gene.(ABSTRACT
P02138915A1060|110 118|TRUNCATED
P02138915A1060|115 116|AT
P02138915A1060|121 129|250 WORDS)
P02139473A1603|60 63|entC
P02139473A1603|161 174|Shine-Dalgarno
P02139891A0532|52 64|activators EIA
P02139891A0532|68 70|EIV
P02139891A0532|96 104|TAGA motif
P02139891A0532|119 122|TATA
P02139891A0532|130 133|EIIF
P02139891A0532|175 182|ATF/CREB
P02141425A0175|15 38|fingertip-to-floor (MFTF)
P02142240A0506|79 95|estrogen receptors
P02142240A0506|108 127|progesteron receptors
P02142993A0176|59 71|anthropogenic
P02143023A0729|18 32|octamer elements
P02143023A0729|104 118|octamer elements
P02143186A0867|19 27|16 introns
P02143186A0867|38 41|AHA3
P02143186A0867|39 46|HA3, AHA2
P02143186A0867|70 90|5'-untranslated region
P02143186A0867|112 133|C-terminal coding region
P02143186A1306|33 40|AHA2 mRNA
P02143186A1306|64 66|RNA
P02143961A0400|72 75|pCPA
P02144610A1306|0 7|TCR alpha
P02144610A1306|11 18|beta gene
P02144610A1306|87 99|T beta 2 element
P02144610A1306|119 144|AMP response element-binding
P02144610A1306|173 179|e T alpha
P02144610A1306|174 187|T alpha 1 element
P02144610A1306|198 213|TCR alpha enhancer
P02144610A1306|220 233|decamer element
P02144610A1306|271 286|TCR beta promoters
P02145268A0746|92 104|collagen genes
P02145268A0746|143 152|COL3A1 gene
P02145268A1454|36 41|EDS-IV
P02145268A1454|52 59|cyanogen
P02145268A1454|79 89|collagenase
P02146266A0000|1 25|4.8-kilobase BamHI-HindIII
P02146266A0000|51 93|Neurospora crassa CuZn superoxide dismutase gene
P02146266A0000|155 161|60-base
P02146495A0706|85 103|leucine zipper domain
P02146495A0706|139 141|CRE
P02147223A1047|14 16|CRE
P02147223A1047|27 39|c-fos promoter
P02147223A1047|70 73|cAMP
P02147223A1047|86 89|HeLa
P02147223A1047|93 96|PC12
P02147422A0000|49 59|U1-70K snRNP
P02148291A0173|25 27|HSE
P02148291A0173|76 92|HSE binding domains
P02148291A0173|145 154|DNA-ligand
P02148508A0374|0 10|Fluid (AVLF)
P02148508A1478|44 46|TCM
P02148799A0000|3 9|nmr gene
P02149566A0478|10 18|P-31 NMR-S
P02149566A0478|45 48|[Pi]
P02149566A0478|66 70|[PCr]
P02149566A0478|102 104|LVH
P02151229A0000|41 72|N-isopropyl-123I-iodoamphetamine
P02151229A0000|106 119|tomography (CT)
P02151229A0000|176 181|(NIDDM
P02151229A0000|233 239|mmol/L)
P02151229A0000|279 285|mmol/L)
P02151229A0921|0 10|Mean ROI-A/B
P02153243A0965|47 55|int-2 gene
P02153683A1579|81 105|uvomorulin or Na+,K+-ATPase
P02153977A0364|71 75|mRNAs
P02154467A0709|3 5|PC2
P02154467A0709|52 63|NH2-terminal
P02154467A0709|82 90|furin gene
P02154467A0709|108 137|membrane-inserted receptor-like
P02154474A1504|39 42|cAMP
P02154474A1504|96 108|steroidogenic
P02154474A1504|109 118|P-450 genes
P02154599T0000|3 19|zta transactivator
P02154599T0000|46 54|cycle gene
P02154599T0000|67 78|Epstein-Barr
P02154599T0000|115 118|AP-1
P02154599T0000|122 124|ZRE
P02154599T0000|132 145|target promoter
P02154599T0000|149 163|enhancer regions
P02154599A0382|95 103|Zta fusion
P02154599A0382|130 147|TGTGCAA-like motifs
P02154599A0382|154 156|DSL
P02154686A0185|22 45|21-base-pair repeat region
P02154686A0185|97 114|beta-galactosidase
P02154686A0185|149 174|polyomavirus enhancer region
P02154885A0153|19 29|mutagenesis
P02155017A1106|21 23|LMW
P02156828A0164|118 129|pH-sensitive
P02157141A0923|39 51|topoisomerase
P02157141A0923|69 71|DNA
P02157141A0923|114 135|T-antigen-dependent DNA
P02157141A0923|186 191|50 base
P02157764A1115|104 107|cDNA
P02158099A0487|51 54|(CCL
P02158099A0487|59 64|pM1 DNA
P02158099A0487|125 139|pSV2CAT reporter
P02158927A0000|46 54|7.5-kb COR
P02158927A0000|95 99|(CYC1
P02158927A0000|101 104|UTR1
P02158927A0000|102 109|TR1, UTR3
P02158927A0000|103 114|R1, UTR3, OSM1
P02158927A0000|104 124|1, UTR3, OSM1, tRNA(Gly)
P02158927A0000|128 132|RAD7)
P02159559A0779|37 50|HSV-induced DNA
P02160955A0899|27 32|AATAAA
P02160955A0899|39 51|GT-rich region
P02162049A0291|66 68|DNA
P02162103A0000|23 27|cDNAs
P02162103A0000|42 44|RNA
P02162103A0000|48 51|mRNA
P02162103A0000|55 71|phosphoprotein (P)
P02162103A0000|79 108|parainfluenza type 2 virus (PIV-2)
P02162103A0000|80 113|arainfluenza type 2 virus (PIV-2). cDNA
P02162103A0000|130 132|RNA
P02162103A0000|168 174|poly(A)
P02162467A0311|10 13|cytR
P02162467A0311|51 54|CytR
P02162467A0311|88 102|cAMP/CAP complex
P02162754A0339|53 82|3T3-L1 adipocyte insulin receptor
P02162754A0801|0 2|PAO
P02163347A0472|3 6|cDNA
P02163347A0472|30 46|reading frame (ORF)
P02163382A0169|17 28|O7-LPS region
P02163382A0169|44 57|cosmids pJHCV31
P02163382A0169|61 67|pJHCV32
P02163382A0169|85 105|transposon mutagenesis
P02163382A0169|110 117|Tn3HoHo1
P02163382A0169|132 143|promoterless
P02163382A0169|144 152|lac operon
P02163382A0169|176 179|lacZ
P02163382A0169|206 214|target DNA
P02163394T0000|3 10|sacT gene
P02163394T0000|24 34|sacPA operon
P02164585A0416|3 6|TraD
P02164585A0416|83 102|amino-terminal region
P02164585A0814|19 22|orfD
P02164585A0814|43 49|tra gene
P02164585A0814|56 60|traX)
P02164588A0266|13 19|HN genes
P02164588A0266|72 90|signal-anchor domain
P02164588A0266|160 161|HN
P02164604A0399|43 63|E2 transactivation gene
P02164604A1574|77 81|BPV-1
P02164637A0515|15 22|IRA2 gene
P02165589A0000|52 56|2C1-3
P02165589A0000|126 140|hormone receptor
P02165589A0888|10 17|Region II
P02166040A0385|38 46|PEPCK gene
P02166040A0385|114 149|P-enolypyruvate carboxykinase promoter
P02166040A0385|205 238|amino-3-glycosyl phosphotransferase
P02166040A0385|246 277|chloramphenicol acetyltransferase
P02166040A0385|462 494|chloroamphenicol acetyltransferase
P02166416A0419|67 70|ARDS
P02166825A0198|200 213|promoter region
P02167321T0000|1 8|DNA motif
P02167321T0000|21 42|cAMP-responsive element
P02167321T0000|48 59|exon-located
P02167321T0000|99 141|tissue-type plasminogen activator gene promoter
P02167321T0000|204 207|cAMP
P02167467T0000|3 9|26S rRNA
P02167784A0109|51 57|CO2/95%
P02167784A0109|106 129|steady-state end-tidal CO2
P02168640A0268|51 54|SSEP
P02168640A0268|67 68|AS
P02168640A0268|140 150|psychogenic
P02169887A0360|85 92|EMCV-RNA
P02169887A0360|103 107|mRNAs
P02170687A0000|3 15|E6/E7 promoter
P02170687A0000|85 101|transforming genes
P02173399A0333|63 85|tissue radiographs (STRs)
P02174427A1574|94 137|wild-type ubiquinol-cytochrome c oxidoreductase
P02174861A0736|12 15|irgA
P02174974A0000|68 70|TOL
P02174974A0000|113 120|xylR gene
P02175433A0575|31 46|beta A-globin gene
P02175908A0805|48 61|Ulysses element
P02176152A0896|14 15|RA
P02176152A0896|54 65|reporter gene
P02176152A0896|77 79|TPA
P02176152A0896|90 92|AP1
P02176152A0896|114 126|HSV tk promoter
P02176209A0954|21 23|EFI
P02176209A0954|22 28|FI, NF-Y
P02176209A0954|32 38|CBF DNAs
P02176232T0001|65 66|II
P02176232T0001|69 72|IIIA
P02176822A0000|15 33|protein kinase (MFPK)
P02176822A0000|48 63|ATP-citrate lyase
P02176822A0000|80 86|ites, BT
P02176822A0000|90 91|BS
P02176822A0000|159 174|glycogen synthase
P02179815A0582|30 41|protein in CEF
P02179815A0582|89 98|JD214c-rel
P02179815A0582|107 109|CEF
P02180935A0535|87 91|HL-60
P02181760A0311|34 51|Doppler ultrasound)
P02182240A0355|27 38|anistreplase
P02182323A0121|36 53|tRNA(Val)(UAC) gene
P02182618A0168|55 95|chloramphenicol acetyltransferase (CAT) gene
P02182618A0168|139 155|5'-flanking region
P02183467A0668|15 18|ORFs
P02183467A0668|39 41|BIV
P02183467A0668|188 191|ORFs
P02185140A0000|26 33|14DM gene
P02185140A0000|43 91|cytochrome P450 lanosterol 14 alpha-demethylase (14DM)
P02185140A0000|177 203|yeast transcription promoters
P02185140A0000|204 209|(pADC1
P02185140A0000|211 214|pGPD
P02185140A0000|212 221|GPD, pPHO5)
P02185250A0726|147 159|SRP-dependent
P02187871T0000|3 6|ANB1
P02187871T0000|47 84|protein synthesis initiation factor eIF-4D
P02188168A0000|0 39|Serum beta 2-microglobulin levels (beta-2-M)
P02188168A0000|102 106|HIV-1
P02188168A0000|153 163|generalized
P02188168A0000|164 186|lymphadenopathy (P.G.L.)
P02194273A0913|30 38|pathogens
P02194972T0000|29 31|(HR
P02195025T0000|12 20|yeast LEU2
P02196176A0749|0 4|TREB7
P02196176A0749|8 13|TREB36
P02196176A0749|51 55|TREB5
P02196311A1034|23 29|5 KE X 3/W
P02196311A1034|83 85|RNL
P02196450A0870|80 82|QBP
P02196450A0870|169 171|QBP
P02196450A0870|202 225|TATA-independent promoter
P02196565A0606|29 54|(GRFI)/repressor/activator
P02196565A0606|74 91|(RAP1)/translation
P02196565A0606|100 110|factor (TUF)
P02196565A0606|138 145|MAT alpha
P02196565A0606|174 177|PYK1
P02196565A0606|206 218|GRFI/RAP1/TUF
P02198259A0685|41 44|repA
P02198259A0685|51 58|69 codons
P02198259A0685|81 89|286-codon
P02198289A0436|117 119|DNA
P02199311A0620|117 120|RET1
P02199311A0620|142 145|tRNA
P02200150A1381|83 102|ncologist, geneticist
P02200315A0278|0 2|IgG
P02200315A0278|6 16|IgM antibody
P02200736A1003|64 67|AP-4
P02200736A1003|71 74|MLTF
P02200736A1003|89 101|CACCTGTC motif
P02201770A0188|42 57|(Anomiopsyllinae
P02201901A0229|59 62|SSN6
P02201905A1004|31 34|ABFI
P02201905A1004|50 53|RAP1
P02204029A0184|0 4|RNase
P02204029A0184|110 116|130 base
P02204621T0000|52 77|tRNA nucleotidyltransferase
P02204621T0000|105 130|tRNA nucleotidyltransferase
P02204623A0000|3 21|juxtamembrane region
P02204623A0000|27 57|insulin receptor (IR) beta-subunit
P02204623A0000|84 105|tyrosyl residue (Tyr960)
P02204623A0000|170 179|endogenous
P02204623A0000|219 224|(White
P02204623A0000|226 229|M.F.
P02204623A0000|228 245|F., Livingston, J.N.
P02204623A0000|230 257|, Livingston, J.N., Backer, J.M.
P02204623A0000|233 277|vingston, J.N., Backer, J.M., Lauris, V., Dull, T.J.
P02204623A0000|294 300|ahn, C.R
P02204625A1130|88 95|mitogens
P02204810A1080|6 14|egion, GA2
P02206430A0197|79 80|DA
P02206858A0000|10 21|protein C (PC)
P02209237A0239|22 34|shunting (IPS)
P02209237A0239|52 57|4 cases
P02209237A0239|94 102|99mTc-MAA
P02209243A0237|12 33|otein, serum albumin, BUN
P02209243A0237|37 39|SCr
P02209605A0510|21 28|MSAS gene
P02209811T0000|11 20|peroxidase
P02213566A0000|12 27|coenzyme Q10 (CoQ)
P02218094A0395|16 36|tissue O2 transfer (Ft')
P02218094A0395|53 70|O2 utilization (Fm')
P02219751A0517|55 58|FEMs
P02220304A0501|34 51|medium MS risk region
P02220304A0501|93 94|MS
P02220304A0501|129 130|MS
P02223652A0939|5 27|ntithrombin unit basis, CY
P02223652A0939|34 35|CY
P02223652A0939|70 71|UH
P02223773A0000|0 39|Chick brain actin depolymerizing factor (ADF)
P02223773A0000|43 48|19-kDa
P02223773A0000|88 100|actin monomers
P02225687A0546|44 52|teratogen
P02227438A0492|26 28|RNA
P02227438A0492|83 92|rat ODC mRNA
P02227438A0492|135 144|start codon
P02228615A0974|3 6|85Sr
P02229068A0156|55 62|env genes
P02229068A0156|89 93|COS-1
P02229068A0156|101 114|precursor SU-TM
P02229068A0156|102 127|recursor SU-TM (gp160), SU.TM
P02229282A0454|22 29|serum TNF
P02233680A1115|27 48|cis-regulatory elements
P02233680A1115|85 106|HaG3-A helianthinin gene
P02233715A0914|35 38|IL-6
P02233715A0914|61 68|IL-6 TATA
P02233715A0914|78 80|RNA
P02233715A0914|107 114|element)
P02233715A0914|124 132|MRE region
P02233715A0914|169 179|wild-type GR
P02236002A0958|112 130|chicken TCR beta cDNAs
P02236022A0000|3 15|protooncogene
P02236022A0000|66 68|DNA
P02236064A1178|0 7|S6 kinase
P02237431A0000|20 46|T cell receptor (TCR) alpha gene
P02237431A0000|114 122|kilobases
P02237431A0000|134 143|C alpha gene
P02237431A0833|34 54|17-base pair (bp) region
P02237431A0833|69 74|T alpha
P02241742A0766|50 51|HD
P02241892A0681|88 92|mRNAs
P02243093A0000|29 36|(HTLV-I)
P02243093A0000|45 50|40-kDa
P02243093A0000|107 113|21-base
P02243093A0000|134 141|U3 region
P02243386A0113|52 54|MHV
P02243386A0113|62 66|DI RNA
P02243386A0113|63 72|I RNA, DIssF
P02246362T0000|30 40|CPI-revised
P02246803A0692|25 39|non-invasive TTD
P02247069A0261|3 10|TUP1 gene
P02247069A0261|61 64|(V.L
P02247072A0794|3 7|SUP44
P02247081A0223|29 33|VPS34
P02247081A0223|101 109|VPS34 gene
P02248732A1113|93 94|LC
P02248732A1113|152 153|NA
P02248732A1113|167 171|DOPAC
P02249872A1051|83 95|800 microC/cm2
P02249872A1051|138 143|microC
P02251119A0319|49 74|U14 snRNA-homologous regions
P02251119A0319|123 140|hsc70 heat shock gene
P02252953A0300|47 49|EAT
P02253274A0000|63 81|closed-circular DNAs
P02253274A0000|133 144|mtDNA introns
P02254282T0000|33 52|Zymomonas mobilis gene
P02254418A0641|88 90|CNS
P02254749A0133|8 12|cDNAs
P02254749A0133|26 28|60K
P02254749A0133|27 32|0K, 87K
P02254749A0133|28 37|K, 87K, 110K
P02254749A0133|41 44|170K
P02254749A0133|89 101|ATG start codon
P02254749A0133|108 111|cDNA
P02254749A0133|125 127|60K
P02254749A0133|147 149|TAA
P02256678A1224|89 97|HSC82 gene
P02256678A1224|131 146|protein complexes
P02257899T0000|31 40|generation
P02259334A0205|87 93|Mr 39 kDa
P02259795A0570|81 88|water PO2
P02262439A0508|0 10|MCh infusion
P02262439A0508|18 48|concentration-dependent increase
P02262439A0508|77 79|QBA
P02264601A0000|77 79|(P)
P02264601A0000|87 110|alcohol nonpreferring (NP)
P02265055A0417|113 115|CSF
P02269426A0428|0 2|IST
P02269426A0428|11 24|RNA target (TAR)
P02269426A0428|100 110|ctivity, IST
P02269426A0428|136 138|RNA
P02269426A0428|206 209|mRNA
P02270834A0123|21 23|HML
P02277005A0227|3 4|CT
P02277452A0116|43 46|LVEF
P02277452A0116|44 52|VEF, LVESV
P02277452A0116|56 64|PSP/LVESV
P02277452A0116|166 168|ECG
P02278474A0000|0 34|Serum Fibrin Degradation Products (FDP)
P02280777T0000|3 21|uteroglobin promoter
P02280777T0000|43 50|estrogen
P02281330A0556|39 44|(FiO2)
P02281948A0245|76 88|sucrose (0.3M)
P02283378T0000|33 52|cephalosporin DQ-2556
P02283378A0385|97 111|ultrafiltration
P02284393A0751|69 75|e high EE
P02284393A0751|74 79|EE/low
P02284573A0943|12 13|IF
P02284573A0943|14 17|MoAB
P02284573A0943|25 27|BAL
P02284573A0943|95 97|BAL
P02284573A0943|96 101|AL, TBB
P02287860T0001|0 14|Ultrastructural
P02289639A0989|15 18|HbA1
P02290216T0001|42 52|serum SPan-1
P02291144A0493|114 118|MCHCH
P02291628A0264|71 73|NMR
P02293019A0000|0 23|Antileukoproteinase (ALP)
P02293019A0000|127 145|proteinases elastase
P02293019A0000|149 159|cathepsin-G
P02293664A0946|36 51|vimentin promoter
P02293664A0946|86 91|30 base
P02293664A0946|118 124|210 base
P02293664A0946|143 146|mRNA
P02296509A0997|38 45|anti-HIV
P02298741A0809|22 33|anti-peptide
P02298741A0809|56 64|lpha, beta
P02298741A0809|68 75|gamma PKC
P02298741A0809|104 106|PKC
P02298741A0809|121 122|JK
P02298741A0809|137 140|JKPE
P02298741A0809|169 173|82 kDa
P02298741A0809|218 238|anti-PKC alpha antibody
P02300541A0000|87 104|dose inhalers (MDIs)
P02300577A0852|63 77|endoglycosidase
P02300759A0000|110 121|forms (T1B-T2
P02303158T0000|68 78|trk oncogene
P02305014A0226|19 43|xperiments, Sprague-Dawley
P02307371A0263|178 206|Burkitt's lymphoma c-myc alleles
P02307613A0783|60 61|(P
P02307848T0042|50 61|Crry-ps genes
P02307848A0347|23 30|Crry gene
P02307848A0347|50 52|DNA
P02307848A0347|104 115|5.6-kb Eco-R1
P02307850A0000|6 11|RNK-16
P02307850A0000|63 92|cDNA rat NK cell protease 1 (RNKP-1)
P02307850A0000|123 137|serine proteases
P02307850A1197|14 19|RNKP-1
P02307850A1197|89 90|NK
P02308496A0000|55 58|ACTH
P02308496A0000|56 62|CTH, STH
P02308496A0000|57 66|TH, STH, TSH
P02308496A0000|60 96|STH, TSH, cortisol, T3, insulin, C-peptide
P02308496A0000|167 180|oxygen (GHM-10)
P02310300A0298|38 39|CT
P02310350A0221|82 85|ABRs
P02310496X0000|212 229|nucleus basalis (NB)
P02310496X0000|268 281|Broca (MS-VDBB)
P02311544A0086|47 50|MSMR
P02312470A0774|3 15|BAL-to-plasma
P02312470A0774|94 96|ELF
P02315472A0583|68 71|RASE
P02315472A0583|78 80|C/A
P02317413A0364|68 85|neutrophil elastase
P02317413A0364|188 199|heart disease
P02318208A0817|3 19|cis-acting element
P02318208A0817|33 43|CACGTGACCCG
P02318208A0817|158 163|Ad2MLP
P02319610A1527|99 103|P.HCl
P02320008A0651|0 5|TMBr-1
P02320008A0651|27 49|muscle alpha-tropomyosin
P02320008A0651|92 110|COOH-terminal region
P02323517A0557|113 135|prostaglandin generation
P02324102A1157|55 82|ell-surface proteoglycan, 48K5
P02324102A1157|107 114|(Marynen
P02324104A0151|26 57|cAMP-dependent phosphotransferase
P02324104A0151|101 111|homogenates
P02324104A0516|12 20|C subunits
P02324104A0929|13 20|C subunit
P02324104A0929|21 26|(CeCAT
P02324104A0929|27 32|alpha'
P02324104A0929|56 88|56-residue carboxyl-terminal region
P02324104A0929|95 103|generated
P02324104A0929|133 141|C pre-mRNA
P02324104A1195|159 168|CeCAT alpha
P02325895T0000b|19 33|mechanoreceptor
P02326716A0139|40 57|evaluation (T7-T12)
P02326716A0139|75 105|concave rib-vertebra angles (RVAs)
P02326716A0139|76 141|oncave rib-vertebra angles (RVAs), rib-vertebra angle differences (RVADs)
P02326946T0000|0 46|Plasma lecithin/cholesterol acyltransferase (LCAT)
P02327159T0001|7 13|AIDS--a
P02328328A0419|14 45|tatus, tumour progesterone receptor
P02329840A0383|85 89|[K+]o
P02330041A0335|80 83|hUBF
P02330041A0335|141 154|control element
P02330041A0335|167 182|rRNA gene promoter
P02330333A0325|19 24|(202Tl
P02332018A0538|19 45|exercise-induced asthma (EIA)
P02332018A0538|60 61|WH
P02332018A0538|110 115|mean GH
P02332798A0725|3 17|afferents' phase
P02332798A0725|53 55|EVS
P02333545A0313|22 31|fibrinogen
P02333749A0411|39 41|SPT
P02333749A0411|45 48|RAST
P02333749A0411|69 76|serum IgE
P02335034A0584|81 84|LBNP
P02335521T0000|2 40|NF1-related vitellogenin activator element
P02335521T0000|69 119|estrogen-regulated Xenopus laevis vitellogenin promoter
P02335713A0905|38 40|PbB
P02335713A0905|44 47|ALAD
P02335815A0530|66 70|TRF.C
P02339447A0162|17 32|[7,7-2H2]-19-OHA
P02339447A0162|73 82|[7,7-2H2]A
P02339447A0162|86 106|[9,11-2H2]estrone (E1)
P02339447A0162|141 156|serum level 19-OHA
P02340595A0124|93 101|tRNA genes
P02341669A0000|31 71|brain-stem auditory-evoked responses (BAERs)
P02341669A0000|97 146|seudorandom pulse trains: maximum length sequences (MLS)
P02341669A0000|150 171|Legendre sequences (LGS)
P02342477A1292|8 11|UfAP
P02342477A1292|15 18|UTMP
P02342477A1292|223 226|UfAP
P02342477A1292|233 236|UTMP
P02347102A0000|91 101|generalized
P02347407A0217|49 57|SE-sector
P02347655A0193|180 210|entilation, blood tissue perfusion
P02348225A0192|0 10|Mean (+/- SE)
P02348225A0192|58 67|mL/min/m2)
P02348728A1153|14 16|DNA
P02349827A0193|27 36|(Videoplan
P02349998A0297|0 11|Dopamine SERS
P02351239A0693|130 132|HDC
P02351239A0693|167 169|ECL
P02351239A0693|218 232|gastrin infusion
P02353453A1249|13 25|helicase motif
P02353453A1249|32 49|nsP3 homology region
P02353453A1249|55 57|RUB
P02353453A1249|90 99|alphavirus
P02353875A0800|116 143|eosinophils in non-atopic cases
P02354381A0207|10 30| treatments: control (C)
P02354381A0207|67 73|cage (S)
P02354381A0207|120 126|cage (H)
P02354381A0207|147 151|(H/S)
P02354381A0207|205 207|(N)
P02355920A0681|27 48|transcription factor SP1
P02355920A0681|87 120|proenkephalin germ cell cap site region
P02357537A0451|35 39|paCO2
P02357537A0451|42 44|pHa
P02358975A0709|120 122|IgA
P02360336A0574|58 62|40-mL
P02361575T0000|17 31|carcinogenicity
P02361575T0000|80 85|B6C3F1
P02361812A1110|3 10|kg FFM SMR
P02361812A1110|50 51|EX
P02361812A1110|116 118|(EX
P02361812A1110|134 135|DE
P02362161T0000|0 5|MK-927
P02362161T0000|48 56|anhydrase
P02362803A0608|0 10|PCR-derived
P02362803A0608|56 67|U3 snRNA genes
P02368931A0587|2 17|addition serum IgE
P02370571A0663|170 180|goitrogenic
P02371273A0144|52 61|55 kilobase
P02372496A0782|19 21|5FU
P02372496A0782|34 35|II
P02372496A0782|159 161|5FU
P02372712A0002|12 18|tap (TW)
P02372712A0002|31 34|(CW)
P02372712A0002|50 51|pH
P02372712A0002|70 88|carbon dioxide (PCO2)
P02373686T0000|29 56|chicken progesterone receptors
P02373686T0000|116 119|mRNA
P02373686T0000|125 143|mechanism generating
P02373686T0000|147 162|receptor isoforms
P02376023A0307|51 54|IgG1
P02376023A0307|55 56|(P
P02376023A0307|75 78|IgG4
P02376023A0307|79 80|(P
P02376023A0307|126 128|IgE
P02376023A0307|153 157|kU/l)
P02378615A0807|70 96|threonine/serine-rich region
P02383693A0301|102 105|M KOH
P02384389A0854|27 28|YG
P02384389A0854|42 43|YG
P02386485A0554|37 58|5'-end non-coding region
P02386485A0554|90 111|3'-end non-coding region
P02386485A0554|122 132|20 bp poly(A)
P02388685A0577|32 66|oyster shell supplementation generally
P02388685A0577|76 94|alkaline phosphatase
P02388685A0577|177 189|variation (CV)
P02390538A0000|119 127|ultrathin
P02390538A0000|146 153|(Olympus
P02390538A0000|154 157|PF18
P02390633T0000|38 61|graft-versus-host disease
P02390989A0745|29 35|GPB gene
P02390989A0745|30 40|PB gene, exon
P02390989A0745|47 53|GPE gene
P02390989A0745|106 114|stop codon
P02391344T0000|19 22|cDNA
P02391344T0000|31 59|rat NADH-cytochrome b5 reductase
P02392511T0000|0 21|Serotonin 5-HT2 receptor
P02393001A0324|8 10|%BF
P02393001A0324|34 37|BMIs
P02393001A0324|96 99|BMIs
P02393001A0324|102 104|%BF
P02393895A0918|3 4|RF
P02394707A0789|0 15|Promoter elements
P02394707A0789|33 45|TATA box (GTTA)
P02394707A0789|50 54|CCAAT
P02394707A0789|116 127|CCAAT (ATTGG)
P02395868A0322|93 110|main-chain hydrogen
P02398897A0000|43 55|RNA polymerase
P02398897A0000|56 57|II
P02398897A0000|128 130|RNA
P02399053A0153|0 13|Sprague-Dawley
P02399053A0153|43 52|oxygen (O2)
P02399053A0153|55 65|room air (RA)
P02399053A0153|99 100|RA
P02400457A0469|12 13|II
P02400457A0469|52 54|VO2
P02400457A0469|83 86|LBNP
P02402678A0463|91 93|ULV
P02403035A0621|68 75|fumarase
P02403634A0788|43 45|ATA
P02403634A0788|49 50|GC
P02403634A0788|124 143|muscle-specific genes
P02403634A0788|146 149|CArG
P02403634A0788|156 192|91 bp; myocyte-specific enhancer-binding
P02403634A0788|214 227|site homologies
P02403634A0788|253 263|muscle-CAAT
P02403926A0000|3 16|trk-2h oncogene
P02403926A0000|38 66|breast carcinoma cell line MDA-MB
P02403926A0000|79 94|DNA-transfection
P02403926A0000|99 104|NIH3T3
P02403926A0000|124 160|trk proto-oncogene receptor kinase domain
P02403926A0000|192 231|tivating sequence (Kozma, S.C., Redmond, S.M.
P02403926A0000|208 213|(Kozma
P02403926A0000|215 218|S.C.
P02403926A0000|217 233|C., Redmond, S.M.S.
P02403926A0000|218 244|., Redmond, S.M.S., Xiao-Chang
P02403926A0000|274 281|ynes, N.E
P02403926A0307|43 73|beta gal-trk receptor kinase fusion
P02403926A0307|182 187|NIH3T3
P02404451A1532|233 238|GM-CSF
P02405393T0000|53 56|ETS2
P02405393T0000|66 76|c-ets-2 gene
P02406570A0466|3 14|ABFI-binding
P02406570A0466|52 54|UAS
P02406570A0898|50 53|ARS1
P02406570A0898|80 83|ABFI
P02406570A0898|107 126|DNA replication at ARS1
P02409297A0984|10 27|antiserum generated
P02409297A0984|73 97|46-kilodalton polypeptides
P02409297A0984|121 132|polypeptides
P02409297A0984|155 159|HBsAg
P02411513A0667|22 28|N22/P22
P02417023T0001|6 24|superoxide dismutase
P02418701A0000|219 243|peroxidase-antiperoxidase
P02419327A0998|20 22|DNA
P02419327A0998|116 127|endonuclease
P02419327A0998|128 129|IV
P02419327A0998|162 164|DNA
P02420432A1060|106 116|serum PAPP-A
P02423533A1314|15 27|MAP1-specific
P02423533A1314|31 48|MAP2-specific mRNAs
P02423533A1314|96 112|MAP1-specific mRNA
P02423533A1314|136 142|rat PC12
P02423533A1790|3 7|cDNAs
P02423533A1790|58 67|chicken DNA
P02423533A1790|65 67|DNA
P02423850A0292|45 61|5'-flanking region
P02423850A0292|101 113|yeast CYC1 gene
P02427024X0000|143 152|generality
P02427812A0865|42 47|6-OHDA
P02427812A0865|55 62|alpha-MD
P02427869A0939|63 65|BHT
P02437625A0197|41 68|histoplasmosis syndrome (POHS)
P02437625A0197|90 106|degeneration (AMD)
P02437792T0000|26 32|amylase
P02437792T0000|27 39|mylase, lipase
P02437895A0000|155 176|hemisphere (LH)-damaged
P02437895A0000|223 244|hemisphere (RH)-damaged
P02438637T0000|17 18|IV
P02443028A0695|71 81|reperfusion
P02445751A0925|52 56|mRNAs
P02445751A0925|70 86|cytochrome oxidase
P02445751A0925|93 103|beta subunit
P02445751A0925|106 113|F1 ATPase
P02446871A1021|1 9|5.8S-like
P02446871A1021|37 53|5'-terminal region
P02446871A1021|83 90|LSU rRNAs
P02446871A1021|105 113|4.5S-like
P02449431A1121|0 2|ATP
P02449431A1121|54 56|ATP
P02449431A1121|55 61|TP, dATP
P02449431A1121|56 68|P, dATP, araATP
P02449431A1121|72 76|ddATP
P02452313A0114|0 7|ASL-8123
P02452313A0114|35 53|beta-adrenoreceptor
P02452313A0114|103 106|a pA2
P02452313A0114|184 191|ASL-8123
P02454390T0000|11 26|promoter elements
P02454390T0000|78 99|alpha 1-fetoprotein gene
P02455821A0099|25 46|1.8-kilobase AccI-EcoRI
P02455821A0099|106 113|UL region
P02455821A0099|119 123|EHV-1
P02456827A0899|3 14|4-AP (4-20 mM)
P02456827A0899|84 86|TEA
P02457922A0991|59 62|RNAs
P02457922A0991|106 128|2.8-kilobase (kb) message
P02458234T0000|76 78|EEG
P02459309T0000|0 9|Endogenous
P02459309T0000|10 16|release
P02461368A0162|109 112|cDNA
P02461368A0162|110 112|DNA
P02462305A1071|118 128|polypeptide
P02462523A0394|1 15|9.5-kb KpnI-SalI
P02462523A0394|36 38|DNA
P02462523A0394|60 65|su(Hw)
P02462523A0394|104 109|su(Hw)
P02462523A0394|130 147|P-element-mediated
P02464097T0000|95 113|reperfusion-induced
P02466414A0000|22 44|ogs, plasma viscosity (Ep)
P02466414A0000|75 92|blood viscosity (Ea)
P02466414A0000|126 144|exchange transfusion
P02466665A0202|8 18|IGF-binding
P02468795A1086|14 28|acid phosphatase
P02469451A0239|88 92|MAO-B
P02470955A0101|47 51|CSF AP
P02473156A0000|1 4|cDNA
P02473198A0613|49 53|86Rb+
P02473619A0202|220 222|IgE
P02473693A0174|41 50|rotein, HGB
P02473718A0000|86 105|catecholamine (5-HIAA
P02473718A0000|109 112|VMA)
P02473718A0000|110 127|MA), T-cells (OKT3+)
P02473718A0000|111 143|A), T-cells (OKT3+), T-helper (OKT4+)
P02473718A0000|112 163|), T-cells (OKT3+), T-helper (OKT4+), T-suppressor (OKT8+)
P02473718A0000|167 185|B-cells (EAC-rosette
P02473907A1338|3 7|84.1C
P02473907A1338|8 10|mAb
P02473907A1338|28 30|IgE
P02473907A1338|109 111|IgE
P02473942A1207|86 98|alpha-helical
P02474110A1039|75 85|enzyme (ACE)
P02474204A0105|79 98|hromogranin, a general
P02474356A0559|55 58|(T:N
P02475506A0878|3 6|mRNA
P02475506A0878|21 24|cDNA
P02475506A0878|42 51|polymerase
P02476664A0563|57 58|(D
P02477373A0930|10 13|TATA
P02477373A0930|26 31|29 base
P02479635A0659|51 59|PKI(1-31)
P02479635A0659|68 82|cAMP-stimulated
P02479823A0727|52 53|GC
P02479823A0727|76 79|TATA
P02480419A0735|37 56|1 (53.3%), cryptogenic
P02480959A0470|4 15|P-450scc mRNA
P02480959A0470|44 49|LH/hCG
P02480959A0470|222 225|cAMP
P02481230A1258|23 42|bovine alpha transgene
P02481779A0213|0 6|NIK-244
P02481779A0213|286 290|+/- SD
P02482293A1518|2 14|TNF-resistant
P02482293A1518|3 42|NF-resistant T24 bladder carcinoma cells, TNF
P02482293A1518|56 81|EGF-R tyrosine protein kinase
P02482293A1518|102 104|EGF
P02482511A0860|5 21|phosphodiesterase
P02482511A0860|167 176|naltrexone
P02483210A0000|40 46|amylase
P02483210A0000|41 53|mylase, lipase
P02483438A0498|75 91|phosphodiesterase
P02484714T0000|40 60|mouse estrogen receptor
P02485188A0415|9 24|chondroitinase AC
P02485188A0415|28 30|ABC
P02487898A0315|4 6|NGF
P02487898A0315|80 82|NGF
P02488148A1156|26 29|RSNA
P02489032A0000|19 28|chain (IgL)
P02489032A0000|40 48|generated
P02489032A0000|102 113|variable (VL)
P02489032A0000|124 131|(JL) gene
P02489032A0000|190 197|VL region
P02489753A0581|41 43|EMG
P02489753A0581|54 55|FB
P02489753A0581|117 118|CG
P02489753A0581|122 123|GF
P02492111A0670|52 55|LXRF
P02492111A0868|188 190|U.S
P02493644A0588|9 11|3T3
P02493644A0588|10 22|T3 cells, jun-D
P02493644A0588|66 70|jun-B
P02495745T0000|30 68|tissue-type plasminogen activator (AK-124)
P02496109A0754|41 55|ranscripts, gene
P02496109A0754|72 82|alpha region
P02496109A0754|233 243|alpha operon
P02496109A0754|295 297|IF1
P02497340A0989|20 32|antibody genes
P02497340A0989|49 50|JH
P02497340A0989|54 55|VH
P02498322A0226|11 30|DNA-protein complexes
P02498322A0226|72 75|HeLa
P02498652A0460|26 40|TSH beta promoter
P02498652A0460|65 98|TRH-responsive pituitary-derived GH3
P02500432A1416|32 34|CAT
P02500432A1416|74 81|kilobase
P02500432A1416|84 86|DNA
P02500432A1416|104 115|1.6-kilobase
P02500432A1416|168 174|CAT gene
P02502602A0323|68 76|acid-base
P02504603T0000|35 46|CDC group IIf)
P02505087A1037|91 94|GCN4
P02507523A0791|3 6|ORF1
P02507523A0791|44 47|ORF2
P02507523A0791|74 77|ORF1
P02507815A0000|26 35|cortex (VC)
P02508306A0528|8 19|infiltration
P02508726A0498|42 46|LiCO3
P02509123A0371|18 20|IFN
P02509123A0371|55 57|VEP
P02510242A0313|5 12|100 cases
P02510242A0313|15 30|post-transfusion
P02510242A0313|96 98|HBs
P02510242A0313|121 130|non-A non-B
P02510242A0313|209 211|CMV
P02511069A0532|87 95|Df(3L)RR2
P02511069A0532|111 119|DRE region
P02511430A0000|1 23|215-base-pair (bp) region
P02511430A0000|29 81|mouse MOPC 41 kappa light-chain immunoglobulin gene enhancer
P02511898A0000|46 58|Chagas disease
P02512010A0801|3 8|PETCO2
P02514498A0000|7 14|CO2/HCO3
P02514498A0000|99 105|pCO2/pH
P02514498A0000|160 180|Henderson-Hasselbalch
P02514498A0000|161 185|enderson-Hasselbalch. pCO2
P02518645T0001|8 20|Chagas disease
P02518691A0251|12 28|IL2R alpha promoter
P02518691A0251|65 67|DNA
P02518691A0251|155 168|kappa B enhancer
P02518691A0251|200 212|IL2R alpha gene
P02521674T0000|9 12|RNA-
P02521674T0000|97 100|nsP4
P02522297A0000|27 46|(TXA2)/prostaglandin
P02522297A0000|47 66|endoperoxide receptor
P02522297A0000|48 79|ndoperoxide receptor antagonist, SQ
P02523800A1178|36 43|CHS1 gene
P02523800A1178|78 85|a TGAAACA
P02523800A1178|128 161|alpha-factor-inducible BAR1 promoter
P02523800A1178|162 170|[Kronstad
P02525044A1026|3 24|recovery index (T25-T75)
P02526165X0000|9 20|Leser-Trelat
P02526165X0000|43 54|Leser-Trelat
P02527365T0000|0 13|Xenopus homolog
P02527365T0000|19 34|mos protooncogene
P02528329A0000|50 60|F1F0-ATPase
P02528329A0000|94 117|hydroxylamine mutagenesis
P02528329A0000|139 150|uncB (subunit
P02529378A0536|0 9|S1 nuclease
P02529378A0536|20 22|RNA
P02529378A0536|55 57|HIV
P02529378A0536|72 75|HeLa
P02529378A0536|129 139|nhancer, SP1
P02529378A0536|130 144|hancer, SP1, TATA
P02529378A0536|162 194|transactivation-responsive element
P02529378A0536|222 237|E1A/E1B-mediated
P02529378A0536|253 258|HIV LTR
P02530413A0195|3 25|upine position, plasma ANP
P02530470A0604|22 24|HBV
P02531203A0241|98 101|SSTS
P02532032A0385|22 30|ANF (pANF)
P02532032A0385|23 47|NF (pANF), aldosterone (PAC)
P02532032A0385|51 60|renin (PRC)
P02532210A0000|3 19|adenovirus E1A gene
P02534067A0316|64 78|plasma 17 alpha OH
P02534067A0316|65 112|lasma 17 alpha OH progesterone, 11 beta-desoxycortisol
P02534067A0316|66 117|asma 17 alpha OH progesterone, 11 beta-desoxycortisol, DHEA
P02534067A0316|182 250|nary excretion of androsterone, 11 beta OH androsterone, etiocholanolone, DHEA
P02534067A0316|198 217|ndrosterone, 11 beta OH
P02534067A0316|200 250|rosterone, 11 beta OH androsterone, etiocholanolone, DHEA
P02534067A0316|201 263|osterone, 11 beta OH androsterone, etiocholanolone, DHEA, and 16 alpha OH
P02535460A1443|0 2|RNA
P02536096A0327|2 5|HeLa
P02536096A0327|43 88|herpes simplex virus type 1 thymidine kinase promoter
P02536096A0327|100 135|chloramphenicol acetyltransferase gene
P02536096A0327|181 203|thymidine kinase promoter
P02536096A0327|221 256|chloramphenicol acetyltransferase gene
P02536160A0518|90 92|CAT
P02536160A0518|110 119|TK promoter
P02536160A0518|122 128|pUTKAT1
P02538450A0000|14 17|cDNA
P02538450A0000|78 99|Na,K-ATPase beta subunit
P02538656A0172|56 63|R regions
P02538720A0582|0 3|UbiA
P02538720A0582|26 43|polyubiquitin genes
P02538720A0582|60 77|cis-spliced introns
P02541251A1327|9 14|T2 gene
P02541251A1327|67 88|transcription factor SP1
P02541251A1327|95 105|TATA or CCAAT
P02541251A1327|192 197|T1 gene
P02542270A0000|26 40|chloroplast DNAs
P02542270A0000|100 120|C4 photosynthesis genes
P02542612A0530|0 9|S1 nuclease
P02542612A0530|20 22|RNA
P02542612A0530|87 108|NotI repeat promoter-CAT
P02542612A0530|183 185|RNA
P02543621A0788|13 15|DNA
P02543621A0788|20 26|15 cases
P02543679A1291|68 71|DnaJ
P02543679A1291|75 78|DnaK
P02543734A0414|85 106|IE1/2 enhancer/promoter
P02544059A0377|17 20|(PN2
P02544059A0377|26 31|14 MPa)
P02544059A0377|41 44|(PHe
P02544059A0377|51 56|14 MPa)
P02545357A0000|3 24|mustard chloroplast gene
P02545357A0000|51 52|II
P02545357A0000|56 59|III)
P02545903A0639|30 32|NS3
P02545903A0639|65 67|NS3
P02545903A0639|71 74|NS3A
P02545903A0639|77 94|BTV-10-infected BHK
P02545903A0639|116 121|BTV-10
P02547706T0001|138 146|allogenic
P02547706A0928|16 18|ISH
P02547706A0928|22 24|IHC
P02547706A0928|100 105|CMV-IP
P02547706A0928|109 111|IIP
P02547778A0786|34 37|ANT1
P02547778A0786|53 67|control elements
P02549036A0000|143 153|homogeneity
P02549036A0000|180 190|DNA-binding
P02549343A1008|17 19|gpI
P02549343A1008|48 51|mO74
P02549343A1008|98 100|gpI
P02549343A1008|105 116|VZV-infected
P02549343A1008|200 210|polypeptide
P02550118A0610|33 45|infiltrations
P02550682A0411|23 29|type IIc
P02550682A0411|57 59|IIc
P02550682A0411|61 63|III
P02552143A0748|0 2|VP5
P02552143A0748|52 87|chloramphenicol acetyltransferase gene
P02554310A0419|37 54|38-base-pair region
P02555177A0488|7 17|pet54::LEU2
P02555177A0488|78 96|COX1 introns aI5 alpha
P02555177A0488|89 91|aI5
P02555177A0488|100 106|aI5 beta
P02555177A0488|124 131|COX3 gene
P02555177A0488|150 157|COX1 mRNA
P02555177A0488|154 157|mRNA
P02555418A0973|25 38|non-Ig-related
P02555519A0798|58 61|CDR3
P02555519A0798|78 103|determining region) peptides
P02555519A0798|148 155|D-region
P02555703T0000|0 22|Tyrosine kinase oncogenes
P02556264A0278|4 8|TC-II
P02556264A0278|39 49|kappa B motif
P02556264A0278|57 74|kappa chain enhancer
P02556264A0278|187 197|kappa B motif
P02556269A0187|3 5|DNA
P02556269A0187|105 134|single-strand-specific nuclease
P02556269A0187|190 192|DNA
P02557217A0000|1 18|eta-endorphin, ACTH
P02557217A0000|86 109|spray administration 200 IU
P02557217A0398|37 58|beta-endorphin increase
P02557217A0398|80 109|corticotrophin-cortisol release
P02557350A0632|3 5|DNA
P02557350A0632|33 39|SRP54sc
P02557350A0632|43 49|SRP54sp
P02557350A0632|77 84|SRP54mam
P02559630A0270|53 110|omboplastin times, prothrombin times, thrombin times, fibrinogen
P02559630A0270|130 146|fibrin/fibrinogen
P02560415T0012|4 13|neurogenic
P02560415T0012|47 57|face regions
P02562787A0637|35 44|NBP" (CNBP)
P02562825A0413|16 21|beta-2
P02565807A1198|14 30|neu proto-oncogene
P02565807A1198|41 46|kinase
P02565807A1198|109 129|NIH 3T3 cells.(ABSTRACT
P02565807A1198|130 138|TRUNCATED
P02565807A1198|135 136|AT
P02565807A1198|141 149|250 WORDS)
P02566613T0000|0 15|Somatostatin gene
P02566613T0000|60 90|cell-specific DNA control elements
P02566613T0000|94 104|DNA-binding
P02566613A0831|36 71|cAMP-responsive enhancer (CRE) TGACGTCA
P02568930T0000|31 34|cDNA
P02568930T0000|93 95|CD2
P02571924A0000|122 134|undecapeptide
P02573303A0000|28 31|(LV)
P02573303A0000|58 85|end-expiratory pressure (PEEP)
P02573303A0000|112 113|LV
P02573336A0000|17 35|return-of-fear (ROF)
P02573336A0000|178 180|ROF
P02573829T0000|26 44|homeodomain-binding
P02573829T0000|124 139|segmentation gene
P02573836A0244|38 40|NBS
P02573836A0244|156 178|ucleotide binding, GXGKST
P02574016A0428|20 22|TOF
P02574052A0910|62 78|beta-adrenoceptor
P02574193A0663|34 86|Institute Withdrawal Assessment-Benzodiazepines (CIWA-B)
P02575490A1021|36 41|oIGF-I
P02575959A0643|78 89|training (T2)
P02576405A0223|21 23|VAD
P02576405A0223|59 111|elphalan, a CBV combination (cyclophosphamide-BCNU-VP-16)
P02576405A0223|116 132|EDAP regimen (VP-16
P02577458A0412|70 109|nzyme inhibitors, alpha-adrenergic receptor
P02577867T0000|28 35|oncogene
P02580830A1131|66 72|AFP gene
P02580830A1131|123 134|mouse AFP gene
P02582240A1009|4 10|ATP/GTP
P02582240A1009|37 39|RNA
P02582240A1009|57 64|3'-dCTTT
P02582240A1009|81 87|ATP/GTP
P02582240A1009|102 120|initiation at 3'-dCCC
P02582918A0000|6 47|epatitis B vaccine immunization, serum antibody
P02582918A0000|74 80|33 cases
P02582918A0000|85 92|anti-HBs
P02582918A0000|104 106|S/N
P02582918A0000|107 110|(S/N
P02582918A0000|129 136|anti-HBs
P02585492A1005|77 82|P1 parA
P02585492A1005|85 88|parB
P02586485A0511|0 4|GN101
P02586485A0511|1 12|N101, YC819-9
P02586485A0511|17 19|SB3
P02586513A0622|95 98|RNAP
P02586513A0622|99 100|II
P02586513A0622|143 157|zinc finger motif
P02586513A0622|183 205|carboxyl-terminal domain
P02590097A0093|34 45|infiltration
P02590097A0093|118 137|gammopathy (IgA--Type
P02590540A0741|46 47|CA
P02590869A0743|3 13|GALT-primed
P02590869A0743|32 39|serum IgG
P02590869A0743|33 49|erum IgG, lavage IgG
P02590869A0743|53 55|IgA
P02590869A0743|68 70|LNA
P02590869A0743|115 116|SC
P02591078A0000|134 137|OKT6
P02591969A0961|52 58|ADH gene
P02592640A0466|26 38|beta-carotene
P02592640A0466|238 250|beta-carotene
P02592961A0327|0 5|COGLAB
P02595451A1136|18 34|aniridia gene (AN2)
P02595451A1136|48 77|T-cell leukemia breakpoint (TCL2)
P02595451A1136|115 118|MIC1
P02597484A0624|35 47|platelets (De)
P02597484A0624|79 81|(K)
P02598034A0000|28 44|potentials (MAEPs)
P02599995A1031|47 54|times MBC
P02600306A0140|59 71|envelope phase
P02600306A0140|138 139|AM
P02601707A0986|32 36|DNase
P02601707A0986|140 144|BC3H1
P02602150A0993|62 77|sequence elements
P02602150A0993|87 109|replication origin region
P02602150A0993|139 148|generation
P02605160A0000|23 26|59Fe
P02605182A0936|51 87|16-residue amino-terminal signal peptide
P02605182A0936|114 135|239-residue polypeptide
P02607766A0000|59 86|a quality control material (QCM)
P02607766A0000|121 131|cadmium (Cd)
P02607766A0000|136 147|microgram/L)
P02607766A0000|151 158|lead (Pb)
P02607766A0000|164 177|micrograms/dL)
P02607766A0000|206 208|QCM
P02607766A0000|225 237|micrograms/L)
P02607766A0000|226 249|icrograms/L), mercury (Hg)
P02607766A0000|279 292|micrograms/dL)
P02617623A0740|0 5|LON-72
P02617623A0740|10 24|solates), LON-73
P02617623A0740|11 34|olates), LON-73 (1), LON-71
P02617623A0740|41 46|LON-10
P02623038A0632|25 31|FR-task
P02627159A0899|3 30|antigen-specific IgG4 antibody
P02629109A0000|109 118|paralleled
P02630543A0210|35 40|anti-T
P02631505A0382|0 14|Ampicillin (AMP)
P02631505A0382|28 46|aminoglycoside (AMI)
P02631505A0382|68 74|16 cases
P02631743A0275|75 79|H-R-R
P02631887A0000|26 29|HGGM
P02631887A0000|34 46|non-Hodgkin's
P02632904A0619|18 23|VE/VO2
P02632904A0619|27 31|Q/VO2
P02634490A0186|81 82|CT
P02634490A0186|114 116|ATB
P02637597A0362|68 75|serum ANA
P02637597A0362|69 79|erum ANA, IgA
P02637597A0362|83 85|IgM
P02637597A0362|101 103|IgG
P02641762T0001|8 19|heart disease
P02641762T0001|93 97|SPECT
P02642466T0000|47 63|membrane immunogen
P02644735A0427|2 3|FP
P02644735A0427|3 19|P mutant, AcFP875-2
P02644735A0427|44 57|. frugiperda DNA
P02645276T0088|15 18|RIP1
P02647918A0423|21 22|GH
P02647918A0423|26 38|somatomedin-C
P02647918A0588|71 72|GH
P02647918A0588|115 127|somatomedin-C
P02647918A0588|161 162|GH
P02647918A0588|196 199|OGTT
P02647918A0588|281 282|GH
P02647918A0588|293 300|TRH/GnRH
P02648396A0565|33 41|c-jun mRNA
P02648396A1033|40 43|RECs
P02648396A1033|92 104|tumor promoter
P02648646A0216|129 142|capacity (Vp30)
P02648646A0932|39 50|baseline PC40
P02649445A0412|4 5|BG
P02649445A0412|9 11|IRI
P02649445A0412|35 38|OGTT
P02651448A0000|12 18|release
P02651448A0000|32 40|diffusion
P02651448A0000|118 122|(Type
P02651448A0000|164 168|(Type
P02651487A0000|206 220|glucagon release
P02655381A0000|136 165|ypogonadism, hyperprolactinemia
P02656257A0000|3 18|site-specific DNA
P02656257A0000|75 85|recombinase
P02657388A1011|3 18|terminator region
P02657388A1011|63 75|RNA polymerase
P02657883A0000|0 9|US-Doppler
P02657883A0000|97 109|fistulas (FAV)
P02664229A0138|139 142|ease
P02666034A1520|88 102|beta-adrenergic
P02666404A0220|117 133|HepG2-erythrocyte
P02666404A0220|234 251|arabinose permeases
P02666568A0000|55 68|protocol TCL821
P02667259A0331|32 46|reactions (ADRs)
P02668691A0570|4 7|mRNA
P02668691A0570|23 26|nagB
P02668691A0570|30 33|nagA
P02668691A0570|77 85|enes, nagC
P02668691A0570|89 92|nagD
P02669199A0000|0 23|Tumor necrosis factor (TNF)
P02669199A0000|78 91|endotoxin (LPS)
P02674141A1202|27 30|CTSE
P02674141A1202|49 71|activation peptide region
P02674327A0493|3 11|p34.8 gene
P02674327A0493|75 88|polyhedrin gene
P02674671A0601|5 22|single-stranded DNA
P02674671A0601|93 101|exogenous
P02674671A0601|102 116|wild-type allele
P02674674A1308|41 52|OBF1-binding
P02674674A1308|64 67|OBF1
P02674674A1308|96 98|ARS
P02674679A1237|12 21|S1 nuclease
P02674679A1237|42 44|RNA
P02675492A0806|55 67|Ritchie-Index
P02675492A0806|57 81|tchie-Index, pain score, ESR
P02675492A0806|85 87|CRP
P02677002A0205|30 39|nzymes, ATP
P02677002A0205|53 60|[14C]Asp
P02677002A0205|63 102|equilibrium N-carbamyl-L-aspartate (C-Asp)
P02677002A0205|109 121|[32P]carbamyl
P02677002A0205|122 135|phosphate (C-P)
P02677429A0366|219 222|AIDS
P02677429A0366|270 288|AIDS-related complex
P02677666A0356|88 94|ag alpha
P02680843A0724|21 22|RS
P02680843A0724|22 28|S 86, REM
P02684159A0870|43 46|mRNA
P02684159A0870|57 65|kilobases
P02684585T0001|28 35|rhGM-CSF
P02685331A0523|4 24|. meliloti nifH promoter
P02685331A0523|46 57|nifH promoter
P02685331A0523|178 203|sigma 54-dependent promoters
P02685565A0165|37 53|c-myb-encoded mRNA
P02685565A0165|118 127|c-myb genes
P02686588A0592|71 73|BUN
P02686588A0592|77 95|alkaline phosphatase
P02686985A0811|54 57|PCF1
P02689439A0000|12 36|glutathione S-transferases
P02689439A0000|37 41|(GSTs
P02689439A0000|43 44|EC
P02689439A0402|15 36|3'-untranslated regions
P02689439A0402|39 44|pmGT10
P02689439A0402|93 102|rat Yb1 gene
P02689439A0402|121 125|pmGT2
P02689439A0402|177 186|rat Yb2 gene
P02689544A0456|5 6|IV
P02691557A0273|122 130|plasma PGE
P02691998A0672|128 131|ET-1
P02692881A0354|71 73|PIH
P02694731A0241|43 60|Parkinson's disease
P02700977A0444|69 80|XR bond/Silus
P02703121T0000|64 91|serum alanine aminotransferase
P02703925A0359|295 312|weight (HW)-bearing
P02703925A0359|348 365|weight (LW)-bearing
P02703925A0359|490 498|HW regions
P02703925A0359|521 530|LW-bearing
P02704579A1078|68 73|CRS/BW
P02704579A1078|98 102|(FIO2
P02704579A1078|106 110|a/AO2
P02704579A1078|117 118|(P
P02705072A0464|52 65|infarction (MI)
P02705296A0231|52 55|ORF1
P02705296A0231|58 75|33 kilodaltons (kDa)
P02705556A1049|4 5|RV
P02705556A1049|22 23|RC
P02707909A0209|21 23|UKM
P02708288A0139|36 51|detection (LC/AD)
P02708288A0621|81 85|PRP-1
P02708353A1080|78 91|position on gene
P02708353A1080|92 93|IV
P02708353A1080|149 158|P-450e gene
P02708353A1452|17 26|polymerase
P02708353A1452|67 68|IV
P02709819A0495|7 9|ADR
P02711145T0000|0 2|HIV
P02711145T0000|23 26|AIDS
P02711167A0818|25 33|PFB-group
P02711167A0818|55 69|serum pepsinogen
P02711601A0601|28 42|acid phosphatase
P02712450A0989|11 16|(PACO2
P02712450A0989|91 95|(Type
P02712450A0989|142 146|(Type
P02713310T0000|20 22|II)
P02713520T0000|21 61|ethyl parathion on nuthatches: cholinesterase
P02713994A0482|14 16|HSV
P02713994A0482|29 31|HSV
P02714852T0000|18 22|HLA-B
P02714852T0000|26 30|HLA-C
P02714852T0000|60 71|HLA-B alleles
P02720966A0455|23 25|ADA
P02720966A0455|57 63|mu kat/L
P02721169A0171|0 8|NERVTRACK
P02724227T0000|0 8|Perfusion
P02725495A0929|26 36|U2 RNA region
P02725495A0929|56 63|pre-mRNA
P02725495A0929|115 128|metazoan U2 RNAs
P02725513A0617|25 41|CHO spacer promoter
P02725513A0617|79 99|metazoan RNA polymerase
P02727909A0383|43 51|a decrease
P02727909A0383|86 88|ADP
P02727909A0383|120 127|types IIa
P02727909A0383|131 136|IIb HLP
P02727909A0383|134 136|HLP
P02727909A0383|142 144|CHD
P02731671A0000|21 36|nickel oxide (NiO)
P02731671A0000|22 73|ickel oxide (NiO), nickel sulfate hexahydrate (NiSO4.6H2O)
P02731671A0000|78 100|nickel subsulfide (Ni3S2)
P02731671A0000|113 118|F344/N
P02731671A0000|126 131|B6C3F1
P02732341A0000|156 176|chloroacetate esterase
P02733690T0000|74 82|reductase
P02735364A1330|69 88|progesterone receptor
P02736482A0550|27 57|adiation therapy, brain metastases
P02739739T0000|0 3|COUP
P02739739T0000|37 51|steroid receptor
P02740347A0644|26 29|VNTR
P02740627A0137|3 19|oxygen uptake (VO2)
P02740627A0137|4 45|xygen uptake (VO2), carbon dioxide output (VCO2)
P02740627A0137|58 65|rate (fR)
P02740627A0137|59 87|ate (fR), minute ventilation (VE)
P02740627A0137|97 111|ventilation (VA)
P02740627A0137|121 140|oxygen pressure (PAO2)
P02740627A0137|145 150|VE/VO2
P02740627A0137|189 198|volume (VT)
P02740627A0137|219 227|space (VD)
P02740874A0957|70 72|SO2
P02743842A0000|143 185|16,16-dimethyl prostaglandin E2 (16,16-dm PGE2)
P02743842A0000|235 242|tissue pH
P02743842A0000|236 259|issue pH, H+ back-diffusion
P02743842A0000|322 327|mM HCl)
P02743981A0347|74 86|L1e-L10e-L12e
P02743981A0347|126 133|NAB-L11e
P02743981A0347|150 152|NAB
P02743981A0347|181 183|ORF
P02744490A0894|35 38|cDNA
P02744490A0894|54 63|S1 nuclease
P02744490A0894|117 125|PTHrP gene
P02744490A0894|144 147|mRNA
P02745280A0276|13 16|PaO2
P02745280A0276|66 75|blood gases
P02745280A0276|181 183|ATP
P02745280A0276|196 198|31P
P02745444A0391|45 54|S1 nuclease
P02745666A0000|22 41|plasma oestradiol (E2)
P02745666A0000|45 60|progesterone (P4)
P02748188A0091|32 34|(PT
P02748188A0091|112 114|(PS
P02748595A0492|34 36|ADH
P02748595A0492|74 81|ADH-beta
P02751080A0176|73 77|163 dB
P02752303A0000|64 96|plasma concentrations (0.59-0.74 mM)
P02756878A0075|125 126|AF
P02758382A0478|116 146|sex hormone binding globulin (SHBG)
P02758382A0478|171 180|SHBG-bound
P02760922A0000|0 12|Heterogeneous
P02760922A0000|20 43|ribonucleoprotein (hnRNP)
P02760922A0000|85 89|hnRNP
P02761008X0000|0 18|Brain cholinesterase
P02761008X0000|101 124|brain cholinesterase (ChE)
P02761492A0124|42 48|genesis
P02761537A0168|60 63|rRNA
P02761537A0168|127 159|transcription termination at a region
P02761537A0168|201 207|28S rRNA
P02761540A0873|29 34|NF-4FA
P02761540A0873|30 41|F-4FA, NF-4FB
P02761540A0873|46 49|AP-1
P02762198T0001|24 29|7 cases
P02763467A0903|61 83|[35S]methionine-labeled
P02763467A0903|259 264|N1L ORF
P02764797A0182|0 4|PULSE
P02764797A0182|20 22|NMR
P02764797A0182|90 101|ates, rf phase
P02765001A0105|8 11|JPsA
P02766508A0421|84 92|mean IQRST
P02767166A0368|128 139|pathogenesis
P02767733A0690|36 42|68 cases
P02772495A0641|45 47|ASA
P02772495A0641|65 66|AT
P02772495A0641|81 84|INTR
P02773507A0750|65 77|clearance (CL)
P02773507A0750|162 172|drug (CLunb)
P02773930T0000|33 47|hyperfiltration
P02774271A0000|89 98|acid (TFAA)
P02774271A0000|102 113|bromide (Br-)
P02774271A0000|154 165|fluoride (F-)
P02774808A0194|30 31|(P
P02775136A1151|23 30|HAPE-S-S
P02775136A1151|128 130|AMS
P02775136A1151|220 222|AMS
P02775333A1137|24 45|dose-dependent increase
P02776742A0000|0 12|Heart rate (HR)
P02776742A0000|20 35|temperature (Tre)
P02776742A0000|156 160|r, VO2
P02776742A0000|191 215|fire fighter's uniforms (SU)
P02776742A0000|279 300|breathing apparatus (FE)
P02776823A0000|41 43|FCE
P02776823A0000|56 58|(5R
P02776823A0000|60 128|6S)-6-[(1R)-hydroxyethyl]-2-carbamoyloxymethyl-2-penem-3-carboxylate)
P02777797A0720|0 2|DNA
P02777797A0720|77 82|PtdIns
P02778237A0585|8 37|term corticosteroid-dependent IA
P02778237A0585|73 74|IA
P02778873A0761|16 19|CRL3
P02778873A0761|87 101|sequences (DR-A1
P02778873A0761|105 110|DR-A2)
P02779752A0000|0 29|1-(1-Naphthyl)piperazine (1-NP)
P02779752A0000|85 89|5-HT2
P02779752A0000|161 165|5-HT1
P02779752A0776|0 27|1-(m-Chlorophenyl)piperazine
P02779752A0776|28 32|(mCPP
P02779752A0776|87 92|(TFMPP
P02779752A0776|135 139|5-HT1
P02779752A0776|211 214|1-NP
P02780157A0576|34 41|spleen MP
P02780157A0576|64 66|VHA
P02780157A0576|81 85|HBsAg
P02780157A0576|151 158|spleen MP
P02780157A0576|232 233|MP
P02780157A0576|276 280|HBsAg
P02781495T0001|9 23|xanthine oxidase
P02783181A0000|61 63|(ES
P02784507A0000|8 40|immunodeficiency virus type 1 (HIV-1)
P02784507A0000|62 65|CD4+
P02789062A0000|22 24|4F2
P02789062A0000|30 45|chain (4F2HC) gene
P02789062A1420|1 4|cDNA
P02789062A1420|16 29|NF-4FB enhancer
P02789062A1420|69 82|lambda gt11 cDNA
P02789062A1420|141 146|NF-4FB
P02789217A1323|6 12|IL6 mRNA
P02789217A1323|23 31|generated
P02789217A1323|92 100|kilobases
P02790009A1052|60 75|region homologous
P02790009A1052|90 103|serine protease
P02792270A1220|13 16|EPSP
P02792270A1220|149 160|flexion phase
P02793216A0876|131 133|CgA
P02793753A0354|18 19|PA
P02793753A0354|37 43|10 cmH2O
P02793753A0354|46 48|CFV
P02793753A0354|77 78|PA
P02795923A0000|36 37|CT
P02797877A0475|3 32|combination PIP 64 micrograms - PEF
P02798953A0307|67 81|nstrument, WPL-R
P02799892A0154|34 45|cells (WRBCs)
P02799892A0154|86 96|transfusion
P02799892A0154|111 113|PNH
P02800417A0332|72 84|PC20 PGF2 alpha
P02800435A0000|107 116|field (PMF)
P02802280A0495|43 44|TS
P02802280A0495|51 53|PTS
P02805945A0000|279 286|microEin
P02806916A0000|8 10|DNA
P02806916A0000|24 40|oryzacystatin (Oc)
P02806916A0000|43 60|cysteine proteinase
P02806916A0000|103 113|lambda EMBL3
P02806916A0000|141 146|Sau3AI
P02806916A0000|178 180|DNA
P02806916A0000|199 204|oc cDNA
P02807780A0143|54 58|M NaCl
P02807780A0143|108 110|CIS
P02809722A0926|67 68|GH
P02809831A0799|14 17|PPSF
P02809831A0799|19 21|DBP
P02810911A0372|66 74|131I-MIBG
P02813404T0000|0 23|Male-enhanced antigen gene
P02813404T0000|26 41|phylogenetically
P02813404T0000|77 91|spermatogenesis
P02814182A1211|13 42|Walker-256-carcinosarcoma 4-EPI
P02814182A1211|46 64|effective.(ABSTRACT
P02814182A1211|65 73|TRUNCATED
P02814182A1211|70 71|AT
P02814182A1211|76 84|250 WORDS)
P02815229A0139|93 95|MBq
P02815229A0139|96 109|[14C]diltiazem
P02820128A1333|61 80|hexanucleotide ATTGTT
P02820128A1333|136 141|ORF T3C
P02820128A1670|46 48|ORF
P02821340A0434|7 28|ub-maximal exercise, DCR
P02821340A0434|34 35|UT
P02824334A0972|23 35|G-protein gene
P02825139A0661|16 18|DNA
P02826127A0709|50 65|SV40 octamer motif
P02826127A0709|80 105|cell-specific protein oct-B2
P02826729A0790|1 10|rowth, 4-PA
P02826729A0790|14 16|14C
P02826729A0790|42 43|WB
P02828926A1870|13 20|myogenic
P02828926A1870|127 135|actin gene
P02829183A0117|0 2|DNA
P02829183A0117|66 76|translocase
P02830214A0000|11 28|acetazolamide (ACZ)
P02830214A0000|31 35|HCO3-
P02830265A0341|0 5|RPA190
P02830265A0341|14 24|polypeptide
P02830282A0155|51 53|UP1
P02830282A0155|96 106|V-8 protease
P02830282A0155|119 130|polypeptides
P02831556A0173|19 27|alpha-MSH
P02831796A0000|6 31|immunodeficiency virus (SIV)
P02831796A0000|142 171|immunodeficiency syndrome (AIDS)
P02832149A1009|226 241|mouse myb oncogene
P02832293T0000|8 13|CRF-41
P02832744A0403|26 38|Northern (RNA)
P02832744A0403|49 51|RNA
P02833012A0428|12 16|L mRNA
P02833012A0428|129 131|a MW
P02833049A1041|21 28|state RNA
P02833049A1041|167 176|RD-114 mRNA
P02834843A0000|22 101|y of six new rifamycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP
P02834843A0000|31 66|rifamycin derivatives--rifabutin (RBU)
P02834843A0000|32 80|ifamycin derivatives--rifabutin (RBU), FCE 22250 (F22)
P02834843A0000|33 97|famycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE)
P02834843A0000|34 111|amycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP 29861 (C29)
P02834843A0000|35 124|mycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP 29861 (C29), CGP 7040 (C70)
P02834843A0000|113 115|CGP
P02834843A0000|128 140|CGP 27557 (C27)
P02834843A0000|144 164|rifampicin (RMP)--have
P02834843A0000|184 191|log phase
P02834843A0000|264 293|ycobacterium tuberculosis, H37Rv
P02836623A1094|3 21|SV M-MuLV-inoculated
P02836623A1094|87 105|SV M-MuLV-inoculated
P02837575A0979|49 61|topoisomerase
P02837575A0979|119 121|DNA
P02837763A0259|27 43|liver clone (HL-14)
P02837763A0259|75 97|muscle phosphatase 2A cDNA
P02838246A0225|52 56|T4/T8
P02838246A0225|227 228|(P
P02838319A0527|0 3|RVEF
P02838319A0527|7 10|LVEF
P02838710A0299|11 16|NPY-ir
P02839716A0673|86 112|HPV-11 enhancer-SV40 promoter
P02839716A1907|19 22|E2-C
P02839716A1907|32 51|E2-dependent enhancer
P02839716A1907|139 152|site.(ABSTRACT
P02839716A1907|153 161|TRUNCATED
P02839716A1907|158 159|AT
P02839716A1907|164 172|400 WORDS)
P02840376A0461|0 9|(anti-IIa)
P02843495A0544|24 28|CSF-1
P02843694T0001|7 9|E-B
P02843694T0001|46 58|ymphoma: a case
P02844767A0191|42 51|petCA genes
P02844767A0191|63 72|Rieske-FeS
P02844767A0191|148 154|(Kallas
P02844767A0596|3 18|Nostoc petBD genes
P02844767A0596|43 50|psbB gene
P02844767A0596|63 68|51-kDa
P02844767A0596|80 81|II
P02844767A0596|82 93|polypeptide)
P02844767A0596|137 152|chloroplast genes
P02844767A1022|0 2|RNA
P02844767A1022|33 42|1.8-kb mRNA
P02844767A1022|73 74|IV
P02844767A1022|101 110|0.8-kb mRNA
P02844767A1022|131 132|IV
P02844797A1225|10 22|muscle isoform
P02844797A1225|66 88|sequence Ala-Ile-Leu-Glu
P02844797A1225|218 236|transmembrane domain
P02845654A0510|51 64|position -2 (P2)
P02845654A0510|163 185|amino acid position -1 (P1)
P02846640A0643|37 54|indoxyl phosphatase
P02846640A0643|59 61|a pI
P02846852A1459|11 21|polymerases
P02846852A1459|40 54|E strand promoter
P02846852A1459|78 88|polymerases
P02846852A1459|94 108|L strand promoter
P02848842A0643|9 11|RNA
P02848842A0643|26 41|2.0-2.2-kilobase
P02849759A0865|3 14|SV40 enhancer
P02850472A0112|42 44|DNA
P02850967T0000|11 24|proto-oncogene
P02850967T0000|51 66|adenylate cyclase
P02850967T0000|93 115|a cAMP-responsive element
P02850971A0180|55 58|VtHb
P02850971A0180|152 185|broad-host-range cosmid vector pVK102
P02853799T0001|16 20|non-A
P02853799T0001|17 26|on-A, non-B
P02853922A0596|8 10|IOP
P02861067A0000|150 154|a beta
P02861144A0242|21 23|DNA
P02861144A0242|92 97|89 kDal
P02862656T0000|9 24|dopamine receptor
P02863492A0544|102 123|platelet-associated IgG
P02863747T0000|18 29|histone genes
P02865502T0000|40 61|tissue-type plasminogen
P02868446A0184|3 25|C-terminal domains (CTDs)
P02868446A0184|31 46|RPase beta subunit
P02868446A0184|50 59|DNA primase
P02868446A0184|60 64|(dnaG
P02868446A0184|147 156|RPase alpha
P02868446A0184|174 190|alpha subunit-like
P02868446A0184|228 245|core enzyme subunits
P02868446A0184|249 255|primase
P02869125A0120|20 36|mu-opiate receptor
P02870720A0188|33 49|beta-adrenoceptor
P02870720A0188|64 66|pA2
P02870851A0349|8 15|99mTcO-4
P02872786A0147|3 18|Hagen-Poiseuille
P02873593A0581|69 94|elayed-but-large reward, BZP
P02873593A0581|168 171|5-HT
P02874078A0252|13 23|luteal phase
P02875224A1059|0 10|Reperfusion
P02876820A0841|63 68|-100 mV
P02876899A0568|108 122|absorption phase
P02877124A0000|12 16|B6AF1
P02877124A0000|20 25|B6D2F1
P02877124A0000|58 72|promethazine HCl
P02877124A0000|92 101|H1 receptor
P02877124A0000|364 366|(Tc
P02877124A0000|367 372|99m MDP
P02879906A0000|138 145|myogenic
P02879951T0000|30 42|gent, SGB-1534
P02880841A0313|19 21|TF1
P02880841A0313|73 75|TF1
P02880841A0313|104 114|beta subunit
P02880841A0313|190 195|beta's
P02883327A0413|53 61|(E) region
P02883327A0413|72 74|DNA
P02883327A0413|101 109|(L) region
P02883871A1075|9 11|ISA
P02883871A1075|27 39|beta receptors
P02883871A1075|77 94|post-beta-blocking
P02883871A1075|140 142|ISA
P02883963A0000|48 81|(HTLV-I)-associated myelopathy (HAM)
P02885517T0000|21 25|non-A
P02885517T0000|22 31|on-A, non-B
P02889352A0000|20 36|blood pressure (BP)
P02892762A0296|17 30|repeat elements
P02894689A0000|27 29|DNA
P02894741A0000|75 88|22-h-long NLA II
P02894789A0954|58 62|T1/T0
P02894789A0954|66 70|T4/T1
P02895472A0178|72 75|cDNA
P02895472A0178|85 87|BiP
P02895472A0178|90 108|hybrid-selected mRNA
P02895566A0187|0 2|DPA
P02895754A0000|46 62|phosphodiesterase
P02895754A0000|225 233|(Horner's
P02898752A0683|43 48|CFU-GM
P02899792T0000|0 8|Oestrogen
P02900760A0073|5 20|sequence elements
P02900760A0073|90 102|RNA polymerase
P02900760A0073|180 191|rDNA minigene
P02900760A0073|206 208|3T6
P02901498A0354|74 86|wild-type erbB
P02901763A0977|88 106|protein-coding genes
P02901763A0977|163 179|. reinhardtii mtDNA
P02901763A0977|210 214|tRNAs
P02902615A0000|33 43|HBV-related
P02902656A0481|76 93|repetition time (TR)
P02902656A0481|101 108|time (TE)
P02902656A0481|158 162|TR/TE
P02902844A1219|3 15|subunit-a gene
P02902844A1219|99 108|atp operons
P02902844A1219|118 129|bacterium PS3
P02902927A0145|38 49|rat GHF-1 cDNA
P02903500A0278|67 76|fusion gene
P02906027A0553|54 70|5'-terminal region
P02906027A0553|92 94|CpG
P02906027A0553|128 130|CpG
P02906249A1195|100 105|Oxy-Hb
P02906249A1195|108 116|PGF2 alpha
P02906673T0000|28 54|Bacillus thuringiensis (H-14)
P02907308T0001|0 5|2 cases
P02907308T0001|12 13|II
P02907308T0001|14 40|tyrosinosis (Richner-Hanhart
P02910496A0583|2 33|ecamer sequence, 5'-CGA-CCCCUCC-3'
P02910496A0583|120 122|RNA
P02910496A0583|139 149|ent in the RNA
P02910496A0583|147 155|RNAase MRP
P02910989T0000|17 40|beta-adrenergic-blockade
P02910989T0000|43 64|standing-induced QT/QS2
P02914492A0183|16 18|ICU
P02914492A0183|78 84|mEq/dl)
P02914492A0183|134 140|mEq/dl)
P02914492A0183|199 205|mEq/dl)
P02919530A0000|28 38|reperfusion
P02920591A0251|88 89|IV
P02920591A0251|123 124|IV
P02926499A0340|107 109|CBF
P02927391A0238|49 65|founder SWR/J-RF/J
P02928112T0000|21 24|cDNA
P02928112T0000|36 51|U2 snRNA-specific
P02928376A0312|61 67|O2 gases
P02934778A0702|29 33|5-HT2
P02934889A0558|78 81|(May
P02934891A0845|20 35|DNA-footprinting
P02935638A0000|49 57|Spec1 gene
P02936163T0000|90 109|platelet lipoxygenase
P02938185A0223|47 53|E1b gene
P02938185A0223|225 228|CREF
P02939260A1553|55 57|43K
P02939260A1553|61 63|42K
P02939260A1553|124 126|DNA
P02939260A1553|173 175|39K
P02940334A0141|54 67|globulin (HBIG)
P02941237A0160|48 83|hosphorous ion concentrations, tissue pH
P02941237A0160|152 170|alkaline phosphatase
P02943562T0000|0 12|Penicillinase
P02949170A0184|76 120| mg cyproterone acetate on gonadotropins, prolactin
P02949170A0184|77 165|g cyproterone acetate on gonadotropins, prolactin, testosterone, sex hormone binding globulin (SHBG)
P02950216A0084|31 56|laser Doppler flowmetry (LDF)
P02950216A0084|70 99|utput signal, blood cell flux (BCF)
P02957125A0601|87 95|plasma ANP
P02958204A0175|39 41|HDL
P02958204A0175|48 55|sured HDL
P02958204A0175|53 57|HDL-C
P02958204A0175|54 82|DL-C, HDL phospholipids (HDL-PL)
P02958204A0175|108 131|HDL-C subfractions (HDL2-C
P02958204A0175|135 141|HDL3-C)
P02958660A1094|63 65|LDF
P02959089T0000|18 25|ONO-3708
P02960012A0838|14 17|PPNG
P02962859A0276|36 59|beta-galactosidase fusion
P02962859A0276|94 109|U1 snRNP-specific
P02963517A0453|66 69|PTCA
P02964329A0000|3 14|pathogenesis
P02964329A0000|24 41|Joint Mobility (LJM)
P02965149A0727|16 22|(Brandl
P02966671A0551|20 29|mg/kg c-DDP
P02966671A0551|212 223|12 mg/kg c-DDP
P02967915A0000|103 116|calbindin-D28K
P02967915A0968|14 35|calbindin-D28K promoter
P02968055A0984|3 5|HOI
P02968055A0984|38 40|ANF
P02969316A0002|85 96|peptide (ANP)
P02969316A0002|118 126|plasma ANP
P02969819A0814|0 5|Ig D-JH
P02969819A0814|30 36|TcR gene
P02970061A0271|3 11|RAD18 gene
P02970640A0341|62 64|E1A
P02971710A0734|7 8|RV
P02971710A0734|8 11|V, LV
P02971710A0734|17 18|2A
P02971710A0734|134 135|CO
P02973304A0000|20 30|Budd-Chiari
P02975680A0000|9 34|ccommodation night, sleep EEG
P02975680A0000|120 130|generalized
P02975680A0000|131 150|anxiety disorder (GAD)
P02975680A0000|227 229|GAD
P02975680A0000|263 275|disorder (MDD)
P02975753A1333|0 25|Oligonucleotide mutagenesis
P02975753A1333|33 46|binding domains
P02975753A1333|106 115|E3 promoter
P02976332A1277|18 21|PGI2
P02979834T0000|150 152|A/J
P02981840A0907|1 8|114-base
P02981840A0907|90 94|d(AC)
P02982332T0001|0 4|Phase
P02982332T0001|5 6|II
P02982332T0001|14 18|VP-16
P02983316A0310|47 80|complementarity-determining regions
P02983316A0310|167 177|caiman genes
P02983316A0310|321 332|phylogenetic
P02983331T0000|18 27|endogenous
P02985812A0984|55 58|mRNA
P02985812A0984|103 106|mRNA
P02985820A1287|9 24|sequence elements
P02985820A1287|57 65|c-myc gene
P02985820A1287|82 88|genesis
P02985820A1287|97 105|oncogenic
P02985820A1287|106 121|retroviruses CMII
P02985820A1287|107 126|etroviruses CMII, MC29
P02985820A1287|130 132|MH2
P02986279A0000|91 110|cytomegalovirus (CMV)
P02987220A0472|12 14|DNA
P02987220A0472|31 42|8.5-kilobase
P02987220A0472|55 59|pAVO4
P02987220A0472|68 74|4-kb DNA
P02987220A0472|110 117|FBP+ gene
P02989786A0328|35 51|adenovirus E1A gene
P02989786A0328|67 72|CATase
P02991060A0465|5 7|IgG
P02991060A0465|83 88|3 cases
P02993630A1190|66 73|nuclease
P02993630A1190|118 132|sequence (G-A)12
P02994253A0482|25 31|mean NTE
P02994336A0864|0 1|FK
P02994336A0864|50 59|plasma ACTH
P02994336A0864|83 103|bromocriptine (CB-154)
P02995967T0000|1 27|v-erbB-related protooncogene
P02995967T0000|2 36|-erbB-related protooncogene, c-erbB-2
P02995967T0000|55 97|c-erbB-1/epidermal growth factor-receptor gene
P02995999A0000|124 151|attachment (att) site generates
P02997622A0916|44 59|SCLC cell line DNAs
P02997622A0916|68 71|SCLC
P02997777A0609|115 122|isogenic
P02998016A0527|129 141|nonsense codon
P02998043A1199|29 42|Punta Toro M gene
P02998043A1199|149 158|region (G2)
P02999267A0606|8 10|FAP
P02999267A0885|32 41|Tc-99m-PYP
P02999267A0885|164 177|appearance (GS)
P02999267A0885|249 250|GS
P03000457A1554|3 8|210 kDa
P03000457A1554|72 85|125 kDa (alpha')
P03000457A1554|73 77|25 kDa
P03000457A1554|89 100|83 kDa (beta')
P03000489A0822|62 65|AIDS
P03000489A0822|98 100|CGL
P03001084A0406|28 36|4024-base
P03001084A0406|86 92| of alpha
P03001086A0587|131 152|heat-inducible dnaK gene
P03001110A0546|21 29|exogenous
P03001110A0546|72 113|eceptor self-phosphorylation, tyrosine kinase
P03001353A0146|78 89|4.0-kilobase
P03001353A0146|99 101|RNA
P03001353A0146|149 152|mRNA
P03001645A0785|11 19|his3 genes
P03001705T0000|43 68|herpes simplex virus type 2 DNA
P03001705T0000|44 78|erpes simplex virus type 2 DNA: oncogenic
P03001952A0958|66 68|HSV
P03002501A1327|44 72|guinea-pig alpha s1-casein mRNAs
P03003695A0395|32 40|c-sis cDNA
P03003695A0395|46 53|(Collins
P03003695A0395|102 113|kbp DNA region
P03003695A0395|131 139|c-sis exon
P03004364A0775|47 50|5-FU
P03004364A0775|48 54|-FU, ADM
P03004364A0775|58 60|MMC
P03004364A0775|63 68|FAMLIP
P03004364A0775|81 85|FULIP
P03004364A0775|82 92|ULIP, ADRLIP
P03004364A0775|96 101|MMCLIP
P03004739A0753|52 54|CAT
P03004739A0753|148 150|CAT
P03004982A0199|61 63|DNA
P03004982A0199|92 100|genes fbcF
P03004982A0199|93 105|enes fbcF, fbcB
P03004982A0199|109 112|fbcC
P03004982A1094|49 51|FeS
P03004982A1094|91 94|fbcF
P03006066A0653|55 69|c-myb (P75c-myb)
P03007281A0905|3 8|Dox-A2
P03007281A0905|37 46|Df(2L)OD15
P03008094A0697|22 32|polypeptide
P03008405A0532|60 64|HVC-1
P03009366A0438|7 21|ultrastructural
P03009366A0438|63 64|II
P03009366A0438|109 115|release
P03011793A0582|22 25|rbsD
P03011793A0582|23 30|bsD, rbsA
P03011793A0582|35 38|rbsC
P03013477A0000|62 75|leucocyte (PMN)
P03013477A0000|106 127|emodialysis, generation
P03013477A0000|130 149|superoxide anion (O2-)
P03013477A0000|152 154|PMN
P03014515T0000|5 23|alpha-galactosidase
P03014515T0000|47 50|cDNA
P03014593A0681|10 26|mg/kg) generalized
P03015611A0331|94 104|ATP-binding
P03015628A1078|169 192|serum alkaline phosphatase
P03015953T0000|54 80|mouse glucocorticoid receptor
P03015953T0000|94 96|DNA
P03016301A0605|8 18|v-myc codons
P03016301A0605|76 84|c-myc exon
P03016301A0605|89 97|412 codons
P03016506A0611|54 60|BamHI-K
P03016506A0611|123 136|EBV-associated
P03016506A0611|144 157|antigen EBNA-1)
P03016506A0611|187 193|BamHI-C
P03016506A0611|225 234|marker gene
P03016883A0000|35 64|herpes simplex virus type 2 (HSV-2)
P03017225A0706|85 86|II
P03017996A0731|37 48|polypeptides
P03017996A0731|53 65|signal peptide
P03018491A0840|3 28|hexanucleotide 5'-TGTCCT-3'
P03018491A0840|53 55|GRE
P03018491A0840|102 118|5'-flanking region
P03020001A0781|16 30|mini-Mu elements
P03020001A0781|40 47|kilobase
P03020001A0781|78 80|DNA
P03020001A0781|100 107|kilobase
P03020001A0781|139 146|kilobase
P03020001A0781|201 208|kilobase
P03020513T0000|3 19|52-protein subunit
P03020513T0000|22 39|T4 DNA topoisomerase
P03020513T0000|57 68|gyrA-protein
P03020513T0000|71 76|gyrase
P03021088A0135|115 116|II
P03022129A0842|30 39|MPE X Fe(II)
P03023682A0271|21 24|SV40
P03023682A0271|30 84|promoter-dependent chloramphenicol acetyltransferase (CAT)
P03023859A0000|5 8|DNAs
P03023859A0000|164 177|cluster region)
P03023887A0470|0 7|Nuclease
P03023887A0470|40 61|glucocorticoid receptor
P03023887A0470|132 144|sequence motif
P03023970A0922|100 109|generation
P03023970A0922|113 122|p53 product
P03024703A1036|46 56|polypeptide
P03025606T0000|122 125|mRNA
P03025655T0000|44 66|protein-tyrosine kinases
P03025655T0000|78 83|kinase
P03025661A0260|1 11|luzman, EMBO
P03025862A0860|94 97|mRNA
P03025862A0860|110 125|poly(A)-addition
P03026915A1024|65 74|yeast genes
P03026915A1024|107 116|lacZ fusion
P03027661A0000|31 35|miniF
P03027779A0000|0 4|SPECT
P03027779A0000|21 23|TMJ
P03027779A0000|29 37|99m Tc-MDP
P03032143A0218|44 46|DNA
P03032143A0218|99 114|sequence elements
P03033283A0837|11 21|NF1-binding
P03033283A0837|54 61|IE68 gene
P03033283A0837|64 77|HCMV(Towne) DNA
P03033283A0837|95 97|DNA
P03033283A0837|213 235|promoter-enhancer region
P03033283A1415|61 74|repeat elements
P03033283A1415|195 205|NF1-binding
P03033283A1415|284 291|SCMV IE94
P03033283A1415|304 311|HCMV IE68
P03034570A0943|53 84|chloramphenicol acetyltransferase
P03034570A0943|146 148|ORF
P03034956A0666|28 35|androgen
P03034956A0666|135 136|(P
P03035056T0000|15 31|kappa antibody gene
P03035056T0000|60 89|leukemia virus-transformed pre-B
P03035658A0355|38 40|VO2
P03035658A0355|144 147|(VO2
P03035658A0355|175 178|(VO2
P03036415T0000|11 25|cyclo-oxygenase
P03036415T0000|41 59|leukotriene receptor
P03036817A0213|0 34|Oligonucleotide-directed mutagenesis
P03036817A0213|52 55|NdeI
P03036817A0213|83 85|ATG
P03036933A0774|0 10|ACTH release
P03036933A0774|53 61|exogenous
P03036933A0774|62 65|ACTH
P03037334A0932|33 47|promoter element
P03037334A0932|53 66|yeast RP39A gene
P03037334A0932|91 104|sequence motifs
P03038643A1374|38 51|alpha-spectrin
P03038643A1374|105 125|alpha-fodrin-like gene
P03038891A0935|18 21|RNAs
P03038891A0935|63 69|p11 mRNA
P03039177A0503|13 16|cDNA
P03039177A0503|38 49|2.9-kilobase
P03039177A0503|77 92|IR2 repeat element
P03039177A0503|135 144|enzyme SmaI
P03039387A0920|50 52|BCG
P03039387A0920|152 154|BCG
P03040403A0155|3 9|PSS gene
P03040403A0155|46 53|yeast DNA
P03040403A0155|59 63|YEp13
P03041046A0127|7 12|A-MuLV
P03041046A0127|49 59|Moloney MuLV
P03041046A0127|83 93|lymphogenic
P03041046A0127|102 107|A-MuLV
P03041046A0127|145 160|BALB/c endogenous
P03041046A0127|161 172|N-tropic MuLV
P03041046A0127|198 208|lymphogenic
P03041046A0127|218 219|(N
P03041802A0975|61 74|fibrinopeptide
P03041802A0975|168 179|pathogenesis
P03045117A0936|133 144|Glu24----Gly
P03045117A0936|156 167|Asp27----Gly
P03045117A0936|183 193|Pro7----Thr
P03045117A0936|205 216|Tyr29----Gly
P03045117A0936|228 239|Leu47----His
P03046931A0247|13 28|eIF-4A intronless
P03046931A0247|62 65|cDNA
P03048024A0418|54 55|IB
P03048024A0418|63 65|NIB
P03050147A0896|50 56|E1a-E1b
P03050147A0896|101 116|P/C-specific mRNA
P03050147A1520|128 131|mRNA
P03050147A1520|147 163|initiator AUG codon
P03053713A0752|0 2|DNA
P03053713A0752|18 25|DPM1 gene
P03053713A0752|54 61|801 bases
P03060846T0000|38 44|23S rRNA
P03061301A0624|60 96|metabolite 6-keto-prostaglandin F1 alpha
P03061301A1409|19 45|6-keto-prostaglandin F1 alpha
P03061383A0000|97 111|beta-lactamases
P03061383A0000|117 121|TEM-1
P03062370A0000|0 3|GCN4
P03062370A0384|24 27|GCN3
P03062370A0384|75 78|GCN4
P03064811A0485|26 39|. aureus peptide
P03064811A0485|78 149|Gln-Val-Val-Ser-Thr-Phe-Met-Gly-Asn-Gly-Leu-Ala-Ile-Pro-His-Gly-Thr-Asp-
P03065140A0273|31 34|GAL4
P03065140A0273|46 61|DNA binding domain
P03065140A0273|69 97|transcription activation domain
P03065141A0448|31 35|(citA
P03065141A0448|39 43|citB)
P03065141A0448|99 106|citB gene
P03065141A0448|158 163|pMS185
P03065610A0375|3 9|rci gene
P03065610A0375|22 25|lacZ
P03065621T0000|74 78|MRP13
P03072021A0696|111 122|polypeptides
P03073091A0338|6 20|insulin infusion
P03073091A0449|47 66|2 hour insulin infusion
P03073091A0449|117 119|(K+
P03073091A0449|170 172|(K+
P03073091A0449|223 225|(K+
P03073192T0000|0 39|Mycobacterium avium-intracellulare complex
P03076124A0496|123 126|(HMG
P03076124A0496|127 139|CoA) reductase
P03076124A0496|289 303|LDL-cholesterol
P03080793T0000|55 58|AIDS
P03088643A0000|69 79|stimuli (CS)
P03090372A0607|75 77|CyA
P03091849A0000|41 54|ultrastructure
P03091849A0000|148 170|intra-arterial perfusion
P03091849A0000|195 205|superfusion
P03097509A0654|14 16|RNA
P03097509A0654|30 51|3'-untranslated regions
P03097509A0654|72 78|945 base
P03097643A1357|8 17|BALB/c gene
P03098018A0139|67 76|imbs, P2-A2
P03102289A0786|48 50|hCG
P03102289A0786|124 133|ultrasound
P03102289A0786|159 161|hCG
P03104248A0322|6 12|Stage IA
P03104248A0322|46 54|tumor (G1)
P03104248A0322|89 97|tumor (G2)
P03104248A0322|135 138|(G3)
P03108171A0088|62 72|S2 receptors
P03108171A0088|76 79|5-HT
P03109147A0000|96 99|NMRI
P03109147T0127|46 57|carcinogenic
P03109954A0945|31 40|estrogenic
P03109954A0945|67 95|ethinyl estradiol-containing OC
P03109954A0945|192 200|plasma HDL
P03109954A0945|318 330|atherogenesis
P03110119A0267|6 7|BH
P03110678A0702|89 103|haemofiltration
P03110678A0702|174 182|diffusion
P03110692A0156|11 18|mg/l (SD)
P03110692A0156|175 176|(P
P03110692A0156|225 237|7 months). beta
P03110746A0146|66 86|adipose tissue (PLASAT)
P03110801A0532|20 34|plasma prolactin
P03112412A0985|38 81|temperature-sensitive threonyl-tRNA synthetase
P03112412A0985|105 113|thr operon
P03114995T0000|28 52|nutrition on gastrin release
P03115787A0633|71 87|cisplatin (CHAP-5)
P03117046T0000|31 42|vinculin cDNA
P03117147A1059|58 72|oesophageal EMGd
P03117147A1059|91 101|surface EMGd
P03119227A0079|3 5|DNA
P03119227A0079|49 64|sequence homology
P03119227A0079|75 93|c-abl proto-oncogene
P03119227A0079|182 195|tyrosine kinase
P03123310A0000|25 32|Gart gene
P03125422A0202|58 80|activator sequences (UAS)
P03126531T0000|67 69|REM
P03127463A1017|5 9|rIL-3
P03127463A1017|21 24|COS7
P03127463A1017|47 49|CSF
P03132498A0730|17 21|PaCO2
P03132498A0730|104 108|PaCO2
P03133250A0000|86 102|gonadotropin (hMG)
P03133250A0000|111 143|follicle-stimulating hormone (hFSH)
P03133250A0000|171 192|embryo transfer (IVF-ET)
P03133360A1215|97 104|trpE mRNA
P03137346A0319|3 15|nucleolin gene
P03137346A0319|55 61|14 exons
P03137601A0212|8 42|L-threo-dihydroxyphenylserine (DOPS)
P03137601A0212|56 73|norepinephrine (NE)
P03137601A0212|115 122|ice, DOPS
P03137601A0212|185 200|NE neurotoxin DSP4
P03138190A0347|95 107|monocytogenes
P03139750A0000|40 41|VH
P03142875A0366|23 36|6-kilobase cDNA
P03143048A1091|0 14|HDL-cholesterol
P03143048A1091|36 52|apolipoprotein A-I
P03143485A0366|19 29|protein gene
P03143485A0366|62 74|protein operon
P03146017A0983|52 58|ORFtrpA
P03146017A0983|98 100|ORF
P03146017A0983|103 126|1227 nucleotides (ORFtrpB)
P03146017A0983|136 158|409 amino acid polypeptide
P03146150T0000|39 74|single-chain urokinase (Pro-urokinase)
P03146784A0158|2 12|49 receptors
P03146784A0158|92 107|stretch receptors
P03146784A0158|147 167|stretch receptors (PSR)
P03146784A0158|197 228|CO2-sensitive chemoreceptors (IPC)
P03147912A0422|126 131|PETCO2
P03149774A0173|5 6|IA
P03149774A0173|201 212|GABA receptor
P03150015T0001|18 22|non-A
P03150015T0001|19 44|on-A, non-B post-transfusion
P03150296A0594|25 34|endogenous
P03150296A0594|77 95|filtration rate (GFR)
P03150296A0594|207 216|endogenous
P03159903A0352|122 124|IHF
P03166458A1356|38 49|GC box element
P03167060A0000|24 25|II
P03167060A0000|26 32|(IGFII)
P03167060A0000|36 44|mitogenic
P03167060A0000|45 55|polypeptide
P03167060A0000|60 64|mRNAs
P03171279A0158|60 64|toe MP
P03171279A0158|127 132|toe PIP
P03178097A0000|3 8|CHARGE
P03178161A0000|164 176|carcinoma (EC)
P03181276A0422|0 14|26 micrograms PAF
P03183103A0000|10 11|MR
P03183127A0068|69 70|CT
P03183127A0068|71 85|, myelography, CT
P03183127A0068|106 107|CT
P03185540T0000|49 61|RNA polymerase
P03185540T0000|62 63|II
P03185540T0000|66 84|urification, genetic
P03185540T0000|100 115|TATA box-promoter
P03185540T0000|130 134|TFIID
P03186091T0000|8 33|plasma cystyl aminopeptidase
P03190481A0292|10 31|alpha-naphthyl esterase
P03190481A0292|79 90|infiltration
P03190914A0149|49 60|chemokinetic
P03192537A0370|54 65|HMG-I(Y) cDNA
P03192537A0370|116 120|HMG-I
P03192724A0000|93 98|FIRO-B
P03192950A0566|54 56|TSH
P03194410A0771|2 11|UOxase mRNA
P03194410A0771|95 104|UOxase gene
P03195167A0104|96 126|basic-polymers polyurethane (PUR)
P03195167A0104|97 149|asic-polymers polyurethane (PUR), polyvinylchloride (PVC)
P03195167A0104|154 168|polystyrene (PS)
P03198525A0164|101 103|MGA
P03198525A0164|130 133|MGA)
P03198525A0164|136 143|DEPO-MGA
P03198525A0164|174 183|90 mg MGA/hd
P03199043A0248|150 158|diffusion
P03199436A1060|62 80|psbB-psbH-petB-petD
P03199436A1060|87 95|psbE-psbF
P03200488A0439|30 32|TIQ
P03200844A1211|23 28|62-kDa
P03208493A0849|13 22|filtration
P03209019A0662|46 49|CD-1
P03209019A0662|93 96|DMBA
P03212551T0001|3 14|pathogenesis
P03212929A0000|2 6|ELISA
P03212929A0000|52 54|IgE
P03214709A0559|13 19|release
P03218714A0000|31 59|Dandy-Walker malformation (DWM)
P03218714A0000|85 95|Fallot (TOF)
P03228518A0339|90 109|Community/Vocational
P03228785A1047|184 201|control).(ABSTRACT
P03228785A1047|202 210|TRUNCATED
P03228785A1047|207 208|AT
P03228785A1047|213 221|250 WORDS)
P03233862T0000|19 26|(Devic's
P03235487A0404|23 39|M sodium dihydrogen
P03243027T0000|41 51|protein gene
P03249840A0411|46 53|1 s (FEV1)
P03249840A0411|63 85|airway conductance (SGaw)
P03249840A0411|140 149|SGaw (PD35)
P03249840A0411|169 178|FEV1 (PD20)
P03251210A0981|16 18|BGC
P03257146A1037|24 28|CSFHU
P03259437A0140|13 38|neonates serum alpha-amylase
P03259437A0140|137 140|IU/l
P03259437A0140|223 226|IU/l
P03261005A0216|23 26|AIDS
P03261005A0216|29 47|AIDS-related complex
P03261223A0644|64 68|SPECT
P03261223A0644|76 78|TCT
P03261331A0563|0 4|SPECT
P03261331A0563|37 55|AIDS dementia complex
P03263357A0112|164 187|plasma interleukin 1 (IL-1)
P03263465T0000|9 11|MHC
P03263465T0000|19 28|enes, H-2Dq
P03263465T0000|32 36|H-2Lq
P03263465T0000|73 77|H-2Ld
P03264073A0224|124 134|ulcerogenic
P03264299A0679|111 123|monocytogenes
P03264886A0000|81 115|south-western Germany 552 (3.03%) cases
P03275867A0187|0 3|GRFI
P03275867A0187|73 89|mating type loci HML
P03275867A0187|94 96|HMR
P03275867A0187|124 136|sequence (UAS)
P03275867A0187|166 178|MAT alpha genes
P03275873A0379|17 40|mutations on RNA polymerase
P03275873A0379|41 42|II
P03275873A0379|104 117|alpha-amanitin
P03276246A0037|54 71|blood cell (TAC-WBC)
P03276924A0090|75 80|MoMuLV
P03280021A1615|3 14|SSB-poly(dT)
P03280021A1615|64 69|5 M NaCl
P03280021A1615|81 92|1.8-2.5 M NaBr
P03280021A1615|96 121|measure alpha log Kobsd/alpha
P03280021A1615|125 130|[NaBr]
P03280021A1615|165 167|T/O
P03280807A0000|109 120|glycine (GGX)
P03280807A0000|124 141|proline (CCX) codons
P03280807A0000|151 153|UGA
P03280807A0000|157 159|UAG
P03280807A1447|13 29|suf12-null/SUF12+
P03280807A1447|100 119|suf12 allele-specific
P03280807A1447|207 221|wild-type SUF12+
P03280946A0375|45 68|[35S]methionine-labelled
P03280946A0375|118 128|lac promoter
P03280946A0375|202 224|bacteriophage T7 promoter
P03282232A0743|47 50|DP1A
P03282232A0743|79 82|DP-I
P03282232A0743|86 88|-II
P03282813A0794|27 29|QO2
P03282813A0794|71 74|ARDS
P03282813A0794|97 104|non-ARDS
P03285764A0675|0 18|Hyperprolactinaemia
P03296212A0603|190 192|IFN
P03296254A0556|130 131|II
P03296254A0556|135 143|factor VII
P03297181A0127|54 64|release (RR)
P03297181A0127|91 101|release (SR)
P03297181A0127|139 140|SR
P03297181A0127|152 161|food (SR-F)
P03298134A0000|52 58|(Intron
P03298134A0000|60 76|; Schering-Plough)
P03298134A0000|98 114|cell leukemia (HCL)
P03309892A0637|93 101|actin gene
P03312514A0756|14 19|SSEP's
P03319621A0707|16 19|mRNA
P03319621A0707|34 47|beta actin mRNAs
P03325081A0524|81 96|keratopathy (PBK)
P03326381A0423|3 17|ultrastructural
P03326381A0423|45 53|C-peptide
P03329716A0187|16 34|EGF receptor promoter
P03329716A0187|51 53|E1A
P03329716A0187|64 74|receptor RNA
P03330711T0000|33 44|(Azadirachta
P03331525T0001|0 2|"In
P03332022A1094|8 31|cysteine clustering region
P03332022A1094|36 51|N-terminal region
P03332022A1094|113 136|cysteine clustering region
P03332022A1094|182 197|N-terminal region
P03332022A1094|200 212|protein kinase
P03334950A0000|83 87|(CESS
P03335127A0176|27 33|generic
P03335127A0176|34 38|BASIC
P03335398A0568|70 72|NVS
P03335444A0000|53 57|241Am
P03335651A0000|58 70|resonance (MR)
P03335923A0257|118 155|duodenal-gastric reflux gastropathy (DRG)
P03335923A0257|199 207|bulb (RUD)
P03335923A0257|226 242|Moynihan's disease
P03340548A1018|26 38|chicken MT mRNA
P03340548A1018|65 69|(Cd2+
P03343730A0486|61 62|pH
P03344812A0924|33 34|BP
P03344812A0924|38 39|HR
P03344812A0924|176 177|BP
P03344812A0924|181 182|HR
P03344812A0924|281 294|individual's BP
P03344812A0924|298 299|HR
P03345706A0561|21 25|PaCO2
P03345706A0561|29 33|PtcO2
P03345706A0561|36 38|RDS
P03346157A0000|34 42|ABCC/RERF
P03346157A0000|71 91|Adult Health Study (AHS)
P03346157A0000|195 198|RERF
P03346210A0000|12 36|growth factor (EGF) receptor
P03346210A0000|60 80|protein tyrosine kinase
P03346210A0000|157 159|EGF
P03348382A0785|42 46|HCO3-
P03352727T0000|0 3|UK's
P03352947T0001|7 34|AIDS-related complex (ARC/LAS)
P03354341A0177|13 22|filtration
P03360948A0477|10 12|CAP
P03360948A0477|103 105|CAP
P03360948A0477|112 114|MHI
P03360948A0477|121 140|Behavioral/Emotional
P03371806A0000|10 28|data processing (EDP)
P03371806A0000|67 92|acid phosphatase (anti-HSAP)
P03372422A0558|28 29|IV
P03372422A0558|61 63|III
P03373755T0001|86 108|roblems; gastrin receptor
P03375184A0000|106 145|formula C9H19-C6H6-O-(CH2CH2O)n-1 CH2CH2OH
P03377864A0000|29 37|diffusion
P03379058A0188|37 47|E1 alpha cDNA
P03379058A0188|55 62|1821 base
P03379058A0188|113 134|a 3'-untranslated region
P03380547A0169|0 2|SPA
P03380547A0169|7 9|PAG
P03381039A0364|14 16|MAN
P03395009A1750|206 209|(T12
P03395009A1750|223 226|(T11
P03395164A0000|35 51|compound WEB 1881 FU
P03395249A1044|67 68|II
P03395249A1044|160 177|neonates.(ABSTRACT
P03395249A1044|178 186|TRUNCATED
P03395249A1044|183 184|AT
P03395249A1044|189 197|250 WORDS)
P03396628A0207|78 83|BALB/c
P03398433T0001|20 30|generalized
P03398714A0594|13 14|RH
P03400694A0245|0 7|PATIENTS
P03400694A0245|11 17|METHODS
P03402183A0171|3 4|TA
P03402183A0171|76 99|oluntary contractions (MVC
P03402183A0171|84 100|contractions (MVC)
P03406054A0351|9 31|line spread function (LSF)
P03413681A0659|8 19|heart disease
P03413890T0001|11 24|Bowen's disease
P03413890T0001|39 55|ano-genital region
P03417668A1233|46 57|Thr286 (alpha
P03417668A1233|58 65|subunit)
P03417668A1233|69 79|Thr287 (beta
P03417668A1233|80 87|subunit)
P03417668A1233|116 127|CaM-kinase II
P03420266A0000|69 81|Dunning R3327G
P03423732A0341|22 27|De-Nol
P03423732A0341|57 60|HCO3
P03423732A0341|119 122|HCO3
P03423732A0341|133 158|16,16-dimethyl PGE2 (dmPGE2)
P03428274A0000|13 15|III
P03428274A0000|16 22|(NFIII)
P03428274A0000|37 40|HeLa
P03428274A0000|75 97|adenovirus type 2 (Ad2) DNA
P03434347A0358|0 7|Mean rCBF
P03436877A0950|7 8|CT
P03436877A0950|139 146|% delta CT
P03436877A0950|225 253|blocker pretreatment.(ABSTRACT
P03436877A0950|254 262|TRUNCATED
P03436877A0950|259 260|AT
P03436877A0950|265 273|250 WORDS)
P03439248A0000|179 191|artery disease
P03440780A0779|34 37|EDLF
P03440780A0779|176 180|EDLFs
P03443144A0409|4 18|aspirin esterase
P03443566A0675|68 69|TR
P03443566A0675|73 74|CR
P03443609A0000|22 45|fluid chromatography (SFC)
P03446332A0831|42 43|LH
P03446332A0831|53 56|LHRH
P03449358T0001|0 14|Ultrastructural
P03451761A0215|7 22|aseline study, WPW
P03451761A0215|109 113|RNV's
P03457330A0271|17 18|CA
P03459736A0184|41 54|generalization
P03463537T0001|36 37|II
P03463543A1613|57 59|UTI
P03473253A0000|159 161|U.S
P03478354A0436|65 84|prostaglandin F2 alpha
P03479897A0961|28 35|angle ANB
P03479897A0961|89 96|Class III
P03484894A0782|2 8|14 cases
P03484894A0782|54 55|II
P03484894A0782|72 74|III
P03484894A0782|98 99|IV
P03485064A0135|8 13|117 EVS
P03486405A0341|9 18|prepeptide
P03486405A0341|31 50|precursor polypeptide
P03486405A0341|98 106|IL-1 alpha
P03487348A0000|59 85|afterhyperpolarization (AHP)
P03491190A0233|30 32|RCA
P03491190A0233|35 43|LAD region
P03494649A0472|52 54|CBF
P03494649A0472|80 83|MABP
P03499608A1054|89 106|11 beta-hydroxylase
P03499657A0000|17 24|bone-Gla
P03499657A0000|18 37|one-Gla protein, sBGP)
P03499657A0000|19 67|ne-Gla protein, sBGP), serum alkaline phosphatase (sAP)
P03499657A0000|78 128|hydroxyproline/creatinine ratio (uOH-Prol/creatinine)
P03499657A0000|168 192|hyperparathyroidism (PHPT)
P03499657A0000|230 243|malignancy (HM)
P03507689A0000|57 64|pUC18/19
P03507689A0000|83 107|single-stranded DNA (ssDNA)
P03507689A0000|158 181|a bacteriophage T7 promoter
P03507689A0000|191 212|beta-galactosidase gene
P03513989A0580|17 24|estrogen
P03513989A0580|44 58|UROD-deficiency
P03513989A1149|136 147|pathogenesis
P03515840A0000|159 172|generalization
P03517388A0763|23 27|CK-MB
P03517388A0763|38 60|ss after BC (BC, 31 +/- 17 U/L
P03517388A0763|45 46|BC
P03517388A0763|47 49|(BC
P03517388A0763|51 60|31 +/- 17 U/L
P03517388A0763|52 63|1 +/- 17 U/L; CC
P03522105A1011|4 17|trough serum TOB
P03526279T0000|23 32|nursing R.N
P03536864A0000|14 15|(E
P03537686A0099|29 39|mutagenesis
P03537686A0099|50 71|supF suppressor tRNA gene
P03537686A0099|214 223|plasmid DNA
P03537686A0099|231 240|UV-induced
P03537721A0491|60 67|PEP4 gene
P03537721A0491|78 81|GAL4
P03537721A0491|84 96|chromosome XVI
P03537721A0876|86 93|PEP4 gene
P03537721A0876|164 173|hydrolases
P03537727A0243|3 9|poly(A)
P03537727A0243|22 24|RNA
P03537727A0243|86 89|(72K
P03540591A0330|20 22|RNA
P03540591A0330|47 51|cDNAs
P03540853A0652|38 53|sequence homology
P03540853A0652|58 60|DNA
P03543485A0069|8 19|pathogenetic
P03543936A0000|3 10|rho genes
P03543936A0000|78 88|ras oncogene
P03544858A0374|59 61|VO2
P03544858A0374|102 116|HDL-cholesterol
P03549045A0878|0 2|SCL
P03553149A0299|6 40|oligonucleotide-directed mutagenesis
P03553149A0299|55 68|MucA homologous
P03553149A0299|74 80|Ala-Gly
P03553149A0299|95 98|LexA
P03553439A0404|91 112|umor cells; Type II-solid
P03553439A0404|157 182|umor cells; Type III-isolated
P03559193A0000|81 91|scale (FTAS)
P03559232T0000|19 26|pyogenic
P03561622A0659|80 103|DiaTAP button graft complex
P03563399A0534|42 45|SoNo
P03563604A1075|34 35|RK
P03568311A0273|50 67|wedge pressure (PWP)
P03568311A0273|51 71|edge pressure (PWP), RAP
P03568311A0273|76 78|IPP
P03568311A1361|106 110|TMFP1
P03568311A1361|121 125|TMFP2
P03568311A1361|143 147|TMFP3
P03570455A0433|103 108|TSST-1
P03572706A0329|159 161|F-K
P03572706A0329|179 182|MMPI
P03575656A0120|26 41|hemical form, 90Sr
P03577670A0102|17 27|generalized
P03577670A0236|27 45|leukodystrophy (MLD)
P03577670A0236|75 93|arylsulfatase A (ASA)
P03581160A0583|119 133|non-medicated TH
P03582149T0001|34 45|valve disease
P03582184A0448|31 32|II
P03582982A0000|41 43|RNA
P03584426A0706|0 30|Heat-labile-like enterotoxin (LT)
P03584426A0706|192 198|LT-like
P03586925T0001|67 80|"Roentgenology
P03592297A0138|0 14|Dorsal foot TcpO2
P03592297A0138|171 175|TcpO2
P03592297A0679|76 90|ord trauma, TcpO2
P03592297A0679|141 144|mmHg
P03592297A0679|154 158|TcpO2
P03595418A0688|41 67|ornithine decarboxylase mRNAs
P03595418A0688|98 116|3'-noncoding regions
P03597218A0901|28 55|lpha 2-plasmin inhibitor, alpha
P03597218A0901|87 89|III
P03597269A0409|65 76|b[exp(cVO2)]
P03601275A0601|5 20|dopamine infusion
P03608916A0790|9 19|1 degrees HPT
P03608916A0790|24 40|plasma 1,25-(OH)2D
P03608916A0790|73 74|(P
P03608989A0668|115 123|rod region
P03612316A0102|107 109|BW)
P03615550A0000|97 125|fixed-consecutive-number (FCN)
P03615763A0170|258 269|heart disease
P03619249A0428|80 91|epatitis: HBV
P03619249A0428|92 95|(HBs
P03619249A0428|101 103|HBe
P03619249A0428|102 114|Be Ag, anti-HBs
P03619249A0428|103 123|e Ag, anti-HBs, anti-HBe
P03619249A0428|127 134|anti-HBc
P03619249A0428|132 134|HBc
P03619249A0428|141 148|erum, HBs
P03619249A0428|154 178|c Ag in the liver); non-A non-B
P03619249A0428|158 173|n the liver); non-A
P03619249A0428|163 184|iver); non-A non-B (non-A
P03619249A0428|197 219|ntibody, anti non-A non-Bc
P03619249A0428|205 219| anti non-A non-Bc
P03622423A0000|22 41|ischer 344 rats, B6C3F1
P03622423A0000|144 164|methyl isocyanate (MIC)
P03622571A0208|58 69|degeneration
P03628596A0000|70 78|acid alpha
P03628713A0961|27 29|AIB
P03628713A0961|33 38|86RbCl
P03628713A0961|47 52|36B-10
P03628713A0961|162 168|trap AIB
P03628794A0648|62 70|I-131 MIBG
P03629974A1468|37 40|M RNA
P03629974A1468|185 197|COOH-terminal
P03635597A0377|125 126|(P
P03649340A1119|17 29|mono-intronic
P03651330T0000|0 10|UVA-induced
P03651840A0266|6 8|MAO
P03651840A0266|32 37|DPGPEA
P03651840A0266|55 59|MAO-B
P03659603A0797|68 80|increase in CO2
P03659805A0404|128 130|IMB
P03663789A0568|53 56|RHAL
P03663789A0568|117 120|RHAL
P03663789A0568|118 120|HAL
P03664038A0000|90 93|(GSS
P03673640A0533|3 5|MAO
P03673640A0533|44 46|KSP
P03673640A0533|45 63|SP Impulsiveness, EPQ
P03673640A0533|79 81|KSP
P03673640A0533|127 129|KSP
P03673640A0533|243 253|platelet MAO
P03673881A0000|41 48|wave (CW)
P03673881A0000|56 85|pulse repetition frequency (HPRF)
P03673881A0000|222 233|valve disease
P03676054A0865|11 23|w, delta V, PaO2
P03676054A0865|32 33|VT
P03676174A0730|47 58|80-260 g DM/kg
P03684517A0462|77 78|II
P03685073A0200|38 57|acetylcholinesterase
P03687313A0000|6 16|glucosidase
P03687313A0000|27 30|(BAY
P03687313A0000|39 41|BAY
P03687313A0000|78 79|II
P03688202A0377|57 59|PBB
P03688202A0377|63 64|CN
P03691316A0560|33 36|K-CG
P03692331A0000|12 28|beta-adrenoceptor
P03693543A0405|255 260|genera
P03694102A0000|17 24|data base
P03694102A0000|70 72|ECG
P03697587T0000|1 7|9, XXXXY
P03697798T0001|46 61|stretch receptors
P03697971A0311|19 39|glutathione peroxidase
P03700952A0273|31 32|PL
P03700952A0273|74 81|McDonald
P03701640A1178|81 89|FR30 FI600
P03701640A1178|141 157|similar.(ABSTRACT
P03701640A1178|158 166|TRUNCATED
P03701640A1178|163 164|AT
P03701640A1178|169 177|250 WORDS)
P03703493A0654|67 93|RPE-choriocapillaris complex
P03704087A0394|85 115|nxiety: Spielberger's State-Trait
P03710973A0817|12 31|skin temperature (Tsk)
P03710973A0817|40 41|(P
P03710973A0817|117 118|(P
P03710973A0817|132 141|Tre-to-Tsk
P03712106A0000|56 78|a soy protein isolate (SPI)
P03712106A0000|93 110|short-term nitrogen
P03712153T0000|15 47|Haemophilus influenzae type b disease
P03713187A0691|8 26|lesions infiltrating
P03713187A0691|98 116|lesions infiltrating
P03713187A0691|207 218|infiltrating
P03714348A0833|49 53|CIC's
P03714348A0833|85 87|CIC
P03714348A0833|106 108|NIH
P03714348A0833|177 184|serum IgG
P03721594A0000|118 138|acrophages, fibrinogen
P03722016A0797|3 5|FFA
P03722016A0797|27 28|(P
P03732252A0556|54 56|VO2
P03732252A0556|57 58|AT
P03732252A0556|92 97|VO2max
P03732252A0556|262 269|delta VO2
P03732252A0556|270 271|AT
P03733563A0716|44 50|liver TG
P03733563A0820|0 6|Liver TG
P03733563A0820|10 18|serum NEFA
P03743683A0000|50 60|plaques (PP)
P03743702A0158|181 208|ross-sectional area: mean +/- SD
P03744168T0001|23 102|eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz
P03746906A0000|72 75|(JAS
P03751308T0001|66 84|(14C)2-deoxyglucose
P03753022A0000|23 35|heterogeneous
P03755623A1233|86 89|DLIS
P03755673A0054|10 16|26 cases
P03757294A0414|14 16|PLD
P03757294A0414|64 67|APCD
P03758250A0000|106 108|EMG
P03759330A0713|49 51|CHD
P03759330A0713|58 71|population (G1)
P03759731A0992|83 85|IV)
P03761122T0000|83 84|IQ
P03761523A0000|64 72|exogenous
P03765552A0582|87 107|system (RES) Fc receptor
P03766370A0546|64 65|LV
P03766370A0546|86 98|non-MI regions
P03766370A0546|135 145|homogeneous
P03769224A0000|40 62|Lupus Erythematosus (SLE)
P03771670T0058|33 35|III
P03771703A0000|0 12|N-Substituted
P03771749A0465|0 3|MICs
P03772471A1054|23 32|Group II(a)
P03776080A0400|104 106|E/S
P03776080A0400|110 112|CWE
P03776438A0000|63 72|sodium (Na)
P03780248A0274|107 122|ventilation (IMV)
P03780248A0274|208 209|pH
P03780248A0274|213 216|PCO2
P03780371A0792|55 77|cytochrome P-450PBc2 gene
P03780371A0792|97 113|5'-flanking region
P03780704A0573|115 127|tilization, WW
P03780704A0573|141 142|CW
P03780704A0573|151 152|CC
P03783160A0285|17 29|21-O-angeloyl
P03783160A0285|18 42|1-O-angeloyl, 22-O-tigloyl
P03783160A0285|59 70|21-O-tigloyl
P03783160A0285|60 84|1-O-tigloyl, 22-O-angeloyl
P03785212A0091|55 59|cDNAs
P03785212A1128|0 11|RPS14 introns
P03791645A1124|57 68|pathogenesis
P03791645A1124|71 73|MAL
P03791645A1124|89 91|OSA
P03795488A0487|50 51|CR
P03795488A0487|73 74|PR
P03799323A0501|49 72|oxygen saturation decrease
P03802195A0481|78 94|DNA binding domains
P03802195A0481|100 103|ToxR
P03805090A0645|173 184|degeneration
P03806696A0000|28 34|(HgCl2)
P03806696A0000|45 53|(CH3HgCl)
P03806696A0000|91 99|(Japanese
P03810867A0305|77 103|TNM system (Lederman-Gadeberg
P03810867A0305|78 117|NM system (Lederman-Gadeberg, Sisson-Jesse)
P03811852A0109|114 128|beta-adrenergic
P03814493T0000|31 48|grade non-Hodgkin's
P03818467A0180|22 27|IU/kg)
P03818467A0180|122 156|plasma glutathione peroxidase (GSH-Px)
P03827071T0040|0 1|II
P03830147A0000|38 52|lactate increase
P03830147A0000|39 73|actate increase: lactate threshold (LT)
P03830147A0000|78 80|VO2
P03830147A0000|169 184|xercise test), LT1
P03830147A0000|189 191|VO2
P03830147A0000|220 222|1 mM
P03830147A0000|239 247|evel), LT2
P03830147A0000|252 254|VO2
P03830147A0000|307 310|2 mM)
P03830147A0000|343 347|(OBLA
P03830147A0000|352 354|VO2
P03830147A0000|397 400|4 mM)
P03830147A0000|425 440|capacity (VO2max)
P03836777T0001|71 73|HBs
P03836854T0000|49 55|40 749 RP
P03838797A0903|94 97|mRNA
P03838797A0903|110 113|cDNA
P03838797A0903|142 145|cDNA
P03840480T0000|5 13|multigene
P03843676A0381|79 90|carcinogenic
P03857577A0413|45 47|DNA
P03857577A0413|116 119|HeLa
P03857577A0413|138 148|EIA-induced
P03860162A0000|35 52|amphotericin B (AMB)
P03862898A0563|0 7|Serum IgM
P03862898A0563|11 13|IgE
P03862898A0563|12 48|gE concentrations, allergen-specific IgE
P03862898A0563|62 69|tumor E2R
P03863561A0405|71 87|trep. mutans/Strep
P03865743A0859|24 27|T.C.
P03865743A0859|25 34|.C., LDL-C.
P03865743A0859|26 41|C., LDL-C., HDL-C.
P03865743A0859|27 49|., LDL-C., HDL-C., HDL2-C.
P03865743A0859|29 63| LDL-C., HDL-C., HDL2-C., apo B, apo A-I/B
P03865743A0859|72 80|apo A-II/B
P03865743A0859|123 134|heart disease
P03866085A0795|50 54|CZX-S
P03869442A0223|108 130|1-desamino-8-D-arginine
P03871298A0217|32 48|tomography (SPECT)
P03871298A0217|149 151|CAD
P03873141A0304|72 78|(Visick
P03873141A0304|79 83|I-II)
P03874921A0862|112 113|EP
P03875231A0627|0 2|MRI
P03878585A0507|3 15|percentage RFR
P03878585A0507|35 37|CPB
P03878585A0507|72 74|CPB
P03878585A0507|94 118|oxygen flow rate index (OFRI)
P03878585A0507|173 196|blood flow rate index (BFRI)
P03878585A0507|238 261|heart-lung machine/min CPB
P03881260A0000|1 8|yeast DNA
P03881260A0000|28 33|gene CP
P03881260A0000|64 107|arginine pathway carbamoyl-phosphate synthetase
P03882029A0000|60 75|granuloma complex
P03883541A0200|3 12|H2 receptor
P03885983A0254|39 46|Class III
P03887085A0000|123 141|short-term exogenous
P03887085A0000|167 170|(CBA
P03887085A0000|171 179|X C57Bl)F1
P03887769A0584|105 106|II
P03888621A0185|20 30|hydrogenase
P03890486A0000|74 89|imaging confusion
P03891766A1473|52 56|ELISA
P03894482A0549|30 37|serum IgE
P03898382A0000|50 53|67Ga
P03898382A0000|64 68|99mTc
P03904004A1577|80 89|159 keV 123I
P03904004A1577|203 206|124I
P03908493A0246|53 68|immunoperoxidase
P03911052A0909|14 19|DIL-CP
P03911052A0909|39 40|CP
P03911052A0909|43 46|CABG
P03911052A0909|78 79|CP
P03911052A0909|102 105|CABG
P03915540A0863|71 83|GCN4-lacZ mRNA
P03921727A0523|19 24|apo A-I
P03921727A0523|28 34|apo A-II
P03922116A0197|38 52|group 1--complex
P03922116A0197|70 90|ases), group 2--complex
P03922116A0197|140 154|group 3--complex
P03923828A1031|35 39|DDAVP
P03923976T0001|48 56|factor XII
P03928357A0340|38 41|PCBs
P03928357A0340|65 69|PCDFs
P03928357A0340|96 100|PCDFs
P03928357A0340|104 108|PCDDs
P03928442A0463|61 69|Mtase gene
P03928442A0463|79 86|phage SPR
P03929486A0309|38 41|COCM
P03929486A0309|42 46|(NYHA
P03929486A0309|47 53|II-III)
P03929486A0309|88 110|ejection fraction (LV-EF)
P03929486A0309|146 173| (0.25-0.5 mg/d), placebo (PLAC)
P03929486A0309|181 188|releases
P03929486A0309|187 192|es = SR)
P03929486A0309|190 192|SR)
P03930894T0000|19 40|acetylcholine receptors
P03933784A0420|26 37|CSF prolactin
P03934667A0124|16 19|crsA
P03934667A0124|17 34|rsA mutations, crsA1
P03934667A0124|18 40|sA mutations, crsA1, crsA4
P03934667A0124|45 50|crsA47
P03934667A0124|72 76|"gene
P03934667A0124|98 119|. subtilis plasmid pRPD11
P03934667A0124|145 157|wild-type rpoD
P03934667A0124|205 226|. subtilis RNA polymerase
P03934667A0124|231 236|pUB110
P03935375A0414|136 138|RPN
P03935375A0414|194 205|degeneration
P03935797A0183|60 75|sry messenger RNAs
P03935797A0183|170 190|protein-coding regions
P03935797A0183|211 220|order) beta
P03935797A0183|212 226|rder) beta, alpha
P03939317A0352|62 71|HS promoter
P03939317A0352|77 98|soybean HS-protein genes
P03940426A0618|30 32|GLC
P03940818T0000|28 30|HBV
P03944212A0166|1 18|issue pressure, rCBF
P03944212A0166|104 106|MCA
P03944212A0166|127 130|MCAO
P03944239A0780|134 136|rT3
P03952387A0336|81 99|oxyhemoglobin (HbO2)
P03953361A0000|68 78|reperfusion
P03953361A0000|110 127|creatine kinase (CK)
P03953361A0000|131 141|calcium (Ca)
P03953361A0000|153 154|CK
P03953361A0000|158 171|lactic acid (LA)
P03956647A1063|16 23|Pt-30%Ir
P03956647A1063|104 116|200 microC/cm2
P03956647A1063|230 239|microC/cm2
P03959045A0000|84 116|Medical College Admission Test (MCAT)
P03963860A0137|49 52|MY-1
P03964489A1195|18 21|PaO2
P03964489A1195|19 26|aO2, NADH
P03964855A0254|35 38|rCBF
P03965012A0163|97 109|heart diseases
P03965012A0163|110 113|(ICD
P03965012A0163|114 121|A83-A84)
P03970191A0275|52 75|electrocorticogram (ECoG)
P03970191A0275|89 90|DC
P03972038A0000|71 81|region (STR)
P03974790A0053|10 11|CT
P03976323A0821|52 61|SCR-change
P03978045A0857|44 46|(0T
P03978045A0857|48 50|0N)
P03978045A0857|74 76|VWF
P03978132A0108|2 5|MCCP
P03979084A1019|85 88|IMPK
P03979084A1019|91 94|IBPK
P03980386A0000|49 50|II
P03981421A0246|18 22|5 mL/h
P03981421A0246|62 64|mL)
P03981640A0168|46 50|mRNAs
P03985849A0221|126 129|CVID
P03985849A0221|196 198|IgA
P03987818A0440|20 23|AP-A
P03987857A0733|28 38|floor region
P03988001A0227|89 92|ClO2
P03989827T0000|14 20|lactase
P03992022A0330|84 99|TMO N-demethylase
P03992022A0330|103 120|aniline hydroxylase
P03998813A0406|95 102|ontogeny
P03999219A0463|0 13|Ultrastructure
P04000347A0442|112 114|BEN
P04000347A0442|140 142|BEN
P04001490T0001|3 7|POEMS
P04001490T0001|16 30|(Polyneuropathy
P04002131A0506|43 45|GAG
P04004168A0000|38 61|triosephosphate isomerase
P04005190A1288|23 25|PCA
P04005190A1288|36 51|non-carcinogenic
P04013604A0412|57 67|low--3 cases
P04013604A0412|92 103|slow-release
P04014833A0400|46 56|blastogenic
P04014833A0400|129 136|mitogens
P04014861A0000|84 128|liposome-encapsulated superoxide dismutase (SOD)
P04014861A0000|131 138|catalase
P04019066A0000|69 82|formation (MRF)
P04019066A0000|95 98|(CG)
P04019066A0000|115 125|cortex (SCX)
P04021281T0001|0 13|Ultrastructure
P04021431A0000|0 3|OODG
P04024685A0650|47 56|ncrease: RS
P04024685A0650|71 75|mVolt
P04024685A0650|108 110|EDD
P04024685A0650|150 151|HV
P04024685A0650|194 196|EDV
P04024685A0650|238 240|RBV
P04025178A0126|80 113|(LV) end-diastolic volume index (EDVI)
P04032268A0358|7 8|UV
P04032268A0358|46 49|(EC)
P04032268A0358|87 101|Ag/AgCl/3 M NaCl)
P04032349A0000|133 142|(Urokinase
P04032349A0000|165 179|Lys Plasminogen)
P04033402A1112|14 23|androgenic
P04033402A1112|38 52|HDL-cholesterol
P04033402A1112|73 88|HDL2-cholesterol
P04033402A1112|127 144|triglyceride lipase
P04036838A0918|47 51|RV/LV
P04037809A0964|38 44|KW-2083
P04038454A0984|57 59|RBP
P04039307A0613|28 29|(P
P04039439A0000|41 60|5000 ppm manganese (Mn)
P04039439A0000|74 94|manganese oxide (Mn3O4)
P04039439A0842|67 71|Mn3O4
P04039525A0475|70 72|DDP
P04039525A0475|207 209|DDP
P04039667T0000|49 62|Sprague-Dawley
P04039667T0000|76 89|99mTc-labelled
P04039744A0141|43 44|-D
P04040307A0145|81 82|NE
P04040339T0001|72 90|beta-adrenomimetics
P04048245A0331|71 78|serum CPN
P04051521T0001|78 80|MTX
P04051521T0001|84 87|5-FU
P04052919A0205|70 80|luteal phase
P04052919A0205|107 121|mid-luteal phase
P04052919A0205|136 150|mid-luteal phase
P04052919A0205|283 297|mid-luteal phase
P04056218A0463|42 47|dB/dB)
P04056218A0463|67 70|80 dB
P04058985A0000|83 97|plasma prolactin
P04066194A0163|23 27|N1-P2
P04066194A0163|31 41|baseline-P2
P04066194A0163|56 63|probe EPs
P04066274A0265|77 97|parotidectomy (T.C.P.)
P04066274A0265|108 110|S.P
P04068663A0452|21 34|mouse CRF-flora
P04068663A0452|122 129|mouse CRF
P04068969A0300|0 4|L3-L4
P04070725A0442|104 112|generator
P04071063A0863|73 88|roups, fibrinogen
P04075021T0000|0 24|[14C]-beta-phenethylamine
P04075021T0000|97 112|monoamine oxidase
P04079738A0677|29 33|+/- SD
P04079738A0677|57 58|kJ
P04084607A0663|23 29|O6meG.T
P04084607A0663|46 52|O6meG.N
P04084607A0663|158 187|imino protons in Watson-Crick base
P04086403A1016|18 19|(P
P04086403A1016|61 62|(P
P04086403A1016|90 95|AS-VFA
P04088733T0001|10 23|acid hydrolases
P04088936T0001|35 37|III
P04088936T0001|46 56|plasminogen
P04102280T0000|11 24|Paget's disease
P04103248T0000|16 18|CRT
P04115870T0000|46 51|Urat-I
P04139081T0001|0 3|HL-A
P04164669T0000|0 10|Ultraviolet
P04176625T0000|10 12|EMG
P04189158T0000|21 42|h sensitization: anti-Rh
P04196986T0000|29 30|II
P04214345T0000|22 29|serum IgG
P04239041T0045|28 59|sodium-potassium-activated ATPase
P04246054T0028|30 66|rabbit-anti-lymphocyte globulin (RAMLG)
P04305850T0000|0 8|Androgens
P04308979T0000|52 54|BCG
P04321861T0001|8 27|glutathione reductase
P04328746T0073|0 9|Ultrasound
P04328746T0073|21 37|cytochrome oxidase
P04364369T0000|0 9|Pre-beta-1
P04364369T0000|62 73|heart disease
P04369884T0000|36 64|colony-stimulating factor (CSF)
P04377003A0000|105 114|fluid (CSF)
P04377003A0000|131 133|CSF
P04377003A0000|173 183|system (CNS)
P04407649T0000|63 67|99mTc
P04418687T0000|9 16|estrogen
P04428800T0001|15 33|CO-induced increases
P04428800T0001|36 38|LAP
P04428800T0001|42 44|GPT
P04512496T0000|0 15|Hodgkin's disease
P04518624T0000|0 20|Glutathione peroxidase
P04536964T0000|13 14|pH
P04539552T0001|22 27|SF-837
P04552263T0000|23 35|nursing--R.N.
P04580044T0047|27 42|development phase
P04624863T0001|11 23|immunogenesis
P04627477T0001|44 45|(H
P04661961T0001|55 64|(Armenian)
P04712626T0000|65 87|Swertia chirata Buch.-Ham
P04757217T0000|9 27|lipoprotein-X (LP-X)
P04757217T0000|50 53|LCAT
P04778129T0000|0 8|9,11-Seco
P04789916T0001|30 41|bengal-I-131
P04810131T0000|1 32|etter: Aryl hydrocarbon hydroxylase
P04824747T0000|0 16|Nonteratogenicity
P04826272T0074|0 2|VII
P04839176T0001|9 25|high-intensity SHF
P04843031T0000|11 31|galactosyltransferase
P04852635T0000|43 45|(BC
P04863895T0000|78 89|disease (CRD)
P04863895T0000|92 98|poultry
P04890336T0001|84 87|RPCF
P04890336T0001|91 93|FTA
P04911925T0001|0 31|Electrocardiographic QRS complexes
P04911925T0001|54 56|QRS
P04919613T0001|61 76|collagen diseases
P04941419T0000|0 23|Yusuf Dawood Docrat L.R.C.P
P04948325T0000|26 30|MC-63
P04970918T0069|0 9|LA-3848-MS
P04976988T0000|0 12|Heterogeneity
P04992478T0000|0 16|Plasma histaminase
P04999086T0001|69 79|ontogenesis
P05000171T0000|41 61|horseradish peroxidase
P05005311T0000|0 13|Immunogenicity
P05015678T0000|0 16|Nitrogen-hydrogen
P05027295T0034|0 13|Cholinesterase
P05028628T0001|37 52|occlusion disease
P05034373T0000|24 38|function oxidase
P05068271T0000|24 26|VMA
P05114515T0000|15 27|enzyme release
P05132558T0000|55 70|monoamine oxidase
P05133723T0000|20 34|gluconeogenesis
P05145925T0000|34 53|infiltrate-producing
P05170106T0034|129 130|NF
P05172970T0001|86 93|395 cases
P05203499T0001|36 63|131-I-tagged BSP--description
P05203499T0001|112 120|131-I-RB)
P05303700T0066|0 11|SAM-TR-68-54
P05308271T0000|0 2|BIM
P05316745T0000|0 15|Aedes aegypti (L.)
P05316745T0000|19 40|Aedes albopictus (Skuse)
P05359130T0086|0 1|IX
P05364951T0001|17 28|pathogenesis
P05368978T0000|0 2|CNS
P05368978T0000|52 59|biogenic
P05394461T0001|15 16|HB
P05410641T0000|38 50|airway disease
P05412122T0000|0 8|3'-Methyl
P05424220T0001|21 26|lipase
P05425195T0001|10 34|aspartate aminotransferase
P05425195T0001|35 37|(EC
P05425195T0001|49 71|alanine aminotransferase
P05425195T0001|72 74|(EC
P05441564T0001|12 24|pathogenicity
P05441564T0001|27 37|ECHO 9 (HILL)
P05451324T0000|57 58|CO
P05466177T0001|0 10|Teratogenic
P05500957T0001|28 47|hydergine (Brinedine)
P05529283T0000|22 24|IgA
P05552149T0000|0 2|18F
P05552149T0000|6 9|85Sr
P05555149T0001|40 42|SH-
P05555149T0001|46 55|S-S-groups
P05556977T0001|0 12|Morphogenesis
P05556977T0001|45 56|regeneration
P05567721T0000|32 40|factor VII
P05671267T0000|0 70|5-(Dimethylaminopropyl)-19,11-dihydro-5H-benzo[2,3]pyrido[6,7-b]azepine
P05672903T0001|0 11|Osteogenesis
P05684081T0001|44 58|chamber VA-K-254
P05684081T0001|64 77|osimeter VA-J18
P05689427T0052|0 40|3-(N-Alkyl-N-2-chloroethylaminomethyl)-5-
P05689427T0052|43 68|7-halogenobenzo[b]thiophen
P05693605T0001|15 27|transaminases
P05749438T0001|12 77|anesthetics 2-(o-chlorophenyl)-2-methyl-amino cyclohexane HCL (CI-581)
P05750950T0001|30 48|androgen-sterilized
P05763347T0000|34 57|beta-adrenergic receptors
P05779953T0000|32 38|serum LH
P05779953T0000|42 44|FSH
P05781385T0000|20 44|phenolphthalein sulphatase
P05787318T0000|18 38|clofibrate (Atromid-S)
P05789870T0001|0 28|Phosphate glucose dehydrogenase
P05792911T0000|9 31|beta-adrenergic receptor
P05794247T0000|34 55|serum lipoprotein lipase
P05805644T0001|44 48|228Ra
P05805644T0001|52 56|224Ra
P05805644T0001|62 64|RES
P05805644T0001|107 119|colloidal ThO2
P05822499T0034|14 25|digiprogenin
P05857301T0000|49 53|CC1-4
P05858571T0000|19 64|,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962
P05890093T0000|82 99|hypervitaminosis-A
P05908762T0031|0 1|IV
P05919308T0001|46 61|monoamine oxidase
P05930797T0000|46 55|(Australia
P05947377T0001|3 25|3-hour test iodine (I-132)
P05960999T0001|147 154|anti-CRP
P05992157T0001|3 15|pathogenicity
P05999607T0001|9 19|lipogenesis
P06027841T0000|13 17|249Bk
P06070204T0025|0 2|XXI
P06084279A0218|43 54|serum amylase
P06084279A0218|64 67|ERCP
P06084810A0169|3 21|immuno-purified mRNA
P06084810A0169|27 41|polysome complex
P06084810A0169|58 61|cDNA
P06089575A0464|15 17|MCh
P06089575A0464|59 62|cGMP
P06090369A0000|41 47|WR-2721
P06090369A0000|50 58|Phase I-II
P06090458A0407|3 15|PEPCK promoter
P06090458A0407|86 91|TK gene
P06091914A0000|38 53|tumor virus (MMTV)
P06091914A0000|144 151|oncogene
P06093354A0000|16 18|DNA
P06093354A0000|27 36|endogenous
P06093354A0000|43 72|leukemia virus (MuLV)-related DNA
P06093354A0000|130 143|Balb/c mouse DNA
P06093363A0612|0 2|USA
P06094591A0000|26 46|Rous sarcoma virus (RSV)
P06095774T0001|0 11|Histogenetic
P06096246T0000|23 33|psychogenic
P06096380A0662|6 9|mRNA
P06096380A0662|22 53|phosphoenolpyruvate carboxykinase
P06096380A0662|71 79|kilobases
P06096380A0662|120 123|mRNA
P06096863T0000|28 35|CYC1 gene
P06096863T0000|113 117|"TATA
P06097027A0000|103 126|myeloblastosis virus (AMV)
P06098828A0352|45 56|SV40 G-C-rich
P06098828A0352|90 102|RNA polymerase
P06098828A0352|103 104|II
P06098828A0352|105 135|transcriptional-control elements
P06099656T0000|53 83|adenovirus DNA binding protein gene
P06099656T0000|109 119|HSV-1 tk gene
P06109017A0000|27 32|beta-1
P06109017A0000|178 181|(LV)
P06109017A0000|180 204|V) pressure, diameter, dP/dt
P06111283T0032|33 55|des-Tyr-gamma-endorphin
P06131038A0000|34 50|lipoprotein lipase
P06131378A0818|8 11|mRNA
P06131378A0818|68 75|DHFR cDNA
P06131378A0818|128 135|DHFR cDNA
P06136374A0151|7 26|ater temperatures, VO2
P06138313A0948|3 19|distribution phase
P06138313A0948|34 49|elimination phase
P06141764A0339|39 53|PB-inducible RNA
P06141764A0339|71 80|plasmid DNA
P06141764A0339|108 119|PB-inducible
P06142279T0000|6 9|HTLV
P06150069A0422|19 21|VCR
P06151518A0000|31 34|LD50
P06151942A0235|129 160|olesterol, triglyceride, gamma-GTP
P06153936A0784|24 26|SjS
P06158844A0000|22 33|CM-Pf complex
P06162419A0118|98 115|lymphadenosis NK/Li
P06163433T0000|75 90|monoamine oxidase
P06165132A0000|98 106|mesogenic
P06165132A0000|162 165|RIHA
P06165132A0000|195 204|pathogenic
P06167806A0000|19 24|UM-272
P06173860A0000|52 53|ST
P06173860A0000|127 128|ST
P06181216A0070|52 59|serum IgA
P06184487A1485|4 7|mRNA
P06184487A1485|19 32|cDNA homologous
P06184487A1485|38 60|HindIII-P/EcoRI-B region
P06184487A1485|66 70|AcNPV
P06184487A1485|96 98|31K
P06184487A1485|102 104|30K
P06184487A1485|135 137|31K
P06184487A1485|141 143|30K
P06184487A1485|166 168|RNA
P06184487A1485|182 209|HindIII-A/EcoRI-C/SstI-G cDNA
P06185493A0468|1 11|polypeptide
P06185493A0468|100 102|ADP
P06185493A0468|122 141|muscle pyruvate kinase
P06193351A1010|70 71|VF
P06193351A1010|84 90|release
P06198532A0982|76 77|MS
P06198532A0982|100 102|RHD
P06198532A0982|196 198|RHD
P06199132A0179|60 62|WBC
P06200300A0409|32 34|VEP
P06208024A0168|37 41|DNase
P06208024A0168|46 50|RNase
P06208477A0000|47 49|DNA
P06208477A0000|75 82|(Pietras
P06209403A0562|23 32|pseudogene
P06209499A0682|18 35|transmitter release
P06209499A0682|56 58|MAP
P06212776A0000|2 17|Cabras (Oristano)
P06212776A0000|70 73|G6PD
P06216125A0470|51 52|ET
P06218005A0948|30 32|L-L
P06218005A0948|47 49|A-P
P06223586A0000|22 39|schizophyllan (SPG)
P06223586A0000|91 99|syngeneic
P06223586A0000|100 111|tumor-C3H/He
P06223586A0460|90 92|SPG
P06224974A0833|30 44|15 beta-hydroxy-
P06224974A0833|58 60|CPA
P06227570A0523|13 14|LL
P06227570A0523|29 31|ENL
P06227570A0523|35 46|ConA-induced
P06234369T0000|0 10|Hepatitis-B
P06237518A0117|59 88|,3-dimethylbarbituric acid; CNCl
P06237518A0117|133 135|KCN
P06238540A0798|60 62|LVH
P06238540A0798|150 152|LVH
P06240448A0652|85 86|LV
P06240448A0652|187 188|LV
P06241980A0855|53 61|diffusion
P06241980A0855|114 122|diffusion
P06244732T0000|18 36|serum creatine kinase
P06246254A0676|70 73|FeSV
P06246254A0676|114 117|FeSV
P06246254A0676|146 153|kilobase
P06251469A0830|48 54|7-kb IAP
P06252883A0100|40 53|(O149:K88:H10)
P06252883A0100|90 92|PWD
P06254403A0000|31 35|SA-11
P06254973A1757|0 7|Poly(dT)
P06254973A1757|20 32|calf thymus DNA
P06254973A1757|109 114|19 HDP*
P06254973A1757|116 120|(dT)8
P06254973A1757|158 162|(dT)n
P06254973A1757|167 171|(dT)4
P06254973A1757|175 179|(dT)6
P06254973A1757|240 245|19 HDP*
P06254973A1757|287 291|(dT)n
P06258699T0000|51 52|GU
P06259220A0464|86 95|naltrexone
P06259389A0000|49 77|and, foot and mouth disease (HFMD)
P06270347A0740|1 14|22K polypeptide
P06270347A0740|53 55|RNA
P06270347A0740|76 78|DNA
P06272844A0000|17 29|virus 40 (SV40)
P06272844A0000|124 138|nuclease (MNase)
P06272844A0000|202 205|SV40
P06278424A0145|38 43|CH gene
P06278424A0145|79 90|gamma 2b genes
P06278424A0145|112 131|mouse myeloma (MPC-11)
P06279309A0000|77 87|loci (v-erbA
P06279309A0000|91 97|v-erbB)
P06279309A0000|138 148|oncogenesis
P06281759A1086|7 11|RNase
P06281759A1086|12 14|III
P06281759A1086|69 74|PL mRNA
P06281759A1086|86 101|endoribonuclease
P06281759A1086|110 116|int mRNA
P06281786A1222|11 24|lone, lambda HHG
P06281786A1222|52 63|histone genes
P06281786A1222|102 104|RNA
P06286443A0498|13 21|serum ACTH
P06286549A0000|0 13|WR-2721 (S-2-(3
P06286549A0000|124 140|fibrosarcoma (FSa)
P06287212A1352|17 28|polypeptides
P06287212A1352|55 76|translation at AUG codons
P06287212A1352|101 103|VP1
P06287212A1352|163 171|generated
P06287212A1352|206 209|AUGs
P06287231A0914|3 25|ddition, TRP1 RI Circle DNA
P06287737A0477|22 32|transfusion
P06287737A0477|89 96|type NANB
P06287737A0477|157 171|posttransfusion
P06287737A0477|221 233|liver diseases
P06287737A0477|280 291|transfusions
P06287737A0477|323 330|type NANB
P06287737A0477|339 350|type B disease
P06290859A0426|89 96|anti-HBs
P06291369A0000|169 190|ejection fraction (RVEF)
P06295429A0412|16 19|MISO
P06295429A0412|23 29|WR-2721
P06296833A0000|28 45|cuticle protein gene
P06298720A0893|96 107|VL30 elements
P06298720A0893|111 114|MuLV
P06300662T0000|1 4|cDNA
P06300662T0000|41 44|cDNA
P06300836A0285|49 51|RR1
P06300836A0285|64 74|32P-labeled
P06300836A0285|80 89|genome RNAs
P06300836A0285|115 117|DNA
P06300836A0285|149 162|10 reovirus RNAs
P06304771A1284|8 23|equence, GGGXGGAG
P06304771A1284|118 120|DNA
P06304771A1284|167 169|JCV
P06306342A1156|37 40|LiCl
P06308536T0001|3 35|hepatitis A virus antibody (anti-HAV)
P06308536T0001|52 64|liver diseases
P06308607A0375|60 62|DNA
P06308607A0375|141 150|polymerase
P06310159A0000|5 7|RNA
P06310159A0000|34 36|DNA
P06310159A0000|69 81|retrovirus MH2
P06310553T0000|53 67|muscle actin gene
P06310608A0749|57 65|M-MuLV DNA
P06310608A0749|63 65|DNA
P06310608A0749|98 124|iruses, Ableson MuLV (Ab-MuLV)
P06310608A0749|141 159|sarcoma virus (M-MSV)
P06314276T0000|36 66|full-length double-stranded cDNAs
P06314276T0000|84 87|SV40
P06314276T0000|99 110|gene promoter
P06316347A0852|3 11|dnaQ-lacZ
P06316347A0852|18 25|rnh-lacZ
P06316347A0852|72 89|beta-galactosidase
P06316623A0188|99 113|immunodiffusion
P06318078T0000|12 33|herpes simplex virus beta
P06318078T0000|37 46|gamma genes
P06318078T0000|94 102|alpha gene
P06318322A0350|39 41|SSV
P06318322A0350|45 53|generated
P06318322A0350|84 86|DNA
P06318322A0350|180 200|viral-sis messenger RNA
P06319040A1627|56 75|carotid chemoreceptor
P06319071A0173|99 101|AMP
P06319071A0173|181 183|AMP
P06319072A0711|90 101|cell receptor
P06319072A0711|162 178|beta-adrenoceptor
P06319421A0937|140 161|alpha 2-adrenoreceptors
P06319740A1331|147 161|Rauscher disease
P06320380T0001|28 37|metastases
P06321505A0401|1 33|promoter sequence (Goldberg-Hogness
P06321505A0401|36 39|TATA
P06321505A0401|54 59|28 base
P06321505A0401|127 136|S1 nuclease
P06321505A0401|193 202|rat PTH mRNA
P06321634A0123|18 22|mRNAs
P06321634A0123|56 63|249 bases
P06321634A0123|95 102|540 bases
P06321634A0123|134 140|TRs/IRs
P06321770A1353|15 46|chloramphenicol acetyltransferase
P06322183A1070|0 4|NPT II
P06322183A1070|90 94|NPT II
P06323556A0126|37 50|EOE-13 infusion
P06324089A0453|24 27|GAL7
P06324121A0256|9 15|MW (12K)
P06324121A0256|16 17|IE
P06324121A0256|18 28|polypeptide
P06324121A0256|38 45|IEmRNA-5
P06324121A0256|64 70|88 codon
P06324121A0256|95 103|a 1200 base
P06324121A0256|106 125|non-translated region
P06325415A0757|37 43|Ad5 DBPs
P06327039A0743|39 41|LVM
P06327039A0743|187 190|CD25
P06327292A0846|14 27|Shine-Dalgarno
P06327292A0846|81 91|start codons
P06327638A0155|24 80|chloramphenicol-inducible chloramphenicol acetyltransferase
P06327638A0155|96 107|1.1-kilobase
P06327638A0155|114 116|DNA
P06328002A0000|21 38|sarcoma virus (MPSV)
P06328002A0000|60 87|Moloney sarcoma virus (Mo-MuSV)
P06328012A0549|3 16|same-sized EBNA
P06328012A0549|73 79|BamHI-K
P06328012A0549|84 91|kilobase
P06328272A0705|4 12|generated
P06328485A0277|107 112|MH2 DNA
P06328485A0277|191 213|myc-containing oncogenic
P06328485A0277|236 255|chicken proto-myc gene
P06328504A0161|0 2|USA
P06328504A0161|38 53|clone lambda PGK-1
P06328504A0161|93 119|phosphoglycerate kinase (PGK)
P06333433A0000|81 103|. influenzae type b disease
P06333433A0000|155 177|lipopolysaccharide (LPS)
P06336045A0261a|9 11|(Ft
P06336045A0261b|9 11|(Ft
P06336045A0261b|25 26|II
P06336045A0261a|25 26|II
P06336045A0261a|27 29|(Ft
P06336045A0261b|27 29|(Ft
P06336045A0261b|30 32|II)
P06336045A0261a|30 32|II)
P06336045A0261a|47 50|(SA)
P06336045A0261b|47 50|(SA)
P06336045A0261a|79 94|indentation phase
P06336045A0261b|79 94|indentation phase
P06336045A0261a|102 128|threshold response phase (TRP)
P06336045A0261b|102 128|threshold response phase (TRP)
P06336045A0261a|102 123|threshold response phase
P06340643A0598|0 3|DMCM
P06341661T0001|47 63|Blalock-Taussig's
P06345840A0348|27 29|CI)
P06345840A0348|86 99|velocity (mVCF)
P06345840A0348|117 119|TPR
P06349364A1051|100 102|III
P06350092A0916|24 26|AMI
P06350092A0916|38 41|CCHD
P06350092A0916|58 71|high-grade VPBs
P06360426A0501|89 90|pH
P06361318A0440|35 48|151 cases (KS-R1
P06361318A0440|56 62|77 cases
P06361318A0440|134 138|KS-R1
P06361318A1127|72 85|163 cases (KS-R1
P06361318A1127|93 99|83 cases
P06361318A1127|159 163|KS-R1
P06362143A0565|56 75|isoprenaline infusion
P06362602T0001|70 78|aerogenic
P06369355A0834|66 75|trfA region
P06369355A0834|115 126|trfA-encoded
P06369355A0834|147 156|plasmid RK2
P06370553A0444|7 30|plasma norepinephrine (NE)
P06370553A0444|34 47|epinephrine (E)
P06370553A0444|119 133|ontrol: plasma NE
P06373409A1163|57 65|generated
P06373855A0000|123 127|PLEVA
P06373855A0000|169 184|immunoperoxidase
P06376227A0217|0 2|EGV
P06376227A0217|26 27|PP
P06379363A0415|34 39|HDL-2M
P06388818A0000|43 55|non-Hodgkin's
P06388818A0000|147 172|high-dose chemotherapy (HDC)
P06388818A0000|213 236|bone marrow infusion (ABMT)
P06391496T0000|29 40|polypeptides
P06395804A0382|0 5|Urease
P06402480A0373|22 25|PPNG
P06402859A0000|0 14|Antithrombin III
P06402859A0000|15 17|(AT
P06402859A0000|18 21|III)
P06406060A0000|0 13|195mPt-labeled
P06407348A0516|0 15|New beta-blocking
P06407348A0516|136 151|receptors (beta1)
P06407348A0516|169 190|muscle receptors (beta2)
P06412385A0356|22 32|lung disease
P06412385A0356|208 234|carbon dioxide tension (PaCO2)
P06414990A0057|30 32|TRH
P06414990A0057|150 157|area (As)
P06426493A0331|63 65|IOP
P06426493A0331|77 97|essure, heart rate, FIO2
P06426493A0331|78 104|ssure, heart rate, FIO2, FE'CO2
P06426493A0331|108 110|CVP
P06429992T0000|46 47|DZ
P06433442T0000|43 48|VIII:C
P06434572A0157|65 66|GH
P06434572A0157|283 284|GH
P06434587A0551|24 25|LH
P06434587A0551|29 31|FSH
P06434587A0551|79 80|LH
P06434587A0551|84 86|FSH
P06434587A0551|98 100|LRH
P06435565A0648|94 97|mmHg
P06439135A0250|0 10|Regional CBF
P06441624A0263|22 29|serum BGP
P06444119A0340|70 90|mperature, salinity, pH
P06451557A0777|72 74|(De
P06452461A0930|32 37|LVM/M2
P06452461A0930|41 44|PWVn
P06452461A0930|48 54|pre-AVR
P06452461A0930|58 64|post AVR
P06454625A0000|109 136|Infrared-Contact-Coagulation
P06460889A0111|23 27|SG-75
P06460889A0111|58 75|blood pressure (SBP)
P06460889A0111|135 148|blood flow (PBF)
P06460889A0512|10 31|.03-0.3 mg/kg i.v., SG-75
P06460889A0512|112 124|pressure (LVP)
P06460889A0512|128 134|LVdP/dt
P06463429A0414|7 8|VE
P06467797A0233|49 50|NT
P06467797A0233|85 98|ratio (D/4-OH-D
P06468565A0000|50 51|(N
P06468565A0000|122 147|frequency gain constants (G1)
P06468565A0000|158 183|frequency gain constants (Gm)
P06468673A0358|96 105|CC-treated
P06468673A0358|111 112|(P
P06473219T0000|45 46|II
P06473252A1073|81 96|factor.(ABSTRACT
P06473252A1073|97 105|TRUNCATED
P06473252A1073|102 103|AT
P06473252A1073|108 116|250 WORDS)
P06479976A0386|69 71|AMB
P06479976A0386|121 122|(P
P06479976A0386|188 189|(P
P06482665A0735|26 29|AMPH
P06482665A0735|161 188|amphetamine-induced increases
P06483863A0000|31 40|BALB/cCrgl
P06483863A0000|43 56|BALB/cfC3HCrgl
P06483863A0000|94 120|5 micrograms 17 beta-estradiol
P06483863A0000|218 229|(Experiments
P06483863A0000|234 236|II)
P06487290A0000|8 33|estradiol 17 beta (E2-17 beta)
P06487290A0000|37 51|progesterone (P)
P06493655A0415|8 10|FHR
P06494297A0939|77 81|HPC SS
P06495195A0536|57 75|alkaline phosphatase
P06501086A0165|176 189|alpha-globulin
P06501086A0165|238 260|sperm agglutinin antibody
P06503132A0784|0 2|SFP
P06503329A0588|43 48|+/- 2 SD
P06503329A0588|86 91|+/- 2 SD
P06503329A0588|98 99|(P
P06503885A0342|186 200|blood flow (rCBF)
P06503885A0342|189 199|od flow (rCBF
P06503885A0342|205 212|xenon/CT
P06506074A0456|20 30|hen plasma TG
P06506074A0456|31 34|7.2X
P06506074A0456|36 37|PL
P06506074A0456|38 41|5.1X
P06506074A0456|47 50|7.2X
P06506074A0456|61 68|plasma TG
P06506074A0456|69 72|6.8X
P06506074A0456|74 75|PL
P06506074A0456|76 79|3.7X
P06506074A0456|85 88|2.5X
P06507629A0717|79 81|NH3
P06508393T0000|77 84|(Testryp
P06508393T0000|85 89|CATT)
P06513456T0001|0 12|Adenyl cyclase
P06517816A0388|0 1|HA
P06517816A0388|55 56|HR
P06520418A0325|41 61|valve orifice area (MVA)
P06520418A0325|103 105|III
P06520418A0325|111 114|LVIT
P06521802A0251|23 26|CMEA
P06521802A0251|131 154|Sciences (Czechoslovakia)
P06521802A0251|175 178|CMEA
P06524202A0167|16 22|EMG-BFB
P06524761A0596|274 275|RH
P06527379T0044|36 48|beta B1 subunit
P06527379T0044|74 76|DNA
P06527872T0000|152 173|an acid phosphatase (ACP)
P06531286A0382|82 85|HPLC
P06535384A1115|133 150|subjects.(ABSTRACT
P06535384A1115|151 159|TRUNCATED
P06535384A1115|156 157|AT
P06535384A1115|162 170|250 WORDS)
P06539738T0000|48 51|(CFC
P06545651A0346|96 110|protein nitrogen
P06545651A0346|124 147|non-protein nitrogen (NH3)
P06546392A0542|136 148|antiproteases
P06548953T0001|5 26|thyroid stimulator (HTS)
P06548953T0001|29 43|thyroid diseases
P06555107A1227|104 116|beta-mimetics
P06568939A0000|23 38|responses (BAERs)
P06579152A1061|30 32|NPF
P06582285A0222|32 34|U-P
P06582285A0222|38 40|D&E
P06582285A0222|57 59|U-P
P06582285A0222|68 70|D&E
P06584416A0157|108 110|PGF
P06585277A0000|67 81|acid phosphatase
P06588306A0076|69 77|AIL- AIEOP
P06600533T0000|75 76|CT
P06602600A0582|3 10|Sarns 51F
P06609166A0209|130 146|C18 reversed-phase
P06610347A0581|22 23|AV
P06610347A0581|85 86|AV
P06615053A0202|91 104|ejection (RVEF)
P06615053A0202|122 148|end-diastolic volume (RVEDVI)
P06615403A0718|13 15|LAD
P06615403A0718|55 65|9 microns TMs
P06615403A0718|106 125|igation, 15 microns TMs
P06627569T0001|0 1|HL
P06630319A0244|0 6|Brain pH
P06634712A0557|82 84|PTH
P06634712A0557|88 89|CT
P06653755A0192|85 86|AP
P06655634A0195|37 39|TOL
P06658029A0086|3 12|carcinogen
P06659982A0231|85 103|delta-wave stage (DS)
P06659982A0231|109 110|QS
P06659982A0231|142 161|parameters) increases
P06659982A0231|189 197|sleep (PS)
P06662623A0124|0 9|[82Br]MISO
P06662623A0124|43 49|Br-MISO
P06662623A0124|53 60|SLOWPOKE
P06667015A0832|131 140|serum CK-MB
P06667868T0001|116 119|BR-1
P06668316A0178|6 31|MOS-Hypersil reversed-phase
P06670732A0000|31 34|(ASA
P06670732A0000|147 154|(Innovar
P06671047A1124|39 41|NOM
P06671047A1124|80 97|hyperprolactinemic
P06671047A1124|133 139|to CD/LD
P06671047A1124|135 139|CD/LD
P06671047A1124|146 148|DOM
P06671047A1124|225 226|DA
P06671047A1124|274 291|etiopathogenetical
P06671047A1124|318 335|hyperprolactinemic
P06671385A0856|3 4|NA
P06671385A0856|62 63|PA
P06674516A0350|13 24|drip infusion
P06674516A0350|27 29|AMK
P06674977A1181|49 51|IX)
P06674977A1181|93 95|VI)
P06684624A0298|80 86|diet 41B
P06684624A0736|7 29|N-acetylglucosaminidase
P06685004A0000|22 62|sex-hormone-binding globulin capacity (SHBG)
P06685004A0000|24 85|x-hormone-binding globulin capacity (SHBG), age, body mass index (BMI)
P06685177T0000|0 23|Dipetalonema (Alafilaria)
P06685643A0179|24 29|C1-INH
P06686454A0585|80 102|Klebsiella-Enterobacter
P06689413A0174|38 51|source(300 mCi)
P06689413A0174|92 97|K alpha
P06689413A0174|127 130|KeV)
P06689513T0001|0 14|Ultrastructural
P06694380A1483|0 7|Plasma NE
P06694380A1483|56 58|SD)
P06694380A1483|79 96|resting).(ABSTRACT
P06694380A1483|97 105|TRUNCATED
P06694380A1483|102 103|AT
P06694380A1483|108 116|250 WORDS)
P06698047A0445|64 66|TRH
P06702257T0001|0 14|Antithrombin III
P06702643A0000|147 156|artery (SA)
P06712314A0148|14 22|1628 cases
P06713204A0867|3 4|AD
P06714298X0000|252 261|maxLVdP/dt
P06715792A0295|0 2|HBB
P06723849A0197|42 55|Formation (MRF)
P06726257T0000|50 65|serotonin release
P06726257T0000|119 139|serotonin autoreceptor
P06726257A1179|22 47|5-hydroxytryptophan (5-HTP)
P06726257A1179|62 64|LSD
P06726257A1179|171 180|paralleled
P06726257A1179|184 195|autoreceptor
P06726257A1179|230 244|vitro.(ABSTRACT
P06726257A1179|245 253|TRUNCATED
P06726257A1179|250 251|AT
P06726257A1179|256 264|250 WORDS)
P06728580A0291|27 34|l Paso , TX
P06731302A0930|13 38|bradyarrhythmia -related SCD
P06732946A0281|129 152|image analyser (Videoplan)
P06740919A0162|79 82|(Bos
P06748227A0423|9 12|Case
P06750608A1442|21 28|lts genes
P06753902A0437|99 106|class IIM
P06753902A0437|115 117|IIS
P06755468A0180|41 44|cobA
P06755468A0180|67 73|cob gene
P06755468A0180|89 105|amino acid homology
P06760394T0001|37 39|ITI
P06760394T0001|40 53|(International
P06762025A0171|38 41|PGE2
P06762025A0171|45 53|PGF2 alpha
P06762321T0000|20 22|DNA
P06763897A0216|27 29|PRA
P06763897A0216|67 68|II
P06763897A0216|69 73|(AII)
P06763897A0216|80 84|[Sar1
P06763897A0216|86 93|Ile8] ALL
P06772370A0342|27 30|DMDZ
P06772370A0342|65 68|DMDZ
P06772612A0000|71 95|carotid body chemoreceptors
P06775834A0000|0 4|HLA-A
P06781728A0690|33 47|osteoprogenitor
P06782612A0142|62 75|urine volume (V)
P06782612A0142|85 105|lithium clearance (CLi)
P06782869A0263|0 7|Nitrogen
P06782869A0263|77 79|BUN
P06782869A0263|80 124|, serum creatinine, creatinine clearance, serum CO2
P06782869A0263|81 134|serum creatinine, creatinine clearance, serum CO2, SGOT, SGPT
P06782869A0263|82 143|erum creatinine, creatinine clearance, serum CO2, SGOT, SGPT, serum LDH
P06782869A0263|148 171|serum alkaline phosphatase
P06784123T0000|16 36|immunoglobulin C mu gene
P06784123A0286|12 18|C mu RNAs
P06784123A0286|26 32|mu mRNAs
P06784123A0286|75 84|region (JH)
P06784123A0771|3 14|1.9-kb C mu RNA
P06786756T0000|9 11|DNA
P06786756T0000|39 41|RNA
P06786756T0000|69 92|immunoglobulin delta genes
P06788388A0000|30 37|ICRF-159
P06791500A0622|23 37|fluid delta OD450
P06794666A0208|55 58|ATCI
P06794666A0208|141 168|cardiomyocyte adrenoreceptors
P06795119T0000|0 18|Lens aldose reductase
P06795654A0434|31 55|0.0625-4.0 mg/kg/infusion)
P06795654A0434|127 129|(FR
P06795832A0148|13 26|Hepatitis A HBs-
P06795832A0148|30 40|HBe-antigen
P06795832A0148|49 55|HBc(IgM
P06795832A0148|59 63|IgG)-
P06795832A0148|60 68|gG)-, HBs-
P06795832A0148|72 85|HBe-antibodies
P06795900A0000|19 37|acid cyclo-oxygenase
P06795900A0000|69 82|blood flow (CBF)
P06795900A0000|105 117|oxygen (CMRO2)
P06795971A0000|51 61|amelgenesis
P06797063A0000|6 9|VIII
P06797063A0000|137 139|DIC
P06798609A0000|74 93|gamma-vinyl GABA (GVG)
P06798609A0000|104 113|240 mg/kg IP
P06802500T0001|0 16|Thyreoliberin VUFB
P06805537T0001|51 54|VIII
P06807149A0222|71 73|DSG
P06807149A0222|81 83|EIB
P06807192A0312|0 3|LCBF
P06807192A0312|59 82|glucose utilization (LCGU)
P06807192A0312|125 130|(Duffy
P06808529A0167|63 65|NTA
P06808529A0167|68 71|EDTA
P06809474A1156|37 48|haem infusion
P06810694A0328|13 27|HDL-cholesterol
P06810694A0328|42 59|VLDL-triglycerides
P06810694A0328|111 116|apo A-I
P06810694A1000|0 5|Apo A-I
P06812389A0658|0 4|TEMTU
P06812389A0658|8 11|DPTU
P06812389A0658|29 38|teratogens
P06816123A0526|25 45|glutathione peroxidase
P06816442T0001|17 37|serum myoglobin in cases
P06816609A0639|6 31|lood pressure reduction, PCO2
P06816609A0639|42 44|kPa
P06816609A0639|43 54|Pa, a decrease
P06816609A0639|86 88|CBF
P06818113A0384|152 162|plasminogen
P06818113A0384|189 192|VIII
P06822645T0039|10 37|increase growth hormone release
P06826813A0264|49 51|UVA
P06829082A0187|76 98|brain tissues glutaminase
P06830033A0661|55 61|15 cmH2O
P06830351A0397|78 79|II
P06830351A0397|93 95|III
P06833047A0000|108 124|ventilation (HFOV)
P06833422T0000|15 65|20 alpha-hydroxy-9 beta,10 alpha-pregna-4,6-dien-3-one
P06837312A0000|86 87|IU
P06842629A0446|11 14|GMBF
P06849842T0000|0 11|Penicillin-G
P06851280A0144|0 15|Plasma fibrinogen
P06851327A0000|20 22|III
P06856669A1004|56 59|5-HT
P06856669A1004|78 83|5-HIAA
P06858967A0167|0 24|Serum lactate dehydrogenase
P06863087A0664|23 24|DB
P06864955T0000|12 15|MMWR
P06869215A0347|12 13|IC
P06872800T0000|45 47|HBV
P06873504T0000|0 11|Pathogenetic
P06875478A0542|0 8|5 microU/l
P06880563A0516|15 18|CPAF
P06882578A0464|5 17|ultramarathon
P06884450A0234|46 47|FB
P06884450A0234|58 60|TBN
P06886031A0898|5 7|PGE
P06891270A0000|11 38|emotional-painful stress (EPS)
P06895559A0000|13 28|beta2-adrenergic
P06895559A0000|54 70|phosphodiesterase
P06895663A0810|51 53|RBT
P06895663A0810|57 59|RLF
P06895663A0810|96 97|(P
P06897114A0240|4 17|two-helix motif
P06897114A0240|49 51|DNA
P06897114A0240|73 75|CAP
P06931124A0109|42 47|(NH4Mg
P06931124A0109|48 57|PO4.6H2O)n
P06935514A0000|149 162|dentinogenesis
P06938948T0001|9 11|IgA
P06938948T0001|15 34|serum immunoglobulins
P06946314T0000|0 7|Serum IgE
P06946693T0000|5 24|prostaglandin F2 alpha
P06946693T0000|25 29|(PGF2
P06946693T0000|30 35|alpha)
P06953957A0503|7 20|creatine kinase
P06959130A0996|3 16|arginyl peptide
P06959130A0996|64 65|IX
P06959130A0996|66 76|to factor IXa
P06959130A0996|85 87|XIa
P06959130A0996|104 116|Arg145-Ala146
P06959130A0996|120 132|Arg180-Val181
P06962492A0612|99 107|bone bases
P06969638A0180|40 42|CNS
P06972179A0556|8 10|IgE
P06975206A0279|24 36|betamethasone
P06981991A0756|33 36|CABG
P06981991A0756|84 86|ECG
P06981991A0756|166 168|ECG
P06981991A0756|199 211|artery disease
P06984225A0367|0 2|REV
P06986168A0304|103 112|V8 protease
P06993660A0000|49 61|potassium (K+)
P06993660A0000|197 202|(AHR)2
P06997203A0325|44 45|HI
P06997203A0325|50 51|IF
P06997203A0325|111 113|PHA
P07007591A0324|28 34|C-11 CPZ
P07007591A0324|111 113|CPZ
P07007591A0324|199 214|t) = [RT(t) - RR(t)]
P07007591A0324|202 207|[RT(t)
P07007591A0324|203 204|RT
P07007591A0324|208 217|- RR(t)]/[1
P07007591A0324|209 210|RR
P07007591A0324|273 275|CPZ
P07015018A0395|59 68|allogeneic
P07015262A0396|78 80|CRP
P07015262A0396|107 133|28 microgram/ml (CRP-positive
P07016141A0238|11 24|blood flow (RBF)
P07016141A0238|35 48|blood flow (NBF)
P07021505A0510|40 42|DPB
P07021505A0510|52 53|(P
P07021505A0510|73 77|9 mmHg
P07026328A0369|6 27|iabetics, Ca2+ infusions
P07034479A1050|0 15|Fifty-eight RMI's
P07034479A1050|68 69|AC
P07038189A2301|27 29|CXD
P07040659A0212|64 67|PEFR
P07044562T0000|9 12|ApUp
P07045156A0204|59 61|GBS
P07061263A0293|12 25|pressure (Pvas)
P07061263A0293|54 58|cmH2O
P07061350A0042|62 73|bundle (COCB)
P07062036A0072|20 28|90-95% JIB
P07064923T0000|11 34|phenylalanine hydroxylase
P07065206A0398|20 29|plasma TXB2
P07068493A0414|78 100|nspiration; end-tidal CO2
P07068493A0414|145 147|SIP
P07068493A0636|98 100|SIP
P07068887A0000|96 97|(N
P07072635A0000|64 82|desferrioxamine (DF)
P07073520A0153|18 31|hemofiltration
P07073520A0153|77 84|140 mEq/L
P07075024A0540|58 61|CMIR
P07080496A0097|64 91|high-density lipoprotein (HDL)
P07080496A0097|148 175|low-density lipoproteins (LDL)
P07088195T0019|25 26|UV
P07090151A0165|32 49|release bolus (MSRB)
P07094905A0644|43 44|KA
P07094905A0644|99 101|CA3
P07097182A0480|73 84|regenerating
P07097182A0480|123 134|regenerating
P07097182A0480|157 171|nonregenerating
P07106323A0560|78 84|E3-16-G
P07106534A0160|74 88|length' increase
P07106534A0160|110 122|mass' increase
P07107287A1083|62 75|99Mo generators
P07107462A0202|81 89|(increase
P07109788A0333|9 10|II
P07112320A0086|0 33|CSF adenosine deaminase activity (ADA)
P07113897A0285|35 36|EF
P07113897A0285|98 100|NS)
P07113897A0285|146 148|NS)
P07114083A0153|5 8|MOPP
P07114083A0153|36 51|Hodgkin's disease
P07114083A0153|86 103|glucocerebrosidase
P07116298A1079|84 91|stage IVA
P07116298A1079|176 178|BCG
P07116298A1079|225 227|BCG
P07116298A1079|228 232| + DTIC
P07116298A1079|229 232|DTIC
P07116962A0299|3 10|COP-PAWP
P07124743A1223|32 37|(As2O3
P07126413A0000|75 81|release
P07126413A0000|128 136|(Eudragit
P07130335A1081|86 87|(P
P07130335A1081|105 120|24-h plasma 18-OHB
P07147622T0000|13 26|storage disease
P07149047A0260|27 30|Q/Dk
P07149303T0000|33 35|CNS
P07160491A0547|76 82|LD50/30
P07162146A0000|16 30|ultrafiltration
P07172690A0547|108 130|calcium pump (Ca++-ATPase
P07172690A0547|149 161|eticulum, SPR)
P07174122A0000|0 23|Serum creatine kinase (SCK)
P07179412A1131|42 45|US+0
P07180901A0539|53 85|well-known prostaglandin synthetase
P07182523A0462|31 33|SOA
P07182523A0462|60 62|SOA
P07183576A0157|84 86|(SD
P07183576A0157|123 125|(SD
P07183576A0157|157 159|(SD
P07183576A0157|199 201|(SD
P07184375T0001|47 64|prednisolone (VM*P)
P07184375T0001|104 116|non-Hodgkin's
P07184774T0000|19 22|ED01
P07184795A0517|39 46|serum CPK
P07184795A0517|58 76|262 +/- 113 I.U./liter
P07190627T0000|15 41|plasminogen activator release
P07190869A0316|0 3|CDDP
P07190869A0316|28 40|non-Hodgkin's
P07192369T0000|81 102|l-alpha-acetylmethadol
P07192722A0682|63 71|serum iPTH
P07192722A0682|86 87|CL
P07192722A0682|90 99|group 2 PMNs
P07192722A0682|142 143|CL
P07192722A0682|152 155|PMNs
P07194905A0332|0 2|TCZ
P07202224A0452|69 70|TP
P07205120T0000|42 44|ECG
P07208984A0000|13 26|99mTc-labelled
P07208984A0000|49 52|(MAA
P07208984A0000|74 94|tomography studies (CT)
P07214665A0000|126 130|(FIVB
P07217329A0000|52 78|, alpha-acetylmethadol (LAAM)
P07217329A0000|236 248|a normal-phase
P07217329A0000|259 260|UV
P07218008T0000|76 81|(Aotus
P07221179A0156|21 24|GABA
P07221179A0156|44 55|GABA decrease
P07234308A0121|21 26|C-MOPP
P07234308A0121|22 31|-MOPP, CHOP
P07234308A0121|35 39|BACOP
P07235317T0000|37 48|Phadebas RAST
P07235355A0462|23 26|COPD
P07236351A0812|36 38|EEG
P07236351A0812|78 85|areas CA3
P07236351A0812|89 91|CA4
P07237560A1038|52 55|tRNA
P07237560A1038|134 140|Hind III
P07237817T0000|17 31|theophylline RIA
P07243380A0327|35 36|(P
P07247059A0775|34 45|step increase
P07249497A0688|36 46|estrogen PPI
P07249497A0688|87 103|long-term estrogen
P07249497A0688|109 111|PPI
P07249544A0343|28 46|serum creatine kinase
P07249895A0177|73 75|LES
P07251564A0569|82 85|ASDC
P07260389A0221|38 55|serotonin receptors
P07260987A0336|24 47|disposition phase t1/2 beta
P07262625A0000|143 150|known.We
P07266969A0246|22 31|estrogenic
P07267675A0000|25 40|ephalosporin, CGP
P07268828A0000|132 142|solid-phase
P07270163A0684|68 70|CNF
P07270163A0684|181 183|CNF
P07270991A0149|51 59|RAST-test
P07274042A0249|0 2|DMI
P07274042A0249|6 13|2-OH-DMI
P07274042A0249|59 71|61 DMI-treated
P07274428A0000|83 100|contrast agent (RCA)
P07274428A0000|180 182|RCA
P07274428A0000|239 251|membranes (PM)
P07278578T0001|30 45|Hodgkin's disease
P07280654A0000|16 18|HBE
P07282444A0075|0 14|Forty-five cases
P07282943A0097|11 18|100-mmHg
P07282943A0097|62 74|pressure (PO2)
P07282943A0097|91 103|2 aeration, PO2
P07282943A0097|92 116| aeration, PO2, 620-650 mmHg)
P07286057A0159|7 9|AUC
P07293100T0001|48 61|system diseases
P07293327T0001|0 9|Fibrinogen
P07293327T0001|31 35|KZM-1
P07295417A0092|90 105|technique--phase
P07296997A0125|49 51|OCG
P07296997A0125|67 76|Tc-99m-PyG
P07298209A0291|78 80|VO2
P07298523T0000|23 42|prostaglandin F2 alpha
P07299857A0294|0 3|LD50
P07299857A0294|19 20|KP
P07299857A0294|69 74|KP-CMC
P07299857A0294|143 148|KP-T10
P07299857A0294|207 212|KP-CMC
P07299857A0294|219 222|LD50
P07299857A0294|273 274|KP
P07304905A0336|0 14|Autotransfusion
P07304905A0336|37 75|Heparin-ACD-B- Heparin-DPD- Heparin-ACD-B
P07311881T0000|0 3|MSMS
P07323063A0000|43 56|Sprague-Dawley
P07323063A0000|89 98|rats (SHRs)
P07326596A0061|3 5|IgA
P07326596A0061|33 35|IgE
P07327097A0647|2 3|PB
P07330073T0000|12 22|transfusion
P07337609A0531|12 61|mean hemagglutination-inhibition antibody titers (GMT)
P07340196T0001|30 37|HBSAG--a
P07355527A0467|23 34|Lich-Gregoir
P07365183A0000|45 54|endogenous
P07365183A0000|155 168|therapy (MMECT)
P07365183A0000|198 210|therapy (SECT)
P07375864A0431|41 51|platelet MAO
P07375864A0431|174 184|platelet MAO
P07377378A0143|0 7|Estrogen
P07377378A0143|28 43|17 beta-estradiol
P07377378A0143|46 70|beta-estradiol-3-benzoate
P07377954A0117|116 137|oxygen consumption (VO2)
P07385933A0085|63 76|2 mu Ci generally
P07385933A0085|77 88|14C-labelled
P07385933A0085|78 103|4C-labelled galactose, 14CO2
P07393856A0314|4 53|esult, beta-apo-8'-carotenoic acid ethyl ester (apo-EE)
P07394364A0738|213 215|VO2
P07397066T0000|21 40|blood aspirin esterase
P07401318A0823|37 45|staircase
P07401318A0823|74 82|staircase
P07405701T0000|32 55|platelet monoamine oxidase
P07406527A0212|102 117|in HCB-CQ-treated
P07406527A0212|148 150|HCB
P07413242A0000|60 64|T1-L3
P07415340A0280|53 54|II
P07426101A0124|17 76|ipoprotein lipid concentrations, adipose tissue lipoprotein lipase
P07428037A0989|36 49|mouse mt 12S rRNA
P07428037A0989|137 139|RNA
P07428037A0989|199 221|mRNA binding site (ACCUCC)
P07428037A0989|238 257|corn chloroplast rRNAs
P07431059A0000|98 109|pineal region
P07432288A0218|0 12|Serum antibody
P07436702A0156|37 40|DNFB
P07436794A0148|25 44|carotid arteries (CCA)
P07438346A0381|2 3|pH
P07438482A0145|87 98|oestrone (E1)
P07438482A0145|102 115|oestradiol (E2)
P07440430A1074|81 82|NB
P07440430A1074|110 111|(P
P07440430A1074|163 164|(P
P07449253A0411|44 49|50 mmHg
P07450031A0691|37 105|9-methoxy-5-phenylpyrrolo[2,1-d][1,5]benzothiazepin-6,6-dioxide (NF19)
P07450031A0691|109 183|9-chloro-5-p-nitrophenylpyrrolo[2,1-d][1,5]benzothiazepin-6,6-dioxide (NF20)
P07450388A0406|22 27|CCK-PZ
P07453919A0000|132 146|acid phosphatase
P07453919A0000|194 197|(IgM
P07453919A0000|201 203|IgG
P07455521A0414|3 8|ESEG's
P07455521A0414|30 33|NEXT
P07456774A0448|14 25|SLE-inducing
P07457931A0655|45 51|5-OH-DA
P07457931A0655|78 92|ultrastructural
P07461848A0230|68 69|CO
P07461848A0230|75 79|pm, NO
P07461848A0230|82 89|2 ppb, NO2
P07466831A0714|38 40|HCB
P07469692A0000|48 58|bone disease
P07471210A0384|3 5|87K
P07471210A0384|96 118|(1-strand) messenger RNAs
P07472582A0993|43 59|99mTc-tetrofosmin
P07472582A0993|63 67|201Tl
P07473169A0133|0 4|EUK-8
P07473169A0133|24 65|low-molecular-weight salen-manganese complex
P07473169A0133|82 100|superoxide dismutase
P07473169A0133|104 111|catalase
P07473742A0187|3 14|protein ELT-1
P07473742A0187|26 50|single-copy gene homologous
P07473742A0187|56 59|GATA
P07474078A0838|95 96|CA
P07474124A1360|35 37|PI2
P07474124A1360|41 43|PI3
P07474140A1036|2 25|site-specific mutagenesis
P07474140A1036|51 55|ICP27
P07474140A1036|113 125|ICP27 homologs
P07474140A1036|133 151|herpesviruses (D-357
P07474451A0000|8 28|resonance imaging (MRI)
P07474617A1035|54 56|PRL
P07475733T0000|19 23|HIV-1
P07475793T0000|0 2|BSE
P07476164A1602|61 64|F17A
P07476164A1602|62 69|17A, K13Q
P07476164A1602|63 74|7A, K13Q, F15Y
P07476164A1602|78 81|F27Y
P07476164A1602|136 148|wild-type CspB
P07476701A0654|24 26|IgE
P07476963A0000|0 47|Peroxisome proliferator-activated receptors (PPARs)
P07476963A0000|51 74|retinoid X receptors (RXRs)
P07476963A0000|85 100|hormone receptors
P07476971A0381|35 44|SKUT-1B-20
P07476975A0492|131 134|POMC
P07477245A0625|85 86|AF
P07478523A0551|124 140|RET protein isoform
P07478525A1177|13 17|MHBst
P07479004A0421|40 43|PERE
P07479004A0421|69 71|(P1
P07479004A0421|114 117|HeLa
P07482069A0606|19 21|MTX
P07483276A0139|39 57|reading frames (ORFs)
P07483276A0139|76 78|UL1
P07483276A0139|77 82|L1, UL2
P07483276A0139|78 86|1, UL2, UL3
P07483276A0139|91 95|UL3.5
P07483276A0139|130 156|herpes simplex virus-1 (HSV-1)
P07483276A0139|131 179|erpes simplex virus-1 (HSV-1), pseudorabies virus (PRV)
P07483285A0322|5 19|HPV16 E6/E7 cDNAs
P07483285A0322|38 58|SV40 enhancer/promoter
P07483285A0322|65 71|MMTV LTR
P07483285A0322|149 151|DNA
P07483285A0322|181 189|the E7 gene
P07483857A0350|52 54|NIT
P07487067A0592|55 58|APS1
P07487067A0592|154 168|transit peptides
P07487363A0447|16 18|IgE
P07487363A0447|23 27|asIgE
P07487363A0447|31 35|IgG-4
P07487811A0000|112 137|Systems Experiment-1 (PSE-1)
P07487811A0000|165 169|PSE-2
P07487908A0230|61 100|chloramphenicol acetyltranferase (CAT) gene
P07487908A0230|120 133|origin (AR-42J)
P07487908A0230|169 172|(Rat
P07487908A0230|177 179|IEC
P07488247T0000|20 42|aryl hydrocarbon receptor
P07488247T0000|78 100|aryl hydrocarbon receptor
P07489502A0000|3 19|influenza virus NS1
P07489502A0000|115 135|poly A-containing mRNAs
P07489502A0000|151 158|pre-mRNA
P07490079T0000|36 73|striatum-enriched phosphatase (STEP) gene
P07490079A0825|78 81|STEP
P07490079A0825|107 114|STEP gene
P07490083A0000|8 16|anhydrase
P07490083A0000|18 20|(CA
P07490742A0636|43 61|dsRNA binding domains
P07490742A0636|98 107|subdomains
P07490766T0000|70 74|c-Myc
P07490770A0267|17 25|coxI genes
P07490770A0267|94 97|coxI
P07490770A0267|98 106|intron aI4
P07490770A0267|126 168|a 279-amino-acid site-specific DNA endonuclease
P07491111A0221|12 13|GR
P07491111A0221|16 21|DMS-79
P07491111A0221|44 57|ACTH-secreting
P07491305A0102|98 107|QRS complex
P07491305A0102|130 139|surface ECG
P07491791A0263|42 44|E1A
P07491791A0263|70 95|helper adenovirus type 5 (Ad5)
P07493327A0507|62 69|U6 snRNAs
P07493627A0882|11 20|PCC4.aza1R
P07493627A0882|32 44|RAR-selective
P07493627A0882|80 87|EC-1 mRNA
P07493627A0882|108 120|RXR-selective
P07493627A0882|135 138|EC-1
P07494244A0335|14 19|E1A243
P07494244A0335|15 23|1A243, YY1
P07494244A0335|33 45|CRE-dependent
P07494244A0335|93 100|ATF/CREB
P07494244A0335|119 124|-67 CRE
P07494274A1015|129 136|alpha TIF
P07494306A0240|28 31|VP16
P07494306A0240|99 102|VP16
P07494306A0240|154 164|polypeptide
P07494306A0240|208 218|protein VP22
P07494314A1287|22 45|gulation, splicing, kinase
P07494314A1287|94 106|LMP2A homologs
P07494314A1287|142 163|sequences heterogeneity
P07494314A1287|180 192|repeat regions
P07494314A1287|223 226|EBVs
P07495059T0078|12 15|ECAT
P07495120A0260|22 26|Phase
P07495120A0260|27 28|II
P07495726A1189|19 26|Chi motif
P07495726A1189|31 45|Chi-like element
P07495726A1189|66 91|recombination hotspot region
P07495726A1189|97 115|Bcl-2 proto-oncogene
P07495726A1189|137 154|breakpoints in T-ALL
P07496400A0525|35 43|HMGR1 mRNA
P07496400A0525|44 50|(HMGR1S
P07496400A0525|51 55|mRNA)
P07496400A0525|102 116|lant, HMGR1L mRNA
P07498727A0724|46 54|G.C-->T.A
P07498727A0724|140 161|rad6-mediated G.C-->T.A
P07498791A0680|70 77|ene, PBS2
P07498791A0680|100 112|protein kinase
P07499242A0898|49 53|RAFTK
P07499252A0150|2 22|hGM-CSF receptor (hGMR)
P07499252A0150|67 76|PI 3-kinase
P07499252A0150|68 81|I 3-kinase, hGMR
P07499252A0150|143 152|PI 3-kinase
P07499401A0444|18 23|hnRNPs
P07499409A0367|0 3|TPBF
P07499409A0367|19 36|coiled-coil regions
P07499409A0367|52 69|proline-rich region
P07499421A0237|93 98|CYP3A1
P07499421A0237|127 166|chloramphenicol acetyltransferase reporter
P07499848A0409|47 62|CD40L-expressing
P07500386A0870|12 17|GapIII
P07500386A0870|63 79|GapIII-GRD domains
P07500386A0870|154 157|IRA1
P07500597A0212|22 25|BPVs
P07500597A0212|68 72|+/- SD
P07500950A0000|1 23|tobacco homologue (trolC)
P07500950A0000|29 36|rolC gene
P07500950A0000|42 64|Agrobacterium rhizogenes
P07500953A0305|4 11|ADR1 gene
P07500953A0305|101 108|ADR1 gene
P07501016T0000|34 51|galaxy TXFS2226-184
P07501458A0578|15 19|C/EBP
P07501458A0578|16 42|/EBP family inhibitors, Ig/EBP
P07501458A0578|17 46|EBP family inhibitors, Ig/EBP, LIP
P07501458A0578|50 56|CHOP-10
P07501458A0578|62 67|Ig/EBP
P07501700A0000|67 70|(MLA
P07501992A0125|69 97|spectroscopy analysis (SEM-EDS)
P07504171A0715|1 58|platelet-derived growth factor receptor (PDGF-R) phosphopeptide
P07504171A0715|103 114|Src SH2 domain
P07504171A0715|136 141|PDGF-R
P07504171A1214|16 21|Src SH2
P07504171A1214|130 141|Src SH2 domain
P07505798A0000|11 21|immunogenic
P07505798A0000|32 78|type A influenza A/Japan/57 (H2N2) hemagglutinin (HA)
P07505798A0000|111 140|histocompatibility complex (MHC)
P07505798A0000|112 157|istocompatibility complex (MHC), H-2Kd-restricted
P07505798A0000|167 184|T lymphocytes (CTLs)
P07506253A0742|34 35|TK
P07506253A0742|52 55|HeLa
P07507187T0000|24 26|DNA
P07507187T0000|113 122|plasmid DNA
P07507207A0991|17 19|IRF
P07507207A0991|48 60|IRF-2 promoter
P07507207A0991|80 88|IRF-2 gene
P07507207A0991|124 128|IRF-1
P07507458A0250|84 103|hepatitis C virus (HCV)
P07507458A0250|122 126|ELISA
P07507458A0250|130 133|RIBA
P07508140A0448|59 81|hepatitis C virus antibody
P07508441A0487|86 88|56K
P07508441A0487|102 106|a HeLa
P07508441A0487|103 122| HeLa cell extract. cDNA
P07508441A0487|148 154|56K cDNA
P07508441A0487|240 248|annexin XI
P07508441A0487|267 273|56K cDNA
P07508441A0487|289 297|homologue
P07508441A0487|300 308|annexin XI
P07508954A0000|3 39|avidin-biotin complex peroxidase (ABC-P)
P07508954A0000|127 143|Ziehl-Neelsen (ZN)
P07509053A0139|48 52|c-Myb
P07509449A0000|29 44|sarcoma virus CT10
P07509449A0000|79 84|v-Crk)
P07509449A0000|157 174|Src homology regions
P07509449A0000|180 183|(SH2
P07509449A0000|187 189|SH3
P07509450A0705|53 61|HSV tk gene
P07509450A0705|155 163|HSV tk gene
P07509472A1320|0 9|CONCLUSION
P07509624T0000|22 32|11q23 region
P07509811A1357|0 3|GTRE
P07509811A1357|1 7|TRE, TRE
P07509811A1357|12 14|CRE
P07509811A1357|87 95|congeners
P07509811A1357|173 179|the GTRE
P07509811A1357|176 179|GTRE
P07509811A1357|188 190|CRE
P07509811A1357|222 228|the GTRE
P07509811A1357|225 228|GTRE
P07509811A1357|237 239|CRE
P07509811A1357|315 321|Jun/Fos
P07509811A1357|325 354|cAMP-responsive element-binding
P07509811A1357|373 402|transcription factors (CREB/ATF)
P07510635A0479|4 17|ntibody, mAb1C2
P07510635A0479|103 117|TATA-containing
P07510635A0479|129 146|TATA-less promoters
P07510635A0479|193 194|II
P07510635A0479|200 202|III
P07511444T0000|56 76|veno-occlusive disease
P07511444A0728|0 2|HCV
P07511444A0728|33 35|BMT
P07511444A0728|133 135|BMT
P07511818A0485|10 29|IFN-beta-transformed
P07511818A0485|91 93|IFN
P07511818A0485|206 213|IFN-beta
P07512258A0441|78 80|PMN
P07512258A0441|138 142|G-CSF
P07513703T0000|15 54|SH2-containing protein tyrosine phosphatase
P07513703T0000|16 62|H2-containing protein tyrosine phosphatase, SH-PTP2
P07513703T0000|66 99|phosphotyrosine-containing peptides
P07513703T0000|111 125|insulin receptor
P07514295A0000|80 105|T-cell antigen receptor (TCR)
P07514301A0000|3 51|interferon-induced RNA-dependent protein kinase (PKR)
P07514301A0000|162 180|tumor suppressor gene
P07516337A1119|50 55|p95Vav
P07516337A1119|94 111|in anti-CD3-treated
P07516466A1054|83 86|PP2A
P07516466A1054|184 187|CREB
P07516466A1054|214 219|NIH 3T3
P07516469A1025|7 20|Src SH3-binding
P07516597A1017|51 53|MVE
P07516597A1017|103 115|proteinase NS3
P07516597A1017|155 173|MVE H-2Kk-restricted
P07516866A0000|1 28|full-length PRL receptor (PRLR)
P07516866A0000|42 44|DNA
P07516866A0000|136 145|polymerase
P07517869A0411|50 60|DNA-binding
P07517869A0411|70 80|C/EBP-delta
P07517869A0411|143 153|phosphatase
P07518257A0351|28 37|S1 nuclease
P07518426A0000|0 18|Interleukin-8 (IL-8)
P07518426A0000|72 86|C-X-C chemokines
P07518460A0771|31 35|PTP1C
P07518460A0771|84 94|mutagenesis
P07518460A0771|119 129|phosphatase
P07518561A0496|22 48|p72syk protein tyrosine kinase
P07518561A0496|78 91|TCR/CD3 complex
P07518578A0000|104 112|oncogenic
P07519447T0000|55 67|oxide synthase
P07519463A0000|59 71|work/regional
P07519481A1275|8 22|Sl(pan)/Sl(pan)
P07519481A1275|110 111|KL
P07519606A1269|0 12|Anti-NPROSP-C
P07519606A1269|63 77|5-10-kDa proSP-C
P07519606A1269|102 112|homogenates
P07520098A0211|23 33|B6.CH-2bm13
P07521009A0377|49 56|MW104-1B
P07521009A0377|112 114|DNA
P07521009A0377|125 128|(G/T
P07521009A0377|130 132|A/C
P07521009A0377|131 136|/C, G/G
P07521009A0377|149 155|(Kramer
P07521285A1109|63 65|GBS
P07521285A1109|69 72|CIDP
P07522163T0000|15 37|horse cytochrome c peptide
P07522163T0000|63 92|histocompatibility complex (MHC)
P07522163T0000|104 111|C57BL/6-
P07522163T0000|165 167|MHC
P07522163T0000|199 217|peptide-specific CTL
P07523363A0440|21 25|HpaII
P07523363A0440|91 94|USF2
P07523710T0000|107 121|ultrasonography
P07524265T0000|9 50|granulocyte-colony stimulating factor (G-CSF)
P07525548A1380|71 87|activity (rsVCAM-1
P07525548A1380|118 120|CS1
P07525596A0584|79 97|COOH-terminal domain
P07525596A0584|122 127|PPIase
P07525843A0859|17 30|H-2d NP peptides
P07525843A0859|55 67|H-2b NP peptide
P07525843A0859|90 98|syngeneic
P07525843A0859|113 124|CTL-specific
P07525843A0859|185 209|histocompatibility complex
P07525843A0859|268 272|NP CTL
P07525843A0859|336 337|NP
P07526609A0736|30 41|S4 (3'UTR/S1)
P07526609A0736|59 61|PKR
P07526609A0736|94 99|3'-UTR
P07527168A0524|63 74|angiogenesis
P07528028A1192|39 63|FGF-1 cell surface receptors
P07528028A1192|134 142|exogenous
P07528028A1192|143 147|FGF-1
P07528028A1192|185 202|normally.(ABSTRACT
P07528028A1192|203 211|TRUNCATED
P07528028A1192|208 209|AT
P07528028A1192|214 222|250 WORDS)
P07528325A0165|45 54|GH receptor
P07528325A0165|195 197|DNA
P07528531A0904|8 22|nfections, G-CSF
P07528531A0904|140 142|CRP
P07528746A1049|38 50|ASGPR subunits
P07528746A1049|61 66|Ser(P)
P07528746A1049|104 109|Thr(P)
P07528746A1049|157 167|polypeptide
P07528746A1049|193 198|Tyr(P)
P07528746A1049|218 221|RHL1
P07528772A0616|43 48|ZAP-70
P07528772A0616|67 69|TCR
P07528772A0616|111 140|glutathione S-transferase fusion
P07528772A0616|162 165|NH2-
P07528772A0616|172 194|COOH-terminal SH2 domains
P07528772A0616|197 202|ZAP-70
P07528772A0616|273 275|TCR
P07528772A0616|285 288|(TCR
P07528772A0616|319 337|CD3 epsilon TAM motifs
P07528772A1539|35 45|TAM peptides
P07528772A1539|93 102|SH2 domains
P07528772A1539|105 110|ZAP-70
P07529124A0119|31 32|RT
P07529124A0119|128 139|weights 66 kDa
P07529124A0119|143 148|51 kDa)
P07529504A0000|53 70|non-ionic monomeric
P07529504A0000|71 107|X-ray contrast agent iopromide (Ultravist
P07529504A0000|98 107|(Ultravist
P07529504A0000|109 111|CAS
P07529516A0474|59 62|EDXR
P07530128A0578|10 44|ost-treatment, pre-operative serum PSA
P07530502T0000|46 59|tyrosine kinase
P07530502T0000|89 105|c-kit gene-encoded
P07530502A0974|33 35|SLF
P07530502A0974|38 45|SI4-h220
P07530549A0956|29 33|BLAST
P07530549A0956|37 41|GRAIL
P07531321A0369|20 28|250 PVC/24
P07531321A0369|63 65|PVC
P07531321A0369|69 70|CI
P07533527A0128|121 123|PCR
P07533758A1038|35 38|RfbA
P07533758A1038|42 53|RfbB homologs
P07533858A1503|92 106|oligomerization
P07533858A1503|121 127|GP64 EFP
P07533880T0000|3 6|FinO
P07533880T0000|16 19|IncF
P07533880T0000|33 36|FinP
P07533880T0000|46 48|RNA
P07533880T0000|56 69|arget, traJ mRNA
P07534285A0155|68 71|BaF3
P07534285A0155|105 126|Mpl receptor (BaF3/mMpl)
P07534286A0842|1 19|chicken paxillin cDNA
P07534297A0141|9 34|4.1-kilobase pair HindIII DNA
P07534297A0141|74 96|AP endonuclease gene (APE)
P07534297A0141|102 142|chloramphenicol acetyltransferase (CAT) gene
P07534306A0444|16 30|His6-tagged GrsA
P07534306A0444|150 162|ATP-dependent
P07535593A0714|0 8|CD7+/CD3-
P07535593A0714|32 39|V delta 2D
P07535768A1076|0 7|HVH2 mRNA
P07535768A1076|45 49|CL100
P07535768A1076|56 64|homologue
P07535768A1076|67 76|mouse MKP1)
P07535768A1076|80 83|PAC1
P07535768A1076|108 128|MAP kinase phosphatases
P07537267A2094|74 79|HPFH-3
P07537267A2094|188 204|gamma-globin genes
P07537362A1112|24 49|Shb-SH3 domain proteins v-Src
P07537736A0453|47 50|PRLR
P07537736A0453|166 181|cytokine receptor
P07537851A0000|26 58|cell adhesion molecule 1 (VCAM-1) gene
P07537851A0000|124 149|cytokines interleukin-1 beta
P07537851A0000|153 187|tumor necrosis factor alpha (TNF-alpha)
P07537851A0891|54 76|high-mobility-group I(Y)
P07537851A0891|116 122|ng of IRF
P07537851A0891|120 124|IRF-1
P07537851A0891|130 134|VCAM1
P07537851A0891|156 160|IRF-1
P07537851A0891|195 217|high-mobility-group I(Y)
P07538068A1094|29 42|control element
P07538068A1094|43 45|(AX
P07538068A1094|109 122|Hoxa-7 enhancer
P07538122A0800|48 51|(Fab
P07538122A0800|101 103|nM)
P07538173A0307|0 37|MBP-Rep68 delta-mediated DNA-RNA helicase
P07538173A0307|54 56|ATP
P07538818A0197|60 66|hG-CSFR
P07538818A0197|154 160|hG-CSFR
P07538818A0197|174 178|cDNAs
P07538818A0197|207 240|interleukin-3 (IL-3)-dependent Ba/F3
P07538818A0197|244 247|FDCP
P07539119A0291|51 67|c-abl kinase domain
P07539119A0291|70 81|NH2-terminus
P07539119A0291|86 90|G128R
P07539119A0291|155 159|G128R
P07539119A0985|44 55|Abl SH3 domain
P07539314T0000|34 40|(Chanos
P07539314T0000|99 107|(Furanace
P07540773A0576|11 13|NSE
P07540773A0576|17 19|MBP
P07540773A0576|25 28|IJVB
P07540773A0576|53 55|PVB
P07540866A1069|37 42|ras GTP
P07540866A1069|55 63|MAP kinase
P07540866A1069|87 93|A/K1018
P07540866A1069|125 128|Y/F2
P07541912A0485|37 40|CAAT
P07541912A0485|67 83|G-C content regions
P07542577A0438|29 33|ELISA
P07542577A0438|64 70|anti-La
P07542616A0313|0 4|GCD10
P07542616A0313|61 64|GCN4
P07542616A0486|0 4|GCD10
P07542616A0486|10 12|RNA
P07542616A0486|79 96|RNA-binding subunit
P07542616A0486|94 127|nit of yeast initiation factor-3 (eIF-3
P07542616A0486|99 128|yeast initiation factor-3 (eIF-3)
P07542616A0486|137 149|a multisubunit
P07542698A0137|83 93|probe RH-414
P07543684A1027|14 17|cAMP
P07543684A1027|32 34|PKA
P07543684A1027|65 72|CFTR gene
P07543684A1027|109 112|CFTR
P07543868A0414|62 65|cDNA
P07543868A0414|129 135|poly(A)
P07544357A0808|4 8|PPC-1
P07544357A0808|12 18|ALVA-31
P07544357A0808|31 43|tumorigenesis
P07544357A0808|77 81|LNCap
P07544357A0808|147 164|CD44 variant (CD44v)
P07545510A0735|16 19|cotS
P07545510A0735|56 63|SDS-PAGE
P07545510A0735|136 145|cotS region
P07545920A1336|80 82|DNA
P07546293A0968|40 47|E2F-like
P07546294A0000|3 15|RAD6/UBC2 gene
P07546294A0000|88 90|DNA
P07546294A0000|105 115|mutagenesis
P07546794A0100|49 62|collapse (RVDC)
P07547500A0066|23 45|fusion protein (GAL4-p40)
P07547500A0066|59 75|DNA-binding domain
P07547500A0066|78 81|GAL4
P07547500A0066|96 115|chicken l kappa B-alpha
P07547510A0261|52 72|-184 HNF-3 beta promoter
P07547510A0261|187 214|ell-specific factor, LF-H3 beta
P07547510A0261|206 214|LF-H3 beta
P07547510A0261|244 256|HNF-3 beta gene
P07549005A0530|40 43|150K
P07553942A0810|3 16|pea rps10 intron
P07553942A0810|95 113|Marchantia rps10 gene
P07553942A0810|119 126|an intron
P07554541A0587|16 18|CHF
P07557091A0314|0 6|METHODS
P07557091A0314|1 13|ETHODS: rHb1.1
P07557276A0526|0 27|Alanine aminotransferase (ALT)
P07557387A0241|38 46|C/EBP beta
P07557387A0241|62 71|adipogenic
P07557387A0241|95 103|C/EBP beta
P07557387A0241|120 126|NIH-3T3
P07557424A0124|0 3|XYL1
P07557424A0124|49 53|'lacZ
P07557446T0000|21 29|generated
P07557446T0000|37 45|VCSA1 gene
P07557446T0000|70 76|poly(A)
P07558583A0562|129 150|Src-like tyrosine kinase
P07559233A0534|0 14|Citrate synthase
P07559347A0000|26 36|operon bglPH
P07559347A0000|72 81|bglP'-lacZ
P07559355A0066|40 45|urease
P07559355A0066|127 137|pecific gene
P07559356T0000|3 16|hypBFCDE operon
P07559356T0000|72 87|Fnr-type promoter
P07559356T0000|99 109|mutagenesis
P07559356T0000|115 118|fnrN
P07559402A0622|18 27|VT+ peptide
P07559402A0622|59 77|protein kinase C (PKC)
P07559402A0622|94 112|protein kinase A (PKA)
P07559478A0389|2 19|, 2500-2508; O'Neill
P07559488A0440|75 90|estradiol-17 beta
P07559488A0440|114 133|ERE-LacZ reporter gene
P07559488A0440|157 162|type ER
P07559510A0000|8 38|Micrococcus luteus UV endonuclease
P07559510A0000|60 65|18-kDa
P07559510A0000|97 114|16-kDa endonuclease
P07559510A0000|135 141|(Gordon
P07559524A0000|16 24|oncogenes
P07559524A0000|48 54|G1 phase
P07559524A0741|0 15|Cyclin D1 promoter
P07559524A0741|55 93|mitogen-activated protein kinase (p41MAPK)
P07559524A0741|96 102|c-Ets-2
P07559524A0741|121 126|22 base
P07559555A0557|7 9|ERM
P07559555A0557|13 17|c-Jun
P07559555A0557|45 51|EBS-CRE
P07559563A0282|36 53|Ca2+/CaM-dependent
P07559639A0996|14 21|R206S HSF
P07559639A0996|83 101|a consensus HSE (HSE2)
P07559640A1230|89 98|UAS element
P07559640A1230|133 136|bHLH
P07559640A1230|137 145|core motif
P07559650A0558|27 34|PCNA gene
P07559650A0558|44 53|target gene
P07559650A0558|56 58|E2F
P07560137T0000|28 33|MMPI-2
P07563072A0773|13 23|rrnB P1-lacZ
P07563072A0773|45 49|ppGpp
P07563072A0773|75 85|rpoD(P504L)
P07563072A0773|126 130|ppGpp
P07563090A0124|32 45|plus-strand DNA
P07563090A0124|60 74|yeast Ty1 element
P07563090A0124|137 148|repeat (PPT1)
P07563090A0124|170 176|pol gene
P07563090A0124|182 190|integrase
P07563090A0124|197 210|sequence (PPT2)
P07563090A0624|32 45|plus-strand DNA
P07563090A0624|105 108|PPT2
P07563090A0624|159 183|plus-strand strong-stop DNA
P07563090A0624|286 288|RNA
P07563994A0488|21 24|VTLB
P07563994A0488|62 66|(VTLB
P07563994A0488|86 88|OLB
P07563994A0488|129 133|(VTLB
P07563994A0488|149 151|OLB
P07564004A0292|17 21|Cr2O3
P07564004A0292|18 38|r2O3 inhalation, FEV1.0
P07565049A1032|89 90|NB
P07565104A0084|18 26|pilin gene
P07565104A0084|19 31|ilin gene, tcpA
P07565104A0084|48 51|ToxR
P07565104A0084|59 62|ToxT
P07565113A0000|87 105|parent plasmid plP401
P07565669T0000|0 8|Ras p21Val
P07565669T0000|17 26|myogenesis
P07565669T0000|45 47|DNA
P07565669T0000|87 94|myogenic
P07565685A0420|48 56|GABP alpha
P07565685A0420|60 67|GABP beta
P07565685A0420|79 89|Notch motifs
P07565688T0000|38 83|double-stranded-RNA-specific adenosine deaminase
P07565688T0000|123 131|deaminase
P07565688A0797|69 75|110-kDa
P07565688A0797|115 121|150-kDa
P07565709A0000|98 111|T-cell receptor
P07565712A0286|26 33|LYS2 gene
P07565713A0634|16 19|SCS1
P07565713A0634|40 55|HSP60-null allele
P07565720A0256|3 18|DNA binding domain
P07565720A0256|21 24|NirA
P07565720A0256|60 83|glutathione S-transferase
P07565723A0200|3 8|kinase
P07565723A0200|55 57|CTD
P07565731A1629|16 31|ARE-mediated mRNA
P07565731A1629|76 88|heterogeneous
P07565731A1629|117 127|ARE-binding
P07565736A2134|25 34|C/EBP alpha
P07565736A2134|51 77|GM-CSF receptor alpha promoter
P07565740T0000|38 76|plasma membrane-localized Pdr5 ATP-binding
P07565775T0000|20 23|mRNA
P07565775T0000|67 69|GTP
P07565775T0000|107 109|GMP
P07565775T0000|120 122|RNA
P07565775A1265|27 29|III
P07565775A1265|31 32|IV
P07565775A1265|83 85|GTP
P07565775A1265|113 116|(EpG
P07565775A1265|143 145|GMP
P07565775A1265|158 160|RNA
P07565776A0612|15 18|HOG1
P07565776A0612|22 30|PBS2 genes
P07565776A0612|60 64|HSP12
P07565797A0116|24 27|CRY1
P07565797A0116|64 71|CRY2 mRNA
P07567830A0072|0 6|METHODS
P07567979A1266|78 91|testis receptor
P07567979A1266|96 100|hERR1
P07567980T0000|4 31|p53 DNA-binding domain peptides
P07567980T0000|43 62|p53-response elements
P07567980T0000|73 75|DNA
P07568026A0622|3 12|Stat5b mRNA
P07568116A0902|43 58|N-terminal region
P07568116A0902|86 98|signal peptide
P07568118A1267|23 27|G beta
P07568118A1267|152 186|growth factor tyrosine kinase receptors
P07568865A0305|96 101|CFU/ml
P07568865A0305|169 177|100 CFU/ml
P07568865A0305|178 184|(Figure
P07569075A0585|5 15|31 stage I-II
P07569075A0585|6 36|1 stage I-II lung cancer patients, CR
P07569075A0585|68 69|PR
P07569075A0585|111 128|hest radiography, CT
P07569075A0585|112 132|est radiography, CT, FBS
P07569770A0298|0 6|METHODS
P07571766A0122|124 149|exercise-induced ST-segment
P07572582A0000|10 12|(Ro
P07574064A1416|84 85|VE
P07574064A1416|89 92|PCO2
P07574064A1416|95 100|60 mmHg
P07574682T0000|0 3|cDNA
P07574682T0000|29 69|liver/bone/kidney-type alkaline phosphatase
P07575416A0000|0 18|Protein kinase C (PKC)
P07575416A1970|81 84|cDNA
P07575416A1970|98 108|PKC zeta mRNA
P07575438A1409|56 64|E1 element
P07576178A0000|0 10|Polypeptide
P07576179A0781|37 39|CpG
P07576307A0144|72 94|rat enkephalin (rENK) gene
P07576307A1654|16 33|ENK-specific motifs
P07576307A1654|65 84|protein-DNA complexes
P07576307A1654|116 134|tumor cell line (HeLa)
P07576307A1654|155 157|ENK
P07579164A0409|14 17|cDNA
P07579164A0409|41 43|RNA
P07579164A0409|72 80|atp9 genes
P07579328A0653|0 4|MZF-1
P07579328A0653|14 28|CAT reporter gene
P07579328A0653|42 45|GAL4
P07579328A0653|79 93|cell lines NIH 3T3
P07579328A1345|21 36|DNA binding domain
P07579328A1345|22 42|NA binding domain, MZF-1
P07579328A1345|52 63|reporter gene
P07579683A0660|10 24|hGMR beta subunit
P07579683A0660|86 98|c-myc promoter
P07579695A0336|57 60|MIF2
P07579695A0336|97 138|yeast centromere protein genes-CEP1/CBF1/CPF1
P07579695A0336|98 149|east centromere protein genes-CEP1/CBF1/CPF1, NDC10/CBF2
P07579695A0336|154 163|CEP3/CBF3B
P07579695A0693|127 149|order protein-DNA complex
P07580058A0000|34 45|liquor (CPOL)
P07580058A0000|48 84|tissue-type plasminogen activator (t-PA)
P07580058A0000|88 121|plasminogen activator inhibitor (PAI)
P07580058A0000|155 166|heart disease
P07580330A0331|14 26|intakes (EDIs)
P07580330A0331|61 63|HCH
P07580330A0331|81 89|gamma-HCH
P07580330A0331|138 140|DDT
P07580330A0331|161 163|HCB
P07581364A0500|36 38|III
P07581364A0500|39 42|SMA)
P07581364A0500|74 79|Ag1-CA
P07582316A0696|33 37|(case
P07582316A0696|66 71|IS6110
P07582316A0696|115 117|MTB
P07582592A0545|0 3|HRES
P07582592A0545|109 111|LES
P07583190A0306|158 163|phrase
P07583562A1826|9 11|BMI
P07583562A1826|19 20|OR
P07583562A1826|43 44|TG
P07583562A1826|45 46|(P
P07583562A1826|75 76|RP
P07583562A1826|77 78|(P
P07583562A1826|112 113|TG
P07583562A1826|113 119|G, LDL-C
P07585246T0000|0 2|SL1
P07585246T0000|28 34|AU-rich
P07585246T0000|44 46|RNA
P07585246T0000|67 95|Caenorhabditis elegans pre-mRNA
P07585559A0000|2 93|yrazolo-quinoline compound, 6-methoxy-4-[2-[(2-hydroxyethoxyl)-ethyl]amino]-3-methyl-1M-pyrazo
P07585559A0000|112 115|(SCH
P07585559A0000|175 199|muscle alpha-actin promoter
P07586403A0765|28 58|risk factor-selection scale (RFSS)
P07588240A0000|3 46|Caenorhabditis elegans death susceptibility gene
P07588240A0000|103 151|interleukin-1 beta (IL-1 beta)-converting enzyme (ICE)
P07588240A0000|166 170|CPP32
P07588245T0000|12 42|glucocorticoid receptor-mediated
P07588245T0000|80 105|thyroid hormone receptor (TR)
P07588245T0000|103 104|TR
P07588245T0000|108 125|TR isoform-specific
P07588603A1054|60 61|DH
P07588608A1687|16 18|ERF
P07588628A0318|16 27|wild-type p53
P07588628A0318|52 54|LCL
P07588633A0362|10 14|c-Fos
P07588633A0362|19 36|c-fos protooncogene
P07588633A0362|168 173|NIH 3T3
P07588750T0061|36 63|3-phosphoglycerate kinase gene
P07588777A1524|41 44|RNAP
P07588777A1524|45 46|II
P07588777A1524|47 49|CTD
P07588777A1524|96 112|p44mapk MAP kinases
P07589069A1245|49 55|CD6 cDNA
P07589069A1245|80 103|membrane-proximal regions
P07589069A1245|160 166|CD6-PB1
P07590264A0373|87 90|DHFR
P07590264A0373|94 98|mRNAs
P07590264A0373|175 180|end RNA
P07590264A0373|216 222|poly(A)
P07590268A0350|37 44|(Dm) cDNA
P07590268A0350|54 64|polypeptide
P07590268A0350|113 121|MAPKAPK-2
P07590268A0740|1 22|2.4-kb MAPKAPK-2 message
P07590283A0820|25 36|TdT::Pol beta
P07590283A0820|64 91|template-dependent polymerase
P07590283A0820|120 126|Pol beta
P07590283A0820|229 249|8-kDa N-terminal domain
P07590283A0820|252 258|Pol beta
P07590283A0820|268 280|ssDNA-binding
P07590283A0820|289 294|[Kumar
P07590744A0829|17 20|cDNA
P07590744A0829|95 102|GAR1 gene
P07592072A0217|49 53|14, NF
P07592072A0217|90 92|(IF
P07592072A0217|122 141|prostaglandin F2 alpha
P07592220A0846|0 11|End-tidal PO2
P07592220A0846|44 68|oxygen consumption (VE/VO2)
P07592220A0846|83 88|PETCO2
P07592220A0846|104 105|(P
P07592337A0891|25 28|NfxB
P07592337A0891|67 70|nfxB
P07592439A0000|43 63|Listeria monocytogenes
P07592485A0734|2 18|NCR-sensitive gene
P07592485A0734|95 97|NCR
P07592485A0734|112 117|gene's
P07592647T0000|18 25|Pur alpha
P07592647T0000|79 122|single-stranded DNA Pur alpha recognition element
P07592647A0797|3 46|single-stranded DNA Pur alpha recognition element
P07592658A0309|3 35|insulin-induced DNA-binding complex
P07592676A0466|83 91|NIP region
P07592706A1465|13 15|LPL
P07592706A1465|19 20|HL
P07592706A1465|70 75|lipase
P07592710T0000|3 38|interferon-inducible protein kinase PKR
P07592710T0000|78 100|immunoglobulin kappa gene
P07592711T0000|56 76|a G protein alpha subunit
P07592711T0000|107 117|beta subunit
P07592721A0827|79 81|DNA
P07592723A0814|40 45|CSK 35H
P07592723A0814|102 104|PKC
P07592723A0814|134 136|PKC
P07592730A0204|8 13|TSG-14
P07592730A0204|32 37|PTX-3)
P07592730A0204|178 183|TSG-14
P07592771A0258|3 27|mouse beta 2-syntrophin gene
P07592771A0258|75 84|homologues
P07592771A0258|116 136|alpha 1-syntrophin gene
P07592790A1457|29 32|PEDF
P07592790A1457|85 100|N-terminal region
P07592946A0261|33 44|p44 MAP kinase
P07592946A0261|59 80|signal-regulated kinase
P07592946A0261|109 119|intron/exon
P07592946A0997|23 26|TATA
P07592946A0997|52 67|start sites region
P07592946A0997|72 75|AP-1
P07592946A0997|83 86|AP-2
P07592946A0997|105 108|GAGA
P07592946A0997|116 142|half serum-responsive element
P07592946A0997|171 186|p1 (five), GC-rich
P07592946A0997|172 213|1 (five), GC-rich binding factor (five), CTF-NF1
P07592946A0997|175 254|ive), GC-rich binding factor (five), CTF-NF1 (one), Myb (one), p53 (two), Ets-1 (one), NF-IL6
P07592946A0997|176 264|ve), GC-rich binding factor (five), CTF-NF1 (one), Myb (one), p53 (two), Ets-1 (one), NF-IL6 (two), MyoD
P07592946A0997|229 231|p53
P07593266A1174|64 70|11-base
P07594047T0000|120 121|QT
P07594592A0755|13 41|NF-IL6 beta leucine zipper domain
P07595221A0733|35 39|CIITA
P07595221A0733|36 50|IITA, endogenous
P07595221A0733|51 53|MHC
P07595221A0733|59 60|II
P07595221A0733|97 99|MHC
P07595221A0733|105 106|II
P07595221A0733|166 181|CIITA-expressing
P07595374A1215|12 16|EBNA2
P07595374A1215|202 213|LMP1 promoter
P07595857A0521|89 90|(A
P07595857A0521|94 96|PVA
P07595857A0521|127 136|wave (PVS1)
P07596287A0183|39 42|fimA
P07596287A0183|59 75|eading frames, ORF5
P07596287A0183|79 82|ORF1
P07596287A0183|149 159|ATP-binding
P07596287A1724|3 6|ORF3
P07596287A1724|67 70|ORF3
P07596287A1724|94 104|mutagenesis
P07596558A0824|42 49|IL-1 beta
P07596697A0971|24 34|polypeptide
P07597030A0260|69 81|32-kDa subunit
P07597030A0260|89 96|(h) TFIID
P07597030A0260|104 111|hTAFII32
P07597488T0000|22 25|G6PD
P07597804A1007|68 87|glycoprotein gene EUS4
P07598106A0709|28 29|II
P07600111A0000|62 68|2 (HIV-1
P07600111A0000|63 75| (HIV-1, HIV-2)
P07600111A0000|110 111|II
P07600111A0000|112 122|(HTLV-I/II)
P07600111A0000|227 239|Guinea-Bissau
P07601078A1003|127 129|: OR
P07601078A1003|139 140|CI
P07601078A1003|161 162|II
P07601078A1003|164 165|OR
P07601078A1003|175 176|CI
P07601121A0153|62 78|5'-flanking region
P07601445A0207|16 19|BAT1
P07601445A0207|79 95|WM6 Drosophila gene
P07601445A0207|165 168|DEAD
P07601445A0207|184 208|ATP-dependent RNA helicases
P07601827A0778|7 17|lacZ fusions
P07601827A0778|45 47|DNA
P07601827A0778|96 123|pfl promoter-regulatory region
P07601828A0095|57 58|II
P07601828A0095|59 72|flagellar genes
P07601828A0095|87 95|orfX-fliP
P07603956A0115|106 108|RSB
P07604047A0704|1 4|cDNA
P07604047A0704|36 47|GA 20-oxidase
P07604047A0704|91 107|transcription-PCR
P07604047A0704|134 137|cDNA
P07604047A0704|232 235|GA53
P07604047A0704|238 241|GA44
P07604047A0704|245 248|GA19
P07604047A0704|251 254|GA20
P07605990A1110|60 64|PEBP2
P07605990A1110|70 83|GM-CSF promoter
P07605990A1110|162 174|PEBP2 isoforms
P07607197A1048|5 28|plasma renin activity (PRA)
P07607197A1048|61 62|(P
P07607342A0703|70 84|aldose reductase
P07607537A0954|98 117|VP16 activation domain
P07607607T0000|0 7|Increase
P07607607T0000|39 54|fructose infusion
P07607669A1112|27 28|GC
P07607669A1112|46 48|CpG
P07608268A0194|32 35|GnRH
P07608268A0194|121 128|males IGD
P07608268A0194|137 138|DP
P07608649A1429|28 30|CyA
P07608649A1429|67 70|ET-1
P07608968A0836|66 76|core domains
P07608968A0836|149 151|TBP
P07609037A0775|80 100|a sequence-specific DNA
P07609037A0775|150 170|wild-type MMTV promoter
P07609079A0387|20 27|HIV-1 LTR
P07609079A0387|30 37|T3R alpha
P07609079A0387|78 109|50-amino-acid N-terminal A/B region
P07609079A0387|112 119|T3R alpha
P07609079A0387|148 171|transcription factor TFIIB
P07609079A0387|257 259|LTR
P07609372A0261|0 4|M.M.C
P07609372A0261|19 34|minutes in 44 cases
P07609372A0261|38 39|HR
P07609372A0261|39 52|R patients, 24 LR
P07609372A0261|69 85|5 minutes in 66 cases
P07609372A0261|89 90|HR
P07609372A0261|90 103|R patients, 20 LR
P07610052A1064|49 60|C35 complexes
P07610052A1064|102 111|SAA element
P07610052A1064|114 117|EMSA
P07610052A1064|203 216|rat APP promoter
P07610716A0117|57 68|MS-frequency
P07612174A1064|77 80|PCBs
P07615541T0000|20 26|DNase-I
P07615541T0000|51 83|mouse porphobilinogen deaminase gene
P07615634A0535|50 61|NH2-terminal
P07615634A0535|98 102|121 kD
P07616056A0278|21 30|chain genes
P07616056A0278|65 73|chain gene
P07616563A0532|8 11|CarP
P07616563A0532|29 46|carAB control region
P07616563A0532|65 69|DNase
P07616563A0532|143 146|GATC
P07616569A0168|42 58|cytochrome oxidase
P07616569A0168|107 130|NADH dehydrogenase complex
P07616569A0168|139 145|, nad4L)
P07616569A0168|150 163|ATPase subunits
P07616569A0168|192 195|RNAs
P07616569A0168|209 219|rn), 23 tRNAs
P07622058A0411|3 12|PEBP2 alpha
P07622058A0411|29 52|128-amino-acid (aa) region
P07622058A0411|96 111|segmentation gene
P07622060A0967|29 44|NADP-dependent ME
P07622521A0418|27 49|G beta gamma binding region
P07622521A0418|52 58|beta ARK
P07622521A0418|89 96|PH domain
P07622521A0418|154 160|beta ARK
P07622521A0418|206 210|G beta
P07622521A0418|219 222|PIP2
P07623807A0162|115 120|v-Ras-
P07623807A0162|124 140|v-Src-transformed
P07623814A1040|2 5|CV-1
P07623814A1040|42 58|estrogen receptors
P07623814A1040|108 119|RA-dependent
P07623814A1040|132 133|ER
P07623821T0000|12 26|Gax homeobox gene
P07623821T0000|80 103|myocyte-specific enhancer
P07623821A0649|11 22|actors, HRF-1
P07623821A0649|35 44|cis element
P07623825T0000|3 40|carboxyl-terminal transactivation domain
P07623840A0352|49 52|GCN2
P07623840A0352|78 83|kinase
P07623840A0352|118 121|tRNA
P07623844A0639|25 30|E1B 19K
P07623844A0639|75 87|p53-dependent
P07623844A0639|125 127|DNA
P07623844A0639|184 195|wild-type p53
P07624119A0528|12 15|PAX3
P07624119A0528|27 57|PAX3-FKHR transactivation domains
P07624119A0528|106 126|GAL4 DNA-binding domain
P07624119A0528|149 160|reporter gene
P07624581A0312|26 28|ECG
P07624581A0312|83 85|TSH
P07624581A0312|85 104|H, thyroid hormone, PRL
P07624581A0312|87 132|thyroid hormone, PRL, glucose, creatinine, nitrogen
P07624581A0312|88 154|hyroid hormone, PRL, glucose, creatinine, nitrogen, glutamine transaminase
P07624581A0312|201 211|therapy (T0)
P07624581A0312|218 237|30 treatment days (T30)
P07624581A0312|247 264|15 days washout (T45)
P07624615A0267|15 33|body temperature (TB)
P07624615A0267|41 45|PaCO2
P07624615A0267|57 61|mmHg)
P07624615A0267|65 83|[HCO3-]a(24.20 mEq/L
P07624615A0267|91 96|mEq/L)
P07624615A0267|107 109|pHa
P07624615A0267|140 149|[OH-]/[H+]
P07624615A0267|183 187|[SID]
P07624615A0267|190 195|[Atot]
P07624615A0267|224 227|[PT]
P07624615A0267|249 252|[Pi]
P07626469A1341|44 94|M1 domain in LHR-expressing mouse Leydig tumor cells (MLTC)
P07626469A1341|103 119|non-expressing CHO
P07626806A1098|3 10|RAT3 gene
P07628389A0145|0 24|Tumor necrosis factor-alpha
P07628389A0145|25 28|(TNF
P07628389A0145|29 34|alpha)
P07628389A0145|69 83|cAMP-stimulated
P07628438T0000|13 34|insulin receptor homolog
P07628438T0000|83 98|receptor isoforms
P07628451A0114|14 15|RA
P07628451A0114|19 21|E1A
P07628451A0114|48 67|E1A-associated 300 kDa
P07628456A0000|3 40|double-stranded RNA binding domain (dsRBD)
P07628456A0000|58 73|65 amino acid motif
P07628456A0000|121 142|double-stranded (ds) RNA
P07628456A0000|165 169|RNase
P07628456A0000|170 172|III
P07628456A0000|179 199|dsRNA-dependent kinase
P07628456A0000|180 203|sRNA-dependent kinase, PKR
P07629103T0000|0 40|CCAAT/enhancer-binding protein isoforms beta
P07629103T0000|112 134|beta-casein gene promoter
P07629113A0726|0 2|SCA
P07629113A0726|48 63|metalloproteases
P07629122A0323|66 69|NIMA
P07629122A0323|67 75|IMA, NIM-1
P07629122A0323|87 100|protein kinases
P07629122A0323|115 118|NIMA
P07629123A0885|85 105|eterodimerization, DNA
P07629150A0155|15 25|CYP11A1 gene
P07629163A0770|0 3|NH2-
P07629163A0770|7 19|COOH-terminal
P07629163A0770|55 56|PH
P07629163A0770|68 105|guanine nucleotide exchange factor domains
P07629196A0274|30 45|GTPase-deficient
P07629196A0274|55 67|alpha 12 (alpha
P07629196A0274|68 75|12Q229L)
P07629196A0274|78 90|alpha 13 (alpha
P07629196A0274|91 98|13Q226L)
P07629196A0274|127 175|Jun kinase/stress-activated protein kinase (JNK/SAPK)
P07630687A0010|190 192|III
P07630934A0343|1 8|arel, E.M
P07633444T0000|60 83|mouse WD-repeat gene DMR-N9
P07633756A0690|3 6|ARX2
P07633756A0690|68 80|background EEG
P07635140A0172|33 45|enzyme (CYP19)
P07635140A0172|67 90|tissue-specific promoters
P07635312A0692|5 15|mutagenesis
P07635312A0692|56 74|actin-binding domain
P07635572A1153|0 8|CIITA mRNA
P07635572A1153|30 38|IFN-gamma
P07635572A1153|46 47|II
P07635572A1153|49 73|on-inducible, RB-defective
P07635572A1153|108 109|RB
P07635572A1153|115 131|effect on CIITA mRNA
P07636179A0000|57 82|tumor-suppressor protein pRb
P07636179A0000|100 122|cyclin-dependent kinases
P07636187A0585|18 43|rotein expression data, V beta
P07636187A0585|102 118|wild-type promoter
P07636337A0687|91 93|HRT
P07636648A1229|16 19|DTaP
P07636648A1229|74 86|serum antibody
P07636648A1229|185 195|DTaP-primed
P07636962A1288|66 77|HSV-alpha TIF
P07636962A1883b|30 45|DNA binding domain
P07636962A1883b|48 51|GAL4
P07636962A1883b|82 93|BHV-alpha TIF
P07636984A1349|31 33|SP1
P07636984A1349|64 76|HCMV-infected
P07637718A0218|14 26|messenger RNAs
P07637718A0218|35 50|trans-sialidases
P07638517A0000|82 96|individuals AIDS
P07639106A0678|44 48|TBBMD
P07639106A0678|104 112|body TBBMC
P07640309A0000|3 19|C-terminal peptide
P07640309A0000|62 107|mobility group (HMG)-box transcription factor TCF-1
P07640309A0000|167 170|VIII
P07642490A0318|5 17|ector, pHBK280
P07642538A0138|23 25|RSK
P07642538A0138|49 61|RSK cDNA (RSK3)
P07642538A0138|101 116|site-directed RSK
P07642538A0138|102 134|ite-directed RSK mutants; K91A (N-Lys
P07642538A0138|103 158|te-directed RSK mutants; K91A (N-Lys, NH2-terminal ATP-binding
P07642538A0138|104 177|e-directed RSK mutants; K91A (N-Lys, NH2-terminal ATP-binding mutant), K444A (C-Lys
P07642538A0138|105 202|-directed RSK mutants; K91A (N-Lys, NH2-terminal ATP-binding mutant), K444A (C-Lys, COOH-terminal ATP-binding
P07642538A0138|106 217|directed RSK mutants; K91A (N-Lys, NH2-terminal ATP-binding mutant), K444A (C-Lys, COOH-terminal ATP-binding mutant), N/C-Lys
P07642538A0138|192 202|ATP-binding
P07642538A0138|225 253|ATP-binding mutant) T570A (C-Thr
P07642538A0138|274 277|MAPK
P07642538A0138|299 307|subdomain
P07642538A0138|308 311|VIII
P07642538A0138|317 325|C-domain)
P07642538A0138|318 337|-domain), S218A (N-Ser
P07642538A0138|363 374|NH2-terminal
P07642538A0744|15 19|C-Lys
P07642538A0744|23 27|C-Thr
P07642538A0744|48 53|kinase
P07642544A0868|27 73|protein-tyrosine phosphatase alpha-overexpressing
P07642544A0868|127 134|NF-kappa
P07642633T0000|1 17|TATA-less promoter
P07642633T0000|120 155|transcription enhancer factor-1 (TEF-1)
P07644127A0000|158 184|rat substantia innominata (SI)
P07644466A0578|36 41|NS3-4A
P07644466A0578|37 56|S3-4A polyprotein, NS3
P07644466A0578|61 82|serine proteinase domain
P07644466A0578|110 113|NS3)
P07644466A0578|121 124|NS4A
P07644503A0729|28 34|RAR beta
P07644503A0729|91 93|RAR
P07644503A0729|117 127|target genes
P07646439A0535|53 66|DEAE-Sepharose
P07646439A0535|91 93|mAb
P07647303T0000|3 18|homeobox gene ATK1
P07647570A0713|124 133|deiodinase
P07648338A0815|102 104|TNF
P07648338A0815|127 129|SMA
P07649098A0676|129 134|5'-UTR
P07649098A0676|147 169|PGE2-stimulated reporter
P07649098A0676|190 208|PGE2-driven reporter
P07649098A0676|285 297|IGF-I promoter
P07649098A0676|318 350|IGF-I promoter-luciferase-reporter
P07649098A0676|384 396|alpha-isoform
P07649098A0676|426 457|cAMP-dependent protein kinase (PKA)
P07649098A0676|498 501|PGE2
P07649098A0676|579 581|PKA
P07649098A0676|596 599|cAMP
P07649098A0676|607 626|PGE2-induced reporter
P07651131A1407|19 23|DNase
P07651131A1407|61 81|42 kDa repressor isoform
P07651131A1407|95 98|CIRs
P07651141A0265|19 30|p-gvpF-M mRNA
P07651141A0265|65 70|p-gvpF
P07651141A0265|77 82|p-gvpE
P07651340A0286|18 23|uvsH77
P07651340A0286|59 71|MMS-resistant
P07651340A0286|112 113|UV
P07651340A0286|117 119|MMS
P07651386A0925|30 32|p53
P07651398T0000|53 77|DER receptor tyrosine kinase
P07651398A0257|11 14|dShc
P07651398A0257|77 108|growth factor receptor homolog (DER)
P07651398A0257|149 151|DER
P07651398A0803|27 39|dShc PTB domain
P07651398A0803|61 63|DER
P07651400A0335|46 51|exon's
P07651424A0487|78 80|60S
P07651424A0743|3 21|ild-type cells, SSM1b
P07651424A0743|60 64|SSM1a
P07651424A0743|91 95|SSM1b
P07651734A0961|43 52|LIMK-1 mRNA
P07651734A0961|94 103|LIMK-2 mRNA
P07652575A0435|69 93|Rho inhibitor C3 transferase
P07652575A0435|101 116|serum-induced DNA
P07652582A0000|0 8|INF-alpha
P07652582A0000|56 58|CML
P07653094A0169|200 230|plasmid vector (pcDL-SR alpha-296)
P07653094A0169|233 236|CV-1
P07653094A0169|240 243|HeLa
P07653812T0000|11 30|acetyl cholinesterase
P07653892A0306|16 28|isoflurane MAC
P07653892A0306|109 116|(U50488H
P07654712A0774|145 146|pH
P07655184A0852|79 80|ER
P07655184A0852|147 148|ER
P07655505A0527|16 24|oots, GT-2
P07655505A0527|167 182|phytochrome A gene
P07655509T0000|88 94|PS-IAA4
P07655509T0000|102 107|(Pisum
P07656588A0101|11 13|DNA
P07656588A0101|39 67|Genethon microsatellite D19S596
P07656588A0101|106 109|FUT1
P07656588A0101|161 164|FUT1
P07656588A0101|168 176|FUT2 genes
P07656588A0101|186 188|4 cM
P07656588A0101|197 203|D19S412
P07656588A0101|234 240|D19S571
P07657162A1412|39 43|LEF-1
P07657162A1412|103 124|trans-activation domain
P07657162A1412|140 148|HMG domain
P07657668A0642|0 5|TH-SH3
P07657668A0642|79 89|Btk TH domain
P07657668A0642|95 100|Fyn SH3
P07657705A1181|42 57|GPI-anchored HSPG
P07658262A0944|79 87|infusions
P07659085A1520|13 50|transcription factor Oct-1 forms complexes
P07659085A1520|57 68|octamer motif
P07659085A1520|82 85|FPIV
P07659085A1520|179 186|androgen
P07659515T0000|4 10|non-LTR
P07659515T0000|61 81|site-specific elements
P07659515T0000|84 111|Crithidia fasciculata miniexon
P07659529A0135|47 58|reporter gene
P07659529A0135|81 108|transcription control elements
P07659529A0135|140 147|EpoR gene
P07659746A1464|3 9|CVA16.4
P07659746A1464|57 75|proteolipid messages
P07659757A0191|41 54|[gamma-32P]ATP
P07660712A0118|109 111|VHB
P07663138A0835|50 52|PBV
P07663138A0835|56 58|PBF
P07663160A0287|12 14|DNA
P07663160A0287|85 87|16S
P07663160A0287|97 99|RNA
P07663998T0000|26 27|IV
P07665172A0000|36 62|helix-loop-helix (bHLH) motif
P07665172A0000|86 105|tissue-specific genes
P07665187A0208|18 21|cDNA
P07665187A0208|67 76|Nramp1 mRNA
P07665187A0824|18 27|S1 nuclease
P07665477A0901|0 3|EsaR
P07665477A0901|66 69|esaI
P07665567A0495|21 37|5'-flanking region
P07665567A0495|43 50|CD69 gene
P07665567A0495|82 98|TATA element 30 base
P07665567A0495|195 223|transcription factors (NF-kappa
P07665567A0495|197 236|anscription factors (NF-kappa B, Egr-1, AP-1)
P07665605A1127|33 40|105-kDa)
P07665605A1127|80 81|DD
P07665633A0284|44 56|disk diffusion
P07665948A0591|0 2|IgE
P07665948A0591|57 59|IgE
P07666414A0614|30 38|tmy-1 gene
P07666414A0614|71 93|promoter/lacZ fusion gene
P07666415A0000|26 43|chloroplast (cp) DNA
P07666415A0000|53 56|(Zea
P07666523T0000|48 51|mRNA
P07666523T0000|72 100|T7-generated negative-sense RNA
P07666538A0000|33 55|hepatitis C virus (HCV) RNA
P07666538A0000|109 121|region (5'NCR)
P07667097A0267|24 40|splicing complexes
P07667097A0267|68 73|mAb CC3
P07667097A0267|102 134|immunoprecipitate pre-messenger RNA
P07667621T0001|0 16|Doppler ultrasound
P07668009A0172|24 41|hepatitis A diseases
P07669351A1278|18 38|phi 29 SSB-ssDNA complex
P07670504A0834|152 154|GBF
P07670943A0308|44 46|CAD
P07670943A0308|130 132|CAD
P07672821A0763|23 26|FHR2
P07672821A0763|33 44|factor H genes
P07672822T0000|43 74|mouse pre-T-cell receptor alpha gene
P07673128A0989|28 51|cAMP response element (CRE)
P07673154A0688|33 39|CAK beta
P07673154A0688|100 102|3Y1
P07673178A0982|30 39|muscle gene
P07673178A0982|102 111|MDF/bH-L-H
P07673178A0982|132 136|MCK-L
P07674649A0508|1 11|single-case
P07674649A0508|24 27|ABAB
P07675445A0463|49 54|p(CA)n
P07675445A0463|70 101|sequence length polymorphism (SSLP)
P07675449A0848|72 76|PDGFR
P07676492A1000|112 114|IHD
P07676655A0214|23 24|iP
P07676655A0214|31 42|dialysis (HD)
P07677715A1076|3 5|TAF
P07677715A1076|48 50|OCD
P07678006A0472|0 4|RNase
P07678006A0472|41 56|61-kDa CaM PDE mRNA
P07678006A0472|106 119|CaM PDE isoforms
P07678006A0901|110 112|RNA
P07678051A1303|3 7|PDGFR
P07678051A1303|40 42|PLC
P07678051A1303|71 84|PDGF-dependent
P07678242A0473|61 68|acc genes
P07678593A0708|44 46|DNA
P07678602A0153|2 10|generated
P07678695A0604|112 136|octamer-dependent promoter
P07679390A0721|0 4|RNase
P07679390A0721|57 70|non-coding exon
P07679390A0721|86 97|DDT1 aFGF mRNA
P07679836A0387|23 24|FK
P07680035A0221|32 34|AMP
P07680035A0221|49 52|GnRH
P07680120A1008|0 5|RT-PCR
P07680120A1008|11 22|1.D-specific
P07680120A1008|75 77|1.D
P07680120A1008|78 81|mRNA
P07680120A1008|133 136|aFGF
P07680629T0000|102 111|cell fusion
P07681147A1420|162 176|beta-adrenergic
P07681513A0000|16 32|phosphodiesterase
P07681513A0000|33 35|III
P07681539A0000|0 10|Cytogenetic
P07681539A0000|82 104|radiation (1.6-42.71 mSv)
P07682842A0294|27 32|fMLF-R
P07682842A0294|75 87|receptor genes
P07682842A0294|107 116|fMLF-R gene
P07682842A0294|229 238|fMLF-R gene
P07683131A0885|37 46|SRC-family
P07683131A0885|70 80|exon/intron
P07683375A0000|44 47|cAMP
P07683375A0000|56 68|estradiol (E2)
P07683375A0000|119 138|estrogen receptor (ER)
P07683375A0000|199 212|protein kinases
P07683375A0000|252 253|ER
P07685263A0503|8 17|polymerase
P07685263A0503|9 50|olymerase chain reaction, Whipple-specific DNA
P07685263A0503|62 68|284 base
P07685263A0503|108 118|(Tropheryma
P07685823A1234|0 12|RNA polymerase
P07685823A1234|23 26|+10A
P07685823A1234|76 80|DNase
P07685874A0258|77 79|SLE
P07685874A0258|167 173|amylase
P07687320A0526|11 23|plasmid pFV100
P07687541A0200|160 170|poly(A)+ RNA
P07687541A0992|5 9|RCC1p
P07687541A0992|16 19|GNRP
P07687541A0992|40 45|GTPase
P07687541A0992|112 116|(CNR1
P07687541A0992|120 124|CNR2)
P07687745T0000|20 24|FK506
P07688112A0274|84 98|acid phosphatase
P07689154A0168|50 56|uPA gene
P07689154A0168|75 92|ells; protein kinase
P07689154A0168|165 171|uPA mRNA
P07689154A0168|186 204|AMP (cAMP)-dependent
P07689154A0168|241 252|8-bromo cAMP)
P07689154A0168|260 266|uPA mRNA
P07691837A1359|30 42|K3 keratin gene
P07691837A1359|70 98|keratinocyte-specific promoter
P07691837A1359|157 160|NFkB
P07691837A1359|193 194|GC
P07691885T0000|49 62|proto-oncogene
P07692366A0000|0 9|BACKGROUND
P07692366A0000|65 82|degeneration (ARMD)
P07692366A0000|162 173|pathogenesis
P07692668A0326|42 44|RNA
P07692668A0326|85 88|RNAs
P07692668A0326|229 232|ORFs
P07693132A0100|39 47|Zm-ERabp1
P07693132A0100|40 57|m-ERabp1, Zm-ERabp4
P07693132A0100|62 75|Zm-ERabp5 genes
P07693672A0259|0 4|DNase
P07693708A0000|0 50|Insulin-like growth factor-binding protein-2 (IGF-BP-2)
P07693967A0905|16 17|RV
P07693967A0905|18 24|5'(+)SL
P07693975T0000|7 19|transcriptase
P07693975T0000|23 30|protease
P07693975T0000|48 73|leukosis virus Gag-Pol fusion
P07693975A1418|93 94|PR
P07696183A0567|55 69|Src-like kinases
P07696183A0567|233 244|NH2-terminal
P07696183A0567|367 375|SH2 domain
P07696450A0271|0 7|PATIENTS
P07696450A0271|8 10|AND
P07696450A0271|11 17|METHODS
P07696450A0271|72 90|bowel Crohn's disease
P07696450A0271|129 136|TGF-beta
P07696450A0271|138 146|(Specific
P07696450A0271|157 174|iet; Nestle-Clintec
P07696878A0222|30 33|cDNA
P07696878A0222|89 103|initiation codon
P07696878A0222|144 154|homeodomain
P07697294A0329|14 24|HSP81-1 mRNA
P07698219A0551|45 54|alpha 6 beta
P07698219A0551|66 80|laminin receptor
P07698219A0551|114 125|F9-derived PE
P07698727A0386|64 66|HIV
P07699632A0522|27 40|Chukcha-Eskimo
P07699632A0522|44 45|AS
P07699632A0522|50 63|Eskimo-Russian
P07699632A0522|76 89|arthritis (PsA)
P07699632A0715|93 95|SPA
P07699632A0715|99 105|HLA-B27
P07699845A0537|8 20|studies SY5555
P07699845A0537|309 329|ymphadenitis, S.S.S.S.
P07700361A0125|12 19|SH2-pTyr
P07701266A0808|0 6|RESULTS
P07701266A0808|48 50|TPN
P07701266A0808|142 144|TPN
P07702327T0000|46 62|tissue plasminogen
P07702378A0668|76 78|VO2
P07702752A0545|30 47|rat P450c17 promoter
P07702752A0545|75 93|cAMP-stimulated gene
P07702752A0545|152 158|-53 base
P07702752A0545|166 179|5'-flanking DNA
P07702752A0545|187 200|rat P450c17 gene
P07702752A0545|235 256|reporter gene luciferase
P07702752A0545|322 332|Leydig MA-10
P07702808A0427|0 15|Within-subject BP
P07702808A0427|112 118|24-h ABP
P07704040A0000|27 39|mouse NMO1 cDNA
P07704040A0000|56 86|NAD(P)H:menadione oxidoreductase
P07704040A0000|83 136|tase [also called NAD(P)H:(quinone acceptor) oxidoreductase
P07704040A0000|98 136|NAD(P)H:(quinone acceptor) oxidoreductase
P07704040A0000|145 153|reductase
P07704040A0000|162 182|eductase; DT diaphorase
P07704040A0000|163 185|ductase; DT diaphorase; EC
P07704273A0000|15 20|JRG582
P07704273A0000|25 32|ampD ampE
P07704273A0000|53 62|strain HfrH
P07704273A0000|125 142|beta-lactamase gene
P07704273A0000|174 186|plasmid pNU305
P07704456A1014|36 47|degenerative
P07704456A1014|126 128|HMS
P07706273T0000|38 61|H(+)-ATPase B2 subunit gene
P07706273T0000|79 83|THP-1
P07706287A0698|28 30|RNA
P07706291T0000|2 12|E box element
P07706291T0000|44 52|ad4bp gene
P07706291T0000|64 72|homologue
P07706291T0000|75 84|ftz-f1 gene
P07706307A0914|91 99|proteases
P07706396T0000|14 22|VPS45 gene
P07706396T0000|25 37|SEC1 homologue
P07707523A0704|26 33|NF-kappa
P07707523A0704|27 57|F-kappa B inhibitor, I kappa B-alpha
P07707523A0704|90 92|LMP
P07707531A0550|104 113|alpha 4 gene
P07707531A0550|129 132|ICP4
P07708058A0178|3 5|GRE
P07708058A0178|34 42|GRE (cGRE)
P07708058A0178|66 94|activator protein-1 (AP-1) motif
P07708497A0000|27 44|thyroid hormone (T3)
P07708497A0000|75 88|T3 receptor (TR)
P07708497A0000|92 115|T3 response elements (TREs)
P07708497A0000|155 160|AGGTCA
P07711667A0766|53 58|ge, WBC
P07711667A0766|106 120|arrow blasts, FAB
P07711667A0766|180 262|sion, maintenance therapy, consolidation therapy, marrow cell dose, donor-recipient sex, GVHD
P07711730A0000|0 33|Carnitine palmitoyltransferase (CPT)
P07711730A0000|34 35|II
P07713421A1435a|113 117|SxlM4
P07713421A1435b|113 117|SxlM4
P07713421A1435b|138 142|SxlM1
P07713421A1435a|138 142|SxlM1
P07713936A0393|9 13|meAda
P07713936A0393|61 73|response genes
P07713936A0393|109 112|aidB
P07713936A0393|139 143|meAda
P07714608A1252|54 55|pH
P07714608A1252|55 61|H, PaCO2
P07715602A1088|45 57|a multisubunit
P07715602A1088|58 77|cytochrome c haem lyase
P07715922A0188|121 123|PRK
P07719527T0000|30 52|hirudin CGP 39393 (REVASC)
P07720572A0701|15 26|myoD promoter
P07720572A0701|31 42|myoD enhancer
P07720572A1584|49 54|10T1/2
P07720572A1584|128 143|myoD core enhancer
P07720572A1584|162 173|myoD enhancer
P07720572A1584|187 196|epigenetic
P07720572A1584|209 214|10T1/2
P07720709A0755|5 25|Ki-ras-transformed 3T3
P07720709A0755|60 61|RA
P07720709A0755|197 199|AP1
P07720710A0861|9 12|HMG2
P07721422A0241|89 110|mouse type 2 receptor gene
P07721878A1163|3 13|beta subunit
P07721878A1163|33 38|33-kDa
P07721878A1163|125 139|Fc epsilon R1 beta
P07723247A1161|27 47|cell-associated IL-1Ra
P07723247A1161|51 58|IL-1 beta
P07728201A0660|49 73|sickle-hemoglobin C disease
P07729427A0942|29 31|TBP
P07729427A0942|35 42|hTAFII18
P07729427A0942|66 73|hTAFII28
P07729427A0942|67 82|TAFII28. hTAFII18
P07729427A0942|100 102|TBP
P07729427A0942|134 141|hTAFII28
P07729427A0942|145 152|hTAFII30
P07730273A1309|3 6|NarX
P07730273A1309|10 13|NarQ
P07730273A1309|115 128|NarL-phosphate
P07730328A0000|100 129|cell activation-associated genes
P07730336A0606|7 11|ATF-1
P07730336A0606|15 18|CREM
P07730336A0606|35 59|cAMP response elements (CRE)
P07730336A0606|94 105|kappa E3'-CRE
P07730337T0000|42 69|neuron-specific protein kinase
P07730337T0000|91 94|(RC3
P07730337A1439|3 8|Ng/RC3
P07730337A1439|12 25|PKC-gamma genes
P07730795A0104|48 52|DdRPs
P07731686A0000|3 11|TTG-2 gene
P07731686A0000|72 94|T-cell leukemia's (T-ALL)
P07731898A0823|170 195|superoxide anions generation
P07731898A0823|171 212|uperoxide anions generation, erythrocyte SOD-1
P07731898A0823|216 223|catalase
P07733075A1200|68 70|CBS
P07735833A1078|0 10|CONCLUSIONS
P07735833A1078|28 31|LysU
P07735833A1078|76 99|aspartyl-tRNA synthetases
P07737118A0317|3 6|MPS1
P07737118A0317|55 58|LexA
P07737118A0317|71 73|GST
P07737508A0649|12 26|single-copy gene
P07737508A0649|33 41|tRNA genes
P07737508A0649|34 49|RNA genes, tRNAGln
P07737508A0649|53 59|tRNAIle
P07737944A0000|58 68|transfusion
P07737944A0000|113 133|blood cell transfusions
P07738026A0216|63 65|ADH
P07738839A0173|6 7|IC
P07738839A0173|27 28|EC
P07738839A0173|32 33|VC
P07738839A0173|33 76|C breaths at rest, end-tidal CO2 pressure (PET,CO2)
P07738839A0173|96 99|mmHg
P07739382A0457|0 11|Phylogenetic
P07739520A1250|29 39|Surfeit gene
P07739520A1250|94 109|Surf-3/rpL7a gene
P07739542A1419|66 69|G1/S
P07739544A0364|34 41|SGC1 gene
P07739544A0364|94 121|basic-helix-loop-helix domain
P07739544A0364|138 148|DNA-binding
P07739566A1076|10 25|Pax-6-BSAP fusion
P07739566A1076|152 162|DNA-binding
P07740487A0167|46 62|dysfibrinogenemia
P07740487A0167|153 155|SSC
P07740487A0167|170 179|Fibrinogen
P07740490T0000|10 18|estrogens
P07742363A0135|23 51|haem-controlled repressor (HCR)
P07742363A0135|58 99|double-stranded RNA-activated inhibitor (dsI)
P07742363A0135|125 136|alpha subunit
P07742363A0135|209 213|eIF-2
P07742363A0941|7 15|Ser-->Ala
P07742363A0941|28 42|yeast eIF-2 alpha
P07742363A0941|108 119|casein kinase
P07742550A0407|50 53|(DAL
P07742550A0407|163 176|lymphomas (TFL)
P07742550A0407|198 210|lymphomas (FL)
P07742550A0407|199 237|ymphomas (FL), 14 mantle cell lymphomas (MCL)
P07742550A0407|259 277|cell lymphomas (SNCL)
P07742917T0001|10 25|beta-thalassemia
P07743472A0181|59 90|Roswell Park Cancer Institute (RPCI)
P07743515A0223|37 40|AAMP
P07743697A0703|11 16|V-HeFT
P07743697A0703|17 18|II
P07744763A0514|53 67|orphan receptors
P07744763A0514|181 187|CYP2C11
P07744763A0514|198 202|HNF-4
P07744776A0617|60 64|U6 RNA
P07744846A1006|10 20|Bcl-2/Bcl-2
P07744846A1006|144 154|Bcl-2/Bcl-2
P07744846A1006|204 222|NH2-terminal A domain
P07744846A1006|289 296|C domains
P07744954A0418|30 42|alpha-helical
P07744954A0418|75 77|NH2
P07744954A0418|81 84|COOH
P07744954A0418|148 160|alpha-helical
P07745311A0264|11 14|FHCS
P07745684T0000|62 74|protein kinase
P07745684T0000|94 96|RNA
P07745685A1442|113 114|SN
P07745685A1442|118 126|CAT fusion
P07745693A0914|32 43|Lb proteinase
P07745693A0914|70 80|IRES-driven
P07745696A0932|39 42|cDNA
P07745696A0932|48 60|HHV-6A(U1102)
P07745696A0932|68 72|BamHI
P07745696A0932|137 140|SalI
P07745696A0932|194 206|repeat regions
P07745726A0960|3 21|replication reporter
P07745726A1496|134 151|E1 recognition motif
P07746397A0233|0 6|METHODS
P07746397A0233|185 190|[aPTT]
P07746794A0000|50 72|Cyclosporin A (Sandimmun)
P07746794A0000|99 108|(Cremophor
P07746794A0000|109 111|EL)
P07746937A0100|0 21|Lung function tests (EFR)
P07747462A0332|32 34|RCR
P07747462A0332|135 158|active-site tyrosine motif
P07748493A1045|33 43|candidate PC
P07748493A1045|87 116|egg-laying hormone (ELH)-related
P07748502A0794|15 23|8-OH-DPAT
P07748952A0462|23 36|romoters, PmiaA
P07748952A1329|24 27|mutL
P07748952A1329|25 32|utL, miaA
P07748952A1329|179 183|RNase
P07749461A0632|8 24|5'-flanking region
P07749461A0632|47 62|sGTH alpha subunit
P07749461A0632|103 119|lone, sGTH alpha-G1
P07749461A1022|23 46|sGTH alpha subunit promoter
P07749461A1022|82 94|sGTH alpha/CAT
P07749461A1022|186 198|GSE-dependent
P07750217T0000|0 23|Indium-111 OncoScint CR/OV
P07750217T0000|27 33|F-18 FDG
P07751848A0222|3 36|carnitine palmitoyltransferase (CPT)
P07751848A0222|41 42|II
P07752223A0960|3 7|Myc LZ
P07752454A0341|23 25|CNS
P07752454A0341|63 80|methicillin (DMPPC)
P07752644A1031|5 6|VF
P07752886A0595|17 20|FecR
P07752886A0595|87 99|wild-type FecR
P07753027A0240|3 20|gene pairs psbB-psbT
P07753027A0240|24 32|psbH-psbN
P07753030A0173|45 48|DNAs
P07753796A0625|94 116|liver eIF-2B alpha subunit
P07753796A0743|16 19|cDNA
P07753796A0743|67 77|eIF-2B alpha
P07753796A0743|80 97|SDS/polyacrylamide
P07753837A0724|4 6|RNA
P07753837A0724|18 27|tail domain
P07753837A0724|57 70|plakoglobin RNA
P07754713A0227|10 13|NUC1
P07754713A0227|11 19|UC1, PRP21
P07754713A0227|31 36|SPP91)
P07754713A0227|32 41|PP91), CDC6
P07754713A0227|33 46|P91), CDC6, CRY2
P07755914A0000|0 8|OBJECTIVE
P07755914A0000|117 120|AIDS
P07755914A0000|136 166|Mycobacterium avium complex (DMAC)
P07757315A1227|103 129|observation period.(ABSTRACT
P07757315A1227|130 138|TRUNCATED
P07757315A1227|135 136|AT
P07757315A1227|141 149|250 WORDS)
P07758167A1488|40 47|clone CA9
P07758167A1488|98 106|clone ME10
P07758459A1277|3 5|UAS
P07758459A1277|11 18|AAC2 gene
P07758459A1277|54 64|DNA-binding
P07758459A1277|126 149|core HAP2/3/4 binding motif
P07758459A1277|171 174|ABF1
P07758837A1118|49 62|GH receptor gene
P07758837A1118|113 118|exon 1B
P07758837A1118|208 231|liver-specific P1 promoter
P07759094A0634|24 31|(GT/CA)n
P07759094A0634|52 55|NHE5
P07759094A0634|92 108|microsatellite PCR
P07759525A0417|54 72|protein kinase domain
P07759525A0417|102 113|casein kinase
P07759529A0288|37 43|CDP/cut
P07759529A0288|64 76|gp91-phox gene
P07760790A0327|17 32|MEF2 reporter gene
P07760790A0327|56 61|NIH 3T3
P07760790A0327|82 85|MEF2
P07760819A0731|50 74|olecules, PDGF beta receptor
P07760841A0221|0 3|UAS1
P07760841A0647|17 20|ADH2
P07760841A0647|55 58|UAS1
P07760841A0647|83 86|ADH2
P07760841A0647|92 107|promoter elements
P07760841A0647|93 126|romoter elements, UAS2-dependent gene
P07760841A0647|177 186|helix phase
P07760844A0413|11 17|AP-1 DNA
P07760844A0413|51 52|GH
P07760844A0413|79 88|c-fos genes
P07761091A0294|14 23|MAP kinases
P07761091A0294|42 52|phosphatase
P07761091A0294|43 58|hosphatase, MKP-1
P07761420A0909|12 23|45Ca-binding
P07761420A0909|42 46|CCaMK
P07761434A1084|5 8|AP-1
P07761434A1084|32 44|tumor promoter
P07761467A0666|72 77|36-kDa
P07762431A0356|32 35|cDNA
P07763727A1035|0 13|Plasmids pAMS12
P07763727A1035|1 20|lasmids pAMS12, pAMS13
P07763727A1035|24 29|pAMS14
P07763727A1035|99 104|pAMS15
P07765118A0967|21 31|ACC-oxidase
P07766885A0405|11 21|polypeptide
P07766885A0405|75 83|plant CDPK
P07766885A0405|76 90|lant CDPK; kinase
P07766885A0405|160 173|junction region
P07768824A0167|11 17|fla gene
P07768824A0167|74 86|RNA polymerase
P07768848A1880|0 11|Polypeptides
P07768848A1880|56 59|cotE
P07768848A1880|110 119|cotJ operon
P07768953T0039|0 3|EEA1
P07768953T0039|16 28|alpha-helical
P07768953T0039|92 116|calmodulin-binding IQ motif
P07770033A0978|71 87|reading frame (ORF)
P07770033A0978|106 137|6-amino acid, cysteine-rich peptide
P07772036A1000|36 50|actors, USF/MLTF
P07772036A1000|57 111|CAAT-binding transcription factor/nuclear factor 1 (CTF/NF1)
P07774137A0000|45 50|(Strep
P07774137A0000|51 55|A OIA)
P07774137A0000|81 100|group A beta-hemolytic
P07774137A0000|114 120|(GABHS)
P07774807A0405|3 6|bHLH
P07774807A0405|58 77|tissue-specific genes
P07774925A0084|0 2|YAC
P07774925A0084|30 40|BRCA1 region
P07774925A0084|57 60|cDNA
P07774925A0084|78 82|cDNAs
P07774925A0084|100 111|lacenta, HeLa
P07775428A0172|64 72|Ash-l cDNA
P07775428A0172|78 97|amino-terminal region
P07776685A0000|69 85|tumor infiltrating
P07776685A0000|165 167|III
P07776711A0295|0 7|MATERIAL
P07776711A0295|8 10|AND
P07776711A0295|11 17|METHODS
P07776882A0000|85 95|reperfusion
P07776979A0702|3 17|ontrast, COUP-TF
P07776979A0702|36 64|repCRS2-dependent reporter gene
P07777518A0483|0 2|DNA
P07777518A0483|54 57|cDNA
P07779558T0000|0 11|Muscle GSH-Px
P07779811A0901|13 22|Sp1 element
P07779812A0000|3 11|c-myc gene
P07780148A1153|11 13|PML
P07780148A1153|49 55|M phases
P07780148A1153|88 94|G1 phase
P07780738A0091|22 28|S phases
P07780738A0091|82 94|antigen (PCNA)
P07780738A0091|104 106|DNA
P07782087A0559|122 133|ribonuclease
P07782087A0559|166 169|RACE
P07782302A0479|24 30|-DEDDDL
P07782302A0479|49 51|GDP
P07782302A0479|122 152| Ran-binding protein, HTF9A/RanBP1
P07782775A0889|11 14|ORFs
P07782775A0889|65 69|20 kDa
P07782775A0889|83 86|BBTV
P07783064A0452|60 79|creatinine kinase (CK)
P07783641A0591|0 3|CodY
P07783641A0591|18 27|homologues
P07783641A0591|33 42|data-bases
P07783822A0000|0 8|OBJECTIVE
P07784061A0894|59 61|TTF
P07784078A1064|72 79|RAR alpha
P07784078A1064|82 84|PML
P07784078A1064|98 100|APL
P07784079A1018|45 50|NIH3T3
P07784079A1018|181 183|FGF
P07784197A0827|94 97|HeLa
P07784197A0827|120 127|TGF-beta
P07784197A0827|138 148|RNA-protein
P07784197A0827|176 184|BALB/c 3T3
P07784199A0000|12 35|protein (rp) gene promoters
P07786820A0284|0 5|CPT-11
P07786820A0284|25 44|0-minute i.v. infusion
P07786821A2292|0 9|CONCLUSION
P07786821A2292|14 16|MTD
P07786821A2292|20 25|CPT-11
P07787179A0312|13 15|(X1
P07787179A0312|16 22|region)
P07787179A0312|28 41|PRB-1b promoter
P07787179A0312|126 137|reporter gene
P07789342A1352|35 39|TSH-R
P07789342A1352|76 78|TSH
P07789342A1352|119 137|transmembrane domain
P07789342A1352|148 150|TSH
P07789396A0504|35 38|EDTB
P07789971A0758|108 119|pseudogenes)
P07789971A0758|208 212|GSTT2
P07790377A0561|20 24|PTS1R
P07791760A0424|0 3|GnRH
P07791760A0424|69 72|MAPK
P07791760A0424|86 89|MAPK
P07791760A0424|121 133|complex kinase
P07791763T0000|29 62|insulin receptor substrate 1-like cDNA
P07791763T0000|79 106|phosphatidylinositol 3-kinase
P07791768A0930|132 135|SIR1
P07791769A0826|0 3|ICP4
P07791769A0826|61 64|TATA
P07791769A0826|86 90|TFIIB
P07791769A0826|93 95|DNA
P07791769A0826|108 111|ICP4
P07791769A0826|127 130|TATA
P07791769A0826|134 135|(C
P07791783A0000|0 14|SRY-related cDNA
P07791783A0000|36 59|high-mobility-group (HMG)
P07791783A0000|67 84|leucine zipper motif
P07791783A0000|104 109|SOX-LZ
P07791783A0000|127 148|rainbow trout testis cDNA
P07794556A0000|46 56|DNA-testing
P07794556A0000|60 78|Huntington's disease
P07794556A0000|137 147|DNA-linkage
P07796935A0284|55 61|hTR beta
P07796935A0284|83 90|hTR alpha
P07796935A0284|84 110|TR alpha 1 mutants, c-erbA alpha
P07796935A0284|123 169|peroxisome proliferator-activated receptor (hPPAR)
P07796935A0284|187 211|T3-response elements (TREs)
P07796935A0284|188 219|3-response elements (TREs), TRE-PAL
P07796935A0284|189 222|-response elements (TREs), TRE-PAL, DR
P07796935A0284|228 234|TRE-LAP
P07797077A0842|3 33|amino-terminal DNA-binding domain
P07797077A0842|73 90|DNA-binding domains
P07797077A0842|125 135|factor (IRF)
P07797077A0842|156 160|IRF-1
P07797077A0842|157 166|RF-1, IRF-2
P07797077A0842|158 172|F-1, IRF-2, ICSBP
P07797077A0842|177 181|ISGF3
P07797476A1001|3 14|RAP74 subunit
P07797476A1001|17 21|TFIIF
P07797476A1001|114 126|COOH-terminal
P07797583A0222|6 14|generated
P07797583A0222|70 72|DRE
P07797583A0222|151 158|PCNA gene
P07797583A0222|215 230|DREF (DRE-binding
P07797583A0222|241 248|PCNA gene
P07798134T0000|3 11|hsp70 gene
P07798207A0759|39 53|W3A1 ETF subunits
P07798207A0759|122 124|ETF
P07798217T0000|27 33|CREB341
P07798217T0000|58 70|cAMP-mediated
P07798217T0095|8 23|glycogen synthase
P07799437A0656|54 65|pNeo.Myc-2.4
P07799925A0526|44 58|src family kinase
P07799925A0526|67 70|HeLa
P07799925A0526|169 171|SH3
P07799925A0526|175 184|SH2 domains
P07799931A0287|63 68|L7 gene
P07799931A1232|53 57|c-Maf
P07799939A0628|3 16|27-base element
P07799939A0628|31 44|PDGF-activated
P07799939A0628|111 125|PDGF-treated 3T3
P07799948A0777|66 76|Raf-1 kinase
P07799950A0282|55 57|CRE
P07799950A0282|63 86|somatostatin gene promoter
P07799950A0282|108 129|cAMP-responsive element
P07799950A0282|141 144|CREB
P07800479A0201|9 16|ene, NSR1
P07800479A0201|78 80|RNA
P07800505T0000|40 44|85 kDa
P07800505T0000|54 72|phospholipase A2 gene
P07802355T0000|72 91|nalyzers: Coulter STKS
P07802355T0000|73 100|alyzers: Coulter STKS, Sysmex NE
P07802655T0000|18 25|FIII/YY1
P07802655T0000|108 119|protein genes
P07803809A1852|32 49|Ep-induced increase
P07803809A1852|52 66|beta-globin mRNA
P07803809A1852|88 101|tyrosine kinase
P07803809A1852|126 138|protein kinase
P07803809A1852|157 167|3.(ABSTRACT
P07803809A1852|168 176|TRUNCATED
P07803809A1852|173 174|AT
P07803809A1852|179 187|250 WORDS)
P07806507A0121|34 47|CD3-TCR complex
P07806507A0121|80 91|polypeptides
P07806507A0121|81 95|olypeptides, CD3
P07806507A0121|93 95|CD3
P07806532A0659|0 11|Protein cHMGI
P07806532A0659|33 42|AT-rich DNA
P07806532A0659|73 74|nM
P07806651A0097|61 78|Mexican-Americans'
P07806651A0097|102 103|MF
P07806651A0097|115 120|MMPI-2
P07807002A0500|19 21|DNA
P07807002A0500|59 76|germline epsilon RNA
P07807002A0500|91 112|luciferase reporter gene
P07807002A0500|182 184|IgE
P07808210A1510|43 46|NCEP
P07809128T0000|0 8|Oncogenic
P07809128T0000|22 29|E2F1 gene
P07809410A0606|27 40|esion, serum TSH
P07809410A0606|76 79|131I
P07809410A0606|94 109|iodine (131I-PBI)
P07811964A1252|7 34|leucine-proline repeat element
P07811964A1252|55 71|DNA-binding domain
P07811964A1252|74 79|EmBP-1
P07811964A1252|106 116|DNA-binding
P07812450A0849|11 13|ORF
P07812450A0849|58 65|nspC gene
P07813466A0074|3 10|U14 genes
P07813466A0074|110 145|70-kDa-cognate-heat-shock protein gene
P07813786A0641|10 14|cDNAs
P07813786A0641|61 75|XMyoDa TATA motif
P07814321A0850|14 17|prfA
P07814321A0850|21 24|ponA
P07814323A0313|43 46|FliQ
P07814323A0313|50 53|FliR
P07814388A0662|49 55|M6P/IGF
P07814388A0662|56 57|II
P07814388A0662|59 74|eceptors, 30 nM IGF
P07814388A0662|75 76|II
P07814405A1170|81 104|guanylyl cyclase receptors
P07814717A0669|0 7|Increase
P07814717A0669|10 18|blood NEFA
P07814717A0669|47 48|AA
P07815811A1487b|56 75|ischemia-reperfusion
P07816049A0686|2 19|cys1, Athyp1, AKin10
P07816049A0686|26 28|ORF
P07816049A1157|81 86|AKin10
P07816617A0763|23 26|HAC1
P07816619A0000|20 42|Arabidopsis thaliana cDNA
P07816619A0000|141 161|cAMP phosphodiesterase
P07816619A0872|115 120|genera
P07816630A1333|52 75|translation terminator TGA
P07816630A1333|81 103|beta-tubulin 2 (BTU2) gene
P07816630A1333|138 145|H4-I gene
P07816808A1102|27 29|STR
P07818416A0895|84 88|10 g/L
P07818416A0895|115 117|THR
P07818416A0895|123 127|10 g/L
P07818416A0895|148 158|revision THR
P07819225A1094|166 197|tetracycline resistance.(ABSTRACT
P07819225A1094|198 206|TRUNCATED
P07819225A1094|203 204|AT
P07819225A1094|209 217|250 WORDS)
P07820057A0000|0 23|Tumor necrosis factor alpha
P07821790A1084|12 16|UCRBP
P07821790A1084|86 90|UCRBP
P07821790A1084|128 136|a reporter
P07821790A1084|145 155|UCR elements
P07822329A0773|147 151|50 kDa
P07823919A1422|23 37|Oct-3/4 promoter
P07823919A1422|40 46|RAR:RXR
P07823919A1422|83 96|EAR-3/COUP-TFI
P07823919A1422|102 116|ARP-1/COUP-TFII
P07823951A1100|27 30|EKLF
P07823951A1100|119 122|EKLF
P07823951A1100|147 167|CACCC element-directed
P07823953A0777|15 26|I kappa B alpha
P07823953A0777|66 77|I kappa B alpha
P07823953A0777|100 115|C-terminal region
P07823953A0777|118 129|I kappa B alpha
P07823953A0777|233 248|C-terminal region
P07823953A0777|274 276|DNA
P07823953A0777|351 366|e PEST-like region
P07823953A0777|352 366|PEST-like region
P07823953A0777|373 383|DNA-binding
P07823964A0922|34 49|N-terminal domain
P07824325A0714|177 179|MIC
P07824657A1456|31 36|pCSK4F
P07826412T0112|58 71|gamma-subunits
P07826625X0000|42 45|(RNA
P07826625X0000|46 55|polymerase
P07826625X0000|56 57|II
P07826625X0000|59 70|TATA-binding
P07826625X0000|86 102|activation domains
P07826625X0000|119 139|C-terminal domain (CTD)
P07826625X0000|142 154|RNA polymerase
P07826625X0000|155 156|II
P07826625X0000|167 182|enhancer domain"?
P07826625X0000|258 274|activation domains
P07826625X0000|315 326|TATA-binding
P07828584A0681|0 10|Mutagenesis
P07828584A0681|13 15|IM1
P07828584A0681|36 40|c-Fos
P07828584A0681|53 70|AP1 bearing promoter
P07828600A0095|9 11|SSP
P07828600A0095|17 41|stage selector element (SSE)
P07828600A0095|55 74|gamma-globin promoter
P07828600A0095|119 131|beta-promoter
P07828600A0095|149 174|stage erythroleukemia (K562)
P07828811A0556|29 32|G1/S
P07828824A0307|18 30|photoreceptor
P07829057T0000|30 49|Werner syndrome region
P07829057A1097|32 33|RH
P07829097A0000|16 20|DXS52
P07829097A0000|30 33|VIII
P07829097A0000|75 83|a G+C-rich
P07829102T0000|40 53|mouse Nramp gene
P07829519A1251|19 26|intronic
P07829554A0257|70 85|hapten-syngeneic
P07829554A0257|88 97|allogeneic
P07829554A0257|205 216|assay (ELISA)
P07830112A0532|22 30|rate (PFR)
P07830112A0532|56 66|volume (EDV)
P07830112A0532|70 85|stroke volume (SV)
P07830112A0532|110 119|PFR-to-PER
P07830112A0532|145 153|PFR (TPFR)
P07831310A0000|48 94|tobacco etch virus (TEV) polymerase (NIb)-expressing
P07831310A0000|142 157|NIb-defective TEV
P07831799T0000|49 65|DNA polymerase gene
P07831829A1324|24 27|PMTV
P07831829A1324|25 33|MTV, BNYVV
P07831829A1324|38 42|SBWMV
P07831829A1324|82 94|heterogeneity
P07832086A1023|28 42|vancomycin (VCM)
P07832086A1023|50 62|imipenam (IMP)
P07832086A1023|70 84|minomycin (MINO)
P07832086A1023|92 104|amikacin (AMK)
P07832086A1023|114 128|fosfomycin (FOM)
P07832779A0719|19 33|endoglycosidase
P07834582A0115|38 44|n-3 EFAs
P07835088A0238|3 8|HSD3B1
P07835088A0238|12 22|HSD3B2 genes
P07835088A0238|43 44|II
P07835088A0238|45 53|3 beta-HSD
P07835088A0238|130 151|chromosome 1p13.1 region
P07835214A0603|41 43|GDM
P07835273A0000|61 75|insulin receptor
P07835273A0411|50 53|EGFR
P07835273A0411|153 158|3T3-L1
P07835710T0000|0 10|Intron-exon
P07835710T0000|25 56|porcine I kappa B alpha-encoding gene
P07835826A0195|17 33|1,25(OH)2-vitamin
P07835826A0195|19 60|25(OH)2-vitamin D3, vitamin D3, 25(OH)-vitamin
P07835826A0195|66 85|1,24,25(OH)3-vitamin
P07835886A0894|3 17|kallistatin gene
P07835886A0894|90 100|serpin genes
P07835886A0894|111 155|pha 1-antichymotrypsin, protein C inhibitor, alpha
P07835888A0402|19 24|XD gene
P07836218A0128|35 55|beta-endorphin release
P07836218A0128|135 141|release
P07836218A0128|144 157|beta-endorphin
P07836228A1052|50 51|LV
P07836364A0000|66 95|histocompatibility complex (MHC)
P07836364A0000|125 151|antigen presenting cells (APC)
P07836390A1152|23 42|VirD1/VirD2-mediated
P07836390A1152|105 108|IncP
P07836390A1152|139 149|transfer DNA
P07836406A0884|28 44|peptides generated
P07836406A0884|49 53|MHC-B
P07836406A0884|72 81|cdc2 kinase
P07836406A0884|98 111|phosphopeptide
P07836406A0884|129 141|reverse-phase
P07836471A0375|49 52|hNUC
P07838156A0789|41 43|RVR
P07838156A0789|80 101|hormone response element
P07838156A0789|113 124|reporter gene
P07838156A0789|169 176|ROR alpha
P07840643A1006|16 49|Flavobacterium glycosylasparaginase
P07840643A1006|64 83|glycosylasparaginase
P07841230T0000|15 26|complexation
P07841663A0685|0 23|Superoxide dismutase (SOD)
P07841663A0845|50 68|stimulation generate
P07841663A0845|99 101|SOD
P07844142A0640|32 35|cDNA
P07844142A0640|44 49|SR beta
P07844142A0640|62 67|SR beta
P07844142A0640|99 105|SR alpha
P07844142A0640|109 113|SRP54
P07844142A0640|129 134|GTPase
P07844155A0327|25 59|receptor-linked tyrosine phosphatases
P07844155A0327|98 108|LAR isoforms
P07844155A0327|180 182|LAR
P07844555A0406|99 113|wild-type M-MuLV
P07846153A0403|16 19|EMBO
P07846163A0422|3 7|mRNAs
P07846163A0422|13 20|GRF genes
P07846942A0717|21 33|beta-receptor
P07847036A0353|0 3|VIII
P07848358A0254|15 39|aspartate aminotransferase
P07851643A1365|32 45|104-kDa isoform
P07851758A0330|8 23|analysis maps SAL6
P07851758A0330|26 38|chromosome XVI
P07851758A0330|46 49|TPK2
P07852037A0548|15 17|DCT
P07852037A0548|53 55|TBF
P07852361A0868|9 12|PDMP
P07852361A0868|93 98|S phase
P07852400A0519|0 9|Rho GDP/GTP
P07852400A0519|1 33|ho GDP/GTP exchange inhibitor, Rho GDI
P07852400A0519|56 59|RhoA
P07853488T0000|58 90|immunodeficiency virus type 1 gag gene
P07853524A1944|12 20|GST domain
P07853524A1944|25 31|GST-Tax
P07853524A1944|80 117|Tax-CREB-21-bp-repeat complex.(ABSTRACT
P07853524A1944|118 126|TRUNCATED
P07853524A1944|123 124|AT
P07853524A1944|129 137|400 WORDS)
P07854130T0000|3 10|pilE gene
P07854130T0000|53 67|pilus biogenesis
P07854130A1387|16 19|PilE
P07854130A1387|22 36|pilus biogenesis
P07854130A1387|79 82|pilE
P07854324A0281|36 59|cell cycle control elements
P07854324A0281|93 103|mik1 homolog
P07857762A0611|3 11|MAP kinase
P07858986A0310|81 101|Carpentier-Edwards SAV
P07858986A0310|106 115|BioImplant
P07859301A0325|24 40|DNA-binding domain
P07859301A0325|70 89|leucine-zipper motifs
P07859739T0000|6 25|cyclin D-Cdk complexes
P07859739T0000|70 101|p16INK4/MTS1 tumour suppressor gene
P07859777A0000|16 33|serum albumin (rHSA)
P07860208A0000|17 23|release
P07860208A0000|26 48|interleukin-1 beta (IL-1)
P07860208A0000|52 82|tumour necrosis factor-alpha (TNF)
P07860208A0000|132 154|lipopolysaccharide (LPS)
P07860208A0000|224 246|glomerulonephritis (AGN)
P07860646A1363|57 86|angiogenesis-dependent diseases
P07860646A1363|96 100|FGF-2
P07862108A0987|0 1|UV
P07862108A0987|34 36|TEP
P07862108A0987|78 82|65 kDa
P07862129A1391|2 12|acute-phase
P07862129A1391|50 59|HNF-3 alpha
P07862129A1391|118 127|target gene
P07862129A1391|121 127|get gene
P07862129A1391|132 134|TTR
P07862141A0317|14 36|loss-of-function alleles
P07862141A0317|55 58|cAPK
P07862141A1412|16 25|amily, RFX1
P07862150A0429|39 56|TGF-beta-inducible
P07862150A0429|114 121|TGF-beta
P07862150A0429|194 201|TGF-beta
P07862154A0340|83 86|RAF1
P07862162A0408|61 68|OPI1 gene
P07862162A0408|104 116|UASINO element
P07862165A0184|10 18|monkey COS
P07862165A0184|67 75|generated
P07862165A0184|102 114|virus 40 (SV40)
P07862168A0000|3 49|interleukin 2 receptor alpha-chain (IL-2R alpha) gene
P07862168A0000|97 105|mitogenic
P07862533A0000|3 36|Wilms' tumour suppressor protein (WT1)
P07862533A0000|132 147|sequence homology
P07862533A0000|158 180|growth response-1 (EGR-1)
P07863047A0229|0 9|OBJECTIVES
P07863047A0229|24 31|serum ACE
P07863047A0229|54 57|COPD
P07863047A0229|99 117|oxygen therapy (CAOT)
P07863047A0229|162 164|ACE
P07863992A0908|90 101|heart disease
P07864652A0753|34 43|E2L1(1-98)
P07864652A0753|35 58|2L1(1-98), E2L1.H1(1-128)
P07864652A0753|36 72|L1(1-98), E2L1.H1(1-128), E2L2(120-233)
P07864652A0753|37 88|1(1-98), E2L1.H1(1-128), E2L2(120-233), E2H1.L2(98-233)
P07864652A0753|93 109|E2L1.H1.L2(1-233)
P07864652A1901|85 88|E2L1
P07864652A1901|92 95|E2L2
P07864709A0324|0 6|METHODS
P07864709A0324|11 26|influenza A (H3N2)
P07865129A0293|16 22|ATF/CRE
P07865129A0293|26 47|TBP/TATA sequence motifs
P07865129A0293|56 66|87-bp region
P07865787A1086|39 51|octamer motifs
P07865787A1086|156 173|wheat histone H3 gene
P07865876A1292|30 31|DP
P07865876A1292|73 78|DP/E2F
P07865876A1292|105 113|DRTF1/E2F
P07865888A1309|21 30|cells PBP74
P07865895A0896|62 64|mAb
P07865895A0896|85 90|LGL/NK
P07865895A0896|124 129|LGL/NK
P07865917A0191|20 23|FSGS
P07865917A0191|36 78|igh-dose steroids, high-dose cyclosporine (CSA)
P07865917A0191|98 100|ACE
P07867604A1777|31 63|inhibin/activin beta B-subunit mRNAs
P07867604A1777|218 221|cAMP
P07867622X0000|0 13|Promoter region
P07867622X0000|47 95|lpha 1-chimaerin, a neuron-specific GTPase-activating
P07867622X0000|107 117|21rac. alpha
P07867622X0000|131 163|a neuron-specific GTPase-activating
P07867944A0365|84 105|consensus sequence motif
P07867944A0365|112 138|sigma 35-recognized promoters
P07869721A0000|40 51|closing phase
P07869913A1076|6 19|ISO+AT infusion
P07869937A1142|39 41|GIT
P07869937A1142|56 57|dF
P07869937A1142|84 86|RMR
P07870305A1015|172 173|(P
P07871718A1132|33 44|CGGAAR motifs
P07871718A1132|52 63|ICP4 promoter
P07871718A1132|74 89|factors GABP alpha
P07871721A0000|38 60|scorch carlavirus (BBScV)
P07871721A0000|114 119|223 kDa
P07871721A0392|26 41|phylogenetically
P07871721A0392|107 133|papain-like proteinase domain
P07871754A0857|62 68|HPV gene
P07871755A0521|10 19|ethod, VLPs
P07871757A0846|35 49|initiation codon
P07871891A0227|0 4|SUP46
P07872673A0332|107 115|c-fos gene
P07872673A0332|133 151|SV40 promoter complex
P07872788A1717|43 51|hydrolase
P07872788A1717|132 148|carboxylesterases
P07873876A1035|3 5|NR2
P07874060A0810|0 4|TDEYA
P07874060A0810|50 68|xanthine oxidase (XO)
P07875595A0910|14 27|PITSLRE PK genes
P07875595A0910|82 100|hybridization (FISH)
P07876134A0348|64 71|AFAP-110
P07876134A0348|95 101|258 base
P07876191A0808|17 18|IV
P07876191A0808|19 25|ADH mRNA
P07876192A0443|2 4|ICE
P07876192A0443|20 29|propeptide
P07876192A0443|102 104|ICE
P07876194T0000|43 63|growth factor receptors
P07876194T0000|110 129|tyrosine kinase domain
P07876210A0275|69 86|5'-flanking regions
P07876210A0275|147 162|Barbie box element
P07876210A0751|13 20|P450BM-3
P07876210A0751|71 78|P450BM-3
P07876210A0751|82 86|Bm3P1
P07876210A0751|124 135|P450BM-3 gene
P07876562A1646|128 132|HIV-1
P07877619A1284|48 70|RA-stimulated zif268 gene
P07877619A1284|99 104|29 base
P07877619A1284|150 168|RA-responsive region
P07877619A1284|174 183|zif268 gene
P07878029A0721|10 14|CBF-A
P07878029A0721|18 22|CBF-C
P07878029A0721|51 68|CBF-A-CBF-C complex
P07878029A0721|76 80|CBF-B
P07878029A0721|100 104|CBF-A
P07878029A0721|107 111|CBF-C
P07878029A0721|150 167|CBF-A-CBF-C complex
P07878040A0505|46 58|mouse enhancer
P07879204T0000|0 3|OKT3
P07879204T0000|148 149|US
P07880442A0236|8 14|PKC beta
P07880442A0236|75 84|S1 nuclease
P07880449A0091|57 59|ICR
P07880449A0091|149 153|15 cGy
P07880650A0493|172 186|crotoxin complex
P07881077A0195|0 29|Supplementary Phase Contraste RSE
P07881077A0195|30 36|("Rapid
P07883167A0157|24 27|UPF1
P07883167A0157|31 39|UPF3 genes
P07883167A0157|173 196|nonsense-containing mRNAs
P07883168A0090|11 14|UPF1
P07883168A0090|48 52|mRNAs
P07883168A0090|125 129|mRNAs
P07883193A0000|1 3|DNA
P07883193A0000|23 39|DNA-binding domain
P07883193A0000|119 125|pGEX-KT
P07883193A0000|175 198|glutathione S-transferase
P07883754A0993|29 33|HepG2
P07883754A0993|107 109|NRE
P07885999A0000|72 90|mouse tyrosinase gene
P07887226A0858|60 83|serum transferrin receptor
P07887226A0858|215 217|IDA
P07887859A0315|51 55|tcPO2
P07887859A0315|84 88|(ABI)
P07887859A0315|104 108|(TBI)
P07887859A0998|0 4|TcPO2
P07888306A1659|18 22|COS-1
P07888306A1659|60 61|IV
P07888306A1659|62 64|PDE
P07888306A1659|79 82|cAMP
P07888306A1659|90 93|cGMP
P07888306A1659|148 155|Ca2+/CaM
P07888306A1659|158 161|cGMP
P07888306A1659|198 215|rolipram.(ABSTRACT
P07888306A1659|216 224|TRUNCATED
P07888306A1659|221 222|AT
P07888306A1659|227 235|400 WORDS)
P07888623A0721|0 4|PMEK1
P07888623A0721|48 58|tobacco NTF3
P07888623A0721|62 85|Arabidopsis ATMPK1 kinases
P07888623A0721|122 141|plant MAP kinase MsERK1
P07888629A0344|48 53|MsPRP2
P07888629A0344|176 223|cysteine-rich carboxyl-terminal sequence homologous
P07888828A0765|43 54|RH-like genes
P07890485A0827|35 52|(photoreceptor) QO2
P07890485A0827|104 106|QO2
P07890599A0132|17 25|mouse cDNA
P07890599A0132|37 40|MIN6
P07890599A0132|117 120|cDNA
P07890599A0132|180 200|munc-18/n-Sec1/rbSec1
P07890674A0916|17 19|APC
P07890674A0916|54 56|APC
P07890680A1193|18 34|core DNA polymerase
P07890680A1193|35 37|III
P07890740A0997|3 10|PSD2 gene
P07890740A0997|104 123|10-fold increase in PSD
P07891685A1051|23 35|gluconeogenic
P07891685A1051|100 106|release
P07891685A1051|109 120|Cat4p (Mig1p)
P07891685A1051|128 139|CAT8 promoter
P07891708A0690|5 12|po, HNF-4
P07891708A0690|42 46|Hep3B
P07891708A0690|60 63|HeLa
P07891708A1192|42 51|endogenous
P07891708A1192|52 58|Epo gene
P07891708A1192|86 90|Hep3B
P07891708A1192|117 121|HNF-4
P07891713T0000|74 78|NF-E2
P07891720A0818|26 28|C1F
P07892076A0578|37 50|infection (P-2)
P07892353A0667|50 53|rCBF
P07892353A0667|174 185|brain regions
P07894021A1130|36 38|DS2
P07894021A1130|69 71|DNA
P07894359T0000|45 46|RU
P07894761A0000|84 98|hemorrhage (ECH)
P07896088A0720|74 77|RAP1
P07896088A0720|89 98|factor RIF1
P07896088A0720|90 110|actor RIF1: rap1 alleles
P07896088A0720|146 167|RIF1 interaction domains
P07896291A0693|42 52|cytogenetic
P07896291A0693|127 130|WAGR
P07896615A0554|129 131|NIR
P07896817A0204|50 68|VEGF-stimulated BAEC
P07896817A0204|83 113|phospholipase C-gamma (PLC-gamma)
P07896817A0204|132 149|SDS-polyacrylamide
P07896817A0204|184 194|Immobilon-P
P07896846T0000|79 94|suppressor region
P07896846T0000|105 115|beta-myosin
P07896846T0000|121 129|chain gene
P07896852T0000|45 64|apolipoprotein AI gene
P07897359A0354|55 60|BHK-21
P07897359A0354|64 67|HeLa
P07897359A0354|96 129|vaccinia virus-encoding T7 polymerase
P07897696A0000|0 51|Erythrocyte delta-aminolevulinic acid dehydratase (ALAD)
P07897696A0000|90 99|(ZPP)/heme
P07897696A0000|116 133|coproporphyrin (UC)
P07898275A0254|73 78|31P MRS
P07898275A0254|161 181|volume-selection 1H MRS
P07898275A0254|267 270|ISIS
P07898275A0254|301 306|31P MRS
P07898840X0000|80 88|OBJECTIVE
P07898840X0000|246 267|growth restriction (FGR)
P07899581A0000|55 78|superoxide dismutase (SOD)
P07899581A0000|112 130|superoxide dismutase
P07899634A0000|0 6|PURPOSE
P07901121T0000|31 47|class homeo domains
P07901121T0000|50 52|DNA
P07901125A0416|32 49|aa sequence homology
P07901125A0416|57 62|DAHPSs
P07901125A0416|90 103|ARO3 homologues
P07901125A0416|111 120|pathogenic
P07902532A0312|29 34|BOX DNA
P07902532A0312|63 89|thymidine kinase (TK) promoter
P07902532A0312|99 100|EC
P07902532A1655|60 68|BOXF1 gene
P07902532A1655|82 87|BOX DNA
P07902532A1655|121 122|EC
P07902583A0545|45 65|Grf10-Swi5-DNA complex
P07902583A0545|89 108|protein-DNA complexes
P07903099A0918|42 50|IVS2C beta
P07903670A1202|20 37|alpha 1-tubulin gene
P07905413A0585|108 109|ST
P07905413A0585|210 211|(P
P07905453A0281|89 97|447-bp ORF
P07906265A0897|60 63|fasD
P07907846A0623|55 68|cholinesterase
P07908012A0678|27 30|LNNB
P07908012A0678|172 175|LNNB
P07908187T0000|0 3|ISIS
P07908827A1200|59 65|RAR beta
P07908827A1200|77 96|DNA-protein complexes
P07908827A1200|132 135|RARs
P07908827A1200|149 151|COS
P07908827A1200|212 214|RAR
P07910716A0359|47 53|SC rIL-2
P07910716A0359|78 86|IU/m2/day
P07910716A0359|140 149|rIFN-alpha
P07910716A0359|231 242|SC rIFN-alpha
P07910716A0359|281 287|SC rIL-2
P07910716A0359|306 314|IU/m2/day
P07910946A0323|84 95|reporter gene
P07910946A0323|135 157|182-bp 5'-flanking region
P07910946A0323|188 202|IL-2-stimulated
P07911736A1715|5 7|MTD
P07912123A0711|0 14|Mitogen-induced
P07913080A0564|1 40|decanucleotide promoter sequence homologous
P07913080A0564|108 116|horse gene
P07913891A0174|130 137|Hox genes
P07913926A0878|18 20|RNA
P07913926A0878|67 70|ntcA
P07913926A0878|99 109|glnA message
P07914192A0211|0 3|HER2
P07914192A0211|45 49|DNase
P07914192A0211|106 131|ets response element (GAGGAA)
P07914192A0211|140 146|38 bases
P07914192A0211|165 168|CAAT
P07914192A0211|190 193|TATA
P07914192A0211|207 218|HER2 promoter
P07914192A0844|72 93|0.125-kb promoter region
P07914192A0844|104 128|ETS-immunoreactive complex
P07914192A0844|172 175|HER2
P07914192A0844|215 235|GAGGAA response element
P07914507A1029|12 15|cDNA
P07914507A1029|43 46|mRNA
P07914507A1029|84 99|poly(A)-addition
P07914700A0000|13 53|RNA-dependent eIF-2 alpha protein kinase (PKR)
P07914700A0000|81 83|DNA
P07916003A0688|12 20|mouse gene
P07916003A0688|48 56|CD79 alpha
P07916003A0688|62 66|a TATA
P07916003A0688|85 98|mouse CD79 alpha
P07916003A0688|110 121|octamer motif
P07916326A0000|79 104|homeodomain-containing gene
P07916327A0250|32 49|goosecoid gene (GSC)
P07916577A0190|24 37|candidate genes
P07916577A0190|140 165|zinc finger-containing cDNAs
P07916588A0471|41 71|passion fruit woodiness virus (PWV)
P07916588A0471|83 84|CP
P07916588A0471|117 119|CPs
P07916588A0471|145 147|PWV
P07916588A0471|206 208|PWV
P07916685A0455|23 44|arogenate dehydrogenase
P07916685A0455|53 75|prephenate dehydrogenase
P07916689A0312|11 14|POT1
P07916689A0312|37 41|kb RNA
P07916689A1407|22 29|POT1 gene
P07916689A1407|89 91|DNA
P07916689A1407|105 123|. lipolytica LEU2 gene
P07916729T0000|1 19|leucine zipper domain
P07916983A0623|17 18|CT
P07916983A0623|58 73|N1-N3 neck disease
P07917016A0581|12 22|DNA-binding
P07917016A0581|13 39|NA-binding, zinc finger domain
P07917540A0000|76 91|interferon-alpha
P07918097T0000|8 21|Notch homologue
P07918128A0000|0 9|BACKGROUND
P07918128A0000|38 40|MDL
P07918128A0000|41 48|73,147EF
P07918128A0000|54 87|5 hydroxytryptamine 3 (5-HT3) receptor
P07918128A0000|120 129|emetogenic
P07918494A1163|51 70|thioredoxin reductase
P07918494A1163|75 80|NADPH)
P07918494A1163|135 146|0.6-0.8 dCTPs
P07919540A0240|98 105|AUG codon
P07919540A1119|52 56|c-Myc
P07919540A1119|89 115|a Myc/Max-responsive reporter
P07925022A0285|35 37|CNS
P07925097A1205|14 15|AR
P07925097A1205|36 40|COS-1
P07925097A1205|74 82|8-Br-cAMP
P07925282A0705|58 60|SRP
P07925282A0705|135 136|ER
P07926729A0000|76 84|oncogenic
P07926739A0766|22 24|GL2
P07926739A0766|103 112|progenitor
P07926748A0383|0 3|NOT4
P07926748A0383|17 20|NOT1
P07926748A0383|24 27|NOT3
P07926748A0383|68 71|NOT3
P07926748A0383|74 77|NOT4
P07926749A0471|66 73|ROR alpha
P07926749A0471|78 94|ROR alpha 2 isoforms
P07926749A0471|99 101|DNA
P07926749A0471|114 136|hormone response elements
P07926749A0471|148 158|6-bp AT-rich
P07926749A0471|177 207|half-site core motif PuGGTCA (RORE)
P07926774A0652|3 25|p73pct1/p85cdc10 complex
P07926774A0652|53 55|MCB
P07926774A0652|62 64|SCB
P07926774A0652|67 69|E2F
P07926789A0960|3 5|DNA
P07926789A0960|27 34|lacZ gene
P07926789A0960|67 77|fusion genes
P07927130A0625|0 2|CMV
P07927130A0625|31 39|(Cytotect
P07927130A0625|140 149|infiltrate
P07927130A0625|153 159|CMV-DNA
P07927267T0000|65 76|regeneration
P07927711A0698|0 2|ORF
P07927711A0698|67 90|membrane-spanning regions
P07927838A0000|127 137|finger (VWF)
P07928954A0545|0 2|DNA
P07928954A0545|136 159|lipoprotein signal peptide
P07929165T0000|0 2|DNA
P07929165T0000|28 38|actVI region
P07929411A0087|25 35|polypeptide
P07929431A0949|30 48|mouse promoter region
P07929431A0949|60 108|reporter gene chloramphenicol acetyltransferase (CAT)
P07929431A0949|149 153|INS-1
P07929559A0000|20 31|multisubunit
P07929560T0000|19 43|plakoglobin-binding domain
P07931490A0237|0 7|PATIENTS
P07931490A0237|8 10|AND
P07931490A0237|11 17|METHODS
P07932095A0000|34 35|(I
P07932095A0000|37 38|IV
P07932095A0000|42 49|VII-XII)
P07932095A0000|80 82|(II
P07932095A0000|84 86|III
P07932095A0000|88 89|VI
P07932095A0000|89 95|I, XIII)
P07932943A0113|54 108|areness strategy, (2) a non-awareness strategy, (3) a Five-Step
P07933066T0000|62 79|retinoblastoma gene
P07933066T0000|108 112|E2F-1
P07933066T0000|116 119|DP-1
P07933076A0211|18 22|EBNA2
P07933095A0000|22 26|v-Rel
P07933095A0000|52 66|retrovirus Rev-T
P07933095A0000|186 187|(S
P07933101A0131|38 48|TATA element
P07933101A0131|70 89|Tat-induced HIV-1 gene
P07933107A0991|39 45|p54 gene
P07933107A0991|66 69|ASFV
P07933107A0991|77 80|(E70
P07933107A0991|108 117|virus Ba71V
P07933116A0412|3 9|p55 mRNA
P07933116A0412|26 41|non-EBV-infected
P07933116A0412|77 90|cell line (U937)
P07934666A0158|76 80|(T2f)
P07934666A0158|91 95|(T2s)
P07935094A0516|0 6|RESULTS
P07935094A0516|30 32|FDG
P07935094A0516|121 123|FDG
P07935370A0000|26 28|CD4
P07935370A0000|32 34|CD8
P07935375A1197|13 36|dominant-negative ras gene
P07935375A1197|47 56|TIS10/PGS2
P07935379A0347|8 22|tTG-transfected
P07935383A0108|7 11|RNase
P07935383A0108|52 64|64-kDa subunit
P07935383A0108|67 70|CstF
P07935383A0108|95 103|pre-mRNAs
P07935383A0108|106 118|U-rich regions
P07935383A0108|178 198|adenovirus L3 pre-mRNAs
P07935395A0094|19 24|114 kDa
P07935395A0094|41 56|zinc finger motifs
P07935418A0447|6 11|v-erbA
P07935418A0447|29 32|cDNA
P07935418A0447|52 77|45-amino-acid protein, RLD-1
P07935426A0714|30 55|N-terminal zinc finger domain
P07935426A0714|87 97|TdT promoter
P07935447A0972|35 37|USF
P07935447A0972|99 102|MLE1
P07935447A0972|100 108|LE1, HF-1a
P07935447A0972|113 115|PRE
P07935447A0972|153 168|protein complexes
P07935447A0972|210 215|MLC-2v
P07935447A0972|219 246|alpha-myosin heavy-chain genes
P07935451T0000|44 56|NF-kappa B/Rel
P07935451T0000|96 107|I kappa B alpha
P07935451T0000|111 114|RelA
P07935451T0000|143 151|c-rel gene
P07935468T0000|12 20|c-fos gene
P07935468T0000|59 78|growth factor receptor
P07935471A0613|7 16|endogenous
P07935471A0613|17 30|HSF DNA-binding
P07935471A0613|47 64|anti-hHSF1 antibody
P07935471A0613|81 90|Xenopus HSF
P07935471A0613|115 135|mapping regions in hHSF1
P07935471A0613|173 181|monomeric
P07935472A0276|93 108|T-cell line EL4.E1
P07935472A0276|126 135|LVb element
P07935472A0276|197 199|LVb
P07935472A0276|202 211|LVc element
P07935472A0276|221 248|phorbol ester-induced enhancer
P07935472A0790|63 82|DNA-protein complexes
P07935491A0495|5 7|RZR
P07935491A1182|19 34|response elements
P07935491A1182|80 110|acid receptor-retinoid-X receptor
P07935577A0305|125 134|fluid (CSF)
P07935626A1249|26 44|tRNA(trp)(CCA)-gene
P07935997A0000|33 62|immunity--serum immunoglobulins
P07935997A0000|72 86|complexes--were
P07935997A0000|149 155|(Stages
P07935997A0000|156 158|IIB
P07935997A0000|162 166|IIIB)
P07936635A1134|10 13|KRKR
P07936635A1134|16 19|NGER
P07936635A1134|27 30|MO15
P07936640A0900|113 128|TGF alpha promoter
P07936640A0900|192 201|endogenous
P07936650A0656|15 23|subdomain
P07936650A0656|60 85|N-terminal activating region
P07936650A0656|113 115|BEC
P07936650A0656|119 144|Ets-1-beta/Ets-2-Conserved
P07936650A1752|31 47|ets-1/ets-2 gene's
P07937106A0100|3 15|v-ets oncogene
P07937106A0100|61 70|progenitor
P07937108A0325|22 26|mRNAs
P07937108A0325|42 51|endogenous
P07937108A0325|52 64|RNA polymerase
P07937127A0645|40 69|enhancer-type activation domains
P07937132A0819|86 92|28S rRNA
P07937147A0205|75 76|IR
P07937147A0205|80 81|DR
P07937147A0205|82 86|(York
P07937147A0205|93 103|Gene (Amst.)
P07937656A0182|36 57|Kaplan-Meier-estimates
P07937656A0182|61 73|Log-Rank-Test
P07937656A0182|153 155|NSE
P07937656A0182|198 221|serum alkaline phosphatase
P07937841A0790|38 66|p53-induced Waf1/Cip1-mediated
P07937841A0790|108 118|myb oncogene
P07937954A0612|0 2|HBx
P07937954A0612|27 35|GTP-bound
P07937954A0612|108 116|MAP kinase
P07937965T0000|31 53|tumor antigen-induced DNA
P07937965T0000|74 79|3T3-L1
P07941739A0000|67 79|chromosome XIV
P07941750A0344|54 69|hydantoinase HyuA
P07941750A0344|89 103|hydatoinase HyuB
P07942448A1227|20 23|NYHA
P07942448A1227|29 31|III
P07942448A1227|43 54|IV.(ABSTRACT
P07942448A1227|55 63|TRUNCATED
P07942448A1227|60 61|AT
P07942448A1227|66 74|250 WORDS)
P07943556A0694|58 62|Og4C3
P07944461A0321|0 5|TG-day
P07944461A0321|9 16|TG-night
P07945330A0103|31 38|acid (RA)
P07945330A0103|58 66|Rex-1 gene
P07945937A0358|97 105|Egr1 genes
P07947930A0499|3 12|fibrinogen
P07948129A0297|37 49|repeat (chLTR)
P07948129A0297|74 122|chloramphenicol acetyl transferase (CAT) reporter gene
P07948129A0297|149 152|SV40
P07948129A0297|163 176|region promoter
P07948129A0297|188 213|neomycin phosphotransferase
P07948129A0297|214 215|II
P07948129A0297|216 224|(NEO) gene
P07948921A0051|38 73|elicitor-induced stilbene synthase cDNA
P07949137A0000|56 69|bone marrow (BM)
P07949137A0000|89 93|(ASTA
P07949164A0799|29 39|kappa B motif
P07949164A0799|42 49|IL-6/CAT
P07949164A0799|90 101|IL-6 promoter
P07951410A0647|3 6|HeLa
P07951410A0647|45 49|E2F-1
P07951410A0647|46 54|2F-1, DP-1
P07951410A0647|67 68|RB
P07951410A0647|154 164|E2F-1 or DP-1
P07951410A1332|0 2|E1A
P07951410A1332|106 116|E1A promoter
P07953785A0648|104 106|H/L
P07953785A0648|136 154|marble spleen disease
P07954475A0714|57 74|rosses, A/J x C3H/HeJ
P07954475A0714|93 98|AC3F1)
P07954475A0714|102 112|C3H/HeJ x A/J
P07954475A0714|131 136|C3AF1)
P07954475A0714|196 225|chromosome 4 tumor suppressor gene
P07954891T0000|0 3|ERV1
P07956869A0000|177 179|DNA
P07956869A0000|189 195|S-phase
P07957106A0471|38 50|GST-POU fusion
P07957106A0875|49 69|HSV transactivator VP16
P07957106A0875|100 103|VP16
P07957158A1532|13 22|filtration
P07957158A1532|116 125|neurogenic
P07957559A1557|41 54|Ba/F3-EpoRgp55
P07957559A1557|63 65|MEL
P07957559A1557|90 100|p70 S6 kinase
P07957632A0000|27 86|(2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine (DCG-IV)
P07957632A0000|117 134|glutamate receptors
P07958446A0000|20 43|factor-3 (HNF-3)/forkhead
P07958446A0000|163 182|helix DNA binding motif
P07958898A1050|14 23|dTFIIA-L/S
P07958898A1050|121 127|p1, VP16
P07958898A1050|132 136|NTF-1
P07958911A0500|64 75|fork head gene
P07958911A0500|65 92|ork head gene, a region-specific
P07958915A1507|91 94|cAMP
P07958915A1507|159 197|Ca2+/calmodulin-dependent protein kinases
P07958920A1157|28 31|SNM1
P07958920A1157|57 67|RNase MRP RNA
P07958920A1157|147 155|RNase P RNA
P07959011A0379b|0 9|C/EBP alpha
P07959011A0379a|0 9|C/EBP alpha
P07959011A0379b|0 4|C/EBP
P07959011A0379a|0 4|C/EBP
P07959011A0379b|39 55|rat class-I ADH gene
P07959011A0379a|39 55|rat class-I ADH gene
P07959011A0379b|39 51|rat class-I ADH
P07959011A0379a|39 48|rat class-I
P07959011A0379b|39 48|rat class-I
P07959011A0379a|82 88|[Potter
P07959011A0379b|82 88|[Potter
P07959015A0478|21 23|ORF
P07959015A0478|26 30|hAMPK
P07959015A0478|62 65|kDa)
P07959015A0478|90 94|rAMPK
P07959760A0763|14 16|YAC
P07959760A0763|52 55|YACs
P07959760A0763|59 92|orders 19 sequence-tagged sites (STSs)
P07959760A0763|227 229|DNA
P07959760A0763|278 298|icrosatellite, D11S912
P07959760A0763|299 303|(CA)n
P07959760A0763|334 342|Fli-1 gene
P07959952A1446|1 4|cDNA
P07959952A1446|24 33|pseudogene
P07959952A1446|54 74|mouse mast cell chymases
P07959952A1446|88 97|polymerase
P07959953A0423|0 4|IFI16
P07959953A0423|63 73|28 kilobases
P07959953A0423|80 82|DNA
P07961755A0474|41 54|transit peptide
P07961755A0474|65 80|cysteine synthase
P07961957A1565|44 48|TEF-1
P07961957A1565|57 69|HF-1a-related
P07961957A1565|96 117|alpha-MHC gene EM element
P07961958T0000|0 24|Rat kidney carboxylesterase
P07963540A0795|11 23|I-kappa B alpha
P07963540A0795|33 43|kappa B motif
P07963540A0795|61 78|actor-kappa B1, RelA
P07963540A0795|83 87|c-Rel
P07963540A0795|113 114|UV
P07964162A0941|46 54|MAP kinase
P07964458A0179|1 13|candidate gene
P07964458A0179|38 82|resistance-associated macrophage protein (Nramp)
P07964459A0845|38 46|LIM domain
P07964459A0845|53 56|RING
P07964459A0845|93 112|metal-binding regions
P07964624A0491|3 9|P131 ORF
P07964624A0491|37 39|ORF
P07964624A0491|89 107|UGA termination codon
P07964624A0491|113 119|P131 ORF
P07964624A0491|130 140|polypeptide
P07964624A0491|143 158|M(r) 191044 (P191)
P07965152A0764|23 27|BMIPP
P07965152A0764|38 41|MIBI
P07966565A0901|21 24|mRNA
P07966565A0901|68 76|1.9-kb RNA
P07966583A1268|47 49|RNA
P07966583A1268|112 127|Env/Mlvi-4 fusion
P07966583A1268|164 168|33 kDa
P07966873A0693|26 37|heart disease
P07966873A0693|90 103|Chagas' disease
P07967360A1048|42 45|TGBM
P07967360A1048|77 79|IgA
P07967725A0262|85 101|DNA-binding domain
P07967725A0262|106 125|a ligand binding domain
P07968409A0123|23 43|HIV-infected-patients
P07968409A0123|101 108|Diseases
P07968409A0123|125 133|"Ospedale
P07969115A0000|102 112|protein-DNA
P07969115A0000|157 168|500-bp region
P07969115A0000|184 192|D-loop DNA
P07969115A0000|206 220|promoter regions
P07969132A0268|27 40|tRNA(His) genes
P07969135A0913|21 34|Cln2 PEST domain
P07969136A0273|114 121|NF-kappa
P07969136A0273|134 153|kappa light-chain gene
P07969152A0721|9 28|carboxyl-terminal HSF
P07969152A0721|44 59|activation domain
P07969152A0721|88 91|CUP1
P07969181A0313|34 40|CKB mRNA
P07969181A0313|43 46|HeLa
P07969181A0313|123 132|p53 protein
P07969181A0313|140 145|in HeLa
P07969954T0000|34 59|high-titer serum IgM anti-GM1
P07971282A0000|63 70|pre-mRNA
P07971709A0907|39 40|IF
P07971709A0907|56 62|rhG-CSF
P07972012A0956|1 15|full-length cDNA
P07972012A0956|69 74|55-kDa
P07972012A0956|140 168|ANP-receptor kinase-like domain
P07972012A0956|212 242|protein-serine phosphatase domain
P07972237A0665|53 55|DNA
P07972237A0665|78 86|generated
P07972237A0665|89 102|subcloning YACs
P07972831A0563|0 4|PAI-1
P07973364A0325|69 83|carcinogenicity
P07973364A0325|105 135|2400 OFA (Sprague-Dawley-derived)
P07973364A0325|164 170|2400 OF1
P07973364A0325|174 177|NMRI
P07975763A0000|15 34|hepatitis C virus (HCV)
P07975763A0000|61 72|liver disease
P07977239A1283|122 123|II
P07977239A1283|165 166|II
P07977648A0880|15 29|TP53 transcripts
P07978406A0998|5 7|ISO
P07978406A0998|16 22|pre-DEX
P07978406A0998|17 26|re-DEX, CBF
P07978406A0998|48 67|166 +/- 19 mL.min-1.100
P07978406A0998|94 98|(PCO2
P07978406A0998|112 128|90 mmHg).(ABSTRACT
P07978406A0998|129 137|TRUNCATED
P07978406A0998|134 135|AT
P07978406A0998|140 148|250 WORDS)
P07979827A0722|0 6|KRN2391
P07979827A0722|29 50|dose-dependent increase
P07980440A0138|2 6|H4IIE
P07980440A0138|61 86|AMP (cAMP) increase PEPCK gene
P07980669A0373|5 13|plasma AVP
P07980669A0373|23 32|AVP release
P07980669A0373|68 76|plasma NPY
P07981143A0633|40 45|IL-4RE
P07981143A0633|59 62|IL-4
P07981143A0633|84 105|nucleoprotein complexes
P07981246A0112|29 89|pertussis toxin (IAP)-sensitive GTP-binding protein(s) (G-protein)
P07981246A0112|131 143|hormones/IBMX
P07982964A1017|0 2|ATX
P07982964A1017|8 11|PC-1
P07982964A1017|40 56|phosphodiesterase
P07982995A0000|38 89|mouse platelet-derived growth factor (PDGF) beta-receptor
P07982995A0000|107 112|Na+/H+
P07982995A0000|169 175|(NMuMG)
P07982995A0000|186 202|hamster ovary (CHO)
P07983011A0617|28 33|kinase
P07983011A0617|69 91|serine/threonine kinases
P07983011A0617|123 162|ily of microtubule-associated protein kinase
P07983011A0617|128 175|microtubule-associated protein kinase kinase kinases
P07983011A0617|182 211|fibroblast growth factor receptor
P07983011A0617|232 263|alpha-helical leucine zipper motifs
P07983011A0617|326 337|NH2-terminal
P07983011A0617|355 367|COOH-terminal
P07983011A0617|371 401|NH2-terminal proline-rich domains
P07983011A0617|376 400|erminal proline-rich domain
P07983011A0617|414 450|src homology 3 (SH3) domain binding regions
P07983704A0330|135 140|HERV-K
P07983712A0914|28 29|II
P07983715A0996|47 50|NF-Y
P07983715A0996|109 118|P4 promoter
P07983715A0996|160 162|USF
P07983715A0996|217 238|luciferase reporter gene
P07983716A1082|13 25|Northern (RNA)
P07983716A1082|48 65|transcriptase-PCRs
P07983716A1082|94 98|COS-7
P07983716A1082|101 104|HeLa
P07983716A1082|124 127|RNAs
P07983716A1082|140 143|Y88S
P07983716A1082|147 154|Y88L RNAs
P07983744A0920|27 31|IE110
P07983744A0920|65 69|IE175
P07983744A0920|121 125|IE110
P07983744A0920|155 159|IE175
P07984088A0592|66 78|virulence gene
P07984088A0592|113 116|PrfA
P07984105A1509|31 36|WA fyuA
P07984105A1509|54 61|fyuA gene
P07984261A0536|3 6|ICBF
P07987924A0670|56 70|USCI Tuohy-Borst
P07988559A0836|20 24|RBP-J
P07988730A0220|63 70|U5 region
P07988730A0220|76 78|LTR
P07988730A0220|92 128|chloramphenicol acetyltransferase (CAT)
P07988730A0220|158 161|HeLa
P07988731A0002|110 127|cis-acting elements
P07988731A0002|174 188|G-box (CCACGTGG)
P07988731A1301|27 30|GF14
P07988731A1301|69 85|GBF protein complex
P07990136A1124|50 55|polIII
P07990136A1124|83 90|tRNA gene
P07990136A1124|184 189|polIII
P07991582A1023b|20 28|yeast CEG1
P07993559A0233|12 21|(Fluorosis
P07994021A1223|64 78|PECAM-1 isoforms
P07995173A0585|42 48|juice pH
P07997174A0936|93 107|. vinelandii NifL
P07999066A0238|9 11|HIV
P07999066A0238|53 55|LTR
P07999066A0238|74 81|IL-2 gene
P07999066A0238|142 148|tat gene
P07999066A0238|218 270|IL-2 promoter-chloramphenicol acetyltransferase reporter
P07999363A0000|35 64|transmembrane FGF receptor (FGFR)
P07999363A0000|94 103|ectodomain
P07999363A0000|118 136|juxtamembrane domain
P07999363A0000|157 168|kinase domain
P07999982A0086|32 35|FRDA
P07999982A0086|39 42|D9S5
P07999982A0086|53 56|FRDA
P07999982A0086|60 64|D9S15
P07999995A0000|1 26|receptor-like protein kinase
P07999995A0000|2 33|eceptor-like protein kinase, OsPK10
P07999995A0000|56 61|(Oryza
P08000074A0162|120 124|kb DNA
P08000427A0000|1 13|cDNA clone pCZ1
P08000427A0000|48 74|NaCl-adapted tobacco cell cDNA
P08000427A0000|105 120|full-length 29 kDa
P08000427A0000|158 159|pI
P08000497A0179|0 10|METHODS--16
P08000497A0179|120 127|gas (VTG)
P08001136T0000|14 33|CDK-activating kinase
P08001136T0000|37 49|RNA polymerase
P08001136T0000|50 51|II
P08001136T0000|52 71|CTD kinase TFIIH/TFIIK
P08001792A0284|30 39|git10 genes
P08001792A0284|53 68|adenylate cyclase
P08001792A0284|90 105|adenylate cyclase
P08001966A0563|58 68|roteins, CNC
P08002564A0249|0 2|DNA
P08002564A0249|57 72|C-terminal region
P08002564A0249|78 89|alpha subunit
P08002564A0249|130 149|histidine (rpoAL290H)
P08002857A1070|0 10|CONCLUSIONS
P08003700T0000|36 39|cDNA
P08003700T0000|137 140|atpA
P08004442A0265|99 132|hypothalamo-pituitary-adrenal (HPA)
P08005230A0222|9 20|reporter gene
P08005230A0222|50 60|EPO-induced
P08005230A0222|76 88|c-fos promoter
P08005230A0222|146 155|luciferase
P08005412A0608|71 85|a protein complex
P08005412A0608|116 117|PS
P08005412A0608|169 171|DNA
P08005438A1185|0 4|SPP41
P08006773A0836|44 47|PGI2
P08006773A0836|60 63|TxA2
P08006773A0836|181 184|PGI2
P08006773A0836|220 223|TxA2
P08007835A0538|59 60|FB
P08007954A0374|32 46|response element
P08007975A0000|3 10|IPL1 gene
P08011017A0169|8 29|oxygen saturation (SaO2)
P08011017A0169|80 84|(EEG)
P08011166A0207|116 125|polymerase
P08012448T0000|0 3|INO2
P08013348A0143|9 12|ABPs
P08013348A0143|16 20|SHBGs
P08013457A0342|0 20|Src homology (SH) domain
P08013457A0342|71 92|tyrosine kinase receptor
P08014228A0278|64 72|labetalol
P08014919A0530|149 151|DGR
P08015672A1282|55 56|II
P08015672A1282|71 73|III
P08015672A1282|75 76|IV
P08016102A1238|73 80|NF-kappa
P08016102A1238|85 88|AP-2
P08016102A1238|201 204|HO-1
P08017290A1347|67 68|pH
P08017290A1347|68 73|H, PCO2
P08020702A0000|57 77|shock pathogenetically
P08020806A0187|62 75|Crohn's disease
P08020962A1226|24 28|V beta
P08020962A1226|69 79|DNA elements
P08020962A1226|100 102|MER
P08020962A1226|112 137|retrovirus-related elements
P08021175A0486|3 6|pexB
P08021175A0486|98 108|AMP receptor
P08021177A0000|3 11|fepA-entD
P08021177A0000|15 29|fes-entF operons
P08021225A0000|33 46|EcoRI-fragment
P08021225A0000|49 59|Alcaligenes
P08021225A0000|104 144|dihydrolipoamide dehydrogenase-specific DNA
P08021225A0000|150 151|(A
P08022212A0071|38 40|(AC
P08022212A0071|77 100|admittance locus plot (ALP)
P08022212A0071|106 124|low-frequency region
P08022212A0071|207 252|requency-independent parameters; phase angle alpha
P08022212A0071|299 302|1/R0
P08025669A0724|30 33|rpoN
P08028671A0687|34 41|anti-CBP
P08028671A0687|94 97|cAMP
P08029001A1020|67 79|RNA polymerase
P08029001A1020|80 81|II
P08029334T0000|32 46|acid desaturases
P08030239A0833|38 39|IE
P08030239A0833|40 50|polypeptide
P08030239A0833|58 59|IE
P08030239A0833|126 142|activation domain)
P08030239A0833|167 181|EHV-1 tk promoter
P08030239A0833|221 235|EHV-1 IE promoter
P08030243A1011|12 27|NS35-specific RNA
P08030243A1011|74 84|RNA-binding
P08030243A1011|118 121|NS35
P08030704A1503|0 9|CONCLUSION
P08030704A1503|62 90|progesterone/17 beta-estradiol
P08034318A0724|76 78|UBE
P08034318A0724|129 132|NF-1
P08034486A0579|14 18|HSV-2
P08034486A0579|27 54|subjects (HSV-2/HSV-1 antibody
P08034680A0180|19 25|zeta PKC
P08034680A0180|35 42|NF-kappa
P08034680A0180|88 100|I kappa B kinase
P08034680A0180|129 133|50 kDa
P08034682T0000|27 69|inositol 1,4,5-trisphosphate receptor subunits
P08034682T0000|72 74|3T3
P08034708A0000|32 42|progenitors
P08034708A0000|85 108|eosinophil-specific genes
P08035498A0833|60 71|A stem element
P08035498A0833|96 113|AAV promoter regions
P08035499A0941|125 144|protein-DNA complexes
P08035499A0941|196 197|TR
P08035505A0586|15 21|NS3'-5B
P08035517A0753|31 35|IEP86
P08035517A0753|77 81|IEP72
P08035796A0890|0 3|32Pi
P08035796A0890|43 52|eIF-2 alpha
P08035796A0890|68 79|casein kinase
P08035796A0890|80 81|II
P08035796A0890|119 128|eIF-2 alpha
P08035796A0890|165 174|eIF-2 alpha
P08035833A1556|5 8|YMIP
P08035833A1556|31 34|RMIP
P08036004A0292|3 10|R2 region
P08037338A0000|0 6|PURPOSE
P08037338A0000|31 49|erythropoietin (EPO)
P08037338A0000|73 84|pathogenesis
P08037338A0000|117 119|EPO
P08039422A0000|3 33|nerve growth factor beta gene (NGFB)
P08040336A0435|23 44|lement, collagen element
P08040336A0435|84 104|LAP binding cis-element
P08040336A0435|110 124|albumin promoter
P08040391T0000|37 43|(Ag-NOR
P08040468A0303|54 65|pathogenesis
P08041362T0000|19 38|cysteine synthase cDNA
P08041793A0242|122 131|enes, COX5b
P08043523A0000|53 80|acetylcholine receptor (nAChR)
P08044794A0000|42 44|p53
P08044800A0550|4 24|DNA containing promoter
P08044802A0462|111 117|p53 gene
P08044802A0462|128 131|p53-
P08045431A0894|0 3|HupI
P08045834A0783|3 5|PCr
P08045834A0783|21 22|(P
P08045834A0783|70 72|ATP
P08045834A0783|82 83|(P
P08048582A0821|16 19|MVO2
P08048582A0821|54 56|CFX
P08048582A0821|111 119|LAD region
P08048916A0000|0 2|IGF
P08048916A0000|7 22|insulin receptors
P08049444A0351|60 64|98-kD
P08049444A0351|115 144|A-T-rich binding protein 1 (SATB1)
P08049444A0351|175 207|matrix/scaffold-associated regions
P08049444A0351|210 223|DNA (MARs/SARs)
P08049885T0000|19 36|multisystem disease
P08051059A1000|24 35|rhlA promoter
P08051059A1000|99 102|RhlR
P08051074A0000|70 110|mmunodeficiency virus, type 1 (HIV-1) promoter
P08051074A0000|136 140|DNase
P08051102A0532|20 25|rAC-st
P08051102A0532|37 52|chain phosphatase
P08051102A0532|70 88|B subunit-containing
P08051151A0347|46 49|mRNA
P08051151A0347|72 95|transcription-polymerase
P08053697A0000|0 9|BACKGROUND
P08053697A0000|10 12|AND
P08053697A0000|13 18|DESIGN
P08054281A0731|19 28|201Tl SPECT
P08054281A0731|157 161|201Tl
P08055939A0159|80 102|carboxyl-terminal domain
P08055939A0159|121 136|hexapeptide motif
P08055939A0707|72 87|Arabidopsis genes
P08055939A0707|165 175|domain (exon
P08055941A1264|31 42|beta subunits
P08055941A1264|48 62|artifactual beta
P08055941A1264|92 101|alpha 3 beta
P08056474A0438|7 10|NMSC
P08057356A0531|34 51|substitution (V88A)
P08057356A0531|80 95|regulator) region
P08057356A1824|20 39|operon control regions
P08057356A1824|62 65|NarL
P08057421A1583|90 93|CBF1
P08057421A1583|119 122|CBF1
P08057421A1583|145 159| the CD23 promoter
P08057421A1583|148 159|CD23 promoter
P08057421A1583|166 173|EBV LMP-1
P08057762A0878|46 48|(T1
P08057762A0878|112 114|(T1
P08057833A0573|6 9|ParA
P08057833A0573|90 100|start codons
P08058948A0810|0 9|CONCLUSION
P08058948A0810|91 93|CRF
P08062824A0626|28 34|FKBP-33
P08062824A0626|51 83|peptidyl-prolyl cis-trans isomerase
P08062824A0626|134 140|FKBP-12
P08062833A0000|57 71|mouse desmin gene
P08062833A0000|87 94|E box (E1)
P08062833A0000|115 138|helix-loop-helix myogenic
P08063108A0109|3 10|acfD gene
P08063766A0595|14 15|II
P08063766A0595|16 18|PKC
P08063766A0595|75 82|alpha PKC
P08063766A0595|95 101|kinases
P08063775T0000|23 55|hormone-related protein (PTHrP) gene
P08063791A1370|40 70|carboxyl-terminal sequence motifs
P08063836A0904|14 18|c-Abl
P08063836A0904|76 78|DNA
P08063836A0904|88 92|c-Abl
P08065310A1144|91 108|receptor-inhibitor
P08065310A1144|168 179|receptor gene
P08065324A0458|29 38|snRNA genes
P08065324A0458|73 75|USE
P08065324A0458|79 90|TATA elements
P08065327A0000|9 11|DNA
P08065331A0279|56 58|DNA
P08065331A0279|89 100|wild-type HLF
P08065331A0279|112 118|E2A-HLF
P08065338T0000|25 53|proline-rich activation domains
P08065365A0000|23 46|ribonucleoprotein (snRNP)
P08065365A0000|52 59|pre-mRNA
P08065901A0997|25 34|KRAB domain
P08065901A0997|47 62|non-finger region
P08065901A0997|69 76|ZFP genes
P08065901A0997|156 167|KRAB-A domain
P08067013T0001|27 47|creatine phosphokinase
P08067013T0001|78 94|non-coronarogenic
P08067123A0248|49 70|assay systems ORTHO ELISA
P08067123A0248|74 90|ABBOTT HCV EIA (USA)
P08067123A0248|110 124|anti-HCV-C100-3
P08067123A0248|195 199|HBsAg
P08067123A0248|232 246|anti-HCV-C100-3
P08067546A0000|67 71|(ETO)
P08067546A0000|68 85|ETO), propofol (PRO)
P08067546A0000|90 110|sodium thiopental (STP)
P08067546A0000|165 183|oxide (NO)-dependent
P08067607A0568|24 26|CBC
P08067607A0568|37 44|serum CRP
P08069298A0492|44 46|RNA
P08069298A0492|132 155|leptomeningeal cells (LMC)
P08069427T0000|0 8|Roux-en-Y
P08070004A0782|32 34|PCZ
P08070004A0782|96 101|alpha)
P08070004A0782|140 154|135-180 mg/m2 PCZ
P08070393A0631|25 35|100 ng/ml EGF
P08070654A0000|0 3|KAR1
P08070654A0000|48 60|pole body (SPB)
P08070654A0000|90 92|SPB
P08070654A0574|0 4|CDC31
P08070654A0574|18 20|SPB
P08070654A0574|91 108|caltractin/centrin
P08071356A0232|40 42|DNA
P08071356A0232|109 130|transcription complexes
P08071982T0000|18 31|skeletogenital
P08072352A0567|119 121|IgE
P08072547T0000|0 4|c-Fos
P08072547T0000|40 67|H-Ras-activated protein kinase
P08072547T0000|80 82|JNK
P08072547T0000|86 88|ERK
P08072547A0690|7 43|ultra-violet-responsive protein kinases
P08072547A0690|61 65|c-Jun
P08072547A1009|33 35|JNK
P08072547A1009|57 61|c-Jun
P08072547A1009|75 79|c-Fos
P08072547A1009|94 109|activation domain
P08072547A1009|125 129|c-Fos
P08073505T0000|4 13|generation
P08073505T0000|70 78|ExPASy WWW
P08075070A1632|43 45|DNA
P08075070A1632|86 101|repressor domains
P08075070A1632|109 126|sequence homologies
P08075070A1632|134 160|helix-turn-helix (HTH) motifs
P08075070A1632|168 178|DNA-binding
P08075421A0621b|10 12|ORF
P08075421A0621a|10 12|ORF
P08075421A0621b|50 54|HrpJ2
P08075421A0621a|50 54|HrpJ2
P08076631A0000|12 34|transcription factor AP-1
P08076631A0000|38 58|vitamin D receptor (VDR)
P08076631A0000|73 76|AP-1
P08076631A0000|81 119|vitamin-D-responsive promoter region (AP-1
P08076631A0000|121 125|VDRE)
P08076631A0000|136 150|osteocalcin gene
P08076631A0000|167 196|in osteocalcin-producing (MG-63)
P08076631A0000|200 218|non-producing (U2-Os
P08076631A0000|201 226|on-producing (U2-Os, SaOs-2)
P08076937A0851|62 74|PCR-amplified
P08076937A0851|82 84|DNA
P08076937A0851|136 141|a Tru9I
P08077236A0243|17 24|Epo cDNAs
P08077236A0243|63 66|COS1
P08077236A0243|70 73|COS7
P08078167A0000|0 12|OBJECTIVE--To
P08078473A1107|12 20|ME31B cDNA
P08079268T0028|5 17|Medi-Jector EZ
P08082215A0230|65 68|RTID
P08082292T0000|7 8|NK
P08082292T0000|46 49|HIV-
P08082360A0411|22 43|oxygen saturation (SaO2)
P08082440A0339a|0 2|(LH
P08082440A0339a|10 15|LH/FSH
P08083011A0584|72 74|R-L
P08083011A0584|95 96|RH
P08083011A0584|111 113|R-L
P08083011A0584|156 168|ales, estrogen
P08083220A0988|75 92|c-fos protooncogene
P08083220A0988|161 183|serum response factor-DNA
P08083963A0795|3 13|LTR-binding
P08083963A0795|26 28|VBP
P08083963A0795|27 35|BP, a1/EBP
P08083963A0795|91 103|el shift, DNase
P08083998A1723b|23 39|leader-mRNA fusion
P08083998A1723a|23 39|leader-mRNA fusion
P08083998A1723b|23 33|leader-mRNA
P08083998A1723a|23 33|leader-mRNA
P08083998A1723b|86 92|RNA-RNA
P08083998A1723a|86 92|RNA-RNA
P08083999A0501|32 48|full-length HPV-16
P08083999A0501|52 56|BPV-1
P08083999A0501|114 116|(Kd
P08084339A0907|85 100|J alpha 11-2 region
P08084339A0907|145 159|TCR C alpha region
P08084339A0907|182 204|a 36 amino acid polypeptide
P08084592A0145|2 5|HeLa
P08085228A0000|119 144|immunodeficiency virus (HIV)
P08085609A0384|19 24|KNM-LU
P08085782A0164|10 16|49 cases
P08086450A0467|40 56|5'-flanking region
P08086450A0467|62 70|hATP1 gene
P08086450A0467|87 106|guanine-cytosine (GC)
P08086450A0467|134 146|binding motifs
P08086450A0467|179 185|p1, AP-2
P08086450A0467|190 192|GCF
P08086453T0000|1 17|tructure, promoter
P08086453T0000|60 67|APEX gene
P08087887A1067|3 19|polyubiquitin gene
P08087887A1067|76 85|1.6-kb mRNA
P08088022A1417|56 67|heart disease
P08088022A1417|76 87|pathogenetic
P08088513A0419|89 92|DEAH
P08088513A0419|131 136|snRNAs
P08088777A0754|3 15|consensus gene
P08088777A0754|60 147|D2Mit1-(Dbh,Notch1)-(Col5a1,Rxra)-Spna2-Ab l-(Ak1,Fpgs)- (Grp78,Pbx3)-(Epb7.2,Hc,Gsn)-Acra
P08088818A1053|58 61|YACs
P08088818A1053|140 148|RAD52 gene
P08089184A0825|14 27|megabase region
P08089184A0825|42 45|dagA
P08089887A0742|0 8|SECONDARY
P08089887A0742|9 36|OUTCOME MEASURE--Double-blind
P08090746A1288|2 23|8-bp sequence (ATTTCAAA)
P08090746A1288|134 159|tomato fruit-ripening E4 gene
P08090767A0000|21 33|DNA polymerase
P08090767A0000|163 171|exogenous
P08090767A0000|172 174|DNA
P08091655A0000|19 47|Marek's Disease Virus (MDV) genes
P08091655A0000|57 63|EcoRI-B
P08091655A0000|74 79|MDV-GA
P08091655A0000|87 89|DNA
P08091665T0000|78 79|II
P08091665T0000|80 90|TNF receptor
P08091669A0828|37 47|39k promoter
P08091669A0828|62 64|IE1
P08091669A0828|117 127|ie1 promoter
P08093450A0688|0 10|Mutagenesis
P08093450A0688|17 26|NRF-1 motif
P08093450A0688|32 43|ALAS promoter
P08093450A0688|76 107|chloramphenicol acetyltransferase
P08093450A0688|126 136|mutagenesis
P08093450A0688|143 153|NRF-1 motifs
P08093616T0000|5 10|8-base
P08093616T0000|23 33|(Drosophila
P08093616T0000|34 63|DNA replication-related element)
P08093616T0000|131 148|DNA polymerase alpha
P08093616A1214|0 4|DNase
P08093616A1214|39 42|DREF
P08093616A1214|53 66|24-bp DRE region
P08093616A1214|72 93|DNA polymerase alpha gene
P08093642A0600|73 75|RET
P08093642A0600|175 180|D10S94
P08093642A0600|206 227|high-resolution genetic
P08094464A0869|8 11|tyrA
P08094464A0869|96 99|aroF
P08094464A2014|15 30|attenuator region
P08094464A2014|68 71|mRNA
P08094464A2014|142 158|looped-out regions
P08094927A0311|39 40|6K
P08094927A0311|60 66|release
P08095872A1672|117 125|LONG/CIRC
P08095875T0000|54 58|He-O2
P08096066A0623|3 6|RFLP
P08097732A0000|21 47|ectoderm-specific Spec2a gene
P08097732A0000|137 156|sequence element (RSR)
P08097732A0000|174 189|Spec1/Spec2 genes
P08098228A0625|38 40|PPO
P08098914A0400|18 24|Pes-Ves
P08098914A0400|89 94|(Ees)]
P08098914A0400|129 139|(SD) mmHg/ml
P08098914A0400|140 141|(P
P08099443A0359|10 12|HRI
P08099443A0359|16 23|dsRNA-PK
P08099443A0359|37 51|yeast eIF-2 alpha
P08099443A0359|96 99|GCN2
P08099443A0359|118 121|GCN4
P08100057A0577|58 70|CD68-positive
P08100057A0577|85 98|XIIIa-positive
P08100765A0361|25 33|transgene
P08100843A0134|25 27|DNA
P08100843A0134|87 95|mCD22 cDNA
P08100843A0134|132 136|mCD22
P08100843A0134|146 153|copy gene
P08101134A0376|19 28|plasma ACTH
P08101134A0376|65 68|MPTP
P08101839A0000|48 55|mdr1 gene
P08101839A0000|73 84|mdr1 promoter
P08101843A0151|3 29|tyrosine hydroxylase gene (TH)
P08101843A0151|52 63|consensus CRE
P08101843A0151|71 77|-38 base
P08102364A0000|34 43|(Nicotiana
P08103379A0577|45 54|MADS domain
P08103935T0000|30 32|SRF
P08104189A1168|21 30|(a) proSRIF
P08104189A1168|55 57|TGN
P08104189A1168|93 94|pH
P08104189A1168|116 150|Golgi-associated vacuolar-type ATPase
P08105727A0099|12 27|dopamine receptor
P08105994T0000|32 61|serum gamma-glutamyl transferase
P08106087A0139|26 38|27 kDa zein gene
P08106087A0139|47 57|AATAAA-like
P08106087A0139|101 107|GT-rich
P08106313A1492|22 26|hrpRS
P08106313A1492|30 33|hrpL
P08106313A1492|68 71|HrpR
P08106313A1492|75 78|HrpS
P08106313A1492|99 102|hrpL
P08106313A1492|106 109|HrpL
P08106313A1492|151 170|HrpL-responsive genes
P08106325A0000|0 3|DtxR
P08106325A0000|8 49|iron-dependent sequence-specific DNA-binding
P08106325A0000|140 158|diphtheria toxin gene
P08106369A0000|0 15|Vasopressin (AVP)
P08106369A0000|49 59|nonapeptide
P08106369A0000|108 124|membrane receptors
P08106369A0000|166 169|(V1a
P08106398A1003|38 50|leader peptide
P08106512A0522|7 20|promoter region
P08106512A0522|47 58|reporter gene
P08106512A0522|74 87|promoter region
P08106512A0522|105 132|interferons (interferon-alpha
P08107167A0222|0 5|Anti-B
P08107167A0222|1 17|nti-B. burgdorferi
P08107167A0222|19 24|anti-B
P08107167A0222|38 43|anti-B
P08107167A0222|99 108|assay (IFA)
P08107167A0222|178 184|IFA-ABS
P08107208A0673|88 107|EBV cosmid-cloned DNAs
P08107208A0673|108 109|(B
P08108343A0000|25 36|antiandrogen
P08108343A0000|57 60|GnRH
P08108413A0964|90 93|PANG
P08111035A0098|37 49|872 bp promoter
P08111035A0098|61 78| B. napus oleosin gene
P08111035A0098|103 125|beta-glucuronidase (GUS)
P08111035A0098|171 191|an oleosin promoter-GUS
P08111974A1034|36 37|CX
P08111974A1034|62 72|tubulin mRNA
P08112870A0484|56 58|SOD
P08112870A0484|139 143|29 kDa
P08113736A0309|21 29|CRSV RNA-1
P08113736A0309|65 77|mosaic (RCNMV)
P08113736A0309|100 112|mosaic (SCNMV)
P08113736A0309|147 155|CRSV RNA-1
P08113736A0309|177 190|3'-terminal ORF
P08114702A0000|12 56|myocyte-specific enhancer-binding factor 2 (MEF2)
P08114702A0000|99 106|A/T-rich
P08114702A0000|120 133|control regions
P08114702A0000|144 163|muscle-specific genes
P08114710A0137|25 29|LBP-1
P08114710A0137|39 43|HIV-1
P08114710A0137|81 85|TFIID
P08114710A0137|91 94|TATA
P08114745A0953|44 46|RNA
P08114745A0953|115 117|III
P08114745A0953|158 179|transcription complexes
P08114745A0953|185 187|III
P08115744A0846|3 12|GafChromic
P08116245A0174|12 14|RNA
P08118044A0318|0 9|GATA-1 mRNA
P08118044A0318|79 84|FDC-P1
P08119149A0000|0 24|Tumor necrosis factor-alpha
P08119149A0000|25 28|(TNF
P08119149A0000|29 34|alpha)
P08119907A0000|60 92|insulin-like growth factor-I (IGF-I)
P08119958A0273|12 19|C2 domain
P08119958A0273|25 44|Ca(2+)-dependent PKCs
P08119958A0273|68 79|NH2-terminal
P08119958A0273|102 114|signal peptide
P08119958A0273|149 151|PKC
P08119958A0273|191 194|PKCs
P08119995A0814|36 42|T3R-RXR
P08119995A0814|57 72|response elements
P08120019A1500|63 64|PI
P08120029A0864|59 71|20-nt sense RNA
P08120029A0864|107 115|R2 message
P08122364A0954|21 30|pCD41 ORF-A
P08122364A0954|110 114|pCD41
P08122370A0331|32 33|US
P08122370A0331|36 60|herpes simplex type 1 (HSV-1)
P08122370A0331|37 83|erpes simplex type 1 (HSV-1), pseudorabies virus (PRV)
P08122370A0331|94 116|herpesvirus type 1 (EHV-1)
P08123787A0554|47 50|HemB
P08124785A0445|0 6|METHODS
P08124785A0445|7 9|AND
P08124785A0445|10 16|RESULTS
P08124785A0445|216 217|(P
P08124912A0456|38 39|SF
P08124912A0456|48 51|IL-8
P08124912A0456|64 73|actate, LDH
P08124912A0456|65 78|ctate, LDH, beta
P08125258A0142|48 55|CHOP gene
P08125319A1085|3 11|ipiO genes
P08125949A1162|43 56|spinach L12 mRNA
P08125949A1162|73 81|AUG codons
P08125949A1162|101 110|rpl12 genes
P08125949A1162|155 164|generating
P08126096A0478|160 181|anti-cytoplasmic domain
P08126096A1071|3 16|alpha 7A form RNA
P08126096A1071|80 91|coding region
P08126096A1071|101 109|B form RNAs
P08127950A0000|33 72|hypothalamic-pituitary-thyroid (HPT)-axis
P08127950A0000|140 153|thyroxine (FT4)
P08127950A0000|159 179|triiodothyronine (FT3)
P08127950A0000|184 213|thyroid stimulating hormone (TSH)
P08127950A0000|230 243|ultrasensitive
P08127950A0000|244 259|assays (TSH-IRMA)
P08128629A1164|0 2|CRS
P08128629A1164|16 29|LTR-linked gene
P08128629A1164|75 80|p60CRS
P08128629A1164|84 89|p40CRS
P08128629A1164|106 111|LTR RNA
P08129955A0572|39 43|CK-MB
P08131746A0140|0 2|MEK
P08131746A0140|54 69|activator kinases
P08131746A0140|92 100|MEK kinase
P08132541A0000|7 9|DNA
P08132541A0000|49 55|MAL gene
P08132574A0831|9 11|SVA
P08132574A0831|31 46|complement C2 gene
P08132574A0831|59 69|20 kilobases
P08132574A0831|80 82|RP1
P08132574A0831|88 90|HLA
P08132574A0831|99 118|cytochrome CYP1A1 gene
P08133502T0105|0 35|European Community Huntington's Disease
P08134108A0277|19 42|alpha-actin gene promoters
P08134108A0277|50 52|YY1
P08134108A0277|103 120|cis-acting elements
P08134115A1161|0 5|MSSP-1
P08134115A1161|42 44|GST
P08134115A1161|71 91|single-stranded TCTTAT
P08134115A1161|97 107|myc(H-P)21)
P08134115A1161|111 117|ACT-ATT
P08134115A1161|126 136|myc(H-P)21)
P08134115A1161|174 185|A/TCTA/TA/TT
P08136383A0359|18 19|MR
P08138180A0593|90 94|SPT10
P08139001A1235|52 54|NS1
P08139004A0278|5 7|UTR
P08139004A0278|63 70|(A/U)UGC
P08139017A1465|111 119|Ets-1 cDNA
P08139031A1168|15 62|oligonucleotide-directed site-specific mutagenesis
P08139031A1168|106 120|ORF4 polypeptide
P08139031A1168|312 315|ORF4
P08139539A0446|3 15|at 1a cells, m1R
P08139539A0446|29 46|phospholipase C beta
P08139539A0446|101 109|AMP (cAMP)
P08139539A0446|146 158|protein kinase
P08139542T0000|10 13|mRNA
P08139542T0000|25 37|leader peptide
P08139542T0000|43 50|CPA1 gene
P08139542T0000|93 101|yeast gene
P08139542A1229|39 42|CPA1
P08139543A0427|35 43|SLK1-SLT2
P08139543A1520|41 45|NHP6A
P08139543A1520|49 53|NHP6B
P08139543A1520|74 77|SLT2
P08139562A0404|71 74|GCN4
P08139562A0404|99 103|uORF1
P08139562A0404|140 143|GCN4
P08139577T0000|21 48|yeast transcription factor IIIB
P08139577T0000|91 94|TATA
P08139577T0000|112 125|TATA-less genes
P08139914A0554|30 34|dnHLH
P08139928T0000|0 3|RNP1
P08139928T0000|9 29|ribonucleoprotein gene
P08140847X0001|0 13|Crohn's disease
P08140847X0001|160 173|Crohn's disease
P08140847X0001|202 206|(CDAI
P08143667A0222|3 41|mean (+/- sd) intra-vesicular pressure (IVP)
P08143667A0222|60 81|closure pressures (MUCP)
P08143667A0222|115 119|cmH2O
P08143667A0222|152 155|MUCP
P08143667A0222|159 161|IVP
P08144037A0000|0 14|Thioredoxin (TR)
P08144037A0000|33 49|dithiol-reductase
P08144470A0711|20 32|asgB480 allele
P08144470A0711|50 55|A-to-G
P08144497T0000|3 21|cysteine-rich region
P08144497T0000|24 34|raf-1 kinase
P08144497T0000|104 110|GTP-ras
P08144504T0064|32 34|ATP
P08144572A0786|0 2|ATP
P08144572A0786|22 32|polypeptide
P08144572A0786|126 128|BiP
P08144572A0786|132 135|DnaK
P08144615A0533|11 16|NF-IL6
P08144615A0533|21 37|endoprotease Asp-N
P08144615A0533|67 93|TCD (NF-IL6 bZIP domains (NFBD)
P08144615A0533|155 157|DNA
P08144631A0000|11 25|tyrosine kinases
P08144631A0000|71 94|Src homology 2 (SH2) domains
P08144668A0802|56 57|IV
P08144668A0802|60 65|exon VI
P08144668A0802|114 121|GPHe(P2)
P08144852A0000|26 62|rmones" cortisol, 11-deoxycortisol, ACTH
P08144852A0000|27 79|mones" cortisol, 11-deoxycortisol, ACTH, vasopressin (AVP)
P08144852A0000|106 116|factor (CRF)
P08144852A0000|189 207|11-beta-hydroxylase
P08145646T0000|39 53|igma factor, RpoN
P08145646T0000|118 138|nifU2-rpoN superoperon
P08145770A1078|53 55|PKC
P08148463A0000|3 33|colony-stimulating factors (CSFs)
P08148463A0000|96 109|granulocyte CSF
P08148463A0000|97 135|ranulocyte CSF, granulocyte-macrophage CSF
P08148463A0000|133 135|CSF
P08148463A0000|182 191|multi-CSF)
P08149484A0151|40 51|kinase domain
P08149484A0151|54 61|PKC alpha
P08149484A0151|65 67|PKC
P08149484A0151|73 76|(PKC
P08149484A0151|74 76|PKC
P08149484A1551|28 35|PKC alpha
P08149484A1551|57 59|PKC
P08149484A1551|113 130|TPA-inducible genes
P08149484A1551|142 145|AP-1
P08149484A1551|149 156|non-AP-1
P08150970A0434|19 24|TSST-1
P08150970A0434|90 95|TSST-1
P08151787T0000|22 40|localization domains
P08151787T0000|91 95|IE110
P08151787T0000|99 103|IE175
P08151787A0355|48 77|amino acid motifs 726-GRKRKSP-732
P08151787A0355|82 86|IE175
P08151787A0355|90 104|500-VRPRKRR-506
P08151787A0355|109 113|IE110
P08151790A0354|3 15|revertant TATA
P08151790A0354|45 47|HIV
P08151790A0354|86 88|LTR
P08151790A0354|173 184|wild-type HIV
P08152800A0357|8 16|ETS domain
P08152800A0357|108 111|PEA3
P08152800A0357|115 118|ER81
P08152800A0357|153 156|'Ets
P08152800A0357|164 186|Molecule PEA3-like' (ERM)
P08152800A0709|32 45|full-length ERM
P08152800A0709|109 143|consensus nucleotide core sequence GGAA
P08154171A0649|26 30|LMWHs
P08154182A0955|18 27|lambda PG15
P08154182A0955|34 42|lambda AD5
P08154182A0955|91 110|Neurospora crassa cDNA
P08157009T0000|26 33|APS1 gene
P08157009T0000|80 98|clathrin AP-1 complex
P08157009T0000|149 160|Golgi complex
P08157009A0264|55 66|sigma subunit
P08157009A0264|96 106|AP-1 complex
P08157009A0264|140 169|plasma membrane AP-2 sigma subunit
P08157663A0882|63 77|a vertebrate gene
P08157663A0882|158 169|polypeptides
P08157674T0000|56 76|protein tyrosine kinase
P08160905A0217|34 64|hepatitis B surface antigen (HBsAg)
P08163183T0000|3 36|xylose isomerase-encoding gene (xylA)
P08163183T0000|93 101|phylogeny
P08163183T0000|104 107|XylA
P08163498A0789|3 17|phosphopeptides
P08163498A0789|31 52|RS-[32P]SGASGLLTSEHHSR
P08163498A0789|56 76|S-[32P]SGASGLLTSEHHSR
P08163546A1230|128 137|hydrolases
P08164302A0547|13 15|TPN
P08164302A0547|29 42|isonitrogenous
P08164661A0414|13 23|TFIIIC alpha
P08164661A0414|52 57|TFIIIC
P08164661A0414|135 147|RNA polymerase
P08164661A0414|148 150|III
P08164679A0809|0 20|Transactivation domain
P08164679A0809|45 76|128-amino-acid runt homology region
P08164679A0809|93 102|Runt domain
P08164680A1086|17 24|protease
P08164680A1086|76 80|pre-B
P08164684A1266|12 14|RXR
P08164684A1266|72 95|heterodimeric-DNA complex
P08169201A0291|48 51|carA
P08169709T0000|38 44|11 cases
P08170400T0000|63 84|ranscription factor, FNR
P08172416A0860|110 125|folliculogenesis
P08172598A0237|23 26|mRNA
P08172598A0237|66 69|xynB
P08172598A0237|86 91|kb mRNA
P08172653A1589|38 48|TnT isoforms
P08172653A1589|134 145|TnT multigene
P08172905A0000|8 9|II
P08172905A0000|25 45|alanine tRNA synthetase
P08172905A0000|59 61|RNA
P08172905A0000|107 117|alanine tRNA
P08172905A0000|133 142|G3:U70 base
P08173532A0000|6 21|reaction time (RT)
P08173532A0000|41 50|target (S2)
P08173532A0000|67 88|non-informative cue (S1)
P08173693A0390|100 102|III
P08175188A0685|20 25|ppm SO2
P08175188A0685|84 86|MCA
P08175188A0685|108 110|CBF
P08178446A1160|18 22|ICP10
P08178446A1160|64 65|TM
P08178490A0879|63 66|6.7K
P08178490A0879|67 74|SA domain
P08178572A1118|46 52|350 base
P08178572A1118|88 89|IX
P08180129A1256|16 18|TPA
P08181755A0989|29 33|pcbAB
P08181755A0989|99 102|mRNA
P08182041A1067|58 62|PEPCK
P08182041A1067|65 67|PKA
P08182041A1067|103 122|CREB activation domain
P08182041A1067|129 137|PEPCK TATA
P08182056A0695|34 37|NQO2
P08182056A0695|41 48|NQO1 gene
P08182056A0695|85 92|NQO2 gene
P08182056A0695|121 127|NQO gene
P08183552T0000|8 16|eps15 gene
P08183552T0000|27 40|tyrosine kinase
P08183915A0000|18 24|105-kDa
P08183915T0000|21 23|RNA
P08183915A0000|52 61|p50 subunit
P08183915T0000|53 78|p105 NF-kappa B gene generates
P08183915A0000|64 90|transcription factor NF-kappa
P08183915T0000|79 98|I kappa B gamma isoforms
P08184923A0829|7 11|L-NNA
P08184923A0829|46 49|CoBF
P08184923A0829|62 65|CeBF
P08187085A0086|64 83|tyrosine kinase domain
P08187088A0530|14 32|heterozygosity (LOH)
P08187177A0405|27 29|CPY
P08188258A0000|0 22|Glutamyl-tRNA synthetase
P08188258A0000|26 46|prolyl-tRNA synthetase
P08188258A0000|73 97|aminoacyl-tRNA synthetases
P08188290A0544|40 56|TCRAC/TCRDC region
P08188290A0544|73 82|polymerase
P08188290A0544|144 152|TCRAJ gene
P08188603A0230|96 103|CPA2 gene
P08188603A0230|129 164|carbamoyl-phosphate synthetase (CPS-A)
P08188606A1034|113 125|monocytogenes
P08188978A0822|28 30|ECG
P08188978A0822|52 55|MSNA
P08189174A0148|0 8|DESIGN--A
P08189498T0000|18 36|immediate-early gene
P08189498T0000|42 55|Marek's disease
P08189498T0000|73 84|repeat region
P08189498T0000|104 127|14-kilodalton polypeptide
P08189503A0000|11 25|full-length cDNA
P08189503A0000|82 88|(DI) RNA
P08189503A0000|83 96|DI) RNA, pMIDI-C
P08189503A0000|101 119|cassette mutagenesis
P08189503A0000|162 165|mRNA
P08189533A0203|71 74|NS53
P08189533A0203|148 171|vaccinia virus/T7 (vTF7-3)
P08189533A0919|120 123|NS53
P08190633A0000|3 25|transcription factor AP-2
P08190633A0000|69 71|HLA
P08190633A0273|9 16|AP-2 mRNA
P08190633A0273|30 35|7 exons
P08190633A0273|71 73|DNA
P08192451A0885|69 81|increase in NAO
P08193147A0831|59 68|(Kissinger
P08194139A0498|0 10|CONCLUSIONS
P08194139A0498|1 25|ONCLUSIONS: Serum prolactin
P08194549A0000|82 90|power (CP)
P08194549A0000|104 133|blood lactate accumulation (OBLA)
P08194753A0157|45 48|MluI
P08194753A0157|76 102|DNA damage-responsive element
P08195186A0000|8 11|cDNA
P08195186A0000|36 71|T lymphocyte early-activation gene (Tea)
P08195186A0000|121 147|retrovirus receptor/cationic
P08195186A0000|148 178|amino acid transporter (ecoR/CAT1)
P08195186A0000|183 185|RNA
P08195186A0000|242 249|(MacLeod
P08195186A0000|251 254|C.L.
P08195216A1022|28 31|HIS3
P08195216A1022|57 65|TATA-like
P08195216A1022|116 120|GCN4p
P08195216A1022|135 143|TATA-like
P08195216A1022|160 164|GCN4p
P08195216A1022|177 180|TRP3
P08195217A0799|108 113|37-kDa
P08195233A0147|15 20|kinase
P08195233A0147|150 162|tumorigenesis
P08196607A0280|21 32|ICL1 promoter
P08196607A0280|77 91|sequence element
P08196607A0280|78 99|equence element, UASICL1
P08196607A0280|103 112|CATTCATCCG
P08196607A0280|199 210|reporter gene
P08196616A1112|30 35|ZAP-70
P08196616A1112|79 94|ZAP-70 SH2 domains
P08196616A1112|148 153|ZAP-70
P08196616A1112|218 227|SH2 domains
P08196618A0473|0 4|PRL-1
P08196624A0593|2 6|Mv1Lu
P08196624A0593|22 33|ells, ActR-IB
P08196624A0593|37 44|T beta R-I
P08196624A0593|156 157|II
P08198524A1134|0 4|50 kDa
P08198524A1134|8 17|130-170 kDa
P08199204A0746|46 48|PKC
P08199204A0746|99 111|PtdIns(3,4)P2
P08200528A0970|33 44|Tn903 neo gene
P08200528A0970|51 117|Rhodosporidium toruloides phenylalanine ammonia lyase (PAL)-encoding gene
P08200528A0970|150 159|pPGK::REP2
P08202546A1206|27 39|hUBF-promoter
P08202546A1206|94 106|cisplatin-DNA
P08203260A1204|17 20|SIMV
P08204348T0000|0 4|VP-16
P08204348T0000|19 32|cisplatin (VIP)
P08204403A0000|142 147|CEA/CA
P08204824A0000|19 27|cyc07 gene
P08204824A0000|62 67|S phase
P08204824A0000|119 131|(Catharanthus
P08205827A0940|0 10|CONCLUSIONS
P08206848A0296|3 6|pyrR
P08206848A0296|10 18|pyrP genes
P08206848A0296|26 37|polypeptides
P08206848A0296|80 82|kDa
P08206867A0874|54 63|COXVb genes
P08207022T0000|41 45|Spo0A
P08207232A0503|49 55|NF-IL-6
P08207232A0503|118 124|NF-IL-6
P08207232A0503|134 145|IL-8 promoter
P08207405A0372|0 2|BYV
P08207405A0372|1 27|YV, citrus tristeza virus (CTV)
P08207405A0372|39 54|stunt virus (BYSV)
P08207405A0372|188 197|HSP70 genes
P08207795A0409|57 62|64-kDa
P08207795A0409|72 94|step-by-step mutagenesis
P08207805A0000|3 31|p53 tumor suppressor gene product
P08207805A0000|34 61|sequence-specific DNA-binding
P08208247T0030|31 41|segment 64AB
P08208247T0030|71 91|acid decarboxylase gene
P08208540A0000|19 27|NFKB2 gene
P08208540A0417|38 42|cDNAs
P08208540A0417|123 126|85 kD
P08208540A0417|149 168|DNA-binding rel domain
P08208540A1114|39 43|NFKB2
P08208540A1114|64 84|kappa B-driven reporter
P08208540A1114|105 109|NFKB2
P08208540A1114|171 175|NFKB2
P08208618A1334|5 10|HR21ap
P08208618A1334|19 25|HR21Xap
P08209423T0000|48 62|MDV-1 BamHI-D DNA
P08209423T0000|93 96|mRNA
P08209423T0000|110 125|glycoprotein gene
P08209772A0167|3 9|ns2 gene
P08209772A0167|25 41|reading frame (ORF)
P08209772A0167|127 132|32-kDa
P08212571A0597|67 72|tat ORF
P08212897A0404|29 45|methyltransferase
P08212897A0404|86 105|transmembrane domains
P08213235A1024|13 16|SaO2
P08213747A0000|44 89|immunodeficiency virus type 1 (HIV-1) infection in US
P08213747A0000|301 313|baseline HIV-1
P08213747A0000|309 313|HIV-1
P08213747A0000|357 368|non-Hispanic
P08213747A0000|448 468|(Baltimore/Washington
P08213747A0000|470 471|DC
P08218056A0000|3 16|ultrastructure
P08218230A1505|113 126|factor 1 (HNF-1)
P08218230A1920|22 24|GRE
P08218230A1920|82 86|HNF-1
P08218230A1920|162 194|Xenopus fibrinogen B beta subunit gene
P08219081A0000|3 12|PRB-1b gene
P08219081A0000|48 71|pathogenesis-related PR-1
P08219227A0830|16 18|CRE
P08219227A0830|39 42|AP-1
P08219227A0830|147 150|AP-1
P08219227A0830|159 162|a CRE
P08220494A0231|3 15|T-cyt promoter
P08220494A0231|64 79|30 bp cyt-1 element
P08221251A0239|13 14|CT
P08222384A0455|0 4|SIN-1
P08222384A0455|53 81|surface electrocardiogram (ECG)
P08222384A0455|100 102|ECG
P08222618A0000|3 7|BASIC
P08223425T0000|3 15|yeast SSS1 gene
P08223554A0574|23 33|polypeptide
P08223554A0574|67 80|transit peptide
P08223576A1261|12 20|H4PteGlun
P08223576A1261|82 90|H4PteGlun
P08223592A0424|0 3|TATA
P08223592A0424|7 11|CCAAT
P08223592A0424|140 149|intronless
P08223613A0105|0 3|GGS1
P08223613A0105|19 22|TPS1
P08223613A0105|64 111|trehalose-6-phosphate synthase/phosphatase complex
P08223613A0519|73 81|genes TPS2
P08223613A0519|85 88|TSL1
P08223613A0519|123 146|trehalose synthase complex
P08223613A0519|154 167|a TSL1 homologue
P08223613A0519|155 172| TSL1 homologue, TPS3
P08223823T0000|46 61|Stroop Color-Word
P08223875A0711|13 18|[3H]PA
P08223875A0711|33 35|CD3
P08223875A0711|75 79|CD45-
P08223875A0711|91 95|CD45+
P08223875A0711|144 148|CD45-
P08224260A1248|0 9|CONCLUSION
P08224260A1248|47 61|ultrasonography
P08224907A0000|29 40|rat EFIA (gene
P08224907A0000|41 56|encoding enhancer
P08224907A0000|103 106|cDNA
P08225657A0000|50 53|NYHA
P08225657A0000|63 64|II
P08226616A0000|3 11|nit-3 gene
P08226616A0000|64 72|reductase
P08226777A0936|40 45|DdPTPa
P08226794A0501|0 15|[Ala85]Dk(69-85)
P08226798A1124|15 17|CaM
P08226798A1124|27 29|HIV
P08226798A1124|104 114|HIV-induced
P08226798A1124|157 169|CaM-regulated
P08226956A1397|68 75|fad7 mRNA
P08227129T0000|8 27|myosin-binding domain
P08227129T0000|38 49|muscle MyBP-C
P08227129T0000|50 51|(C
P08227129T0000|72 84|COOH-terminal
P08227129T0000|73 106|OOH-terminal, immunoglobulin C2 motif
P08228805A0540|26 28|TCR
P08228805A0540|110 112|TCR
P08228805A0540|116 136|protein tyrosine kinase
P08229102A0768|17 20|QLMI
P08229102A0768|76 77|QL
P08229102A0768|80 87|post-AMI
P08230418A0812|30 32|LTR
P08230418A0812|88 119|rus 40, c-fms, urokinase plasminogen
P08230418A0812|89 159|us 40, c-fms, urokinase plasminogen activator, or type 5 acid phosphatase promoter
P08230445A0000|41 73|immunodeficiency virus type 1 (HIV-1)
P08230445A0000|77 82|15-kDa
P08230452A0551|133 151|vaccinia virus (VVP3)
P08230452A0551|168 188|poliovirus 3CD protease
P08230452A0551|395 396|(D
P08230452A1489|93 106|VP1 (VP1-G001V)
P08230452A1489|164 177|RNA-containing
P08231398A0802|0 6|RESULTS
P08231398A0802|242 244|CD4
P08231816A1473|93 103|DNA-binding
P08231816A1473|187 190|IPNS
P08232304A1166|59 61|TSS
P08232304A1166|121 132|promoterless
P08232304A1166|133 164|chloramphenicol acetyltransferase
P08232412A1342|3 12|lemdr1 gene
P08232412A1342|27 49|expression vector pALTNEO
P08234166A0425|115 116|RT
P08234276A0556|44 55|IL-8 promoter
P08234276A0556|78 83|NF-IL6
P08234276A0556|87 94|NF-kappa
P08237112A0553|28 30|36K
P08237578A0253|48 86|iglycerides, cholesterol, LDL-cholesterol
P08237578A0253|90 104|HDL-cholesterol
P08238626A0248|3 7|PaCO2
P08238626A0248|10 15|40 mmHg
P08238626A0248|11 32|0 mmHg, baseline brain pHi
P08239164A0551|0 3|CPAP
P08239164A0551|49 60|exercise) VO2
P08239164A0551|100 110|lung disease
P08239164A0551|175 185|lung disease
P08241139A0378|10 27|single-stranded DNA
P08241139A0378|61 66|MgdTDP
P08242861A0368|4 14|4,8-DiMeIQx
P08242861A0368|18 23|A alpha
P08243476A1177|77 99|nitrous-oxide reductases
P08244034T0000|11 43|Leishmania surface glycoprotein GP63
P08244034T0000|95 111|metalloproteinase
P08245013A0000|63 66|mRNA
P08245013A0000|69 93|G-protein-linked receptors
P08245125A0822|65 69|L266D
P08245456A0501|28 31|IL-5
P08245456A0501|50 52|PMA
P08245456A0501|68 94|6, O2-dibutyryl cAMP (Bt2cAMP)
P08245456A0501|113 115|PMA
P08245456A0501|146 149|IL-5
P08245456A0501|165 168|mRNA
P08245461A0700|0 11|Hu-Met-1 mRNA
P08246984A0512|0 12|Northern (RNA)
P08246984A0512|50 59|PI 3-kinase
P08246984A0923|46 63|PI 3-kinase isoforms
P08246984A0923|103 112|PI 3-kinase
P08246987A0260|15 42|protein-tyrosine kinase domain
P08246987A0260|59 69|Src homology
P08246987A0260|75 78|(SH2
P08246987A0260|82 92|SH3) domains
P08246987A0260|108 123|N-terminal region
P08247005A0584|39 41|20S
P08247005A0584|62 68|18S rRNA
P08247005A0584|92 94|40S
P08248246A0838|106 131|cell-cycle-dependent R1 gene
P08248253A1785|59 74|chicken L-CAM gene
P08248688A0726|87 88|NO
P08251506A0503|3 16|247-kDa complex
P08251506A0503|44 63|protein-DNA complexes
P08251506A0503|85 90|256 kDa
P08251506A0503|146 148|DRE
P08251506A0503|183 198|115-kDa complexes
P08251506A0503|214 224|protein-DRE
P08251622A0000|33 69|Brassica napus 2S storage protein napA gene
P08252067A0917|44 46|NH2
P08252067A0917|50 53|COOH
P08252976A0467|57 82|viscoelastic/inhomogeneous
P08253386A0800|39 65|fibronectin splicing enhancer
P08253386A0800|81 89|SE element
P08253386A0800|127 143|splicing complexes
P08253386A0800|183 189|U2 snRNP
P08253387A0801|57 65|hLEF/GAL4
P08253387A0801|89 93|TCF-2
P08253387A0801|157 168|hLEF-binding
P08253387A1291|35 41|hLEF HMG
P08253387A1291|91 106|TCR alpha enhancer
P08253387A1291|142 145|hLEF
P08253777A0301|1 24|cAMP response element (CRE)
P08253777A0301|58 75|5'-noncoding region
P08253777A0301|59 80|'-noncoding region. cAMP
P08253777A0301|105 113|Kv1.5 gene
P08253958A0000|47 98|Helicobacter pylori-specific serum immunoglobulin G (IgG)
P08254738A0428|119 127|TS677-->A
P08254738A0428|131 143|TS677,679-->A
P08254738A0428|161 175|T-antigen kinase
P08255022A0827|11 23|hypoperfusion
P08255022A0827|54 60|FEV1.0%
P08255022A0827|68 71|PaO2
P08255758A0000|88 90|LTR
P08257666A0662|30 39|OPT complex
P08257666A0662|71 73|IHA
P08257666A0662|77 79|HD)
P08257754A0711|61 62|HB
P08257754A0711|85 92|100 IU/ml
P08257754A0711|125 126|HB
P08257754A0711|146 152|10 IU/ml
P08258025A1131|0 10|CONCLUSIONS
P08258025A1131|92 115|graft-versus-host disease
P08259650A0640|31 36|HA gene
P08259650A0640|66 68|HA-
P08260635A0926|69 88|transit peptide region
P08260635A0926|102 111|GAPDH genes
P08260635A0926|112 116|(GapA
P08260635A0926|120 124|GapB)
P08261398A0392|3 35|drug-resistant cell lines P388/ADR/3
P08261398A0392|39 48|P388/ADR/7
P08261398A0392|70 71|II
P08261398A0392|72 80|alpha mRNA
P08261398A0838|29 32|cDNA
P08261398A0838|58 62|cDNAs
P08261398A0838|131 140|P388/ADR/3
P08261398A0838|144 153|P388/ADR/7
P08262041A0727|3 8|phi AP3
P08262054A0565|51 74|membrane protein 2A (LMP2A)
P08262054A0565|80 101|Epstein-Barr virus (EBV)
P08262054A0565|126 156|Tyr-X-X-Leu/Ile-containing motif
P08262067A1608|109 121|morphogenetic
P08263933T0000|19 34|P-type ATPase gene
P08264579A1209|12 15|PTR2
P08264579A1209|91 110|peptide transport gene
P08264582A0750|166 169|LIFR
P08264591A1190|40 52|RNA polymerase
P08264591A1190|53 54|II
P08264591A1190|58 62|TFIIB
P08264617A0000|32 50|EGFR/ErbB-3 receptor
P08264617A0000|53 58|NIH 3T3
P08264617A0000|123 128|ErbB-3
P08264628A0418|65 76|TATA-binding
P08264628A0418|83 88|TIF-IB
P08264628A0418|84 94|IF-IB, TFIID
P08264628A0418|99 104|TFIIIB
P08264631A0746|3 18|227-to-239 region
P08264631A0746|26 29|ADR1
P08264631A0746|56 58|TAD
P08264631A0746|65 71|t on ADR1
P08264631A0746|68 71|ADR1
P08264631A0746|69 79|DR1, ADR1 DNA
P08264631A0746|99 110|ADH2 promoter
P08264650A0925|60 63|MDS1
P08264664A0128|0 6|TGF beta
P08264664A0128|42 45|AP-1
P08265602T0000|0 8|Val-->Ala
P08265955T0000|20 22|NHS
P08267658A0391|30 31|UW
P08267658A0391|48 70|(+)-lactobionate, KH2PO4
P08267658A0391|49 76|+)-lactobionate, KH2PO4, MgSO4
P08267667A0748|24 27|GRg2
P08267667A0748|63 73|CYP-induced
P08267667A0748|110 122|CYP-decreased
P08267667A0748|155 183|d 3 learning acquisition (F(1,14)
P08267667A0748|225 252|48 h memory acquisition (F(1,14)
P08267667A0748|296 321|24 h memory retention (F(1,12)
P08268718A0676|37 55|(p50)2-DNA complexes
P08268833T0000|22 44|cyclosporin A (Sandimmun)
P08268912A0657|42 45|cDNA
P08268912A0657|53 55|RNA
P08268912A0657|93 99|44-46 kD
P08268912A0657|102 104|SDS
P08269424A0339|35 37|CRF
P08269424A0339|41 43|TRH
P08269424A0339|42 48|RH, ACTH
P08270257A0551|1 16|sequence homology
P08270257A0551|37 43|nm23-H1
P08270257A0551|50 60|homolog gene
P08270257A0551|66 79|rat (NDP-K beta)
P08270257A0551|89 99|exon-intron
P08273122A0708|0 6|RESULTS
P08273122A0708|27 31|QA/QI
P08273122A0708|176 196|component transfusions
P08274774A0958|3 15|ddition, REP21
P08274774A0958|117 133|osaic virus, TMV-U5
P08276234A0119|21 23|YY1
P08276234A0119|47 57|DNA-binding
P08276234A0119|91 103|c-fos promoter
P08276234A0119|130 132|DNA
P08276732A0799|20 24|DPOAE
P08276762T0000|33 48|glycine-870 codon
P08276762T0000|51 76|gramicidin S synthetase 2 gene
P08276851A0347|44 61|ATP-binding domains
P08276851A0347|109 119|ATP-binding
P08276851A0347|178 187|biogenesis
P08276854A1894|35 53|decorin gene promoter
P08276854A1894|83 102|proteoglycan promoter
P08276865A1188|3 8|kinase
P08276865A1188|33 39|microM)
P08276865A1188|46 56|LPA-induced
P08276865A1188|115 123|MAP kinase
P08276865A1188|153 165|protein kinase
P08276865A1188|176 186|LPA receptor
P08277632A0997|44 52|N2 disease
P08278423A0147|47 49|HIV
P08278423A0147|69 70|TB
P08278548A0597|3 6|psaD
P08278548A0597|4 11|saD, psaF
P08278548A0597|5 16|aD, psaF, psaH
P08278548A0597|21 24|psaL
P08278548A0597|134 137|psaE
P08278929A0866|4 12|Hy-Vac SPF
P08278929A0866|60 64|in CRS
P08278929A0866|62 64|CRS
P08278929A0866|118 120|VSD
P08278929A0866|176 177|(P
P08280476A0602|23 31|HIV-1 HXB2
P08280476A0602|35 56|HIV-1 Z2Z6 core enhancers
P08280476A0602|67 70|Z2Z6
P08280476A0602|116 126|ETS-binding
P08280925A0261|53 59|C57Bl/6
P08280925A0261|153 155|IgM
P08280925A0261|159 169|IgG anti-KLH
P08281740A0000|103 105|IgG
P08281740A0000|147 151|ELISA
P08282576A0297|64 69|3 cases
P08282749A1474|36 39|CO2)
P08283292A0779|1 9|lasma, LDL
P08283531A0700|40 49|Dornier HM3
P08284227A0336|46 51|kb mRNA
P08284227A0336|89 104|cell types Id1 mRNA
P08284337A0825|30 32|IHD
P08285710A0634|7 26|1.8-kb transcript mRNA
P08285710A0634|40 52|Northern (RNA)
P08286035A0587|45 62|c11/1-specific cDNA
P08286035A0587|66 74|generated
P08286035A0587|79 89|poly(A)+RNA
P08286035A0587|98 102|PMNLs
P08286035A0587|142 169|polymerase chain reaction (PCR)
P08288240A0304|37 41|SCG10
P08288240A1343|40 63|neuron-specific SCG10 gene
P08288240A1343|124 141|stathmin/Lap18 gene
P08288554A0295|32 44|mouse HO-1 gene
P08288554A0295|113 126|mouse BALBc/3T3
P08288596A0663|60 67|rGH-TRE-
P08288596A0663|71 77|TREpal-
P08288596A0663|85 91|ME-TRE-
P08288596A0663|95 101|F2-TRE-
P08288596A0663|134 137|TREs
P08288596A0663|159 161|rGH
P08288596A0663|194 197|TATA
P08288606A0240|6 15|polymerase
P08288606A0240|53 60|150-base
P08288606A0240|79 88|sialymotif
P08288606A0240|98 109|placenta mRNA
P08288606A0240|194 197|cDNA
P08288622A0725|44 56|heterogeneity
P08288622A0725|62 68|HDC mRNA
P08288622A0725|163 170|12th exon
P08288633A0144|14 16|DNA
P08288633A0144|65 75|polypeptide
P08288633A0144|79 104|438 amino acid residues, CeGAP
P08288633A0144|153 204|COOH-terminal segment (GTPase-activating protein region)
P08288633A0144|223 239|GTPase-activating
P08289339A0527|10 20|exonuclease
P08289339A0527|21 23|III
P08289339A0527|54 63|core region
P08289341A1202|50 71|E2-C) promoter-proximal
P08289341A1202|80 84|E2-RS
P08289342A0931|12 14|AAV
P08289342A0931|57 59|DNA
P08289357A0724|85 87|LTR
P08289593A1404|49 54|MK-801
P08289593A1404|175 180|MK-801
P08289783A0000|3 13|Oct-3/4 gene
P08289783A0000|39 41|POU
P08289783A1476|5 28|site-directed mutagenesis
P08289783A1476|43 49|RAREoct
P08289783A1476|93 107|Oct-3/4 promoter
P08289783A1476|151 160|RA-induced
P08289783A1476|173 191|RA-differentiated EC
P08289793A1226|46 53|COUP-TFs
P08289793A1226|105 129|stem cell-specific enhancer
P08289831A0290|10 16|mig/CAT
P08289831A0290|64 66|RAW
P08289831A0290|109 135|IFN-gamma-responsive element
P08289831A0290|142 146|RE-1)
P08289834A0341|21 34|est cells, Atr-I
P08289834A0341|49 56|TGF-beta
P08289834A0341|68 84|bone morphogenetic
P08290278A0374|52 80|candidate tumor suppressor genes
P08290421A0165|19 20|IV
P08291233A0000|1 4|cDNA
P08291233A0000|26 42|chicken embryo cDNA
P08291233A0000|60 72|PCR-generated
P08291233A0000|104 111|U3 region
P08291233A0000|117 135|Rous sarcoma virus LTR
P08291761A0416|40 42|CSF
P08291761A0416|58 65|serum IgG
P08293412T0000|81 93|5-HT3 receptor
P08293992A0432|48 61|equence, K/NPAG
P08293993A0948|0 2|ENV
P08293993A0948|52 63|alpha-factor
P08293993A0948|103 111|invertase
P08294386A0000|0 9|BACKGROUND
P08294429A0153|19 25|hGH gene
P08294429A0153|28 51|hGH 5'-flanking DNA (5'-FR)
P08294429A0153|64 70|hGh cDNA
P08294429A0153|73 104|chloramphenicol acetyltransferase
P08294429A0153|107 121|luciferase genes
P08294429A0153|136 139|cAMP
P08294429A0153|159 169|hGH promoter
P08294459A0446|34 42|SAP-1 cDNA
P08294459A0446|59 63|SAP-1
P08294459A0446|92 113|a transmembrane-type PTP
P08294459A0446|136 154|PTP-conserved domain
P08294511A0639|36 40|69-kD
P08294511A0639|115 119|snRNP
P08294865A0236|89 107|peptide/DR complexes
P08297376A0236|37 76|CCAAT/enhancer binding protein (C/EBP) alpha
P08297376A0236|80 88|C/EBP beta
P08297376A0236|107 138|rat uncoupling protein gene promoter
P08298129T0000|31 47|TATA-less promoter
P08298129T0000|59 75|beta 3 integrin gene
P08298129A0274|80 96|beta 3 gene promoter
P08299896A0626|13 16|IBDQ
P08299896A0880|22 25|IBDQ
P08300527T0000|47 84|malonyl-coenzyme A decarboxylase gene eryM
P08300601A0745|35 37|DNA
P08300601A0745|47 50|MyoD
P08300601A0745|70 77|E12/MyoD
P08300605A0432|165 186|cis-regulatory elements
P08300605A0671|22 47|homeodomain-binding element
P08300611T0000|42 44|DNA
P08300611T0000|80 93|relaxase (TraI)
P08300611T0000|107 116|plasmid RP4
P08300611A0341|0 23|Site-directed mutagenesis
P08300611A0341|29 32|traI
P08300611A0341|77 80|TraI
P08300625A1352|3 23|COOH-terminal 46 codons
P08300625A1352|26 29|slyD
P08300625A1352|47 67|histidine-rich peptide
P08300625A1352|110 113|slyD
P08301702A1083|35 55|rat cytochrome P-450 1A1
P08301702A1083|158 163|(Ardea
P08301841A0000|9 14|GSH-Px
P08301841A0000|56 70|infarction (AMI)
P08301841A0000|82 100|angina pectoris (UAP)
P08302589A1132|3 13|HGF-induced
P08302589A1132|78 90|protein kinase
P08304301A0331|0 6|METHODS
P08304301A0331|1 22|ETHODS: Forty-nine cases
P08304301A0331|56 58|HCC
P08304301A0331|106 109|HCCs
P08304342A0605|108 117|RFLP-typed
P08304342A0605|194 198|HLA-F
P08304342A0605|232 236|HLA-A
P08306356A0000|73 76|cGy)
P08306959A0278|0 7|IFN alpha
P08306959A0278|11 13|IFN
P08306959A0278|101 127|IFN gamma activation site (GAS)
P08307338A0227|21 28|gene CBP1
P08307338A0227|97 115|cytochrome b (cob) RNA
P08307564A0233|0 37|Twenty-three sequence-tagged sites (STSs)
P08308008A0201|41 63|GA-binding protein (GABP)
P08308008A0201|66 82|ets sequence motifs
P08308008A0201|148 160|COXIV promoter
P08309726A0000|27 38|pathogenesis
P08309726A0000|60 81|distress syndrome (ARDS)
P08309726A0000|175 190|neutrophils (PMN)
P08309726A0000|252 255|ARDS
P08309726A0000|292 295|ARDS
P08309953A0776|27 42|dopamine receptor
P08312243A0177|32 41|NaFe3+EDTA
P08312243A0177|73 79|Na2EDTA
P08314163T0000|64 118|granulocyte-macrophage colony stimulating factor (rhGM-CSF)
P08316209A0000|41 51|rotein, CYS3
P08316240A1068|41 45|CHL15
P08316240A1068|70 83|hexamer element
P08316240A1068|71 90|examer element, ACGCGT
P08316240A1068|94 97|MluI
P08316240A1068|178 194|DNA synthesis genes
P08317092A0304|3 18|C-terminal region
P08317092A0304|24 30|150-kDa
P08317092A0304|48 71|NTP-binding helicase motif
P08317092A0304|98 115|RNA polymerase motif
P08317092A0304|167 187|RNA replication complex
P08317094A0778|11 13|F3R
P08317094A0778|54 69|sequence 5'-TAAAG
P08317094A0778|127 141|initiation codon
P08319907A0754|8 19|rap1t alleles
P08320120A0361|112 120|diffusion
P08321199T0000|0 9|Epigenetic
P08321199T0000|107 109|HMR
P08321203A0840|0 7|NF-kappa
P08321203A0840|38 52|ergize with C/EBP
P08321203A0840|48 57|C/EBP alpha
P08321203A0840|49 67|/EBP alpha, C/EBP beta
P08321203A0840|59 63|C/EBP
P08321227A0854|48 66|cDNA-transfected COS
P08321741A0396|25 27|BMB
P08321741A0396|80 87|"Chronic
P08321741A0396|88 130|Megakaryocytic-Granulocytic Myelosis"--CMGM-
P08321741A0396|150 158|Agnogenic
P08321741A0396|166 182|Metaplasia-AMM-in
P08321741A0396|214 216|CML
P08321741A0396|235 252|increase-CML.MI-in
P08322117A1019|78 85|60 cmH2O)
P08322117A1019|97 104|60 cmH2O)
P08322823A0839|36 38|MFA
P08322823A0839|58 60|UTS
P08323294T0000|1 54|hicken sterol carrier protein 2/sterol carrier protein x: cDNA
P08325504A0226|7 10|RD19
P08325504A0226|14 21|RD21 mRNA
P08325639A0129|31 33|20S
P08325639A0129|65 67|26S
P08325639A0129|120 129|proteinase
P08325639A0129|152 164|ATP-dependent
P08325720A0840|92 99|synthase
P08325720A0840|93 131|ynthase, 3-hydroxyacyl-CoA-dehydrogenase
P08325720A0840|94 153|nthase, 3-hydroxyacyl-CoA-dehydrogenase, lactate dehydrogenase)
P08325720A0840|164 183|uscle capillaries, %ST
P08325883A0368|24 27|RBP1
P08325883A0368|56 74|RNA recognition motif
P08325883A0368|100 120|asparagine-rich region
P08325883A0368|164 176|alpha-helixes
P08327488A0839|12 14|RNA
P08327488A0839|170 172|RNA
P08331064A0440|0 6|Release
P08331067T0000|31 54|bacteriophage K1F tail gene
P08331067T0000|63 94|endo-N-acylneuraminidase (endo-N)
P08331067T0000|112 124|endo-N homolog
P08331067T0000|127 143|bacteriophage PK1E
P08332492A0145|15 23|multigene
P08332492A0145|25 36|amily, GATA-3
P08332492A0145|101 133|immunodeficiency virus type 1 (HIV-1)
P08332495A0408|25 27|CAT
P08332495A0408|54 79|lung adenocarcinoma (A549-1)
P08332495A0408|120 134|T7 RNA polymerase
P08332495A0408|121 149|7 RNA polymerase, pT7-EMC-CAT DNA
P08332495A0408|153 159|DC-chol
P08334158A0660|80 83|Fe/S
P08334304A0473|103 123|GTP-loaded p21 rasVal12
P08334989A0070|183 205|a luciferase reporter gene
P08334989A0070|225 230|NIH3T3
P08336012A0632|56 58|BAL
P08336012A0632|102 103|FN
P08336543A0243|27 36|L1 elements
P08336543A0243|44 47|"A,"
P08336543A0243|48 51|"F,"
P08336543A0243|55 58|"V,"
P08336698T0000|0 3|TFEC
P08336698T0000|56 59|TFE3
P08336698T0000|71 84|TFE3-dependent
P08336738A1273|46 65|PSTAIRE sequence motif
P08337828A0895|38 79|Autographa californica MNPV (AcMNPV)-infected
P08337841A0612|28 30|ARV
P08337841A0612|35 42|GNS genes
P08337841A0612|82 85|mRNA
P08337841A0612|113 136|consensus sequence (AACAG)
P08337841A0612|152 156|G gene
P08337841A0612|176 206|polyadenylation signal (CATG[A]7)
P08337841A0612|243 268|GNS protein termination codon
P08340400T0000|31 35|RPE65
P08343216A0883|0 14|PPD-specific IgG
P08343216A0883|52 54|IgG
P08344248A0910|0 4|GAP-N
P08345191A1140|98 114|bcl-2-related gene
P08345191A1140|99 119|cl-2-related gene, MCL1
P08347677A0308|153 163|nonapeptide
P08347677A0308|164 189|(Arg)4-Ala-Ala-Ser-Val-Ala
P08347677A0308|241 243|(Km
P08347677A0308|245 253|15 microM)
P08349104A0000|26 29|GAL1
P08349104A0000|33 42|GAL10 genes
P08349104A0000|180 183|UASG
P08349104A0450|57 64|TSF genes
P08349104A0450|139 165|yeast CYC-GAL hybrid promoters
P08349104A0450|174 178|lacZ)
P08349632A0679|36 39|5'/L
P08349632A0679|43 45|L/N
P08349632A0679|48 52|PSG12
P08349632A0679|93 99|L/N exon
P08349632A0679|105 116|PSG12 psi gene
P08349632A0679|126 134|stop codon
P08350061A0209|54 60|CD8 gene
P08350398A1616|16 17|ER
P08350398A1616|41 45|gp19K
P08350398A1616|125 137|alpha 2 domains
P08350398A1616|146 157|heavy (alpha)
P08352066A0000|19 38|17 beta-estradiol (E2)
P08352268A0000|101 104|(SC)
P08355062A0000|29 45|tomography (SPECT)
P08355062A0000|50 91|99mTc-hexamethylpropyleneamine oxime (HMPAO)
P08355063A0456|3 6|rCBF
P08355539A0133|0 6|METHODS
P08355539A0133|157 160|EAA)
P08355539A0133|198 201|EAT)
P08355539A0133|263 266|EAI)
P08355680A0824|0 3|2-AP
P08355680A0824|31 34|mRNA
P08355680A0824|92 96|HIV-1
P08355680A0824|127 136|endogenous
P08355680A0824|162 192|glucose 6-phosphate dehydrogenase
P08355696A0236|3 4|UV
P08355696A0236|36 53|UV response elements
P08355696A0236|66 74|AP-1-like
P08355697A0000|0 32|Protein tyrosine phosphatases (PTPs)
P08355697A0000|46 73|protein tyrosine kinases (PTKs)
P08355857A1293|0 1|ST
P08356792T0000|0 9|HTLV-1 gene
P08356792A1275|13 16|p21X
P08356792A1275|94 97|p21X
P08356792A1275|117 126|1.6-kb mRNA
P08356944A0589|152 161|generation
P08357834A0285|56 64|PKC-delta
P08357834A0285|84 98|mouse homologues
P08357834A0285|124 157|sequence divergence (89-90% homology)
P08357834A0285|225 227|PKC
P08360112T0036|0 2|XII
P08360180A1041|16 26|barley PSI-K
P08360180A1041|30 34|PSI-G
P08360180A1041|50 54|PSI-K
P08360180A1041|178 187|progenitor
P08361754A0733|33 43|b-Zip domain
P08361755A0734|38 42|cDNAs
P08361755A0734|48 55|NF-kappa
P08361755A0734|63 86|serum response factor (SRF)
P08361755A0734|132 139|NF-kappa
P08361755A0734|151 154|CArG
P08361761A0174|14 18|v-Rel
P08361761A0174|125 154|chicken embryo fibroblasts (CEFs)
P08361761A0174|166 170|v-Rel
P08361761A0174|197 206|ites. v-Rel
P08361761A0174|266 298|immunodeficiency virus type 1 (HIV-1)
P08361761A0174|311 321|repeat (LTR)
P08365944A1537|0 9|CONCLUSION
P08365944A1537|86 96|Mitomycin-C
P08367388T0035|0 47|Cerebro-oculo-facioskeletal syndrome (Pena-Shokeir
P08367388T0035|56 58|II)
P08367487A1014|37 47|17S U2 snRNPs
P08367487A1014|57 67|12S U2 snRNPs
P08367487A1014|71 74|HeLa
P08367487A1014|101 111|endogeneous
P08367487A1014|112 119|U2 snRNPs
P08367487A1014|155 163|anti-PRP9
P08367487A1014|190 202|mRNA-splicing
P08369887A0781|59 61|EAD
P08369887A0781|64 65|RA
P08370119A0642|19 29|1977-bp exon
P08370119A0642|151 177|muscle cell AT1a receptor cDNAs
P08370119A1521|21 34|promoter region
P08370119A1521|82 85|TATA
P08370119A1521|161 174|luciferase cDNA
P08371713T0000|26 60|nonselective-type endothelin receptor
P08373972A0335|0 3|SvO2
P08374753A0335|13 30|relaxation time (T2)
P08374753A0335|42 50|diffusion
P08375651T0000|26 34|chain gene
P08376397A0788|58 60|E2F
P08376397A0788|81 83|E2F
P08376796A0172|12 20|VH regions
P08376796A0172|103 111|generated
P08376796A0172|116 118|IgG
P08376796A0172|125 128|IgG1
P08376796A0172|135 142|IgG3) mAb
P08376796A0172|235 238|SLE)
P08378082A1031|48 49|RB
P08380736A0895|3 10|7-kb mRNA
P08380896A0938|40 55|polymerase domain
P08381121A0773|8 27|transmembrane regions
P08382296A0766|0 8|McCann III
P08382300A0341|61 85|a temperature-sensitive VP5
P08382300A0341|110 112|VP5
P08382300A0341|116 119|VP23
P08382303A0507|12 25|transport motif
P08382303A0507|118 124|E1 genes
P08382359A0469|148 158|pRb-binding
P08382769A0924|88 122|sequence-specific recognition element
P08382769A0924|129 133|SRP54
P08382778A0891|71 80|Raf kinases
P08382778A0891|104 108|TFIIE
P08383129A0776|15 36|mass polypeptide complex
P08383129A0776|61 89|ntigen presentation, generating
P08383214A0389|19 20|RT
P08383214A0389|23 37|Trp-595-Tyr-596
P08383214A0389|73 94|C-terminal RNase H domain
P08383217A0357|117 142|C-terminal activation domain
P08383217A0357|145 148|VP16
P08383287A0611|8 23|-172/-148 element
P08383287A0611|37 44|estrogen
P08383287A0611|104 125|hormone response element
P08383492A1205|150 167|cytochrome oxidases
P08383622T0000|10 13|GABP
P08383622T0000|18 22|NRF-2
P08383622T0000|25 36|multisubunit
P08383622T0000|48 64|cytochrome oxidase
P08383622T0000|101 109|ETS domain
P08383850A0206|13 46|tudy, beta-funaltrexamine (beta-FNA)
P08383850A0206|50 65|naltrindole (NTI)
P08384309A0000|21 63|region/helix-loop-helix (bHLH) dioxin receptor
P08384309A0000|150 168|ligand-activated DNA
P08384309A0000|206 216|target genes
P08384309A0000|228 249|dioxin response elements
P08385131A0000|3 34|alpha 2A-adrenergic receptor (alpha
P08385131A0000|35 39|2AAR)
P08385131A0000|73 107|pertussis toxin-sensitive GTP-binding
P08385337A0282|29 63|CCAAT/enhancer binding protein (C/EBP)
P08385337A0282|88 103|DNA binding region
P08385337A0282|126 131|(bZIP1
P08385337A0282|135 140|bZIP2)
P08385581A0126|11 21|enes, REC114
P08385581A0126|60 65|REC114
P08385581A0126|69 101|meiosis-specific recombination gene
P08386279A1621|28 32|EBNA2
P08386279A1621|53 56|HeLa
P08386279A1621|93 95|EBV
P08386279A1621|99 103|HIV-1
P08386279A1621|115 119|non-B
P08386279A1621|136 148|HIV-1 promoter
P08386280T0000|13 17|C/EBP
P08386280T0000|72 83|gag enhancers
P08386317T0000|7 26|protein phosphatase 2A
P08386317T0000|43 75|protein kinase A-phosphorylated CREB
P08386317T0000|88 91|CREB
P08386318A1102|10 13|IL-6
P08386318A1102|23 29|JRE-IL6
P08386318A1102|76 88|protein kinase
P08386318A1102|97 115|AMP-dependent kinase
P08386318A1102|126 152|calmodulin-dependent kinases
P08386318A1102|166 171|NF-IL6
P08386318A1102|172 177|(C/EBP
P08386318A1102|178 182|beta)
P08386592A0089|144 164|Elk-1 C-terminal region
P08386592A0089|198 208|Elk-1 kinase
P08387155A1248|42 46|c-Jun
P08387155A1248|70 71|II
P08387155A1248|81 85|c-Fos
P08387155A1248|107 108|II
P08387507A1015|23 26|MyoD
P08387507A1015|38 51|cAMP-dependent
P08387507A1015|86 101|signals generated
P08387519A0000|68 102|280-base pair muscle-specific enhancer
P08387743A0624|16 43|wild-type 5'-regulatory region
P08387743A0624|134 155|Mn-superoxide dismutase
P08387994A0980|3 11|orf61 gene
P08387994A0980|39 47|exogenous
P08387994A0980|105 108|attB
P08388496A1117|23 26|LCLs
P08388496A1117|140 146|BamHI-A
P08388496A1117|245 271|BamHI-C/W promoter-initiated
P08388496A1117|247 271|mHI-C/W promoter-initiated
P08388496A1117|278 307|BamHI-F promoter-initiated mRNAs
P08388510A0891|52 59|UL28 gene
P08388543A1263|27 38|(Y977F/Y989F
P08388543A1263|39 42|[PLC
P08388543A1263|109 121|protein kinase
P08388543A1263|167 173|GDP/GTP
P08388600A0000|0 7|Estrogen
P08389074A1227|33 36|EIAV
P08389074A1227|52 54|RNA
P08389074A1227|65 80|activation domain
P08389365A1344|76 82|d(GATC)
P08389453A0193|0 19|Uracil DNA glycosylase
P08389453A0193|102 110|duplex DNA
P08390665A0000|0 26|Lithium phthalocyanine (LiPc)
P08390665A0000|48 57|generation
P08390747A0586|49 62|17 hep syn gB gene
P08390747A0586|95 104|pathogenic
P08391748A0452|87 102|use-dependent QRS
P08391748A0452|125 139|use-dependent QT
P08391748A0452|172 187|use-dependent QRS
P08391748A0452|222 236|use-dependent QT
P08391748A0452|274 289|use-dependent QRS
P08391748A0452|312 326|use-dependent QT
P08392221A0449|63 70|estrogen
P08392623A1374|0 6|IE2-IE2
P08392623A1374|57 77|helix-turn-helix motif
P08392623A1374|103 105|IE2
P08393143A1281|3 11|Sp1 region
P08393143A1281|53 55|TRE
P08394019A0695|18 26|GST fusion
P08394019A0695|45 50|Fyn SH2
P08394019A0695|46 54|yn SH2, SH3
P08394019A0695|59 72|SH2/SH3 domains
P08394019A0695|85 94|PI 3-kinase
P08394019A0695|116 124|SH3 domain
P08394255A0000|16 19|cDNA
P08394255A0000|40 45|pcDNA1
P08394255A0000|68 81|probe generated
P08394255A0000|84 111|polymerase chain reaction (PCR)
P08394255A0000|163 181|hormone receptor cDNA
P08394464A1080|56 60|16 kDa
P08394464A1080|110 115|16-kDa
P08394862A0565|28 37|CMV disease
P08394862A0565|62 64|CMV
P08395004A0141|76 88|delta promoter
P08395004A0141|128 154|increase in wild-type HIS4 mRNA
P08395004A0558|65 73|SPT2/SIN1
P08395004A0558|119 129|protein HMG1
P08395010T0000|60 72|acid receptors
P08395014A1364|26 29|BCK2
P08395014A1364|68 71|BCK2
P08395014A1364|107 110|PPZ1
P08395014A1364|114 117|PPZ2
P08395654T0000|0 12|Steroidogenic
P08395654T0000|72 87|rat aromatase gene
P08395681A0388|47 50|HPV5
P08395681A0388|54 57|HPV8
P08395681A0388|71 75|HPV16
P08395681A0388|204 228|retinoblastoma protein (RB)
P08395681A0388|263 288|RB-nonbinding adenovirus E1A
P08396120A0690|3 6|rhaB
P08396261A0388|71 81|PKA subunits
P08396261A0388|85 88|cAMP
P08396261A0388|119 122|cAMP
P08396261A0388|163 169|cyclase
P08396261A0388|227 235|exogenous
P08396261A0388|236 239|cAMP
P08396261A0388|274 288|wild-type RI cDNA
P08396261A0388|283 288|RI cDNA
P08396261A0388|343 346|cAMP
P08396261A0388|407 415|BL21(DE3)
P08396261A0388|443 448|C alpha
P08396667T0000|0 6|BCR-ABL
P08396667T0000|10 23|v-abl oncogenes
P08396713A0305|30 32|6-S
P08396713A0305|103 143|2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
P08396713A0305|155 164|Ah receptor
P08396713A0305|175 178|ARNT
P08396713A0305|188 193|90-kDa
P08396749A1112b|0 2|LDL
P08396749A1112a|0 2|LDL
P08396749A1112a|81 82|(P
P08396749A1112b|81 82|(P
P08396749A1112a|129 130|(P
P08396749A1112b|129 130|(P
P08396913A1379|88 94|DGK gene
P08397123T0000|28 47|promoter-like element
P08397123T0000|58 91|corticotropin-releasing hormone gene
P08400240A0166|8 33|hypersensitivity site 2 (HS2)
P08400240A0166|41 63|locus control region (LCR)
P08400240A0166|68 83|gamma-globin gene
P08400240A0166|84 85|(A
P08400240A0166|152 161|endogenous
P08400240A0166|162 177|gamma-globin mRNA
P08400928A0318|0 22|INTERVENTIONS--Patients
P08400928A0318|47 72|levodopa/dopa decarboxylase
P08400928A0318|94 115|levodopa/decarboxylase
P08401570A0828|110 128|cis-acting enhancers
P08401614A0187|45 47|PAL
P08401614A0187|62 70|enes, PAL2
P08401614A0187|74 77|PAL3
P08401614A0187|124 127|mRNA
P08405433A0000|32 33|II
P08405433A0000|34 45|(IGF-II) gene
P08405433A0000|67 69|(P1
P08406004A0691|21 42|ransfection assays, PU.1
P08406004A0691|88 100|JB cis-element
P08406004A0691|192 195|PU.1
P08406419A0155|61 77|second-generation
P08406419A0155|85 89|(RIBA
P08406419A0155|92 129|Ortho Diagnostic Systems Inc, Westwood, MA)
P08406497A0000|9 23|fibrillin (FBN1)
P08407784A0850|18 22|recJ+
P08407784A0850|19 34|ecJ+ strains, srjA
P08407784A0850|76 84|hyper-UVr
P08408194T0000|83 92|generating
P08408194T0000|102 116|Na+,K(+)-ATPase
P08408841A0281|35 45|mutagenesis
P08408841A0281|80 90|single-gene
P08409284A0262|36 38|NBB
P08409284A0262|109 111|PHE
P08409593A0357|2 5|CFDN
P08409593A0357|3 10|FDN, AMPC
P08409593A0357|14 16|MNZ
P08409593A0357|81 84|AMPC
P08410042T0000|0 23|Creutzfeldt-Jakob disease
P08410097A0356|20 24|CLTPA
P08410097A0356|50 74|regression coefficient beta
P08410097A0356|105 121|oxygen uptake (beta
P08410097A0356|162 177|plasma fibrinogen
P08411276A0302|16 18|PIC
P08411276A0302|103 110|(Glascow
P08411276A0302|210 223|Trauma) (ASCOT)
P08411276A0302|270 274|ASCOT
P08412120A0839|7 15|bowel TPO2
P08412120A0839|26 28|DO2
P08412120A0839|41 42|(P
P08412620A0688|65 68|virB
P08412620A0688|131 134|VirF
P08412662A0333|31 33|DNA
P08412662A0333|60 86|transposon insertion in 257DH4
P08412662A0333|113 119|kb EcoRI
P08412665A0000|15 20|pUR400
P08412665A0000|79 85|KAY2026
P08412665A0000|124 138|repressor (ScrR)
P08413186A0077|167 180|reductase genes
P08413186A1199|3 10|Ntl1 gene
P08413205A0733|44 56|Pax-8 isoforms
P08413205A0733|109 117|a promoter
P08413205A0733|140 152|paired-domain
P08413209A0159|43 66|high-mobility-group motif
P08413209A0159|83 93|DNA-binding
P08413215A0327|33 49|NF-kappa B subunits
P08413215A0327|91 102|IL-8 promoter
P08413223A0847|23 38|IL-1 beta NF-kappa
P08413223A0847|58 69|enhancerless
P08413223A0847|76 90|virus 40 promoter
P08413223A0847|119 165|phorbol ester- or lipopolysaccharide-inducible gene
P08413239A0490|14 52|3'-end-adjacent sequence CA (N)3-10AGTNNAA
P08413239A0490|65 94|plant Pol II-specific U snRNA genes
P08413260A1437|106 112|G2 phase
P08413274A0452|0 3|MDBP
P08413274A0452|8 11|HeLa
P08413274A0452|30 49|DNA-protein complexes
P08413274A0452|123 126|MDBP
P08413291A1473|26 45|rat TnI-CAT fusion gene
P08414410A0270|0 6|METHODS
P08414502A0244|64 82|wild-type p53 protein
P08414502A0244|88 90|DNA
P08415637A0000|3 29|ADP-ribosylation factor (ARF)
P08415637A0000|63 65|RAS
P08415637A0000|91 107|weight GTP-binding
P08415637A0000|116 117|(G
P08415643A0555|3 8|E1 gene
P08415643A0555|50 53|RCC1
P08415712A1153|57 61|GPRK6
P08415712A1153|154 157|GPRK
P08415712A1153|172 188|Huntington disease
P08416952A0956|129 139|Leu99-->Pro
P08416977A0892|5 14|CTD kinases
P08416977A0892|26 30|CTDK1
P08416977A0892|34 38|CTDK2
P08417117A0592|8 11|mRNA
P08417330A0149|24 36|51-bp promoter
P08417330A0149|109 129|CYC1-lacZ reporter gene
P08417330A0149|144 145|(N
P08417331A0745|16 23|HIR1 gene
P08417331A0745|34 39|88-kDa
P08417331A0745|65 70|a motif
P08417331A0745|81 92|G beta subunit
P08417349A1633|38 47|UV-damaged
P08418183A0000|96 103|(HTLV-I)
P08418183A0000|197 224|95 husband HTLV-I-seropositive
P08418183A0000|225 233|(H+)/wife
P08418183A0000|246 249|(W+)
P08418183A0000|247 257|W+), 33 H+/W-
P08418183A0000|248 265|+), 33 H+/W-, 64 H-/W+
P08418183A0000|270 277|342 H-/W-
P08419333A0126|33 35|DNA
P08419376A0357|39 49|polypeptide
P08419376A0357|70 73|kDa)
P08419376A0357|89 112|membrane-spanning domains
P08420230A0544|0 4|SAECG
P08420571A1880|14 18|PACE4
P08420571A1880|22 24|PC4
P08421295A0365|55 57|DNA
P08421295A0365|76 88|CTGT(at)4ACAG
P08421295A0365|111 114|LexA
P08421823A1041|0 10|CONCLUSIONS
P08421897A0000|36 45|endogenous
P08421897A0000|140 142|DNA
P08421897A0000|172 192|animal retrovirus genes
P08421910A0599|43 47|TRBPs
P08421910A0599|99 104|TAR RNA
P08422975A1205|94 98|mRNAs
P08425050A0898|38 41|rpeA
P08425050A0898|81 89|PE operons
P08425221A0000|27 40|tyrosine kinase
P08425221A0000|48 50|BPK
P08425221A0000|51 52|(B
P08425221A0000|53 66|cell progenitor
P08427501A0221|49 63|HA-synthesizing
P08428722A1123|70 94|urvival: blood urea nitrogen
P08428722A1123|71 130|rvival: blood urea nitrogen level, serum aspartate aminotransferase
P08428722A1123|160 200|spital-acquired peritonitis, age, Child-Pugh
P08428750T0000|17 26|intronless
P08428750T0000|40 64|calmodulin-like protein CLP
P08428907A0653|26 28|OBP
P08428907A0653|91 93|RNA
P08428940A1763|50 51|PR
P08428940A1763|86 89|MerR
P08428940A1763|93 105|RNA polymerase
P08428940A1763|162 169|merR mRNA
P08428952A0399|132 144|tumorigenesis
P08428952A1957|52 65|plastin isoform
P08428953A1718|53 78|reporter beta-galactosidase
P08428953A1718|332 347|SV40-transformed
P08428965A1868|17 35|serum-induced CBP/tk
P08428965A1868|75 86|1 h.(ABSTRACT
P08428965A1868|87 95|TRUNCATED
P08428965A1868|92 93|AT
P08428965A1868|98 106|400 WORDS)
P08429019A0735|3 7|DNase
P08429019A0735|33 46|silencer region
P08429019A0735|74 93|a six-nucleotide motif
P08429019A0735|129 134|6 bases
P08429019A0735|142 147|GATA-1
P08429019A2022|35 37|YY1
P08429019A2022|117 126|yeast ABF-1
P08429019A2022|147 159|not.(ABSTRACT
P08429019A2022|160 168|TRUNCATED
P08429019A2022|165 166|AT
P08429019A2022|171 179|400 WORDS)
P08429020A0495|47 55|kilobases
P08429020A0495|58 60|DNA
P08429020A0495|105 106|IX
P08429568A0000|22 36|plasmid pRmeGR4b
P08429568A0000|140 148|strain GR4
P08430095A0161|53 64|unction, SMD1
P08430095A0161|88 92|PRP38
P08430095A0913|85 89|snRNA
P08432137A0000|30 47|adenosine deaminase
P08432137A0000|48 52|(PADA
P08432137A0000|74 85|nts), the PADA
P08432137A0000|82 91|PADA/serum
P08432137A0000|100 106|(P/SADA
P08432137A0000|125 137|lysozyme (PLYS
P08432137A0000|133 137|(PLYS
P08432137A0000|152 161|PLYS/serum
P08432137A0000|170 176|(P/SLYS
P08432137A0000|213 216|(IFN
P08432137A0000|281 289|effusions
P08432526A0580|36 50|sequencing cDNAs
P08432526A0580|61 70|polymerase
P08432526A0580|99 113|a fibroblast cDNA
P08432696A1117|13 20|apeA gene
P08432696A1117|56 66|proteinases
P08432696A1117|67 75|(protease
P08432696A1117|76 77|IV
P08432696A1117|81 94|aminopeptidase
P08435755A1078|0 2|PNT
P08435755A1078|1 6|NT, ADD
P08435755A1078|10 12|BSS
P08435794A0658|0 10|CONCLUSIONS
P08437521A0000|91 98|areA gene
P08437521A0000|198 201|areA
P08437521A0000|245 248|areA
P08437737A0100|35 37|%BF
P08438584T0000|16 34|coat protein promoter
P08438584T0000|83 91|C1-C2 gene
P08438584A0524|55 71|C2 ORFs (C1-C2 gene)
P08438584A0524|94 98|V1 ORF
P08439564A0883|31 32|TC
P08439564A0883|33 34|II
P08439597A0000|58 80|enzyme immunoassay (FEIA)
P08440238T0000|152 178|ransformation, tumorigenesis
P08440688A1509|31 36|G alpha
P08440688A1509|68 74|LLC-PK1
P08440720A1404|23 42|full-length PfCPK cDNA
P08440720A1404|100 105|60-kDa
P08441379A0912|16 48|proIL-1 beta cap site-proximal region
P08441379A0912|82 92|proIL-1 beta
P08441379A0912|105 127|virus 40 enhancer elements
P08441379A0912|170 173|HeLa
P08441379A0912|211 218|IL-1 beta
P08441394A1297|10 15|PC-PLC
P08441394A1297|88 91|junB
P08441394A1297|135 143|PKC-delta
P08441411A1260|2 19|mitogen-stimulated
P08441411A1260|192 195|IL-2
P08441411A1260|252 257|S phase
P08441423A0145|33 36|GCD6
P08441423A0145|40 48|GCD7 genes
P08441423A0145|94 97|GCN4
P08441869A0334|3 12|plateau MO2
P08442384T0000|3 23|SCH9 protein kinase mRNA
P08442384A0430|66 83|reading frame (uORF)
P08442384A0430|124 141|54 amino acid peptide
P08443122A0657|21 40|fibroblasts PILOT gene
P08443122A0657|66 76|signal (PMA)
P08443122A0657|95 97|CyA
P08443339A1374|27 29|GUS
P08443340A0522|68 82|promoter regions
P08443340A0522|102 114|glucanase gene
P08443340A0522|120 154|beta-glucuronidase (GUS) reporter gene
P08443341A0384|64 71|. napus MA
P08443341A0384|75 80|MB cDNA
P08443341A0384|97 113|MA type myrosinases
P08443341A0384|139 144|4 genes
P08443341A0384|151 167|MB type myrosinases
P08443341A0384|188 194|10 genes
P08444344A0000|0 14|Zinc fingers (Zf)
P08444345A0403|16 21|EFIA#1
P08444345A0403|59 65|rat EFIA
P08444345A0403|89 139|EFIA/DbpB/YB-1 family member DNA-binding protein B (DbpB)
P08445729A0657|43 46|ARMs
P08445729A0657|87 89|RNA
P08445792A0469|4 5|II
P08445792A0469|39 42|(IIA
P08445792A0469|46 49|IIB)
P08446579A0784|10 34|transcription factor Gal-ER
P08446579A0784|119 134|activating domain
P08446579A0784|140 161|herpesvirus protein VP16
P08446579A1210|3 11|exogenous
P08446579A1210|12 18|fos gene
P08446579A1210|64 71|estrogen
P08449943A0225|57 65|8-Cl-cAMP
P08449943A0225|88 108|kinase isozymes in HL-60
P08449978A0000|99 111|protein kinase
P08449986A0455|29 44|full-length cDNAs
P08449986A0455|48 55|MMI alpha
P08450015A0175|80 90|solid-phase
P08453101A0128|0 19|Pokeweed mitogen (PWM)
P08453101A0128|22 29|anti-CD3
P08453101A0128|52 74|c-jun messenger RNA (mRNA)
P08453950A0498|10 29|eizure induction, MABP
P08453950A0498|51 58|brain pHi
P08453950A0498|114 115|(P
P08454077A0956|24 30|U74500A
P08454077A0956|34 49|g/kg i.v. infusion
P08454077A0956|107 110|GMBF
P08454077A0956|121 131|reperfusion
P08454077A0956|132 134|[PI
P08454077A0956|256 259|[GMV
P08454077A0956|319 322|(NS)
P08454077A0956|336 357|6 h ischaemia].(ABSTRACT
P08454077A0956|358 366|TRUNCATED
P08454077A0956|363 364|AT
P08454077A0956|369 377|250 WORDS)
P08454591A0692|13 24|1.3-kilobase
P08454591A0692|38 54|5'-flanking region
P08454591A0692|60 67|TSG6 gene
P08454591A0692|78 86|TATA-like
P08454591A0692|90 93|CAAT
P08454591A1322|34 37|IL-1
P08454591A1322|40 42|TNF
P08454591A1322|95 99|IRF-1
P08454591A1322|104 109|2, AP-1
P08454591A1322|114 120|NF-IL-6
P08454858A0285|0 7|Ig-alpha
P08454858A0285|11 17|Ig-beta
P08455598A0000|75 81|a/alpha
P08455598A0000|166 173|a1-alpha
P08455611A0000|54 72|zeta 2 globin promoter
P08455611A0000|100 113|element (HS-40)
P08455611A0000|138 152|zeta 2 globin gene
P08455611A0154|40 44|HS-40
P08455611A0154|76 104|high-level zeta 2 globin promoter
P08455623A0630|30 40|23S pre-rRNA
P08455623A0630|100 125|RNA-associated proteins NOP1
P08455623A0630|129 132|GAR1
P08456879A0000|0 8|OBJECTIVE
P08457205A0240|123 128|G alpha
P08457205A0240|141 145|cDNAs
P08457291A0170|43 57|proto-oncogenes
P08457291A0170|119 131|c-fos oncogene
P08458849A0364|25 28|flaN
P08458849A0364|58 72|sigma 54 promoter
P08458849A0364|79 89|ftr elements
P08459465A0257|147 161|Harris-Benedict
P08460918A0252|48 49|II
P08460918A0252|128 169|lirubin, 47 mumol liter-1; alkaline phosphatase
P08460918A0252|129 175|irubin, 47 mumol liter-1; alkaline phosphatase, 280 IU
P08460918A0252|130 211|rubin, 47 mumol liter-1; alkaline phosphatase, 280 IU liter-1; gamma-glutamyltranspeptidase
P08460918A0252|131 217|ubin, 47 mumol liter-1; alkaline phosphatase, 280 IU liter-1; gamma-glutamyltranspeptidase, 190 IU
P08460918A0252|232 234|III
P08461981A0882|64 75|regeneration
P08463284A1531|11 12|II
P08463284A1531|13 15|PKC
P08463284A1531|21 33|p34cdc2 kinase
P08463320A1219|126 128|SSB
P08463320A1219|175 177|SSB
P08463485T0000|21 69|endotoxin infusion on milking-induced oxytocin release
P08464056A0000|16 47|box-zinc finger proteins (FAX-ZFPs)
P08464056A0000|77 88|C2H2 type ZFPs
P08464056A0510|42 48|FAX-ZFP
P08464924A0243|1 7|rat cDNA
P08464924A0243|19 23|eIF-5
P08464924A0243|95 99|eIF-5
P08466864A0878|105 107|AMP
P08466864A0878|118 144|element binding protein (CREB)
P08466864A0878|159 166|TGF-beta
P08466864A0878|171 173|PMA
P08466864A0878|199 202|PU-1
P08468475A1280|2 16|F42A-stimulated
P08468475A1280|40 60|forskolin-induced YT-1
P08468475A1280|70 79|IL-2R alpha
P08468475A1280|125 140|IL-2R beta subunit
P08468475A1280|155 164|IL-2R alpha
P08468475A1280|190 210|F42A-IL-2R beta complex
P08468475A1280|224 236|alpha-subunit
P08468475A1280|272 275|F42A
P08470021A0195|25 27|IgG
P08470021A0195|116 123|"Ignacio
P08470895A1617|40 43|mRNA
P08470895A1617|62 65|TATA
P08471629A0816|49 63|Ca-dependent PKC
P08471629A0816|82 89|beta-PKC
P08471629A0816|96 99|nPKC
P08471629A0816|119 129|Histone IIIS
P08471629A0816|132 145|peptide(19-31)
P08472750A0999|116 117|pH
P08473731A0149|21 28|B29 genes
P08473731A0149|38 47|alpha/beta
P08473731A0149|63 83|BCR-associated complex
P08473731A0149|92 96|sIgM+
P08473967T0000|35 46|Myers-Briggs
P08474438A0000|76 88|RNA polymerase
P08474438A0000|89 90|II
P08474438A0000|144 146|RNA
P08474438A0000|176 183|pre-mRNA
P08474438A0000|235 238|mRNA
P08474439A0877|67 74|A/T-rich
P08474439A0877|147 150|MEF1
P08474439A0877|151 156|(Right
P08474439A0877|234 237|CArG
P08474456A1041|64 74|10-bp region
P08474456A1041|112 116|LyF-1
P08474464A0348|35 36|TR
P08474464A0348|36 44|R, Rev-Erb
P08474464A0348|58 59|TR
P08475104A0341|17 36|25-bp promoter element
P08475104A0341|71 74|G1-S
P08475104A0341|95 122|thymidine kinase (htk) promoter
P08475104A0341|179 194|p33cdk2 complexes
P08476087A0814|89 94|30 mmHg
P08476854A0097|0 4|DNase
P08476854A0097|61 82|protein-binding domains
P08476854A0097|103 116|796 base pair DNA
P08476854A0097|125 129|(base
P08479742A0985|50 54|wt p53
P08481004A0321|29 40|endonuclease
P08482539A0913|35 37|RNA
P08482539A0913|51 54|xylP
P08483412A0000|3 6|nifJ
P08483412A0000|10 22|nifH promoters
P08483412A0000|70 95|sigma 54-dependent promoters
P08483412A0000|127 130|NifA
P08483479A1056|17 19|PTH
P08483479A1056|23 26|cAMP
P08483479A1056|37 52|collagen promoter
P08483479A1056|113 116|1(I)
P08483479A1056|117 132|collagen promoter
P08483479A1056|167 179|-2.3 kilobases
P08483479A1056|191 193|PTH
P08483479A1056|197 200|cAMP
P08483479A1056|213 224|collagen gene
P08485317A0000|3 23|fission yeast dsk1+ gene
P08485317A0000|87 104|61-kd protein kinase
P08486276A0419|38 40|ORF
P08486276A0419|45 59|protein database
P08486276A0419|85 102|aa sequence homology
P08486276A0419|114 130|transmembrane (TM)
P08486276A0419|162 180|chloramphenicol (Cm)
P08486276A0419|184 199|tetracycline (Tc)
P08486705A0181|3 11|yeast gene
P08486705A0181|23 27|eIF-5
P08486705A0181|39 42|TIF5
P08486705A0181|115 119|eIF-5
P08491383A0154|3 15|alpha-subunit
P08491383A0154|40 42|DNA
P08491383A1291|17 29|alpha-subunit
P08491383A1291|100 110|DNA-binding
P08491383A1291|114 146|protein-protein interaction domains
P08492290A0306|75 99|tability constants, log beta
P08492290A0306|93 99|log beta
P08496157A0000|3 11|bcl-2 gene
P08496157A0000|38 43|22-kDa
P08496185A0484|58 76|adenylate kinase gene
P08496475T0000|16 25|cariogenic
P08496475T0000|44 72|Corynebacterium (Bacterionema)
P08496599A0310|34 40|BGP gene
P08496599A0310|78 81|mRNA
P08496601A1153|28 38|muMIP-1 beta
P08496601A1153|42 53|muMIP-1 alpha
P08496601A1153|71 81|CK-1 element
P08496601A1153|114 116|RAW
P08496601A1153|165 175|muMIP-1 beta
P08496601A1153|181 192|muMIP-1 alpha
P08496601A1153|216 260|growth hormone reporter gene link LPS-inducibility
P08496601A1153|315 327|consensus CK-1
P08496848A0692|54 56|FSE
P08496848A0692|95 96|SE
P08497248A0000|29 70|macrophage colony-stimulating factor 1 (CSF-1)
P08497248A0000|75 92|c-fms protooncogene
P08497259A0452|13 22|SUP4A53T61
P08497269A0999|46 49|GCN1
P08497269A0999|74 77|tRNA
P08497269A0999|116 119|GCN2
P08497269A0999|141 144|tRNA
P08497273T0000|0 10|NF-HB (BSAP)
P08497273T0000|61 73|alpha enhancer
P08497280T0000|8 39|SWI6-dependent cis-acting elements
P08497280T0000|47 50|SWI4
P08497280A0266|20 23|SWI4
P08497280A0266|114 117|SWI4
P08497280A1397|55 58|SWI4
P08497280A1397|86 89|SWI6
P08499376A0000|9 11|PRK
P08499916A0000|3 12|COL7A1 gene
P08499916A0000|26 32|type VII
P08499916A0000|62 74|candidate gene
P08500524A0424|28 36|gamma gene
P08500938A0408|19 21|III
P08500938A0408|22 25|BGCT
P08501030A0456|25 38|aeg-46.5 operon
P08501030A0456|74 77|narL
P08501030A0456|89 92|(M.H
P08501678A0498|99 108|Hib disease
P08503348A0226|3 17|HMG CoA reductase
P08504707A0376|5 28|iology, pathology, brain CT
P08504928T0000|10 27|230-kD TFIID subunit
P08504928T0000|57 69|cell cycle gene
P08504928T0000|97 99|DNA
P08504928T0000|112 133|TATA box-binding subunit
P08504928T0000|136 140|TFIID
P08504932A0123|20 23|GATA
P08504932A0123|53 56|GATA
P08504932A0123|93 103|DNA-binding
P08504933A0000|8 31|tissue-specific POU domain
P08505340T0000|55 95|rat prostaglandin endoperoxide synthase 2 gene
P08505495A0253|14 21|75SeHCAT
P08506317A0000|12 16|C/EBP
P08506317A0000|25 49|basic-leucine zipper (bZip)
P08506317A0000|98 101|CAAT
P08506317A0000|113 142|sequence-related enhancer motifs
P08506384A0146|34 43|eIF-2 alpha
P08506384A0146|65 70|eIF-2B
P08506384A0146|75 81|GDP-GTP
P08506384A0146|99 103|eIF-2
P08507921A1021|67 68|MI
P08507921A1021|79 87|plasma ANF
P08508774A0242|51 53|DNA
P08508774A0242|100 102|DNA
P08508778A0112|30 37|NOP1 gene
P08508778A0112|121 128|pre-rRNA
P08509333A0843|1 6|36-kDa
P08509333A0843|98 105|ftsN gene
P08509333A0843|121 124|FtsN
P08509335T0000|0 3|SSG1
P08509335T0000|19 56|sporulation-specific 1,3-beta-glucanase
P08509419A0785|110 114|TyrRS
P08509430A0372|60 79|hlamydomonas, CC-2341
P08509430A0372|125 132|psaB gene
P08510320A0000|60 65|(MRSA)
P08510320A0000|106 125|concentrations (MICs)
P08510320A0000|166 179|arbekacin (ABK)
P08510320A1249|36 40|MRSAs
P08510320A1249|156 167|beta-lactams
P08510924A0490|59 71|HSP70 promoter
P08512728A0991|0 6|RESULTS
P08512728A0991|71 72|II
P08512728A0991|171 172|RR
P08513025A0000|101 114|bilirubin (TcB)
P08514766A0732|3 8|GTPase
P08514766A0732|19 25|CDC42Ce
P08514766A0732|56 84|-chimaerin, a GTPase-activating
P08515619A0184|141 144|COPD
P08515619A0184|179 187|B type COPD
P08516308A0669|12 15|RAD+
P08516324A0000|166 172|EWS gene
P08516324A0000|178 211|carboxyl-terminal DNA-binding domain
P08516324A0000|224 231|FLI1 gene
P08518797T0000|0 24|X-linked liver glycogenosis
P08518797T0000|53 65|candidate gene
P08519862T0001|13 23|anti-HCV IgM
P08521414A1384|39 41|CpG
P08521414A1384|73 80|p16INK4A
P08521414A1384|123 126|mRNA
P08521414A1384|159 161|(E1
P08521414A1384|162 166|beta)
P08521414A1384|200 207|p16INK4A
P08521717A0126|2 17|immunoperoxidase
P08521717A0126|19 29|eaction, PAP
P08521717A0126|61 64|VIII
P08521717A0126|140 143|VIII
P08521717A0126|204 213|LNG-IUD-20
P08522175A0306|24 28|BTF3b
P08522175A0306|53 63|beta subunit
P08522175A0306|82 123|nascent-polypeptide-associated complex (NAC)
P08522175A0306|196 204|[Wiedmann
P08522511A1250|8 10|PLB
P08522511A1250|24 28|lyase
P08522511A1250|39 40|pH
P08522511A1578|26 29|pelA
P08522511A1578|33 36|pelB
P08522511A1578|66 87|beta-glucuronidase gene
P08522511A1578|126 143|beta-glucuronidase
P08522530A1342|4 11|nifA mRNA
P08523545T0000|48 65|adenovirus type 5 E1A
P08523545T0000|144 146|ATF
P08523545T0000|150 157|Oct-1 DNA
P08524036A0747|65 85|stripe 2 enhancer region
P08524229T0000|16 75|soybean ribulose-1,5-bisphosphate carboxylase small-subunit mRNA
P08524229T0000|17 80|oybean ribulose-1,5-bisphosphate carboxylase small-subunit mRNA, SRS4
P08524235A0695|32 35|dMax
P08524235A0695|99 120|helix-loop-helix region
P08524235A0695|164 169|max RNA
P08524241A0212|26 30|HSP82
P08524241A0212|59 67|IME1-IME2
P08524260A0835|26 31|LTBP-2
P08524260A0835|61 66|LTBP-2
P08524260A0835|208 223|8-cysteine motifs
P08524260A0835|253 258|LTBP-1
P08524267A1022|45 73|wild-type prothymosin alpha gene
P08524267A1022|116 131|myc-derived genes
P08524272T0000|27 65|alpha/beta interferon-stimulated Jak/Stat
P08524272T0000|78 122|SH2 domain-containing tyrosine phosphatase SHPTP1
P08524284A0309|38 42|cDNAs
P08524284A0309|51 53|PTF
P08524284A0309|62 64|PTF
P08524284A0309|139 148|PTF complex
P08524284A0309|151 154|HeLa
P08524292A1022|44 46|YY1
P08524292A1022|93 95|AP1
P08524292A1022|123 125|YY1
P08524292A1022|147 149|DNA
P08524294A0652|3 11|skp1+ gene
P08524314A0216|3 6|TEA1
P08524314A0216|7 9|(Ty
P08524314A0216|10 31|enhancer activator) gene
P08524314A0216|62 64|kDa
P08524314A0216|102 118|dimerization motif
P08524314A0216|148 158|DNA-binding
P08526620A1344|42 64|SC5b-9 complement complex
P08528796A1470|3 5|MCA
P08528796A1470|9 12|UA PI
P08529098A0549|73 84|roteins, SMF1
P08529098A0549|88 91|SMF2
P08529098A0549|128 138|omains: exon
P08529098A0549|250 263|transport motif
P08529630A0840|26 37|P protein mRNA
P08529654A0589|75 92|cyclophilin isoform
P08529654A0589|119 125|(Cyp-1)
P08529662A0507|42 52|ERp57/GRP58
P08530105A0308|27 40|Langer-Giedion
P08530107A1003|48 56|histidase
P08530107A1003|81 89|histidase
P08530149A0689|71 91|initiator (Inr) element
P08530149A0689|72 104|nitiator (Inr) element: TCA(+1)YYYNY
P08530342T0000|8 19|gp39 promoter
P08530345A0880|55 66|TGACCT motifs
P08530345A0880|90 95|HD PPRE
P08530345A0880|109 111|DR1
P08530345A0880|115 124|DR2 element
P08530345A0880|173 178|HD PPRE
P08530369A0099|96 119|Src family tyrosine kinases
P08530384A0559|81 83|DNA
P08530384A0559|119 125|Oct-DNA
P08530384A0559|157 167|BOB.1/OBF.1
P08530384A0559|210 212|DNA
P08530418A1182|30 46|TR2 orphan receptor
P08530418A1182|101 104|HREs
P08530418A1182|102 113|REs, RARE beta
P08530418A1182|117 123|CRBPIIp
P08530503A1004|6 8|ARF
P08530503A1004|13 15|ARP
P08530503A1004|89 94|3T3-L1
P08531373A0470|75 77|SjS
P08531373A0470|86 94|SS-A/SS-B
P08532516A0000|36 43|cdc10-C4
P08532536A0925|0 3|TIEG
P08532536A0925|16 19|hFOB
P08532536A0925|43 50|TGF-beta
P08532536A0925|54 70|bone morphogenetic
P08532536A0925|71 86|protein-2 (BMP-2)
P08532536A0925|121 137|growth factor (EGF)
P08533472A0777|29 32|ORFs
P08533472A0777|162 201|interleukin enhancer-binding factor (ILF-2)
P08533473A0375|31 38|ADH1 gene
P08533473A0375|58 65|database
P08533473A0375|78 82|20 EST
P08533757A0204|46 53|185delAG
P08533757A0204|140 144|BRCA1
P08534217A0402|61 63|FVC
P08534217A0402|67 70|FEV1
P08534217A0402|93 105|Viskovo region
P08534367A0984|0 5|PTP-S3
P08534367A0984|17 22|PTP-S4
P08534848A0188a|8 17|NR isoforms
P08534848A0188b|8 17|NR isoforms
P08534848A0188a|8 9|NR
P08534855A0000|3 21|Arabidopsis FAD7 gene
P08534855A0000|53 66|acid desaturase
P08535138A0857|85 103|lant hormones, cycMs4
P08535138A0857|143 145|DNA
P08536694A0000|0 13|Protein kinases
P08537388A0825|123 129|631 base
P08537388A0825|137 142|WNT-5A
P08537403A0336|3 22|protein kinase domains
P08537403A0336|25 29|LIMK1
P08537403A0336|33 37|LIMK2
P08537403A0336|73 108|sequence motif Asp-Leu-Asn-Ser-His-Asn
P08537403A0336|111 119|subdomain
P08537403A0336|120 122|VIB
P08537403A0336|151 163|subdomains VII
P08537403A0336|167 170|VIII
P08538052A0000|17 20|cDNA
P08538052A0000|61 87|zinc-finger protein (THZif-1)
P08538052A0000|109 112|cDNA
P08538052A0000|150 161|leukemia HL60
P08538052A0000|276 286|DNA-binding
P08538052A0000|308 342|nuclease-hypersensitive element (NHE)
P08538052A0000|353 361|c-myc gene
P08538382A1012|0 12|Erythrocyte AA
P08538382A1012|15 33|FO+EPO-supplemented
P08538483A0207|50 69|one mass, total (TBBMC)
P08538483A0207|135 138|GnRH
P08538702A0214|10 20|polypeptide
P08538702A0214|45 49|ABA-1
P08538702A0214|149 154|15-kDa
P08541499A0306|78 91|tobacco operons
P08542026A0792|0 2|DAF
P08542026A0792|6 9|70 kD
P08542026A0792|57 78|consensus repeats (SCRs)
P08542026A0792|113 141|complement activation (RCA) gene
P08542027A1471|3 9|XS2 gene
P08542027A1471|53 59|LU genes
P08542027A1471|88 91|CD44
P08543173A0314|9 12|TATA
P08543275A0130|141 152|Arctic region
P08543810A0000|35 47|LPS-activated
P08543810A0000|121 124|cDNA
P08543810A0000|156 173|sequence tags (ESTs)
P08544820T0000|20 26|EcR/USP
P08544820T0000|97 105|Lsp-2 gene
P08545502A0914|5 9|SPECT
P08545502A0914|29 31|PET
P08546707T0000|30 48|chicken lysozyme gene
P08546707T0000|51 68|NF-kappa Bp65 (RelA)
P08546707T0000|72 76|c-Rel
P08546707T0000|86 93|NF-kappa
P08547205A1060|104 106|SVT
P08548291A1059|28 32|SAPKs
P08549859A1604|56 68|Centre d'Etude
P08550425A1401|49 51|POR
P08550460A0374|3 28|transposon-inactivated gene
P08550460A0374|40 43|pilP
P08550460A0374|77 84|19.1-kDa
P08550462A0815|13 19|dra gene
P08550467A0863|28 31|scrB
P08550467A0863|74 85|sequence (OB)
P08550467A0863|125 128|scrB
P08550470A1021|9 12|CheW
P08550470A1021|59 68|kinase CheA
P08550476A0610|22 29|ene, epiF
P08550476A0610|45 64|activator protein EpiQ
P08550476A0610|109 112|EpiQ
P08550476A0610|129 140|epiA promoter
P08550476A0610|164 167|EpiQ
P08550564T0000|0 12|CXC chemokines
P08550564T0000|130 150|interleukin-8 receptor
P08551572A0155|44 71|translation initiation regions
P08551572A0155|74 77|ICP4
P08551572A0155|81 89|pp38 mRNAs
P08551572A0155|114 117|MSB1
P08551572A0155|129 143|MDCC-CU91 (CU91)
P08551577A0000|53 72|transcripts generated
P08551577A0000|85 87|DNA
P08551577A0000|106 109|mRNA
P08551577A0000|154 160|src mRNA
P08552042A1497|66 70|T-DNA
P08552042A1497|113 136|steady-state poly(A)+ mRNA
P08552042A1497|216 226|generations
P08552045A0973|29 39|phosphatase
P08552045A0973|53 67|5'-GCACGTGGG-3'
P08552045A0973|71 85|5'-GCACGTTTT-3'
P08552082A0480|19 36|proline-rich region
P08552082A0480|39 41|CAP
P08552082A0480|59 68|SH3 domains
P08552086A0150|33 61|vitamin D response element (VDRE)
P08552092A1678|115 128|promoter region
P08552092A1678|199 206|rep3 gene
P08552093A0657|54 69|GTPase-deficient
P08552095A0758|48 55|isogenic
P08552095A0758|134 137|PAF1
P08552095A1115|74 83|yeast genes
P08552096A0151|52 66|yeast gene (UBS1)
P08552387A0000|141 143|EWS
P08552387A0000|164 178|factor gene ATF-1
P08552643A0261|19 21|DBD
P08552643A0261|105 124|stomatitis virus (VSV)
P08552643A0261|138 140|IFN
P08552670A0665|40 42|ARS
P08552670A0665|55 76|DNA polymer poly[d(A.T)]
P08553580A0102|10 27|reading frame (ORF2)
P08553580A0102|61 63|FIV
P08554069A0743|66 70|G-->T
P08554069A0743|149 151|RNA
P08554540A1480|26 52|HIT protein similarity regions
P08554723A0187|71 79|PBN (PBNx)
P08554723A0187|115 129|LiCl-induced CTA
P08555076A0333|9 22|Amphotericin-B
P08555446A0000|69 83|pyrophosphatase
P08555446A0000|93 107|35S CaMV promoter
P08555498A0427|5 9|LAF-4
P08555597A0808|24 26|(Hb
P08555753A0591|0 2|CBT
P08556707A1390|74 84|p53 promoter
P08556707A1390|142 144|p53
P08556707A1390|169 180|248trp allele
P08556707A1390|183 188|SNU-C5
P08561607A1443|12 13|II
P08561607A1443|17 18|IV
P08561893A0100|38 41|bHLH
P08561893A0100|77 84|E-box DNA
P08561893A0100|113 116|bHLH
P08561897A0604|62 72|factor (USF)
P08561897A0604|140 147|CREB/ATF
P08561897A0604|151 154|AP-1
P08561897A0604|164 177|CRE/TRE element
P08563483A0094|43 59|gonadotropin (hCG)
P08563483A0094|79 81|TSH
P08563483A0094|99 101|hCG
P08564488A1359|4 13|fibrinogen
P08564588A1318|98 114|overall.(ABSTRACT
P08564588A1318|115 123|TRUNCATED
P08564588A1318|120 121|AT
P08564588A1318|126 134|250 WORDS)
P08565330A1783|13 22|epigenetic
P08565548A0196|22 34|arthritogenic
P08565548A0196|91 92|II
P08565548A0196|93 97|(BII)
P08565548A0196|129 130|DA
P08566747A0756|0 2|SBF
P08566747A0756|79 93|Cln/Cdc28 kinase
P08566747A0756|130 132|SBF
P08566751A0455|38 55|vertebrate Hox genes
P08566751A0455|147 154|Hox genes
P08566751A0788|18 24|gHoxb-1
P08566754A0783|97 122|ribonucleoproteins (snRNPs)
P08566754A0783|137 175|splicing factor/splicing factor 2 (ASF/SF2)
P08566756A0752|24 26|SAP
P08566756A0752|52 68|SF3a/SF3b subunits
P08566756A0752|53 71|F3a/SF3b subunits, UV
P08566756A0752|85 92|pre-mRNA
P08566756A0752|96 114|20-nucleotide region
P08566756A0752|128 130|BPS
P08566773A1023|13 16|CTS1
P08566773A1023|20 23|CTS2
P08566773A1023|66 75|chitinases
P08567556A0000|24 46|myoglobin-bound O2 (MbO2)
P08567683A0401|8 15|purH cDNA
P08567683A0401|18 25|1776 base
P08567683A0401|74 76|(Mr
P08567717T0000|26 59|spindle pole body duplication gene MPS1
P08567847A1005|16 21|SM-CMA
P08569680A0636|7 10|areA
P08569680A0636|77 99|GATA (DNA-binding) domain
P08569684A0000|115 133|protein kinase C (PKC)
P08569684A0000|163 172|polymerase
P08569684A0000|214 216|DNA
P08570615T0000|12 19|RB/E2F-1
P08570615T0000|55 59|E2F-1
P08570615T0000|68 74|S-phase
P08573083A0645|115 125|factor (USF)
P08573083A0645|147 161|insulin promoter
P08574414A1037|20 22|PCR
P08574583A0658|3 12|Clb5 kinase
P08574583A0658|27 32|S phase
P08574583A0658|56 63|G2-phase
P08575609A0526|3 5|C/D
P08575609A0526|32 37|9 cases
P08575614A0264|64 100|protein in DNA damage-induced mutagenesis
P08575618A1138|0 4|RNase
P08575754T0000|68 79|CDKN2D/INK4d
P08575754T0000|94 117|cyclin D-dependent kinases
P08576042A0765|16 19|HrcA
P08576042A0765|44 47|hrcA
P08576042A0765|60 74|plasmid (phrcA+)
P08576042A0765|99 107|delta hrcA
P08576042A0765|147 150|dnaK
P08576042A0765|154 164|groE operons
P08576042A0765|236 239|mRNA
P08576131A0151|58 69|USF2 isoforms
P08576131A0151|87 99|44-kDa subunit
P08576131A0151|88 105|4-kDa subunit, USF2a
P08576131A0151|114 126|38-kDa subunit
P08576131A0151|115 132|8-kDa subunit, USF2b
P08576131A0151|116 142|-kDa subunit, USF2b, generated
P08576131A0685|35 45|USF subunits
P08576131A0685|128 130|USF
P08576179A0126|9 11|PKR
P08576179A0126|58 109|translation initiation factor 2 alpha subunit (cIF-2 alpha)
P08576179A0126|119 129|polypeptide
P08576245A0000|0 4|GRP78
P08576262A0160|3 14|IL-8 receptor
P08576262A0160|18 52|seven-transmembrane spanning receptor
P08576546A0975|42 48|PDC/HDC
P08580083A0259|148 183|chloramphenicol acetyltransferase gene
P08580083A0259|192 197|HIV LTR
P08580671A0137|72 83|beta-blocker
P08580671A0137|173 184|liver disease
P08581174A0472|30 46|non-inducible qutA
P08581174A0472|124 127|QUTA
P08582143A0614|65 75|chromogenic
P08582143A0614|143 156|beta-lactamase
P08582633T0000|78 80|HMR
P08583783A0870|8 10|ANP
P08583783A0870|35 44|filtration
P08583783A0870|52 65|alf, filtration
P08583783A0870|80 82|ANP
P08583846A0121|32 37|beta-2
P08583846A0807|11 27|methodology beta-2
P08584026A0115|3 12|hIGF-I gene
P08584035A0740|130 144|3 beta I-A element
P08584035A0740|158 177|DNA-protein complexes
P08584035A0740|178 180|(R1
P08584074A0000|93 109|lobe epilepsy (TLE)
P08584530A0545|37 40|FEV1
P08584530A0545|69 76|aw, MEF50
P08584530A0545|80 84|MEF25
P08585324A0467|28 35|SSC1 gene
P08585324A0467|36 41|(Smith
P08585324A0823|38 45|Leu-tRNA
P08585324A0823|69 78|tau element
P08585883A0381|16 21|(C57BL
P08585883A0381|22 26|x CBA)
P08585883A0381|41 58|breeder males (CD-1)
P08585883A0381|62 64|LNG
P08585957A0101|166 190|"AT-hook" DNA-binding motif
P08585994A0567|91 101|cytogenetic
P08585994A0567|102 119|band interval 89A1,2
P08585994A0567|179 194|segmentation gene
P08586643A0951|67 69|ATP
P08586643A0951|72 74|UMP
P08586643A0951|78 80|CMP
P08586874T0000|40 45|(Looss
P08587075T0000|26 31|5 cases
P08588852A0236|18 42|pregnancy ultrasonographic
P08589358A0235|36 56|erythropoietin (rhEPO)
P08589358A0841|67 76|allogeneic
P08589358A0841|77 92|blood transfusion
P08589735A0577|8 20|onstructs, GUS
P08589735A0577|42 56|promoter regions
P08589735A0577|71 107|Arabidopsis alcohol dehydrogenase (Adh1)
P08589735A0577|72 128|rabidopsis alcohol dehydrogenase (Adh1), maize ubiquitin (Ubi1)
P08589735A0577|73 144|abidopsis alcohol dehydrogenase (Adh1), maize ubiquitin (Ubi1), rice actin (Act1)
P08589735A0577|148 159|CaMV 35S genes
P08590465A0773|50 57|URA1 gene
P08590465A0773|100 107|URA2 gene
P08591700A0972|3 24|mean body mass index (BMI)
P08593813A0967|41 65|germ cell-specific Sp1 mRNAs
P08595012A0817|27 31|tcPO2
P08595012A0817|40 42|LDF
P08595184A0407|98 118|field potentials (LFPs)
P08595627A1513|13 16|KATP
P08595627A1513|106 114|(iii) KATP
P08595627A1513|132 152|reperfusion-induced VF
P08595627A1513|167 184|ischemia-induced VF
P08595658A0961|3 5|DNA
P08595658A0961|130 138|generated
P08595658A0961|141 143|RNA
P08595878A0201|42 45|PP2A
P08595878A0201|85 111|receptor tyrosine kinase (RTK)
P08595878A0201|150 164|R7 photoreceptor
P08597108A0642|0 4|QBMDs
P08597108A0642|19 34|response (QBMD05)
P08597108A0642|81 85|NOAEL
P08597177T0000|60 62|EEG
P08597596A0135|16 26|ATP-binding
P08597596A0135|17 38|TP-binding cassette, ABC
P08597636A0000|3 12|T-box motif
P08598051T0000|66 104|RNP consensus-sequence RNA-binding domains
P08598359X0000|74 78|T1-T2
P08598359X0000|113 126|larynx? PURPOSE
P08598359X0000|225 229|T1-T2
P08598449A0784|57 72| lymphocytes, CD38
P08598449A0784|129 158|src-like protein tyrosine kinases
P08598449A0784|185 205|ras-GTPase-activating
P08598449A0784|256 259|CA2+
P08599945T0000|14 27|alpha-amanitin
P08599945T0000|64 81|yeast RNA polymerase
P08599945T0000|82 84|III
P08599945T0000|99 101|RNA
P08599946A0999|39 48|p40 complex
P08599946A0999|52 75|ribonucleoprotein complex
P08599946A0999|86 95|L1Hs RNA(s)
P08599946A0999|137 147|alpha-helix
P08600028A1129|52 65|intron enhancer
P08600048T0000|86 100|ultrastructural
P08601283A0875|21 33|SECIS elements
P08601283A0875|43 61|reading frames (ORFs)
P08601283A0875|112 126|type 1 deiodinase
P08601283A0875|141 143|ORF
P08601283A0875|151 162|SECIS element
P08601283A0875|199 203|SECIS
P08601284A0000|24 40|spacer (ETS) region
P08601284A0000|46 53|pre-rRNA
P08601284A0000|133 140|U3 snoRNA
P08601616A0726|86 89|G1/S
P08601806A0875|20 24|RPF-1
P08602169A0484|40 51|endonuclease
P08602169A0484|52 54|III
P08602169A0484|90 93|CPDs
P08602169A0484|99 106|MAT alpha
P08602169A0484|110 112|HML
P08602608A1056|49 54|CD3500
P08602608A1056|61 64|STKS
P08604338A0198|4 12|EWS-FLI-1
P08604338A0198|16 20|FLI-1
P08604338A0198|115 130|promoter elements
P08604338A0885|3 37|lectromobility shift assays, EWS-FLI-1
P08604338A0885|50 52|SRE
P08604338A0885|79 81|SRF
P08604338A0885|101 105|FLI-1
P08604338A0885|144 146|DNA
P08604338A0885|192 196|FLI-1
P08604708A1086|38 48|regenerated
P08604708A1086|85 90|mL/min
P08604708A1086|132 134|BTG
P08605302A1770|0 2|DNA
P08605302A1770|70 79|GATC motifs
P08605302A1770|130 142|rice CatA gene)
P08605302A1770|173 184|CatA promoter
P08605324A0434|8 10|LTR
P08605326A0772|11 14|cDNA
P08605705A0676|3 23|onclusion, IgM class CIC
P08605705A0676|40 42|CIC
P08605931A0777|70 82|epitope domain
P08605931A0777|95 112|C-terminal RNP motif
P08605931A0777|118 120|U1A
P08606267A0740|160 198|Tc-99m 2-methoxy isobutyl isonitrile (MIBI)
P08608126A0811|98 109|1409 +/- 423 nM
P08608222T0000|42 84|granulocyte colony-stimulating factor receptor
P08608222T0000|98 102|STAT3
P08608222T0000|109 113|STAT1
P08608447A0806|50 52|TPI
P08608448A0353|104 115|phylogenetic
P08608448A0353|141 144|4.5S
P08608448A0353|145 147|RNA
P08608448A0353|146 157|NA, generally
P08610328A0228|0 6|SUMMARY
P08610328A0228|7 8|OF
P08610328A0228|9 14|REVIEW
P08610582A0150|48 49|CT
P08610582A0150|81 82|MR
P08612852A0553|0 6|RESULTS
P08612852A0553|13 23|plasma IGF-I
P08612852A0553|38 55|body mass index (BMI)
P08614403A0557|26 42|Rev-erbA alpha mRNA
P08614403A0557|53 57|C2C12
P08614403A0989|24 41|GAL4-REV-erbA alpha
P08614403A0989|64 67|'AB'
P08614403A0989|84 86|'E'
P08614403A0989|117 136|GAL4 response elements
P08614403A0989|152 160|8-Br-cAMP
P08614403A0989|169 193|ligand-binding domain (LBD)
P08614410A0000|22 36|GnRH-responsive
P08614410A0000|75 85|oncogenesis
P08614410A0000|132 163|glycoprotein hormone alpha-subunit
P08615012A0627|21 27|ie1 gene
P08615025A1214|286 288|CD4
P08615025A1214|324 337|membrane fusion
P08615025A1214|342 345|CD4+
P08615183T0000|36 53|Parkinson's disease
P08617216A0584|20 23|DnaJ
P08617216A0584|40 43|DnaK
P08617216A0584|54 64|rotein, GrpE
P08617216A0584|93 102|luciferase
P08617237A0489|29 33|STAT5
P08617237A0489|54 56|DNA
P08617237A0489|92 114|tyrosine phosphopeptides
P08617238A0334|0 2|TNF
P08617238A0334|30 41|p38 MAP kinase
P08617238A0334|88 99|p38 MAP kinase
P08617238A0334|122 143|substrate protein MAPKAP
P08617311A0979|44 56|membrane exons
P08617311A0979|64 67|mIgY
P08617311A0979|80 83|mIgG
P08617311A0979|87 89|IgE
P08617311A0979|125 135|Xenopus mIgY
P08617800A0150|27 36|erbB-2 gene
P08617800A0675|0 4|DNase
P08617800A0675|67 69|PBP
P08617800A0675|112 140|core recognition sequence TGGGAG
P08617802A0993|41 57|SH2/SH3/SH2 region
P08617802A0993|60 66|p120 GAP
P08618433A0000|21 46|growth factor FLT3 ligand (FL)
P08618433A0000|71 74|FLT3
P08618433A0000|72 100|LT3, tyrosine kinase receptor (R)
P08618433A0000|118 122|FLK-2
P08618433A0000|126 130|STK-1
P08618433A1720|40 49|eceptor, FL
P08618864A0754|36 46|mutagenesis
P08618882A0343|10 17|RAR alpha
P08618882A0343|60 75|DNA binding domain
P08618882A0343|103 107|BZLF1
P08619866A0000|10 41|serum hepatocyte growth factor (HGF)
P08619866A0000|105 117|heart diseases
P08619910A0000|286 307|nigra zona compacta (SNc)
P08620003T0000|29 31|N-O
P08620856A1172|136 146|polypeptide
P08620856A1172|192 218|spermatid-specific c-kit cDNA
P08620856A1172|250 264|spermatogenesis
P08620889A0771|16 32|(G+C)-rich element
P08620889A0771|38 54|aldolase C promoter
P08621017A1186|0 7|LY290181
P08621017A1186|24 34|uPA promoter
P08621017A1186|107 139|uPA PEA3/12-0-tetradecanoylphorbol
P08621017A1186|160 171|element (TRE)
P08621384A0935|50 75|growth factor receptor (EGFR)
P08621384A0935|80 87|TGFalpha
P08621384A0935|125 132|PKCdelta
P08621420A1166|79 87|NF-kappaB
P08621448A0862|24 32|DNA (cDNA)
P08621448A0862|44 49|RL95-2
P08621453A0815|59 63|80K-H
P08621453A0815|81 94|FGF-stimulated
P08621542A0535|8 21|protein kinases
P08621542A0535|9 83|rotein kinases, c-Jun NH2-terminal kinases (JNKs)/stress-activated protein kinases
P08621542A0535|103 111|TNF-alpha
P08621542A0535|104 116|NF-alpha, IL-1
P08621542A0535|121 124|CD28
P08621628A1233|5 11|hGRbeta
P08621628A1233|62 69|hGRalpha
P08621659A0189|14 34|NH2-terminal Gla domain
P08621659A0189|99 108|(G) domains
P08621661A1035|4 12|P5CDh cDNA
P08621661A1035|103 106|cDNA
P08621661A1035|120 140|3'-untranslated intron
P08621664A1430|98 100|PKN
P08621719A0000|34 52|c-cbl proto-oncogene
P08621719A0000|114 126|T cell receptor
P08621719A0568|91 104|Grb2 SH3 domains
P08621730T0000|2 5|AP-1
P08621730T0000|55 87|alpha2(I) collagen (COL1A2) promoter
P08621730T0000|110 126|growth factor-beta
P08622030A0667|127 156|serum lactate dehydrogenase (LDH)
P08622070A0889|25 26|CA
P08622645A1026|15 17|VDR
P08622645A1026|53 59|9-cis RA
P08622645A1026|75 95|RXR-responsive element
P08622668A1155|54 58|U6 RNA
P08622668A1155|116 122|C1 hnRNP
P08622668A1155|178 185|pre-mRNA
P08622698T0000|33 57|CBF1/RBPJk-repressed genes
P08622698T0000|86 107|Epstein-Barr virus EBNA2
P08622887A1026|15 40|mobility shift assays (EMSAs)
P08622887A1026|54 96|glucocorticoid receptor DNA binding domain (DBD)
P08622887A1026|117 121|GRE-2
P08622887A1026|125 132|-3 motifs
P08622887A1026|145 147|DBD
P08622887A1026|234 236|DBD
P08622893A0000|19 47|receptor tyrosine kinases (RTKs)
P08622893A0000|56 58|EPH
P08623554A1058|3 8|17-kDa
P08624445A0257|84 94|transposase
P08624445A0257|128 142|wx-m9::Ac allele
P08624445A0257|168 176|tenth exon
P08625806A0263|9 22|zinc finger gene
P08625900T0000|9 46|adenylate cyclase-activating polypeptide
P08625900T0000|56 72|prolactin promoter
P08625900T0000|85 97|protein kinase
P08625924A0411|0 8|Clones 33F
P08625924A0411|12 14|34B
P08625924A0411|31 39|aromatase
P08625924A0411|142 146|mRNAs
P08625987A1086|39 48|VpreB genes
P08625987A1086|62 73|pro-B/pre-BI
P08625987A1086|82 88|pre-BII
P08625987A1086|103 105|RNA
P08625987A1086|154 160|pre-BII
P08626065A0000|25 54|3574-bp Bacillus subtilis (Bs) DNA
P08626065A0000|80 83|nrdA
P08626065A0000|87 95|citB genes
P08626290T0000|69 87|embrane protein, OmpA
P08626313A1037|44 50|msp gene
P08626325A0543|50 53|UmuD
P08626325A0543|57 61|UmuD'
P08626325A0543|79 98|homodimers (UmuD-UmuD
P08626325A0543|102 113|UmuD'-UmuD')
P08626325A0543|118 140|heterodimer (UmuD-UmuD')
P08626437A0332|0 8|Lyn kinase
P08626437A0332|50 52|BCP
P08626437A0332|62 111|full-length glutathione S-transferase (GST)-Lyn fusion
P08626493A1468|24 35|region 2 (CR2)
P08626493A1468|38 40|E1A
P08626493A1468|64 66|E1A
P08626493A1468|72 101|retinoblastoma gene product (pRb)
P08626493A1468|153 165|PEPCK promoter
P08626493A1468|191 197|type E1A
P08626529A0000|76 82|230-kDa
P08626529A0000|143 153|trans-Golgi
P08626529A0000|154 158|(Kooy
P08626529A0799|12 30|proline-rich regions
P08626529A0799|121 133|alpha-helices
P08626529A0799|190 207|sequence ESLALEELEL
P08626529A0799|215 233|cids 538-546), a motif
P08626539T0000|36 49|ApoA-I promoter
P08626596A0000|35 66|AMP-activated protein kinase (AMPK)
P08626596A0000|115 117|ATP
P08626596A0000|141 153|ATP-consuming
P08626610A0931|38 44|SREBP-1
P08626610A0931|78 96|COOH-terminal region
P08626610A0931|114 117|COOH
P08626667A1372|0 3|EMSA
P08626667A1517|147 153|GPT gene
P08626698A0989|10 24|10-fold increase
P08626698A0989|27 30|ERK3
P08626698A0989|45 51|PKC beta
P08626698A0989|97 105|anti-ERK3
P08626698A0989|146 158|complex kinase
P08626698A0989|147 158|omplex kinase
P08626777A0537|22 41|100-bp Col2a1 enhancer
P08626777A0537|57 70|sequence motifs
P08626777A0537|123 137|link protein gene
P08626777A0537|126 137|k protein gene
P08626785A0674|33 62|tissue transglutaminase promoter
P08626785A0674|156 191|mouse tissue transglutaminase promoters
P08626785A0674|214 262|cludes a 30-base pair retinoid response element (mTGRRE1
P08626785A0674|221 263|30-base pair retinoid response element (mTGRRE1)
P08626785A0674|344 356|a DR7/DR5 motif
P08626785A0674|369 375|RAR*RXR
P08626785A0674|373 375|RXR
P08626809A0729|14 17|pPKR
P08626809A0729|73 89|eIF-2alpha peptide
P08626809A0729|114 129|eIF-2alpha kinase
P08627354A0000|86 108|neurotransmitter release
P08627649A0734|56 60|FREJ4
P08627649A0734|137 141|P4 EBS
P08627649A0734|217 218|GC
P08627667A0132|0 4|ZEBRA
P08627667A0132|16 23|AP-1 bZip
P08627667A0132|41 45|c-Fos
P08627667A0132|61 78|DNA-binding domains
P08627667A0132|88 98|DNA-binding
P08627719A0784|0 1|UV
P08627719A0784|42 44|HSV
P08627719A0784|104 109|64-kDa
P08627719A0784|121 151|cleavage stimulation factor (CstF)
P08627719A0784|122 169|leavage stimulation factor (CstF), to poly(A) site RNAs
P08627719A0784|174 183|virus genes
P08627719A0784|250 253|IE63
P08628251A1455|0 6|CM-ACO3
P08628254A0665|60 62|AP1
P08628254A0665|95 102|c-Ha-Ras
P08628255A0932|14 17|HeLa
P08628255A0932|36 45|luciferase
P08628255A0932|80 82|DNA
P08628255A0932|124 134|E2F-binding
P08628255A0932|144 156|H2A.1 promoter
P08628260A0895|39 43|HepG2
P08628260A0895|84 87|VIII
P08628260A0895|155 172|increase in promoter
P08628284A0181|14 26|yeast reporter
P08628284A0181|46 53|lacZ gene
P08628284A0181|74 85|CYC1 promoter
P08628284A0181|113 117|TRE-1
P08628302A0683|2 6|hnRNP
P08628302A0683|54 66|RNA polymerase
P08628302A0683|67 68|II
P08628681A0364|28 33|kb mRNA
P08628681A0364|63 71|oocyte RNA
P08628681A0364|80 91|X.laevis cDNA
P08628681A0821|79 88|pol domains
P08628681A0821|100 112|DNA polymerase
P08629348A0237|41 42|BI
P08630548A0000|62 71|somnogenic
P08630548A0000|85 103|interleukin-1 [IL-1]
P08630548A0000|86 141|nterleukin-1 [IL-1], tumor necrosis factor-alpha [TNF-alpha])
P08630583A1056|2 3|pH
P08630599A0534|14 27|elastin peptide
P08630599A0534|103 107|+/- SD
P08631667A0851|37 43|tmk gene
P08631667A0851|85 100|a yeast dTMP kinase
P08631667A0851|167 172|kinase
P08631685A0000|34 73|quinone-containing monoamine oxidase (maoA)
P08631685A0000|86 101|amine oxidase gene
P08631760A0609|30 38|SH2 domain
P08631760A0609|66 79|phosphopeptide
P08631760A0609|93 111|Crk-SH2 binding motif
P08631797A0982|14 19|ErbB-2
P08631797A0982|32 46|receptor subunit
P08631797A0982|149 151|NDF
P08631797A0982|154 156|EGF
P08631817T0000|17 47|consensus cyclin-dependent kinase
P08631817T0000|96 138|deoxyuridine triphosphate nucleotidohydrolase
P08631820A0755|3 6|cDNA
P08631820A0755|25 32|FPS1 gene
P08631820A0755|100 104|in FPS
P08631820A0755|113 121|(Delourme
P08631822A0677|29 32|VEGF
P08631822A0677|95 107|VEGF receptors
P08631822A0677|139 153|cell mitogenesis
P08631908A0224|0 6|VDR/RXR
P08631908A0224|21 25|VDREs
P08631908A0224|31 33|DR4
P08631908A0224|37 39|DR5
P08631934A0000|71 87|DNA-binding domain
P08631934A0000|99 151|Myb-binding site (MBS) sequence (YG(A/G)C(A/C/G)GTT(G/A))
P08631944A0663|38 52|C epsilon4 domain
P08631944A0663|72 77|M2 exon
P08631944A0663|78 81|(IgE
P08631944A0663|105 109|J558L
P08631958T0000|5 44|cytomegalovirus immediate-early protein IE2
P08631958T0000|68 83|repression domain
P08631958T0000|86 88|p53
P08632009A1067|24 28|C/EBP
P08632009A1067|123 125|DNA
P08632009A1067|180 182|DNA
P08632015A0879|52 77|DNA polymerase alpha promoter
P08632015A1226|51 65|DREF polypeptide
P08632015A1226|144 147|DREF
P08632015A1226|194 220|DNA replication-related genes
P08632015A1226|229 231|DRE
P08632018A0587|1 3|DNA
P08632018A0587|50 66|5'-flanking region
P08632018A0587|72 81|UGT1A1 gene
P08632018A0587|94 95|MC
P08632463A1508|36 47|beta' subunit
P08632779A0351|3 12|XPG regions
P08632779A0351|25 27|NLS
P08632779A0351|34 41|acid (AA)
P08632779A0351|54 58|NLS-B
P08632779A0351|59 61|(AA
P08632779A0351|75 79|NLS-C
P08632779A0351|80 82|(AA
P08632779A0351|133 140|beta-gal
P08632779A0351|172 175|HeLa
P08633855A1064|3 10|lacS gene
P08633855A1064|25 43|. coli-Streptococcus
P08633855A1064|79 82|lacS
P08633855A1064|123 133|pNZ63-cured
P08633855A1064|149 154|NZ6091
P08634290A0000|48 51|RNAs
P08634420A1784|0 6|HuEpo-R
P08634420A1784|37 40|UT-7
P08634420A1784|96 102|muEpo-R
P08634420A1784|122 125|UT-7
P08634423A0498|53 60|lacZ gene
P08634423A0498|145 147|32D
P08634697A1155|22 26|cDNAs
P08635771A0000|30 35|ONLINE
P08635771A0000|39 44|EMIT II
P08635771A0000|61 103|gas chromatographic/mass spectrometric (GC/MS)
P08636031A1413|62 73|pvdS promoter
P08636124A0410|24 27|cDNA
P08636124A0410|46 52|p150TSP
P08636124A0410|57 70|TPR-containing
P08636124A0410|58 82|PR-containing, SH2-binding
P08636211A0983|0 3|EMBO
P08636428A1363|147 154|mitogens
P08637006A0000|17 42|adenovirus E2-early promoter
P08637006A0000|75 92|cis-acting elements
P08637006A0000|115 117|TBP
P08637006A0000|126 128|E2F
P08637006A0000|189 191|ATF
P08637711A1121|27 41|IL-6/interferon
P08637711A1121|47 50|(IFN
P08637711A1121|51 71|gamma) response element
P08637711A1121|77 99|IRF-1 promoter (IR/IRF-1)
P08637711A1121|144 151|CRE-like
P08637711A1121|166 193|IL-6-induced binding complexes
P08637711A1121|203 213|JRE-IL6-BCs
P08637717A0817|114 125|cyclin E/Cdk2
P08637717A1231|1 10|p21 peptide
P08637717A1231|50 53|PCNA
P08637717A1231|110 117|p21-PCNA
P08638435A0522|25 37|agar diffusion
P08639310A0548|0 2|OND
P08639310A0548|74 76|MCP
P08639310A0548|113 114|CT
P08639310A0548|118 120|MCP
P08639561T0000|19 28|N-ras codon
P08639561T0000|43 113|(-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]
P08639561T0000|158 203|SRSR(61,2) (-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10-
P08639561T0000|258 262|1H NMR
P08639742T0000|11 13|PCR
P08639742T0000|17 20|cDNA
P08639837A0268|62 67|GATA-1
P08640866A0473|50 52|PHA
P08640866A0473|55 74|cross-linked anti-CD3
P08640866A0473|110 124|increases in MAPK
P08640866A0473|128 130|MEK
P08641705A0986|53 76|A --> G mutation at codon beta
P08641705A0986|135 149|beta-globin gene
P08642285A1548|0 16|DNA-STAT complexes
P08642285A1548|34 52|Bcr/Abl-transformed
P08642285A1548|104 108|STAT1
P08642285A1548|112 116|STAT5
P08642313T0000|29 72|Notch/translocation-associated Notch homologue
P08642313A0770|33 46|ell line, TAN-1C
P08642313A0770|98 109|reporter gene
P08642693T0000|56 70|3C-like protease
P08642693T0000|93 103|mutagenesis
P08643111A0855|12 20|LL2 (hLL2)
P08643111A0855|128 136|LL2 (cLL2)
P08643111A0855|239 249|VK-appended
P08643111A0855|273 276|mLL2
P08643382A0752|10 33|N-terminal transit peptide
P08643382A0752|57 63|poly(A)
P08643382A0752|78 81|cDNA
P08643513A0361|18 61|rOC promoter-chloramphenicol acetyltransferase
P08643513A0361|90 102|AML-1-binding
P08643513A0361|178 192|osteocalcin gene
P08643557A0259|27 29|HOX
P08643557A0259|60 70|target genes
P08643578A0000|0 8|RAS2val19
P08643578A0000|124 144|reporter FG(TyA)::lacZ
P08643578A0000|164 194|mating pathway reporter FUS1::lacZ
P08643578A0532|44 56|morphogenetic
P08643578A0532|110 122|FG(TyA)::lacZ
P08643633A1187|40 50|N1(deltaEC)
P08643633A1187|54 57|CBF1
P08643646A0479|18 21|verA
P08643646A0479|68 69|ST
P08643646A0479|184 195|ST-producing
P08643682A0268|29 44|wild-type CBFbeta
P08643682A0268|51 69|CBFbeta-SMMHC fusion
P08643682A0268|93 118|immunofluorescence of NIH 3T3
P08643759A0338|0 19|Menstrual-cycle phase
P08644734A0404|27 41|cDNAs homologous
P08644734A0404|68 92|(dsh) segment-polarity gene
P08645214A1052|15 18|BL21
P08645214A1052|19 28|(DE3)plysS
P08645214A1052|72 94|catalase-peroxidase gene
P08645214A1052|143 150|SDS/PAGE
P08645219A1377|13 33|Zn2+ binding in S100 beta
P08645219A1377|63 67|MRP14
P08645219A1377|138 155|Ca2+ binding domains
P08647086T0000|0 29|Cyclin-dependent kinase-2 (Cdk2)
P08647086T0000|116 128|Cdk7-cyclin-H
P08647086A0720|3 23|Cdk2-cyclin-D1 complex
P08647086A0720|70 81|1 histone, pRB
P08647086A0720|71 86| histone, pRB, SV40
P08647086A0720|93 109|antigen, p53, E2F-1
P08647086A0720|101 103|p53
P08647086A0720|145 148|HeLa
P08647086A0720|147 178|La cells; in contrast, Cdk2-cyclin-E
P08647086A0720|182 194|Cdk2-cyclin-A
P08647091A0592|40 48|Adh-2 gene
P08647091A0592|71 81|12-kb region
P08647091A0592|144 151|ADH genes
P08647264T0000|10 13|CD40
P08647264T0000|21 33|Ramos-Burkitt
P08647264T0000|72 96|antigen receptor-triggered
P08647264T0000|133 158|cysteine protease CPP32/Yama
P08647264T0000|175 187|substrate PARP
P08647434A1124|50 66|epitope-tagged TBP
P08647434A1124|51 77|pitope-tagged TBP, endogenous
P08647434A1124|78 80|TBP
P08647434A1124|79 92|BP, hTAF(II)100
P08647434A1124|80 104|P, hTAF(II)100, hTAF(II)130
P08647434A1124|109 119|hTAF(II)250
P08647434A1124|141 150|holo-TFIID
P08647451A0663|41 47|HEP-COP
P08647802A0000|89 106|SH3-SH2-SH3 domains
P08647822T0000|100 112|reductase gene
P08647884A0547|0 5|E3/19K
P08647884A0547|52 54|MHC
P08648408A0792|7 9|PHT
P08648408A0792|13 15|CSA
P08648408A0792|72 78|PHT-GO+
P08648408A0792|93 99|CSA-GO+
P08648665A0956|8 10|LE6
P08648665A0956|112 123|wild-type LE6
P08648665A1320|0 2|ORF
P08648665A1320|17 19|ORF
P08648665A1320|123 129|pZipNeo
P08648726A0713|19 27|ZI domains
P08648726A0713|73 75|ZIA
P08648726A0713|74 79|IA, ZIC
P08648726A0713|84 93|ZID domains
P08648726A0713|104 106|ZIB
P08648726A0713|117 119|TPA
P08649372A0501|0 15|Clb2/Cdc28 kinase
P08649372A0501|47 57|MCB-binding
P08649372A0501|94 99|M phase
P08649373T0000|8 33|single-stranded cis elements
P08649373T0000|79 87|c-myc gene
P08649386A1032|4 7|UASH
P08649389A0000|30 37|CTCF cDNA
P08649389A0000|83 106|11-zinc-finger factor CTCF
P08649389A0692|23 37|P2-proximal CTCF
P08649389A0692|102 105|CTCF
P08649389A0692|143 151|c-myc gene
P08649393A0000|91 105|centromere (CEN)
P08649403A0963|82 106|SNF1-encoded protein kinase
P08649405T0000|21 33|CD11c promoter
P08649405T0000|83 85|AP1
P08649424A0000|15 42|phenylalanine hydroxylase gene
P08649424A0000|126 128|AMP
P08649425A0373|21 30|enhancer's
P08649425A0373|57 61|DNase
P08649427A0689|32 35|cDNA
P08649427A0689|62 90|GTPase-activating protein (GAP)
P08649427A0689|99 104|GTPase
P08649428A1227|62 77|the c-mos oncogene
P08649440T0000|3 15|heterogeneity
P08649440T0000|24 33|IgG2--VIII
P08649773A1374|12 16|BCL-6
P08649841A0956|15 18|uORF
P08649841A0956|94 97|SV40
P08649841A0956|102 116|CAT reporter gene
P08649841A0956|145 147|CAT
P08649841A0956|173 189|decrease in CAT mRNA
P08650818A0000|69 80|strain (MRSA)
P08651853A0607|93 108|CA1/prosubiculum
P08651853A0607|176 184|CA4 region
P08652081A1953|98 101|IL-1
P08652081A1953|131 134|IL-3
P08652081A1953|182 185|IL-4
P08654200A0274|202 205|(ICG
P08654375A0544|124 142|DNA binding POU domain
P08654390A0000|0 12|Heme oxygenase
P08654435A0540|19 32|ortmannin, WM12
P08654435A0540|46 60|TCR/CD3-induced
P08654946A0475|47 63|Xenopus laevis FGF3
P08654946A0986|61 73|mouse promoter
P08654972A0000|36 65|(Sp) cell cycle-controlling genes
P08654983A0000|14 60|signal recognition particle (SRP)-SRP receptor (Srb)
P08654983A0000|69 88|Bacillus subtilis (Bs)
P08654983A0000|101 109|Bs srb gene
P08654983A0000|124 132|homologue
P08654983A0000|147 170|SRP receptor alpha-subunit
P08654983A0000|171 176|[Oguro
P08654983A0000|183 185|DNA
P08655555A1368|3 5|DNA
P08655555A1368|62 69|TGn motif
P08655555A1368|91 99|-10 region
P08656672A0678|10 16|ufo mRNA
P08656672A0678|127 153|cervix carcinoma cell line HeLa
P08657135A1444|30 33|CKII
P08657135A1444|62 71|myogenesis
P08657135A1444|115 124|muscle gene
P08657150A1049|33 36|NCE3
P08657150A1049|68 75|SIN5 gene
P08657157A0000|37 61|POU domain DNA-binding motif
P08657157A0000|81 102|multi-protein complexes
P08657157A0000|117 125|POU domain
P08657157A0000|166 188|octamer sequence elements
P08657183A0145|30 32|DNA
P08657183A0145|58 66|enes, DHFR
P08657183A0145|93 96|DHFR
P08657918A0360|0 8|MATERIALS
P08657918A0360|9 11|AND
P08657918A0360|12 18|METHODS
P08657918A0360|13 31|ETHODS: Coronal 3D GRE
P08657918A0360|91 93|SLL
P08657918A0360|134 136|SLL
P08657918A0360|175 177|SLL
P08659545A0000|153 169|chromosome 21 genes
P08660866A0504|75 81|progeny
P08660866A0504|97 100|SOPs
P08660866A0504|135 142|thecogen
P08660866A0504|168 176|trichogen
P08660866A0504|187 194|tormogen
P08660892A1044|55 66|wild-type SRF
P08660892A1044|122 129|myogenic
P08660892A1044|144 147|MyoD
P08660892A1044|151 156|Mef-2C
P08660998A0851|3 16|mMIWC1 promoter
P08660998A0851|42 45|TATA
P08660998A0851|43 50|ATA, CAAT
P08660998A0851|44 55|TA, CAAT, GATA
P08660998A0851|60 71|AP-2 elements
P08660998A0851|96 100|mMIWC
P08660998A0851|146 151|mMIWC1
P08661007T0000|5 14|MN/CA9 gene
P08661007T0000|41 49|anhydrase
P08661007T0000|75 87|protein domain
P08661100A0285|3 13|exon-intron
P08661100A0285|68 74|App gene
P08661101A0396|0 2|DNA
P08661101A0396|70 76|rat CRP1
P08661104A0687|36 45|1.5-kb mRNA
P08661114A0564|30 45|sequence homology
P08661114A0564|55 57|SIM
P08661114A0564|71 73|SIM
P08661116A0963|59 68|endogenous
P08661116A0963|69 74|D3 mRNA
P08661119A0085|22 36|EP4 receptor gene
P08661119A0085|80 87|EP4R cDNA
P08662193A0404|13 32|activation subdomains
P08662193A0404|40 60|negative-acting region
P08662193A0404|98 120|carboxyl-terminal region
P08662193A0404|123 126|NIT4
P08662499A0484|3 10|front (F)
P08662499A0484|50 52|RNA
P08662617A2051|34 36|HIP
P08662617A2051|40 68|membrane-associated HP-binding
P08662789A0673|38 54|GenBankTM data base
P08662789A0673|83 88|RPS30A
P08662852A1297|21 24|GRK2
P08662852A1297|28 31|GRK5
P08662852A1297|85 91|beta2AR
P08662852A1297|113 125|GRK1-mediated
P08662928T0000|12 29|interleukin (IL)-10
P08662928T0000|33 41|IL-6-type
P08662928T0000|111 130|IL-6 response elements
P08662928A1153|65 68|STAT
P08662936A0428|23 27|FR-19
P08662936A0428|80 101| identity to chicken TEF-1
P08662936A0428|90 102|chicken TEF-1A
P08662936A0428|132 151|TEA domain-containing
P08662980A0762|27 29|DNA
P08663000A0000|32 50|motility (RHAMM) gene
P08663000A0000|115 143|growth factor-beta1 (TGF-beta1)
P08663120T0000|0 8|Oncogenic
P08663120T0000|23 33|p70 S6 kinase
P08663120T0000|38 54|mitogen-activated
P08663127A0697|20 23|KCC1
P08663127A0697|53 56|NKCC
P08663127A0697|172 188|C-terminal regions
P08663141T0000|1 20|cis-acting DNA element
P08663141T0000|35 38|TATA
P08663141T0000|120 138|angiotensinogen gene
P08663219A0246|16 27|rat PGS-2 gene
P08663219A0246|37 56|CAAT enhancer-binding
P08663219A0246|77 81|(CAAT
P08663219A0246|122 142|PGS-2.CAT reporter gene
P08663219A0246|161 171|E-box region
P08663310A0157|8 10|SRF
P08663310A0157|67 79|response genes
P08663310A0157|86 111|immediate-early genes (IEGs)
P08663326A0000|8 28|sigma54-dependent DmpR
P08663326A0000|65 73|dmp operon
P08663392A0215|32 39|DSG3 gene
P08664229T0000|61 72|Nidek AR-1000
P08664347A0923|13 41|proprotein processing proteases
P08664347A0923|74 80|pro-LPH
P08664667A0093|0 13|SETTING--Delhi
P08665853A0228|65 68|ErbB
P08665853A0228|108 113|ErbB-3
P08665853A0228|152 157|ErbB-1
P08665853A0228|161 166|ErbB-2
P08665853A0228|200 208|mitogenic
P08666102A0820|0 3|ZIOS
P08666102A0820|61 66|Ptc,O2
P08666102A0820|100 103|FEV1
P08666241A0930|29 39|43-bp region
P08666241A0930|45 56|24p3 promoter
P08666383A1252|30 33|cDNA
P08666398T0000|0 2|YAC
P08666398T0000|30 54|Batten disease (CLN3) region
P08666404A0311|16 30|full-length cDNA
P08666404A0311|46 54|brain cDNA
P08666404A0311|70 104|a protein serine-threonine phosphatase
P08666404A0311|109 131|a tetratricopeptide motif
P08666404A0311|155 164|PPP5C (PP5)
P08666404A0311|186 191|rat PPT
P08666913A0000|18 19|II
P08668124A0744|3 11|Dox-A2 ORF
P08668124A0744|23 34|TDH3 promoter
P08668142A1048|17 21|hARF4
P08668158A0765|56 69|ubstrates, tRNA
P08668158A0765|77 83|tRNAPro
P08668158A0765|118 121|tRNA
P08668158A0765|203 206|tRNA
P08668158A0765|218 221|RPM1
P08668158A1252|29 37|RPM1 genes
P08668158A1252|118 127|biogenesis
P08668190A1364|46 52|Ca2+/H+
P08668201A1059|8 18|mutagenesis
P08668201A1059|24 50|element's rare-codon/AU-rich
P08668201A1059|108 118|MATalpha1 IE
P08668201A1059|154 172|element's rare-codon
P08668203A1230|0 2|FTF
P08668203A1230|109 112|SF-1
P08668203A1230|115 127|steroidogenic
P08668210A0000|61 118|Raf-1/MEK/mitogen-activated protein kinase pathway in oncogenic
P08669676A1644|34 46|roup), Q wave MI
P08669676A1644|88 94|Q wave MI
P08670556A0425|80 90|infinity AUC
P08670910A0156|0 12|DNA polymerase
P08670910A0156|1 23|NA polymerase E, DNA ligase
P08670910A0156|24 26|III
P08670910A0156|31 63|DNA structure-specific endonuclease
P08670910A0156|84 101|polypeptide complex
P08672242A0517|7 18|reporter gene
P08672242A0517|65 74|P1 promoter
P08675026A0420|54 70|sequence tags (EST)
P08675395A0751|0 6|RESULTS
P08675763A0788|0 11|Mean increase
P08675769A0158|35 44|elementary
P08675769A0158|228 231|an AI
P08675821A0657|10 13|EMPD
P08676266A0838|15 22|protease
P08676383A0518|52 62|cis peptides
P08676454A0731|21 23|(N0
P08676454A0731|33 37|ICP35
P08676454A0731|38 43|(ICP35
P08676456A0879|9 16|VP16-Tat
P08676456A0879|72 75|AP-1
P08676456A0879|115 134|VP16 activation domain
P08676495A0129|80 93|BPV-1 pre-mRNAs
P08676495A0129|96 112|BPV-1-transformed
P08676858A0309|36 47|S-RNase genes
P08676858A0309|78 83|(Malus
P08676858A0309|110 115|(Pyrus
P08676858A0309|180 192|T2-type RNases
P08676858A1084|1 12|phylogenetic
P08676858A1084|31 40|T2/S-RNase
P08677443A0238|47 67|extensive-disease SCLC
P08677443A0238|48 79|xtensive-disease SCLC patients, VIP
P08677678A0258|30 60|immunomodulator neurotropin (NSP)
P08678959A0640|64 78|ultrasonography
P08680702A0548|164 170|(Vo2DIR
P08680702A0548|283 291|(Vo2INDIR
P08680706A0889|9 19|reperfusion
P08680706A0889|10 28|eperfusion, PO2/FlO2
P08682317A0900|0 1|HS
P08682317A0900|25 27|HSE
P08682317A0900|43 72|HS transcription factor-1(HSF-1)
P08682317A0900|116 117|HS
P08682868A0738|11 16|DSK2-1
P08682868A0738|53 77|Dsk2p ubiquitin-like domain
P08683106A0374|8 11|IL-2
P08683106A0374|15 23|IFN-alpha
P08683106A0374|33 42|STAT1 alpha
P08683106A0374|46 50|STAT5
P08683106A0374|47 55|TAT5, IL-2
P08683106A0374|78 82|STAT5
P08683106A0374|89 97|IFN-alpha
P08683106A0374|120 129|STAT1 alpha
P08683108A0965|44 47|CREB
P08683108A0965|96 107|junB CRE-like
P08683108A0965|141 148|CRE-like
P08683108A1501|51 63|protein kinase
P08683108A1501|95 97|mIg
P08683108A1501|106 109|junB
P08683983A1163|74 82|c-myb gene
P08684522A0415|88 89|IV
P08684742A0000|0 8|OBJECTIVE
P08686381A0527|5 20|ORFs (9765orfR002
P08686381A0527|9 20|(9765orfR002
P08686381A0527|22 32|9765orfR011
P08686381A0527|36 47|9765orfR013)
P08686381A0527|154 161|38.1-kDa
P08686381A0527|174 176|BCR
P08688190A0000|7 53|lavone glucosides, nevadensin 5-O-beta-D-glucoside
P08688190A0000|57 108|nevadensin 5-O-beta-D-glucosyl(1-->6)beta-D-glucoside
P08688556A0242|137 140|(Chc
P08690118A0845|77 80|IVOS
P08690198A0346|0 6|METHODS
P08690198A0346|88 94|oatbase
P08690198A0346|89 119|atbase, Lactobacillus reuteri R2LC
P08690198A0346|124 148|Lactobacillus plantarum DSM
P08691106A0733|30 37|nuclease
P08691962T0000|14 22|PCR-based
P08691962T0000|34 49|Whipple's disease
P08692885A0663|22 30|NF-kappaB
P08692885A0663|55 80|C-terminal zinc finger domain
P08692892A0330|3 22|Pro-258-->Leu (P258L)
P08692892A0330|148 159|alpha-factor
P08692924A0328|8 10|DNA
P08692924A0328|57 61|BCL-6
P08692924A0328|84 88|BCL-6
P08692924A0328|100 119|DNA-binding complexes
P08698756A1240|0 10|CONCLUSIONS
P08700531A1420|104 122|chemical carcinogens
P08700531A1420|126 134|oncogenic
P08700531A1420|211 221|cph oncogene
P08702517A0000|21 29|oncogenic
P08702517A0000|59 65|B6SUtA1
P08702517A0000|73 82|progenitor
P08702543A0000|0 10|Gap1(IP4BP)
P08702543A0000|26 45|Ras GTPase-activating
P08702543A0000|83 128|inositol 1,3,4,5-tetrakisphosphate (IP4)-binding
P08702543A0000|136 142|(Cullen
P08702556A0000|40 45|83-kDa
P08702556A0000|58 77|acid phosphatase (PAP)
P08702556A0000|107 112|(Kanoh
P08702633A0164|20 54|Gbetagamma subunit-mediated increases
P08702633A0164|86 117|hc adapter protein, Shc*Grb2 complex
P08702644A0499|1 4|cDNA
P08702644A0499|35 46|apoB (apoB17)
P08702644A0499|58 61|cDNA
P08702644A0499|92 120|decay-accelerating factor (DAF)
P08702728A1325|40 44|Y317F
P08702728A1325|58 61|HIRc
P08702756A0000|8 13|GTPase
P08702807A0964|78 81|MKK1
P08702807A0964|109 124|cyclin D1 promoter
P08702826A0870|34 53|GSTP1 silencer element
P08702826A0870|102 105|MCF7
P08702845A0000|86 109|dopamine transporter (DAT)
P08702845A0000|121 132|[3H]dopamine
P08702845A0000|150 156|[3H]CFT
P08702845A0000|181 185|COS-7
P08702845A0000|218 221|DATs
P08702845A0000|232 235|COOH
P08702936A0168|46 66|portion-enriched cDNAs
P08702936A0168|145 173|signal sequence-deleted CD4 cDNA
P08702936A0168|178 189|Epstein-Barr
P08702936A0984|23 26|TARC
P08703005A0645|3 20|cis-acting elements
P08703005A0645|96 103|alphaCbf
P08703005A0645|106 116|60-kDa CCAAT
P08703010A0905|27 43|cis-acting element
P08703010A0905|68 87|GAP-43 promoter region
P08703010A0905|147 156|GAP-43 gene
P08703908A1814|39 42|SF-1
P08703908A1814|80 94|cAMP-stimulated
P08703908A1814|110 117|StAR gene
P08704124A0420|16 32|fragments (CPK3-8)
P08704124A0420|45 64|2022 bp cDNA (VrCDPK-1)
P08704240A1111|10 13|TF-1
P08704240A1111|26 31|GM-CSF
P08704240A1111|39 52|tarvation, CREB
P08704240A1111|93 99|PIXY321
P08706368A1024|0 6|RESULTS
P08706368A1024|11 12|LV
P08706368A1024|104 107|FIO2
P08706662A1125|116 158|killer-cell-specific trans-acting factor NF-P2
P08706731A1303|84 93|Ypr10 genes
P08706731A1303|97 113|ribonuclease genes
P08706731A1303|170 188|ginseng ribonuclease
P08706731A1303|212 224|a ribonuclease
P08706731A1303|236 240|PR-10
P08707424A0709|15 25|ERV3 env mRNA
P08707825A0063|137 146|muscle cDNA
P08707825A0063|182 192|antibody R4A
P08707825A0063|198 210|full-size cDNA
P08707840A0753|93 103|pore complex
P08707846A2308|183 198|a-factor receptor
P08707922A0334|36 37|II
P08707922A0334|38 42|beta-
P08707922A0334|39 50|eta-, III beta
P08707922A0334|55 71|O beta-globin genes
P08707922A0334|90 95|52 base
P08707922A0334|121 151|translation initiation codon (ATG)
P08709224T0000|0 11|Epstein-Barr
P08709224T0000|24 38|protein 2 (EBNA2)
P08709224T0000|66 79|SNF-SWI complex
P08709224T0000|67 90|NF-SWI complex, hSNF5/Ini1
P08709245A1521|132 135|HDAg
P08709245A1521|157 170|virus-like HDAg
P08709245A1521|206 210|HDAgs
P08709251A0000|61 84|polyhedrosis virus (AcNPV)
P08709251A0000|95 109|0.6-kbp-long DNA
P08709251A0000|140 154|DNA helicase gene
P08709251A0000|174 199|polyhedrosis virus generates
P08709251A0000|186 208|virus generates eh2-AcNPV
P08709251A0000|200 208|eh2-AcNPV
P08709251A0000|242 243|(S
P08709637A1471|29 38|IL-7R alpha
P08709637A1471|81 84|JAKs
P08709637A1471|88 92|STATs
P08710371A0000|37 45|oncogenic
P08710371A0000|51 69|polyomavirus BK (BKV)
P08710371A0000|77 102|tumor-suppressor protein p53
P08710371A0000|176 178|p53
P08710371A0499|0 7|Site S-II
P08710377A0577|33 42|SH3 domains
P08710377A0577|71 90|amino-terminal domain
P08710377A0577|124 126|BCR
P08717391A0466|179 192|immunogenicity
P08717391A0466|195 199|HBcAg
P08717559A0223|19 24|anti-D
P08717559A0223|94 99|anti-D
P08719155A0105|205 217|protein (TRAP)
P08719155A0105|245 264|circumsporozoite (CS)
P08719156A0953|78 85|a 377-kDa
P08719697A0221|0 6|METHODS
P08719697A0221|1 10|ETHODS: DSF
P08719697A0221|48 49|CF
P08719697A0221|101 103|KCS
P08720407A1386|0 9|CONCLUSION
P08720407A1386|95 112|interleukin-1 alpha
P08721989A1012|58 74|cytokine receptors
P08721989A1012|126 133| that beta
P08721989A1012|138 142|IL-2R
P08721999A0432|67 72|snoRNA
P08721999A0727|67 73|28S rRNA
P08722011A0103|25 36|GTPase domain
P08722011A0103|47 57|subunit rRNA
P08722011A0103|125 138|(Saccharomyces
P08722568A1001|26 41|replacement genes
P08722568A1001|103 127|replacement H3 histone genes
P08723352A0084|37 70|G1-specific cyclin-dependent kinases
P08723352A0084|107 140|retinoblastoma tumour suppressor gene
P08723352A0084|108 144|etinoblastoma tumour suppressor gene, pRb
P08723883A0823|0 10|Blood GSH-Px
P08726024A0532|22 24|PCR
P08726024A0532|50 55|26-kDa
P08727192A0000|0 10|STUDY DESIGN
P08727992A0570|23 31|PGF2 alpha
P08728040T0000|40 61|signal-regulated kinase
P08728040T0000|41 71|ignal-regulated kinase, Jun kinase
P08728040T0000|75 90|Janus kinase-Stat
P08728040T0000|144 155|AIDS-derived
P08731155A0499|31 42|regenerating
P08731222A0000|77 110|subnucleus reticularis dorsalis (SRD)
P08731222A0000|129 146|Cuneate nucleus (Cu)
P08731222A0000|193 231|Phaseolus vulgaris leucoagglutinin (PHA-L)
P08731511A0625|11 20|fibrinogen
P08731511A0625|41 43|III
P08731511A0625|44 50|(ATIII)
P08731511A0625|69 70|II
P08731511A0625|71 76|(HCII)
P08732665A0000|35 46|c-erbB-2 gene
P08732665A0000|49 54|21MT-2
P08732665A0000|58 63|21MT-1
P08732665A0000|141 173|tyrosine-phosphorylated p185erbB-2
P08732665A0000|204 232|insulin-like growth factor (IGF)
P08732665A0000|244 256|IGF/epidermal
P08732665A0000|257 273|growth factor (EGF)
P08733123A0000|27 41|dystrophy (FSHD)
P08733123A0951|9 23|chromosome 4 FRG1
P08733874A0000|132 135|131I
P08733874A0000|169 175|serum TG
P08733881A0343|76 78|TSH
P08733881A0343|114 116|TSH
P08734538A0613|28 29|AM
P08734538A0613|120 121|AM
P08738510A0254|11 34|tumor FDG-uptake (Q-MRGlu)
P08740416A0239|71 93|membrane-spanning region
P08740416A0919|3 15|SEB1 homologue
P08740416A0919|29 32|SEB2
P08741206A1551|81 91|generalised
P08742135A0000|24 34|hormone ACTH
P08742135A0000|122 139|corticosterone (CS)
P08745669A0000|68 80|non-Hodgkin's
P08745669A0000|168 176|methyl GAG
P08746605A0377|22 24|ACE
P08748033A0874|12 16|cpxA*
P08748033A0874|59 67|LamB-LacZ
P08748033A0874|133 136|DegP
P08749393A0783|3 14|PI3K_68D cDNA
P08749393A0783|32 37|210 kDa
P08749393A0783|77 91|p110 PI 3-kinases
P08749393A0783|163 185|ich could bind to SH3 domain
P08749393A0783|177 186|SH3 domains
P08749394A0874|46 70|glutathione-S-transferase
P08749394A0874|82 86|RBP-J
P08749394A0874|95 99|Su(H)
P08749394A0874|117 128|RAM23 regions
P08750173A0000|0 11|AIMS/METHODS
P08750190A0000|122 131|generation
P08750190A0000|134 159|CD44 variant (CD44v) isoforms
P08750702A0183|45 85|alpha1-adrenoceptor-subtype blockers WB4101
P08751635A0135|47 69|hippocampus subfields CA1
P08751635A0135|48 73|ippocampus subfields CA1, CA3
P08754777A1214|3 7|upTRE
P08754777A1214|17 19|T3R
P08754777A1214|37 43|T3R-RXR
P08754777A1214|63 67|dnTRE
P08754777A1214|131 135|upTRE
P08754827A0231|1 9|oeben, F.J
P08754834A1097|37 52|response elements
P08754834A1097|113 119|NN-84AG
P08754840A0793|9 22|glucan synthase
P08754852A0960|25 27|RCS
P08754852A0960|94 96|RCS
P08755898A0339|23 31|pathogens
P08755898A0339|117 122|avrBs2
P08756332A0000|31 41|GTP-binding
P08756332A0000|129 146|protein kinase c-Raf
P08756332A0000|153 204|Ral-specific guanine nucleotide exchange factor (Ral-GEF)
P08756433A0282|29 42|promoter region
P08756433A0282|136 144|MAP1B gene
P08756556A0406|3 6|cDNA
P08756597A0854|62 69|psaB mRNA
P08756636T0000|71 82|Srs2 helicase
P08756712A0227|36 60|16 amino acid, 70-kDa subunit
P08756712A0227|63 65|RPA
P08756712A0227|66 69|(RPA
P08757265A0466|17 21|-67 mV
P08757943A0876|50 72|thymidine kinase promoter
P08759870A1128|14 17|fbpA
P08760286A0696|81 91|GTP-binding
P08760286A0696|195 201|GTPases
P08760286A0696|229 232|MAPK
P08760286A0696|235 237|JNK
P08760776A1559|0 9|CONCLUSION
P08760872A0696|32 35|E2F-
P08760872A0696|39 50|CDE-mediated
P08760872A0696|114 141|promoter-specific CHR elements
P08760889A0170|3 6|cDNA
P08760889A0170|76 79|H2A1
P08760889A0531|74 77|H2As
P08760889A0531|149 152|H2A1
P08760889A0531|173 176|H2A2
P08761480A0331|39 60|N-terminal splice region
P08761480A0331|63 68|RPDE-6
P08761480A0331|75 79|PDE4A
P08761480A0331|93 99|RPDE-39
P08761480A0331|117 122|RPDE-6
P08761480A0331|167 175|v-Src-SH3
P08761480A0331|168 184|-Src-SH3; met26RD1
P08761480A0331|182 184|RD1
P08761480A0331|196 213|rat 'dunc-like' PDE)
P08761480A0331|226 247|N-terminal splice region
P08761480A0331|277 285|v-Src-SH3
P08761480A0331|306 311|RPDE-6
P08761480A0331|363 384|N-terminal splice region
P08762472A0000|11 40|ligustrazine hydrochloride (LTH)
P08763207A0402|83 85|DPV
P08763207A0402|134 151|Nafion-modified CPE
P08763311A0189|20 40|alpha-1 adrenoreceptor
P08763925A0588|44 54|unit (c-gvpD
P08763925A0588|58 64|c-gvpE)
P08763953A0805|14 17|traA
P08763953A0805|15 22|raA, traF
P08763953A0805|27 30|traB
P08763953A0805|53 56|traC
P08763953A0805|54 61|raC, traD
P08763953A0805|66 69|traG
P08764136A0000|57 60|mRNA
P08764136A0000|72 80|oncogenic
P08764136A0000|119 129|cells (MECs)
P08764136A0000|179 190|MEC strain 76N
P08764136A0000|239 244|76R-30
P08766049A0000|0 9|CASE REPORT
P08768374A0765|10 17|P-rr cDNA
P08768377A1387|64 79|phytochrome C gene
P08769132A0000|8 16|MSH-2 gene
P08769132A0000|86 133|ost-replication mismatch repair. hMSH-2 is homologous
P08769132A0000|151 152|(E
P08769132A0000|159 162|MutS
P08769132A0000|188 192|MSH-1
P08769132A0000|196 200|MSH-2
P08769132A0000|236 238|DNA
P08769132A0000|259 263|e base
P08769132A0000|303 318| base pairs. hMSH-2
P08769132A0000|362 394|cancer (HNPCC) tumor suppressor genes
P08769409A0114|56 67|RAR beta 2 gene
P08769409A0114|135 154|reading frames (uORFs)
P08769409A0114|160 180|5'-untranslated region
P08769409A0114|181 187|(Zimmer
P08769409A0114|190 194|., A.M
P08769566A0000|25 28|cDNA
P08769566A0000|74 106|finger homeodomain enhancer-binding
P08769566A0000|136 152|zinc finger domains
P08769566A0000|137 156|inc finger domains, ZD1
P08769566A0000|160 162|ZD2
P08769566A0000|180 182|DNA
P08769566A0000|188 198|homeodomain
P08769568A0949|60 68|PLA2 genes
P08770021T0000|9 13|PTHRP
P08770021T0000|27 48|tyrosine kinase oncogene
P08770021T0000|28 56|yrosine kinase oncogene, Tpr-Met
P08770896A1121|30 35|IGF-II
P08770896A1121|126 130|appMr
P08770896A1121|134 136|17K
P08770896A1121|140 142|14K
P08770920A1220|80 84|IDX-1
P08770920A1220|113 126|wild-type IDX-1
P08770920A1220|208 228|TAAT-1 element reporter
P08770981A0328|22 45|von Willebrand factor (vWF)
P08770981A0328|124 132|weight vWF
P08771781A0103|81 118|reading frame (ORFII) in Brassica napus (L.)
P08771781A0103|164 168|ORFII
P08771781A0103|165 189|RFII, cDNA clones homologous
P08771781A0103|214 221|leaf cDNA
P08771781A1103|3 11|ORFII gene
P08771781A1103|102 105|PMSR
P08771787T0000|18 20|LRP
P08771787T0000|23 45|leucine-rich repeat (LRR)
P08771787T0000|90 101|pathogenesis
P08775674A0000|0 9|OBJECTIVES
P08776735A0000|53 89|type rat LH/CG receptor (rLHR) or receptors
P08776735A0000|152 160|rLHR-t653
P08776735A0000|153 170|LHR-t653, rLHR-t631
P08776735A0000|175 184|rLHR-t628)
P08776901A0000|122 134|non-Mendelian
P08778700A0476|77 80|ARVD
P08780339A0142|149 158|starch (RS)
P08780339A0142|166 192|high-amylose cornstarch (RS2)
P08780339A0142|210 236|high-amylose cornstarch (RS3)
P08781119A0723|24 41|mouse Met-ase-1 gene
P08781119A0723|109 124|rat Met-ase-1 gene
P08781144A1520|3 12|[18F]FMISO
P08781144A1520|13 16|TMRR
P08781144A1520|77 79|NPC
P08784787A0383|11 26|thrombin receptor
P08784787A0383|12 31|hrombin receptor, PAR2
P08784787A0383|51 61|hexapeptide
P08787110A0981|14 17|CPET
P08789441A0339|96 99|CMPD
P08789441A0339|201 215|17q24-q25 region
P08790288A0068|33 37|cDNAs
P08790288A0068|49 57|(Spinacia
P08790288A0068|76 83|(Hordeum
P08790291A1022|61 63|DNA
P08790387A0299|5 16|rat rnu allele
P08790387A0299|60 66|whn gene
P08792217A1407|41 50|TIMP-2 mRNA
P08792217A1407|186 211|cell steady-state TIMP-2 mRNA
P08793693A0237|0 5|DESIGN
P08794254A2957|5 7|SPK
P08794254A2957|11 13|PTA
P08794254A2957|12 33|TA category, anti-T-cell
P08794326A0405|23 43|Tas-responsive element
P08794326A0405|55 61|TRE (GP)
P08794326A0405|80 86|gag gene
P08794326A0405|102 108|pol gene
P08794326A0405|111 115|SFV-1
P08794339A1162|20 22|IE2
P08794339A1162|44 58|full-length CREB
P08794339A1162|61 69|deltaCREB
P08794339A1162|80 82|IE2
P08794339A1162|116 139|CREB-binding protein (CBP)
P08794339A1162|158 161|CREB
P08794339A1162|193 196|CREB
P08794348A1067|51 53|NIa
P08794348A1067|130 132|NIa
P08794363A0259|15 18|bZIP
P08794363A0259|68 78|jun-fos gene
P08794547A0648|3 6|rCBF
P08794547A1403|73 75|SAH
P08794869A0274|46 53|PKC-zeta
P08794869A0274|66 83|alpha 2 integrin gene
P08797362T0037|63 66|USSR
P08797362T0037|64 84|SSR, January 1995-March
P08798420A0207|24 37|promoter region
P08798420A0207|99 102|AP-1
P08798420A0207|117 120|TRE)
P08798420A0207|123 140|PRDII/kappaB domain
P08798420A0207|145 149|a CAAT
P08798443A0660|78 91|alanine (S528A)
P08798443A0660|183 209|mim-1A Myb-responsive element
P08798443A0660|221 236|herpes tk promoter
P08798443A1218|3 5|DNA
P08798443A1218|43 47|c-Myb
P08798443A1218|73 77|S528A
P08798443A1218|193 197|c-Myb
P08798512A1197|35 37|GEO
P08798512A1197|53 61|u-PAR gene
P08798610A0843|0 3|PIP2
P08798610A0843|109 115|Cdc42Hs
P08798610A0843|130 138|GDP-bound
P08798610A0843|148 158|GTP-binding
P08798610A0843|182 197|GTP-bound Cdc42Hs
P08798635A0870|8 16|spleen GAP
P08798635A0870|40 42|GTP
P08798635A0870|61 64|ARF1
P08798635A0870|62 69|RF1, ARF3
P08798635A0870|63 74|F1, ARF3, ARF5
P08798635A0870|79 82|ARF6
P08798635A0870|94 105|NH2-terminal
P08798643T0000|6 34|phosphotyrosine-binding domain
P08798643T0000|40 67|N-terminal transforming region
P08798643T0000|108 113|ZAP-70
P08798648A1816|16 45|(Fe4S4)-siroheme-binding domain
P08798700A0134|170 192|activation sequence (UAS)
P08798762A1279|85 87|PKC
P08798782A0976|40 42|SH2
P08798782A0976|46 55|SH3 domains
P08798893A0611|108 124|CCCD heterogeneity
P08801403T0001|18 25|effusion
P08803710A0701|68 69|II
P08803710A0701|71 73|III
P08803710A0701|75 77|IVA
P08803710A0701|81 83|IVB
P08804012A0662|25 27|SIP
P08804389A0893|130 137|Ltp4 mRNA
P08805338A1061|23 30|OGG1 gene
P08805338A1061|53 71|OG glycosylase/lyase
P08805338A1061|149 152|OG:G
P08806491A0542|18 24|ODV-E18
P08806491A0542|28 35|ODV-EC27
P08806491A0542|57 66|TAAG motifs
P08806693A0584|37 50|GATA-1 promoter
P08806693A0584|79 82|ME26
P08806693A0584|140 149|luciferase
P08806693A0584|224 229|GATA-1
P08806817A0244|56 71|DNA binding domain
P08806817A0244|78 91|orphan receptor
P08806817A0244|118 128|TR2 receptor
P08806817A0716|7 9|DNA
P08806817A0716|35 40|SpSHR2
P08806817A0716|44 58|single-copy gene
P08807288T0000|43 60|UAS2-dependent ADH2
P08807408A0524|0 6|METHODS
P08807408A0524|7 9|AND
P08807408A0524|10 16|RESULTS
P08807408A0524|48 49|AV
P08807408A0524|100 109|pathway" AV
P08808120A0774|67 80|40 micrograms/L
P08808120A0774|84 86|DAI
P08808120A0774|88 103|150 micrograms/L)
P08808120A0774|282 295|40 micrograms/L
P08808120A0774|299 301|DAI
P08808120A0774|303 318|150 micrograms/L)
P08808275A1193|11 15|RAD23
P08808275A1193|92 103|UV-inducible
P08808707A0631|0 8|Ha-RasV12
P08808707A0631|61 71|kinase (ERK)
P08808707A0631|78 112|stress-activated protein kinase (SAPK)
P08808707A0631|115 138|Jun N-terminal kinase (JNK)
P08808707A0631|170 186|PEA3-mediated gene
P08808756A0587|46 58|cDNA generated
P08808756A0587|68 70|RNA
P08808756A0587|215 218|mRNA
P08808924A0326|145 160|alpha-helix (L-61
P08808924A0326|222 225|ProW
P08808927A0417|1 13|1.5-kb HindIII
P08808927A0417|40 47|vspA gene
P08808927A0417|53 62|. bovis PG45
P08808939A0000|31 39|gnt operon
P08808939A0000|73 100|catabolite control protein CcpA
P08808939A0000|106 108|HPr
P08808939A0000|137 154|phosphotransferase
P08810278A0682|51 57|BCR/ABL
P08810278A0682|68 81|CRKL-SH2 domain
P08810278A0682|76 92|domain is p130(CAS)
P08810278A0682|84 92|p130(CAS)
P08810278A0682|154 157|CRKL
P08810278A0682|160 166|BCR/ABL
P08810278A0682|210 212|CML
P08810278A0682|216 218|ALL
P08810323A0735|12 30|polyglutamine motifs
P08810323A0735|47 67|histidine-rich regions
P08812106T0000|0 7|PCNA mRNA
P08812106T0000|12 16|3'UTR
P08812106T0000|34 44|crescent RNA
P08812490A0000|1 10|1.8-kb cDNA
P08812490A0000|25 28|hKID
P08812490A0000|26 45|KID, gene symbol AQP2L)
P08812490A0000|94 103|kidney cDNA
P08812490A0542|0 11|PCR/Southern
P08812490A0542|31 40|kidney cDNA
P08812490A0542|64 67|hKID
P08812490A0542|103 117|full-length mRNA
P08812490A1509|7 22|sequence homology
P08812490A1509|77 80|hKID
P08812490A1509|78 84|KID, MIP
P08812490A1509|89 93|AQP-2
P08812490A1509|102 114|MIP family gene
P08813766A0605|8 19|ORF generates
P08813766A0605|116 135|C2H2 zinc finger domain
P08813766A0605|177 181|Cre-A
P08813900A1088|6 12|phytase
P08813900A1088|16 17|nP
P08816052A0238|28 35|WISC-III
P08816052A0238|85 90|K-FAST
P08816052A0238|97 153|Kaufman Short Neuropsychological Assessment Procedure (K-SNAP)
P08816438A0316|40 47|cdc28-1N
P08816438A0316|132 134|DNA
P08816443A1674|8 20|multidomained
P08816443A1674|21 28|ROK alpha
P08816443A1674|157 168|kinase domain
P08816443A1674|225 241|adhesion complexes
P08816452A0936|74 75|SR
P08816453A0000|20 28|AMP (cAMP)
P08816453A0000|73 83|Raf-1 kinase
P08816459A0090|26 41|repression domain
P08816459A0090|47 66|orphan receptor RevErb
P08816459A0090|77 81|N-CoR
P08816459A0090|100 125|thyroid hormone receptor (TR)
P08816459A0090|137 153|acid receptor (RAR)
P08816460A1769|36 44|Jun kinase
P08816461A0892|89 92|mRNA
P08816483A0869|20 24|(SIC1
P08816483A0869|26 29|SWI5
P08816483A0869|34 38|RIC3)
P08816498A0000|3 24|serine/threonine kinase
P08816498A0000|97 105|mitogenic
P08816504T0000|50 77|phosphatidylinositol 3-kinase
P08816504T0000|108 128|SH2-domain-containing
P08816507A1125|11 28|cotransfections E1A
P08816507A1125|56 66|p53 promoter
P08816507A1125|75 85|evel; 12S E1A
P08816507A1125|111 116|13S E1A
P08816507A1125|135 137|YY1
P08816759A0000|3 23|retinoid Z receptor beta
P08816759A0000|24 27|(RZR
P08816759A0000|28 32|beta)
P08816759A0000|36 49|orphan receptor
P08816759A0000|73 84|acid receptor
P08816759A0000|85 97|(RAR)/thyroid
P08816759A0000|98 116|hormone receptor (TR)
P08816792A0000|0 33|DNA-dependent protein kinase (DNA-PK)
P08816792A0000|58 68|protein (Ku)
P08816792A0000|87 103|subunit (DNA-PKcs)
P08817323A0714|58 69|DXS6673E gene
P08817323A0714|85 102|sequence tags (ESTs)
P08817323A0714|126 137|DXS6673E gene
P08817323A0714|147 149|EST
P08817324A1070|18 26|11.1/Xq28
P08817324A1070|83 106|immunoglobulin-like CAGGG
P08818718A1229|61 75|vector complexed
P08818718A1229|123 126|MDR1
P08818718A1229|130 136|GC cDNAs
P08820324A1699|27 29|DBS
P08820324A1699|33 35|TOF
P08820642A0173|3 25|harpin-encoding hrpZ gene
P08820642A0173|122 129|hrp genes
P08820642A0173|139 150|cosmid pHIR11
P08820642A0173|236 237|HR
P08820648A0123|33 55|ribonucleotide reductase
P08820648A0123|60 72|nrdAB-encoded
P08820648A0123|124 138|nrdAB-defective
P08823163T0000|29 61|diphtheria toxin repressor complexed
P08823163T0000|93 100|SH3-like
P08823187A1020|81 99|membrane dipeptidase
P08823260A1161|0 3|FEV1
P08823260A1161|58 61|GVHD
P08823646A1012|61 64|SaO2
P08824585A0260|18 30|protein kinase
P08824585A0260|51 73|progenitor kinase 1 (HPK1)
P08824585A0260|138 147|progenitor
P08824798A0761|5 13|ESP1/CRP2
P08824798A0761|27 36|LIM domains
P08824798A0761|92 116|cysteine-rich protein (CRP)
P08824798A0761|120 126|rat CRIP
P08824881A0133|23 40|locus heterogeneity
P08824881A0133|48 54|TSC gene
P08824884A0000|3 13|cytogenetic
P08824884A0000|52 60|ite, FRAXE
P08824884A0000|83 86|a GCC
P08825087A0213|0 2|DNA
P08825087A0213|22 37|3213 bp BamHI-ClaI
P08825087A0213|67 85|reading frames (ORFs)
P08825178A0071|47 59|HIV-related TB
P08825178A0071|114 115|TB
P08825554A0000|0 19|Tristetraprolin (TTP)
P08825554A0000|100 103|CCCH
P08825556A0522|18 34|CREsp-a (TGACCTCA)
P08825556A0522|74 76|CRE
P08825556A0522|77 83|(CREpal
P08825556A0522|85 93|TGACGTCA)
P08825556A0522|113 116|CREB
P08825633A0304|22 24|DNA
P08825633A0304|34 43|intronless
P08825633A0304|77 82|G alpha
P08825633A0304|84 87|cDNA
P08825636T0000|11 21|exon-intron
P08825636T0000|47 55|gene NFKB1
P08825636T0000|92 119|transcription factors NF-kappa
P08825636T0000|153 160|NF-kappa
P08825639A0827|10 25|Alu repeat element
P08828142A0000|6 27|leukemia viruses (FeLVs)
P08828152A1238|38 53|RPO1 polypeptides
P08828152A1238|56 59|IIV6
P08828152A1238|57 64|IV6, LCDV
P08828152A1238|69 73|MCV-1
P08828152A1238|176 187|phylogenetic
P08828152A1825|3 6|RPO1
P08828152A1825|9 12|LCDV
P08828152A1825|43 46|RPO1
P08828152A1825|49 52|IIV6
P08828152A1825|97 107|polymerases
P08828152A1825|108 109|II
P08828152A1825|113 115|III
P08828857A2423|15 16|GE
P08829393A0083|38 40|SEP
P08831364A1252|77 78|AV
P08831364A1252|164 165|AV
P08832146A0959|8 10|CBD
P08832146A0959|37 59|bone alkaline phosphatase
P08832146A0959|85 87|PTH
P08833153A0628|27 35|hCHLR gene
P08833153A0628|58 66|databases
P08833153A0628|153 175|carboxyl-terminal region
P08833653A0304|17 25|LIM domain
P08833653A0304|58 74|rat amylin promoter
P08833653A0783|37 62|amylin gene promoter elements
P08833653A0783|209 215|InR1 -G9
P08835393A2829|96 119|promoter response elements
P08835393A2829|126 129|SRE)
P08835895A1292|3 5|CD4
P08835895A1292|80 91|AIDS-related
P08835969A0000|89 101|pregnancy (EP)
P08835969A0000|189 199|beta subunit
P08835969A0000|216 237|gonadotropin (beta-hCG)
P08835969A0000|273 275|EPs
P08836032T0000|20 35|AcMNPV homologous
P08836032T0000|37 63|egion sequence (hr1): enhancer
P08836172A1382|0 2|RVR
P08836172A1382|74 76|RVR
P08836172A1382|110 121|p21Cip1/Waf1
P08836172A1382|125 137|myogenin mRNAs
P08836740A1025|7 10|CES1
P08836740A1025|14 17|CES4
P08837503A0392|8 19|repeat motifs
P08837503A0392|94 100|SbHRGP3
P08837503A0392|138 149|repeat motifs
P08837746A0951|26 30|BrAAP
P08838144A0107|41 55|subdomains in PRL
P08838144A0107|102 121|S1 or/and S2 subdomains
P08838148A1218|40 55|mouse TRH receptor
P08838314A0129|50 53|V1aR
P08838314A0129|163 170|V1aR gene
P08838314A0129|164 177|1aR gene, AVPR1A
P08838805T0000|29 52|beta-catenin gene (CTNNB1)
P08839832A0729|17 21|CD30v
P08839832A1220|32 36|CD30v
P08839832A1220|80 84|[32P]
P08840501A0345|30 46|actin-related gene
P08840501A0345|78 81|ACT4
P08840506A0544|8 11|ORFs
P08840997A0765|0 2|MVR
P08840997A0765|11 28|rare-length alleles
P08842143A0000|0 12|Plasmid pAL618
P08842143A0000|114 120|17 genes
P08842143A0000|126 149|hupSLCDEFGHIJK-hypABFCDE
P08843412A0543|27 44|40-amino acid region
P08843412A0543|54 57|LBDs
P08843412A0543|60 62|RXR
P08843412A0543|61 66|XR, RAR
P08843412A0543|62 69|R, RAR, TR
P08843412A0543|196 211|high-affinity DNA
P08843419A1290|0 2|OKA
P08843419A1290|29 44|OCFRE DNA-protein
P08843419A1290|111 121|phosphatase
P08844448A0000|168 173|lipase
P08844712A0000|15 24|oxide (N2O)
P08844712A0000|124 139|alpha-chloralose
P08845378A0368|71 79|MZF-1 gene
P08845378A0368|83 97|single-copy gene
P08846775A0110|102 110|enes, CLN1
P08846775A0110|113 116|CLN2
P08847403T0000|44 47|IVF?
P08847723A2351|0 11|IMPLICATIONS
P08848013A1469|15 18|TATA
P08848013A1469|81 84|TATA
P08848052A0733|35 44|RNA-export
P08848052A0733|76 78|RNA
P08849778A0226|36 43|repA mRNA
P08849778A0226|91 93|RNA
P08849778A0226|92 98|NA, CopA
P08849778A0598|22 25|repA
P08849778A0598|72 79|peptide)
P08849834A0000|85 107|colour Doppler ultrasound
P08853303A0431|78 81|(IV)
P08853303A0431|97 108|(IA) bolus MMC
P08853303A0431|119 123|(Tmax
P08853303A0431|154 164|MMC infusion
P08853303A0431|186 203|l/min.kg, T1/2 alpha
P08853303A0431|209 219|in, T1/2 beta
P08853893A0158|36 47|E2F complexes
P08854844A0637|43 44|GB
P08854844A0637|93 94|AC
P08855804A1528|89 91|SLT
P08856077T0000|26 56|tryptophanyl-tRNA synthetase mRNA
P08856132T0000|32 56|intra-uterine kinin release
P08858211A0694|4 6|GAP
P08858211A0694|28 33|3T3-L1
P08858211A0694|91 104|[alpha-32P]GTP
P08858211A0694|112 119|GST-Rab4
P08858211A0694|124 137|[alpha-32P]GDP
P08858268A1307|0 9|CONCLUSION
P08858268A1307|143 145|CHF
P08858268A1307|148 150|CLZ
P08858463A0853|17 20|AIDS
P08858463A0853|34 65|ryptococcosis, tolerance to ILd-AmB
P08861955A0927|18 31|RCC1-like motif
P08861955A0927|101 104|ARF1
P08861955A0927|159 161|GTP
P08861955A0927|188 198|R-Ras2/TC21
P08861963T0000|42 66|RNA polymerase alpha subunit
P08861963T0000|93 110|DNA enhancer element
P08861963A0375b|16 29|RNA polymerases
P08861963A0375b|43 61|mutant alpha subunits
P08861963A0375b|117 124|cAMP-CRP
P08861963A0375b|131 145|rrnBP1 UP element
P08862522A0690|32 39|cdc28-P8
P08862743A0603|43 48|nmol/L
P08863824A0509|41 44|cDNA
P08863824A0509|129 147|transmembrane domain
P08863824A0509|153 160|5-HT2C-R
P08864061A0000|12 30|thymidine kinase gene
P08864219A0178|20 39|concentrations (MICs)
P08867519A0557|23 26|LDEE
P08868660A0087|63 84|Rivista dell'Infermiere
P08869825A0000|34 69|flavin-containing monooxygenases (FMO)
P08870266A0651|84 87|NodO
P08871542A1352|134 142|Thbs3 gene
P08871567A0000|0 3|MSSP
P08871635A0000|0 32|B cell antigen receptor (BCR)-induced
P08871635A0000|47 54|WEHI-231
P08871635A0000|96 99|CD40
P08872162A0884|58 66|CD4+/CD8+
P08872671A0573|24 52|blood flow shunt fraction (Qs/QT)
P08873063A0493|29 34|LvUSF2
P08873063A0493|54 59|LvUSF1
P08873063A0875|0 2|ECM
P08873063A0875|53 58|USF RNA
P08873063A0875|117 123|LpS1 RNA
P08873159A0791|31 32|II
P08874399A0277|91 114|Ca2+ concentration ([Ca]o)
P08874631A1133|21 25|HIV-1
P08874631A1133|29 33|HIV-2
P08874631A1133|64 68|HIV-1
P08876167A0322|19 36|DNA-binding subunit
P08876167A0322|40 45|HiNF-D
P08876167A0717|3 24|HiNF-D (CDP/cut) complex
P08876167A0717|32 41|H4 promoter
P08876167A0717|79 85|CDP/cut
P08876167A0717|89 91|pRB
P08876167A0717|113 119|CDP/cut
P08876167A0717|175 177|CDP
P08876701A0177|26 37|UmuC-homolog
P08876701A0177|27 42|muC-homolog, DinB
P08877103A0081|53 60|mdr2 gene
P08877103A0081|88 123|inblastine-resistant cell line, J7.V2-1
P08877818A0184|59 120|TRH progenitor sequence (Lys/Arg-Arg-Gln-His-Pro-Gly-Lys/Arg-Arg)
P08878037A0000|3 10|gene ccpA
P08878037A0000|22 49|catabolite control protein CcpA
P08878044A1390|2 5|InlC
P08878045A0606|8 19|N-Nus complex
P08878045A0606|55 57|CTD
P08878045A0606|63 74|alpha subunit
P08878045A0606|77 89|RNA polymerase
P08878573A1370|16 19|RIFA
P08878573A1370|51 53|ATO
P08878573A1370|142 144|ATO
P08878573A1370|147 150|RIFA
P08879080A0265|0 14|Eight-four ACOAs
P08879080A0265|84 92|LISREL VII
P08879237A0744|39 56|sequence homologous
P08879237A0744|62 83|consensus promoter motif
P08879237A0744|99 107|CRTA motif
P08880405A1170|14 18|SC EPD
P08881036A0351|13 15|PCR
P08881036A0351|18 26|VL element
P08881036A0351|39 41|CL2
P08882492A0000|12 22|homeodomain
P08882492A0000|40 47|Hox genes
P08882710A0000|20 37|gene factor 3 (ISGF3)
P08882710A0000|99 114|interferon-alpha
P08882710A0000|128 132|IFNs)
P08884273A1413|3 9|TYAC/P1
P08884273A1413|29 32|STSs
P08884757A0653|54 68|Impression (CGI)
P08884757A0653|102 126|Assessment Geriatric (SCAG)
P08884757A0653|194 211|(Beurteilungsskala
P08884757A0653|213 240|ur geriatrische Patienten; BGP)
P08884757A0653|276 307|Performance Test (Syndrom-Kurztest
P08884757A0653|277 312|erformance Test (Syndrom-Kurztest; SKT)
P08885270A0428|42 51|train, PAO1
P08886845A1274|28 43|myogenin promoter
P08887643A1167|58 61|TC21
P08887643A1167|75 78|TC21
P08887652A0341|43 45|DNA
P08887652A0341|67 97|con-10 promoter-regulatory region
P08887652A0341|180 208|hygromycin B phosphotransferase
P08887661A0138|0 4|IRF-1
P08887661A0138|42 46|IRF-2
P08887661A1061|27 31|TFIIB
P08887661A1061|35 39|IRF-1
P08887661A1061|44 49|NIH 3T3
P08887661A1061|126 139|TATA-dependent
P08887667A0992|162 181|Cdc28/Clb kinase in SPB
P08887674A0630|14 17|DMP1
P08887674A0630|49 51|GGA
P08887674A0630|86 107|Ets-responsive elements
P08887674A0920|38 61|cyclin D-dependent kinases
P08887678A0000|55 67|GAL10 promoter
P08891131A0000|30 54|vanA-mediated glycopeptide
P08891337A0614|3 22|amino-terminal region
P08891337A0614|25 27|E1A
P08891337A0614|137 168|cAMP response element (CRE)-binding
P08891341A0724|32 43|reporter gene
P08891341A0724|181 192|reporter gene
P08891345A0684|13 17|5'UTR
P08891345A0684|34 57|testis-specific c-mos mRNA
P08891345A0684|135 139|5'UTR
P08891345A0684|151 165|beta-globin mRNA
P08891345A0684|194 198|uORFs
P08891346A1217|39 61|soform expression, NIH3T3
P08891346A1217|123 126|cDNA
P08891346A1217|130 134|FGF8a
P08891346A1217|131 140|GF8a, FGF8b
P08891346A1217|144 148|FGF8e
P08892755A0186|3 18|ddition, carp JAK1
P08892755A0186|30 45|sequence homology
P08892755A0186|57 60|JAK1
P08892755A0186|70 85|kinase-like (JH2)
P08892755A0186|89 106|kinase (JH1) domains
P08892755A0981|8 10|DNA
P08892755A0981|41 89|chloramphenicol acetyltransferase (CAT) reporter gene
P08892755A0981|109 114|carp CF
P08892755A0981|150 152|CAT
P08892755A0981|188 199|promoterless
P08892755A0981|200 209|pCAT-Basic
P08892757T0000|63 80|mouse embryogenesis
P08892859A0563|21 63|MDV-transformed T-lymphoblastoid cell line (T9)
P08892859A0563|96 100|C-MYB
P08892859A0563|119 121|RAV
P08892859A0563|142 152|c-myb allele
P08893822A0560|21 35|3.1-kb PWP2H cDNA
P08894144A0330|29 42|Sprague-Dawley
P08894144A0330|80 91|8 days: (1) CsA
P08894144A0330|107 108|FB
P08894144A0330|108 124|B vehicle sc; (2) CsA
P08894144A0330|142 143|FB
P08894144A0330|143 159|B vehicle sc, (3) CsA
P08894144A0330|154 159|(3) CsA
P08894144A0330|175 176|FB
P08894144A1173|0 2|CsA
P08894826A0228|23 25|GUM
P08894826A0228|102 104|HIV
P08894826A0228|161 175|infection (NSGI)
P08895522T0000|0 8|Oncogenic
P08895522T0000|24 43|tyrosine kinase domain
P08895522T0000|54 70|trk proto-oncogene
P08895579A0583|26 29|MDMX
P08895579A0583|35 38|MDM2
P08895579A0583|84 88|mRNAs
P08895579A0583|92 95|MDMX
P08896272A0000|55 56|IV
P08896280A0860|44 47|IME1
P08896280A0860|51 58|IME2 mRNA
P08896402A0587|7 8|FL
P08896402A0587|64 67|65 kD
P08896402A0587|121 132|30 kD subunits
P08896402A0587|148 151|12 kD
P08896473A0282|49 52|HHCA
P08896473A0282|99 101|VGS
P08896590T0000|28 31|RNAs
P08896590T0000|46 50|snRNP
P08896804A0000|66 84|benzodiazepine (BDZ)
P08896804A0000|100 115|gonist, RO19-4603
P08896804A0000|162 172|BDZ receptor
P08896804A0000|163 196|DZ receptor antagonists flumazenil, ZK
P08896804A0000|206 208|CGS
P08896804A0000|239 259|alcohol-preferring (P)
P08896804A0000|300 312|ethanol (EtOH)
P08897721A0000|119 127|immunogen
P08898336A0268|0 4|RNase
P08898336A0268|28 31|rRNA
P08898336A0268|154 157|RNAs
P08898365A0274|82 98|coiled-coil domain
P08898365A0274|124 142|pore complexes (NPCs)
P08898866A0458|111 112|II
P08898866A0458|135 136|II
P08898866A0458|208 223|N-terminal domain
P08898893A0202|3 11|PAI-2 gene
P08898893A0202|26 44|TNF-responsive genes
P08898893A0202|77 122|phorbol ester phorbol 12-myristate 13-acetate (PMA)
P08898893A0202|129 139|phosphatase
P08898893A0202|168 174|HT-1080
P08899719A0318|37 55|reading frames (ORFs)
P08899719A0318|72 84|perons; 56 ORFs
P08900190A0430|51 91|gene products MAP kinase phosphatase-1 (MKP-1)
P08900190A0430|52 97|ene products MAP kinase phosphatase-1 (MKP-1), c-Fos
P08900190A0430|101 105|c-Jun
P08901135A1132|3 6|NIT2
P08901135A1132|169 172|NIT2
P08901658A0498|41 52|flow increase
P08901658A0498|125 128|(GTN
P08902214A1486|43 51|exogenous
P08902214A1486|52 54|PRL
P08902548A0144|31 60|L-5-hydroxytryptophan (L-5-HTP)
P08902641A0930|5 10|VA-SMV
P08902641A0930|61 62|LV
P08902641A0930|116 118|DAo
P08902847A1946|147 159|hCG alpha 1 beta
P08902847A1946|182 183|pH
P08902847A1946|242 246|rehCG
P08903339A0264|62 64|RNA
P08905819A0531|25 27|0-I
P08905819A0531|30 34|0-III
P08906139A2935|52 70|alkaline phosphatase
P08909546A0810|15 18|PEA2
P08909546A0810|103 119|coiled-coil domain
P08910292T0000|21 31|GTP-binding
P08910292T0000|57 107|c-Jun N-terminal kinase/stress-activated protein kinase
P08910373A0315|22 29|mouse PP2
P08910373A0315|33 50|ouse Y1, mouse Y4/PP1
P08910373A0315|59 69|Y2 receptors
P08910550A0501|41 43|CBF
P08910550A0501|56 59|78C1
P08910550A0501|76 79|EGTA
P08910550A0501|83 86|EDTA
P08910550A0501|137 149|78C1-directed
P08910567A2269|39 65|rat liver glucokinase promoter
P08912232A0260|15 16|ML
P08912807A0411|20 31|deer receptor
P08912807A0411|139 157|beta-casein promoter
P08913186A0431|39 43|riMLF
P08913974A0533|23 25|EPs
P08914388A1645|87 93|CS-940*
P08914388A1645|97 114|sparfloxacin (SPFX)
P08914388A1645|126 133|AM-1155*
P08914388A1645|127 153|M-1155*, ciprofloxacin (CPFX)
P08914388A1645|128 172|-1155*, ciprofloxacin (CPFX), levofloxacin (LVFX)
P08914388A1645|129 183|1155*, ciprofloxacin (CPFX), levofloxacin (LVFX), OPC-17116*
P08914388A1645|130 191|155*, ciprofloxacin (CPFX), levofloxacin (LVFX), OPC-17116*, NM-394*
P08914522A0118|3 11|STE20 gene
P08914522A0118|22 34|protein kinase
P08914522A0118|118 133|high-gene-dosage
P08914522A0118|163 167|G beta
P08914532A0598|22 64|(1-->4)-beta-xylan endohydrolase isoenzyme X-I
P08915508A0000|13 53|leukemia virus (MMLV)-derived pUCMoTiN-based
P08915508A0000|235 251|group antigen (Gag)
P08915508A0000|236 265|roup antigen (Gag), protease (Pro)
P08915508A0000|274 290|transcriptase (RT)
P08915508A0000|299 324|envelope (Env) coding regions
P08915508A0000|332 368|immunodeficiency virus type-1 (HIV-1) RNA
P08915559A0366|0 2|REM
P08916928A0950|51 67|PDGF-BB-dependent
P08916928A0950|68 80|[3H]thymidine
P08916928A0950|96 98|PAE
P08916928A0950|117 134|PDGF beta-receptors
P08916960A0350|52 53|FL
P08916960A0350|92 100|bcl-2 gene
P08916960A0350|123 146|reading frame (ORF) regions
P08916960A1331|23 24|FL
P08916960A1331|28 30|DLL
P08916960A1331|55 63|bcl-2 gene
P08916960A1331|78 93|breakpoint region
P08916960A1331|126 134|bcl-2 gene
P08916960A1331|199 200|FL
P08917270A0229|0 9|BACKGROUND
P08917270A0229|14 36|Bazett-corrected QT (QTc)
P08917270A0229|91 111|isease, arrhythmogenic
P08917270A0229|131 132|QT
P08917435A0481|17 21|c-Jun
P08917435A0481|25 29|c-Fos
P08917435A0481|40 53|PMA-stimulated
P08917435A0481|72 80|PAI-1 gene
P08917435A0481|181 199|PMA-stimulated PAI-1
P08917449A0000|0 29|Leukemia-inhibitory factor (LIF)
P08917696A0485|42 45|TCDD
P08917696A0485|114 125|reporter gene
P08917696A0485|146 161|response elements
P08917696A0485|165 206|12-O-tetradecanoyl-phorbol-13-acetate (TRE)
P08917696A0485|166 217|2-O-tetradecanoyl-phorbol-13-acetate (TRE), serum (SRE)
P08917696A0485|167 227|-O-tetradecanoyl-phorbol-13-acetate (TRE), serum (SRE), cAMP (CRE)
P08917696A0485|240 257|hydrocarbons (AhRE)
P08917696A0485|266 277|os and jun gene
P08917696A0485|271 278|jun genes
P08917696A0485|296 305|luciferase
P08917696A0485|330 333|SV40
P08918456A0455|46 49|AP-2
P08918464A0225|0 41|STK/RON-expressing Ba/F3 pro-B cells (BaF/STK)
P08918464A0225|51 63|MSP-dependent
P08918464A0225|78 95|STK/ RON-expressing
P08918464A0225|122 126|(MEL/
P08918464A0225|127 130|STK)
P08918464A0225|140 150|MSP-induced
P08918810A0967|7 11|DNase
P08918810A0967|35 44|OxyR-C199S
P08918810A0967|137 149|wild-type OxyR
P08918885A0811|24 37|GST-Dig1 fusion
P08918918T0000|24 39|HIV-1 LTR promoter
P08918934A0424|29 46|xFxFG repeat regions
P08918934A0424|73 76|NTF2
P08919289A0402|47 49|MFH
P08919907A0763|21 25|VSF-1
P08921387A1182|13 16|cDNA
P08921387A1182|56 59|EZH1
P08921387A1182|78 85|gene GPR2
P08921387A1182|131 134|EZH1
P08921387A1182|156 171|C-terminal domain
P08921667A0294|43 64|distribution volume (Vd)
P08921667A0294|75 78|rCBF
P08921865A1293|32 50|(ss) DNA binding motif
P08921865A1293|71 79|terminase
P08921865A1293|134 145|ssDNA regions
P08921865A1293|173 177|T4DNA
P08922344A1539|54 68|xanthine oxidase
P08922384A0466|61 71|08L antibody
P08922384A0466|84 86|08L
P08922385A0622|77 94|beta-galactosidase
P08922385A0622|108 120|fusion subunit
P08922390A0361|37 58|FAK-interaction domains
P08922390A0793|91 93|FAK
P08922390A2076|100 102|FAK
P08922390A2076|150 159|LIM domains
P08922391A0304|59 61|PDZ
P08922391A0304|73 81|2 (PDZ1-2)
P08923460A0565|0 9|RUSH-1 beta
P08923460A0565|13 18|95-kDa
P08923460A0565|37 47|RUSH-1 alpha
P08923460A0565|85 93|57-bp exon
P08923469A1391|57 59|RXR
P08923469A1391|89 111|hormone response elements
P08923469A1391|120 122|VDR
P08923469A1391|137 151|3'-half-element
P08923470A0458|0 12|PPAR gamma mRNA
P08923470A0458|39 49|3 nM TNF alpha
P08924211A0941|5 7|III
P08924211A0941|10 13|VIII
P08924211A0941|97 99|PST
P08924211A0941|102 109|AST cDNAs
P08925545T0001|11 33|erythropoietin (r-HuEPO)
P08927612T0000|9 20|p53 mutations
P08929089A0231|11 19|ratio M/Pc
P08929563T0000|0 15|Rat liver catalase
P08929563T0000|42 72|C-terminal tripeptide Ala-Asn-Leu
P08929563T0000|90 105|Ser-Lys-Leu motif
P08931991A1026|34 36|E2F
P08931991A1026|41 51|E2F-related
P08932363A0807|7 9|E1A
P08932363A0807|73 83|CBP-induced
P08932363A0807|96 103|E2F1/DP1
P08932363A0807|114 116|E1A
P08932363A0807|130 132|CBP
P08932385T0000|36 71|transcription factor TCF11/Nrf1/LCR-F1
P08933487A0325|10 25|occasion water (W)
P08933640A0000|82 87|KBL:JW
P08934533A0784|44 47|junB
P08934533A0784|58 60|DNA
P08934540A0673|3 21|nm23-H1/nm23-H2 gene
P08935931A0787|0 9|CONCLUSION
P08935931A0787|50 52|EGD
P08935931A0787|79 82|SpO2
P08935931A0787|145 148|SpO2
P08935931A0787|167 169|EGD
P08935991A0844|50 51|CA
P08935991A0844|52 53|IV
P08935991A0844|98 108|exon-intron
P08936640A0105|0 10|DATA SOURCES
P08937112A0561|0 6|RESULTS
P08937981A0840|37 47|p54 subunits
P08937989A1365|42 58|C-terminal regions
P08938420A0862|21 24|LHA4
P08938420A0862|28 36|LHA2 mRNAs
P08938420A0862|61 69|exogenous
P08938420A0862|157 173|3-O-methylglucose
P08938420A0862|188 191|mRNA
P08939891A0285|43 45|NRE
P08939891A0285|57 59|DNA
P08939966A0816|46 58|embryogenesis
P08939966A0816|68 72|SEC-1
P08939966A0816|86 89|mRNA
P08940132A1120|78 95|ICE/Ced-3 proteases
P08940132A1120|121 128|DEVD-CHO
P08940132A1120|161 165|CPP32
P08940132A1120|171 187|ICE/Ced-3 protease
P08940132A1120|205 209|CPP32
P08940132A1120|212 219|DEVD-CHO
P08940134A0705|2 4|3Y1
P08940134A0705|8 10|3Y1
P08940134A0705|59 63|PTP1B
P08940134A0705|82 90|p130(Cas)
P08940298A0962|50 59|AF-2 domain
P08940298A0962|67 83|vitamin D3 receptor
P08940298A0962|89 104|estrogen receptor
P08942999T0000|9 14|G-to-A
P08942999T0000|43 47|SREBP
P08943032A0000|18 36|tet-repressor (TetR)
P08943354A0295|30 34|SHP-1
P08943354A0295|57 80|Jak family tyrosine kinases
P08943354A0295|124 133|Tyk2 kinase
P08943354A0295|162 171|Jak kinases
P08943354A0295|209 213|SHP-1
P08945479T0000|35 50|lymphocyte kinase
P08946166A0568|36 38|ORF
P08946166A0568|44 51|FRDS gene
P08946668A0077|0 4|FK506
P08948440A0628|3 5|ERH
P08950144A0172|13 15|CNV
P08950144A0172|35 37|CNV
P08950144A0172|97 109|interval (ISI)
P08951815A0465|12 15|ASN1
P08951815A0465|19 22|ASN2
P08951815A0465|48 58|lacZ fusions
P08952483A0207|31 41|polypeptide
P08952483A0207|57 83|hamster lysyl-tRNA synthetase
P08952483A0207|143 164|multisynthetase complex
P08952965A1182|40 43|(pN)
P08952965A1182|57 60|(pS)
P08952965A1182|111 121|region genes
P08952965A1182|146 147|pN
P08952965A1182|153 168|framework regions
P08952965A1182|181 182|pN
P08952965A1182|196 212|MHC contact regions
P08952965A1182|213 217|(CDR1
P08952965A1182|221 225|CDR2)
P08953340A0000|16 36|vanadyl sulfate (VOSO4)
P08955071T0000|56 59|ORC1
P08955111A0989|39 53|enhancer regions
P08955111A0989|132 154|activin betaA subunit gene
P08955136A0606|32 42|PIP5KIalpha
P08955136A0606|52 56|PIP5K
P08955136A0606|98 103|PIP5KI
P08955159A0000|5 54|acid ceramidase ((AC) N-acylsphingosine amidohydrolase
P08955159A0000|6 57|cid ceramidase ((AC) N-acylsphingosine amidohydrolase, EC
P08955189A1198|3 27|0.22-kb NheI/BglII promoter
P08955189A1198|37 39|PMA
P08955189A1198|79 99|PMA-responsive element
P08955189A1198|118 122|EGR-1
P08955306A0224|0 12|Northern (RNA)
P08955306A0224|41 48|cdh genes
P08955306A0224|81 98|reading frame (ORF1)
P08955402A0288|70 73|HOL1
P08955402A0288|158 163|HOL1-1
P08955928A0390|11 13|BBB
P08955928A0390|40 52|Evans Blue (EB)
P08955928A0390|106 109|MCAo
P08958137A0534|35 37|LDL
P08958720A1204|34 37|mPAP
P08958720A1204|52 54|SVI
P08958720A1204|65 66|HR
P08958720A1204|83 84|CO
P08958720A1204|88 90|VO2
P08959062A0372|103 105|EBV
P08959117A0708|135 137|ICU
P08959117A0708|200 218|reference group (REF)
P08959778A0292|70 87|graft function (EGF)
P08959778A0292|91 93|DGF
P08960827A1169|28 35|GG motifs
P08960827A1169|88 98|insulin gene
P08962614A0000|18 37|immunoglobulin E (IgE)
P08967963A1735|50 70|rat glioma cell line C6B4
P08967963A1735|91 105|cell line RSMT-A5
P08967963A1735|126 144|beta cell line RIN-5AH
P08967963A1735|171 180|endogenous
P08967963A1735|181 194|alpha2c-AR gene
P08969495A0256|35 48|mutation ts-A13
P08969495A0256|64 67|nrdE
P08969495A0256|142 145|nrdE
P08969495A0256|149 152|nrdF
P08969777A0771|95 105|serum 25-OHD
P08970352A0880|29 31|LDD
P08970352A0880|59 62|MSOF
P08970951A0823|124 129|HBV DNA
P08970979A1246|83 91|exogenous
P08970984A0765|3 9|SCMV SNE
P08970984A0765|42 69|core recognition binding motifs
P08970984A0765|73 75|SRF
P08970984A0765|74 88|RF, Rel/NFkappaB
P08970984A0765|75 92|F, Rel/NFkappaB, ETS
P08970984A0765|97 99|YY1
P08970984A0765|156 179|tumor necrosis factor alpha
P08970991A0747|46 57|p53-mediated
P08971009A0860|155 157|DNA
P08971721A1314|58 61|HspA
P08971835A1057|7 8|IV
P08971835A1057|25 33|alpha-MSH
P08971835A1057|44 54|reperfusion
P08971835A1057|45 60|eperfusion, BAEPs
P08971835A1057|104 110|Group II
P08971835A1057|124 134|reperfusion
P08972182A0000|3 13|Fas receptor
P08972182A0527|24 77|ICE (interleukin-1 beta-converting enzyme) family proteases
P08972182A0527|118 146|cowpox ICE inhibitor protein CrmA
P08972182A0527|160 191|tetrapeptide ICE inhibitor YVAD-CMK
P08972182A0527|199 233|tripeptide pan-ICE inhibitor Z-VAD-FMK
P08972211A0059|27 36|endogenous
P08972211A0059|73 86|14-kb transgene
P08972211A0059|168 193|endoderm-specific enhancers
P08972232A0365|30 34|hGCN5
P08972232A0365|43 45|HAT
P08972232A0365|81 85|yGCN5
P08973185T0061|60 62|AAC
P08973527A0000|13 16|DNAs
P08973527A0000|69 94|Agropyron mosaic virus (AgMV)
P08973527A0000|98 121|Hordeum mosaic virus (HoMV)
P08973917T0000|61 88|tryptophan protein 2 (PWP2) gene
P08973917A0632|7 11|cDNAs
P08973917A0632|35 42|PWP2 gene
P08974103A0451|92 94|PEM
P08975713A0454|12 15|cDNA
P08975713A0454|68 72|p53p2
P08975713A0454|112 115|cDNA
P08975713A0454|131 134|mRNA
P08975713A0454|172 184|p53p2 promoter
P08976253A0637|57 65|plasma PSA
P08977235A0134|0 4|G-CSF
P08977235A0134|53 56|JAK1
P08977235A0134|60 70|JAK2 kinases
P08977235A0134|77 80|STAT
P08977235A0588|85 89|STAT5
P08977235A0588|93 97|STAT1
P08977235A0588|115 119|STAT3
P08977235A0588|133 137|STAT5
P08977235A0588|141 145|STAT1
P08977401A0227|3 13|RI alpha gene
P08977401A0227|144 160|RI alpha pseudogene
P08977401A0227|166 183|5'-noncoding region
P08977401A0227|218 224|RI alpha
P08977401A0227|238 240|RNA
P08977401A0227|257 267|RI alpha gene
P08977401A0227|283 293|leader exons
P08977401A0227|324 343|messenger RNAs (mRNAs)
P08978690A0262|15 23|Rad3/Mec1
P08978690A0262|73 75|DNA
P08978817A0620|139 145|DIM gene
P08978996A0000|54 65|liver disease
P08979089A1197|23 24|BL
P08979089A1197|61 72|core promoter
P08979089A1197|119 122|TATA
P08979089A1197|171 186|Ig kappa enhancers
P08980413A0500|14 19|ppSEPs
P08980413A0500|77 79|PES
P08980522A0280|3 6|cDNA
P08980522A0280|48 50|kDa
P08980533A1160|11 26|C-terminal region
P08980533A1160|29 33|ENBP1
P08980536A1196|48 59|CHS promoters
P08981371A2049b|11 14|PIP2
P08981371A2049a|11 14|PIP2
P08981371A2049a|27 34|85-90 kDa
P08981371A2049b|27 34|85-90 kDa
P08981371A2049b|64 68|CSF-1
P08981371A2049a|64 68|CSF-1
P08985115A1571|33 45|37LRP/p40 gene
P08985122A0501|3 20|promoter region (P1)
P08985122A0501|88 91|TATA
P08985122A0501|95 98|CAAT
P08985122A0501|136 157|transcription factor SP1
P08985122A0501|181 192|C-rich domain
P08985122A0501|196 198|CpG
P08985415A1096|3 8|STAT-1
P08985415A1096|70 76|CAEV LTR
P08985415A1096|79 87|IFN-gamma
P08986190A0927|0 10|Reperfusion
P08986190A0927|70 89|increase in LDH release
P08986214A0000|20 31|regenerative
P08986214A0000|63 74|liver disease
P08986214A0000|153 179|hepatocyte growth factor (HGF)
P08986214A0000|183 204|alpha-fetoprotein (AFP)
P08986228A0000|58 68|teratogenic
P08986692A0306|0 14|INTERVENTION(S)
P08986692A0306|85 90|IVF-ET
P08986770A0268|31 49|I-POU/tI-POU message
P08986770A0268|109 113|I-POU
P08986812A1214|6 17|wild-type p53
P08986812A1214|22 31|delta proAE
P08986812A1214|38 41|cDNA
P08987225A0675|55 69|hepatitis C cases
P08987225A0675|157 158|NT
P08987225A0675|163 165|ACT
P08989025A0359|4 36|voltage-operated Ca2+ channels (VOC)
P08989025A0359|95 101|1 microM
P08990168A0688|8 14|p48 gene
P08990168A0688|37 41|STAT1
P08990168A0688|45 48|JAK1
P08990168A0688|59 63|STAT1
P08990168A0688|77 80|GATE
P08990397A1437|45 56|tscA-lacking
P08990397A1437|100 118|light-stimulated RNA
P08992115A0199|76 86|acute-phase
P08992115A0199|77 98|cute-phase proteins, KKS
P08993393T0000|24 42|immediate-early gene
P08993393T0000|92 147|adenylate cyclase-activating polypeptide receptor (hPACAP-R)
P08993393A0498|77 88|hPACAP-R gene
P08993831A0000|63 71|generated
P08993831A0000|108 126|muscle-specific gene
P08993836A0699|66 79|HNF-3 alpha gene
P08993836A0699|109 121|embryogenesis
P08994825A0000|0 9|BACKGROUND
P08994825A0000|31 33|MPF
P08994825A0000|77 100|Cdc2/28-cyclin B complexes
P08994832A0782|26 31|HEK293
P08994832A0782|34 37|HeLa
P08994968A0926|44 69|dinucleotide-binding domain
P08994968A0926|114 117|NADP
P08995054A0618|29 45|zinc knuckle region
P08995054A0618|70 77|gag genes
P08995054A0618|84 117|replication-competent retroelements
P08995054A1368|14 18|HeT-A
P08995054A1368|82 91|1-31 codons
P08995410A0000|10 32|initiation factor 3 (eIF3)
P08995410A0000|41 52|multisubunit
P08995410A0000|85 110|omplex, eIF2 x GTP x tRNA(Met)i
P08995410A0000|122 125|mRNA
P08995410A0000|151 161|ubunit. eIF3
P08995410A0000|178 192|ribosome subunit
P08995410A1109|68 71|eIF3
P08995410A1109|91 100|10 subunits
P08995410A1109|93 117| subunits: p170, p116 (hPrt1)
P08995614T0000|17 33|cis-acting element
P08995614T0000|50 86|histocompatibility complex gene promoter
P08995652A0812|97 125|C-terminal 65 amino acids) UL80.5
P08995652A0812|181 186|UL80.5
P08995652A0812|240 245|UL26.5
P08995652A0812|300 305|UL80.5
P08995652A0812|317 319|VP5
P08995652A0812|416 421|UL80.5
P08995652A0812|443 454|RRIFVA ALNKLE
P08995652A0812|457 468|RRIFVAAMMKLE
P08995652A0812|578 583|UL26.5
P08995652A0812|587 592|UL80.5
P08995659A0563|10 18|3'-region
P08995659A0563|39 42|MSRs
P08995659A0563|93 126|sequencing RNA-PCR products generated
P08995659A0563|152 163|splice region
P08995681A0518|0 8|(ii) ICP27
P08995681A0518|49 52|ICP4
P08997490A1127|0 8|C/EBP beta
P08997490A1127|43 47|C/EBP
P08997490A1127|64 66|DBP
P08997490A1127|137 167|cholesterol hydroxylase promoters
P08997532A0116|8 10|IgG
P08997532A0116|20 22|IgE
P08997532A0116|31 48|IgE immunoglobulins
P08997532A0116|88 100|antigens (TES)
P08997532A0116|120 124|ELISA
P08998115A0114|0 20|SUMMARY BACKGROUND DATA
P08999414A0819|19 27|subgenera
P08999857A0801|33 49|3'-flanking region
P08999857A0801|122 150|alpha1(I) collagen gene promoter
P09000049A1341|13 33|Mnt:Max:Sin3 complexes
P09000049A1341|60 66|Myc:Max
P09000108A0330|28 33|kb mRNA
P09000108A0330|138 164|translation termination codon
P09000108A0330|168 171|CG30
P09000146T0000|44 53|c-src genes
P09000632A2341|5 14|p51 subunit
P09000632A2341|90 105|wild-type complex
P09001213A1111|177 184|var genes
P09001245A0187|0 5|NUP145
P09001245A0187|65 66|(E
P09001313A0000|12 41|sleep-disordered breathing (SDB)
P09001667A0312|13 23|antigenemia
P09001828A0222|82 84|BPH
P09002648A0202|0 4|BCL-2
P09002672A0439|23 31|mTRF1 cDNA
P09002672A0439|43 47|56 kDa
P09002672A0439|66 71|TTAGGG
P09002672A0439|73 89|epeat arrays. mTRF1
P09002672A0439|127 131|hTRF1
P09002672A0439|151 156|TTAGGG
P09002672A0439|187 192|TTAGGC
P09002672A0439|196 201|TTGGGG
P09003001A1593|27 30|bHLH
P09003001A1593|72 75|bHLH
P09003001A1909|21 23|SE2
P09003001A1909|37 55|transferrin promoter
P09003001A1909|59 64|CATCTG
P09003001A1909|94 123|consensus E-box elements (CANNTG)
P09003311A0478|1 9|5.3-kb DNA
P09003311A0478|51 59|porin gene
P09003311A0478|66 71|porCa)
P09003312A0740|0 17|Full-length AT-PHH1
P09003312A0740|26 32|AT-PHH1
P09003312A0740|36 42|AT-PHH1
P09003312A0740|98 118|photolyase genes) cDNAs
P09003312A0740|199 209|ultraviolet
P09003410A0000|59 70|Epstein-Barr
P09003462A0792|28 31|(S61
P09003462A0792|33 35|SL1
P09003462A0792|35 44|1, S29, SL11
P09003462A0792|36 50|, S29, SL11, SL196
P09003462A0792|54 59|SL126)
P09003462A0792|74 83|nrdB intron
P09003463A0198|54 70|5'-flanking region
P09003463A0198|96 107|RII alpha gene
P09004304A0000|125 139|acid (51Cr-EDTA)
P09004504A0000|22 30|2671 bp DNA
P09004504A0000|49 55|pla gene
P09004504A0000|65 75|plasminogen
P09004504A0000|116 151|wild-type Yersinia pestis plasmid pYP358
P09005273A0322|0 18|MAIN OUTCOME MEASURES
P09005273A0322|114 134|butyrylcholinesterase
P09005273A0322|138 161|neuropathy target esterase
P09005273A1558|0 9|CONCLUSION
P09005273A1558|126 146|butyrylcholinesterase
P09005273A1558|150 173|neuropathy target esterase
P09005979A0841|3 18|GHR mRNA:GHBP mRNA
P09006007A0997|31 61|selenocysteine-specific UGA codon
P09006007A0997|114 117|SelB
P09006007A0997|172 180|SelB-mRNA
P09006010A0527|3 16|linker-peptide
P09006010A0527|31 34|RsaA
P09006010A0527|71 87|S-layer biogenesis
P09006010A0527|160 163|RsaA
P09006022A0252|33 40|cvaA gene
P09006022A0252|82 104|T7 RNA polymerase promoter
P09006051A1162|0 3|PrpB
P09006051A1162|20 62|carboxyphosphonoenolpyruvate phosphonomutase
P09006051A1162|111 143|arnation Dianthus caryophyllus; PrpC
P09006051A1162|183 198|citrate synthases
P09006051A1162|184 203|itrate synthases; PrpD
P09006051A1162|262 273|unction; PrpE
P09006051A1162|290 315|acetyl coenzyme A synthetases
P09006555A0738|0 18|MAIN OUTCOME MEASURES
P09006555A0738|116 173|utrophil content, neutrophil oxidant burst, lung myeloperoxidase
P09006902A0370|15 18|cDNA
P09006902A0370|32 36|MEKK3
P09006910A0000|63 88|retinoid X receptor (RXR) gene
P09006910A0000|103 119|5'-flanking region
P09006910A0000|130 145|RXRgamma2 isoform
P09006914A0812|0 2|JNK
P09006914A0812|49 62|DNA-bound c-JUN
P09006914A0812|66 70|ATF-2
P09006914A0812|91 93|JNK
P09006914A1127|41 47|JNK/p38
P09006914A1127|96 102|kinases
P09006914A1127|116 145|cytokine-induced E-selectin gene
P09006935A0590|11 13|CTC
P09006935A0590|27 36|ffinity, KD
P09006935A0590|42 43|nM
P09006935A0590|63 73|consensus GC
P09006936T0000|80 98|glycoprotein IBalpha
P09009208A0337|11 19|generated
P09009208A0337|65 71|Tf1 mRNA
P09010223A0667|30 33|ELK1
P09010223A0667|31 39|LK1, SAP1a
P09010223A0667|32 44|K1, SAP1a, FLI1
P09010223A0667|33 53|1, SAP1a, FLI1, EWS-FLI1
P09010223A0667|34 58|, SAP1a, FLI1, EWS-FLI1, ETS1
P09010223A0667|35 68|SAP1a, FLI1, EWS-FLI1, ETS1, ETS2, PEA3
P09010223A0667|72 75|PU.1
P09010223A0667|111 113|SRF
P09010223A0667|119 126|Egr1 SREI
P09010223A0667|130 131|II
P09010223A1850|4 11|R-domain
P09010223A1850|41 43|SRF
P09010223A1850|83 86|FLI1
P09010223A1850|90 97|EWS-FLI1
P09010223A1850|136 138|ETS
P09010223A1850|179 186|Egr1 gene
P09011744A0790|38 64|NMDA receptor channel subunits
P09011744A0790|69 84|epsilon 1 (Grin2a)
P09011744A0790|70 101|psilon 1 (Grin2a), epsilon 2 (Grin2b)
P09011744A0790|71 118|silon 1 (Grin2a), epsilon 2 (Grin2b), epsilon 3 (Grin2c)
P09011744A0790|72 135|ilon 1 (Grin2a), epsilon 2 (Grin2b), epsilon 3 (Grin2c), epsilon 4 (Grin2d)
P09011744A0790|139 158|zeta 1 (Grinl) subunits
P09011744A0790|235 246|[(C57BL/6JxM
P09011744A0790|248 267|spretus) F1xC57BL/6J]
P09011745T0000|0 3|CDNA
P09011745T0000|13 86|chick brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors
P09012405A0785|15 19|TTD-A
P09012405A0785|23 26|XP-D
P09012405A0785|61 65|TFIIH
P09012405A0785|113 115|DNA
P09012636A0723|23 36|holesterol, HDL
P09012636A0723|133 142|fibrinogen
P09013499A0198|63 106|N-methyl-D-aspartate receptor antagonist MK-801
P09013760A0000|43 49|(CYP11A
P09013760A0000|51 62|P450scc) gene
P09013760A0000|102 105|cAMP
P09013760A0000|121 124|ACTH
P09013760A0000|128 131|cAMP
P09015757T0000|86 110|bone sialoprotein (BSP) gene
P09015799T0000|0 17|Serotonin receptors
P09016566A0655|62 69|BiP mRNAs
P09018122A1389|14 18|ORF-1
P09018133A0244|0 11|Phylogenetic
P09018133A0244|72 77|PhHV-1
P09018133A0244|117 135|alpha-Herpesvirinae
P09019302A0600|7 15|ethod, PLP
P09020138A0833|4 7|HEF1
P09020138A0833|59 79|tyrosine kinase (RAFTK)
P09020138A0833|118 136|adapter molecule CrkL
P09020169A0552|0 3|SIM1
P09020169A0552|7 10|SIM2
P09020169A0552|55 57|AHR
P09020172A0964|11 16|qTBP42
P09020172A0964|55 57|DNA
P09020172A0964|106 115|3.7-14.6 nM
P09020172A0964|185 187|DNA
P09020856A0560|27 30|TIS1
P09020856A0560|58 68|MCK promoter
P09021684A1418|145 152|NF-kappa
P09022040A0263|118 130|L-plastin gene
P09022040A0263|253 274|L-plastin gene promoters
P09023197T0000|3 12|dnaK operon
P09023378A0959|21 24|CBF1
P09023378A0959|65 77|reporter genes
P09023378A0959|91 102|C-repeat/DRE
P09023378A0959|157 166|DNA element
P09024039A0247|0 11|Forty-one ASA
P09024039A0247|29 30|II
P09024039A0247|118 120|CCA
P09024097A0000|0 8|OBJECTIVE
P09024793A1325|63 70|myogenic
P09024793A1325|72 80|ells, MyoD
P09024793A1325|84 91|myogenin
P09024793A1325|117 130|enhancer region
P09024793A1325|136 142|MCK gene
P09024793A1325|162 166|BMP-2
P09024805A0905b|104 106|ZII
P09024805A0905b|107 112|(CREB/
P09024805A0905b|113 123|AP1) element
P09024805A0905b|131 143|BZLF1 promoter
P09024805A0905b|155 169|beta-globin TATA
P09025122A0374|74 77|COWA
P09027346A1957|25 32|site IIIa
P09027346A1957|38 58|hCG-ectodomain complex
P09027346A1957|78 92|anti-peptide mAb
P09027346A1957|138 140|(pE
P09027346A1957|149 151|LHR
P09027506T0000|0 3|cDNA
P09027506T0000|59 63|a gene
P09027506T0000|82 97|wheat eIF-(iso)4F
P09027506T0000|110 115|eIF-4G
P09028308A0590|29 31|AZQ
P09028308A0590|135 139|G-CSF
P09028942A0000|5 59|granulocyte-macrophage colony-stimulating factor (hGM-CSF)
P09028942A0000|108 125|growth response gene
P09028998A0143|113 115|BCT
P09029091A0881|21 32|TCR-mediated
P09029091A0881|58 70|phospholipase
P09029091A0881|120 125|A2/HCP
P09029104A0226|3 13|14.1(IGLL1)
P09029159A0000|3 85|interferon (IFN)-induced double-stranded RNA (dsRNA)-activated Ser/Thr protein kinase (PKR)
P09029159A0000|139 141|IFN
P09029713A1120|27 40|cAMP-dependent
P09029713A1120|65 77|activator SF-1
P09029713A1120|84 99|repressor COUP-TF
P09029713A1120|114 127|CRS2-dependent
P09030581A0990|15 19|COS-7
P09030581A0990|16 30|OS-7 cells, MKP-4
P09030581A0990|49 58|MAP kinases
P09030581A0990|66 79|selectivity ERK
P09030581A0990|85 92|JNK/SAPK
P09030781A0734|4 10|kinases
P09030781A0734|131 135|(IC50
P09030781A0734|162 167|microM
P09030781A0734|247 251|(IC50
P09030781A0734|253 262|100 microM)
P09031639A0474|8 13|kb cDNA
P09031639A0474|28 44|reading frame (ORF)
P09031639A0474|61 71|polypeptide
P09031639A0474|144 147|U1-C
P09032233T0000|24 56|POU-homeodomain protein GHF-1/Pit-1
P09032233T0000|70 91|pituitary-specific gene
P09032248A0239|31 66|iability, Pcl1,2-Pho85 kinase complexes
P09032248A0239|104 122|Cln1,2-Cdc28 kinases
P09032250A0257|83 90|B subunit
P09032250A0257|96 118|CCAAT binding protein NF-Y
P09032250A0257|124 131|HeLa cDNA
P09032254A0724|31 34|AP-1
P09032258A0395|12 28|HLA-DR-B7-1-LFA-3
P09032258A0395|61 81|LFA-3-induced NF-AT DNA
P09032259A0150|31 34|RhoA
P09032259A0150|68 73|NIH 3T3
P09032259A0972|28 30|JNK
P09032259A0972|33 35|SRF
P09032267A0850|19 39|bZip interaction domain
P09032267A0850|42 44|CBP
P09032267A0850|93 94|TR
P09032267A0850|98 106|p45/NF-E2
P09032275A1133|57 59|AHC
P09032304T0000|17 54|promoter-specific transactivation domain
P09032304T0000|88 98|protein ICP4
P09032328A0650|0 2|DNA
P09032328A0650|66 76|locus (DL-B)
P09032328A0650|84 88|ORF11
P09032328A0650|92 96|ORF17
P09032328A0650|127 130|ORFs
P09034337A0251|58 72|tyrosine 15 (Y15)
P09034337A0251|114 116|DNA
P09035307A0000|93 147|99mTc-methoxyisobutylisonitrile scintigraphy (99mTc-MIBI)
P09035612T0000|7 23|endothelin release
P09035612T0000|102 112|reperfusion
P09036529A0343|77 84|serum IgE
P09036529A0343|89 107|RAST-CAP (Pharmacia)
P09036529A0343|112 115|CAST
P09036529A0343|144 148|(Apis
P09036529A0343|166 173|(Vespula
P09036529A0343|185 192|(Aquagen
P09036529A0343|193 196|ALK)
P09037032T0000|25 50|protein-related (P2P-R) gene
P09037032T0000|70 82|heterogeneous
P09037064A0183|30 49|canarypox ALVAC/HIV-1
P09037064A0183|59 75|vaccine immunogens
P09037064A0183|78 95|HIV-1,-noninfected
P09037064A0183|117 119|CTL
P09037163A1652|59 66|gpc4 gene
P09038166A0818|42 61|124-nucleotide intron
P09038192A0846|1 31|MEK-specific inhibitor (PD098059)
P09038192A0846|32 38|(Dudley
P09038202A1951|50 58|NRSF/REST
P09040011A1316|36 39|G1/S
P09040011A1316|169 180|Ras/Raf/MAPK
P09041123A0195|125 146|heterodimer-DNA complex
P09042078A0202|17 19|MBF
P09042683A0492|3 5|FBF
P09042755T0000|14 30|sigma factor sigmaB
P09042755T0000|69 78|sigB operon
P09042755T0000|91 101|growth phase
P09042911A0626|7 22|promoter elements
P09042911A0626|53 65|cAMP-mediated
P09043768A0139|29 31|BLM
P09043768A0139|43 60|indium-111 (In-111)
P09045636A0789|0 2|CD3
P09045805A0945|32 44|acoABCD operon
P09045805A0945|71 74|acoK
P09045805A0945|117 120|acoK
P09045842T0000|22 37|sigma-70 subunits
P09045842T0000|40 52|RNA polymerase
P09045842T0000|74 82|mer operon
P09045919A1250|51 62|ctivator, NFE
P09045919A1250|95 99|c-Rel
P09045919A1250|203 205|IgH
P09046013A0000|41 91|-type voltage-sensitive calcium channel blocker, SNX-111
P09046090T0000|19 45|transcription factor yTAFII60
P09046090T0000|110 114|kb DNA
P09046090T0000|160 172|chromosome VII
P09046384A0403|48 51|CD4+
P09046384A0403|69 75|amylase
P09046384A0403|91 93|DDI
P09047252A0209|0 6|METHODS
P09047252A0209|67 69|HCC
P09047252A0209|90 92|AFP
P09047344A0000|0 29|Calmodulin-binding peptide (CBP)
P09047344A0000|81 97|chain kinase (MLCK)
P09048617A0648|23 44|tyrosine kinase receptor
P09048617A0648|87 90|cAMP
P09049198A0289|93 99|p21 gene
P09049198A0289|128 144|liver regeneration
P09049198A0289|164 176|liver diseases
P09049270A0488|22 28|LeMT(A)
P09049270A0488|32 38|LeMT(B)
P09049270A0488|66 77|MT-like genes
P09049270A0488|183 184|II
P09049270A0488|185 187|MTs
P09049304A1193|27 30|AP-2
P09049304A1193|69 76|VPF/VEGF
P09049304A1193|109 112|AP-2
P09049304A1193|145 172|TGF alpha-induced VPF/VEGF gene
P09049306A0830|3 9|HBP gene
P09049313A0116|67 75|proteases
P09049313A0116|100 120|initiation factor eIF4G
P09050689A0685|37 41|SnET2
P09050847A0180|6 13|class II-
P09050847A0180|17 44|III-specific TBP-TAF complexes
P09050847A0180|76 129|class I-specific transcription initiation factor TIF-IB/SL1
P09050849A0000|113 120|Sec7 gene
P09050849A1459|43 62|BFA-sensitive ARF-GEP
P09050849A1459|76 85|Sec7 domain
P09050861A0903|32 34|DEK
P09050861A0903|41 46|43-kDa
P09050867A0542|72 83|octamer motif
P09050867A0542|93 107|POU-homeodomain
P09050867A0542|126 141|TN control element
P09051656A0390|90 108|day morphine infusion
P09053494A0612|0 6|RESULTS
P09053494A0612|32 36|CD34+
P09053494A0612|83 84|CY
P09053494A0612|84 87|Y, CE
P09053494A0612|92 94|CEP
P09053494A0612|99 103|G-CSF
P09053494A0612|205 206|CY
P09053494A0612|211 215|G-CSF
P09053494A0612|216 217|(P
P09053835A0865|9 11|p53
P09053835A0865|29 30|OP
P09053835A0865|49 55|p53 mRNA
P09053973A1252|0 9|CONCLUSION
P09055221A0288|17 21|SSTEs
P09055221A0288|61 64|MSEs
P09056761A0000|146 149|mRNA
P09057325A0177|11 21|plasmid pCM2
P09057325A0177|33 45|pathogenicity
P09057325A0177|110 129|a 1.5-kb Bg/II/SmaI DNA
P09057648A0422|25 31|tat cDNA
P09057648A0422|34 56|sense orientation (tat/S)
P09057648A0422|91 103|c-fos promoter
P09057648A0422|104 107|(FC3
P09057648A0422|144 184|chloramphenicol acetyltransferase (CAT) gene
P09057648A0422|177 179|CAT
P09057648A0422|262 275|calf serum (FCS)
P09057648A0422|278 291|5 micrograms/mL
P09057648A0422|314 352|10(-7) mol/L phorbol myristate acetate (PMA)
P09057648A0422|332 351| myristate acetate (PMA
P09057648A0422|379 394|FCS or 10(-7) mol/L
P09057840A0946|34 44|homogeneity
P09057840A0946|47 69|(NH4)2SO4-precipitation
P09057840A0946|99 111|AMP-Sepharose
P09057841T0000|62 80|isocitrate lyase gene
P09058250A0128|51 52|NO
P09058250A0128|56 58|NO2
P09058323A1287|25 35|cis elements
P09058323A1287|129 131|CNS
P09058323A1287|143 152|eta 4, alpha
P09058323A1287|158 167|alpha 5 gene
P09058373A0670|0 4|RNase
P09058373A0670|51 58|GHR1-279
P09058373A0670|68 71|IM-9
P09058373A1620|21 32|reporter gene
P09058373A1620|44 64|Stat5-binding elements
P09058373A1620|148 166|full-length receptor
P09058378A1134|20 42|glucocorticoid receptors
P09058378A1134|81 83|p53
P09058378A1134|107 109|p53
P09059039A0850|0 10|99mTc-HMPAO
P09059039A0850|46 48|ACA
P09059039A0850|52 54|MCA
P09059039A0850|179 181|ACA
P09060045A0576|71 104|antibiotic-induced endotoxin release
P09060444A0557|42 63|luciferase reporter gene
P09060444A0557|138 155|EGF-responsiveness
P09060622A1679|28 57|vitro-synthesized alphavirus RNA
P09060622A1679|66 72|poly(A)
P09060623A0961|8 17|coreceptor
P09060623A0961|43 45|SIV
P09060676A1634|65 74|pathogenic
P09060971A0982|0 6|RESULTS
P09060971A0982|22 44|age-related decline in BMD
P09061697T0000|10 13|SPET
P09061697T0000|25 41|99Tcm-tetrofosmin
P09061697A0629|39 44|250 MBq
P09061697A0629|47 67|mCi) 99Tcm-tetrofosmin
P09061697A0629|91 96|750 MBq
P09061697A0629|100 103|mCi)
P09061697A0629|214 219|500 MBq
P09061697A0629|223 226|mCi)
P09061697A0629|233 249|99Tcm-tetrofosmin
P09061698A0177|0 12|99Tcm-DMP-HSA
P09061698A0177|65 80|blood cells (RBCs)
P09062130A0116|38 55|10-60-fold increase
P09062130A0116|84 94|N-SH2 domain
P09062130A0116|155 164|SH2 domains
P09062130A0116|184 195|PTPase domain
P09064659A1055|46 54|yeast UPF1
P09064659A1055|85 96|nonsense mRNA
P09064659A1055|134 138|HUPF1
P09064659A1055|157 161|UPF1)
P09065463A1012|0 2|DNA
P09065463A1012|65 67|RPA
P09065690A0463|65 68|CAR1
P09065690A0463|101 103|URS
P09065768A0862|16 19|cDNA
P09065768A0862|95 105|lactase mRNA
P09067577A0307|24 30|BCR/ABL
P09067577A0307|25 35|CR/ABL, CRKL
P09067577A0307|67 69|CRK
P09067577A0721|57 60|CRKL
P09067577A0721|74 76|C3G
P09067577A0721|75 80|3G, SOS
P09067577A0721|84 88|c-ABL
P09071308A0376|0 6|RESULTS
P09071308A0376|121 123|MTB
P09071308A0376|127 130|NTMB
P09072361A0357|22 34|raction, SHRSP
P09072361A0357|130 143|age-matched WKY
P09072361A0357|147 151|SHRSR
P09073074T0000|31 46|FGFR-3 psuedogene
P09073582A0444|29 44|548-bp BglII-SmaI
P09073582A0444|58 60|SSO
P09074508A0397|8 15|CD38 gene
P09074508A0397|26 31|8 exons
P09075739A0827|4 5|IV
P09076336A0281|0 1|GH
P09076336A0281|149 150|GH
P09077076A0219|8 10|CRP
P09077108A0458|63 65|IgG
P09077108A0458|64 70|gG, IL-6
P09077108A0458|65 80|G, IL-6, TNF-alpha
P09077108A0458|85 88|PGE2
P09077437T0000|70 82|RNA polymerase
P09077438A0076|33 35|RNA
P09079625A0935|69 71|PKC
P09079638A0883|3 8|3ASubE
P09079638A0883|24 28|CXCR2
P09079650A0136|12 15|MAPK
P09079650A0136|45 59|response kinases
P09079650A0136|60 64|(ERKs
P09079650A0136|67 79|p42/44(MAPK))
P09079650A0136|84 115|c-Jun amino-terminal kinases (JNKs)
P09079650A0136|123 144|p38/Hog 1 protein kinases
P09079689A0472|0 3|MOP5
P09079689A0472|30 38|PAS domain
P09079689A0472|80 83|cDNA
P09079689A0472|93 96|bHLH
P09079817A0928|10 11|NO
P09079817A0928|62 65|mRNA
P09079817A0928|77 88|NO synthetase
P09079878A0000|14 42|Lactobacillus sake plasmid pCIM1
P09079878A0000|90 108|reading frames (ORFs)
P09079878A0000|123 126|lasA
P09079902A0713|47 64|pyruvate kinase (Pk)
P09079902A0713|100 105|12-kDa
P09079902A0713|185 190|12-kDa
P09079904A0995|10 27|ron regulation, sodA
P09079904A0995|60 62|DNA
P09079915T0000|41 51|burgdorferi
P09079915T0000|52 65|motility operon
P09079915T0000|85 108|consensus sigma70 promoter
P09079928A0525|1 11|. leprae OxyR
P09079928A0525|57 65|oxyR-ahpC
P09079928A1319|17 20|OxyR
P09079928A1319|31 36|P1oxyR
P09079928A1319|96 99|oxyR
P09079928A1319|139 142|LysR
P09080250A0212|51 62|p15E cDNA gene
P09080250A0212|90 117|polymerase chain reaction (PCR)
P09080250A0212|130 135|(P815)
P09080250A0212|139 149|xenogenized
P09080250A0212|150 160|(P815/DTIC)
P09083291A1378|5 13|TGF-beta1
P09083291A1378|29 43|mitogen-induced
P09083291A1378|68 74|G1 phase
P09083291A1378|97 99|MCs
P09083291A1378|146 161|mitogen-elicited
P09083291A1378|194 205|pRb in G1 phase
P09083291A1378|200 205|1 phase
P09083345A0851|98 102|SYPLR
P09084174A0667|49 52|leuB
P09084174A0667|62 91|3-isopropylmalate dehydrogenase
P09084174A0667|105 149|aspartate-beta-semialdehyde dehydrogenase (Asd)
P09084174A0667|154 157|orfA
P09084176A0601|62 76|steady-state RNA
P09084176A0601|89 93|lacZ+
P09084621A2567|29 32|rCBF
P09085842A0181|36 42|U1 snRNP
P09085842A0181|112 113|SR
P09085842A0181|126 131|U1-70K
P09085842A0181|142 148|SF2/ASF
P09085842A1559|8 28|tri-snRNP-specific 27K
P09085842A1559|64 65|SR
P09085842A1559|162 169|pre-mRNA
P09086268A0611|73 76|(RNA
P09087430A1046|15 24|U1A peptide
P09087430A1046|42 44|BSA
P09087430A1046|64 66|PAP
P09088371T0000|47 49|III
P09088416A0000|49 66|occlusion (IBRBRAO)
P09088737T0000|82 87|(CMTF)
P09089093A0373|32 38|CA genes
P09089093A0373|68 83|enhancer elements
P09089653A0615|45 47|UTR
P09089653A0615|102 111|luciferase
P09089653A0615|144 155|promoterless
P09089653A1112|11 21|DNA-protein
P09089653A1112|43 49|DNase-I
P09090054A0186|61 77|egulator, permease
P09090054A0186|81 98|alpha-glucosidase)
P09090054A0186|132 152|alpha-glucosidase gene
P09090054A0186|164 167|MAL1
P09090592A0175|35 47|activation fMR
P09091125A0161|68 83|acid phosphatases
P09091125A0161|90 97|NBT-test
P09091403T0001|20 22|DNA
P09091403T0001|70 78|mts1 genes
P09091403T0001|71 86|ts1 genes: kB-like
P09091403T0001|94 110|microsatellite DNA
P09092493A0861|19 25|VIP CyRE
P09092493A0861|31 38|Jak-Stat
P09092493A0861|42 45|AP-1
P09092580A1354|38 46|MAP kinase
P09092636A0802|21 54|temperature-sensitive rad54-3 allele
P09092636A0802|104 107|DYZ3
P09092636A0802|158 184|DYZ5 satellite-containing YAC
P09092675A0283|23 27|OcRNA
P09092675A0283|32 35|(P22
P09092675A0283|36 48|R17 [A(-10)U])
P09093867T0000|12 16|Ac/Ds
P09094093A0578|25 28|TATA
P09094315A0541|41 45|B-Myb
P09094315A0541|56 66|cyclin-Cdks
P09094671A1192|0 28|Candidate tumor suppressor genes
P09094671A1192|1 43|andidate tumor suppressor genes, Mts1 (p16INK4a)
P09094671A1192|47 60|Mts2 (p15INK4b)
P09096229T0000|67 74|MFA2 gene
P09096234T0000|56 58|DNA
P09096234T0000|107 119|phage lambda cI
P09096958A0000|151 165|antibodies TA205
P09096958A0000|169 172|TD77
P09098066A0119|52 86|cytadherence-associated proteins HMW1
P09098066A0119|90 93|HMW3
P09098066A0119|149 175|hemadsorption-negative (HA-)
P09098899A0000|123 148|a Cys-X2-Cys-X22-Cys-X4-Cys
P09098899A0000|160 175|zinc-finger motif
P09098899A0435|3 4|UV
P09098899A0435|64 74|CysS-Cd(II)
P09098899A0435|179 194|psilon 248, 24 mM-1
P09098899A0435|223 232|Cd(Cys-S)4
P09099683A0000|0 24|Diacylglycerol kinase (DGK)
P09099702A0000|63 76|orphan receptor
P09099702A0000|98 107|(GCNF)/RTR
P09099702A0692|23 29|conRTRE
P09099702A0692|49 52|RTRE
P09099702A0692|66 70|P2-RE
P09099702A0692|79 101|promoter-flanking region
P09099702A0692|107 125|mouse protamine 2 gene
P09099702A0692|161 175|spermatogenesis
P09099702A0692|178 180|RTR
P09099743A0585|60 66|320-kDa
P09099743A0585|87 93|mRNP3+4
P09099743A0585|111 122|polypeptides
P09099743A0585|133 156|mRNA-binding polypeptides
P09099743A0585|164 168|36 kDa
P09099743A0585|166 168|kDa
P09099745A1446|201 212|cyclin E-Cdk2
P09099745A1446|233 235|CDK
P09099745A1446|259 272|CDK-activating
P09100202A0000|15 21|Class II
P09101085A0686|67 73|p27Kip1
P09103382T0000|6 9|FIGO
P09103382T0000|30 42|cancer stage IA
P09104816A0610|22 31|biogenesis
P09104816A0610|86 102|vaccinia virus (VV)
P09105042A1497|62 64|HCM
P09105042A1497|286 292|beta MHC
P09106057A0000|40 63|de(N-methyl)-N-ethyl-8,9
P09106057A0000|99 104|(EM523
P09106057A0000|194 213|chromatography (HPLC)
P09106057A0000|218 238|chemiluminescence (CL)
P09108029A0399|13 23|DNA-binding
P09108029A0399|34 56|activator protein 1 (AP-1)
P09108029A0399|70 72|DNA
P09108029A0399|71 104|NA repair enzyme, redox factor 1 (Ref-1)
P09108029A0399|125 127|DNA
P09108029A0399|126 154|NA repair enzyme, AP endonuclease
P09108038A1128|8 16|LRR domain
P09108038A1128|22 38|SH3-binding domain
P09108038A1128|54 70|. elegans homologue
P09108279A0431|19 24|8-OxoG
P09108279A0431|89 97|a 34mer DNA
P09108279A0431|123 128|8-OxoG
P09108279A0431|147 164|cytosine (8-OxoG/C)
P09108451A0160|51 56|UCN-01
P09108451A0160|76 83|G1-phase
P09110176A0890|11 16|RT-PCR
P09111004A0732|56 86|phosphorylation motif Thr-Xaa-Tyr
P09111048X0000|7 25|testis-specific mRNA
P09111048X0000|46 57|NH2-terminal
P09111048X0000|67 86|nitric-oxide synthase
P09111048X0000|68 91|itric-oxide synthase. mRNA
P09111048X0000|132 161|nitric-oxide synthase (nNOS) gene
P09111059A0327|9 25|MAR-binding domain
P09111059A0327|30 40|homeodomain
P09111059A0327|87 89|DNA
P09111309A0674|24 61|p44 mitogen-activated protein (MAP) kinase
P09111309A0674|98 111|HB-EGF promoter
P09111309A0674|134 146|deltaRaf-1:ER
P09111314A0970|49 56|184A1L5R
P09111314A1243|44 51|p15INK4B
P09111314A1243|54 61|TGF-beta
P09111314A1243|96 121|TGF-beta-resistant 184A1L5R
P09111314A1243|157 164|p15INK4B
P09111314A1243|237 242|kinase
P09111331A0119|27 30|MADS
P09111340A0240|10 27|cis-acting elements
P09111340A0240|38 46|c-myc mRNA
P09111340A0240|70 79|myogenesis
P09111340A0240|100 104|C2C12
P09111340A0240|120 127|myc genes
P09111340A0240|188 202|beta-globin gene
P09111340A0240|219 259|chloramphenicol acetyltransferase (CAT) gene
P09111367A1098|27 29|32D
P09111367A1098|51 53|p53
P09111367A1098|161 172|p53-mediated
P09111367A1098|301 309|oncogenes
P09111367A1098|384 394|DNA-binding
P09111367A1098|401 425|heterodimerization domains
P09111367A1098|456 471|tal-1 variant (M3)
P09111367A1098|481 487|in T-ALL
P09112400A1155|0 10|DNA-binding
P09114972A1366|15 17|SOS
P09115242A0934|76 121|CCAAT/enhancer-binding protein-beta (C/EBP-beta)
P09115247A2069|0 24|11-Aminoundecanoyl-SK-NH2
P09115247A2069|28 52|11-aminoundecanoyl-SH-NH2
P09115247A2069|171 193|enzyme's peptide-binding
P09115247A2069|232 244|beta-hydroxyl
P09115265A1160|3 23|carboxyl-terminal CCCC
P09115265A1160|56 72|DNA-binding domain
P09115265A1160|87 111|transcription factor GATA-1
P09115279A0345|95 104|Pch1 kinase
P09115365A0000|20 41|heat shock protein 70 gene
P09115365A0000|85 93|oncogenes
P09115395A0478|110 151|tein-115, Oct91, Elongation factor 1gamma, BRG1
P09115395A0478|164 175|protein L18A)
P09115395A0478|302 331|c5, innercentrosome protein, BRG1
P09115395A0478|338 352|RNA helicase WM6)
P09115395A0478|393 397|(BRG1
P09115395A0478|407 421|co-factor 2alpha
P09115395A0478|437 445|dc5, HoxD1
P09117345A0945|12 21|alpha 4 beta
P09117345A0945|27 32|TS2/16
P09118196A0281|54 73|Test-Revised (NART-R)
P09118196A0281|104 156|Wechsler Adult Intelligence Scale-Revised (WAIS-R)-showed
P09118664A1734|52 64|oxide synthase
P09118704A0771|0 6|RESULTS
P09118704A0771|59 63|G-CSF
P09118704A0771|94 97|[CI]
P09119031A1036|12 44|holoenzyme RNA polymerases generated
P09119031A1036|92 119|core RNA polymerase (alpha2beta
P09119031A1036|120 125|beta')
P09119112A1350|39 44|GATA-5
P09119391A0870|3 8|exonic
P09119391A0870|113 117|GPT-1
P09121424A0296|32 48|Swi3 homolog (Swh3)
P09121424A0296|98 108|Snf2 homolog
P09121430A0132|13 52|Ras/mitogen-activated protein kinase (MAPK)
P09121430A0132|102 112|tyrosine (Y)
P09121430A1075|3 19|ontrast, Y239/240F
P09121430A1075|30 34|Y317F
P09121430A1075|49 71|EGF-induced c-myc message
P09121432A0000|89 111|protein-tyrosine kinases
P09121433A0463|25 47|MEF2-related DNA-binding
P09121433A0463|95 98|MEF2
P09121433A0463|96 111|EF2, CTA(T/A)4TAG
P09121433A0463|118 121|SMP1
P09121433A0463|141 173|onsensus sequence, ACTACTA(T/A)4TAG
P09121435A1183|11 12|II
P09121435A1183|43 59|TFIIIB-DNA complex
P09121452A0538|33 41|C/EBP beta
P09121452A0538|87 102|activation domain
P09121452A0538|105 114|C/EBP alpha
P09121452A0538|138 148|2D5 promoter
P09121452A0538|212 229|high-affinity C/EBP
P09121476T0000|0 4|PRH75
P09121476T0000|38 45|DEAD-box
P09121774T0000|16 21|GTPase
P09121774T0000|27 46|polyomavirus middle-T
P09121774A0611|57 64|middle-T
P09121774A0611|88 96|MAP kinase
P09121998A0663|143 146|(MTT
P09121998A0663|202 211|90 min (F90)
P09122168A1427|47 56|G betagamma
P09122168A1427|104 107|GRK2
P09122168A1427|111 114|GRK3
P09122176A0970|22 32|RA-mediated
P09122176A0970|48 55|hMGP gene
P09122176A0970|80 86|RAR/RXR
P09122176A0970|103 119|RA response element
P09123055T0000|55 56|UW
P09123055T0000|60 62|HTK
P09124054A1164|38 42|ABSCT
P09126622A0466|58 60|CAL
P09128730A0000|63 85|malonyl-S-[acyl-carrier
P09128730A0000|98 119|acetyl-S-[acyl-carrier
P09128730A0000|132 155|alonate, carboxyltransfer
P09128730A0000|208 227|delta mu Na+ generation
P09129147A0644|3 12|Jem peptide
P09129147A0644|81 87|Fos/Jun
P09129147A0644|91 98|ATF/CREB
P09130595A0478|57 59|III
P09130700A0676|86 90|SPC97
P09130700A0676|143 146|TUB4
P09130700A0676|149 153|SPC98
P09130718A0497|64 74|306 bp region
P09130718A0497|106 108|ATG
P09130720A0417|35 50|branch site region
P09130720A0417|86 92|TACTAAC
P09131139T0000|13 15|PAF
P09131139T0000|19 41|acetylhydrolase (PAF-AH)
P09132057A0559|1 11|polypeptide
P09132057A0559|24 26|NTS
P09132057A0559|95 116|receptor protein kinases
P09132057A0559|139 155|S-receptor kinases
P09132057A0559|216 222|Pto gene
P09132057A0559|272 279|pathogen
P09132061A0828|21 24|cDNA
P09132061A0828|73 86|isoperoxidases
P09132061A0828|107 119|200 peroxidase
P09132061A0828|128 131|ESTs
P09135066A0653|74 82|oncogenic
P09135149A0000|43 90|M-phase-inducing Cdc2/Cdc13 cyclin-dependent kinase
P09135149A0000|111 129|Mik1 tyrosine kinases
P09135149A0000|153 176|Pyp3 tyrosine phosphatases
P09135928A0912|37 38|BP
P09135928A0912|89 90|II
P09135928A0912|144 145|(P
P09136080A1469|22 24|DNA
P09138076A1099|141 154|E-box 2 elements
P09138492A0806|1 17|aboratory exam: IDR
P09138492A0806|85 101|alcifications, ORL
P09139665A0784|18 30|PhLP complexes
P09139665A0784|53 62|Gbetagamma
P09139694A0789|0 8|CTF1alpha
P09139694A0789|63 76|palindrome 2 DNA
P09139694A0789|112 125|palindrome 2 DNA
P09139694A0789|163 171|CTF1alpha
P09139737A0000|1 24|sterol-regulated protease
P09139737A0000|34 40|release
P09139737A0000|46 57|NH2-terminal
P09139737A0000|84 114|element-binding proteins (SREBPs)
P09139892A1150|20 23|orfX
P09139892A1150|27 38|vfr promoters
P09139892A1150|117 120|dorf
P09139892A1150|124 135|crp promoters
P09139910A0350|24 26|PCR
P09139910A0350|69 80|nifV-like DNA
P09139910A0350|118 122|nifV-
P09139910A0350|126 138|leuA-specific
P09139910A0350|161 169|clone XbaI
P09139910A0350|184 193|kbp (pOST4)
P09139910A0350|200 209|kbp (pOST2)
P09139910A1572|14 39|Anabaena strain 7120 leuA gene
P09139910A1572|59 62|nifV
P09139910A1572|73 77|R229I
P09140079A2528|34 36|TRs
P09140079A2528|44 46|TRE
P09140474T0000|42 49|(Spain)?
P09142146A0887|0 6|RESULTS
P09142146A0887|21 23|PAF
P09142146A0887|65 74|11 WEB-2086
P09143328A1002|81 93|RNA polymerase
P09143465A0838|9 15|dual-T1
P09143465A0838|46 61|image quality (IQ)
P09144165A0614|40 43|NFAT
P09144165A0614|51 54|AP-1
P09144165A0614|60 79|Rel insert region (RIR)
P09144165A1275|21 27|NFAT RIR
P09144165A1275|54 56|DNA
P09144165A1275|91 94|AP-1
P09144195A1051|21 23|PS1
P09144195A1051|100 105|PS1 CTF
P09144770A0906|27 35|beta-turn
P09144770A0906|77 82|FKBP12
P09144958A0047|44 95|Arabidopsis light-harvesting chlorophyll a/b protein gene
P09146027A0809|25 34|athetoid CP
P09147420T0000|0 2|TAR
P09147420T0000|38 40|HIV
P09147420T0000|94 115|cytomegalovirus IE1/IE2
P09147420A0623|28 38|HCMV IE1/IE2
P09147420A0623|68 75|HIV-1 LTR
P09148770A0977|84 95|Csk SH2 domain
P09148903A1715|26 36|pV-mediated
P09148903A1715|49 56|HIV-1 LTR
P09148903A1715|107 115|NF-kappaB
P09148903A1715|153 164|IkappaBalpha
P09148903A1715|225 245|NF-kappaB-independent
P09148929A0372|78 88|exon-intron
P09148929A0372|106 114|Ctpct gene
P09148935A0805|0 20|FN-stimulated c-Src PTK
P09148935A0805|46 52|type FAK
P09148935A0805|71 83|FN-stimulated
P09148935A0805|96 99|ERK2
P09148935A0805|127 131|c-Src
P09148935A0805|158 160|FAK
P09149825A0151|14 33|ement, 4-META/MMA-TBB
P09150595T0000|43 70|Erwinia carotovora hrpNEcc gene
P09150595A0225|35 46|reaction (HR)
P09150595A0225|58 81|. chrysanthemi (HarpinEch)
P09150595A0225|86 105|. amylovora (HarpinEa)
P09150595A0225|117 122|36-kDa
P09150595A0225|189 211|membrane-spanning domain
P09150728A0596|3 6|mRNA
P09150728A0596|26 29|HES1
P09150774A0616|37 46|(ISO)/N2O/
P09151152A0174|130 138|factor VII
P09151376A0000|20 21|II
P09151376A0000|22 45|hyperbetalipoproteinemia
P09151806A1125|31 39|2.0-kb LAT
P09151806A1125|55 66|mLAT pre-mRNA
P09151828A0919|43 59|9ORF1 polypeptides
P09151828A0919|137 138|II
P09151828A0919|159 174|C-terminal region
P09151828A0919|175 177|III
P09151837A0723|0 6|Rep-Rep
P09151837A0723|108 141|maltose-binding protein-Rep78 fusion
P09151837A0723|166 188|[35S]methionine-labeled
P09151925A0479|3 7|C-LIP
P09151925A0479|58 61|(TAE
P09151925A0479|63 67|C-LIP
P09151925A0479|107 135|ethanol injection therapy (PEIT)
P09152656A0149|48 49|II
P09153010A0499|19 27|Multi-MUP
P09153010A0499|65 68|MUPs
P09153010A0499|104 107|MUPs
P09153010A0499|160 172|threshold MUPs
P09153010A0499|169 172|MUPs
P09153319A1332|79 94|collagen promoter
P09153319A1332|162 187|control phosphorothioate ODN
P09153348A0647|17 25|plasma TBG
P09153348A0647|46 53|androgen
P09153348A0647|175 187|HIV-infection
P09153795A0298|19 22|RDFS
P09154283A0307|53 65|pressure (IOP)
P09154795A0628|70 78|TATA-less
P09154795A0628|84 122|DNA polymerase beta (beta-pol) gene promoter
P09154797A0777|30 39|stk2::lacZ
P09154819A0501|25 29|c-Jun
P09154819A0501|37 46|tenascin-C
P09154819A0501|66 68|REF
P09154819A0501|74 78|FR3T3
P09154822T0000|15 25|Raf-1 kinase
P09154822T0000|34 36|AMP
P09154827A0158|77 107|TAF(II)250/CCG1 (TAF(II)250) gene
P09155015A0140|17 34|protein kinase MEKK1
P09155015A0140|44 55|reporter gene
P09155015A0140|90 108|factor (ANF) promoter
P09155024A0955|16 19|EFG1
P09156883A0294|9 31|arameters: heart rate (HR)
P09156883A0294|41 58|blood pressure (ABP)
P09156883A0294|70 87|O2 saturation (SaO2)
P09157100A0583|53 55|SIB
P09159111A0437|45 57|dichroism (CD)
P09159111A0437|61 63|NMR
P09159111A0437|80 88|Skn domain
P09159183A0119|8 37|ocs element binding factors (OBFs)
P09159183A0119|66 96|basic-region leucine zipper (bZIP)
P09160361A0858|23 25|CPB
P09160361A0858|37 43|non-CPB
P09162084A0956|36 48|Src-SH2 domain
P09162084A0956|57 63|PECAM-1
P09162084A0956|84 94|GST-Src-SH2
P09162092A0675|0 3|MKK3
P09162092A0675|79 82|MKK3
P09162092A0675|87 91|MEKK3
P09162092A0675|103 107|MEKK2
P09162097A0776|22 29|MAdCAM-1
P09162097A0776|75 85|mucin domain
P09162097A0776|119 124|LPAM-1
P09162097A1258|56 67|MAdCAM-1 cDNA
P09162097A1258|92 100|homologue
P09162097A1258|103 115|mouse MAdCAM-1
P09162097A1258|149 156|MAdCAM-1
P09163332A0275|11 34|site-directed mutagenesis
P09163332A0275|64 79|hydroxy (Ser/Thr)
P09164543A0219|0 7|MATERIAL
P09164543A0219|8 10|AND
P09164543A0219|11 17|METHODS
P09164856A0980|38 48|TATA element
P09164856A0980|82 96|glutaminase gene
P09164856A0980|108 124|TATA-less promoter
P09165004A1700|0 2|SRE
P09165035A0842|0 23|Serum alkaline phosphatase
P09165035A0842|159 160|-D
P09165035A0842|207 208|+D
P09165039A0728|3 15|monkey LHR cDNA
P09165039A0728|38 53|sequence homology
P09165039A0728|75 82|LHR cDNAs
P09165039A1372|3 29|onclusion, marmoset monkey LHR
P09165039A1372|78 84|LHR gene
P09165118A0311|3 16|nc-4 mutants, VA
P09165118A0311|105 106|VB
P09165118A0311|145 147|VAs
P09167421A0234|42 58|microSelectron HDR
P09168083A0987|26 28|HAT
P09168083A0987|29 30|(P
P09168134A0858|27 36|kb promoter
P09168134A0858|66 73|Sm-E gene
P09168134A0858|77 88|U1 snRNA genes
P09168134A0858|151 155|snRNP
P09168218A0216|0 6|METHODS
P09168623A0614|1 4|xylE
P09168623A0614|39 50|mxbD promoter
P09168623A0614|99 112|one-carbon (C1)
P09168879A0219|2 16|AcMNPV-infected
P09168879A0219|82 85|TAAG
P09168879A0219|116 119|TAAG
P09168892A1016|34 57|AP-1 cis-response elements
P09169127A0371|25 50|neuropeptide Y receptor genes
P09169127A0371|155 160|y1 gene
P09169127A0371|207 212|y5 gene
P09169127A0371|297 302|y1 gene
P09169420A0000|12 52|phosphoinositide 3-kinases (PI3Ks) p110alpha
P09169420A0000|13 57|hosphoinositide 3-kinases (PI3Ks) p110alpha, beta
P09169420A0000|87 120|Src homology 2 (SH2) domain-containing
P09169420A0000|135 152|p85alpha or p55(PIK)
P09169475A0272|28 44|5'-flanking region
P09169475A0272|55 63|gp130 gene
P09169475A0772|17 39|cytokine response element
P09169475A0772|64 87|site-directed mutagenesis
P09169475A0772|130 142|STAT complexes
P09169593T0000|19 59|mitogen-activated protein kinase kinase (MEK)
P09169593T0000|20 90|itogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase
P09169593T0000|94 105|casein kinase
P09169852A0235|20 31|pag-3 alleles
P09169853A0000|8 30|paired-type homeobox gene
P09170159A0348|46 56|melanogenic
P09170159A0348|77 86|tyrosinase
P09170159A0721|98 104|HLH-Zip
P09171081T0000|29 32|cDNA
P09171081T0000|42 72|bacteriophage-type RNA polymerase
P09171235A0851|51 58|COUP-TFI
P09171235A0851|66 73|COUP-TFI
P09171235A0851|127 132|TRbeta
P09171239A1118|78 93|hormone receptors
P09171239A1118|108 117|core domain
P09171239A1118|124 166|igand-dependent transactivation function, AF-2
P09171239A2146|16 27|RXR-specific
P09171239A2146|68 72|SRC-1
P09171239A2146|78 80|RXR
P09171239A2146|95 103|TRE-bound
P09171389A0549|54 77|Thermus pyr promoter region
P09171389A0549|131 141|Thermus PyrR
P09171389A0549|138 141|PyrR
P09171389A0549|261 267|pyr gene
P09171969A1165|30 32|VO2
P09171969A1165|144 147|COPD
P09172312T0000|18 20|CR1
P09172312T0000|33 35|PCR
P09172414A0000|1 14|reversed-phase
P09172414A0000|52 57|(HPLC)
P09172414A0000|128 141|liver esterases
P09172641A0181|71 79|subdomain
P09172812A0660|50 52|CLL
P09173733A0404|26 27|EA
P09173733A0404|61 86|Fourier transformation (FFT)
P09173733A0404|89 90|EA
P09173733A0404|164 166|EEG
P09173733A0404|222 223|EA
P09174049A1788|14 35|p34CDC2 histone H1 kinase
P09175708A1526|5 9|PRL-R
P09175708A1526|37 53|C-terminal regions
P09175858A1449|8 10|B-S
P09175858A1449|56 61|GAPDHs
P09175858A1449|250 254|GAPDH
P09176340A1194|70 73|mRNA
P09176837A0211|32 37|(CSAO)
P09176837A0211|61 66|PN Ca:P
P09177857A0000|132 139|type 316L
P09178491A0262|30 40|preS2/S gene
P09178491A0262|59 61|HBV
P09178491A0262|84 87|TATA
P09178491A0262|103 118|initiator element
P09178494A1123|35 56|3'-untranslated regions
P09178494A1123|188 190|RNA
P09178752A0574|0 2|EGF
P09178752A0574|25 49|transactivation domain AF-1
P09178752A0574|58 61|cAMP
P09178752A0574|69 93|transactivation domain AF-2
P09178752A0574|99 100|ER
P09180687A0096|24 27|SulA
P09180687A0096|126 129|SulA
P09181130A1067|51 52|ES
P09182527A0443|23 25|p53
P09182527A0443|24 46|53 ubiquitination, mE6-AP
P09182707A0254|0 2|SPP
P09182707A0254|53 77|adhesion kinase (p125(FAK))
P09182707A0254|89 102|tyrosine kinase
P09182990A0245|38 42|SUP45
P09182990A0245|128 136|SUP45 gene
P09182990A0245|137 143|(Sup45p
P09182990A0245|146 150|eRF1)
P09183145T0001|33 54|99mTc-tetrofosmin SPECT
P09183406A0637|41 52|HPA-3a (Baka)
P09185183T0000|74 76|MRI
P09185586A0000|14 18|mRNAs
P09185645T0000|12 35|Tc-99m sestamibi perfusion
P09185645T0000|69 86|arbutamine infusion
P09185645T0000|112 124|artery disease
P09186056A0514|34 47|protein in C2C12
P09186056A0514|79 90|CAT-reporter
P09186056A0514|104 111|E12/MyoD
P09186507A0882|84 87|cDNA
P09186507A0882|116 118|CpG
P09186507A0882|131 141|TATA and CAAT
P09186507A0882|164 166|G+C
P09186507A0882|189 191|CpG
P09187136A0000|0 5|SSeCKS
P09187136A0000|36 48|protein kinase
P09187136A0000|177 178|(X
P09187277A0118|30 33|(PVP
P09187277A0118|54 55|(V
P09187277A0118|107 108|II
P09187371A0450|10 19|1.3-kb mRNA
P09187637A1199|53 55|OP1
P09187637A1199|59 61|OP4
P09188699A1388|11 25|rat SP-A isoforms
P09188699A1388|77 80|SP-A
P09188699A1388|99 106|SDS-PAGE
P09188863A0954|21 26|CDC25B
P09189783A0000|90 106|carbohydrate (CHO)
P09189896A0611|22 24|ERP
P09190202A0166|34 53|Sec23p protein complex
P09190202A0166|86 105|Sec13p protein complex
P09190202A0166|131 137|150-kDa
P09190821A0707|58 75|position 243 (P243L)
P09190940A0127|66 77|switch region
P09191052A0850|8 10|PCE
P09192732A1384|15 26|NH2-terminal
P09192732A1384|39 47|homologue
P09192732A1384|96 108|COOH-terminal
P09192769T0000|38 41|cDNA
P09192769T0000|39 48|DNA, CHEMR1
P09192769T0000|59 75|chemokine receptor
P09192769T0000|99 118|C-C chemokine receptor
P09192769T0000|100 124|-C chemokine receptor, CCR-4
P09192786T0000|22 27|LU gene
P09192786T0000|50 60|Lu(a)/Lu(b)
P09192842A0988|33 36|FISH
P09192842A0988|49 56|PE-2 gene
P09192842A0988|192 194|ETS
P09192842A0988|215 228|carcinogenesis
P09192998A0356|49 73|terminator in T7 DNA (T(phi))
P09192998A0356|77 80|rrnB
P09192998A0356|131 134|rrnB
P09192998A0356|163 165|PTH
P09192998A0356|169 170|CJ
P09193072A0199|29 38|transgenes
P09193077A0000|15 25|unit 1 (LRU1)
P09193077A0000|92 112|chalcone synthase (CHS)
P09193080A0904|75 87|gene-specific
P09193671A0347|45 47|GTP
P09193671A0347|66 72|ARF-GDP
P09194250A0708|81 101|ear 2000, intraregional
P09195923A0125|31 36|FK506-
P09195923A0125|83 116|tetratricopeptide repeat (TPR) domain
P09195923A0125|130 152|receptor heterocomplexes
P09195923A0125|199 215|TPR-binding region
P09197241A0770|31 34|CD45
P09197241A0770|97 102|p53/56
P09197342T0000|53 66|ils, Lipiodol UF
P09197408A0126|15 22|facB gene
P09197408A0126|66 95|N-terminal GAL4-like Zn(II)2Cys6
P09197408A0126|125 127|DNA
P09197408A0126|126 171|NA binding, leucine zipper-like heptad repeat motifs
P09197408A0126|201 220|alpha-helical regions
P09197408A0126|248 258|DNA-binding
P09199292A0536|111 117|kinases
P09199318A1147|62 80|muscle alpha-actinin
P09199327A1250|29 35|EM motif
P09199327A1250|41 57|promoter-reporter
P09199327A1250|138 146|TEF-1-Max
P09199327A1250|206 212|EM motif
P09199328T0000|42 45|VP16
P09199328T0000|59 66|ct-1, HCF
P09199328T0000|71 73|DNA
P09199348A0156|37 67|14 interactions, a stem-loop domain
P09199348A0156|112 118|U14 RNAs
P09199348A0156|123 130|Y domain)
P09199353A1924|99 113|polymerase alpha
P09199413A0518|53 62|CFU/mouse)
P09199413A0518|72 86|RB6-8C5-treated
P09199626A0613|2 8|12 cases
P09199932A1357|48 63|promoter elements
P09199932A1357|73 75|CpG
P09199932A1357|102 104|ATM
P09199932A1357|108 120|E14/NPAT genes
P09199932A1357|158 168|ATM promoter
P09199970A1101|18 21|pMCP
P09199970A1101|169 171|MCP
P09200530A0411|45 52|Zorbax RX
P09200811T0000|9 20|plasmid pDHL1
P09200811T0000|81 106|pGKL1-plasmid DNA polymerase
P09201946A0000|3 13|RNA-binding
P09201946A0000|17 31|RNA-DNA helicase
P09201946A0000|127 129|RNA
P09201980A0910|3 15|p20-CGGBP gene
P09202147A0866|57 59|UBC
P09202669A0614|3 8|pWP-19
P09202669A0614|23 25|AAV
P09202669A0614|83 127|herpes virus thymidine kinase promoter-driven gene
P09202669A0614|131 154|neomycin resistance (neoR)
P09202669A1530|16 32|rAAV-mediated gene
P09202669A1530|69 70|II
P09202859A0091|16 25|beta-human
P09202859A0091|35 51|gonadotropin (HCG)
P09202859A0091|64 88|alkaline phosphatase (PLAP)
P09203585A0660|32 40|H19 allele
P09203586A1197|48 59|rRNA promoter
P09203586A1197|62 64|SL1
P09203731A0497|66 96|Poliomyelitis Eradication (ICCPE)
P09204566T0000|50 62|fixNOQP operon
P09204566T0000|65 96|Rhizobium leguminosarum strain VF39
P09204570A0110|22 32|MADS box gene
P09204570A0110|23 38|ADS box gene, nmhC5
P09204570A0110|58 59|(J
P09205113A0587|4 13|E14.1TG3B1
P09205113A0587|23 24|ES
P09205113A0587|67 74|HPRT gene
P09205677A0577|65 80|non-fatal disease
P09205965A1249|144 154|spinal alpha
P09206230A0000|0 8|OBJECTIVE
P09206968A0000|13 24|regeneration
P09208930T0000|48 64|interleukin-1beta
P09208930T0000|75 84|enzyme gene
P09208930T0000|111 119|proteases
P09209031A0350|49 71|serine carboxypeptidases
P09209312A0968|3 5|RNA
P09209312A0968|99 101|RNA
P09209372A0345|21 25|AML1a
P09209372A0345|125 129|AML1b
P09209372A0345|138 142|AML1a
P09209372A0345|171 181|DNA-binding
P09209372A0345|186 190|AML1b
P09209406A1021|46 96|guanine nucleotide exchange factors or GTPase-activating
P09209406A1021|110 118|c-cbl gene
P09209438A0994|13 19|ATL-16T
P09209438A0994|53 58|GATA-4
P09209438A0994|68 79|GATA-binding
P09209438A0994|104 121|DNA-protein complex
P09209438A0994|129 135|-70 GATA
P09210478A0000|24 55|hypoxia-inducible factor-1 (HIF-1)
P09210478A0000|94 114|oxygen-regulated genes
P09211354A0000|1 45|tromelysin-1, matrix metalloproteinase-3 (MMP-3)
P09211354A0000|60 72|endopeptidase
P09211913A0000|0 22|Aryl hydrocarbon receptor
P09211913A0000|30 47|translocator (ARNT)
P09211913A0000|66 113|ranscription factors, aryl hydrocarbon receptor (AhR)
P09211913A0000|165 175|target genes
P09211913A0000|183 188|CYP1A1
P09211934A0722|0 4|DNase
P09211981A0526|55 85|p13(suc1)-Sepharose-bound kinase
P09211981A0526|179 193|p34(cdc2(kinase
P09212059A1356|72 75|PR-A
P09212059A1356|119 123|DhLBD
P09212059A1356|120 123|hLBD
P09212059A1856|65 84|carboxyl-terminal LBD
P09212059A1856|112 113|PR
P09212059A1856|249 250|PR
P09212063A0425|79 81|DNA
P09212063A0425|103 109|VDR gene
P09215525A0581|50 64|E2F/DP complexes
P09215525A0581|93 97|C2C12
P09215891A0000|39 42|CIN1
P09215891A0000|40 47|IN1, CIN2
P09215891A0000|51 59|CIN4 genes
P09216936T0000|18 23|"Acute
P09218436A0443|18 21|TATA
P09218436A0443|45 49|MED-1
P09218459A0000|0 23|Serum response factor (SRF)
P09218459A0000|51 61|DNA-binding
P09218459A0000|143 170|growth factor-responsive genes
P09218520A0075|102 106|IL-1R
P09218599A0184|62 74|antimitogenic
P09218599A0184|84 87|IL-4
P09218775A0000|55 66|fibrosis (CF)
P09218775A1229|10 14|palgD
P09218775A1229|20 23|cysB
P09218775A1229|33 35|CHA
P09218775A1229|44 62|non-mucoid strain PAO
P09218775A1229|100 114|algD-xylE fusion
P09219526A0383|3 18|Man9-mannosidase
P09219526A0383|35 38|cDNA
P09219526A0383|148 153|49-kDa
P09220158A0537|8 13|62-kDa
P09220158A0537|113 117|ORF-2
P09220177A0564|3 8|CPK-MB
P09220177A0564|26 43|percentage increase
P09220177A0564|51 53|CPK
P09222057A0176|18 35|dialysis fluid (PDF)
P09222115A0545|31 40|endogenous
P09223042A0000|0 12|Liver regional
P09223042A0000|13 29|blood volume (LRBV)
P09223122A0774|7 18|matter NAA/mI
P09223229A0565|23 31|mb-1 genes
P09223229A0565|55 62|mb-1 gene
P09223229A0565|70 73|TATA
P09223475A0898|0 31|Chloramphenicol acetyltransferase
P09223475A0898|59 62|IE86
P09223475A0898|87 90|HCMV
P09223475A0898|96 97|IE
P09223475A0898|119 122|HCMV
P09223475A0898|155 158|RNAs
P09223475A0898|198 201|IE86
P09223479A1193|0 2|ORF
P09223479A1193|47 49|ORF
P09223479A1193|112 134|gammaherpesviruses (gene
P09223479A1193|139 141|HVS
P09223479A1193|145 148|KSHV
P09223479A1193|155 163|BHRF1 gene
P09223479A1193|166 169|EBV)
P09223647T0000|41 48|zymogens
P09223667A0139|30 35|NIH3T3
P09223667A0139|178 183|a CTCCC
P09224655T0000|21 25|ClC-6
P09224655T0000|39 84|CIC chloride-channel family) transcripts generates
P09224655T0000|118 123|ClC-6c
P09224811A0000|61 105|NADPH:cytochrome P450 oxidoreductase (P450R) gene
P09224811A0000|246 254|P450R mRNA
P09225151T0000|29 57|polytetrafluoroethylene (PTFE)
P09225506A0462|68 69|II
P09225506A0462|75 78|VIII
P09225682A0579|22 37|anti-GM1 antibody
P09225682A0579|49 62|Guillain-Barre
P09225682A0579|83 85|PEN
P09225682A0579|118 131|Guillain-Barre
P09225682A0579|174 176|PEN
P09225998A0000|0 12|NF-kappa B/Rel
P09225998A0000|123 151|ytokines, cell surface receptors
P09226345A0436|51 53|ACT
P09226345A0436|103 105|SEP
P09227332A1798|3 12|ummary, DDC
P09227332A1798|94 95|DC
P09227799A0254|108 133|sts: stool examination, ELISA
P09227799A0254|145 159|egg antigen (SEA)
P09227799A0254|176 195|precipitin test (COPT)
P09228092A1779|31 45|dUTPase isoforms
P09228092A1779|73 88|isoform-specific
P09228202A0581|12 52|5-HT3 receptor antagonists ramosetron (YM060)
P09228202A0581|13 67|-HT3 receptor antagonists ramosetron (YM060), YM114 (KAE-393)
P09228202A0581|112 156|benzamides (5-HT4 receptor agonist/5-HT3 receptor
P09228202A0581|190 197|SC-53116
P09230129A0039|19 29|homogeneity
P09230129A0039|76 88|DNA-cellulose
P09230129A0039|133 140|SDS/PAGE
P09230129A0039|168 176|nucleases
P09230216T0000|5 26|thymine-DNA glycosylase
P09230307A0329|0 2|FOG
P09230307A0329|20 25|GATA-1
P09230384A0725|44 55|BACTEC 9000 MB
P09230384A0725|59 69|BACTEC 460 TB
P09230384A1056|9 20|BACTEC 9000 MB
P09230894A0422|18 24|KmMig1p
P09230986A0000|0 25|Autoimmune neutropenia (AIN)
P09232593A0946|48 49|DJ
P09233487A1386|119 127|Prom-EABR
P09233772A0136|22 25|p532
P09233772A0136|60 64|(EMBO
P09233772A0136|172 193|cell cycle regulator RCC1
P09233772A0136|238 248|GTP-binding
P09233772A0136|265 282|beta-repeat domains
P09233772A0136|352 354|SH3
P09233772A0136|395 420|carboxy-terminal HECT domain
P09233772A0136|437 462|E3 ubiquitin-protein ligases
P09233801A1180|26 41|kinase subdomains
P09233801A1180|42 43|IV
P09233801A1180|57 64|TGF-beta
P09233809A0381|39 51|Hnf3g-lacZ YAC
P09233809A0815|7 31|plasmid-derived transgenes
P09233809A0815|53 62|endogenous
P09233809A0815|63 71|Hnf3g gene
P09233809A0815|105 121|3'-flanking region
P09233809A0815|163 174|reporter gene
P09233811A0072|25 31|HMG-box
P09233811A0072|84 114|M cell-controlling protein Mat1-Mc
P09234690A0242|18 32|sequences (UASs)
P09234690A0242|49 69|Ste12p-dependent genes
P09234690A0242|124 127|PREs
P09234696A0238|9 21|protein kinase
P09234696A0238|50 85|mitogen-activated protein (MAP) kinases
P09234703A0192|0 2|JNK
P09234713A0754|37 56|ligation-mediated PCR
P09234713A0754|79 146|recombination-activating gene (RAG)-dependent double-strand breaks (DSBs)
P09234713A0754|149 152|RSSs
P09234717A0000|40 46|120-kDa
P09234717A0000|66 84|c-cbl proto-oncogene
P09234717A0000|115 145|receptor-coupled tyrosine kinases
P09234717A0000|149 162|forms complexes
P09234717A0000|167 169|SH3
P09234717A0000|173 192|SH2 domain-containing
P09234720A1015|38 48|MEK (MEK-2E)
P09234720A1015|52 56|v-Src
P09234720A1015|148 150|MEK
P09234720A1015|154 158|v-Src
P09234723A0846|59 61|PTB
P09234725A1892|111 114|AP-1
P09234727A0770|0 13|Gal4-Eed fusion
P09234727A0770|46 57|reporter gene
P09234727A0770|87 109|Gal4-binding DNA elements
P09234736A0999|96 102|drm mRNA
P09234743A0475|55 66|alpha-globin
P09234743A0475|67 71|3'UTR
P09234743A0475|85 93|complexed
P09234743A0475|110 120|non-poly(C)
P09234743A0475|141 153|alpha-complex
P09235424A1200|46 49|ABPM
P09235618A0000|24 48|euroinfection, Lyme disease
P09235618A0000|97 107|generalized
P09235618A0000|164 166|IgG
P09235618A0000|170 172|IgM
P09235998A0788|38 49|beta subunits
P09235998A0788|114 129|HMG-CoA reductase
P09236118A1455|100 102|DNA
P09236118A1455|159 188|nucleoprotein activation complex
P09236224A0939|85 87|NGF
P09236224A0939|105 108|PC12
P09236441A0639|43 45|ECG
P09236441A0639|67 88|oxygen saturation (SaO2)
P09236656A0124|55 61|10(9)/L
P09236656A0124|62 64|(SD
P09236656A0124|76 82|10(9)/L
P09236656A0124|83 85|(SD
P09238850A0785|12 15|ICER
P09238850A0785|66 75|generating
P09238850A2042|37 46|endogenous
P09238850A2042|81 91|ucleus, SCN)
P09238860A0175|92 128|AMP response element binding proteins CREB
P09238860A0175|132 135|CREM
P09238860A0175|159 171|protein kinase
P09238860A1974|49 52|CREB
P09238860A1974|85 111|cytokine Interleukin-2 (IL-2)
P09238860A1974|179 191|protein kinase
P09239635A0477|21 28|serum IgG
P09239635A0477|80 87|serum IgA
P09241092A1108|0 10|CONCLUSIONS
P09241232A0653|33 35|DNA
P09241232A0653|57 58|AP
P09241232A0653|80 93|cytosine (AP/C)
P09241232A1154|63 74|endonuclease
P09241232A1154|75 77|III
P09242375A1313|36 49|mutations E768D
P09242375A1313|53 57|V804L
P09242375A1313|105 114|RET isoform
P09242375A1313|203 207|MEN2A
P09242375A1313|211 215|MEN2B
P09242499A0505|52 53|UV
P09242506A1033|0 2|E2F
P09242506A1033|38 40|E2F
P09242506A1033|62 63|DP
P09242551A0653|0 8|EBER1 mRNA
P09242551A0653|58 65|PEL cases
P09242551A0653|97 103|non-PEL
P09242551A0653|117 121|EBER1
P09243267A0401|0 6|METHODS
P09243267A0401|106 145|treatment at Roswell Park Cancer Center (RPCI)
P09243385A1314|76 77|PC
P09243505A1194|14 24|DNA-binding
P09243505A1194|61 71|MADS domains
P09243505A1194|114 124|DNA-binding
P09243505A1194|204 213|MADS domain
P09243505A1194|245 255|DNA-binding
P09243587A0000|0 17|PURPOSE/OBJECTIVES
P09243587A0000|60 83|full-term pregnancy (FFTP)
P09243587A0000|160 176|abortion increases
P09243840A0663|61 68|HLA-DQA1
P09243840A0663|84 86|DNA
P09243840A0663|111 113|DNA
P09244282A1371|0 10|Mutagenesis
P09244282A1371|16 19|pecT
P09244350A0000|0 4|BRCA1
P09244350A0000|31 54|cancer susceptibility gene
P09244430A0693|39 52|adducin isoform
P09244430A0693|40 59|dducin isoform, beta-3
P09247645A0000|6 33|temperature-sensitive alleles
P09247645A0000|36 39|SEC3
P09247645A0000|44 64|10 late-acting SEC genes
P09247645A0000|95 104|post-Golgi
P09248639A0152|165 186|collagen lattices (FPCL)
P09249710A0331|0 23|Twenty-one ELISA-positive
P09250554A0402|22 32|diltiazem CD
P09251843A0189|31 43|ound in 15 cases
P09251843A0189|37 43|15 cases
P09251843A0189|90 107|Castleman's disease
P09251843A0189|178 183|3 cases
P09251843A0189|231 236|4 cases
P09252397A0081|98 104|JUN gene
P09252406A0511|78 87|p85 subunit
P09252406A0511|90 118|phosphatidylinositol 3'-kinase
P09252406A0511|91 132|hosphatidylinositol 3'-kinase, phospholipase
P09252406A0511|143 154|a phosphatase
P09252406A0511|144 159| phosphatase, SHP2
P09252879A0470|16 19|HRCT
P09252879A0470|73 95|methacholine PC20 (PC20M)
P09254678A0106|0 6|Gtx mRNA
P09254678A0106|35 38|RNAs
P09254678A0106|93 104|protein (MBP)
P09254678A0106|109 131|proteolipid protein (PLP)
P09254678A0106|148 170|rain development; Gtx mRNA
P09254678A0106|194 196|MBP
P09254678A0106|200 207|PLP mRNAs
P09254678A0106|270 276|PLP gene
P09254709T0000|51 61|protein CcpA
P09254709T0000|65 68|amyO
P09255349A0836|20 25|GTPase
P09255349A0836|53 56|IRA1
P09255349A0836|60 63|IRA2
P09256973A0455|34 36|[G]
P09256973A0455|41 46|10 (G2)
P09256973A0673|0 6|RESULTS
P09256973A0673|71 73|(IV
P09256973A0673|112 129|residence time (MRT)
P09257651T0000|8 17|U4/U6 snRNP
P09257651T0000|31 34|90kD
P09257887A0457|0 4|G-CSF
P09258439A1001|56 61|SsEF-2
P09258439A1001|72 82|mutagenesis
P09259052A0568|73 88|protein complexes
P09259052A0568|97 102|AtT-20
P09259052A0568|132 140|c-jun AP-1
P09259052A0568|161 180|un family members, JunD
P09259052A0568|162 185|n family members, JunD, JunB
P09259052A0568|190 193|cJun
P09259313A0950|13 20|PI kinase
P09259313A0950|60 62|PRL
P09259315A0809|26 36|GT-IIC-like
P09259315A0809|118 123|GT-IIC
P09259315A0809|147 167|CSEn enhancer/silencer
P09259315A0809|180 183|BeWo
P09259315A0809|187 188|GC
P09259320A0830|82 85|SSBP
P09259320A0830|89 92|DSBP
P09259328A0440|77 81|MSC-1
P09259328A0440|176 185|luciferase
P09259328A0440|239 248|-65 regions
P09261155A0833|15 16|PH
P09261155A0833|20 29|PTB domains
P09261155A0833|84 98|insulin receptor
P09261155A0833|116 122|3 (IRS-1
P09261155A0833|117 128| (IRS-1, IRS-2
P09261155A0833|133 138|IRS-3)
P09261178T0000|21 47|signal-regulated kinase 2 gene
P09261184A0170|44 69|upershift experiments, FIRE1
P09261184A0170|120 123|NF-Y
P09261200T0001|0 1|MR
P09261200T0001|37 41|FLAIR
P09261397A0509|0 23|Gag protein sequence motifs
P09261397A0509|29 36|NC domain
P09261397A0509|115 118|FeFV
P09263010T0000|27 46|co-cross-linking CD23
P09263010T0000|50 52|sIg
P09263094A0799|0 11|MEASUREMENTS
P09263094A0799|12 14|AND
P09263094A0799|15 25|MAIN RESULTS
P09263094A0799|16 43|AIN RESULTS: Lung elastance (EL)
P09263094A0799|47 60|resistance (RL)
P09263094A0799|226 232|10 cmH2O
P09263094A0799|327 332|300 mL)
P09263856A0563|42 46|EGF-1
P09263856A0563|61 62|PS
P09264466A0947|3 13|Cut9 subunit
P09264466A0947|46 49|APC/
P09265642A0668|114 121|marker FM
P09267431A0000|3 13|soybean cDNA
P09267431A0000|4 25|oybean cDNA clones, SPK-3
P09267431A0000|29 33|SPK-4
P09267431A0000|51 64|protein kinases
P09267439A0000|39 73|low-molecular-weight GTP/GDP-binding
P09267542A0126|0 9|Naltrexone
P09268298T0000|0 18|Ent-kaurene synthase
P09268387A0293|52 54|ELL
P09268387A0293|100 112|RNA polymerase
P09268387A0293|113 114|II
P09268387A0293|128 144|elongation complex
P09268578A0225|12 15|cDNA
P09268638A0332|62 67|D8S260
P09268638A0332|76 81|D8S285
P09268652A0116|17 42|inc finger protein, dsRBP-ZFa
P09268652A0116|86 90|dsRNA
P09268661A1405|44 56|transcriptase
P09268661A1405|84 87|cDNA
P09268661A1405|113 115|CCA
P09269900A1035|32 42|EGF/Ras/Raf
P09269900A1035|86 95|ATF3/c-Jun
P09269900A1035|100 105|52-kDa
P09269900A1035|127 130|JunD
P09271393A1333|38 50|Tax anchors CBP
P09271393A1333|56 69|HTLV-1 promoter
P09271393A1333|122 135|CBP-associated
P09271394A0558|0 4|DNase
P09271394A0558|49 68|MURA-Mu1 TIR complexes
P09271394A0558|81 84|MURA
P09271394A0558|115 125|32-bp region
P09271394A0558|131 133|TIR
P09271397A1596|81 96|LDL receptor SREBP
P09271400A0475|86 89|E2F2
P09271417A0585|11 23|ouse, ERR alpha
P09271417A1011|3 6|MCAD
P09271417A1011|14 45|receptor response element 1 (NRRE-1)
P09271417A1011|66 73|ERR alpha
P09271417A1011|85 89|COS-7
P09271496T0000|17 30|HIV-1 integrase
P09271496T0000|58 66|target DNA
P09271496T0000|86 102|enzyme-DNA complex
P09272108A1295a|71 74|TATA
P09272108A1295b|71 74|TATA
P09272108A1295b|78 81|CAAT
P09272108A1295a|78 81|CAAT
P09272138A1153|11 22|response (CR)
P09272138A1153|38 41|CODE
P09272138A1153|46 52|rhG-CSF
P09272138A1153|69 72|CODE
P09272138A1153|143 144|(P
P09275159T0000|0 12|Heterogeneous
P09275159T0000|49 78|transcription-regulatory region
P09275159T0000|81 102|mouse hepatitis virus RNA
P09275164A0000|3 9|m7GpppN
P09275164A0000|34 37|mRNA
P09275164A0000|79 103|l action of three enzymes: RNA
P09275164A0000|94 117|nzymes: RNA triphosphatase
P09275164A0000|95 140|zymes: RNA triphosphatase, RNA guanylyltransferase
P09275164A0000|145 176|RNA (guanine-7)-methyltransferase
P09275990A0938|60 63|TA98
P09276882A0479|25 26|CC
P09276882A0479|30 34|CC:SW
P09276882A0479|56 57|pH
P09276882A0479|69 70|(P
P09276882A0479|158 159|pH
P09277472A1070|85 86|DC
P09277629A0268|14 15|(N
P09277629A0268|58 60|ERP
P09278441A1160|21 28|CARP mRNA
P09278441A1160|113 122|Nkx2.5/Csx
P09278441A1777|16 19|CARP
P09278445T0000|25 29|RNase
P09278445T0000|40 57|yeast RNA polymerase
P09278445T0000|58 60|III
P09278450A1338|90 92|NF1
P09278454A1261|16 23|MMP-2 RE1
P09278454A1261|52 78|Y-box sequence (CTGCTGGGCAAG)
P09278454A1261|122 125|YB-1
P09278454A1261|128 130|DMS
P09278494A0762|21 23|ETS
P09278758A1636|0 9|CONCLUSION
P09278758A1636|40 56|neck disease (N1-3)
P09279379A0310|19 24|pBR322
P09279379A0310|41 49|acid (DNA)
P09279379A0310|120 133|H2B histone gene
P09279889A1124|12 47|drug concentration-time curves (AUC0-24
P09279889A1124|54 56|MTX
P09279889A1124|84 90|PG-2.5%
P09279889A1124|99 105|PG-7.5%
P09280747A0195|169 171|ACE
P09282329A0527|47 48|II
P09282329A0527|74 96|cell cycle control element
P09282329A0527|165 173|G1/S phase
P09282329A0527|186 191|FDC-P1
P09282329A0527|205 214|progenitor
P09282911A0277|62 76|RC3/neurogranin
P09285715A1257|89 92|RNAs
P09285715A1257|96 97|5S
P09285715A1257|107 109|RNA
P09285715A1257|114 116|CTE
P09285715A1257|193 196|mRNA
P09285789A0712|17 58|guanine nucleotide exchange factor (GEF) domain
P09285789A0712|90 117|pleckstrin homology (PH) domain
P09286115T0000|0 2|S2F
P09286115T0000|50 66|cis-acting element
P09286115T0000|96 104|RPL21 gene
P09286981A0147|0 3|ArgR
P09287352A0930|23 26|STAT
P09287352A0930|45 49|SHP-1
P09287352A0930|72 82|EGF-induced
P09287352A0930|98 127|mitogen-activated protein kinase
P09287352A0930|148 157|SHP-1-(Cys
P09287352A0930|184 186|MEK
P09287352A0930|225 229|SHP-1
P09287362A0589|26 34|SH3 region
P09287362A0589|49 85|proline-rich region (PPPLPERTPESFVLADM)
P09287362A0589|113 120|PTP-PEST
P09288848A0780|13 18|y, HbO2
P09288916T0000|36 82|N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase
P09288916T0000|89 100|meprin) alpha
P09288916T0000|104 115|beta subunits
P09288916T0000|118 128|Madin-Darby
P09290571A0420|37 39|VTs
P09290571A0420|70 79|study (EPS)
P09290571A0420|71 85|tudy (EPS), 10 VTs
P09290571A0799|23 24|VT
P09290571A0799|28 33|10 VTs)
P09291098T0000|31 62|gamma-glutamyl transpeptidase gene
P09291098A0452|23 28|kb mRNA
P09291098A0452|41 49|kb GGT mRNA
P09291098A0452|133 142|rat GGT gene
P09292499A0887|54 97|polypyrimidine tract binding protein (PTB) in HeLa
P09292499A0887|127 128|UV
P09293006A1412|21 24|lipA
P09293006A1412|69 81|aphII promoter
P09294139A0729|7 30|135-bp core homology region
P09294139A0729|40 52|HS12 enhancers
P09294161A0650|44 51|p45 NF-E2
P09294161A0650|63 78|activation domain
P09294161A0650|83 87|NF-E2
P09294161A0650|114 131|enhancer-dependent
P09294262A0885|3 16|promoter region
P09294262A0885|25 37|consensus TATA
P09294262A0885|54 58|CCAAT
P09294262A0885|62 65|CreA
P09294422A1376|3 9|por gene
P09294422A1376|87 145|isopropyl-beta-D-thiogalactopyranoside-inducible tac promoter
P09294422A1376|173 175|POR
P09294453A0949|3 6|ORF3
P09294453A0949|59 62|ORF3
P09294453A0949|77 81|T beta
P09294471A1198|22 24|CD4
P09294471A1198|32 41|150/microL
P09294471A1198|52 61|200/microL
P09297698A0933|40 50|UbCRBP mRNAs
P09297698A0933|65 70|UbCRBP
P09297698A0933|130 140|enolase gene
P09299696A1074|95 97|DPI
P09300323A1182|41 64|blood flow ratio (ENDO/EPI)
P09300323A1182|128 130|ITF
P09300323A1182|181 183|NTG
P09300697A0000|17 28|multisubunit
P09300697A0000|29 36|protease
P09300697A0000|50 59|generation
P09300697A0000|81 83|MHC
P09300698A1219|46 49|MQ9b
P09300698A1219|66 81|17 motif-positive
P09300698A1219|67 98|7 motif-positive, pathogen-derived
P09301350A0946|84 105|confidence interval (CI)
P09301350A0946|171 178|(MEF25%)
P09301350A0946|266 267|CI
P09303437A0875|34 43|hCRBP1 gene
P09303437A0875|60 62|CAT
P09303437A0875|217 223|CAT gene
P09303635A0000|0 15|Gaucher's disease
P09303635A0000|64 86|beta-glucocerebrosidase
P09305592A0000|47 49|CML
P09305592A0000|65 75|bcr/abl gene
P09305631A0770|16 20|BAG-1
P09305755A0540|51 62|TATA-binding
P09305755A0540|82 93|factor 1 (NF1)
P09305755A0540|83 123|actor 1 (NF1), CAAT-box binding protein (C/EBP)
P09305755A0540|154 158|(HNF1
P09305755A0540|160 164|HNF5)
P09305755A0540|190 193|(AP1
P09305755A0540|195 198|AP2)
P09305870A0894|30 41|p55 PDZ domain
P09305870A0894|73 82|PDZ domains
P09305870A0894|85 88|hDlg
P09305870A0894|95 113|lymphocyte homologue
P09305944A0621|14 19|RanGAP
P09305944A0621|122 137|C-terminal domain
P09305944A0621|185 199|Ran-mediated GTP
P09307065A0553|14 16|MHC
P09307065A0553|22 23|II
P09307065A0553|40 45|D10 TCR
P09307065A0553|121 130|10(4)M(-1)
P09307065A0553|217 222|microM
P09308234A0225|0 15|Mnt:Max complexes
P09308738A1216|5 26|United States high-MW HES
P09308738A1216|100 101|MW
P09308738A1216|125 138|factor VIII/von
P09309457A0680|35 37|HDL
P09309457A0680|36 42|DL, HDL2
P09309457A0680|37 46|L, HDL2, LDL
P09309457A0680|102 104|FSH
P09309457A0680|146 148|ERT
P09310836A1019|21 28|P element
P09310836A1019|40 51|SV40 promoter
P09311568A0595|3 20|cleavage dipeptides
P09311568A0595|23 38|C1YVV NIa protease
P09311568A0595|42 52|Q(E)/S(A,G)
P09311796A0218|69 73|IEP86
P09311796A0218|90 116|TATA-box binding protein (TBP)
P09311810A0814|61 66|alpha0
P09311810A0814|174 179|alpha0
P09311835A0147|77 80|SV40
P09311835A0147|152 154|ATP
P09312025T0000|0 19|Protein phosphatase 2A
P09312025T0000|42 54|protein kinase
P09312025T0000|79 82|SV40
P09312025T0000|111 119|NF-kappaB
P09312025A0373|42 60|kinase-deficient PKC
P09312025A0373|80 120|phosphatidylinositol 3-kinase p85alpha-p110
P09312025A0373|124 141|ortmannin, LY294002
P09312025A0373|171 178|p85alpha
P09312028A0975|17 29|RXRalphaF318A
P09312028A0975|42 58|activity generated
P09312028A0975|92 97|BMS614
P09312028A0975|124 126|RXR
P09312028A0975|130 143|RAR AF-2 domains
P09312032A0165|29 39|snoRNA genes
P09312032A0165|66 79|exonucleolytic
P09312032A0165|80 86|release
P09312032A0165|92 97|snoRNA
P09312087A0000|29 90|Src homology-2 (SH2) domain-containing protein-tyrosine phosphatase
P09312087A0000|30 96|rc homology-2 (SH2) domain-containing protein-tyrosine phosphatase, SHP-2
P09312087A0000|134 140|PECAM-1
P09312087A0000|248 262|phosphopeptides
P09312087A0000|300 306|PECAM-1
P09314306A0571|29 34|pl-ALB
P09314306A0571|45 48|g/dL
P09314487T0000|46 58|air filtration
P09314487T0000|62 71|polymerase
P09314537A1600|21 25|EBP50
P09314554A0149|66 68|AUG
P09314554A0149|199 232|influenza A PR/8/34 nucleoprotein gene
P09314570A0153|25 37|GC-rich motifs
P09314570A0153|57 69|gene promoters
P09315631A1064|13 20|POR2 gene
P09315631A1064|84 87|POR1
P09315631A1064|91 99|POR2 genes
P09315632A1137|63 79|FGFR3 kinase domain
P09315632A1137|150 154|FGFR3
P09315633A0333|83 95|factors (IRFs)
P09315651T0000|13 16|AP-2
P09315651T0000|34 43|R-FABP gene
P09315678A0278|72 83|protein NAP57
P09315678A0278|185 186|(U
P09316937A0133|84 89|API 20E
P09317131A0000|84 90|CH genes
P09317131A1332|30 58|NF kappa B2 nucleoprotein complex
P09317131A1332|75 88|DNA-bound STAT6
P09317131A1332|98 111|IL-4-dependent
P09317131A1332|132 146|IgE germline gene
P09317757T0000|0 7|EXERCISE
P09317757T0000|8 9|IN
P09317757T0000|10 12|THE
P09317757T0000|13 23|TERRESTRIAL
P09317757T0000|24 74|CHRISTMAS ISLAND RED CRAB GECARCOIDEA NATALIS - ENERGETICS
P09317757T0000|75 76|OF
P09317757T0000|77 86|LOCOMOTION
P09317830T0000|0 2|THE
P09317830T0000|3 9|SCALING
P09317830T0000|10 11|OF
P09317830T0000|12 24|SONG FREQUENCY
P09317830T0000|25 26|IN
P09317830T0000|27 33|CICADAS
P09321657A0439|69 81|cox3 promoters
P09321657A0439|101 111|core element
P09321657A0439|126 137|cox3 promoter
P09321930A0567|19 38|tumor suppressor genes
P09321930A0567|45 47|p53
P09321930A0567|46 51|53, DCC
P09321930A0567|47 55|3, DCC, APC
P09321930A0567|48 59|, DCC, APC, MCC
P09321930A0567|49 65| DCC, APC, MCC, BRCA1
P09321930A0567|70 79|WAF1/CIP1)
P09321930A0567|149 167|heterozygosity (LOH)
P09321930A0567|175 189|expression (LOE)
P09322738A0510|3 22|histidine-tagged gene
P09322738A0510|4 30|istidine-tagged gene, rpoCHIS
P09322738A0510|51 65|wild-type allele
P09322872A0745|29 34|TK gene
P09323366A0000|3 20|malate synthase gene
P09323366A0000|4 25|alate synthase gene, MLS1
P09323366A0299|23 39|MLS1 control region
P09323366A0299|57 65|ites, UAS1
P09323366A0299|69 72|UAS2
P09323612A0374|36 66|sleep electroencephalograms (EEG)
P09324878A0952|36 45|ultrasound
P09325022A0192|41 44|CD-1
P09325022A0192|64 66|C3H
P09325022A0192|70 76|C57BL/6
P09325135A0737|3 14|Trx-CT fusion
P09325273A1240|23 27|UBP41
P09325273A1240|97 125|poly-ubiquitin chains generated
P09325273A1240|291 305|ubiquitin fusion
P09325278A0458|1 16|data base homology
P09325278A0458|47 49|ER1
P09325278A0458|135 159|metastasis-associated gene
P09325284A0469|12 15|cDNA
P09325284A0469|64 76|progelatinase
P09325322A1293|76 79|EC50
P09325322A1293|92 96|InsP3
P09326163A0942|0 6|RESULTS
P09326163A0942|23 41|mortality ratio (SMR)
P09326163A0942|75 76|CI
P09326246A0567|111 120|luciferase
P09326246A0567|134 148|-916-bp reporter
P09326263A0410|5 10|5'RACE
P09326263A0410|21 45|transcription-PCR (RT-PCR)
P09326263A0410|194 201|exon (1A)
P09326263A0410|225 232|exon (1B)
P09326317A0372|69 72|EXT1
P09326317A0372|76 84|EXT2 genes
P09328341A1449|18 34|vit A2 consensus ERE
P09328341A1449|62 64|DNA
P09328341A1449|77 86|TR alpha DNA
P09328343A0181|50 63|protein complex
P09328343A0181|92 95|E2A-
P09328343A0181|99 109|HEB-encoded
P09328343A0181|148 151|bHLH
P09328349A1679|8 12|CCAAT
P09328349A1679|89 105|alpha-subunit gene
P09328476A0068|0 9|U4/U6 snRNP
P09328476A0068|42 65|ribonucleoprotein (snRNP)
P09328476A0068|75 77|(U1
P09328476A0068|87 92|U4/U6)
P09328476A0374|9 13|77 kDa
P09328824A0000|44 57|v-erbA oncogene
P09328824A0000|85 122|chicken thyroid hormone receptor (TR) alpha
P09328824A0000|179 191|antimitogenic
P09328824A0000|199 200|TR
P09328824A0000|212 224|acid receptors
P09328833A0588|17 20|cDNA
P09328833A0588|31 33|HET
P09328833A0588|40 48|MCF-7 cDNA
P09331864A0230|26 29|TBOH
P09331864A0230|148 150|MGA
P09331864A0230|173 181|Revalor-H
P09331864A0230|186 190|mg TBA
P09331864A0230|212 214|MGA
P09331864A0230|218 227|Finaplix-H
P09331864A0230|232 237|mg TBA)
P09331864A0848|81 83|MGA
P09331864A0848|111 113|MGA
P09333018A0000|20 32|Factor (IRF)-1
P09333026A0397|34 39|8 exons
P09333026A0397|76 90|non-receptor PTK
P09333026A0851|54 60|brk cDNA
P09333026A0851|181 189|mitogenic
P09333168A0310|0 24|Anti-hepatitis A virus (HAV)
P09333168A0310|59 72|83 HIV-positive
P09333168A0310|76 89|39 HIV-negative
P09334264A0540|13 26|calf thymus CstF
P09334264A0540|63 75|64-kDa subunit
P09334264A0540|96 100|70 kDa
P09334330A0252|56 63|TGF-beta
P09334330A0252|187 190|DPC4
P09334331A0910|46 64|EGF receptor DER/Egfr
P09334331A0910|79 81|EMA
P09334475A0327|0 7|PATIENTS
P09334475A0327|8 10|AND
P09334475A0327|11 17|METHODS
P09334475A0327|137 138|ST
P09334475A0327|188 189|CK
P09334475A0327|235 237|EKG
P09335267A0142|77 87|mutagenesis
P09335298A0529|24 35|parCBA operon
P09335298A0529|69 70|(M
P09335298A1227|29 33|ColE1
P09335298A1227|48 50|RK2
P09335298A1227|112 118|MC1061K
P09335298A1227|178 183|parCBA
P09335298A2129|181 184|ParE
P09335608T0000|0 22|Splice-junction elements
P09335608T0000|26 33|intronic
P09335608T0000|96 104|chain gene
P09335619A0583|104 105|RU
P09335619A0583|243 252|orf221 gene
P09336455A0000|40 43|mRNA
P09336455A0000|67 71|GAL10
P09336455A0000|75 83|RNR3 genes
P09336455A0000|111 125|ultraviolet (UV)
P09337861T0000|15 38|phosphoinositide 3-kinase
P09337861T0000|44 51|C2 domain
P09338414A0430|65 78|pressure (ESAP)
P09339900A0939|41 57|5'-flanking region
P09339900A0939|111 115|C/EBP
P09339900A0939|112 120|/EBP, PEA3
P09339900A0939|113 124|EBP, PEA3, AP2
P09339900A0939|114 129|BP, PEA3, AP2, NF-Y
P09339900A0939|115 135|P, PEA3, AP2, NF-Y, c-Myc
P09340641T0001|33 37|nCPAP
P09341139A0690|29 70|sequestration-impaired beta2AR mutant (Y326A)
P09341139A0690|121 124|GRK2
P09341139A0690|127 139|beta-arrestin
P09341158A0167|99 103|beta1
P09341158A0167|107 111|beta2
P09341182A0605|61 73|BTB/POZ domain
P09341182A0605|78 95|PLZF (PLZF-BTB/POZ)
P09341192T0000|22 26|GLUT4
P09341192T0000|42 46|3T3L1
P09341192T0000|65 78|tyrosine kinase
P09341193A0362|27 38|NGFI-A/Egr-1
P09341193A0362|85 90|to TRE1
P09343208A1405|134 137|PDVs
P09343210A1112|44 57|VCAM-1 promoter
P09343210A1112|71 102|chloramphenicol acetyltransferase
P09343210A1112|149 162|VCAM-1 promoter
P09343210A1112|169 177|NF-kappaB
P09343210A1112|208 225|VCAM-1 gene promoter
P09343222A0415|3 5|AGM
P09343222A0415|9 26|NIH/Swiss mouse CCR5
P09343398A1193|14 16|DNA
P09343398A1193|79 86|poly(dA)
P09343398A1193|88 96|oligo(dT)
P09343426A0456|33 51|Zta activation domain
P09343426A0456|95 104|D-A complex
P09343432A0209|25 38|homology domain
P09343432A0209|89 97|SPM domain
P09343433A0000|46 58|RNA polymerase
P09343433A0000|59 60|II
P09343433A0000|61 65|(RNAP
P09343433A0000|66 68|II)
P09343433A0360|40 82|telomere-located RNAP II-transcribed genes URA3
P09343433A0360|86 89|ADE2
P09344650A0967|14 32|transmembrane domain
P09345037A0886|48 65|trans-factor GATA-1
P09345037A0886|78 87|progenitor
P09345495A0000|0 2|PET
P09346238T0000|65 90|SCF ubiquitin-ligase complex
P09346621A1181|60 62|ELT
P09346621A1181|123 125|OSF
P09346621A1181|131 138|APACHE II
P09346925A0660|3 12|SH3 domains
P09346925A0660|41 58|proline-rich motifs
P09346925A0660|64 67|HPK1
P09346925A0660|132 135|HPK1
P09346935A0459|2 12|far-Western
P09346935A0459|70 74|ZNF74
P09346935A0459|91 106|zinc finger domain
P09346935A0459|150 162|RNA polymerase
P09346935A0459|163 164|II
P09346935A0459|169 172|IIo)
P09346935A0927|5 9|ZNF74
P09346935A0927|51 58|pre-mRNA
P09346935A0927|80 82|RNA
P09346935A0927|145 150|pol IIo
P09346935A0927|162 174|RNA polymerase
P09346935A0927|201 208|pre- mRNA
P09346935A0927|250 282|KRAB multifinger protein family in RNA
P09346938A1680|0 13|Ki-ras4BVal-12
P09346938A1680|81 96|cysteine protease
P09346938A1680|116 140|up-regulate cathepsin B mRNA
P09346953A0000|30 74|heparan sulfate proteoglycan (HSPGact) generation
P09346953A0000|130 142|ctivity, HSact
P09346953A0000|205 259|heparan sulfate D-glucosaminyl 3-O-sulfotransferase (3-OST)
P09346953A0000|260 267|(Shworak
P09348226A0852|14 16|EGF
P09348226A0852|93 98|Crk-II
P09349501A0196|65 67|MLL
P09349501A0196|87 94|MLL-LTG9
P09349501A0196|98 106|MLL-LTG19
P09349501A0196|182 195|leukemogenesis
P09351242A0719|11 21|AtP5CS1 mRNA
P09351242A0719|115 117|ABA
P09351242A0719|191 193|ABA
P09351823A0414|17 20|MAPK
P09351823A0414|95 109|parthenogenetic
P09352016A1110|6 12|AF G-CSF
P09352016A1110|56 58|CAM
P09352127A0953|44 48|CA III
P09353247A0922|97 106|cyclin/CDK
P09353255A0159|40 52|pore complexes
P09353255A0159|81 94|FG-nucleoporin
P09353296A0510|3 12|CNXA domain
P09353296A0510|61 68|moaA gene
P09353296A0510|82 85|CNXC
P09353296A0510|106 109|moaC
P09353328A0736|18 23|kinase
P09353343T0000|12 31|AUUUA response element
P09353343T0000|41 53|heterogeneous
P09353343A0919|0 12|RNA polymerase
P09353343A0919|13 14|II
P09353343A0919|46 48|ARE
P09353343A0919|49 53|(AUBP
P09353343A0919|66 82|poly(U)-Sepharose
P09353343A0919|96 100|hnRNP
P09353343A0919|116 120|hnRNP
P09354349A0338|102 111|Giemsa (MG)
P09354349A0338|116 133|Warthin-Starry (WS)
P09354349A0338|159 169|method (IMM)
P09354349A0338|210 214|(DAKO
P09354644A0124|64 89|beta1,6-GlcNAc transferases
P09354644A0124|90 95|(IGnT6
P09354644A0124|97 102|GlcNAc
P09354676A1714|98 99|MM
P09354676A1714|118 126|FGFR3 gene
P09354676A1714|177 189|tumorigenesis
P09354676A1714|192 193|MM
P09354757A1444|19 30|beta 1', alpha
P09354757A1444|73 84|RNase H domain
P09354757A1444|117 121|dsDNA
P09358045A0000|7 16|length cDNA
P09358045A0000|45 79|growth factor-beta (TGF-beta) receptor
P09358055A0590|34 69|methylation-sensitive promoter element
P09358055A0590|88 90|LTR
P09358069T0000|47 65|erythropoietin (EPO)
P09359844A0674|10 12|HSL
P09359887A1168|32 44|Rat7p/Nup159p
P09359887A1168|64 66|NPC
P09359887A1168|77 93|coiled-coil region
P09360422A0135|82 99|thrombomodulin (TM)
P09360422A0135|83 128|hrombomodulin (TM), betathromboglobulin (beta-TG)
P09360422A0135|84 140|rombomodulin (TM), betathromboglobulin (beta-TG), D-dimer (DD)
P09360422A0135|144 180|plasminogen activator-inhibitor (pAI-1)
P09360953A1057|77 89|COOH-terminal
P09360953A1057|145 157|PTH-1 receptor
P09360956A0840|56 76|CKIalpha site (Thr-233)
P09360956A0840|108 112|c-Raf
P09360993T0000|0 20|Mouse mast cell protease
P09360993T0000|60 74|serine proteases
P09361007A0922|1 5|DNase
P09361007A0922|48 73|258-base pair enhancer region
P09362105X0422|0 9|[Pulmonary
P09362105X0422|18 32|resistance (PVR)
P09362105X0422|42 47|O2-PVR
P09362105X0422|57 62|O2/PVR
P09362105X0422|106 126|vasoconstriction (HPV)
P09362473A1540|64 79|enhancer elements
P09362473A1540|200 219|early-acting enhancer
P09362473A1540|271 291|twist expression domain
P09362480A0452|49 57|TB domains
P09362480A0452|109 119|alpha-helix
P09362499A0000|22 37|site-specific DNA
P09362499A0000|67 79|DNA invertases
P09363759A0000|0 18|Protein phosphatases
P09364211A0319|3 43|cell cycle-regulated transcription factor E2F
P09364211A0319|61 63|DNA
P09364440A2206|43 66|FSH receptor gene generates
P09364750T0000|27 31|SUP35
P09364750T0000|35 39|SUP45
P09365201A2018|82 90|aromatase
P09365201A2018|123 126|ASCs
P09365431A0314|50 69|acetylcholinesterase
P09366456A0234|0 6|METHODS
P09366517A0835|0 2|PKA
P09366517A0835|17 19|WT1
P09366517A0835|107 117|DNA-binding
P09366517A0835|128 130|WT1
P09366517A1828|51 53|WT1
P09366628T0000|3 12|"Assessing
P09367392A0567|67 70|RNA3
P09367392A0567|100 103|RdRp
P09367392A0567|128 131|RNA3
P09367676A0275|39 41|DNA
P09367676A0275|123 139|1.9-kb mouse TS mRNA
P09367676A0275|169 171|DNA
P09368006A1332|32 40|NF-kappaB
P09368006A1332|106 117|rotein, E2F-1
P09368014A0740|3 13|lysozyme FEF
P09368014A0740|36 37|PU
P09368026A0000|0 14|Osteocalcin (OC)
P09368026A0435|33 58|Msx2 expression on OC promoter
P09368026A0435|69 79|(luciferase
P09368026A0435|80 88|reporter)
P09368026A0435|91 98|FGF2/FSK
P09368026A0435|114 121|MC3T3-E1
P09368057A1083|41 43|SRF
P09368057A1083|90 103|GC-rich element
P09368057A1083|152 154|SRF
P09368058A0969|11 42|CAK-phosphorylated phosphopeptide
P09368058A0969|58 90|Cdc2-phosphorylated phosphopeptide
P09368058A0969|150 152|CAK
P09368100A1354|3 13|mHIF-1 alpha
P09368100A1354|40 46|15 exons
P09368190A1053|28 35|IRE-like
P09368190A1053|58 61|EMSA
P09368190A1053|64 66|DNA
P09368190A1053|120 128|IFN-gamma
P09368190A1053|178 186|IFN-alpha
P09368190A1053|190 198|IFN-gamma
P09368419A0000|29 54|dehydration-responsive gene
P09368419A0000|81 89|acid (ABA)
P09368419A0000|123 139|ABA-dependent gene
P09368419A0628|1 4|cDNA
P09368419A0628|14 27|MYC-related DNA
P09368419A0628|55 64|DNA-ligand
P09368419A0628|90 100|67-bp region
P09368419A0628|123 129|rd22BP1
P09368760A0665|5 8|PDK1
P09368760A0665|26 55|Drosophila protein kinase DSTPK61
P09368760A0665|97 123|ex differentiation, oogenesis
P09368760A0665|127 141|spermatogenesis
P09369450A1358|28 36|HNF-1beta
P09369450A1358|43 44|GR
P09369450A1358|47 78|dexamethasone-stimulated promoter
P09369450A1358|115 119|HNF-1
P09369450A1358|130 132|GRE
P09369450A1358|267 281|steroid receptor
P09369451A0693|33 36|AP-1
P09369451A0693|42 70|equence (-294/-285, TGAATCATCA)
P09369451A0693|76 111|A/T-rich myocyte enhancer factor (MEF)-2
P09369451A0693|117 148|equence (-310/-298, TTAAAAATAAAAA)
P09369451A0693|154 164|33-bp region
P09369451A0693|183 186|OP-1
P09369453A0273|28 54|cl-2 family, BAD (Bcl-xL/Bcl-2
P09369453A0273|65 78|death promoter)
P09369453A0273|66 93|eath promoter), a death enhancer
P09369453A0273|100 128|C-terminal transmembrane domain
P09369482A0690|59 67|HNF1alpha
P09369482A0690|75 78|HNF4
P09369482A0690|118 127|G6Pase gene
P09370307A0093|13 21|AACA motif
P09370307A0093|142 152|MYB-like DNA
P09371431T0000|31 44|genes (thiCOGE)
P09371431T0000|69 83|terminal oxidase
P09371431A1172|0 11|Strain CFN037
P09371431A1172|64 77|promoter region
P09371431A1172|83 93|thiCOGE gene
P09371455A0000|40 51|lipase operon
P09371455A0000|90 104|metalloprotease
P09371564A0713|23 32|tRNA(3Lys)
P09371564A0713|55 57|RNA
P09371566A1384|26 29|HeLa
P09371566A1384|73 74|SR
P09371566A1384|126 127|SR
P09371596T0000|27 31|pre-C
P09371622A0779|18 28|IE1 peptides
P09371626A1345|12 20|replicase
P09371626A1345|46 48|VP2
P09371626A1345|73 89|RNA-binding domain
P09371626A1345|121 123|VP2
P09371626A1345|175 178|mRNA
P09371657A0165|53 64|A (R77A)-K79A
P09371657A0165|68 78|E192A-E194A
P09371657A0165|110 123|triphosphatase
P09371698A1254|14 18|HepG2
P09371698A1254|22 28|SK-N-MC
P09371698A1254|119 131|200 bp promoter
P09371698A1254|153 163|pseudo-TATA
P09371698A1254|181 191|SP1-binding
P09371731A0627|29 38|homologues
P09371731A0627|41 57|eIF-2alpha kinases
P09372287A0296|77 87|tract (LVST)
P09372287A0296|112 122|tract (MVST)
P09372451T0000|68 86|alpha-helical domain
P09372451T0000|92 111|integrin beta 1 subunit
P09372908A1068|168 171|PREs
P09372924A0758|16 21|rhHR23
P09372924A0758|48 50|NER
P09372924A0758|120 124|hHR23
P09372924A0758|138 140|DNA
P09372924A0758|173 175|XPC
P09372950A1283|136 140|U2 RNA
P09372960A0456|82 90|a decrease
P09372960A0456|104 106|40S
P09372968A0532|37 40|cDNA
P09372968A0532|79 83|9-kDa
P09372968A0996|14 17|HeLa
P09372968A0996|22 39|93 cells, endogenous
P09372968A0996|55 65|kappaB alpha
P09372968A0996|102 111|endogenous
P09373155T0000|27 36|chain genes
P09373155T0000|103 112|dynein gene
P09373651A0255|21 30|cyanogenic
P09374082A0504|38 70|mono(2-ethylhexyl) phthalate (MEHP)
P09374082A0504|101 104|DEHP
P09374082A0504|123 146|prostaglandins (PG) PGD(2)
P09374082A0504|124 164|rostaglandins (PG) PGD(2), 9alpha,11betaPGF2
P09374082A0504|169 177|PGF2alpha
P09374541T0000|24 26|E2F
P09374541T0000|57 79|thymidine kinase promoter
P09376782A0328|35 44|MMT general
P09376782A0328|57 76|hepatitis C virus (HCV)
P09377374A0000|69 70|VH
P09380504A1255|3 11|ZnF20 cDNA
P09380507A0514|0 32|Glutathione S-transferase (GST)-E2F
P09380507A0514|36 47|GST-DP fusion
P09380507A0514|95 97|E2F
P09380507A0514|108 137|DNA polymerase alpha gene promoter
P09380697T0000|19 30|element-like
P09380697T0000|62 73|caveolin gene
P09380707A0714|12 29|DNA-bound LAZ3/BCL6
P09380707A0714|38 41|SMRT
P09381261A0970|0 10|CONCLUSIONS
P09381261A0970|28 30|EPO
P09381950A0209|38 39|mL
P09381950A0209|71 90|40-minute reperfusion
P09382498A0618|9 12|MCTs
P09382498A0618|91 94|MCTs
P09382850A0000|0 9|BACKGROUND
P09382850A0000|69 71|DNA
P09382886A1061|52 54|PKD
P09382886A1061|76 78|p53
P09382886A1061|116 118|SBM
P09382886A1061|122 127|p53(-/
P09382924A0131|52 78|interferon-gamma (IFN-gamma)
P09382924A0131|85 101|beta-type subunits
P09382924A0131|113 116|LMP2
P09382924A0131|114 121|MP2, LMP7
P09382924A0131|126 131|PSMB10
P09382924A0131|155 157|20S
P09382924A0131|195 211|beta-type subunits
P09382924A0131|222 226|PSMB6
P09382924A0131|223 232|SMB6, PSMB5
P09382924A0131|237 241|PSMB7
P09383156A0691|8 12|RNase
P09383156A0691|37 43|pSok-6)
P09383156A0691|63 97|polynucleotide phosphorylase (PNPase)
P09383188A0654|45 47|ARG
P09383188A0654|65 71|O(rocD)
P09385169T0000|3 8|AONE's
P09386074A0694|29 30|LV
P09386074A0694|52 53|LV
P09387999A1053|15 19|DPOAE
P09387999A1053|90 102|R-PIA-treated
P09388198A1396|68 70|JNK
P09388198A1396|69 74|NK, ERK
P09388198A1396|79 90|p38 MAP kinase
P09388198A1396|119 122|rhoB
P09388198A1396|180 183|rhoB
P09388199A0948|29 32|FadR
P09388199A0948|44 46|DNA
P09388199A0948|93 106|protein fusions
P09388199A0948|117 132|DNA binding domain
P09388199A0948|135 138|LexA
P09388199A0948|160 163|FadR
P09388200A0639|74 77|MDM2
P09388201A1027|2 3|PU
P09388201A1027|7 8|PD
P09388201A1027|27 30|TATA
P09388201A1027|33 42|CAAT motifs
P09388201A1027|50 56|AT-rich
P09388271A1243|75 96|PKC or mitogen-activated
P09388271A1243|118 143|llular signal-related kinase
P09388271A1243|124 143|signal-related kinase
P09389982A1383|0 10|CONCLUSIONS
P09389982A1383|17 19|INR
P09389982A1383|76 90|log reference INR
P09390125A0379|0 6|RESULTS
P09390125A0379|18 20|FNF
P09390183A1027|50 67|NMT peptide antibody
P09390183A1027|140 149|48.5-50 kDa
P09391173A0811|28 45|plastid ACCase genes
P09391173A0811|73 76|cDNA
P09391173A0811|93 99|5'-RACE
P09391173A0811|121 124|cDNA
P09392979T0000|0 11|AIDS-related
P09393717A1517|69 72|tRNA
P09393717A1517|112 127|UVM-constitutive
P09393717A1517|147 150|mutA
P09393717A1517|154 157|mutC
P09393771A1659|0 8|TNF-alpha
P09393771A1659|51 61|RNA-binding
P09393771A1659|87 112|Mr 50,000-55,000 RNA-binding
P09393875A0873|41 45|mRNAs
P09393875A0873|132 141|c-fos mRNAs
P09393966A0190|17 19|IgH
P09393966A0190|28 38|region genes
P09393966A0190|29 42|egion genes, CHA
P09393966A0190|46 48|CHB
P09394650A0121|101 102|US
P09395456A0424|21 31|chain motifs
P09395456A0424|90 107|proenteropeptidase
P09395456A0424|137 155|transmembrane domain
P09395456A0424|160 173|a signal peptide
P09395470A0294|0 11|CKbeta4GT-II
P09395470A0294|36 37|II
P09395470A0294|65 69|43 kDa
P09395525A0395|20 55|CCAAT/enhancer-binding protein (C/EBP)
P09395525A0395|81 113|PGE2-stimulated DNA-protein complex
P09395525A0395|123 126|HS3D
P09395525A0395|138 147|C/EBPdelta
P09395525A0395|162 174|IGF-I promoter
P09396402A0264|0 7|PATIENTS
P09396402A0264|8 10|AND
P09396402A0264|11 17|METHODS
P09396402A0264|61 73|stages I-III HD
P09396427A1488|126 128|AMI
P09396437A0878|5 7|BMI
P09396437A0878|30 31|NE
P09396437A0878|93 108|subjects (P=.017)
P09396722A0185|3 13|gene (ApxII)
P09396722A0185|39 57|ascorbate peroxidase
P09396796A1173|31 35|CDF-1
P09396796A1173|43 45|E2F
P09396796A1173|114 118|CDF-1
P09396796A1173|122 124|E2F
P09396823T0000|38 50|DNA polymerase
P09396823T0000|60 62|DNA
P09396823T0000|69 89|RNA exonuclease domains
P09398267A0440|50 52|DNA
P09398267A0440|64 90|chick embryo fibroblasts (CEF)
P09398267A0440|104 107|MEK2
P09398267A0440|111 125|single-copy gene
P09398332A0732|39 44|CTLA-4
P09398332A0732|61 76|esidues, 161TTGVY
P09398332A0732|79 84|CTLA-4
P09398332A0732|150 164|SH2 binding motif
P09398332A0732|151 172|H2 binding motif, 165YVKM
P09398332A0732|182 189|in CTLA-4
P09398598A0256|36 52|hamster ovary (CHO)
P09398598A0256|78 80|CD4
P09398598A0256|110 126|N-terminal domains
P09398598A0256|139 147|monomeric
P09398855A0438|0 8|SCID V(D)J
P09398855A0438|63 74|DNA-damaging
P09398855A0438|132 138|p53 gene
P09398855A0438|176 178|DNA
P09398855A0438|248 250|p53
P09400613A0594|14 30|mouse PKR(1-515)WT
P09400613A0594|34 60|Gal4 DNA-binding domain fusion
P09400613A0594|98 112|PKR(1-551) K296R
P09400613A0594|123 143|RNA-binding-deficient
P09400613A0594|149 168|PKR(1-551)K64E/K296R
P09400613A0594|184 209|wild-type mouse PKR(1-515)WT
P09400613A0594|212 253|full-length PKR-Gal4 activation domain fusions
P09400613A0594|279 282|HIS3
P09400613A0594|286 298|lacZ reporters
P09400613A1209|5 17|GST-PKR fusion
P09400613A1209|81 91|PKR homologs
P09400738A1046|76 79|ufCB
P09400738A1046|92 93|CB
P09402029A1632|26 36|strain H37Ra
P09402029A1632|204 214|strain H37Rv
P09402088A2250|84 90|AVP gene
P09402139A1121|22 29|hIGFBP-1
P09402139A1121|33 73|phosphoenolpyruvate kinase (PEPCK) promoters
P09402139A1121|208 214|IGFBP-1
P09403059A0209|34 44|DNA elements
P09403059A0209|56 60|LINES
P09403059A0209|57 66|INES, SINES
P09403059A0209|105 127|a transposon-like element
P09405195A0320|36 45|endogenous
P09405195A0320|80 91|cDNA-derived
P09405195A0320|140 142|DNA
P09405195A0320|197 199|DNA
P09405195A0320|202 214|nonhomologous
P09405685A0113|3 22|sequence-specific DNA
P09405685A0113|50 52|p53
P09405685A0113|73 145|20-bp consensus motif 5'-PuPuPuC(A/T) (T/A)GPyPyPyPuPuPuC(A/T)(T/A)GPyPyPy-3'
P09407026A0426|0 2|TSA
P09407031A0557|4 5|UV
P09407031A0557|99 108|Chk1 kinase
P09407036T0000|0 10|Tcn1p/Crz1p
P09407090T0000|46 56|SR-BI/CLA-1
P09408796A0648|38 43|WAIS-R
P09408796A0648|138 142|WMS-R
P09408796A0648|146 149|CVLT
P09409416A0111|64 68|a 2 MHz
P09409416A0111|75 103|Doppler instrument (TC-2 64B EME)
P09409774A0214|90 98|VCSA1 gene
P09409774A0214|111 140|prohormone-like polypeptide SMR1
P09409774A0214|148 156|VCSB1 gene
P09409774A0214|175 193|Pro-rich polypeptide
P09409821T0000|26 34|RAD30 gene
P09409821T0000|37 45|homologue
P09409821T0000|63 66|dinB
P09409821T0000|70 73|umuC
P09409821T0000|77 79|DNA
P09411459A0729|190 193|CVCC
P09413375A1486|2 4|ICU
P09413375A1486|17 19|LIS
P09413375A1486|51 54|IL-6
P09414074A0827|180 182|SSP
P09414319A1442|0 12|Y15170 (Surf-2
P09414319A1442|2 34|5170 (Surf-2, Surf-4), Y15171 (Surf-3
P09414319A1442|54 69|Y15172 (Surf-5.)]
P09415711A1348|81 88|DDT1MF-2
P09415711A1348|113 115|CRE
P09415711A1348|121 134|alpha 1B-AR gene
P09415711A1348|140 142|CRE
P09416467A0959|43 50|odel, ACE
P09416467A0959|89 108|ischemia-reperfusion
P09416898A1798|69 72|ARVD
P09417082A0127|40 56|urokinase receptor
P09417108A0000|9 21|Htf9-a/RanBP1
P09417108A0000|25 35|Htf9-c genes
P09417108A0000|72 88|TATA-less promoter
P09417493A0823|75 97|inflammation (C-reactive
P09417493A0823|76 110|nflammation (C-reactive protein, alpha
P09417870A0105|39 51|protein kinase
P09417870A0105|100 122|phorbol dibutyrate (PDBu)
P09417870A0105|132 165|cell density-dependent melanogenesis
P09417928A0980|34 44|(His128Asn)
P09417928A0980|48 60|+2 (Gln155Lys)
P09417941A1287|71 80|CUB domains
P09417941A1287|91 96|loop LA
P09417941A1287|100 109|strand beta
P09417941A1287|114 125|loops LE and LG
P09418040T0000|0 11|Mg-chelatase
P09418040T0000|39 46|Chl D cDNA
P09418040T0000|207 214|inant CHL
P09418040T0000|212 214|CHL
P09418057A0684|3 7|R-EST
P09418861A0623|3 13|multidomain
P09418861A0623|32 49|cysteine-rich motif
P09418861A0623|67 79|protein kinase
P09418861A0623|107 130|pleckstrin homology domain
P09418871A0620|21 23|DDB
P09418871A0620|27 30|E2F1
P09418882A0760|92 98|U1 snRNA
P09418905A1396|62 86|as, PLC-gamma1-mediated DAG
P09418905A1396|110 113|EGF-
P09418905A1396|117 135|PDGF-induced S-phase
P09418905A1396|186 188|PKC
P09419415A0236|26 29|STAT
P09419421A0385|36 43|NF-Y/CBF
P09419421A0385|46 49|TKC1
P09419421A0385|90 95|S phase
P09419680A1112|0 9|CONCLUSION
P09420219A0284|117 134|beta-actin minigene
P09420219A0284|155 195|glucocorticoid-inducible enhancer-promoter
P09420219A0284|254 273|adenovirus type 5 (Ad5)
P09420220A0070|92 95|HCMV
P09420220A0070|101 123|immediate-early (IE) gene
P09420220A0070|124 125|(J
P09420234A0654|0 7|MpB GroEL
P09420234A0654|62 66|GroEL
P09420239A1937|85 86|TM
P09420239A1937|91 120|ef coding sequences; changes in RNA
P09420239A1937|136 152|cceptor sites, TATA
P09420239A1937|194 201|V2 region
P09420239A1937|204 205|SU
P09420239A1937|286 287|SU
P09420252A0092|23 41|repeat (LTR) promoter
P09420252A0092|150 156|env gene
P09420269A0000|20 22|RNA
P09420269A0000|25 41|rubella virus (RUB)
P09420269A0000|133 141|[5'(+)SL]
P09420269A0000|188 211|minus-strand RNA [3'(-)SL]
P09420275A0682|31 34|CBF2
P09420275A1111|26 29|CBF2
P09420275A1111|45 49|LMP-1
P09420275A1111|46 55|MP-1, LMP-2
P09420275A1111|60 72|CD23 promoters
P09420671A1190|0 10|CONCLUSIONS
P09420671A1190|33 37|99mTc
P09420671A1190|86 98|artery disease
P09421507A0000|3 4|SR
P09421507A0000|54 61|pre-mRNA
P09421508A0696|26 30|TCF11
P09421508A0696|82 85|MafG
P09421511A0827|59 72|RNA-polymerase
P09421511A0827|86 112|telomerase RNA-gene promoters
P09421511A0827|167 179|telomerase RNA
P09421516A1516|23 37|beta-globin mRNA
P09421516A1516|82 87|NIH 3T3
P09421516A1516|137 151|beta-globin mRNA
P09421521T0000|0 24|Holliday junction resolvase
P09421521T0000|63 74|endonuclease
P09421521T0000|88 104|CCE1 homologue YDC2
P09422351A0000|0 37|Ca2+/calmodulin-dependent protein kinase
P09422351A0000|38 39|II
P09422351A0000|40 44|(CaMK
P09422351A0000|45 47|II)
P09422351A0000|66 94|serine/threonine protein kinase
P09422727A0196|1 36|cAMP-responsive element-like (CRE-like
P09422727A0196|2 54|AMP-responsive element-like (CRE-like, TGACGTGA) promoter
P09422727A0196|67 79|protein kinase
P09422727A0196|143 165|CRE binding protein (CREB)
P09422727A0196|179 206|transcription factor-2 (ATF-2)
P09423123A0000|0 3|IVOX
P09423310A0251|120 123|CD34
P09423310A0251|133 136|VIII
P09423856A1098|0 7|Protease
P09423856A1098|120 125|200 kDa
P09423856A1098|200 218|post-proline peptide
P09423968A0039|244 251|ontogeny
P09425676A0000|28 49|stimulus-response (S-R)
P09425676A0000|64 66|S-R
P09426068A0826|3 21|c-myc/TGF-alpha HCCs
P09426068A0826|76 84|TGF-alpha
P09426068A0826|166 174|c-myc HCCs
P09426143A1358|56 58|CRP
P09426143A1358|62 65|KdgR
P09426143A1358|86 102|pectinolysis genes
P09426143A1358|203 215|RNA polymerase
P09426143A1358|241 249|DNA region
P09426143A1358|255 265|target genes
P09426183A0000|3 25|well-known Rel/NF-kappaB
P09426183A0000|129 131|DNA
P09426239A0386|3 11|cglIM gene
P09426595T0000|0 28|Lysine-ketoglutarate reductase
P09426595T0000|32 56|saccharopine dehydrogenase
P09426958A0110|51 55|CO-Ag
P09426958A0110|67 77|corneal cDNA
P09426958A0110|123 124|(E
P09427544A0000|3 9|pel gene
P09427544A0000|37 48|pectate lyase
P09427544A0000|49 51|(EC
P09427544A0000|98 100|DNA
P09427544A0000|130 133|TK24
P09427551A0501|34 49|1.1-5.8 kb introns
P09427627T0000|33 44|PDGF receptor
P09427627A0802|30 41|PDGF receptor
P09427627A0802|103 120|an FK1012-dependent
P09427627A0930|104 111|p70(S6k)
P09427627A0930|114 122|MAP kinase
P09427627A0930|145 150|FK1012
P09427844A0739|22 31|dAK subunit
P09427844A0739|75 78|a dGK
P09427844A0739|81 90|dCK subunit
P09427844A0739|141 144|dGuo
P09427844A0739|147 150|dCyd
P09428389A1805|0 10|CONCLUSIONS
P09428389A1805|94 99|LHRH-A
P09428787A0138|48 64|5'-flanking region
P09428787A0138|85 108|p69/71 2-5A synthetase gene
P09428799A0897|86 96|intron/exon
P09429913A0528|0 6|RESULTS
P09429913A0528|115 118|EMDR
P09430461A0742|39 43|BMIPP
P09430461A0742|185 194|CONCLUSION
P09430461A0742|278 282|BMIPP
P09430661A0796|31 51|EphB1 receptors (Y594F)
P09430661A0796|75 79|EphB1
P09430661A0796|101 103|JNK
P09430668A0172a|14 28|HMG-CoA synthase
P09430668A0172a|74 104|element-binding proteins (SREBPs)
P09431812A0576|26 37|Patched (Ptc)
P09431828A1472|30 48|cyclosporine DR/C(SS
P09434160A0767|7 13|PTPases
P09434160A0767|42 53|5-FU-treated
P09434160A2078|12 16|PTPRO
P09434160A2078|39 43|CD34+
P09434160A2078|62 73|5-FU-treated
P09434185A0902|17 25|SPP1 genes
P09434185A0902|40 53|eplication, DNA
P09434185A0902|154 171|double-stranded DNA
P09435056A0128|27 37|pediocin AcH
P09435056A0128|38 43|(Lys+1
P09435056A0128|146 149|COOH
P09435056A0128|172 205|protein maltose-binding protein (MBP)
P09435116A0437|35 39|MS-MS
P09435789A0961a|8 12|RAD17
P09435789A0961a|9 18|AD17, RAD24
P09435789A0961a|22 25|MEC3
P09435789A0961a|62 67|S phase
P09435789A0961a|81 95|hydroxyurea (HU)
P09435789A0961a|159 160|HU
P09435789A0961a|206 218|HU-induced DNA
P09435806T0001|79 83|CA125
P09436657A0303|56 69|carcinogenesis
P09436989A1011|58 68|itosis, MOB1
P09438165A0405|6 22|baseline (day-8) PC
P09438165A0405|83 85|VOD
P09438427T0000|87 95|Hoxa1 gene
P09438427A0727|22 31|CE2 element
P09438427A0727|84 92|generated
P09438427A0727|106 140|Hoxa1 beta-galactosidase reporter gene
P09438427A0727|167 176|CE2 element
P09440166A0857|0 6|RESULTS
P09440166A0857|17 20|cDNA
P09440166A0857|72 75|mRNA
P09440166A0857|171 177|poly(A)
P09440616A0422|10 16|46 phase
P09440616A0422|17 19|III
P09441664A0377|28 65|iver-enriched transcription factor, HNF-6
P09441664A0377|85 101|HNF-3 beta promoter
P09441664A0377|156 179|hepatocyte-specific genes
P09441746A0546|1 4|cDNA
P09441746A0546|38 61|GHS-R-related gene (GPR39)
P09442024A0708|1 19|hybridoma clone (7H1)
P09442024A0708|49 57|CEMLAI/NP
P09442024A0708|75 89|fibroblasts MRC5
P09442031A0586|112 125|TSHR ectodomain
P09442072A0716|7 11|DNase
P09442072A0716|167 174|fVII gene
P09442072A0716|229 231|DNA
P09442080A0856|28 31|IM-9
P09442080A0856|48 52|SHP-1
P09442080A0856|56 60|SHP-2
P09442080A0856|90 94|SHP-2
P09442080A0856|102 107|SHP-1)
P09442080A0856|113 142|glutathione S-transferase fusion
P09442080A0856|156 158|GHR
P09442172A0908|19 21|FSH
P09443948A0000|67 80|technique (EIT)
P09443948A0000|140 166|immunofluorescence test (IIF)
P09443972A1145|19 22|GKLF
P09443972A1145|102 111|endogenous
P09443973A1028|0 3|CES4
P09443973A1028|42 50|tif1-A79V
P09443978A0262|130 133|TATA
P09443978A0262|191 194|TATA
P09445056A0215|52 86|bis(sulfosuccinimidyl)suberate (BS3)
P09445056A0215|120 131|gp41 oligomer
P09445488A0230|23 38|USH1C disease gene
P09445488A0230|98 114|chromosomes (YACs)
P09445488A0230|134 136|STS
P09445488A0230|154 160|Alu-PCR
P09445488A1169|0 9|PowerBLAST
P09445488A1169|50 67|sequence tags (ESTs)
P09445488A1169|82 85|(BIR
P09445488A1169|87 91|SUR1)
P09445488A1169|159 166|gene NEFA
P09445488A1169|167 170|(DNA
P09445488A1169|171 180|binding/EF
P09446600A0260|24 41|beta-galactosidase
P09446616A0780|48 53|kinase
P09447917A0000|22 27|(Brain
P09447962A1027|46 49|XRN1
P09447962A1027|64 79|5'-3' exonuclease
P09447962A1027|145 153|rhis4 mRNA
P09447962A1027|165 179|10-fold increase
P09447962A1027|181 197|n steady-state mRNA
P09447962A1027|182 197|steady-state mRNA
P09447962A1027|217 229|wild-type HIS4
P09447963A0223|54 57|SC35
P09447963A0223|79 80|SR
P09447973A0168|63 76|mSos1 (MyrSos1)
P09447973A0168|102 107|NIH 3T3
P09447973A0168|129 157|mSos C terminus (MyrSos1-deltaC)
P09447979A1430|72 108|guanine nucleotide exchange factor (GNEF)
P09447994A0000|79 96|cis-acting elements
P09447994A0000|112 142|AMP (cAMP) response elements (CREs)
P09448268A0186|13 18|kinase
P09448268A0186|63 71|(nmo) gene
P09448574A0964|30 32|FDG
P09448574A0964|48 52|RACLO
P09450932A0142|56 58|DNA
P09450932A0142|110 112|DNA
P09451003A0894|5 21|Esigma54 promoters
P09451003A0894|37 39|CRP
P09451003A0894|154 168|CRP-cAMP complex
P09451016A1037|0 6|GlcNAc-
P09451016A1037|10 28|GlcNAc2-PP-Dolichol
P09451016A1037|175 184|endogenous
P09451857T0001|72 85|creatine kinase
P09452421A1042|23 31|GST mSH2-B
P09452421A1042|60 64|92 kDa
P09452444A0000|0 18|Interleukin-6 (IL-6)
P09452444A0450|63 78|IL-6 gene promoter
P09452444A0450|89 100|reporter gene
P09453537A0863|28 33|CCAATC
P09453537A0863|69 70|GC
P09453537A0863|102 104|SP1
P09453689A0000|40 62|(S4-5) pin sensation (PPS)
P09453689A0000|66 86|bulbocavernosus (S2-4)
P09453689A0000|93 97|(BCR)
P09453689A0000|116 130|cord injury (SCI)
P09454719A0181|51 57|LTR R/U5
P09454719A0181|100 105|AAUAAA
P09454735A1782|11 29|MEK inhibitor PD98059
P09454735A1782|39 60|EGF-induced mitogenesis
P09454735A1782|64 72|MAP kinase
P09454735A1782|100 110|EGF-induced
P09455695A0762|0 2|ALT
P09455695A0762|40 42|AST
P09456312A1064|16 34|COOH-terminal domain
P09456312A1064|37 43|RanGAP1
P09458021A1373|5 14|(P=0.0006)
P09458021A1373|20 22|MMF
P09458021A1373|32 34|AZA
P09458030A0192|43 45|MMF
P09459241A0707|27 29|kPa
P09459241A0707|56 58|kPa
P09459241A0707|73 74|(P
P09459835A0297|16 19|PMEA
P09459835A0297|65 69|FPMPA
P09461594A0000|36 39|DT40
P09461594A0000|80 89|field (EMF)
P09461594A0000|136 167|phospholipase Cgamma2 (PLC-gamma2)
P09463380A1050|9 15|xTAK1KN
P09463380A1050|48 66|mesoderm marker genes
P09463560A0124|0 7|PATIENTS
P09463560A0124|8 10|AND
P09463560A0124|11 16|METHOD
P09464248A0289|10 13|TATA
P09465035A1032|73 80|L(alpha)
P09465783A0449|94 96|ASA
P09466267A1192|5 8|himA
P09466267A1192|32 34|IHF
P09466267A1192|81 89|dmsA-lacZ
P09466931T0000|60 74|response element
P09466931T0000|87 104|ng-2 intermolt genes
P09467044A0973|56 59|PALP
P09467044A0973|63 67|MGDET
P09467707T0000|83 85|A-I
P09467900A0701|3 8|CAPLC1
P09467900A0701|106 112|X domain
P09467900A0701|172 198|EF-hand Ca(2+)-binding domain
P09467955A0468|45 48|PEA3
P09467955A0468|66 77|PEA3 promoter
P09467955A0468|97 100|PEA3
P09468386A0594|27 49|PEA3 ETS DNA-binding motif
P09468509A0463|21 29|F2771 cDNA
P09468509A0463|43 45|COS
P09468515A0621|27 40|promoter region
P09468515A0621|78 81|SF-1
P09468515A0621|128 136|exogenous
P09468515A0621|137 140|SF-1
P09469415A1337|73 75|CTL
P09469415A1337|144 162|epitope-specific CTL
P09469415A1337|180 182|DNA
P09469415A1337|219 236|epitope-linked beta
P09469820A0151|3 7|mRNAs
P09469820A0151|42 46|(YAP1
P09469820A0151|47 51|uORF)
P09469820A0151|58 62|(YAP2
P09469820A0151|63 67|uORF1
P09469820A0151|71 76|uORF2)
P09469820A0151|90 115|eading frames. uORF-mediated
P09469820A0151|155 183|5'-untranslated region (5'-UTR)
P09469820A0151|239 242|mRNA
P09469933A1060|44 51|CLIP-170
P09471984A0000|0 9|BACKGROUND
P09472038T0000|47 99|immunoreceptor tyrosine-based activation motif-dependent
P09472608A0253|41 51|protein YB-1
P09472608A0253|80 92|HIV-1 promoter
P09472608A0253|111 126|cell line (U-87MG)
P09472608A0253|137 153|cell line (SK-N-MC)
P09472608A0253|165 177|cells (Jurkat)
P09472616A1004|55 57|VP7
P09472616A1004|86 97|phylogenetic
P09473040A1303a|9 16|alcR gene
P09473040A1303b|9 16|alcR gene
P09473040A1303a|9 12|alcR
P09473483A0953|127 131|HIV-I
P09473483A0953|171 175|HIV-I
P09473483A0953|179 184|HTLV-1
P09473755A0318|0 7|PATIENTS
P09473755A0318|8 10|AND
P09473755A0318|11 17|METHODS
P09474001A0825|14 16|SPs
P09474001A0825|101 105|MMFCV
P09474001A0825|134 138|MMFCV
P09474001A0825|154 155|SP
P09474648A0298|13 19|P-SAECG
P09474648A0298|32 46|frequency domain
P09475378A1449|18 41|transcription-polymerase
P09475378A1449|58 61|HPLC
P09475378A1449|80 90|RUSH-1alpha
P09475724T0000|0 3|TOR2
P09475898T0000|13 25|amnioinfusion
P09476399A0141|0 6|SETTING
P09476520A1326|177 189|heterogeneity
P09477316A0140|38 44|Hox gene
P09477316A0140|81 87|Hox gene
P09477316A0140|101 139|leucine zipper transcription factor MafB/Kr
P09478921A0126|52 63|pathogenesis
P09478921A0126|66 68|CML
P09478971A1896|72 74|AhR
P09478971A1896|97 108|TCDD-induced
P09478971A1896|121 126|Cyp1B1
P09478976T0000|21 25|c-Fos
P09478976T0000|60 70|AP-1 element
P09478976T0000|97 123|metalloproteinase-1 promoter
P09478976A0718|117 119|OSM
P09479498A0000|23 43|RING-finger gene (RNF4)
P09480831A0272|40 41|AM
P09480831A0272|77 93|5'-flanking region
P09480831A0272|96 101|AM gene
P09480831A0272|137 147|cells (HAEC)
P09480843A0848|3 21|COOH-terminal region
P09480843A0848|68 71|(GCT
P09480843A0848|143 149|rat RL14
P09480929T0000|7 30|FasR ligand-binding domain
P09480929T0000|69 78|non-fusion
P09482107A0551|52 54|C3G
P09482107A0551|110 112|C3G
P09482107A0551|171 176|NIH3T3
P09482902A0423|0 7|C.D2-Chr
P09482902A0423|33 44|DBA/2 alleles
P09482902A0423|81 85|DBA/2
P09482902A0423|109 117|CDK4/CDK6
P09482902A0942|14 29|wild-type (DBA/2)
P09482902A0942|38 42|A134C
P09482902A0942|46 65|G232A BALB/c-specific
P09482902A0942|130 150|cyclin D2/CDK4 in kinase
P09482902A0942|270 275|BALB/c
P09482902A0942|311 320|p16(INK4a)
P09484781A1233|90 96|PKB/Akt
P09485308A1165|3 5|FMN
P09485308A1165|21 28|[3Fe-4S]
P09486035A0051|0 6|METHODS
P09486531A0638|6 18|organogenesis
P09486531A0638|7 24|rganogenesis, HFH-8
P09486531A0638|156 171|gut morphogenesis
P09487130A0383|90 92|DNA
P09487841A0132|3 6|ESEM
P09487841A0132|30 32|SEM
P09488441A0615|34 66|immunoglobulin kappa-chain enhancer
P09488441A0615|69 95|P-selectin promoter NF-kappaB
P09488441A0615|132 149|P-selectin promoter
P09488466A0695|35 49|full-length mRNA
P09488486A0000|3 29|TATA box-binding protein (TBP)
P09488486A0000|82 105|tic nuclear RNA polymerases
P09488486A0000|92 105|RNA polymerases
P09488486A0000|93 122|NA polymerases, polymerases (Pol)
P09488486A0000|125 126|II
P09488486A0000|131 133|III
P09488486A0906|1 16|triple-mutant TBP
P09488486A0906|17 22|(R231E
P09488486A0906|24 28|R235E
P09488486A0906|30 35|R239S)
P09488486A0906|64 79|yeast U6 snRNA gene
P09488486A0906|119 120|II
P09488491A0000|0 2|E2F
P09488713A0886|93 107|full-length SCAP
P09488725T0000|36 49|57-kDa subunits
P09488725A0904|37 39|SFD
P09488725A0904|54 71|57-kDa polypeptides
P09489670A1157|4 16| albicans, HST6
P09489670A1157|132 135|HST6
P09491074A0104|78 91|promoter region
P09492038A0352|39 56|cis-acting elements
P09492038A0352|87 99|exon 2 promoter
P09492038A0352|126 136|mutagenesis
P09492038A0352|147 157|protein-DNA
P09494078A1362|6 18|5HT5A receptor
P09495283A0000|14 35|reporter gene (beta-gal)
P09495283A0000|95 99|(HSF1
P09495283A0000|103 107|HSF2)
P09495283A0000|110 113|HeLa
P09495283A0000|129 142|(Saccharomyces
P09495771A0379|97 100|FtsK
P09498553T0000|34 64|sterol 14-demethylase P450 (CYP51)
P09498553T0000|82 98|P450 monooxygenase
P09498553A0702|2 5|TATA
P09498553A0702|30 43|promoter region
P09498553A0702|56 57|GC
P09498553A0702|141 149|CYP51 gene
P09499031A0000|41 60|stomatitis virus (VSV)
P09499031A0000|77 92|sequence elements
P09499048A1003|16 27|virus progeny
P09499048A1003|58 70|gK-expressing
P09499048A1003|91 92|gK
P09499061A0000|11 13|DNA
P09499061A0000|48 89|immunodeficiency virus type 1 (HIV-1) integrase
P09499061A0000|133 140|HIV-1 DNA
P09499254A1309|3 5|DSF
P09501093A0071|15 21|mitogen
P09501093A0071|31 48|protein (MAP) kinase
P09501169A0000|76 92|histone acetylases
P09501169A0000|96 107|deacetylases
P09501982A1178|0 10|CONCLUSIONS
P09501982A1178|1 16|ONCLUSIONS: XCoe2
P09501982A1178|120 130|Delta-Notch
P09501982A1178|121 146|elta-Notch signalling, XCoe2
P09501982A1178|191 200|progenitor
P09501982A1178|357 363|XNeuroD
P09502627A0705|0 6|RESULTS
P09502627A0705|160 177|peak creatine kinase
P09502627A0705|217 238|ejection fraction (LVEF)
P09502720T0000|102 110|CyIIa gene
P09502720A0214|0 4|CyIIa
P09503017A1021|30 34|HYAL1
P09503526A0614|65 76|diseases WFAg
P09504423A0114|26 35|4E-BP1 gene
P09504423A0114|103 113|[BL21(DE3)]
P09504423A0114|117 126|fusion gene
P09504423A0114|134 167|glutathione-S-transferase (GST) gene
P09504423A0114|185 211|gene fusion vector (pGEX-4T-2)
P09504423A0114|272 279|protease
P09504423A0114|273 294|rotease, alpha-thrombin
P09504514T0000|141 146|MRC AML
P09504906A0099|109 125|DNA-binding domain
P09506439A2179|0 8|PKC-gamma
P09506439A2179|81 95|TPA-independent
P09506439A2179|121 124|SVHK
P09506959T0000|43 62|DNA-binding complexes
P09506959T0000|85 95|Myc/Max/Mad
P09506962A1000|46 47|II
P09506962A1000|101 103|YY1
P09506983A0304|28 31|RACE
P09506983A0304|69 72|RACE
P09506990T0000|5 8|ZFM1
P09506990T0000|63 91|transcription activation domain
P09507032A1144|16 31|CSF1R/IRDelta960
P09507032A1144|51 58|CSF1R/IR
P09507032A1144|70 74|CSF-1
P09508119A0498|0 10|CONCLUSIONS
P09508377A0863|33 34|UV
P09508511A0588|109 114|urease
P09508775A0293|3 25|cAMP-dependent mitogenic
P09508775A0293|60 89|mitogen-activated protein kinase
P09508775A0293|178 205|protooncogenes/transcription
P09509226A1235|0 10|CONCLUSIONS
P09509226A1235|88 90|ICU
P09510189A0192|19 29|exon-intron
P09510189A0192|58 65|CD58 gene
P09510189A0192|92 100|kilobases
P09510189A0192|107 120|5'-flanking DNA
P09510582A0157|40 43|DCBM
P09510582A0157|80 82|geG
P09510582A0157|87 96|mg (geG-25)
P09510582A0157|90 92|geG
P09510582A0157|106 115|mg (geG-50)
P09510582A0157|119 121|HBB
P09510925A0389|5 32|haemoglobin concentration (Hb)
P09510925A0389|44 50|12 g dL-1
P09511724A0483|85 104|calcium (0.05-0.07 mM)
P09511760A0221|9 56|striction enzyme analysis, Southern blots, polymerase
P09511760A0221|81 83|DNA
P09511760A0221|160 168|cHO-1 gene
P09512416A0460|0 6|RESULTS
P09512416A0460|29 41|dbEST database
P09512416A0460|78 106|Arabidopsis thaliana gene (GCR1)
P09512416A0460|144 167|membrane-spanning domains
P09512416A0460|200 211|7TM receptors
P09512550T0000|0 2|E1A
P09512550T0000|12 35|apolipoprotein AI enhancer
P09512550T0000|64 67|pRb-
P09512550T0000|71 85|CBP-independent
P09512559T0000|38 77|nerve growth factor-luciferase reporter gene
P09513759A0716|45 53|serum iPTH
P09514156A1147|13 17|DNase
P09514156A1147|34 57|GC-response element region
P09514156A1147|69 90|GC receptor-GC complexes
P09514159A0562|13 39|hormone-coding gene promoters
P09514260A1083|229 236|EN motifs
P09514272A0482|14 17|MvaT
P09514272A0482|32 43|polypeptides
P09514272A0482|66 74|mass 15 kDa
P09514272A0482|70 74|15 kDa
P09514962A0841|17 22|14-kDa
P09514962A0841|39 42|MMTV
P09514962A0841|51 68|-cell lymphoma, EL-4
P09515031A1020|24 32|TGF-betaf
P09515031A1020|47 54|c-fos SRE
P09515031A1020|66 68|PKC
P09515031A1020|79 81|SRF
P09515032A1230|0 5|RT-PCR
P09515032A1230|19 25|p21 mRNA
P09515665T0000|33 47|AIDS-related CMV
P09515858A0000|0 9|BACKGROUND
P09515858A0000|37 54|neutrophil peptides
P09515921A1662|30 36|pca gene
P09515921A1662|76 84|pca operon
P09515924A0104|31 40|PDH complex
P09515924A0553|3 26|PDH complex-encoding genes
P09515924A0553|99 109|gene regions
P09516472A0292|66 74|TATA motif
P09516472A0292|87 97|Id4 promoter
P09517646A0149|18 27|generation
P09517646A0149|131 136|anti-H
P09517989A0476|40 42|CMV
P09517989A0476|46 48|HIV
P09517989A0476|64 66|CD4
P09518383A0000|0 9|BACKGROUND
P09518383A0000|10 12|AND
P09518383A0000|13 22|OBJECTIVES
P09518383A0000|46 58|diseases (STD)
P09518383A0000|82 96|sex workers (FSW)
P09518383A0000|201 203|STD
P09519757A0482|13 26|utations, D811N
P09519757A0482|38 42|R835C
P09519757A0482|76 102|nucleotide-binding fold (NBF)
P09519757A0482|134 137|SUR1
P09519828A0809|9 15|VP16-E2
P09519828A0809|87 102|BPV-4 LCR promoter
P09519828A0809|118 140|E2 transactivation domain
P09519830A0282|74 78|HSV-1
P09519830A0282|111 119|generated
P09519830A0282|144 159|ICP34.5 promoters
P09519830A0282|187 230|chloramphenicol acetyltransferase reporter gene
P09519830A0282|250 268|thymidine kinase gene
P09521907A0190|37 44|Otx genes
P09521909A0081|0 7|APETALA3
P09521913A0400|29 35|60A gene
P09521913A0400|55 70|TGF-beta-related
P09523478A0572|3 13|ddition, IgM
P09523551A0367|65 89|G protein-coupled receptors
P09524122A0336|21 24|GPA2
P09524122A0336|65 72|RAS genes
P09524222A0769|3 15|COOH-terminus
P09524222A0769|114 123|cell alpha-
P09524222A0769|127 146|beta-adducin subunits
P09524222A0769|186 191|MARCKS
P09524222A0769|241 253|protein kinase
P09524222A0769|259 280|alcium/calmodulin. beta
P09524222A0769|320 342|calmodulin binding domain
P09524222A1113|0 2|PCR
P09524222A1113|31 49|beta-adducin isoform
P09524222A1113|96 99|NT-2
P09524229A0000|24 36|enzyme laccase
P09524229A0000|285 311|inhibitor cycloheximide (CHX)
P09524250A0767|4 19|TRE-like elements
P09524250A0767|40 42|AP1
P09524259A0301|52 56|IGFIR
P09524259A0301|70 98|kinase-negative mutant receptor
P09524259A0301|129 147|insulin receptor (IR)
P09524267A1023|88 122|ocalization signal, DNA-binding domain
P09524267A1023|126 139|helicase motifs
P09524267A1023|180 182|RNA
P09524273A0205|42 52|mouse gC1qBP
P09524276A0939|0 3|LysR
P09524276A0939|35 40|urease
P09524276A0939|43 66|Klebsiella aerogenes (NAC)
P09524276A0939|71 78|catalase
P09524276A0939|96 101|(OxyR)
P09525598A0325|15 23|Raf kinase
P09525598A0325|98 118|Raf (Raf(delta26-303))
P09525888A1482|0 14|Full-length FLAP
P09525888A1482|51 60|muscle cDNA
P09525891T0000|20 33|pbx homeodomain
P09525891T0000|67 95|cAMP-responsive sequence (CRS1)
P09525891T0000|106 110|CYP17
P09527921A1178|16 35|DNA-protein complexes
P09527921A1178|86 88|WDV
P09527921A1178|108 118|core element
P09527921A1178|247 250|TATA
P09528766A0915|27 33|ERK/RSK
P09528766A0915|40 55|p38/MAPKAP kinase
P09528766A0915|84 98|NGF-induced CREB
P09528768A0000|63 75|reticulum (ER)
P09528768A0000|122 132|ER-resident
P09528770A1379|3 42|RAS-cyclic AMP-dependent protein kinase cAPK
P09528770A1379|61 63|UAS
P09528770A1379|74 77|IREu
P09528770A1379|178 180|UAS
P09528784A0000|3 11|mei4+ gene
P09528792A0000|21 59|fibroblast growth factor receptor 2 (FGF-R2)
P09528792A0000|114 122|exons IIIb
P09528792A0000|126 129|IIIc
P09528858A0205|36 39|CpGs
P09528950A0716|41 62|luciferase reporter gene
P09528987A1348|27 48|T/EBP promoter-reporter
P09528987A1348|64 68|T/EBP
P09528987A1348|94 98|HepG2
P09528987A1348|122 126|T/EBP
P09528987A1348|196 204|T/EBP gene
P09529156A1238|44 46|PKC
P09530251A0766|0 3|SNAC
P09530251A0766|6 8|PBS
P09530251A0766|91 101|reperfusion
P09531538A0983|24 41|enhancer-dependent
P09531538A0983|69 83|dU2AF38 RS domain
P09531549A0658|26 34|GST fusion
P09531549A0658|88 94|yAP180A
P09531549A0658|107 120|lathrin. yAP180
P09531559A1153|50 55|130-kD
P09531559A1153|84 87|ZO-1
P09531559A1153|132 135|ZO-2
P09533030T0000|25 26|II
P09533030T0000|28 67|succinate-ubiquinone oxidoreductase): cDNA
P09533030T0000|153 158|(SDHC)
P09533030T0000|167 180|(SDHD) subunits
P09535082A0537|115 118|PrfA
P09535082A0537|133 145|complex (CIII)
P09535082A0537|158 161|PrfA
P09535082A0537|176 178|DNA
P09535082A0537|205 227|PrfA-Paf-DNA complex (CI)
P09535579A1105|113 116|EPOC
P09535579A1105|130 131|kJ
P09535833A0228|31 36|m-Staf
P09535833A0228|75 96|selenocysteine tRNA gene
P09535835A0279|0 5|ROCK-I
P09535835A0279|19 23|mDia2
P09535835A0279|53 56|RhoA
P09535835A0279|68 80|GTP-dependent
P09535851A0591|22 32|beta isoform
P09535851A0591|62 77|PtdIns(4)P kinase
P09535851A0591|92 103|gamma isoform
P09535892A0000|3 13|beta subunit
P09535892A0000|95 123|an amino-terminal alpha-helical
P09535892A0000|166 176|WD (Trp-Asp)
P09535908A0321|26 36|LNX messages
P09535908A0321|92 101|80 kDa (LNX)
P09535908A0321|105 116|70 kDa (LNX-b)
P09536028A0945|61 74|cyclooxygenase
P09536028A0945|121 122|TF
P09536028A0945|126 128|EGF
P09537295T0000|21 28|androgen
P09537295T0000|84 113|rat androgen-binding protein gene
P09537295A0951|78 101|transcriptase-polymerase
P09537295A0951|170 173|cDNA
P09537361A0149|47 50|cvaA
P09537375A0198|3 6|gntR
P09537375A0198|49 64|gntT::lacZ fusion
P09537375A0198|105 108|GntR
P09537375A0198|133 136|gntT
P09537378A1227|58 65|gcv-lacZ
P09537651A0366|8 16|ites, PEA3
P09537651A0366|20 23|STAT
P09537651A0366|125 164|phorbol ester phorbol myristate acetate (PMA)
P09538156A0130|0 4|BRCA1
P09538156A0130|22 50|amino-terminal zinc finger motif
P09538220A0000|54 60|tRNAPhe
P09538220A0000|64 75|tRNAPro genes
P09538220A0000|91 100|DNA (mtDNA)
P09539721A0599|24 27|DnaA
P09539721A0599|41 51|beta subunit
P09539721A0599|54 66|RNA polymerase
P09539721A0599|88 97|pR promoter
P09539746A0781|12 17|Bcl-XL
P09540062A0755|51 52|II
P09540062A0755|149 168|H4 promoter/CAT fusion
P09541280A0404|9 17|plasma IgE
P09541280A0404|39 40|NC
P09541280A0404|62 66|FK506
P09541280A0404|85 93|plasma IgE
P09541636T0000|0 20|Creatine kinase release
P09541721A0894|17 50|ischemia/angiotension II-induced AHF
P09541721A0894|18 59|schemia/angiotension II-induced AHF model, NIC
P09541721A0894|84 111|end-diastolic pressure (LVEDP)
P09544987A1583|24 33|RU486-PR-B
P09544987A1583|57 60|NCoR
P09544991A0483|0 10|PRL receptor
P09544991A0483|24 28|SHP-2
P09544991A0483|40 58|tyrosine phosphatase
P09544991A0750|27 31|SHP-2
P09544991A0750|89 99|DNA-binding
P09544991A0750|110 117|m-Stat5a
P09544991A0750|111 126|-Stat5a, m-Stat5b
P09544991A0750|166 181|m-Stat5adelta749
P09544991A0750|220 227|m-Stat5a
P09544991A0750|231 238|m-Stat5b
P09545146A0884|0 10|CONCLUSIONS
P09545146A0884|79 85|CBZ Cl/F
P09545146A0884|108 126|age-related decrease
P09545146A0884|129 132|Cl/F
P09545293A0590|36 46|a homologous
P09545312A1197|38 42|HMG-I
P09545312A1197|70 82|SRF-dependent
P09545323T0000|0 12|ATP-dependent
P09545323T0000|51 53|DNA
P09545323T0000|68 81|yeast MSH2-MSH6
P09545323T0000|85 109|MLH1-PMS1 protein complexes
P09545332A0137|68 98|insulin receptor substrate 1 (IRS1)
P09545332A0137|137 140|IL-4
P09545353A1071|28 41|kappaB elements
P09545353A1071|53 101|activating transcription factor/cAMP response element
P09545353A1071|138 151|E-selectin gene
P09545353A1071|170 179|TNF-alpha-
P09545353A1071|182 194|LPS-inducible
P09545638T0000|51 76|arginine methyltransferases
P09545638T0000|77 84|(HRMT1L1
P09545638T0000|88 95|HRMT1L2)
P09545638A0330a|30 62|yeast hnRNP methyltransferase (HMT1)
P09545638A0330b|30 62|yeast hnRNP methyltransferase (HMT1)
P09545638A0330a|30 56|yeast hnRNP methyltransferase
P09545638A0330b|30 56|yeast hnRNP methyltransferase
P09545638A0330a|30 56|yeast hnRNP methyltransferase
P09545638A0330b|30 39|yeast hnRNP
P09545638A0330a|30 39|yeast hnRNP
P09545638A0836|11 17|HRMT1L2
P09545638A0836|66 82|methyltransferase
P09545638A1181|18 24|HRMT1L1
P09545638A1181|28 34|HRMT1L2
P09546424A1550|26 42|PDGF beta-receptor
P09547311A1394|45 54|endogenous
P09547349A0000|3 83|ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3
P09548481A0000|36 47|promoter (P1)
P09548481A0000|98 111|IL-5Ralpha gene
P09549179A0774|67 74|p,p'-DDE
P09549398A1463|70 73|SPET
P09549398A1463|105 136|rest/reinjection thallium-201 SPET
P09549632A1189|83 85|ALT
P09550591A0454|70 75|cmH2O)
P09550591A0454|131 134|OSAS
P09550919A0365|109 112|PSVT
P09551096A0108|0 3|RNAs
P09551182A0212|75 84|endogenous
P09551182A0212|149 169|transactivation domain
P09551182A0212|181 192|acid receptor
P09551182A0212|209 224|DNA binding domain
P09551938A0318|79 94|CCR5 gene promoter
P09551972A1033|33 41|metaphase
P09551972A1033|73 106|hybrid cell line 706-B6 clone 17 (CL-17)
P09551972A1033|111 122|cosmid c101F1
P09551972A1033|133 140|9804 gene
P09552469A0225|54 77|x-ray diffractometry (XRD)
P09552469A0225|87 90|(IR)
P09552469A0225|125 137|analysis (DTA)
P09553040A0651|78 87|PI-3 kinase
P09553040A0651|79 97|I-3 kinase, PLC-gamma
P09553134A0596|55 68|tyrosine kinase
P09553134A0596|93 95|PP1
P09553143A0729|8 13|ZAP-70
P09553143A0729|9 29|AP-70 substrate, SLP-76
P09553143A0729|146 149|H2O2
P09553686A0000|37 40|(CAS
P09553686A0000|61 64|(CAS
P09553686A0000|203 221|absorption enhancers
P09553686A0000|288 291|7D")
P09556561A0671|8 19|H/ACA snoRNAs
P09556561A0671|70 76|snoRNAs
P09556561A0671|148 158|the pre-rRNA
P09556566A0174|9 29|vitamin D receptor (VDR)
P09556566A0174|44 71|acid Xalpha receptor (RXRalpha)
P09556566A0174|82 93|T cell line MT2
P09556573A1062|33 75|PPARalpha ligand 8(S)-hydroxyeicosatetraenoic
P09556573A1062|112 120|PPARalpha
P09556573A1062|128 146|co-activator RIP-140
P09556573A1062|175 183|PPARalpha
P09556573A1062|191 206|co-repressor SMRT
P09556861A1018|64 65|OA
P09556861A1018|157 159|ATP
P09556861A1018|176 190|tRNA-synthetase
P09557678A0140|54 93|papillomavirus type 1 (BPV1) E2 protein in HeLa
P09557678A0140|97 100|HT-3
P09557678A0140|181 189|G1/S phase
P09557682A0490|20 25|(hGli2
P09557682A0490|27 35|lpha, beta
P09557682A0490|141 148|DNA motif
P09557682A0490|142 154|NA motif, TRE2S
P09557682A0490|161 163|LTR
P09557708A1426|31 33|IEV
P09557708A1426|148 156|vA33delta
P09557912A0699|9 11|IOP
P09557912A0699|19 21|(SD
P09557912A0699|26 29|mmHg
P09557912A0699|63 65|(SD
P09557912A0699|70 73|mmHg
P09557912A0699|136 138|(SD
P09557912A0699|143 146|mmHg
P09557912A0699|210 212|(SD
P09557912A0699|217 220|mmHg
P09557912A0699|254 256|(SD
P09560221A0282|1 4|cDNA
P09560221A0282|2 11|DNA, cak1At
P09560221A0282|41 43|CAK
P09560221A0282|89 103|fission yeast CAK
P09560221A0282|90 116|ission yeast CAK mutant. cak1At
P09560221A0282|141 150|animal CAKs
P09560325A1285|112 131|protein heterogeneity
P09560430A0000|47 53|a/alpha
P09561560A0579|17 22|BALB/c
P09561560A0579|44 56|Mengo virus SIV
P09561560A0579|84 86|CTL
P09561560A0579|106 112|SIV gene
P09561560A0579|135 141|HIV-Nef
P09561560A0579|166 168|CTL
P09561560A0579|195 208|HIV1 Nef peptide
P09562398A0848|37 39|AUC
P09562558T0000|22 43|IRF-2 DNA-binding domain
P09564860A2139|3 20|ontrast, receptor/G
P09564860A2139|68 80|loop 3i domains
P09564860A2139|111 143|to G(i/o) proteins (M2Ach-muscarinic
P09564860A2139|147 174|alpha2A-adrenergic receptors)
P09564860A2315|51 59|rat GnRH-R
P09564860A2315|128 135|GGH(3)1'
P09564917A0900|17 34|alpha2-antiplasmin
P09564917A0900|82 85|U/mL
P09565576T0000|28 43|DNA topoisomerase
P09565584A0770|16 29|mino acids, KKKR
P09565584A0770|17 39|ino acids, KKKR, generated
P09565584A0770|152 155|4.1H
P09565584A0770|173 196|site-directed mutagenesis
P09565606A0520|31 33|III
P09565606A0520|49 52|repY
P09565606A0520|70 80|5'-rCGCC-3'
P09565606A0520|95 98|repZ
P09566731A0458|57 90|chromosome 16p12.1-p11.2 (homologous
P09566871T0000|52 81|mitogen-activated protein kinase
P09566871A0343|25 30|Ty1 RNA
P09566871A0343|104 107|FUS3
P09566871A0343|138 140|TyA
P09566871A0343|139 150|yA, integrase
P09566871A0343|162 174|transcriptase
P09566871A0343|186 192|Ty1 cDNA
P09566876A0000|10 38|transcription factor IIA (TFIIA)
P09566876A0000|55 77|TATA binding protein (TBP)
P09566876A0000|81 91|promoter DNA
P09566918A1115|17 23|Ser-Thr
P09566918A1115|50 61|Asp generated
P09566918A1115|89 93|IRF-3
P09566918A1115|151 161|PRDI-PRDIII
P09566918A1115|164 167|ISRE
P09570107A0355|10 20|PCDFs/PCDDs
P09570107A0355|28 30|ESP
P09570133A0474|12 22|DNA-protein
P09570133A0474|112 121|ETS-domain
P09570944T0000|14 20|67 exons
P09570944T0000|24 26|YAC
P09570944T0000|64 83|resistance gene region
P09570952A0000|11 21|exon-intron
P09571563A0000|0 6|PURPOSE
P09571563A0000|62 77|keratectomy (PRK)
P09572428A0526|0 17|Mean+/-SD serum VEGF
P09572428A0526|55 56|(P
P09572428A0526|75 77|PCO
P09572428A0526|81 84|PCOS
P09572491A1044|50 56|p53 gene
P09572491A1044|67 70|(p53
P09572511A0148|22 28|RBI-MAP
P09572511A0148|64 73|EM (RBI-EM)
P09572965A1235|6 8|ORF
P09572965A1235|7 13|RF, ORF5
P09572965A1235|32 39|gene agrB
P09572990A0630|20 23|hSIE
P09572990A0630|38 42|MHC-I
P09572990A0630|130 133|hSIE
P09573187T0000|35 56|LysR-type regulator CatR
P09573202A0900|40 51|alpha subunit
P09573202A0900|131 146|N-terminal domain
P09573244A0523|8 11|mRNA
P09573374A0687|55 57|YAC
P09573374A0687|118 124|RIL gene
P09573374A0687|148 155|IRF1 gene
P09573378A0761|70 72|28S
P09573378A0761|82 84|RNA
P09573884A0392|18 31|position (S-N-B
P09573884A0392|35 42|S-N-Pog)
P09573884A0392|88 89|II
P09574799A1072|178 190|helminthiases
P09575143A1189|17 22|ZAP-70
P09575143A1189|75 91|SRC-family kinases
P09575143A1189|135 178|immunoreceptor tyrosine-based activation motifs
P09575143A1189|184 186|TCR
P09575187A1558|16 24|NF-kappaB
P09575187A1558|55 70|ER calcium release
P09575187A1558|103 111|sAPPalpha
P09575187A1558|167 180|kappaB decoy DNA
P09575217A0000|4 20|cytokine receptors
P09575217A0000|27 59|Janus protein tyrosine kinases (Jaks)
P09575217A0000|95 114|transcription (Stats)
P09575217A0971|1 18|site-directed R618K
P09575217A0971|32 45|Stat5 SH2 domain
P09576230T0000|17 29|oxide synthase
P09576230T0000|41 51|reperfusion
P09576915A0269|28 30|HMR
P09577365A0747|75 76|IV
P09577395A0000|39 43|(VOR)
P09578042A0363|85 93|SEEG/ECoG
P09578042A0363|131 147|lobe epilepsy (TLE)
P09578570A0200|102 104|PCR
P09578570A0200|120 131|leukocyte DNA
P09579602A1720|63 66|CD34
P09579808A0000|0 69|UDP-GlcNAc:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase
P09579808A0000|70 71|II
P09579808A0000|72 75|(GnT
P09579808A0000|76 77|II
P09579808A0000|79 80|EC
P09580700A0841|3 5|DNA
P09580700A0841|89 103|CIRs (CIR3-CIR6)
P09580700A0841|145 149|DNase
P09581552A1323|34 54|tetramerization domain
P09581775A0185|58 66|NF-kappaB
P09581775A0185|88 101|HIV-1-infected
P09581775A0185|114 126|U937 (U9-IIIB)
P09581775A0185|142 158|PLB-985 (PLB-IIIB)
P09581834A2578|61 76|anticarcinogenic
P09581834A2578|90 92|PCA
P09581834A2578|139 156|erbB1-SHC-mediated
P09581834A2578|185 189|CDKIs
P09582267A0326|27 47|SINA-homologous (Siah)
P09582267A0326|83 89|Siah-1A
P09582267A0326|141 145|GM701
P09582306T0000|16 22|Galphao
P09582306T0000|26 33|Galphai1
P09582327A0295|25 27|GH3
P09582327A0295|51 77|rat GnRH receptor cDNA (GGH3-1'
P09582327A0295|120 129|fusion gene
P09582327A0295|140 146|797 base
P09582327A0295|154 166|rat LHbeta gene
P09582327A0295|197 201|5 base
P09582327A0295|212 232|5'-untranslated region
P09582327A0295|240 276|a luciferase reporter (-797/+5LHbetaLUC)
P09582327A0295|289 293|a GnRH
P09582331A0506|3 19|5'-flanking region
P09582331A0506|54 57|TATA
P09582331A0506|69 72|CAAT
P09582331A0506|86 95|GATA-1/SP1
P09582343A0000|30 40|cell line SX9
P09582343A0000|52 72|carcinoma cell line FM3A
P09582350A0165|14 41|type IA maple syrup urine disease
P09582350A0165|46 59|E1alpha subunit
P09582350A0165|96 130|branched-chain ketoacid dehydrogenase
P09582635A0523|38 42|H.T.V
P09582635A0523|106 110|R.T.V
P09582953A0000|0 9|OBJECTIVES
P09582953A0000|20 60|coagulation factor VIII:coagulant (F.VIII:C)
P09582953A0000|64 91|C1-esterase inhibitor (C1-INH)
P09582953A0000|65 124|1-esterase inhibitor (C1-INH), hemostasis-associated acute-phase
P09582953A0000|144 171|coagulation factors VII (F.VII)
P09582953A0000|173 174|IX
P09582953A0000|175 180|(F.IX)
P09582953A0000|186 190|(F.X)
P09582953A0000|229 239|acute-phase
P09582953A0000|329 339|acute-phase
P09582953A1097|0 6|RESULTS
P09582953A1097|45 54|fibrinogen
P09582953A1097|76 83|alpha 2AP
P09582953A1097|115 116|PT
P09582953A1097|120 123|APTT
P09582953A1670|18 28|plasminogen
P09582953A1670|19 37|lasminogen, alpha 2AP
P09582953A1670|42 47|C1-INH
P09582953A1670|73 83|acute-phase
P09583208A0171|17 30|creatine kinase
P09583592A0263|0 5|DESIGN
P09583592A0263|6 8|AND
P09583592A0263|9 15|METHODS
P09583592A0263|10 20|ETHODS: Case
P09583823A0238|0 6|METHODS
P09583823A0238|92 95|TMLR
P09583823A0238|122 160|holmium:yttrium-aluminium garnet (Ho:YAG)
P09584165T0000|0 4|RACK1
P09584165T0000|27 33|C kinase
P09584165T0000|37 44|a homolog
P09584165T0000|50 60|beta subunit
P09584165T0000|91 108|src tyrosine kinases
P09584165T0000|120 125|NIH 3T3
P09584180A0701|7 32|IL-4-inducible reporter gene
P09584180A0701|68 77|endogenous
P09584180A0701|86 119|NF-kappaB proteins in IL-4-stimulated
P09584194A0000|0 3|HEF1
P09584194A0000|1 13|EF1, p130(Cas)
P09584194A0000|18 24|Efs/Sin
P09584194A0000|44 54|multidomain
P09584194A1305|59 62|HEF1
P09584194A1305|93 96|G2/M
P09584194A1305|161 164|HEF1
P09584194A1305|178 186|p55(HEF1)
P09585253A1147|32 38|raf-ERK
P09585253A1147|63 64|TF
P09585253A1147|159 160|TF
P09585253A1147|173 182|MDA-MB-231
P09586832A0229|53 67|5-HT1A receptors
P09587549T0001|37 51|interferon alpha
P09588228A0370|22 46|anticytokeratin 19 antibody
P09588228A0370|99 101|MPM
P09590540A0513|3 10|bZP2 cDNA
P09590540A0513|121 123|PCR
P09590540A0513|136 144|Sac1-Sal1
P09590540A0513|191 200|T5 promoter
P09590540A0513|229 235|a pQE-30
P09591221A0137|22 36|potentials (EPs)
P09591221A0137|80 96|90-140 ms range (P1)
P09592125A0000|6 26|alpha1,2-mannosidases
P09592168T0000|30 55|DNA binding domain (M98-F219)
P09592168T0000|63 96|nucleotide excision repair protein XPA
P09593302A1165|77 84|A-domain
P09594299A0468|0 6|RESULTS
P09595496A0000|30 47|endothelin-1 (ET-1)
P09596536A0219|55 57|ACL
P09596536A0219|91 111|cartilage degeneration
P09596638T0000|23 42|Brassica S locus region
P09596738T0000|10 61|Candida albicans mitogen-activated protein kinase homolog
P09598205A0430|58 69|beta-alanine
P09599102A1191|67 85|Cu(I) transport genes
P09599102A1191|112 115|CUP1
P09599664A0881|3 5|DNA
P09599664A0881|61 68|RXR alpha
P09599664A0881|72 78|RXR beta
P09599724A0193|109 112|PCDD
P09599724A0193|116 128|PCDF congeners
P09599724A0193|165 168|PCDD
P09599724A0193|172 175|PCDF
P09599897A0000|48 75|Henoch-Schonlein purpura (HSP)
P09599897A0000|165 178|blood cell (WBC)
P09599897A0000|186 212|serum C-reactive protein (CRP)
P09599897A0000|187 232|erum C-reactive protein (CRP) levels, platelet (PLT)
P09599897A0000|276 278|HSP
P09601007A0223|197 201|CaCO3
P09601510A0215|38 47|FV pol genes
P09601516A0695|63 66|PEP1
P09601940A0280|24 30|CD1 gene
P09601940A0280|43 55|binding motifs
P09601940A0280|63 108|ytokine-inducible transcription factors, NF-IL2-A
P09601940A0280|112 117|NF-IL6
P09603345A1257|0 6|GLRaV-2
P09603345A1257|89 96|roup, BYV
P09605137A0677|20 24|c-Jun
P09605137A0677|61 73|IL-2 promoter-
P09605137A0677|77 97|CD28RE-driven reporter
P09605137A0677|114 119|LFA-3-
P09605930A1428|113 122|endogenous
P09605930A1428|123 129|ALS gene
P09605934A0801|4 23|E box sequence (CACGTG)
P09605934A0801|40 53|binding element
P09605934A0801|57 59|USF
P09606633A0523|0 13|Interferon beta
P09606924T0000|40 63|all-rac-alpha-tocopheryl
P09606924T0000|120 136|matrix solid-phase
P09609342A0000|49 57|pump (CFP)
P09609342A0000|65 77|flow pump (MFP)
P09609342A0000|89 101|flow pump (AFP)
P09609705A0895|29 38|bc1 complex
P09609705A0895|55 60|[Zhang
P09609720A0357|67 74|nuclease
P09609720A0357|103 111|proteases
P09610755A1731|54 56|EXT
P09611016A0652|0 9|CONCLUSION
P09611229A1664|32 35|FAS1
P09611229A1664|38 50|nmt1-451Dino2
P09611234A0098|0 18|Rev-erbAalpha/beta)
P09611234A0098|28 38|Mad bHLH-zip
P09611234A0098|53 68|oncoproteins PLZF
P09611234A0098|72 80|LAZ3/BCL6
P09611234A0098|96 112|corepressors N-CoR
P09611234A0098|116 119|SMRT
P09611877A0455|23 25|CSF
P09611877A0455|39 42|ECHO
P09611877A0455|44 52|0 (9), ECHO
P09611877A0455|59 62|ECHO
P09612351A0386|53 55|ULF
P09612775A0726|3 13|ParaSight-F
P09613574A0905|81 90|[3H]methyl
P09613574A0905|104 115|substrate DNA
P09613574A0905|121 124|MGMT
P09613946A0194|41 58|reversed-phase HPLC
P09613946A0194|82 86|mm I.D
P09614065A0966|108 111|EpRE
P09614065A0966|123 126|AP-1
P09614106T0000|43 61|48-base pair enhancer
P09614106T0000|67 76|Col2a1 gene
P09617765A0174|103 109|poly(A)
P09617807A0929|1 12|phylogenetic
P09617807A0929|33 51|transcriptase domain
P09617807A0929|175 192|Gypsy-like elements
P09618150A0127|27 58|insulin-like growth factor I (IGF-I)
P09618150A0127|91 111|dibutyryl cAMP (dbcAMP)
P09618150A0127|124 131|UCP1 gene
P09618150A0127|160 167|UCP1 mRNA
P09618150A1464|25 31|AP-1 DNA
P09618150A1464|94 98|MEK-1
P09618164A0709|12 52|2'- O -methyl oligoribonucleotides (2'OMeRNA)
P09618475A0747|19 34|CTD-binding motif
P09618481T0000|20 40|p21/WAF1/Cip1 promoter
P09619631A0344|0 6|RESULTS
P09619631A0344|20 31|. elegans cDNA
P09619631A0344|105 115|p120 Ras-GAP
P09619777A1583|100 112|pepsin (SGFsp)
P09620273A0189|111 113|E2F
P09620606A0000|45 47|TCR
P09620873A1710|33 44|luteal HSP-27
P09620873A1710|87 95|PKC-delta
P09620873A1710|134 136|PKC
P09620873A1710|162 165|sHSP
P09620955A0370|33 42|leader mRNA
P09620955A0370|133 144|promoterless
P09620955A0370|145 153|lac operon
P09621062A0810|65 88|site-directed mutagenesis
P09621062A0810|139 179|a chloramphenicol acetyltransferase reporter
P09621372A0369|67 69|CRP
P09621893A0000|83 102|alpha2-adrenoceptors
P09622055A0207|46 58|mammals (c-Cbl
P09622055A0207|75 89|. elegans (Sli-1)
P09622055A0207|108 114|(D-Cbl)
P09622121T0000|23 60|polypyrimidine tract binding protein (PTB)
P09622121T0000|124 132|pre-mRNAs
P09622121A0525|0 7|Anti-PTB
P09622121A0525|43 45|PTB
P09622121A0525|48 50|RNA
P09622121A0525|72 97|supershift RNA-PTB complexes
P09623830A0000|19 39|botulinum toxin (Botox)
P09625762A0426|8 21|oncoprotein E1A
P09625762A0426|30 43|NFAT-dependent
P09625807A0000|16 19|mRNA
P09625807A0000|64 68|mRNAs
P09626662A1076|22 23|TR
P09626662A1076|48 53|RIP140
P09626662A1076|59 68|RXR subunit
P09626662A1076|105 110|TR/RXR
P09627285A0160|0 6|SETTING
P09627285A0554|0 8|RESULT(S)
P09627285A0554|32 34|FSH
P09627285A0554|115 117|hMG
P09627598A0384|0 6|RESULTS
P09627598A0384|25 26|IS
P09627598A0384|91 94|OVAR
P09628375A0700|5 9|ePTFE
P09628419A0812|66 69|ISIs
P09628821A1194|18 24|KG1a EST
P09628890A0455|91 92|HA
P09629449A0540|18 20|ROS
P09629449A0540|90 100|PMN elastase
P09630245A0102|0 11|Yeast U1 snRNP
P09630245A0903|0 11|Yeast U1 snRNP
P09630245A0903|63 67|snRNP
P09630245A0903|86 95|homologues
P09630245A0903|101 124|metazoan U1 snRNP-specific
P09630245A0903|140 160|yeast-specific U1 snRNP
P09631366A0951|14 25|ycle, 18 cases
P09631366A0951|63 74|ycle, 13 cases
P09632217A0477|9 28|antagonist naltrexone
P09632217A0477|99 108|naltrexone
P09632637A0361|52 61|M6P/IGFIIR
P09632637A0361|84 97|M6P/IGFIIR mRNA
P09632637A0361|155 179|carbon tetrachloride (CCl4)
P09632637A0361|188 197|fibrogenic
P09632709A0464|3 6|cDNA
P09632709A0464|22 28|NCoA-62
P09632709A0464|39 46|2, 000-Da
P09632709A0464|75 78|BX42
P09632709A0464|125 149|in ecdysone-stimulated gene
P09632734A0081|34 49|C-terminal region
P09632734A0081|70 85|sequence homology
P09632734A0081|96 102|GDP/GTP
P09632734A0081|142 144|GTP
P09632734A0943|33 36|ERK2
P09632785A0000|3 28|pre-mRNA splicing factor U2AF
P09632785A0000|29 31|(U2
P09632785A0000|69 75|[snRNP]
P09633630A0740|86 93|(v/v) BMC
P09633630A0740|152 159|(v/v) BMC
P09635149A1148|13 16|PaO2
P09635276A1608|12 28|myosin phosphatase
P09636119T0000|19 27|generator
P09636119T0000|50 52|3-D
P09636358A0000|3 24|virus-associated VAI RNA
P09636358A0000|61 63|RNA
P09636358A0000|122 126|mRNAs
P09636670T0000|34 55|cyclin-dependent kinase
P09636708A0460|3 6|YccA
P09636708A0460|38 51|FtsH-dependent
P09636708A0460|85 90|YccA11
P09637689A0150|47 49|DNA
P09637689A0150|68 86|RNA polymerase (RNAP)
P09637689A0150|137 140|RNAP
P09638485A0111|33 43|acid (tt-MA)
P09638485A0111|47 88|leukocyte alkaline phosphatase activity (LAPA)
P09638650A0169|11 33|5'-noncoding region (NCR)
P09638650A0169|71 75|(ORFs
P09638650A0169|104 179|M(r) 160 kDa RNA-dependent RNA polymerase (ORF1), 26 kDa movement protein 1 (ORF2), 13 kDa
P09638650A0169|105 207|(r) 160 kDa RNA-dependent RNA polymerase (ORF1), 26 kDa movement protein 1 (ORF2), 13 kDa movement protein 2 (ORF3), 10 kDa
P09638650A0169|114 116|RNA
P09638650A0169|130 145|polymerase (ORF1)
P09638650A0169|131 173|olymerase (ORF1), 26 kDa movement protein 1 (ORF2)
P09638650A0169|132 201|lymerase (ORF1), 26 kDa movement protein 1 (ORF2), 13 kDa movement protein 2 (ORF3)
P09638650A0169|133 229|ymerase (ORF1), 26 kDa movement protein 1 (ORF2), 13 kDa movement protein 2 (ORF3), 10 kDa movement protein 3 (ORF4)
P09638650A0169|134 252|merase (ORF1), 26 kDa movement protein 1 (ORF2), 13 kDa movement protein 2 (ORF3), 10 kDa movement protein 3 (ORF4), 24 kDa coat protein (OFR5)
P09638650A0169|260 262|NCR
P09638793A1446|37 40|(Hct
P09638793A1446|57 60|LV MC
P09639074A0707|9 19|Sp3 isoforms
P09639074A0707|66 85|DNA-protein complexes
P09639074A0707|99 116|NF-kappaB-proximal
P09639558A0957|47 50|IgG-
P09639558A0957|54 67|IgM-sensitized
P09639565A0225|94 105|SV40 promoter
P09640802A0467|0 4|3--It
P09641167A1359|0 9|CONCLUSION
P09641167A1359|1 18|ONCLUSION: TNF alpha
P09641167A1359|2 26|NCLUSION: TNF alpha, TGF beta
P09641167A1359|3 31|CLUSION: TNF alpha, TGF beta, PDGF
P09641167A1359|35 42|IL-1beta
P09641167A1359|52 59|LDLr gene
P09641167A1359|85 110|rol-independent and mitogene
P09641167A1359|103 125|mitogenesis-independent
P09642042A0646|104 117|beta-phosphate
P09642200A0956|114 117|ahaK
P09642214A0244|30 61|protein-tyrosine phosphatase SHP-2
P09642214A0244|64 76|ErbB-mediated
P09642214A0244|89 124|mitogen-activated protein kinase (MAPK)
P09642214A0244|141 145|SHP-2
P09642214A0244|155 159|COS-7
P09642238A0532|22 47|erythroid-specific enhancer
P09642238A1285|3 23|intron 8 enhancer region
P09642238A1285|41 46|GATA-1
P09642238A1285|92 96|COS-1
P09642276A0881|18 25|caspases
P09642764A0469|32 34|QCM
P09642764A0469|216 218|QCM
P09643153T0000|0 9|[Treatment
P09643153T0000|24 26|T2N
P09643546A0436|57 80|sigmaA-dependent promoter
P09643548A0000|16 23|(2Fe-2S)
P09643548A0000|71 104|cyanobacterium Synechocystis PCC6803
P09645576A0148|0 2|RNA
P09645576A0148|5 9|GBV-C
P09645576A0148|44 46|BMT
P09645942A1164|12 35|Dsg-plakoglobin complexes
P09645942A1164|48 49|8S
P09645961A1158|34 41|CBF/NF-Y
P09645961A1158|55 59|CCAAT
P09645961A1158|109 116|nTPH gene
P09647233A0336|3 35|acrophages, LPS-inducible HIV-1 gene
P09647233A0336|73 80|NF-kappa
P09647233A0336|139 149|repeat (LTR)
P09647240A0000|14 16|p53
P09647240A0000|19 52|cytokine-triggered Janus kinase-STAT
P09647240A0000|84 96|hepatoma Hep3B
P09647240A0000|177 179|p53
P09649265A1575|0 10|CONCLUSIONS
P09649265A1575|43 52|ultrasound
P09649265A1575|222 229|serum PSA
P09649315A0943|28 41|resonance (NMR)
P09649315A0943|81 89|MIP-1 beta
P09649426A0636|14 16|PKA
P09649437A1140|45 50|C/EBPs
P09649437A1140|91 96|GATA-1
P09649438A0182|15 49|transcription elongation factor P-TEFb
P09649438A0182|63 72|CDK9 kinase
P09649438A0182|160 163|HeLa
P09649438A0182|188 193|P-TEFb
P09649501A0358|36 58|HSF1 trimerization domain
P09649501A0358|112 148|heat shock factor binding protein 1 (HSBP1)
P09649501A0358|255 258|HSF1
P09649537A0000|10 29|cDNA clones homologous
P09649537A0000|35 66|yeast GCN2 eIF-2alpha kinase (yGCN2)
P09650180A1130|83 88|100 mGy
P09650299A0000|0 4|VirD2
P09650299A0000|60 64|T-DNA
P09650299A1334|38 42|VirD2
P09650299A1334|77 81|T-DNA
P09650403A0868|3 7|DHEAS
P09650403A0868|36 38|BMD
P09650403A0868|90 92|BMD
P09651321A0000|11 28|cysteine proteinase
P09651367T0000|8 13|RalGDS
P09651367T0000|71 80|myogenesis
P09651375T0000|0 5|GTPase
P09651375T0000|29 33|RGS12
P09651375T0000|79 104|PDZ (PSD-95/Dlg/ZO-1) domain
P09651383A0967|22 26|HNF-4
P09651383A0967|40 50|element CIIB
P09651383A0967|66 70|HNF-4
P09651383A0967|82 86|HepG2
P09651383A0967|103 107|HNF-4
P09651383A0967|130 143|apoCII promoter
P09651383A0967|187 191|HNF-4
P09651383A0967|217 226|apoCII gene
P09652736A1205|21 25|E2F-1
P09652736A1205|45 48|p53-
P09652736A1205|116 121|E2F/DP
P09652736A1205|164 168|E2F-1
P09652737A1244|185 206|AP-1/DNA binding complex
P09652742A0455|33 35|p53
P09652742A0455|114 123|MMTV-c-myc
P09653182A1298|29 43|virus RNAs (BSMV)
P09653182A1298|69 76|MStV mRNA
P09653182A1298|83 92|RNA-primed
P09653641A0471|53 62|start codon
P09653648A0445|12 15|cDNA
P09653648A0445|47 56|ZNF189 gene
P09653648A0445|103 111|t four exon
P09653648A0445|152 167|zinc finger domain
P09655248A0000|3 21|gp330/Megalin/LRP-2
P09655248A0000|41 74|low-density lipoprotein receptor gene
P09655916A0415|5 7|DNA
P09655916A0415|32 33|II
P09655916A0415|52 72|position 62 (N-terminal
P09657003T0000|38 64|RNA-dependent RNA polymerases
P09657003T0000|88 100|virus-like RNA
P09657003T0000|111 120|elm disease
P09657003T0000|165 178|virus-like RNAs
P09658104T0000|9 40|transcription start site core region
P09658104T0000|44 65|transcription factor YY1
P09658104T0000|96 109|repeat promoter
P09658122T0000|49 58|alpha-SNAP
P09658122T0000|50 63|lpha-SNAP, PC-1
P09658403A1207|15 18|KN62
P09658403A1207|91 93|CAT
P09658405A0000|3 11|Dax-1 gene
P09658769A0058|28 38|IFN alpha-2b
P09660823A0934|8 14|Ser/Thr
P09660823A0934|57 67|p70 S6 kinase
P09660836A0983|48 50|MEK
P09660836A0983|134 155|deltaN3-S218E/S222D MEK
P09660836A0983|164 171|PD098059
P09660838A0920|57 69|protein kinase
P09660838A0920|89 92|HSF1
P09661676T0000|36 39|IL-5
P09662339A0744|67 78|AP-1-binding
P09662339A0744|117 124|CD44 mRNA
P09662443A0402|83 94|caveolin gene
P09663062A0175|82 90|(Clearfil
P09663062A0175|86 101|arfil Liner Bond II
P09663062A0175|91 101|Liner Bond II
P09663062A0175|92 104|iner Bond II: LB
P09663062A0175|93 130|ner Bond II: LB II; Scotchbond Multi-Purpose
P09663062A0175|94 134|er Bond II: LB II; Scotchbond Multi-Purpose: MP)
P09664033A1204|102 108|snoRNAs
P09665720A0325|31 41|exonuclease
P09665720A0325|62 71|polymerase
P09665720A1145|76 86|exonuclease
P09665720A1145|112 121|polymerase
P09666103A0496|3 23|missense allele (P236S)
P09666103A0496|52 61|30 degreesC
P09666103A0496|69 83|missense alleles
P09666103A0496|84 89|(L173F
P09666103A0496|91 95|E225K
P09666103A0496|92 101|225K, S269L
P09666103A0496|105 110|E274K)
P09666114A0389|23 41|5'-regulatory region
P09666114A0389|56 68|c-met promoter
P09666114A0389|74 77|TATA
P09666114A0389|80 91|CAAT elements
P09666114A0389|113 115|G-C
P09668063A0274|129 153|Ras-transformed NIH3T3 (DT)
P09668098A0868|18 31|FGF-BP promoter
P09668098A0868|67 69|TPA
P09668098A0868|114 120|118 base
P09668119A0496|186 205|-74/-70 (5'-CTCCT-3')
P09669641A0425|23 31|serum PE-1
P09669641A0425|49 55|amylase
P09670912T0000|0 7|"Complex
P09670943T0000|0 33|B cell antigen receptor (BCR)-mediated
P09670943T0000|46 63|SHP-2-pp120 complex
P09670943T0000|82 97|Fc gamma RIIB1-BCR
P09671313A0334|28 29|MT
P09671464A0316|8 11|SNF1
P09671496A0557|26 30|c-Cbl
P09671496A0557|89 93|c-Cbl
P09671496A0557|90 114|-Cbl locus. c-Cbl-deficient
P09671576A0900|50 68|streak morphogenesis
P09671791T0000|30 65|platelet-derived growth factor receptor
P09671791T0000|109 132|acid-stimulated mitogenic
P09673037A0358|0 6|METHODS
P09673436A0898|3 35|anrenoate-treated rats, ANP infusion
P09673436A0898|75 79|(FENA
P09673436A0898|139 143|(FENA
P09675154A0690|46 51|GSD-Ib
P09675154A0690|72 107|utations: a four-base deletion/two-base
P09675154A0690|170 192|missense mutation (W118R)
P09675896A0959|12 25|carboxyl region
P09676349A0000|1 6|"Level
P09676349A0000|61 67|release
P09676349A0000|80 83|(CAS
P09676349A0000|84 117|58-55-9) preparation (Bronchoretard)
P09676419A0158|0 5|METHOD
P09676419A0158|187 190|(CAP
P09676419A0158|191 194|SX1)
P09676419A0158|219 243|serum immunoglobulin E (IgE)
P09676419A0158|222 242|um immunoglobulin E (IgE
P09676419A0158|273 283|solid-phase
P09677330A0584|3 41|PDE4A-subfamily-specific linker region LR1
P09677330A0584|53 56|UCR1
P09677330A0584|60 63|UCR2
P09677330A0584|92 94|LR2
P09677330A0584|106 109|UCR2
P09677405A0856|0 9|Pol32Delta
P09677405A0856|54 78|damage-induced mutagenesis
P09677410A1059|36 38|p53
P09677410A1059|65 67|HBV
P09677410A1059|100 114|HBV core promoter
P09677410A1059|122 143|liver-specific enhancer
P09677410A1059|144 145|II
P09677410A1059|149 151|HBx
P09677410A1059|198 200|p53
P09678579A0768|35 43|AtCP1 gene
P09678837A0736|152 159|serum IgE
P09679066A1352|46 47|SR
P09679066A1352|85 93|pre-mRNAs
P09679750A0304|74 111|anti-inflammatory drugs (cyclo-oxygenase
P09679750A0304|75 129|nti-inflammatory drugs (cyclo-oxygenase inhibitors; NSAIDs)
P09680994A0169|32 43|. hybrida gene
P09680994A0169|105 120|sequence homology
P09680994A0169|124 134|intron/exon
P09680994A0169|183 193|. mays r genes
P09681822A0520|9 15|c-erbB3
P09682897A0218|89 91|QRS
P09683576A0542|52 65|protease domain
P09683576A0542|53 81|rotease domain, Gln2526-Asp2527
P09685021A0127|0 6|METHODS
P09685021A0127|1 31|ETHODS: Millipore ultrafiltration
P09685021A0127|76 102|model lenticule materials.The
P09685226A0000|52 55|cAMP
P09685226A0000|110 142|hormone-related protein (PTHrP) gene
P09685226A0000|166 188|lung cancer cell line (BEN)
P09685346A0419|31 41|homeodomain
P09685346A0419|97 113|prolactin promoter
P09686344T0000|36 60|ornithine transcarbamylase
P09686603A0124|28 45|cis-acting elements
P09686603A0124|147 157|TCR beta gene
P09687498A1173|59 64|v-erbA
P09687498A1173|69 76|oncogene
P09687498A1173|89 102|c-ErbA/ TRalpha
P09687511A1091|16 18|FUS
P09687511A1091|31 54|BCR/ABL-expressing 32Dcl3
P09687511A1091|143 155|G-CSF-induced
P09688264A1029|47 49|UTR
P09689047A0253|69 142|sugar-nucleotide cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-Neu5Ac)
P09689047A0253|170 192|Golgi sialyltransferases
P09689919A1192|14 21|PEDF cDNA
P09689919A1192|68 71|PEDF
P09693035T0000|5 8|ULK1
P09693035T0000|16 37|serine/threonine kinase
P09693035T0000|47 58|UNC-51 kinase
P09693035T0000|62 86|aenorhabditis elegans: cDNA
P09693134A0782|128 130|DER
P09694034A0713|39 40|LI
P09694034A0713|131 132|LI
P09694514A0000|3 42|complement C3a anaphylatoxin receptor (C3aR)
P09694514A0000|81 103|chemoattractant receptor
P09694514A0000|120 129|C3a peptide
P09694514A0000|179 194|histamine release
P09694599A1355|0 10|CONCLUSIONS
P09694599A1355|35 43|IL-1alpha
P09694599A1355|47 54|IL-1beta
P09694725A0500|37 72|LPS-and IL-1-responsive element (LILRE)
P09694725A0500|151 166|IL-1beta promoter
P09694860A0498|3 18|C-terminal region
P09694860A0498|30 43|PTP-like domain
P09694860A0498|55 70|N-terminal region
P09694869A0932|41 45|STATs
P09694869A0932|66 76|p21 promoter
P09694869A0932|132 142|p21 promoter
P09694869A0932|190 208|STAT response element
P09694897T0000|3 15|heterogeneous
P09694897T0000|70 77|U6 snRNAs
P09694897T0000|92 115|affinity RNA binding domain
P09694897T0000|120 134|bZIP-like motif)
P09696164A0000|43 67|infant death syndrome (SIDS)
P09696819A0450|38 39|gE
P09696819A0450|45 69|vaccinia virus-based vTF7-3
P09696819A0450|106 127|reticulum (ER)-to-Golgi
P09696819A0450|142 165|hetero-oligomeric complex
P09698457A0778|31 45|Cux/CDPDeltaCR1
P09698457A0976|182 184|DNA
P09698512A0296|0 6|METHODS
P09701609A0116|65 71|(PhLOP1
P09701609A0116|75 81|PhLOP2)
P09701609A0116|114 123|Gbetagamma
P09701616A0108|7 51|transcriptase-polymerase chain reaction (RT-PCR)
P09701616A0108|90 92|DNA
P09701821A1108|38 41|opuE
P09703021A0000|3 51|nsects, arylalkylamine N-acetyltransferases (AANATs)
P09703213A0280|20 34|D1 antagonist SCH
P09703276A2346|59 73|carcinogenicity
P09703816A0139|0 4|IA-CT
P09704006A0224|0 8|Arnt3 mRNA
P09704569T0000|51 67|TR2 orphan receptor
P09704569T0000|81 95|steroid receptor
P09704857T0000|30 32|CD4
P09704857T0000|63 70|HIV/AIDS
P09704927A0479|0 4|E2F-6
P09704927A0479|34 37|E2Fs
P09704927A0479|61 63|DNA
P09704927A0479|99 108|box domains
P09705258A0837|3 8|IE13.1
P09705258A0837|75 76|IE
P09705258A0837|124 131|lacZ gene
P09705324A0213|0 4|DNase
P09705324A0213|85 98|factor-1 (HNF1)
P09705324A0213|105 140|CCAAT/enhancer-binding protein (C/EBP)
P09705324A0213|168 197|thyroid hormone response elements
P09705324A0213|212 218|215 base
P09705324A1602|19 32|rat Std promoter
P09705324A1602|53 59|(i) HNF1
P09705324A1602|63 67|C/EBP
P09705324A1602|106 115|rat Std gene
P09705324A1602|107 130|at Std gene; (ii) androgenic
P09705324A1602|179 183|OCT-1
P09705324A1602|187 199|C/EBP elements
P09705324A1602|231 237|(iii) AR
P09705324A1602|319 323|OCT-1
P09705324A1602|327 331|C/EBP
P09705324A1602|356 361|DNA-AR
P09705352A0879|29 46|Cdc19 (Mcm2) subunit
P09705352A0879|52 100|six-member minichromosome maintenance protein complex
P09705497A0227|3 15|yeast MMS2 gene
P09705497A0227|132 134|DNA
P09705564T0000|20 42|papillomavirus type 11 E5A
P09705564T0000|57 63|E1E4,E5
P09706565A1072|14 16|M/K
P09707498A0262|0 5|MK-801
P09708450A0648|131 135|G-CSF
P09708565A0000|128 150|radioimmunotherapy (RIT)
P09708565A0000|154 179|non-Hodgkin's lymphoma (NHL)
P09710582A0535|16 19|AP-1
P09710582A0535|38 67|mitogen-activated protein kinase
P09710582A0535|39 98|itogen-activated protein kinase pathway, as a dominant-negative MEK
P09710582A0535|96 98|MEK
P09710582A0535|103 123|MEK inhibitor (PD98059)
P09710582A0535|136 150|Rho-induced AP-1
P09710589A1111|0 23|Site-directed mutagenesis
P09710589A1111|46 50|(R82A
P09710589A1111|52 55|K85A
P09710589A1111|53 60|85A, K88A
P09710589A1111|65 69|V89A)
P09710589A1111|121 129|HTLV-1 LTR
P09710591A0981|98 106|MAP kinase
P09710591A0981|162 170|MAP kinase
P09710599T0000|22 52|mitogen-activated protein kinases
P09710599A0310|26 57|CSF-1 immediate-early response gene
P09710614T0000|42 44|CD2
P09710614T0000|125 148|phosphoinositide 3-kinase
P09710615T0000|7 18|SNAP-25-like
P09710615T0000|32 52|am3p, a syntaxin homolog
P09710621A0598|87 108|Neu juxtamembrane domain
P09710621A0598|149 161|interreceptor
P09710641A0000|48 69|domain (PD)/homeodomain
P09710641A0000|54 69|(PD)/homeodomain
P09710641A0000|70 73|(HD)
P09710641A0000|150 156|alphaB-
P09710641A0000|151 164|lphaB-, alphaA-
P09710641A0000|177 196|zeta-crystallin genes
P09712037A0470|157 207|immunoreceptor tyrosine-based activation motifs (ITAMs)
P09712037A0470|210 230|lymphocyte Ag receptors
P09712297T0000|3 24|prothrombin gene G20210A
P09712644T0000|30 38|GluR2 gene
P09712859A1110|12 17|NF-ATp
P09712859A1110|30 35|NF-AT4
P09712859A1110|70 84|HTLV-I-mediated
P09712898T0000|30 58|stress-activated protein kinase
P09712898T0000|59 68|(SAPK)/Jun
P09712898T0000|69 91|NH2-terminal kinase (JNK)
P09712898A0911|5 9|TRAF2
P09712898A0911|19 22|SAPK
P09712898A0911|59 72|protein kinases
P09712898A0911|60 76|rotein kinases: GCK
P09712898A0911|80 82|RIP
P09712915A0672|118 121|NF-Y
P09712919A0307|95 98|CREB
P09713584A1193|75 77|BMI
P09713990T0000|17 30|TP53 target gene
P09713990T0000|79 91|wild-type TP53
P09713996T0000|0 10|Cytogenetic
P09713996T0000|85 102|drug resistance gene
P09713996T0000|86 122|rug resistance gene, MDR1/P-glycoprotein
P09713996T0000|177 179|ALL
P09713996A0262|16 19|MDR1
P09714109A0000|0 9|BACKGROUND
P09714109A0000|93 110|nerve activity (SNA)
P09714109A0785|7 27|blood pressure increase
P09714109A0785|108 116|muscle SNA
P09714835A0345|10 37|eport, carboxypeptidase D (CPD)
P09714835A0345|104 130|carboxypeptidase E (CPE)-like
P09714835A0345|182 186|(Song
P09714835A0345|190 202|, Fricker, L.D.
P09715278A1079|0 11|RA-treatment
P09715278A1079|89 105|RA-regulated genes
P09715278A1079|154 159|NT2/D1
P09715278A1526|94 97|FGF4
P09716179A0974|0 8|RXR-gamma
P09716179A0974|57 74|RA-responsive genes
P09716179A0974|87 130|cyclin-dependent kinase inhibitors p21Cip1/WAF1
P09716179A0974|134 140|p27Kip1
P09716179A0974|169 178|cdk2 kinase
P09716179A0974|190 191|RB
P09716183A1036|0 2|TBP
P09716183A1036|83 86|ERK2
P09716183A1036|123 131|ERK kinase
P09716183A1036|151 173|TBP amino-terminal domain
P09716435A1004|9 13|CR/PP
P09716435A1004|25 26|HS
P09716435A1004|136 140|PR/CP
P09717246A0526|9 11|ILC
P09717246A0526|15 18|ILVF
P09717246A0526|125 127|ILC
P09717246A0526|149 152|ILVF
P09717835A0941|32 37|xIRS-u
P09717835A0941|57 59|IRS
P09717835A0941|77 90|Xenopus homolog
P09717887A0239|50 56|VO2peak
P09717887A0239|77 98|occlusive disease (PAOD)
P09717887A0239|172 178|VO2peak
P09718372T0000|17 34|MAPKKK-independent
P09718372T0000|71 88|Sty1/Spc1 MAP kinase
P09718671A0000|14 29|Injury Scale (AIS)
P09718671A0000|53 57|TRISS
P09719636A1134|79 90|H382-X2-H385
P09719636A1134|99 110|H411-X2-H414
P09719636A1134|121 132|H430-X5-H436
P09719636A1134|156 175|histidine-rich region
P09721207A0637|103 115|vacillans gene
P09721798A1734|60 62|HCV
P09722043A2070|12 14|TPN
P09722161A3065|62 73|Igf2/Mpr gene
P09722508A0953|30 42|Galpha11 Q209L
P09722508A0953|53 67|Src family kinase
P09722508A0953|118 134|proteins in HEK-293
P09722766A0706|69 73|BUP-4
P09723896A0000|0 46|Peroxisome proliferator-activated receptors (PPAR)
P09723896A0000|87 131|peroxisome proliferator-response elements (PPRE)
P09723896A0000|177 193|acid receptor (RXR)
P09724654A0761|108 112|RPA's
P09724654A1120|26 31|S-CDKs
P09724654A1120|35 43|Dbf4/Cdc7
P09724654A1120|95 97|RPA
P09724754A0173|22 26|STATs
P09724763T0000|27 56|abalone sperm fertilization genes
P09724763T0000|101 103|DNA
P09724772A0840|28 50|ZiaR-dependent complexes
P09724772A0840|65 84|zia operator-promoter
P09724772A0840|88 95|ZiaR-DNA
P09725292A1473|0 9|CONCLUSION
P09725292A1473|85 86|CT
P09725651A0077|3 14|PC-based RTPS
P09725854A1060|102 117|IS1112C Rf3 allele
P09725854A1060|184 189|orf107
P09726201T0000|0 4|JCAHO
P09726979T0000|53 69|sphingosine kinase
P09726987T0000|6 40|SPT3-TAFII31-GCN5-L acetylase complex
P09726987T0000|53 74|transcription factor IID
P09726988A0275|33 42|M-CPT I mRNA
P09726991T0000|12 27|DNA binding domain
P09727045A0817|87 90|HREs
P09727045A0817|133 134|AR
P09727045A0817|147 165|ligand binding domain
P09727046A0000|27 37|DNA-binding
P09727046A0000|28 51|NA-binding protein, HS2NF5
P09727046A0000|107 116|site 2 (HS2)
P09727046A0000|127 160|beta-globin locus control region (LCR)
P09727046A0000|161 164|(Lam
P09727046A0784|3 6|CBF1
P09727046A0784|17 19|HS2
P09727046A0784|68 73|GATA-1
P09727046A0784|69 79|ATA-1, NF-E2
P09727046A0784|84 87|TAL1
P09729481A0000|3 59|rat branched-chain-2-oxo-acid dehydrogenase (BCOD) kinase mRNA
P09729481A0000|78 94|TATA-less promoter
P09729481A0000|102 108|GC-rich
P09729481A1177|46 56|-58 promoter
P09729481A1177|125 130|kinase
P09729481A1177|188 196|-58 region
P09730413A0642|98 100|TME
P09730413A0642|142 151|Stage T1-T3
P09731354A0963|28 30|APS
P09731354A0963|50 52|NH2
P09731513A1090|53 81|transcription factors NF-kappaB
P09731513A1090|85 88|AP-1
P09731513A1090|120 127|IL-8 gene
P09731513A1090|130 135|HTLV-I
P09731704A0000|46 83|estrogen receptor-alpha (ERalpha) isoform
P09731704A0000|86 110|estrogen (E2)-mediated gene
P09731704A0000|123 127|U2-OS
P09731704A1472|33 45|delta5ERalpha
P09731704A1472|66 77|[ERalpha+]OS
P09731704A1472|107 125|E2-stimulated ERELuc
P09731705A2126|78 84|a VDR-TR
P09733647A1960|5 47|equence, Thr-Gly-X-X-Gly-Asp-Gly-Lys-Ile-Phe
P09733794A1323|34 60|Bcl-2-related proteins (Bcl-x
P09733794A1323|84 100|KCREB-transfected
P09733815T0000|19 35|membrane protein 2A
P09733815T0000|50 70|protein tyrosine kinase
P09733815T0000|93 104|Epstein-Barr
P09733854A0198|57 78|latency-related (LR) RNA
P09735286A0599|93 95|ATP
P09735286A0599|99 107|target DNA
P09735366A1180|44 57|mouse homologue
P09735366A1180|60 64|E(Pc)
P09735366A1180|100 103|EPL1
P09735366A1180|126 129|ESTs
P09735368A0636|23 25|UTR
P09735371A0227|27 45|POU-type homeodomain
P09735371A0227|109 127|LIM-type homeodomain
P09736697A0783|32 35|MEK1
P09736697A0783|40 45|kinase
P09736697A0783|59 62|ERKs
P09736697A0783|82 85|ERK2
P09736697A0783|93 96|JNK1
P09736697A1107|0 3|MEKs
P09736697A1107|7 10|ERKs
P09736697A1107|20 23|IL-6
P09736697A1107|157 168|Janus kinases
P09736697A1107|200 217|Jak-STAT-signaling
P09736715A0729|87 89|ILK
P09736715A0729|149 154|Pi(3)K
P09736715A0729|164 166|ILK
P09736770A0351|52 56|HEFT1
P09736770A0351|93 94|GC
P09737453A0557|38 41|[SD]
P09737453A0557|57 59|IgG
P09737453A0557|162 173|assay (ELISA)
P09738010A0305|3 13|FAS promoter
P09738010A0305|91 100|E-box motif
P09738010A0305|106 113|-65-base
P09738693T0000|9 15|rhG-CSF
P09739401A0000|0 8|OBJECTIVE
P09739913A0194|0 9|CASE REPORT
P09741391A0581|14 40|ingle-chambered body box, PenH
P09741391A0581|46 54|(Enhanced
P09741783A0000|21 29|aromatase
P09743128A0969|19 25|Bis-GMA
P09743233A0526|19 22|AP-1
P09743233A0526|81 84|SMCs
P09743720A0268|0 6|ANIMALS
P09743720A0268|40 41|DM
P09744095A1016|31 37|shy2-1D
P09744095A1016|52 93|hytochrome-deficient mutants hy2, hy3(phyB-1)
P09744095A1016|97 112|fre1-1(phyA-201)
P09744095A1016|126 141|photomorphogenic
P09744095A1016|235 241|CAB gene
P09744095A1016|249 255|shy2-1D
P09747873T0000|3 35|SH2-containing adapter protein GRB10
P09747873T0000|49 55|BCR-ABL
P09748261A0000|40 58|acyl-CoA synthetases
P09748286A0000|19 43|placenta-specific enhancer
P09748286A0000|72 95|factor receptor (LIFR) gene
P09748286A0000|135 154|226-base pair enhancer
P09748513X1360|0 30|Copyright 1998 Elsevier Science B.V
P09748669A0414|42 43|AD
P09748669A0414|47 49|VaD
P09749533A0764|20 27|CONSTANS
P09749988A0000|20 27|(Spatial
P09750325A0000|62 93|power energization technique (PPET)
P09750325A0000|173 180|0157:H7)
P09750325A0000|184 204|Listeria monocytogenes
P09750540A0000|8 31|chemical sensitivity (MCS)
P09751061A0000|0 9|POU-domain
P09751061A0000|73 83|homeodomain
P09751114A0967|18 21|MyoD
P09751114A1987|68 71|MyoD
P09751114A1987|101 111|mitogenesis
P09751166A1460|36 38|CRE
P09751166A1460|75 76|TH
P09751166A1460|92 100|a promoter
P09751458A0845|0 19|desmethyltrimebutine
P09753241A0524|38 51|blood cell (WBC)
P09753241A0524|70 97|myeloperoxidase activity (MPO)
P09753241A0524|100 110|homogenates
P09753241A0524|152 154|DSS
P09753769A0362|14 23|degenerate
P09753769A0362|85 88|PBAN
P09753774A1642|24 32|35S-1-sst
P09753774A1642|56 82|oligofructans 1-kestose (GF2)
P09753774A1642|57 99|ligofructans 1-kestose (GF2), 1,1-nystose (GF3)
P09753774A1642|103 129|1,1,1-fructosylnystose (GF4)
P09753774A2246|83 112|plant fructosyl transferase genes
P09753774A2246|133 149|plant fructan genes
P09753774A2246|165 183|plant invertase genes
P09753775A0734|8 11|ICK1
P09753775A0734|24 26|ABA
P09753775A0734|40 43|ICK1
P09753775A0734|72 95|Cdc2-like histone H1 kinase
P09754571A0169|42 59|display amplicon 3G1
P09754571A0169|91 98|RAG1 mRNA
P09754571A1257|3 11|hBRAG gene
P09755191A0553|29 55|temperature-sensitive allele
P09755191A0553|74 82|chain gene
P09755191A0553|140 143|CHC1
P09755199A0559|80 82|PcG
P09756895A0322|14 19|chCTCF
P09756895A0322|29 35|GC-rich
P09757012A0942|13 15|PDZ
P09757012A0942|19 28|SAM domains
P09757012A0942|34 36|KS5
P09759180A0000|0 9|BACKGROUND
P09759180A0000|1 30|ACKGROUND: Fluoroquinolones (FQ)
P09759691A1051|174 176|SD)
P09759691A1051|228 237|1.0-mmol/L
P09759691A1051|241 246|mg/dL)
P09759865A0673|13 20|IL-1beta
P09759865A0673|24 32|TNF-alpha
P09759865A0673|87 95|NF-kappaB
P09759865A0673|178 207|NF-kappaB-alpha (IkappaB-alpha)
P09759865A0673|243 250|IL-1beta
P09759865A0673|262 272|PDGF-Ralpha
P09760243A0970|19 23|ATF-2
P09760243A0970|27 31|HNF-4
P09760243A0970|88 102|apoCIII promoter
P09760341T0000|61 64|FIO2
P09761723A0226|0 5|GETS-1
P09761791A0489|16 21|U1-70K
P09761791A0489|29 31|SRZ
P09763421A1199|31 41|Fab1p kinase
P09763446A0000|5 11|GTPases
P09763446A0000|17 23|Ypt/Rab
P09763446A1234|3 5|GEF
P09763446A1234|9 11|GAP
P09763470A0000|0 28|Dopamine beta-hydroxylase (DBH)
P09763470A1756|118 121|CREB
P09763470A1756|119 125|REB, AP2
P09763470A1756|166 172|DBH gene
P09763522A2545|31 37|N-SMase
P09763522A2545|49 55|Ox-LDL-
P09763522A2545|59 75|TNF-alpha-induced
P09763607A0521|65 67|JNK
P09763607A0521|76 84|p38 kinase
P09765261A0000|40 47|(HTLV-I)
P09765261A0000|96 128|basic-domain/leucine-zipper (bZip)
P09765261A0000|97 175|asic-domain/leucine-zipper (bZip) protein, cAMP response element binding protein (CREB)
P09765261A0000|192 212|Tax-responsive element
P09765261A0000|239 245|21-base
P09765261A0000|267 285|cAMP response element
P09765261A0000|299 306|G/C-rich
P09765271A1108|138 169|phosphoenolpyruvate carboxykinase
P09765271A1108|139 194|hosphoenolpyruvate carboxykinase, tyrosine aminotransferase
P09765277A0000|21 45|glucose transporter isoform
P09765277A0000|47 51|(Glut
P09765285A0998|33 64|consensus sequence AGGTCA (IRper-1)
P09765285A0998|83 93|AaEcR.AaUSP
P09765285A0998|105 111|IRhsp-1
P09765285A0998|183 189|IRper-0
P09765285A0998|192 198|IRper-5
P09765285A1763|78 101|response elements (IRper-1
P09765285A1763|103 106|DR-4
P09765285A1763|108 115|IRhsp-1)
P09765372A0669|80 81|II
P09765388T0000|14 16|p53
P09765388T0000|28 45|adenovirus type 5 E1B
P09765394A0000|3 33|Epstein-Barr virus transactivator
P09765394A0000|103 114|rigin, oriLyt
P09765394A1590|19 34|helicase-primase
P09765394A1590|77 92|activation domain
P09765394A1590|129 131|CAT
P09765411A0991|93 94|CP
P09765411A0991|124 127|mRNA
P09765411A0991|157 188|structure NH2-ubiquitin-S27a-COOH
P09765754A1727|35 37|PVI
P09767575A0657|43 44|SD
P09767575A0657|94 114|single-stranded region
P09767593A0130|8 11|YopH
P09767593A0130|27 29|PTP
P09767593A0130|115 121|p130Cas
P09767687T0000|0 11|Phylogenetic
P09767687T0000|82 88|18S rDNA
P09767687T0000|92 95|rbcL
P09769209A0100|72 81|nasF operon
P09769910A1700|49 51|TNF
P09770378A0641|0 3|EGFR
P09770415A0139|21 26|THOV NP
P09770415A0139|36 57|motif (KRxxxxxxxxxKTKK)
P09770415A0139|125 147|localization signal (NLS)
P09770493A0499|2 5|PP2A
P09771967A1052|12 18|LB1 gene
P09771967A1052|83 98|breakpoint in DLBL
P09771985A0238|29 56|ethylmercury chloride (EtHgCl)
P09771985A0238|81 86|EtHgCl
P09773975A1873|0 21|Wild-type AT1A receptors
P09773975A1873|83 87|Ang II
P09773975A1873|125 145|internalization (Ymax)
P09773975A1873|206 211|(T332E
P09773975A1873|234 238|S335D
P09773975A1873|261 265|T336E
P09773975A1873|288 292|S338D
P09773981A0415b|12 33|glucocorticoid receptor
P09774444A0351|29 32|UKLF
P09774444A0351|62 70|Cys2-His2
P09774444A0351|95 104|CACCC motif
P09774444A0351|110 128|beta-globin promoter
P09774450A0000|42 73|gamma-glutamyl leukotrienase (GGL)
P09774450A0000|86 104|leukotriene C4 (LTC4)
P09774450A0000|107 125|leukotriene D4 (LTD4)
P09774484T0000|0 7|UGA codon
P09774641A0824|92 109|retinoblastoma gene
P09774662A0958|3 13|ARF promoter
P09774662A0958|48 51|E2F1
P09774662A0958|96 98|RNA
P09776293A0777|0 6|RESULTS
P09776293A0777|20 24|99mTc
P09776293A0777|21 33|9mTc d, 1-HMPAO
P09776360A0620|0 1|CM
P09776360A0620|36 58|transcription factor AP-1
P09776360A1781|0 8|NF-kappaB
P09776360A1781|60 62|NOS
P09776360A1781|63 64|II
P09776360A1781|112 113|CM
P09776360A1781|116 120|DLD-1
P09777999A0796|0 6|RESULTS
P09777999A0796|54 58|PaCO2
P09778006A0718|69 80|blood (PaCO2)
P09778006A0718|93 96|mmHg
P09778006A0718|102 107|+/- SD)
P09778006A0718|135 139|a PaCO
P09778006A0718|152 155|mmHg
P09778006A0718|196 217|alue: cm x s(-1) x mmHg(-1)
P09778006A0718|245 262|baseline Vmca/mmHg)
P09778068A1129|41 50|baseline EF
P09778191A0000|48 56|CBF (rCBF)
P09778191A0000|136 156|resonance imaging (MRI)
P09778197A0415|167 202|beta-hydroxy-beta-methylglutaryl-CoA
P09778197A0415|212 222|A) reductase
P09780002A0996|8 13|E2FBP1
P09780002A0996|22 42|transactivation domain
P09780002A0996|56 58|E2F
P09780002A0996|103 107|E2F-1
P09780228A0122|13 20|40-kb DNA
P09780228A0122|33 41|FK506 gene
P09780228A0613|30 33|FkbB
P09780228A0613|37 40|FkbC
P09780228A0613|61 64|FkbA
P09780228A0613|76 113|30 fatty-acid-synthase(FAS)-like domains
P09780336A0771|10 17|Msy2 mRNA
P09781871A0404|0 7|Glycogen
P09781871A0404|21 45|atabolism, gluconeogenesis
P09781871A0404|114 117|csrA
P09781871A0404|210 234|response elicitor HrpN(Ecc)
P09781871A0404|290 293|rsmA
P09781874A1061|108 118|change A202T
P09784063A0621|70 98|ORF5/deltaX transcript promoter
P09784192A1027|9 26|peptide:MBP fusions
P09784245T0000|7 36|myosin-binding protein C (MyBP-C)
P09784245T0000|54 66|protein kinase
P09784245T0000|71 83|protein kinase
P09785114A1026|10 12|PND
P09785114A1026|36 39|CORT
P09786197A0322|21 23|DNA
P09786197A0322|118 121|csrR
P09786197A0322|125 128|csrS
P09786926A0095|34 59|fatty-acid synthase promoter
P09786926A0095|117 143|fatty-acid synthase (FAS) gene
P09786926A1372|47 52|SREBP2
P09786926A1372|70 80|ADD1/SREBP1
P09786926A1372|111 122|element (SRE)
P09786932A1042|5 9|IRF-7
P09786932A1042|40 44|IRF-3
P09786932A1042|81 85|IRF-7
P09786932A1042|126 130|IFNA)
P09786932A1042|143 147|IRF-7
P09786932A1042|183 190|IFNA gene
P09787323A0000|0 6|PURPOSE
P09787323A0000|11 33|role interleukin-6 (IL-6)
P09788739A1096|0 3|CKII
P09788739A1096|7 33|CD44-associated serine kinase
P09788739A1096|132 137|MDA231
P09789025A0149|0 6|Galphaq
P09789025A0149|1 15|alphaq, Galpha12
P09789025A0149|20 27|Galpha13
P09789025A0149|35 41|Galphai
P09789025A0149|51 53|SRF
P09789025A0149|61 64|RhoA
P09789795A0607|37 39|(A)
P09789795A0607|43 59|noradrenaline (NA)
P09790499A0545|31 39|hBub1 mRNA
P09790768A0621|0 10|Htra2-beta3
P09790986A0689|41 70|glutathione S-transferase fusion
P09790986A0689|91 102|NH2-terminal
P09790986A0689|122 127|NRAMP2
P09792439T0000|15 54|apolipoprotein B mRNA editing enzyme-complex
P09792439T0000|57 61|hnRNP
P09792439T0000|74 90|40S hnRNP complexes
P09792627A0441|0 4|SRC-1
P09792627A0441|18 35|NF-kappaB-mediated
P09792627A0441|48 49|GR
P09792630A1127|32 65|transcription start site CTCA(+1)TTCC
P09792630A1127|81 101|consensus CTCA(+1)NTCT
P09792630A1127|102 103|(N
P09792630A1127|125 140|initiator element
P09792630A1127|156 182|deoxynucleotidyltransferase
P09792702A0754|38 41|JNK1
P09792702A0754|56 85|glucose deprivation-induced JNK1
P09792702A0754|104 112|HSP70 gene
P09792714A1408|16 19|AF-1
P09792714A1408|134 137|AF-1
P09794414T0000|9 21|protein kinase
P09794414T0000|43 45|DRA
P09794795A0183|18 32|receptor complex
P09794795A0183|78 94|Janus kinases (Jak)
P09794795A0183|116 139|signal transducing subunit
P09794795A0183|220 244|transcription factors STAT3
P09794795A0183|248 252|STAT1
P09794795A0183|259 323|src homology domain (SH2)-containing protein tyrosine phosphatase (SHP2)
P09795170A0774|55 57|TGA
P09795213A0129|0 4|RBP56
P09795213A0129|25 32|hTAFII68
P09795213A0129|52 63|TATA-binding
P09795213A0129|81 91|factor (TAF)
P09795213A0129|113 126|TFIID complexes
P09795213A0129|127 137|(Bertolotti
P09795213A0129|141 158|Lutz, Y., Heard, D.J.
P09795213A0129|146 191|Y., Heard, D.J., Chambon, P., Tora, L., 1996. hTAFII68
P09795213A0129|199 215|RNA/ssDNA-binding
P09795213A0129|240 264|proto-oncoproteins TLS/FUS
P09795213A0129|268 270|EWS
P09795213A0129|281 294|ed with both TFII
P09795213A0129|291 295|TFIID
P09795213A0129|299 311|RNA polymerase
P09795341A0806|81 83|TR2
P09797189A0559|47 56|CCAAT motif
P09797456A0000|0 9|BACKGROUND
P09797456A0000|14 32|c-myc proto-oncogene
P09797456A0883|0 4|AMY-1
P09798068A0290|0 6|RESULTS
P09798068A0290|21 35|full-length cDNA
P09798068A0290|152 192|rat gamma-aminobutyric acid B (GABAB) receptor
P09798100A0705|10 15|CIDR-B
P09798100A0705|63 64|IM
P09798263T0000|35 51|serotonin receptor
P09799086A0725|117 124|HPRT exon
P09799086A0725|164 165|LN
P09799237A0624|0 12|SRF-deficient
P09799237A0624|20 23|(Srf
P09799362A0507|56 87|abbreviation AZF1 (Asparagine-rich
P09799362A1463|187 199|RNA polymerase
P09799634A0161|6 14|generated
P09799634A0161|34 49|C-terminal domain
P09799634A0161|108 112|UmuD'
P09799793T0000|96 98|EPO
P09799793T0000|102 106|CUTL1
P09799793T0000|118 124|17 genes
P09800187A0100|7 11|Trp53
P09800187A0100|16 27|mouse homolog
P09800187A0100|30 39|human TP53)
P09800187A0100|35 39|TP53)
P09800187A0100|131 133|DNA
P09800187A0100|210 214|Trp53
P09801156A0220|34 58|amino acid sequence homology
P09801333A0174|3 18|full-length N gene
P09801333A0174|71 74|PRRS
P09801333A0174|72 84|RRS virus, PA-8
P09802206A1058|7 22|sequence homology
P09802206A1058|48 50|TEF
P09802206A1058|60 93|translation elongation factor-1 alpha
P09802206A1058|97 100|RPS7
P09802902A0225|25 28|ARNO
P09802902A0225|86 89|ARF6
P09803081T0000|35 46|childhood SLE
P09804779A0000|50 63|protein kinases
P09804779A1163|68 86|prolactin-activated
P09804779A1163|90 106|PD98059-resistant
P09804779A1163|142 158|PD98059-sensitive
P09804836A0000|15 20|37-kDa
P09804836A0000|86 98|mouse BAC1.2F5
P09804836A0000|112 143|colony stimulating factor-1 (CSF-1)
P09804836A0000|186 196|anti-Tyr(P)
P09805052A0119|72 85|immunogenicity
P09805977A0143|154 166|xenoestrogens
P09806516A1689|0 9|CONCLUSION
P09806546A1270|18 21|RFX5
P09806546A1270|25 29|RFXAP
P09806546A1270|56 65|RFX complex
P09806546A1270|68 82|MHC-II promoters
P09806826A0244|33 39|RIIIS/J
P09806857A0854|67 76|invertases
P09806857A0854|80 89|resolvases
P09806857A0854|124 138|Pac25I R-M operon
P09806858T0000|42 52|plasmid pLS1
P09806858T0000|57 64|rnaI gene
P09808155A0813|13 39|DNA:protein binding complexes
P09808155A0813|140 142|DNA
P09808216A0000|0 9|BACKGROUND
P09808216A0000|47 56|energy (EB)
P09808216A0000|63 73|balance (FB)
P09808366A0828|90 91|KA
P09808366A0828|120 126|VRG-Apa
P09808441A0320|33 47|MOCT-associated
P09810087A0379|0 6|RESULTS
P09810087A0379|79 82|(HSV
P09811695A1146|24 28|HIV-1
P09811695A1146|61 71|PR-mediated
P09811695A1146|87 108|MuLV TM Env protein p15(E)
P09811718A0979a|45 47|SIV
P09811718A0979a|51 55|HIV-2
P09811718A0979a|66 70|HIV-1
P09811718A0979a|79 85|TCRzeta
P09811730T0000|76 97|15-base-pair KCS element
P09811730T0000|139 171|RNA-dependent protein kinase pkr gene
P09811730A1396|0 14|Competition EMSA
P09811730A1396|76 85|KCS element
P09811730A1396|98 100|KCS
P09811730A1396|167 186|transfection reporter
P09813041A1122|0 1|GH
P09813041A1122|48 66|Jun N-terminal kinase
P09813063T0000|24 44|phospholipase D homolog
P09813093A0624|28 34|YCL024W
P09813093A0624|76 79|GIN4
P09813098A0521|37 40|mRNA
P09813110A0982|29 33|CBP90
P09813110A0982|87 104|proline-rich domain
P09813110A0982|110 125|C-terminal region
P09813203T0000|54 71|HIV-1 gp120 IIIB/LAI
P09813203T0000|77 90|immunogenicity
P09813207A0434|101 109|TAAG motif
P09813207A0434|192 201|a TTGT motif
P09813207A0434|235 238|TATA
P09813207A0434|278 280|ATG
P09813254A0000|11 44|5'-oligoadenylate (2-5A) synthetases
P09813254A0000|58 88|family interferon (IFN)-inducible
P09813259A1097|103 105|GBP
P09813259A1097|109 111|IBG
P09813635A0678|105 112|complex)
P09814637A1214|3 7|PbrO2
P09814637A1214|76 77|CT
P09814637A1214|80 82|MRI
P09815578A1245|37 41|CDKN2
P09815578A1245|118 139|prostate carcinogenesis
P09817131A0296|8 16|(HK) SF-36
P09817373A0000|0 6|PURPOSE
P09817373A0000|150 167|oxide synthase (NOS)
P09817601T0000|48 70|aromatase (P450arom) gene
P09819038A0448|11 15|FVIIa
P09819110A0703|0 2|CD4
P09819110A0703|59 61|ARV
P09819110A0703|71 79|the time LD
P09819288A0578|8 15|serum IgE
P09819288A0578|44 46|IgE
P09819377A1209|16 19|C2U4
P09819377A1209|51 56|snR13F
P09819377A1209|81 84|C2U4
P09819377A1209|121 124|RNAs
P09819391A1123|36 50|tyrosine kinases
P09819391A1123|97 113|rganization, ASAP1
P09819411A0897|2 6|DNase
P09819411A0897|30 39|PNR element
P09819411A0897|57 99|high-affinity Ets-binding sites (CTTCCCTGGAAG)
P09819414A1103|55 68|leptin receptor
P09819414A1103|90 103|medium isoforms
P09819421A0000|15 49|cis-trans-peptidyl-prolyl isomerases
P09819421A0000|97 113|cyclosporin A (CsA)
P09819422A0768|41 60|Hsp90 heterocomplexes
P09819430A0000|3 20|Ras-related GTPases
P09819430A0000|35 40|25-kDa
P09819430A0000|76 84|GDP-bound
P09819430A0000|100 108|GTP-bound
P09819440A0000|87 100|RNA polymerases
P09819440A0783|0 9|Endogenous
P09819440A0783|10 12|RMP
P09819440A0783|63 66|RPB5
P09819440A0783|69 81|RNA polymerase
P09819507A0000|64 68|Dexon
P09819507A0000|161 171|mitomycin-C
P09820205A0000|3 19|zona pellucida (ZP)
P09821978A1255|55 60|MK-801
P09821978A1255|67 68|SE
P09822602A0237|47 56|HIF-1alpha
P09822602A0237|152 172|transactivation domain
P09822602A0237|201 212|CREB-binding
P09822602A0237|220 229|(CBP)/p300
P09822602A1172|68 70|CBP
P09822602A1172|153 162|HIF-1alpha
P09822647A0000|3 18|rat aldolase C gene
P09822652A1118|20 30|HCK promoter
P09822661T0073|0 20|Quinone-binding domain
P09822685A0596|40 56|Lu-ECAM-1 peptides
P09822685A0596|68 83|N-terminal region
P09822690A0000|45 58|cAMP-dependent
P09822690A0000|97 109|protein kinase
P09822825A0141|27 30|BAP2
P09822825A0141|50 57|BAP3 gene
P09823014T0000|118 122|NIDDM
P09823561T0001|16 19|MALT
P09823561T0001|53 68|(Gastrospirillum
P09823775A1122|30 36|HMG I(Y)
P09823775A1122|61 71|HLA-DRA gene
P09823775A1122|84 89|Oct-2A
P09824001A1665|56 69|urvival, vWF:Ag
P09824021A1263|0 9|CONCLUSION
P09824021A1263|108 109|NO
P09824158A1336|10 23|BCL-6 POZ domain
P09824158A1336|62 66|N-CoR
P09824158A1336|70 73|SMRT
P09826434T0000|43 71|platelet cAMP phosphodiesterase
P09826434T0000|44 77|latelet cAMP phosphodiesterase, PDE3A
P09826434T0000|81 104|site-directed mutagenesis
P09826658A0691|136 149|BPV-1 pre-mRNAs
P09826778A0943|63 75|myoD-mediated
P09826778A0943|112 118|COUP-TF
P09826778A0943|119 120|II
P09827878A0091|5 30|glutathione peroxidase (GPX)
P09827878A0091|34 57|superoxide dismutase (SOD)
P09827993A0000|10 35|nucleocapsid proteins (NCPs)
P09827993A0000|39 47|CCHC-type
P09827993A0000|77 85|virion RNA
P09827993A0000|145 147|RNA
P09828137A0000|27 61|rad1+ cell cycle checkpoint control gene
P09828137A0000|75 81|S-phase
P09828137A0000|85 88|G2/M
P09828137A0000|111 113|DNA
P09828137A0000|133 135|DNA
P09829836A0000|123 135|kinases (CDKs)
P09829836A0815|40 49|cyclin/CDK
P09829836A0815|95 108|yeast LEU2 genes
P09829843A0119|16 45|colony-stimulating factors (CSF)
P09829843A0819|15 17|CSF
P09829843A0819|101 127|eutrophil recovery. rHu GM-CSF
P09829843A0819|119 121|rHu
P09829843A0819|131 138|rHu G-CSF
P09829916T0000|12 15|lacZ
P09829916T0000|88 104|W205 trp-lac fusion
P09832099A0000|101 111|Fallot (TOF)
P09832436T0000|64 77|prolactin (PRL)
P09832436T0000|65 92|rolactin (PRL) family, PRL-like
P09832436A0738|0 5|RT-PCR
P09832436A0738|24 28|PLP-H
P09832436A0738|37 41|PLP-C
P09832436A0738|45 49|PLP-D
P09832436A0738|100 102|PLP
P09832504A0596|51 56|hCycT1
P09832505A0903|84 103|transcription complex
P09832511A0269|11 22|neurogenesis
P09832518A0615|3 18|repression domain
P09832518A0615|152 159|database
P09833610A0626|3 11|exodomain
P09833610A0626|70 79|generating
P09833740A1112|68 70|LTR
P09833740A1112|112 116|ACH-2
P09833740A1112|140 157|TNF-alpha-mediated
P09834070A0793|35 38|ERK2
P09834070A0793|118 130|protein kinase
P09834070A0793|176 179|CD19
P09835615A0574|30 32|KS1
P09835615A0574|78 93|repressor domains
P09836881A0441|11 13|BCH
P09836881A0441|59 77|Bruininks-Oseretsky
P09836881A0441|100 109|(Bruininks
P09837714A1068|33 34|pH
P09837714A1068|75 79|DdRPA
P09837715A0581|48 50|DNA
P09837715A0581|62 102|chloramphenicol acetyltransferase (CAT) mRNA
P09837715A0581|146 150|HIV-1
P09837715A0581|160 197|leukemia virus (MLV) SL3-3 LTR-CAT reporter
P09837824A0419|12 17|telSMN
P09837824A0419|47 54|SMA-like
P09837824A0419|87 92|telSMN
P09837824A0419|140 148|542delGT)
P09837824A0419|174 177|(A2G
P09837824A0419|179 183|S262I
P09837824A0419|188 193|T274I)
P09837907A0857|13 24|TNF receptors
P09837907A0857|27 30|IL-4
P09837907A0857|64 74|TNF-induced
P09837907A0857|97 136|totoxicity, caspase-3 activation, NF-kappaB
P09837907A0857|140 143|AP-1
P09837907A0857|158 178|c-Jun N-terminal kinase
P09837913A0000|0 18|Type 2 deiodinase (D2)
P09837913A0419|79 90|4.4-kb 3'-UTR
P09837913A0419|101 111|D2 (hD2) cDNA
P09837920A0222|113 117|c-Jun
P09837920A0222|121 123|JNK
P09837933T0000|0 5|P-CIP1
P09837933T0000|57 99|peptidylglycine alpha-amidating monooxygenase
P09837978T0093|21 81|c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK)
P09838122A0489|15 35|full-length coding cDNA
P09838122A0489|49 62|mouse homologue
P09838122A0489|65 68|MPP3
P09840928A0884|45 61|ore histones H3, H2A
P09840928A0884|69 77|exogenous
P09840928A0884|91 100|endogenous
P09840928A0884|112 117|kinase
P09840932A0365|32 36|B-Myb
P09840932A0365|68 79|cyclin A/Cdk2
P09840934A0435|7 12|Ha-Ras
P09840934A0435|13 17|(G12V
P09840934A0435|19 37|T35S) (Ha-RasV12S35)
P09840934A0435|80 90|Ha-Ras(G12V
P09840934A0435|81 110|a-Ras(G12V, E37G) (Ha-RasV12G37)
P09840934A0435|130 135|RalGDS
P09842517A0497|50 57|SieScape
P09842517A0497|93 94|CT
P09842517A0497|98 100|MRI
P09843378A0187|3 20|dopamine D4 receptor
P09843378A0187|86 102|SH3 binding domains
P09843412A0130|9 21|amyloidogenic
P09843412A0130|38 51|Abeta (Abeta42)
P09843412A0130|107 108|AD
P09843577A0000|67 70|G2/M
P09843944A0976|129 137|UP element
P09844106A0835|43 45|FLG
P09844106A0835|73 75|ST2
P09844921A0000|9 37|serine-threonine protein kinase
P09844921A0000|98 120|differentiation messages
P09845043A0000|3 4|US
P09845043A0000|39 55|Alcoholism (NIAAA)
P09845662A0085|48 50|III
P09845662A0085|81 143|sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
P09845856A0560|0 6|RESULTS
P09845856A0560|55 67|ulcer diseases
P09846033A0488|0 6|RESULTS
P09846482A0441|63 88|p21-activated protein kinase
P09847371A0000|0 24|Jembrana disease virus (JDV)
P09847371A0000|90 115|immunodeficiency virus (BIV)
P09847397A0935|94 109|response elements
P09847397A0935|153 157|CCAAT
P09847397A0935|188 191|TATA
P09848653A0597|56 66|RNA-binding
P09849421A0332|160 165|(EORTC
P09849421A0332|166 172|QLQ-C30
P09849722A0797|54 67|signal increase
P09849722A0797|186 202|yrus, brain regions
P09849961A0387|17 21|IRS-1
P09849961A0387|67 76|PI 3-kinase
P09849961A0387|131 135|IRS-1
P09849965A0000|93 117|progesterone receptor (hPR)
P09851614A0109|50 76|5'-untranslated regions (UTR)
P09851614A0109|144 148|mRNAs
P09851700A0000|20 56|tissue-type plasminogen activator (t-PA)
P09852005A1287|24 27|MADS
P09852005A1287|92 126|opaque-phase-specific gene PEP1 (SAP1)
P09852005A1287|138 141|MADS
P09852005A1287|247 249|OP4
P09852068A0150b|8 11|SHBG
P09852068A0150b|41 45|DNase
P09852068A0150b|102 117|regions (FP1-FP6)
P09852068A0150b|160 164|HepG2
P09852109A1475|192 213|5'-untranslated regions
P09852136A0174|25 30|(Ser36
P09852136A0174|120 155|hemagglutinin (HA)-tagged protein in COS
P09852136A0507|0 14|Wild type HA-p190
P09852136A0507|116 131|ADP-ribosylation
P09852752A0950|15 29|ANCA-associated
P09852752A0950|72 73|RA
P09854034A0536|14 30|TATA-less promoter
P09854034A0536|38 40|G+C
P09854034A0536|94 97|mRNA
P09855111A0905|42 61|COOH-terminal domains
P09855111A0905|108 112|SREBP
P09855111A0905|152 166|SREBP-dependent
P09855111A0905|210 213|mRNA
P09855111A0905|258 261|(HMG
P09855111A0905|262 273|CoA) synthase
P09856397A0099|114 116|FB1
P09857197A0289|65 88|export sequence (NES)-like
P09857197A0289|119 124|RanGTP
P09857265A0669|39 46|mg RE/day
P09858094A0583|33 55|potentials (O1+O2+O3+O4)
P09858531A1017|12 16|RING1
P09858531A1017|63 77|proto-oncogenes
P09858571T0000|3 15|yeast RER2 gene
P09858571T0000|85 105|cis-prenyltransferase
P09858577A1186|9 12|SKO1
P09858577A1186|31 34|ENA1
P09858577A1186|149 151|HOG
P09858581A0183|47 56|ene, SPP381
P09858581A0183|109 133|temperature-sensitive (Ts)
P09858588A1046|66 69|G1/S
P09858588A1046|98 101|G2/M
P09858593A0334|48 67|Xenopus NeuroD1/BETA2
P09858593A0334|87 97|insulin gene
P09858593A0334|118 129|neurogenesis
P09858599A0392|4 14|NUP98-HOXA9
P09858599A0392|34 39|NIH 3T3
P09858599A0392|84 95|HOXA9 domains
P09858599A0392|99 101|DNA
P09858599A0392|112 114|PBX
P09858619A0356|56 61|ZAP-70
P09858713A1174|50 52|CiD
P09858713A1174|136 140|ciD/+
P09858713A1174|204 206|CiD
P09858714A1171|7 9|ORF
P09858714A1171|30 33|modA
P09858745A1350|16 18|IBS
P09858745A1350|28 31|catB
P09858745A1350|123 125|IBS
P09858745A1350|156 159|CatR
P09858745A1350|213 215|DNA
P09858745A2033|44 52|TCA-cycle
P09858745A2033|123 126|clcA
P09858883A1106|0 6|BIAcore
P09858883A1106|54 57|N-A3
P09858883A1106|96 99|N-A3
P09860979A0521|12 25|p130(Cas) (Cas)
P09860979A0521|53 65|Crk SH2-domain
P09860979A0521|78 80|JNK
P09860979A0521|112 121|SH2-mutant
P09861099A1011|135 147|g/kg/d (SD.38)
P09861099A1011|141 143|(SD
P09861365A0000|3 7|Og4C3
P09861365A0000|34 45|assay (ELISA)
P09861365A0000|95 102|50 microL
P09862343A0225|13 21|gp200-MR6
P09862343A0225|42 45|IL-4
P09862496A0187|39 55|high-level betaGLU
P09862496A0187|117 123|betaGLU
P09863624A0629|41 49|sheep CRF1
P09863624A0629|70 74|CRF1s
P09863624A0629|182 186|CRF1)
P09863624A2301|0 22|Agonist-induced receptor
P09863624A2301|68 73|[125I]
P09863624A2301|74 82|Tyr0-oCRF
P09863624A2301|209 213|oCRF1
P09864141A0528|20 28|Stat3beta
P09864141A0528|54 68|phosphopeptides
P09864141A0528|135 149|phosphopeptides
P09864335A1226|39 46|FCR1 gene
P09864335A1226|135 137|FCZ
P09864689A1408|28 32|MYO/M
P09864689A1408|107 109|DCM
P09865775A0162|69 73|ALGO2
P09866068A1058|0 10|CONCLUSIONS
P09866068A1058|28 30|OCs
P09867159A1444|89 94|FDG PET
P09867159A1444|127 128|IS
P09867253A0229|4 8|c-Jun
P09867253A0229|30 34|c-Fos
P09867253A0229|78 82|c-Jun
P09867253A0229|92 114|transcription factor AP-1
P09867855T0000|0 39|Dorsal root ganglia neuron-specific promoter
P09867855T0000|53 105|rabbit beta-galactoside alpha1,2-fucosyltransferase gene
P09868412A1628|0 9|CONCLUSION
P09868412A1628|36 42|body BMD
P09868412A1628|53 59|neck BMD
P09868412A1628|188 190|BMD
P09869297A1807|27 29|CE1
P09869297A1807|33 43|CE2 elements
P09869297A1807|56 64|Hoxb1 gene
P09869356A0926|0 2|CAL
P09869356A0926|51 53|CAL
P09869400A0203|71 84|Arabidopsis GLP
P09869528T0000|30 31|RF
P09872326A0566|22 42|EIA-inducible CBF/cdc2
P09872326A0566|57 59|CBF
P09872326A0566|86 111|heat shock protein 70 promoter
P09872337A0000|178 191|clindamycin HCl
P09872832A1262|3 5|BAL
P09872832A1262|90 108|interleukin-6 (IL-6)
P09872832A1262|91 113|nterleukin-6 (IL-6), IL-8
P09872832A1262|92 119|terleukin-6 (IL-6), IL-8, IL-12
P09872832A1262|93 156|erleukin-6 (IL-6), IL-8, IL-12, tumor necrosis factor-alpha (TNF-alpha)
P09872832A1262|161 186|interferon gamma (IFN-gamma)
P09873060A0901|48 54|ERK-1/2
P09873060A0901|101 104|JunD
P09873060A0901|108 111|FosB
P09874803A0000|8 17|pathogenic
P09874803A0000|69 84|cysteine protease
P09874803A0000|99 107|pyrogenic
P09874803A0000|117 123|(SpeB)]
P09875541A0210|102 137|self-initiated hand movement task (SELF)
P09876794T0000|12 23|evidence base
P09877417A0704|0 8|Plasma CCK
P09878256A0000|3 37|peroxisome biogenesis disorders (PBDs)
P09878437A0967|35 39|Asp53
P09878542A1151|77 79|VDR
P09878542A1151|99 113|osteopontin VDRE
P09879766A0402|2 6|PAV-3
P09879766A0402|11 19|E1A region
P09880029A0703|11 13|MDV
P09880029A0703|51 57|non-Rep
P09880029A0703|125 129|FBNYV
P09880029A0703|174 179|MDV-C2
P09880029A0703|226 232|SCSV-C2
P09880103A0387|0 2|MPO
P09880103A0387|17 24|1 mCi 125I
P09880103A0387|67 81|10(-4) M hydrogen
P09880327A0322|153 161|cis-Golgi
P09880512A1251|52 70|acid-bound receptors
P09880543A0570|0 3|HEED
P09880543A0570|20 21|MA
P09880544A0693|0 17|Fas-resistant DT-40
P09880544A0693|41 53|BTK-deficient
P09880544A0693|84 90|btk gene
P09880544A0693|159 175|but wild-type DT-40
P09880544A0693|162 175|wild-type DT-40
P09880544A0693|183 195|BTK-deficient
P09880544A0693|237 243|btk gene
P09881666A0535|1 15|motif (TGATGTCA)
P09881666A0535|29 32|CREB
P09881666A0535|53 56|AP-1
P09881666A0535|77 79|ER2
P09881692A0094|101 111|Ckappa1 gene
P09881692A1109|97 105|probe DNAs
P09882303T0000|0 11|Epstein-Barr
P09882303T0000|59 61|JNK
P09882303T0000|117 121|TRADD
P09882303T0000|125 129|TRAF2
P09882303A1413|0 4|TRAF2
P09882303A1413|27 31|TRADD
P09882303A1413|49 88|dominant-negative N-terminal deletion TRAF2
P09882303A1413|121 135|LMP1-induced JNK
P09882303A1984|30 34|TRADD
P09882303A1984|38 42|TRAF2
P09882303A1984|45 47|JNK
P09882303A1984|72 75|LMP1
P09882303A1984|113 128|TNF receptor/CD40
P09882321A0948|48 53|EBNA-3
P09882321A0948|70 85|increase in EBNA-3
P09882321A0948|117 126|EBNA-3 gene
P09882321A0948|137 146|EBNA-3 cDNA
P09882334A0822|29 43|lamb kidney (FLK)
P09882334A0822|82 84|BLV
P09882334A0822|161 175|N-terminal motif
P09882337A0000|0 39|Varicella-zoster virus (VZV) glycoprotein gI
P09882337A0000|110 131|gE:gI Fc receptor complex
P09882348A0611|56 69|tyrosine kinase
P09882348A0611|144 151|oncogene
P09882451A0195|65 74|endogenous
P09882451A0195|75 99|ferrochelatase gene (HEM15)
P09882499A0231|64 85|cis-regulatory elements
P09882593A0996|30 46|ickel isotope, 61Ni
P09883639A0000|42 58|mycobacteria (NTM)
P09884232A0286|26 29|attP
P09884232A0286|27 34|ttP, attB
P09884232A0286|38 67|bacteria-prophage junctions attL
P09884232A0286|71 74|attR
P09884232A0286|151 163|integrase gene
P09884275T0000|0 15|Interferon-alpha
P09884747A0477|187 194|serum IgE
P09885431A0000|0 8|OBJECTIVE
P09886602A0000|0 9|OBJECTIVES
P09886602A0000|46 88|post-treatment prostate-specific antigen (PSA)
P09886602A0000|223 247|beam radiation therapy (XRT)
P09886602A0000|270 272|PSA
P09886843A0339|75 95|T3-responsive elements
P09886843A0339|98 101|NRGN
P09886850A0145|28 36|PPARgamma
P09886850A0145|125 131|MEK/ERK
P09887544A0000|0 9|BACKGROUND
P09888994A0858|4 21|Tbx6-subfamily gene
P09888994A0858|73 85|somitogenesis
P09889202T0000|31 55|Z-DNA-binding domain Zalpha
P09889202T0000|58 80|dsRNA adenosine deaminase
P09889202T0000|108 113|(alpha
P09889202T0000|115 119|beta)
P09889306A0321|26 35|Glvr-1 gene
P09891009T0000|18 38|mouse glycolate oxidase
P09891046A0269|23 25|PKR
P09891046A0269|89 91|PKR
P09891046A0554|47 49|PKR
P09891049A0761|45 53|nucleases
P09891049A0761|68 71|rRNA
P09891061A0373|57 68|SpHE promoter
P09891061A0373|157 166|cis element
P09891061A1240|22 25|SpHE
P09891061A1240|62 71|SpEts4 gene
P09891061A1240|114 117|SpHE
P09891065A1493|12 27|rhoA-mediated SRE
P09891065A1493|75 83|PKC-alpha
P09891065A1493|86 96|PKC-epsilon
P09891085A0815|89 91|27S
P09891092A1000|39 41|III
P09891707A0000|23 46|spondyloarthropathy (SpA)
P09892017A2151|58 61|ELE1
P09892021A0712|16 19|PTTG
P09892021A0712|33 38|NIH 3T3
P09892642A0172|4 14|DNA helicase
P09892642A0172|35 37|HPV
P09892662A0334|15 32|mutant alpha subunit
P09892662A0334|50 66|receptor-mediated
P09892662A0334|123 129|cyclase
P09892736A0343|20 35|C-terminal region
P09892736A0343|38 46|CDED/LIOR
P09892736A0343|141 144|ORC1
P09892736A0343|148 150|KSR
P09893262A1272|84 91|TGF-beta
P09895323T0000|70 79|Hoxb3 genes
P09914156A1496|63 80|tenascin-C promoter
P09914156A1496|128 153|collagen-dependent promoter
P09914156A1496|175 194|a 122-base pair element
P09914156A1496|227 229|RNA
P09914500A0000|7 29|factor kappa B (NF-kappaB)
P09914500A0000|155 183|tumor necrosis factor (TNF)alpha
P09914500A0000|174 183|(TNF)alpha
P09914518A1217|53 60|COUP-TFI
P09914518A1217|84 87|AF-1
P09914518A1217|113 114|ER
P09914518A1217|174 176|ICI
P09914525A0890|35 44|89 degreesC
P09915798A1077|25 39|ATP-independent
P09915798A1077|69 91|hsp90 dimerization domain
P09915798A1077|134 148|steroid receptor
P09915860A0000|16 32|rat pgp2/mdr1b gene
P09915860A0000|37 57|GC-rich region (pgp2GC)
P09915860A0000|81 88|mdr genes
P09915860A0119|31 48|pgp2/mdr1b promoter
P09916786A0811|147 178|bone-specific alkaline phosphatase
P09916809A0405|5 7|MGP
P09916809A0405|11 15|10-kD
P09916809A0405|37 47|matrix (ECM)
P09916809A0405|93 123|19-aa transmembrane signal peptide
P09917064T0000|18 32|clam CPEB homolog
P09917387T0000|3 41|RNA polymerase III-recruiting factor TFIIIB
P09917387T0000|50 52|DNA
P09917387T0000|67 70|TATA
P09917389A1239|12 16|RNase
P09917389A1239|29 38|finP305 RNA
P09917389A1239|51 54|FinP
P09917389A1239|59 66|GST-FinO
P09917389A1239|80 89|finP305 RNA
P09918715A0304|0 3|MotA
P09918715A0304|14 16|DNA
P09918715A0304|27 30|MotA
P09918715A1158|13 16|MotA
P09918715A1158|20 23|AsiA
P09918715A1158|56 59|TAFs
P09918715A1158|60 64|(TATA
P09918715A1158|65 83|binding protein (TBP)
P09918715A1158|107 118|binding to TBP
P09918715A1158|148 159|core promoter
P09918720A0998|3 7|S229A
P09918842A0184|110 112|RNA
P09920539A0272|37 42|GnRH-a
P09920775A0075|78 89|reporter gene
P09920896A1230|52 63|type peptides
P09920903A1045|26 34|c-met gene
P09920903A1045|50 56|p53 gene
P09920930A0521|26 29|RhoA
P09920930A0521|57 63|SRE:Luc
P09920930A0521|89 107|LPA-stimulated c-Fos
P09920930A0959|67 74|AP-1:Luc
P09920930A0959|131 138|AP-1:Luc
P09920982A0253|163 172|Rap ID ANA II
P09922230A1482|39 42|CAP1
P09922856A0459|61 78|absorption promoter
P09923245A0482|3 6|RMRI
P09924675A0412|65 69|ICIDH
P09924987A0000|17 28|protein (PAP)
P09924987A0000|69 81|N-glycosidase
P09924987A0000|105 110|(A4324
P09924987A0000|113 119|28S rRNA
P09924987A0000|130 137|23S rRNA)
P09925120A0074|0 8|OBJECTIVE
P09925372A0458|10 16|360 ZFPs
P09925372A0458|24 30|ZFP cDNA
P09925372A0458|36 39|HFHZ
P09925372A0458|51 59|heart ZFP)
P09925372A0458|64 79|sequence homology
P09925372A0458|83 109|Kruppel-associated box (KRAB)
P09925372A1063|73 80|HFHZ mRNA
P09925777A1195|11 23|affinity hnRNP
P09925777A1195|55 73|beta-globin reporter
P09925777A1195|126 130|mRNAs
P09927193A0107|15 26|roteins, PLZF
P09927193A0107|30 40|LAZ-3/BCL-6
P09927193A0107|62 72|oncogenesis
P09927449A0421|16 19|POG1
P09927449A0421|28 47|alpha-factor-induced
P09927449A0421|89 92|CLN1
P09927449A0421|96 104|CLN2 genes
P09927570A0507|13 16|RNU2
P09927570A0507|82 93|Ad12 E1B 55 kDa
P09927570A0507|140 142|E1A
P09927570A0507|163 170|E1B 19 kDa
P09927570A0507|166 170|19 kDa
P09927585A0796|0 24|Competitionsupershift EMSA
P09927585A0796|73 88|bandshift complex
P09927585A0796|102 104|KCS
P09927589T0000|12 14|DNA
P09927589T0000|52 77|Caenorhabditis elegans MAB-3
P09927589T0000|103 105|DSX
P09929088A0000|0 6|CONTEXT
P09929088A0000|1 15|ONTEXT: ThinPrep
P09929088A0000|2 23|NTEXT: ThinPrep, AutoPap
P09929811A0000|142 147|CM-251
P09929811A0000|143 154|M-251, CM-266
P09929811A0000|159 164|CM-345
P09929811A0000|192 193|ST
P09931118A1072|22 24|JNK
P09931118A1072|56 63|IL-1beta
P09931435A0357|36 43| nine exon
P09931435A0357|54 58|ZIS-2
P09931435A0357|70 74|ZIS-1
P09931435A0357|98 102|exon)
P09931435A0357|105 109|ZIS-1
P09931435A0357|143 148|3'-UTR
P09932288A0378|21 29|gene (XT3)
P09932288A0378|104 107|cDNA
P09933428A0351|0 8|IFN-gamma
P09933428A0351|32 33|TB
P09933641A0241|58 61|cDNA
P09933641A0241|81 86|an NHE5
P09933641A0241|161 164|cDNA
P09934611A1054|60 69|min LVdP/dt
P09938097T0000|72 75|ZnTe
P09944066T0073|0 1|II
P09945838T0000|38 51|GaAs/(Al,Ga)As
P09947191T0000|50 56|CsMnBr3
P09949160A0600|12 14|32D
P09949160A0600|43 49|bulk PKC
P09949160A0600|99 112|eta PKC isoforms
P09949160A0600|177 181|betaI
P09949178A0264|33 51|interleukin-6 (IL-6)
P09949178A0264|86 95|pre-B-cell
P09949178A0264|104 112|ine, 1A9-M
P09950213A1660|34 51|oblet cells, TbetaRI
P09950213A1660|55 62|TbetaRII
P09950213A1660|90 98|exogenous
P09950213A1660|99 106|TGF-beta
P09950213A1660|132 140|TbetaRIII
P09952378A0529|15 17|CHD
P09952378A0529|92 94|IgG
P09952425A0893|14 18|HIPP-
P09952425A0893|22 33|HCX-lesioned
P09959737T0000|23 29|SN 1987A
P09964171T0000|0 2|NMR
P09965234T0000|29 51|octylcyanobiphenyl (8CB)
P09971776A0838|22 24|CD4
P09971776A0838|133 159|AP-recruiting dileucine motif
P09971776A0838|173 181|dipeptide
P09971776A0838|187 202|C-terminal region
P09971790A0856|28 39|endonuclease
P09971790A0856|43 50|helicase
P09971790A0856|111 133|protein (D40A-D42A-D44A)
P09971790A0856|148 160|AAV hairpin DNA
P09971806A1585|15 18|KSHV
P09971806A1585|55 66|KSHV/Rta gene
P09971806A1585|91 107|tumor pathogenesis
P09971815A2094|40 60|candidate latency genes
P09971815A2094|69 77|gammaHV68
P09971815A2094|222 233|(iii) regions
P09971815A2094|236 261| the viral genome (v-bcl-2 gene
P09971815A2094|244 261|genome (v-bcl-2 gene
P09971815A2094|245 267|enome (v-bcl-2 gene, v-GCR
P09971815A2094|318 326|gammaHV68
P09971822A1542|39 50|NRS-mediated
P09973351A1522|19 27|DcuS-DcuR
P09973607A0254|138 146|Sp100 gene
P09980944T0000|23 47|superconductor Y2Ba4Cu7O15
P09980944T0000|60 62|NQR
P09982923T0000|28 32|NiSi2
P09982923T0000|35 39|CoSi2
P09983871T0000|20 33|YBa2-xLaxCu3O7
P09987176A0260|102 109|anti-HAV
P09987634A1265|13 15|PRK
P09987634A1265|82 84|PRK
P09988682T0033|23 26|cDNA
P09988682T0033|41 79|beta1,6-N-acetylglucosaminyltransferase
P09988767A1496|56 69|mouse 3Ost genes
P09988850A0000|52 67|Records (SCIRFIR)
P09989334A0964|118 138|muscle-specific intron
P09990057T0000|34 43|endogenous
P09990057T0000|83 95|chain intronic
P09990057T0000|96 113|enhancer core region
P09990057T0000|131 153|matrix attachment regions
P09990060A0803|53 71|dyad symmetry element
P09990060A0803|103 114|IL-2 enhancer
P09990060A0803|121 132|CD18 promoter
P09990060A0937|16 30|coactivator CREB
P09990060A0937|69 77|GABPalpha
P09990060A0937|91 99|GABPalpha
P09990060A0937|103 107|-beta
P09990060A0937|113 131|dyad symmetry element
P09990060A0937|154 166|IL-16 promoter
P09990315A0205|0 2|TPO
P09990315A0205|25 28|ERK1
P09990315A0205|26 33|RK1, ERK2
P09990315A0205|37 55|protein kinase C (PKC)
P09990315A0205|64 66|TPO
P09990315A0205|86 98|PKC-dependent
P09990315A0205|111 114|ERKs
P09990315A0205|190 192|PKC
P09990507A0000|0 9|BACKGROUND
P09990507A0000|17 73|biquitin-dependent proteolysis pathway, a ubiquitin ligase (E3)
P09990507A0763|0 10|CONCLUSIONS
P09990507A0763|1 26|ONCLUSIONS: Fission yeast SCF
P09990507A0763|99 113|F-box/WD-repeat
P09994942T0000|0 5|19F NMR
P09994942T0000|15 23|ABF4-type
P09995897T0000|54 65|(111) Si/SiO2
P09999742T0000|0 2|NH3
P09999742T0000|6 7|NO
P10000253T0000|45 72|two-dimensional random-bond XY
P10001333T0038|16 25|Pr3+:YAlO3
P10002245T0000|36 38|CuO
P10002245T0000|47 70|a single-domain YBa2Cu3O7-
P10008261T0000|62 70|YBa2Cu3O6
P10009565T0000|0 1|GW
P10019841T0000|22 35|post-Newtonian
P10021350A0093|18 29|Wingless/Wnt
P10021350A0093|46 67|Armadillo/beta-catenin
P10021350A0093|105 111|TCF/LEF
P10021350A0093|191 202|Wingless/Wnt
P10022032A0000|41 66|vasodilator nicorandil (NIC)
P10022032A0000|85 134|beta-adrenergic receptor antagonists propranolol (PRO)
P10022032A0000|138 150|atenolol (ATN)
P10022032A0000|161 195|calcium channel blocker diltiazem (DTZ)
P10022210A0620|18 42|direct-immersion (DI)-SPME
P10022850A0929|48 57|C/H1 domain
P10022858A0985|18 33|splicing enhancer
P10022858A0985|82 87|20-kDa
P10022858A0985|88 89|SR
P10022867A1069b|13 16|ETH1
P10022867A1069a|13 16|ETH1
P10022875A1265|55 64|PI 3-kinase
P10022880A0000|9 40|Ras GTPase-activating protein (GAP)
P10022880A0000|10 52|as GTPase-activating protein (GAP), p120 Ras-GAP
P10022905A0446|5 16|mog-1 alleles
P10022905A0446|33 42|stop codons
P10022905A0446|124 140|ctivity. mog-1 mRNA
P10022921A0608|17 24|SIN3 gene
P10022978A1261|71 97|beta-heterochromatic regions
P10024498A0783|51 55|HNF-3
P10024498A0783|110 119|HNF-3alpha
P10024498A0783|123 131|HNF-3beta
P10024882A0541|48 74|carboxy-terminal domain (CTD)
P10024882A0541|77 79|RNA
P10024882A0541|83 84|II
P10025050A1052|15 25|H2-receptor
P10025506A0079|14 43|tissue-specific plastin isoforms
P10025506A1078|2 5|TATA
P10026146A0680|18 31|RIalpha subunit
P10026146A0680|79 82|cAMP
P10026146A0680|83 85|(Ka
P10026146A0680|87 91|40 nM)
P10026146A0680|114 117|PrKX
P10026146A0680|132 158|cAMP-dependent protein kinase
P10026146A0680|181 184|cAMP
P10026146A0680|223 235|Calpha subunit
P10026146A0680|238 264|cAMP-dependent protein kinase
P10026211A0136|22 29|PEPCK CRE
P10026211A0136|40 63|CRE-binding protein (CREB)
P10026211A0136|79 114|CCAAT/enhancer-binding protein (C/EBP)
P10026211A0543|20 33|pDeltaCREC/EBP
P10026211A0543|40 49|C/EBPalpha
P10026211A0543|63 66|CREB
P10026211A0543|147 151|H4IIE
P10026229A0950|18 28|mutagenesis
P10026229A0950|152 159|intronic
P10026275A0549|16 32|structure elements
P10026784A0331|95 112|POU DNA binding motif
P10026784A0929|0 28|High-affinity site-specific DNA
P10026784A0929|38 46|POU domain
P10026784A0929|82 93|POU-specific
P10026784A0929|100 114|POU-homeodomain
P10026784A2166|21 38|POU-specific domain
P10026784A2166|50 53|GCAT
P10026784A2166|108 130|Pit-1 POU-specific domain
P10026784A2166|109 135|it-1 POU-specific domain, GTAT
P10026824A0309|30 50|V1a/V2 hybrid receptors
P10026824A0309|92 102|V1a receptor
P10026824A0309|191 200|V2 receptor
P10027498A0536|75 77|U.S
P10029337A0406|68 70|(SD
P10029337A0406|101 123|serum creatine kinase (CK)
P10029337A0406|150 152|(SD
P10032519T0000|57 66|generation
P10034615T0000|70 82|x 2)-H/Ni(110)
P10036181A0603|50 58|GPR34 mRNA
P10036181A0603|87 101|rat brain regions
P10036191A0000|3 25|microphthalmia-TFE (MiT)
P10036191A0000|42 80|helix-loop-helix leucine zipper (bHLH-ZIP)
P10036191A0000|111 114|TFE3
P10036191A0000|112 119|FE3, TFEB
P10036191A0000|113 124|E3, TFEB, TFEC
P10036191A0000|168 186|tissue-specific gene
P10037004A0000|53 65|leukemia (ALL)
P10037004A0000|81 94|bone marrow (BM)
P10037681A0494|23 25|ARF
P10037681A0494|29 37|PKC-alpha
P10037681A0494|42 45|PLD1
P10037681A0494|90 93|PLD1
P10037681A0494|102 106|"D4")
P10037681A0494|138 141|RhoA
P10037681A0494|139 152|hoA, RhoAVal-14
P10037774A0366|72 85|OM-induced LDLR
P10043466T0000|22 41|ultrafast-relaxation
P10043466T0000|62 81|polydiacetylene 4BCMU
P10049357A0608|40 50|HDAC complex
P10049359A1073|48 50|PTB
P10049359A1073|87 100|rhinovirus IRES
P10049742T0000|43 59|DNA-binding domain
P10049742T0000|62 64|ZF5
P10049775T0000|17 53|Voltage-Dependent Anion Channel isoforms
P10049912T0000|16 20|RNase
P10049912T0000|49 50|UV
P10049912T0000|76 102|single-strand DNA exonuclease
P10050883A0967|12 39|phosphatidylinositol-3 kinase
P10050883A0967|70 72|p53
P10051030A1080|64 72|trains, CP
P10051400A0000|53 67|tube defect (NTD)
P10051488A1293|17 23|AP-1 DNA
P10051488A1293|69 72|HSCs
P10051488A1293|96 124|mobility AP-1 complexes (HMAP-1)
P10051488A1610|14 17|AP-1
P10051488A1610|27 40|TIMP-1 promoter
P10051488A1610|65 70|HMAP-1
P10051488A1610|117 120|HSCs
P10052371A0171|0 10|STUDY DESIGN
P10053852T0000|33 53|Gerasimov-Drell-Hearn
P10063122T0000|0 10|Two-Channel
P10063739A0601|80 83|[SD]
P10063739A0601|93 97|mmHg)
P10063739A0601|119 123|mmHg)
P10063739A0601|157 159|EVS
P10063739A0601|162 164|EVL
P10064604A0824|0 3|CPDs
P10064604A0824|41 46|TFIIIA
P10065176A0657|25 39|hormone receptor
P10065176A0657|68 86|lymph node metastases
P10065176A0657|94 112|lymph node metastases
P10065176A0657|129 143|macrometastases
P10065684A0916|53 62|(RV)/total
P10065684A0916|63 79|lung capacity (TLC)
P10065684A0916|174 191|sarcomeres (L(sar))
P10066790A0497|0 12|Gel filtration
P10066790A0497|81 85|beta4
P10066790A0497|101 112|multisubunit
P10066790A0497|113 125|complex (AP-4)
P10066790A0497|145 161|sigma4 polypeptide
P10066790A0497|178 199|adaptor subunit homologs
P10066790A0497|205 216|mu4 (mu-ARP2)
P10066798A0391|0 24|Cyclin D1-associated kinase
P10066798A0391|94 119|tumor virus-pp60(c-src527F)
P10066815T0000|3 50|SH2 domain-containing inositol 5'-phosphatase (SHIP)
P10066815T0000|62 71|p85 subunit
P10066815T0000|74 97|phosphoinositide 3-kinase
P10066815T0000|104 124|FcgammaRIIb1-mediated
P10066815T0000|137 149|B cell receptor
P10068040A0136|47 55|ubc-9 gene
P10068418A1194|123 130|estrogen
P10068446A0124|56 58|PKC
P10068446A0124|94 96|BPO
P10068446A0124|101 133|redox-active cysteine residues in PKC
P10068637A1320|14 21|Csx/Nkx2
P10068674A0644|42 47|Lyp RNA
P10068834A0713|12 13|DM
P10068834A0713|24 25|PE
P10068834A0713|25 28|E, DM
P10068834A0713|39 40|VR
P10068834A0713|44 45|DM
P10068834A0713|55 56|MR
P10070158A0573|56 68|cassette exons
P10070158A0573|110 128|transmembrane domain
P10071205A0833|41 43|ORF
P10071205A0833|50 53|STA2
P10071205A0833|70 86|in-frame AUG codons
P10071761A2374|23 36|promoter region
P10071761A2374|145 148|UCP2
P10072205A0167|44 45|ML
P10072205A0167|49 51|MAP
P10072774A0537|0 5|RT-PCR
P10072774A0537|41 50|degenerate
P10072774A0537|78 101|ligand binding domain (LBD)
P10072774A0537|109 128|beta integrin subunits
P10072774A0537|132 138|Bge cDNA
P10073899A0740|52 54|EAF
P10073899A0740|82 84|CVS
P10073947A1110|29 33|FVIIa
P10073947A1110|37 41|PAI-1
P10074135T0000|91 94|RNA1
P10074282A0236|47 64|L-NNA (NO-synthesis
P10074282A0236|98 104|cGMPase
P10074425A0729|30 48|cyclin E-Cdk2 complex
P10074425A0729|61 67|mitogen
P10074425A0729|94 97|MEFs
P10074425A0729|130 136|p27 gene
P10074520T0000|35 40|IS2404
P10074520T0000|44 49|IS2606
P10074520T0000|116 118|PCR
P10074903A0915|122 125|IFNs
P10074921A1169|35 39|HepG2
P10074921A1169|70 74|wt p53
P10075415A1178|40 46|ORF-Pto
P10075415A1178|68 77|ru/AB genes
P10075415A1178|89 90|UV
P10075415A1178|106 117|plasmid pPSR1
P10076007A0656|3 6|MSY2
P10076007A0656|17 22|kinase
P10076007A0656|28 39|casein kinase
P10076007A0656|45 50|kinase
P10076007A0656|74 80|mRNP3+4
P10076007A0656|110 115|kinase
P10077188A1172|16 33|helicase-like genes
P10077188A1172|185 188|mRNA
P10077533A0976|63 65|MKS
P10077533A0976|72 79|MUL genes
P10078876A0000|164 176|laser-Doppler
P10079173A0000|42 75|RNP-type RNA recognition motifs (RRMs)
P10080875A0772|125 133|NF-kappaB
P10080875A0772|175 183|NF-kappaB
P10080875A0772|197 201|c-Rel
P10080875A0772|199 226|Rel, Rel B), AP-1 proteins (c-Fos
P10080875A0772|200 233|el, Rel B), AP-1 proteins (c-Fos, C-Jun)
P10080875A0772|201 238|l, Rel B), AP-1 proteins (c-Fos, C-Jun), CREB
P10080875A0772|241 257|C/EBPbeta (NF-IL6)
P10080901A0271|84 99|N-terminal domain
P10082137A0262|20 28|IFN-gamma
P10082137A0262|80 96|factor (IRF)-1 mRNA
P10082137A0262|145 168|alpha1(I) procollagen mRNA
P10082554T0000|19 31|c-myc promoter
P10082570A0440|25 33|gene UBP43
P10082573A1015|46 48|HS2
P10082573A1015|47 52|S2, HS3
P10082573A1015|57 59|HS4
P10082573A1015|100 109|globin gene
P10082573A1015|125 136|a holocomplex
P10082573A1015|186 190|DNase
P10082573A1015|206 216|holocomplex
P10082573A1015|249 268|high-level globin gene
P10082585A0512|20 26|non-Sir
P10082585A0512|44 47|rDNA
P10082585A0512|134 146|reporter genes
P10082585A0512|166 169|rDNA
P10084294A0219|35 48|EPO-stimulated
P10084294A0219|58 68|progenitors
P10085088A0918|27 36|p33 subunit
P10085088A0918|39 42|eIF3
P10085088A0918|68 82|initiation phase
P10085088A0918|111 127|RNA-binding domain
P10085120A0000|61 72|therapy (PDT)
P10085140A1004|24 28|ATF-2
P10085140A1004|48 55|TGF-beta
P10085140A1004|108 111|TAK1
P10085383A1367|0 2|KEY
P10085383A1367|3 7|WORDS
P10085505A1184|68 74|56 cases
P10085605A0239|23 39|alpha-fetoprotein
P10085605A0239|65 72|alpha hCG
P10085605A0239|70 72|hCG
P10085697T0000|0 39|FASEB Federal Funding Consensus Conference FY
P10086544A0504|95 97|CPB
P10086544A0504|269 286|neutrophil elastase
P10086725A0000|0 8|MDS1/EVI1
P10086725A0000|46 67|zinc-finger DNA-binding
P10087213A0878|39 48|replicases
P10087549A0720|3 5|JTc
P10087549A0720|49 51|JTc
P10087549A0720|62 63|VT
P10087549A0720|87 89|JTc
P10087549A0720|100 102|PVC
P10087549A0720|133 135|JTc
P10087993A0782|44 56|delta promoter
P10087993A1352|0 23|Site-directed mutagenesis
P10087993A1352|44 63|repressor proteins BP1
P10087993A1352|67 69|BP2
P10087993A1352|95 108|beta globin gene
P10087993A1352|136 153|increase in promoter
P10090125A0750|15 20|alpha1
P10090146T0000|24 32|AP-2alpha
P10090146T0000|36 43|AP-2beta
P10090146T0000|83 96|R-FABP promoter
P10090146T0000|107 110|AP-2
P10090535A1194|23 24|TG
P10090535A1194|36 39|apoB
P10090943A1426|17 21|CD79b
P10090943A1426|27 31|CD79b
P10090943A1426|68 69|SD
P10090943A1426|98 99|SD
P10090943A1426|102 106|B-CLL
P10090943A1426|107 108|(P
P10090943A1976|51 55|CD79b
P10090943A1976|140 144|B-CLL
P10091594A0284|40 61|tructure predictions, CD
P10091594A0284|65 67|NMR
P10091594A0284|92 96|ELISA
P10091594A0284|195 203|anti-K159
P10091619A0104|9 18|England ADL
P10092132A0285|0 20|High-level gains (HLGs)
P10092847A0455|36 39|MREs
P10092847A0455|47 60|promoter region
P10092847A0455|65 75|hMT-IIA gene
P10092847A0455|101 126|mouse metallothionein-I gene
P10092847A0455|142 144|MRE
P10092856A0798|3 6|cDNA
P10092856A0798|75 100|phosphate isomerase promoter
P10094314A0935|17 19|RNA
P10094314A0935|49 62|zinc knuckle 9G8
P10094314A0935|96 100|SRp20
P10094314A0935|131 133|RBD
P10094314A0935|136 138|9G8
P10094314A0935|142 146|SRp20
P10094396A0000|0 14|Topoisomerase II
P10094396A0000|34 58|protein kinase casein kinase
P10094396A0000|60 62|(PK
P10094396A0000|63 66|CK2)
P10094701A0000|54 72|acetate kinase (ackA)
P10095059A1003|41 54|wild-type HIV-1
P10095061A0592|31 34|MEMA
P10095061A0592|58 63|160 kDa
P10095061A0592|71 77|'domain
P10095061A0592|82 96|in serines' (DRS)
P10095062A0558|43 66|topoisomerase IIalpha gene
P10095062A0558|83 89|35 exons
P10096573A0207|65 97|factor (NF)-kappaB consensus element
P10096573A0207|135 152|MGSA/GRO-alpha gene
P10097120T0000|36 39|mRNA
P10097932A0915|4 14|CsA-treated
P10097932A0915|52 55|UAER
P10097932A0915|138 141|UAER
P10098601A1320|23 32|-84/-55 DNA
P10098601A1320|43 47|JEG-3
P10098601A1320|107 110|SF-1
P10099247A1051|5 13|reactor pH
P10099247A1051|84 86|SRB
P10099247A1051|149 168|acetate-utilising SRB
P10099247A1051|181 182|MB
P10101159A0742|20 27|SOC1 gene
P10101159A0742|78 90|cbp1 ts alleles
P10101159A0742|120 124|mRNAs
P10101198A0632|63 78|N-terminal region
P10101198A0946|1 8|database
P10101198A0946|87 123|transcription termination factor (mTERF)
P10101198A0946|146 148|DNA
P10102000A1206|33 38|ERA-II
P10102000A1206|53 59|ERA-III
P10102136A0220|16 18|PSA
P10102136A0646|53 55|PSA
P10102136A0646|64 65|II
P10102627A0217|11 13|DNA
P10102627A0217|12 41|NA binding activity, AP-1 reporter
P10103057A0251|84 93|Runt domain
P10103057A0251|96 99|AML1
P10119827T0000|0 7|Judge OKs
P10120952T0000|0 4|HANYS
P10132730T0000|8 18|CareNetwork
P10134977T0000|0 4|JCAHO
P10146207A0223|0 14|Ultrasonography
P10153759A0360|0 3|UPMC
P10153759A0360|46 49|NHBC
P10171173A0955|26 49|blood transfusion-related
P10171173A0955|108 112|non-A
P10171173A0955|109 118|on-A, non-B
P10187317T0000|20 24|AHERF
P10187798A1098|22 26|DAP-1
P10187798A1098|53 65|TNF-sensitive
P10187798A1098|97 109|TNF-resistant
P10187798A1098|98 134|NF-resistant osteosarcoma cell line, U2OS
P10187842A1155|18 27|PPARgamma2
P10187842A1155|134 142|PPARalpha
P10187864A1372|19 22|KCC3
P10187864A1372|40 42|KCC
P10187864A1372|82 85|KCC1
P10190324A0000|17 27|elastin gene
P10190324A0000|73 86|stenosis (SVAS)
P10190324A0000|140 157|(nonsyndromic) SVAS
P10191090A0000|29 36|PAX3 gene
P10192134A1088|0 7|25-OH-D3
P10192638T0000|0 27|Methanesulfonyl fluoride (MSF)
P10193950A0478|0 6|METHODS
P10193950A0478|71 75|(TNM)
P10193950A0478|160 173|111In-capromab
P10194230A0817|17 36|urgery, dialysate PGE2
P10194230A0817|79 89|296 +/- 127 nM
P10194451A0000|57 90|p210(bcr/abl) protein tyrosine kinase
P10194451A0000|118 130|chronic-phase
P10194451A0000|138 148|myelogenous
P10194451A0000|157 160|(CML
P10194451A0000|231 246|chronic-phase CML
P10194451A0000|260 269|progenitor
P10194762A0648|25 56|glutathione-S-transferase-fusion
P10194762A0648|77 107|C-terminal transactivation domain
P10194762A0648|110 115|STAT5a
P10194762A0648|122 133|GH-regulated
P10194762A0648|147 152|ERK1/2
P10194762A0648|197 213|serine 780 in STAT5a
P10194769A0146|8 16|lement, 1P
P10194769A0146|53 56|cDNA
P10194769A0146|80 94|417-amino acid WD
P10194769A0146|113 116|PREB
P10194769A0146|117 120|(PRL
P10195425T0000|21 44|transcription factor MTF-1
P10195425T0000|70 74|(Fugu
P10195690A0000|3 50|peroxisome proliferator-activated receptors (PPARs)
P10195690A0000|73 87|hormone receptor
P10195697A0456|8 14|F-SRC-1
P10195697A0456|28 48|CBP-interacting domain
P10196248A0482|19 21|TTV
P10196248A0482|118 130|117-nt GC-rich
P10196248A0482|138 140|(GC
P10196266A0000|62 88|mink cell focus-inducing (MCF)
P10196266A0000|105 126|leukemia viruses (MuLVs)
P10196316A0715|24 28|VZV gK
P10196316A0715|52 53|gK
P10196316A0715|88 90|VZV
P10196316A0715|97 99|DNA
P10196318T0000|0 4|CCAAT
P10196318T0000|86 96|E1 promoters
P10197763A0580|47 64|AMP response element
P10197985A0145|7 11|RNase
P10197985A0145|112 143|branchpoint sequence (BPS) elements
P10197985A0145|152 160|U12 snRNPs
P10197985A0145|226 233|pre-mRNA
P10198003A1505|10 13|lacZ
P10198003A1505|48 59|KdgR-binding
P10198003A1505|96 99|rsmB
P10198056A0000|68 100|glycosylphosphatidylinositol (GPI)
P10198061A0339|6 37|ell-free import assay, beta-catenin
P10198061A0339|77 85|exogenous
P10198061A0339|110 116|ATP/GTP
P10199539A1353|85 87|VO2
P10200473A0171|2 11|endogenous
P10200473A0171|74 81|(aliases
P10200473A0171|99 102|CASH
P10200473A0171|101 115|SH, Casper, CLARP
P10200473A0171|102 123|H, Casper, CLARP, FLAME-1
P10200473A0171|103 128|, Casper, CLARP, FLAME-1, FLIP
P10200473A0171|104 136| Casper, CLARP, FLAME-1, FLIP, I-FLICE
P10200473A0171|140 144|MRIT)
P10201468A0297|28 39|insulin (IRI)
P10201468A0297|29 49|nsulin (IRI), C-peptide
P10201468A0297|63 67|GLP-1
P10201468A0297|95 98|OGTT
P10202006A0546|44 50|B domain
P10202006A0546|67 79|protein A (SPA)
P10202006A1266|17 21|ssDNA
P10202006A1266|42 49|VH domain
P10202006A1266|52 81|immunization-induced anti-Z-DNA
P10202006A1266|142 153|VH-dependent
P10202006A1266|245 249|Z-DNA
P10205099A0377|0 12|INTERVENTIONS
P10205176A0000|7 20|receptors (NRs)
P10205176A0704|27 43|DNA-binding domain
P10205176A0704|28 48|NA-binding domain, PSU1
P10205588A0000|0 8|OBJECTIVE
P10205588A0000|73 87|beta-haemolytic
P10205588A0000|102 122|Lancefield group A (beta
P10205588A0000|123 126|HSA)
P10205933A0699|134 144|Burgdorferi
P10205933A0699|168 178|Lyme Disease
P10206152A1024|107 118|messenger RNA
P10206698A2041|28 54|signature-tagged mutagenesis
P10207041A0065|66 76|cyclin genes
P10207041A0065|135 157|cyclin-dependent kinases
P10207049A0693|3 10|GAC1 gene
P10207049A0693|42 87|type 1 serine/threonine phosphoprotein phosphatase
P10207049A1001|28 42|Glc7 phosphatase
P10207049A1001|89 91|HSF
P10207049A1001|104 107|CUP1
P10207087A0956|0 2|MEF
P10207087A0956|6 10|AML1B
P10207087A0956|42 73|interleukin 3 promoter reporter gene
P10207087A0956|110 112|MEF
P10207087A0956|129 131|MEF
P10207087A0956|150 157|AML1/ETO
P10207090A0801|32 34|GRR
P10207092A0924|36 87|break-ended double-stranded DNA-activated protein kinase
P10208865A1246|24 48|steoclast cultures, mrIhh-N
P10208893A0839|60 62|WAD
P10209021A0212|39 51|Gle2p-Nup116p
P10209021A0212|73 76|mRNA
P10209031A0832|3 8|Fyn NH2
P10209031A0832|74 82|Fyn kinase
P10209031A0832|86 95|SH2 domains
P10209031A0832|135 142|zeta ITAM
P10209031A0832|164 171|zeta ITAM
P10209119A0076|66 80|F-box/WD-repeat
P10209119A0076|100 129|SCFCdc4p ubiquitin ligase complex
P10209119A0076|146 172|cyclin-dependent kinase (Cdk)
P10209119A0594|73 81|pop2 genes
P10209759T0000|0 14|Antithrombin III
P10209759T0000|42 60|ischemia reperfusion
P10211329A0457|27 37|serum lipase
P10211329A0457|41 47|serum CA
P10211919A0846|98 103|Y-BOCS
P10211919A0846|110 112|CGI
P10211919A0846|172 175|NIMH
P10211919A0846|179 181|CGI
P10212278A0387|0 29|Stress-inducible protein kinases
P10212278A0387|71 138|stress-activated protein kinase/c-Jun N-terminal protein kinase (SAPK/JNK)
P10212278A0387|157 192|mitogen-activated protein kinase (MAPK)
P10212284A0000|12 34|growth factor (TGF)-beta1
P10215485A0837|57 67|Mini-Mental
P10215485A0837|87 91|NA/mI
P10215485A0837|88 97|A/mI, mI/Cr
P10215594A1728|19 21|LUC
P10215594A1728|49 52|CRE1
P10215594A1728|56 59|CRE2
P10215594A1728|92 113|(CRE1)3(CRE2)2SV40-LUC
P10215594A1728|151 153|pO2
P10215608A0161|62 69|rat GSTA3
P10215608A0161|70 74|(rGST
P10215608A0161|75 89|Yc1) subunit gene
P10215811A0635|77 79|EVL
P10215850A0754|52 60|TrxR2 gene
P10215850A0754|77 83|18 exons
P10218109T0000|34 57|MutT pyrophosphohydrolase
P10218200A0534|60 76|tissue plasminogen
P10218357A0486|0 6|RESULTS
P10218357A0486|7 9|AND
P10218357A0486|10 20|CONCLUSIONS
P10218357A0486|36 49|cuff-tubes (G2)
P10218357A0486|123 125|N2O
P10219091A0246|28 35|gene CTL1
P10219091A0246|44 71|enzyme RNAtriphosphatase-like
P10220275A0694|12 20|PH domains
P10220275A0694|23 32|Gbetagamma
P10220275A0694|62 71|Gbetagamma
P10220275A0694|79 87|GDP-bound
P10220275A0694|97 105|GTP-bound
P10220275A0694|112 118|Gialpha
P10221467T0000|100 117|Parkinson's disease
P10221820A0902|17 20|APBD
P10221820A0902|47 49|AMT
P10221820A0902|124 127|APBD
P10221820A0902|131 133|AMT
P10223338A1601|73 77|HIV-2
P10223338A1601|85 93|V3 domains
P10223338A1601|96 104|HIV-1IIIB
P10223338A1601|97 112|IV-1IIIB, HIV-1MN
P10223338A1601|98 121|V-1IIIB, HIV-1MN, HIV-1SF2
P10223338A1601|125 131|HIV-1RF
P10223338A2186|22 31|V3 peptides
P10223338A2186|52 56|HIV-1
P10223338A2186|66 70|HIV-2
P10223338A2186|95 102|HIV/AIDS
P10223498A0479|144 165|Erectile Function (IIEF)
P10224244T0000|30 49|Glc7-Reg1 phosphatase
P10224244T0000|56 70|Snf1-Snf4 kinase
P10224244T0000|88 91|INO1
P10224257A0079|2 3|XO
P10224257A0079|13 22|her-1 mRNAs
P10224257A0079|94 110|5'-flanking region
P10224289T0000|32 34|HIV
P10224289T0000|69 81|T cell receptor
P10224293A0000|0 41|Receptor protein tyrosine phosphatases (RPTPs)
P10224293A0000|91 108|phosphatase domains
P10224293A0000|114 123|ectodomain
P10224293A0000|136 155|ligand-binding motifs
P10224293A2021|5 34|well-characterized brain regions
P10224293A2021|69 78|RPTP-kappa
P10225279A0450|35 42|MDV2 UL54
P10225279A0450|46 54|UL55 genes
P10225279A0450|77 86|ORF (ORF-1)
P10225945A0436|20 23|MAD2
P10225945A0436|189 190|II
P10226029A0905|21 28|PH domain
P10226029A0905|31 37|Akt/PKB
P10226074A0637|51 57|12 exons
P10228009A0600|14 25|CINC promoter
P10228009A0600|28 32|IL-17
P10228009A0600|35 39|IEC-6
P10228009A0600|48 84|TNF receptor-associated factor-6 (TRAF6)
P10228009A0600|92 96|TRAF2
P10228155A1293|0 6|SCFFWD1
P10228155A1293|72 83|beta-catenin
P10228157T0000|52 62|Dbf2p kinase
P10228561A0539|34 50|DNA polymerase beta
P10228561A0539|88 90|DNA
P10228795A0842|0 6|RESULTS
P10228795A0842|82 84|EFS
P10228795A0842|96 98|IAS
P10229084A0000|146 155|oligomeric
P10229084A0000|156 169|protein complex
P10229084A0000|261 281|protein tyrosine kinase
P10229084A0000|316 336|daptor proteins, SKAP55
P10229084A0000|340 348|SLAP-130)
P10229668A0560|36 49|Cln3p (Cln3-1p)
P10229668A0560|53 73|hybrid UBI4 5'-CLN3 mRNA
P10229668A0560|120 124|eIF4E
P10229682A1151|39 77|nuclear-factor-kappaB-binding-site-like
P10229682A1151|86 92|(kappaB
P10229682A1151|101 162|nuclear-factor-interleukin-6-binding-site-like sequence (NF-IL-6
P10231454A0731|102 120|alkaline phosphatase
P10231485A0342|28 31|TtrA
P10231485A0342|84 92|a [4Fe-4S]
P10231485A0342|105 108|TtrB
P10231485A0342|118 125|[4Fe-4S]
P10231485A0342|142 145|TtrC
P10231581A1125|0 23|Site-directed mutagenesis
P10231581A1125|45 47|SP1
P10231862A1117|124 133|endogenous
P10232078A0552|11 21|reperfusion
P10232078A0552|42 48|release
P10232078A0552|51 66|6-keto-PGF1 alpha
P10232078A0552|70 73|TXB2
P10232600T0000|0 61|Prostate-specific antigen (PSA) promoter-driven androgen-inducible
P10232872A0081|33 34|CD
P10233147A0218|75 111|filamentation MAPK (Cdc42p/Ste20p/MAPK)
P10233147A0218|124 166|cAMP-dependent protein kinase (Cyr1p/cAMP/PKA)
P10233885A0899|113 125|mim-1 promoter
P10233885A0899|137 147|p30 isoforms
P10233946A0000|24 47|spleen necrosis virus (SNV)
P10233946A0000|60 72|repeats (LTRs)
P10233946A0000|90 126|Rex/Rex-responsive element-independent
P10233946A0000|145 160|leukemia virus RNA
P10233946A0000|189 194|SNV RNA
P10233946A0000|204 220|cis-acting element
P10234698A0728|38 40|CNS
P10235265A0197|73 85|APC-dependent
P10235265A0197|125 142|(Clb) cyclin subunit
P10236651T0000|22 39|harmacy school: PCAT
P10243927A0000|51 53|IIT
P10271171A0458|6 10|LATCH
P10304090T0000|0 10|Medicare SNF
P10308312A0203|74 83|ultrasound
P10318806A0000|12 18|mitogen
P10318806A0000|28 45|protein (MAP) kinase
P10318806A0000|66 87|signal-regulated kinase
P10318806A0000|67 143|ignal-regulated kinase, stress-activated protein kinase-1/c-Jun NH2-terminal kinase
P10318806A0000|186 200|signal generated
P10318806A0476|63 87|MAP kinases in PDGF-mediated
P10318806A0918|10 45|tyrosine residue-mutated PDGF receptors
P10318806A0918|54 82|Src homology 2 domain-containing
P10318806A0918|100 115|Src family kinases
P10318806A0918|101 144|rc family kinases, phosphatidylinositol 3-kinase
P10318806A0918|149 165|GTPase-activating
P10318806A0918|182 226|Src homology 2 domain-containing phosphatase SHP-2
P10318806A0918|183 240|rc homology 2 domain-containing phosphatase SHP-2, phospholipase
P10318806A0918|288 299|PDGF-induced
P10318859A0535|31 50|tyrosine phosphatases
P10318900A0637|86 96|Fab (8H2/G5)
P10318900A0637|155 158|mRNA
P10318918A0824|28 31|NS5A
P10318918A0824|43 59|SH3-binding region
P10318918A0824|63 79|proline-rich motif
P10318918A0824|106 108|HCV
P10319320A1022|35 41|16K hPRL
P10319320A1022|53 64|VEGF-induced
P10319320A1022|156 167|angiogenesis
P10319327A1237|10 12|SRE
P10319327A1237|117 119|SRF
P10319327A1237|147 150|bHLH
P10319327A1237|151 164|protein E12/E47
P10319955A0941|108 114|(P=.04)
P10320480A0451|82 92|beta subunit
P10320480A0451|101 113|RNA polymerase
P10320579A1831|13 16|FlgN
P10320579A1831|20 23|FliT
P10320579A1831|75 89|oligomerization
P10320579A1831|95 98|HAPs
P10322022A0263|0 5|Rep63A
P10322022A0263|45 47|ORF
P10322022A0263|115 130|plasmids pAMbeta1
P10322022A0263|116 137|lasmids pAMbeta1, pIP501
P10322022A0263|142 149|pSM19035
P10322022A0263|168 172|pAW63
P10322022A0263|193 200|pAMbeta1
P10322629A0198|83 95|Pax-2/5/8 gene
P10323225A0244|13 38|monium, 2-oxoglutarate, NADH
P10323225A0244|52 55|NAD+
P10323225A0244|85 86|mM
P10323463T0000b|0 15|Interferon-alpha
P10323463T0000a|0 15|Interferon-alpha
P10323463T0000b|114 128|anti-angiogenic
P10323463T0000a|114 128|anti-angiogenic
P10323863A0852|60 69|telomerase
P10325413A1211|20 24|c-Abl
P10325413A1211|27 29|DNA
P10326654A0351|183 198|fibrillation (VF)
P10326654A0351|277 278|VF
P10327051A0688|27 63|Stress-Activated-Protein-Kinase (SAPK)
P10327051A0688|77 80|ATF2
P10327051A0688|129 141|p300/CBP-ATF2
P10329566A0610|40 48|tRNA-like
P10329566A0610|75 89|valine anticodon
P10329566A0610|94 102|tRNA-like
P10329566A0610|167 172|genera
P10329574A1733|1 15|. novo-ulmi RNA-7
P10329574A1733|40 56|satellite-like RNA
P10329574A1733|79 81|RNA
P10329574A1733|94 105|OnuMV4-Ld RNA
P10329586A0414|8 26|ene, fibronectin (FN)
P10329586A0414|62 68|LNCaP-r
P10329586A0414|123 124|FN
P10329625A0715|18 46|cell surface CD4(-)CD8(-)CD3(-)
P10329625A0715|66 73|TCR genes
P10329625A0715|111 133|control-transduced pre-T
P10329625A0715|143 146|FTOC
P10329736A0681|24 49|east two-hybrid system, mIRS3
P10329736A0681|68 77|p85 subunit
P10329736A0681|80 107|phosphatidylinositol 3-kinase
P10329736A1106|42 46|mIRS3
P10329736A1106|52 58|85, SHP2
P10330134A0765|3 6|mRNA
P10330134A0765|19 22|RFX1
P10330134A0765|20 27|FX1, RFX2
P10330134A0765|32 35|RFX3
P10330134A0765|106 108|RFX
P10330146A0730|45 54|luciferase
P10330146A0730|82 93|AUF1-binding
P10330146A0730|109 118|luciferase
P10330159A1258|5 7|VDR
P10330159A1258|68 84|promoter/enhancer
P10330159A1258|100 104|NFAT1
P10330159A1258|161 167|Jun-Fos
P10330159A1258|173 175|DNA
P10330168A0135|26 32|kinases
P10330168A0135|37 83|cyclin B (Clb)/cyclin-dependent kinase (Cdk/Cdc28p)
P10330168A0135|156 158|DNA
P10330396A0387|3 9|RanQ69L
P10330396A0387|44 47|CRM1
P10330396A0387|85 100|pore complex (NPC)
P10330396A0387|121 130|p62 complex
P10330396A0387|134 143|Can/Nup214
P10331646A0595|47 58|family (ART5)
P10331646A0595|61 72|transferases
P10331730A0504|0 6|RESULTS
P10331875A0523|51 61|DNA-binding
P10331875A0523|103 105|HSF
P10332733A0000|3 24|paramyxovirus fusion (F)
P10332733A0000|40 53|membrane fusion
P10333481A1102|34 50|UCP2 promoter-PLAP
P10333481A1102|197 213|5'-promoter region
P10333526A0459|3 11|hTERT gene
P10333526A0459|48 54|16 exons
P10333529A0277|4 14|betaAPP mRNA
P10333529A0277|18 22|Abeta
P10334888A0960|2 12|reperfusion
P10334888A0960|59 72|increase in IL-8
P10336495A0547|91 94|NCoR
P10336495A0547|98 115|PPARalpha.RXRalpha
P10339552A0361|28 37|SRm160/300
P10339552A0361|52 65|purine-rich ESE
P10339552A0361|89 96|pre-mRNA
P10339566A0602|49 61|SPB subcomplex
P10339566A0602|72 83|Spc94p/Nud1p
P10340447A0424|60 62|QMF
P10340447A0424|69 71|QIT
P10340883A1266|3 10|5-year OS
P10340883A1266|14 22|stage IIIB
P10340883A1266|54 55|IV
P10341219A0481|12 23|heparin lyase
P10341219A0481|71 79|YD-repeat
P10341219A0481|87 94|releases
P10342536A0954|62 81|nformation, RAST/EAST
P10342829A0236|24 28|GnRHR
P10342829A0236|100 116|GnRHR (hGnRHR) gene
P10342829A1370|41 49|alphaT3-1
P10342829A1370|77 80|SF-1
P10342829A1370|108 111|SF-1
P10342829A1370|148 157|GSE element
P10344736A0796|0 9|CDK4 kinase
P10344736A0796|55 73|CDK inhibitor p21Cip1
P10344736A0796|83 104|cyclin E immunocomplexes
P10347144A0516|85 93|size 20 kDa
P10347144A0516|122 126|AVQGP
P10347197A0502|14 30|urokinase promoter
P10347197A0502|33 38|HGF/SF
P10347197A0502|45 55|Met receptor
P10347203A0832|23 27|STAT3
P10347203A0832|102 103|PD
P10347220A1477|88 114|RNA 5'-triphosphatase (Cet1p)
P10347220A1477|89 144|NA 5'-triphosphatase (Cet1p), RNA guanylyltransferase (Ceg1p)
P10347220A1477|236 269|triphosphatase-guanylyltransferase
P10347220A1477|281 297|methyltransferase
P10347839A0434|3 6|IC50
P10348859A0292|49 52|MerR
P10348859A0292|74 79|Hg(II)
P10349084T0000|14 25|Epstein-Barr
P10350454A0000|0 3|MutY
P10350454A0000|8 29|adenine-DNA glycosylase
P10350454A0000|67 84|8-oxoguanine (oG.A)
P10350454A0000|87 98|guanine (G.A)
P10350484A0346|13 18|kinase
P10350484A0346|57 60|CheA
P10350484A0346|104 105|KM
P10350484A0346|109 111|ATP
P10350484A0346|116 131|100-fold increase
P10350638A0000|9 24|carboxypeptidase
P10353880A0257|96 105|HSV (P=.98)
P10355085A1119|60 63|(ISS
P10357751A0866|72 74|FFM
P10357751A0866|144 146|CI)
P10358031A0303|67 70|G2/M
P10358075A0984|0 4|DAF16
P10358075A0984|96 105|homologues
P10358075A0984|111 131|insulin/IGF-1 receptor
P10358075A0984|112 146|nsulin/IGF-1 receptor, PtdIns 3-kinase
P10358075A0984|150 152|PKB
P10358079A0391|54 58|ErbB2
P10358079A0391|62 66|ErbB4
P10358080T0000|50 61|linker domain
P10358080A1114|8 20|linker regions
P10358080A1114|61 63|DNA
P10358080A1114|112 115|HSF1
P10358080A1114|146 149|HSF1
P10358080A1114|214 231|HSF1 monomer-trimer
P10358083A0263|85 104|DNA-protein complexes
P10358083A0263|129 151|sequence motifs GTGACT(C)
P10358083A0263|130 157|equence motifs GTGACT(C), ATTGT
P10358083A0263|162 165|GATA
P10358138A0672|37 39|XLP
P10358138A0672|85 88|SLAM
P10358138A0672|133 135|SAP
P10359014A1077|45 48|MAPK
P10359014A1077|92 110|COOH-terminal region
P10359014A1077|120 143|site-directed mutagenesis
P10359014A1077|198 201|MAPK
P10359575A0317|46 54|FcalphaRI
P10359575A0317|65 73|IgA (hIgA)
P10359575A0317|86 96|IgG2 (bIgG2)
P10359575A0317|105 114|bFcgamma2R
P10359575A0317|120 124|bIgG2
P10359575A0317|131 134|hIgA
P10359603A0430|22 35|Sec1p homologue
P10359663A0425|63 69|oIFNtau
P10359663A0425|97 117|virus 40 (SV40) promoter
P10359663A0425|176 189|enhancer region
P10359663A0425|201 216|oIFNtau-SV40-CAT
P10359663A1280|40 44|c-Jun
P10359663A1280|49 53|c-Fos
P10359663A1280|82 92|oIFNtau-CAT
P10359663A1280|111 116|GATA-1
P10359663A1280|112 123|ATA-1, GATA-2
P10359663A1280|126 131|GATA-3
P10359664A0579|16 45|ites, Cdk2-phosphorylated MARCKS
P10359664A0579|61 77|lysyl endoprotease
P10359664A0579|91 104|electrospray MS
P10359673A0000|3 15|yeast LPD1 gene
P10359673A0000|24 45|lipoamide dehydrogenase
P10359673A0000|107 113|the GCN4
P10359792A0610|87 91|dCtBP
P10359792A0610|153 171|histone deacetylases
P10360454A0916|11 20|serum TNF-a
P10360839A1338|69 87|KRAB zinc finger genes
P10360947A1113|84 88|ALG-2
P10360947A1113|150 166|C-terminal domains
P10361038A0281|68 79|protein genes
P10362652A0350|17 23|microM)
P10362652A0350|27 29|EGF
P10362652A0350|33 35|nM)
P10362652A1456|53 59|HA-ERK2
P10362652A1456|94 96|EGF
P10362897A0545|0 6|RESULTS
P10363517A0401|48 62|ultrasonography
P10364076A0429|51 62|repeat motifs
P10364076A0429|70 76|SREBP-1
P10364159A0813|36 44|FRAP/mTOR
P10364159A0813|56 64|FRAP/mTOR
P10364159A0813|103 108|kinase
P10364159A0813|130 135|4E-BP1
P10364163A0092|7 10|FYVE
P10364163A0092|17 32|zinc finger domain
P10364202A0646|55 57|DBP
P10364202A0646|134 147|GAL4-DBP fusion
P10364314A0919|70 76|NS2 gene
P10364319A0109|30 37|EBNA mRNA
P10364319A0109|64 69|EBNA3C
P10364425A0610|104 108|STAT3
P10364523T0000|72 75|SOX9
P10364523T0000|98 110|control region
P10364523A0826|56 64|YAC 946E12
P10365883A1355|30 32|VRE
P10365883A1355|143 151|pathogens
P10366446A0893|1 17|coiled-coil domain
P10366446A0893|71 86|interaction motif
P10366446A0893|90 95|FLI LRR
P10366503A0812|151 159|terminase
P10366503A0812|207 215|terminase
P10366503A1506|11 19|terminase
P10366503A1506|212 227|terminase regions
P10366503A1506|248 263|packasome complex
P10366722T0000|0 3|cDNA
P10366722T0000|49 66|mouse DNA polymerase
P10367240A1354|67 68|SP
P10367385A0000|52 64|beta-carotene
P10367460A0191|3 6|FCMS
P10367460A0191|31 33|2 kW
P10367646A0569|114 145|ncreases: alanine aminotransferase
P10367646A0569|172 173|(P
P10367646A0569|206 207|(P
P10369418A0644|0 3|EMSA
P10369418A0644|59 63|CD40L
P10369418A0644|87 104|NF-kappaB complexes
P10369418A0644|129 137|NF-kappaB
P10369418A0644|171 174|RelB
P10369418A0644|190 194|c-Rel
P10369625A0942|19 21|ODA
P10369757A0000|78 97|acillus subtilis, ArgR
P10369757A0000|101 104|AhrC
P10369757A0000|158 197|l -arginine-dependent DNA-binding complexes
P10369757A0000|298 302|(AhrC
P10369775A0178|35 55|residues Arg183-His267
P10369775A0178|66 67|ER
P10369775A0178|71 91|residues Lys438-Gln520
P10369775A0178|97 101|rat GR
P10369926A0251|3 13|exon:intron
P10369926A0251|25 34|chicken IL8
P10369926A0251|72 74|IL8
P10369926A0251|115 131|CXC chemokine genes
P10369965A0000|3 13|Aa-Pri2 gene
P10370675A0649|15 26|liver disease
P10370675A0649|44 46|HCC
P10370675A0649|51 70|hepatitis C virus (HCV)
P10370675A0649|114 116|HCV
P10370778A0000|8 16|aromatase
P10370778A0000|53 55|III
P10370778A0000|183 191|(ARIMIDEX
P10370778A0000|210 216|(FEMARA
P10370778A0000|238 245|(RIVIZOR
P10371097A0963|0 10|CONCLUSIONS
P10372627A0530|8 23|njuries, 143 cases
P10372627A0530|47 54|158 cases
P10373507A0680|0 8|SRFDelta5
P10373507A0680|76 88|SRF-dependent
P10373507A0680|97 107|alpha-actin
P10373507A0680|116 126|alpha-actin
P10373507A0680|135 154|lpha-actin, SM22alpha
P10373507A0680|159 188|SRF promoter-luciferase reporter
P10373523A0924|3 23|erum-free media, p50E4F
P10373523A0924|35 45|E1A-induced
P10374632A0818|60 62|NBP
P10374632A0897|0 9|CONCLUSION
P10374632A0897|1 13|ONCLUSION: NBP
P10374632A0897|62 65|rCBF
P10374632A0897|78 82|RMCAO
P10375638A0859|20 23|UTR1
P10375638A0859|32 36|NRF-1
P10375638A0859|64 67|mRNA
P10375640A0153|41 44|cDNA
P10375640A0153|42 50|DNA, CBS-1
P10375640A0153|125 131|19.5kDa
P10375718A0000|5 32|fibroblast growth factor (bFGF)
P10375718A0000|53 64|angiogenesis
P10376065A0881|109 112|RF02
P10376446A0000|81 85|(PLR)
P10376446A0000|98 101|(FP)
P10376446A0000|105 120|luteal (LP) phases
P10376873A0706|5 10|sgRNA2
P10376873A0706|17 20|3'TE
P10376873A0706|28 30|UTR
P10376874A0759|33 41|eRF1-eRF3
P10376874A0759|85 96|protein eRF3C
P10376874A0759|118 121|eRF1
P10376877A0611|93 97|5.8Ss
P10376877A0611|98 101|rRNA
P10376877A0611|127 142|C-terminal region
P10376877A0611|180 186|18S rRNA
P10377345A0740|16 36|protein-tagged UNC-49B
P10377345A0740|40 54|UNC-49C subunits
P10377438A0647|12 22|rotein, UBC9
P10377438A0647|49 51|TEL
P10378989A0000|131 143|Sicily (Italy)
P10379547A0000|11 13|NH3
P10379547A0000|44 59|radiation (MASER)
P10379899A0446|76 90|GDF-9-deficient
P10379942T0000|31 75|Marek's disease virus serotype 2 glycoprotein M gene
P10379942T0000|91 108|glycoprotein M genes
P10379942A0956|88 95|MDV2 UL10
P10380232A0000|0 8|OBJECTIVE
P10380232A0000|20 50|cost-effectiveness analysis (CEA)
P10380232A0000|100 122|dexamethasone (CPM-DEX)-
P10380232A0000|127 171|5-HT3 receptor antagonist-tropisetron (TROP)--in
P10380232A0000|210 219|emetogenic
P10380800A0194|59 69|core regions
P10380800A0194|75 87|RNA-dependent
P10380800A0194|91 107|polymerase domains
P10380800A0194|125 130|dsRNAs
P10380878A0542|31 43|non-MBD region
P10380878A0542|93 95|DNA
P10380878A0542|114 131|histone deacetylase
P10380890A0619|48 60|IR-responsive
P10380890A0619|90 91|IR
P10381257A0000|56 78|preprotein import complex
P10381377T0000|18 61|rat SH2-containing inositol phosphatase 2 (SHIP2)
P10381570A1355|110 127|interstripe regions
P10381570A1355|146 158|embryogenesis
P10383764A1809|44 48|VirB4
P10383764A1809|163 165|DNA
P10383764A1809|182 196|an ATP-dependent
P10383966A0000|3 33|penicillin binding proteins (PBPs)
P10384129A0000|0 13|TCR alpha (TCRA)
P10384129A0000|37 39|RNA
P10384129A0000|51 54|PBMC
P10384129A0000|79 82|CD4+
P10384129A0000|80 87|D4+, CD8+
P10384129A0000|92 93|DN
P10385395A0000|7 37|density lipoprotein (HDL) receptor
P10385395A0000|102 116|steroidogenesis
P10385395A0000|124 126|HDL
P10385915A1341|0 6|D3S1261
P10385915A1341|37 40|MITF
P10385915A1341|52 58|D3S2465
P10385915A1341|62 68|D3S1766
P10385915A1341|99 107|cM genetic
P10388670A1976|70 90|dispersant (Tris-Tween
P10390158A1150|68 79|tiGH promoter
P10391075A0000|16 26|autopsy case
P10391075A0000|110 112|MRI
P10391246A0756|12 16|MOM-4
P10391246A0756|20 23|TAK1
P10391246A0756|59 64|kinase
P10391277A0000|0 9|BACKGROUND
P10391277A0000|14 21|MAZE-III
P10391903T0000|9 43|pleckstrin homology domain-containing
P10391903T0000|86 94|ERK kinase
P10392266A0111|67 85|antibetalipoproteic
P10392669A0935|33 45|NSAID-induced
P10392669A0935|225 237|NSAID-induced
P10392669A0935|309 344|omplications; (ii) histamine H2 receptor
P10392669A0935|356 358|(H2
P10392669A0935|442 454|NSAID-induced
P10392669A0935|624 639|NSAID-associated
P10392669A0935|763 775|NSAID-induced
P10392710A1000|42 58|lung morphogenesis
P10392900A1020|18 28|HIV promoter
P10392900A1020|61 65|c-Abl
P10392900A1020|124 136|RNA polymerase
P10392900A1020|137 138|II
P10392903A0000|60 63|HT-3
P10392903A0000|71 82|p53-negative
P10392903A0000|133 155|papillomavirus type 30 DNA
P10392903A0889|52 57|cdc25A
P10392903A0889|61 66|cdc25B
P10392914A0000|0 17|BACKGROUND/PURPOSE
P10392914A0000|62 72|duct (AAPBD)
P10393192A0792|0 21|Neurospora crassa CYT-18
P10393192A0792|35 40|exonic
P10393197A0543|0 3|DDP1
P10393197A0543|19 45|heterochromatin in interphase
P10393201A0654|21 23|DNA
P10393201A0654|46 62|DNA polymerase beta
P10393201A0654|66 83|DNA ligase III-XRCC1
P10393201A0654|175 185|exonuclease
P10393251T0000|34 46|HOX11 oncogene
P10393251T0000|58 65|gene HUG1
P10393251T0000|78 82|T-ALL
P10393251A0283|3 5|PAC
P10393422A0476|19 23|LAMB2
P10393422A0476|57 97|non-processed LAMB2-like pseudogene (LAMB2L)
P10393910A0705|0 23|Site-directed mutagenesis
P10393910A0705|105 116|endonuclease
P10393969A0000|12 31|ell protein no. 0 (ICP0)
P10394900A1166|55 68|enhancer region
P10394900A1166|76 114|cauliflower mosaic virus (CaMV) 35S promoter
P10395199A0792|4 7|scFv
P10395199A0792|58 69|anti-Ras scFv
P10395199A0792|66 69|scFv
P10395199A0792|70 74|(Y259
P10395199A0792|106 116|anti-Ras mAb
P10395199A0792|192 198|[Cochet
P10395199A0792|204 240|enigsberg, M., Delumeau, I., Virone-Oddos
P10395199A0792|207 255|gsberg, M., Delumeau, I., Virone-Oddos, A., Multon, M.C.
P10395199A0792|209 268|berg, M., Delumeau, I., Virone-Oddos, A., Multon, M.C., Fridman, W.H.
P10395199A0792|213 299|, M., Delumeau, I., Virone-Oddos, A., Multon, M.C., Fridman, W.H., Schweighoffer, F., Teillaud, J.L.
P10395283A0960|39 42|OP-1
P10395283A0960|140 149|generating
P10395378A1198|53 54|HA
P10395827A1297|19 30|parallel beta
P10395827A1297|98 109|parallel beta
P10395908A0236|86 101|17 amino acid motif
P10395908A0236|121 123|R7G
P10395908A0236|148 170|membrane-bound receptors
P10395911A0288|21 65|chicken apolipoprotein A-I gene 5'-flanking region
P10395920A1424|35 37|ATF
P10395920A1424|99 105|KGF gene
P10395920A1424|147 149|CRE
P10396343T0000|75 83|(TrypTect
P10396343T0000|84 89|CIATT)
P10396343A0754|94 116|trypanosome-specific DNA
P10396343A0754|119 121|PCR
P10397257A1142|0 10|Mutagenesis
P10397257A1142|16 30|CDE/CHR elements
P10397257A1142|176 192|G2-M-synchronized
P10398682A0365|24 27|VP16
P10399136A0389|87 90|rCBF
P10399136A0389|96 98|HPC
P10400593A1084|3 15|ontrast, PvirE
P10400593A1084|18 29|Plac promoter
P10400593A1084|57 61|VirE2
P10400593A1084|68 72|virE1
P10400593A1084|91 95|virE2
P10400712A0000|6 29|parainfluenza virus 5 (SV5)
P10400712A0000|82 98|negative-sense RNA
P10400712A0577|27 28|GE
P10400712A0577|28 31|E, IG
P10400712A0577|36 37|GS
P10400712A0577|94 98|cDNAs
P10400712A0577|104 117|full-length SV5
P10400712A0577|155 157|(GE
P10400712A0577|159 160|IG
P10400712A0577|165 166|GS
P10400712A0577|194 224|hemagglutinin-neuraminidase (HN)
P10400712A0577|231 248|polymerase (L) genes
P10400757A0000|0 4|CXCR4
P10400757A0000|8 24|chemokine receptor
P10400757A0000|29 38|coreceptor
P10400757A0000|42 63|T-cell-line-tropic (X4)
P10400757A0000|67 83|dual-tropic (R5X4)
P10400757A0000|89 121|immunodeficiency virus type 1 (HIV-1)
P10400757A1498|36 40|CXCR4
P10400757A1498|83 87|HIV-1
P10400757A1498|115 125|mutagenesis
P10400757A1498|166 170|CXCR4
P10400757A1498|184 206|HIV-1 Env-mediated fusion
P10400760A0663|40 49|proteinase
P10400760A0663|59 84|amino acid residues E960-A961
P10400760A0663|60 96|mino acid residues E960-A961, E1071-S1072
P10400760A0663|61 108|ino acid residues E960-A961, E1071-S1072, E1345-T1346
P10400760A0663|113 123|E1419-G1420
P10400785A0912|0 1|SM
P10400785A0912|57 59|CRM
P10400785A0912|92 97|GTPase
P10400785A0912|107 127|nucleoporin CAN/Nup214
P10400794T0000|129 130|2A
P10400794T0000|133 144|Epstein-Barr
P10402467T0000|11 21|chain kinase
P10402467T0000|43 49|Ras/ERK
P10402467T0000|70 94|urokinase-type plasminogen
P10403575A1401|15 22|StAR gene
P10403575A1401|38 42|DAX-1
P10403690A0000|53 91|non-small cell lung cancer (NSCLC) stage IIIb
P10403690A0000|94 95|IV
P10403690A0000|100 124|ECOG performance status (PS)
P10403690A0000|180 188|care (BSC)
P10403690A0000|232 235|(IEP
P10403690A0000|260 261|IV
P10403690A0000|302 303|IV
P10403690A0000|329 330|IV
P10403690A0000|340 342|MVP
P10403690A0000|341 361|VP regimen: mitomycin-C
P10403690A0000|386 387|IV
P10403839A0140|33 50|BMAL1 (hBMAL1) cDNAs
P10403839A0140|115 119|cDNAs
P10403839A0140|152 173|mouse BMAL1 (mBMAL1) gene
P10403839A1459|17 35|bHLH/PAS family genes
P10403839A1459|51 61|intron/exon
P10403839A1459|77 82|mBMAL1
P10403839A1459|110 113|mAhr
P10403839A1459|132 136|BMAL1
P10405635A0374|33 51|full-length promoter
P10406047A1244|163 165|ILD
P10406047A1244|216 219|PPHN
P10406047A1244|240 243|PFTs
P10406122T0000|1 26|13-bp cis-regulatory element
P10406122T0000|32 42|LTR promoter
P10406459A0000|25 58|platelet-derived growth factor (PDGF)
P10406459A0000|26 98|latelet-derived growth factor (PDGF), 12-O-tetradecanoyl-phorbol-acetate (TPA)
P10406459A0000|119 153|CREB (cAMP-responsive element-binding
P10406459A0000|210 225|kinetics in NIH 3T3
P10406462A1127|40 44|SRC-1
P10406462A1127|79 90|OR1/RXRalpha
P10406464A0687|3 18|ontrast, mTRAP100
P10406464A0687|64 83|TRAP complex (TRAP220)
P10406464A0687|98 107|contacts TR
P10406464A0687|114 129|vitamin D receptor
P10406465A0589|23 25|VDR
P10406466A0000|46 67|thyroid hormone receptor
P10406466A0000|77 89|acid receptor)
P10406843A1265|12 24|GlcNAc-TI mRNA
P10406843A1265|56 61|RT-PCR
P10406954A0715|25 48|site-specific mutagenesis
P10406954A0715|81 84|RegS
P10406954A0715|88 91|RegR
P10407184A0149|21 31|betaAPP gene
P10407184A0149|51 52|AD
P10407184A0149|116 117|AD
P10407184A0520|24 38|promoter regions
P10407184A0520|62 73|reporter gene
P10407184A0520|63 111|eporter gene, chloramphenicol acetyl transferase (CAT)
P10407184A0520|64 124|porter gene, chloramphenicol acetyl transferase (CAT): (i) phbetaE-B
P10407184A0520|156 172|(h) promoter region
P10407184A0520|195 197|URE
P10407184A0520|202 215|(ii) prhbetaE-B
P10407184A0520|242 265|rhesus (rh) promoter region
P10407184A0520|254 265|omoter region
P10407184A0520|275 277|URE
P10407184A0520|304 319|hbetaAPP promoter
P10407269A0000b|19 21|DNA
P10407269A0000a|19 21|DNA
P10407269A0000a|93 94|II
P10407269A0000b|93 94|II
P10407985A0574|0 4|G-CSF
P10407985A0574|55 60|GM-CSF
P10409656A1016|16 23|H411 cDNA
P10409656A1016|29 31|RAW
P10409656A1016|153 155|LPS
P10409699A0292|79 121|yeast oligosaccharide-processing mannosidases
P10409699A0292|129 151|full-length coding region
P10409699A0292|165 182|mannosidase homolog
P10409699A0292|233 236|cDNA
P10409699A0292|250 259|polymerase
P10409699A0292|291 294|cDNA
P10409724A1021|12 17|ERK1/2
P10409724A1021|48 75|immediate-early response genes
P10409730A0597|22 28|RP genes
P10409741A0382|34 37|CDC4
P10409755A1846|38 39|NO
P10409755A1846|72 73|TG
P10409755A1846|84 89|JT/Neo
P10411139A0887|17 21|U4/U6
P10411139A1344|104 108|U4/U6
P10411140A0499|17 25|125-nt RNA
P10411140A0499|42 46|RNase
P10411140A0499|63 79|3'-terminal region
P10411140A0499|85 89|mRNAs
P10413604A0063|28 54|cAMP-dependent kinases (PKAs)
P10413604A0063|138 140|DNA
P10413607A0085|55 102|matrix molecules pepsin-solubilized collagen VI (CVI)
P10413607A0085|115 117|DNA
P10413662A0193|34 56|pMJ101 replication region
P10413662A0193|81 84|pJM1
P10413662A0193|186 193|pathogen
P10413676A0000|0 2|FAK
P10413676A0000|21 49|transmembrane integrin receptor
P10413676A0595|19 21|FAK
P10413676A0595|34 37|FAK-
P10413676A0595|53 61|FAK kinase
P10413676A0595|74 90|Tyr-397/SH2 domain
P10413676A0595|114 141|proline-rich SH3 binding region
P10413676A0595|147 165|FAK C-terminal domain
P10413676A0595|190 204|promote full FAK-
P10413676A0595|201 212|FAK-mediated
P10413676A0595|232 233|FN
P10413676A0595|264 266|FAK
P10413676A1193|29 32|FRNK
P10413676A1193|47 68|point mutation (Leu-1034
P10413676A1193|89 92|FRNK
P10414451A0093|35 51|doppler-proven DVT
P10414451A0093|105 119|protein C (APC-R)
P10414451A0093|106 142|rotein C (APC-R), lupus anticoagulant (LA)
P10414451A0093|188 208|otein C, protein S, ATIII
P10416429A0221|0 5|DESIGN
P10416429A0221|36 38|PKU
P10416429A0221|58 71|NSW PKU database
P10416558A0000|0 6|PURPOSE
P10416558A0000|121 131|unction, CD4
P10416558A0000|191 210|pre-AIDS HIV-infected
P10416558A0000|222 223|(N
P10417331A1008|42 43|mM
P10417331A1008|74 75|pH
P10417703A1326|44 45|RP
P10417703A1326|54 56|20S
P10417703A1326|139 154|plant RPT subunits
P10419006A0378|34 41|estrogen
P10419521A0136|16 36|longation activity, ELL
P10419521A0136|57 69|RNA polymerase
P10419521A0136|70 71|II
P10419521A0136|72 88|interaction domain
P10419521A0136|114 123|polymerase
P10419521A0136|134 150|promoter-specific
P10422291A0572|12 14|IgA
P10422342A0535|206 209|131I
P10422342A0535|207 215|31I, 201Tl
P10422342A0535|208 220|1I, 201Tl, 67Ga
P10422342A0535|224 228|111In
P10422468A0524|48 51|ICSI
P10422468A0524|126 128|NOA
P10422468A0524|213 214|OA
P10422468A0524|236 248|fibrosis gene)
P10423156A0265|0 2|TaV
P10423156A0265|45 48|CsCl
P10423156A0265|85 88|6 kDa
P10423193A1309|0 9|CONCLUSION
P10423193A1309|123 125|CTS
P10423292A0782|112 138|CRE (cAMP-responsive element)
P10425094A1006|39 49|s(-1) mM(-1)
P10425445T0000|27 84|mouse growth hormone receptor/growth hormone binding protein gene
P10426450A1458|19 20|SA
P10426450A1458|75 76|SG
P10426450A1458|105 107|ILK
P10426878A0367|15 20|ISIS-2
P10428091A0322|18 35|state-specific MMRs
P10428294A0227|0 12|Preheparin LPL
P10428759A0743|11 39|insulin-induced receptor kinase
P10428811A0628|59 95|beta-adrenergic receptor kinase (betaARK
P10428811A0628|88 95|(betaARK
P10428811A0628|98 103|GRK-2)
P10428811A0628|124 130|Arf-GAP
P10428811A1067|72 85|adhesion kinase
P10428862A0834|35 47|DokR-specific
P10428862A0834|86 95|endogenous
P10428862A0834|96 99|DokR
P10428862A0834|104 110|150-kDa
P10428862A0834|149 167|EGF-stimulated BaF/3
P10429740A0000|75 92|bowel syndrome (IBS)
P10429946A0473|29 32|2(V)
P10429946A0473|33 44|collagen gene
P10429946A0473|139 154|CRE-like elements
P10429946A0988|22 59|B-Myb-glutathionine S-transferase fusion
P10430421T0000|0 12|APOE-epsilon4
P10430421T0000|45 55|AD increases
P10430580A0000|8 32|double-strand breaks (DSBs)
P10430580A0000|46 48|DNA
P10430580A0000|51 63|nonhomologous
P10430580A0000|64 80|end-joining (NHEJ)
P10430583A0000|4 16|DNA repair gene
P10430583A0000|59 62|RecA
P10430883A0000|186 188|III
P10430883A0000|293 313|horseradish peroxidase
P10430886A0838|44 47|TraR
P10430890A1059|22 32|oligomerize
P10430944A1298|16 23|JAK/STAT
P10430944A1298|43 56|EBV-associated
P10433729A1559|2 12|, Bowers, K.E
P10433970A0279|55 70|DNA binding domain
P10433970A0279|100 120|transactivation domain
P10436016A0337|0 12|Gel filtration
P10437043A0164|0 6|METHODS
P10437043A0164|29 30|SS
P10438593A0000|8 41|immunodeficiency virus type-1 (HIV-1)
P10438593A0000|87 99|RNA polymerase
P10438607A0330|10 14|SEBPs
P10438607A0330|11 20|EBPs, SEBP2
P10438627A0885|0 15|Identity elements
P10438627A0885|18 21|tRNA
P10438627A0885|71 77|pfTrm1p
P10438627A0885|131 155|tRNA(Asp)and tRNA(Phe)from
P10438924T0000|3 22|B cell antigen receptor
P10438924T0000|46 70|kinase B)/glycogen synthase
P10438924T0000|98 125|phosphatidylinositol 3-kinase
P10438924A1009|60 112|serine/threonine kinase glycogen synthase kinase-3 (GSK-3)
P10438941A1197|106 115|endogenous
P10438950A0580|0 3|IL-1
P10438950A0580|7 23|TNF increase AND-34
P10439040A0658|15 23|role eIF4E
P10439040A0658|73 83|region (UTR)
P10439040A0658|102 113|CAT reporters
P10440923A0684|111 132|cyclin-dependent kinase
P10440923A0684|179 201|cyclin A-dependent kinase
P10440923A0684|250 275|retinoblastoma protein (pRb)
P10441243A0443|0 6|RESULTS
P10441243A0443|41 42|AN
P10441483A0454|54 57|EpRE
P10441506A0098|0 6|PKNbeta
P10441506A0098|14 29|sequence homology
P10441506A0098|34 41|PKNalpha
P10441506A0098|61 63|PKN
P10441506A0098|96 115|amino acid-rich region
P10441506A0098|147 149|(CZ
P10441506A0098|150 160|region/HR1)
P10441506A0098|237 238|(D
P10441506A0098|239 249|region/HR2)
P10441506A0098|265 276|CZ region/HR1
P10442493A0815|35 38|FLOP
P10442493A0815|60 68|serum FLOP
P10443990A0000|0 9|BACKGROUND
P10444597A0586|95 98|mRNA
P10444813A0448|49 58|metastases
P10446131A0132|0 3|PDGF
P10446131A0132|43 65|smooth muscle cells (SMCs)
P10446131A0132|75 78|ATII
P10446149A0809|0 4|M-Ras
P10446149A0809|78 84|c-Raf-1
P10446149A0809|79 90|-Raf-1, A-Raf
P10446149A0809|80 96|Raf-1, A-Raf, B-Raf
P10446149A0809|81 120|af-1, A-Raf, B-Raf, phosphoinositol-3 kinase
P10446149A0809|82 132|f-1, A-Raf, B-Raf, phosphoinositol-3 kinase delta, RalGDS
P10446206A0000|25 49|presenilin-1 (PS1) promoter
P10446206A0000|161 180|neuroblastoma SK-N-SH
P10446206A0000|184 196|hepatoma HepG2
P10446910A0147|13 28|E2F1 gene promoter
P10446910A0147|48 56|-54 region
P10446910A0147|181 187|GC-rich
P10446910A0147|204 216|CCAAT-binding
P10446912A0883|46 48|OF5
P10446912A0883|52 54|OF3
P10446912A0883|64 70|CYP11A1
P10446912A0883|96 98|OF5
P10446912A0883|102 104|OF3
P10446912A0883|121 125|JEG-3
P10446998T0000|90 110|serum response elements
P10446998A0375|75 83|mitogenic
P10446998A0375|100 103|junB
P10446998A0955|78 80|SRF
P10446998A0955|92 98|junB SRE
P10446998A0955|120 123|SREs
P10446998A0955|194 196|DNA
P10446998A0955|231 241|protein SP-1
P10447593A0144|56 58|SP6
P10447597A1004|3 14|Cr.psbA-4 ORF
P10447597A1004|25 34|H-N-H motif
P10447597A1004|48 59|GIY-YIG motif
P10448036A0748|25 40|full-length 5 S RNA
P10448036A0748|107 117|zf4-7:5 S RNA
P10448036A0748|200 210|protein:RNA
P10448095A0865|3 6|STAT
P10448095A0865|39 43|C/EBP
P10448285A1035|58 59|II
P10448902A0921|22 36|nzymes, catalase
P10448902A0921|23 58|zymes, catalase, glutathione peroxidase
P10448902A0921|62 80|superoxide dismutase
P10448902A0921|87 97|MCT-treated
P10449072A0560|57 59|GPi
P10449072A0560|62 63|PD
P10449899A0881|50 53|PERV
P10451209A0000|0 8|OBJECTIVE
P10451209A0000|115 153|methylprednisolone sodium succinate (MPSS)
P10452306A0502|30 33|MIBG
P10452306A0502|53 83|orepinephrine concentration, LVEF
P10452951A0000|7 27|hormone receptors (NRs)
P10452991A0331|52 69|HLA-DR1-restricted
P10453006A0000|21 26|(Danio
P10453006A0000|113 116|cDNA
P10453006A0000|170 181|beta subunits
P10453006A0000|184 200|proteasomes (PSMB)
P10453006A0478|12 21|homologues
P10453006A0478|32 41|genes PSMB5
P10453006A0478|49 53|PSMB9
P10453006A0478|62 72|enes, PSMB11
P10453006A0478|76 81|PSMB12
P10453371A0640|54 56|BMD
P10453721A0445|90 96|ADAPT II
P10454533A0859|13 15|HRI
P10454533A0859|58 60|HRI
P10454533A0859|116 118|HRI
P10454540A0392|3 23|amino acid changes D206A
P10454540A0392|27 31|D208A
P10454540A0392|63 73|exonuclease
P10454550A0960|91 107|Snf1 kinase complex
P10454557A0000|109 129|sequence (ARS) elements
P10454557A0000|155 157|III
P10454557A0000|166 169|ARSs
P10454557A0000|200 202|HML
P10454557A0975|30 35|HML ARS
P10454557A0975|43 49|(ARS303
P10454557A0975|51 56|ARS320
P10454557A0975|61 67|ARS302)
P10454561A0594|47 61|TD-IkappaBalpha
P10454561A0594|113 160|tumor necrosis factor alpha-induced IkappaBalpha gene
P10454561A0594|186 197|NF-kappaB DNA
P10454561A0594|257 265|RelA(p65)
P10454561A0594|268 282|TD-IkappaBalpha
P10454568A0815|30 33|cDNA
P10454568A0815|93 100|PDGF-BB-
P10454568A0815|94 106|DGF-BB-, IGF-I
P10454568A0815|134 161|growth factor (EGF)-induced DNA
P10454570A0846|24 53|mitogen-activated protein kinase
P10454570A0846|71 119|stress-activated protein kinase-Jun N-terminal kinase
P10454570A0846|162 166|ATF-2
P10454570A0846|163 172|TF-2, c-Jun
P10454570A0846|177 180|JunD
P10454570A0846|205 209|IL-1-
P10454570A0846|223 235|TPA-dependent
P10454570A0846|267 294|signal-related kinase 1 (ERK-1)
P10454570A0846|298 302|ERK-2
P10454570A0846|328 331|TPA-
P10454570A0846|343 356|IL-1-dependent
P10454570A0846|373 383|uPA enhancer
P10455087A1400|0 10|CONCLUSIONS
P10455143T0000|0 10|Interdomain
P10455143T0000|23 32|two-domain
P10455143T0000|51 72|glucocorticoid receptor
P10455183A0530|14 27|xtRNA(Sec) gene
P10455183A0930|155 170|Xenopus tRNA(Sec)
P10455183A0930|179 190|U6 snRNA genes
P10455189A0104|3 12| cells, HEF1
P10455189A0427|46 49|HEF1
P10457075A1198|46 51|VI,max
P10458905A0000|40 66|1.7-Mb sequence-ready YAC/BAC
P10458907A0543|8 13|RAD30B
P10458907A0543|17 31|mouse Rad30b mRNA
P10458914A0674|13 25|mouse STAP gene
P10458914A0674|70 77|STAP gene
P10460015A0465|41 48|estrogen
P10460171A0842|34 47|fragment kinase
P10460172A0823|117 133|34 kDa polypeptides
P10463242A0316|2 4|EEG
P10464185T0000|48 78|polysaccharide biosynthesis genes
P10464250A0275|0 10|(1998) FASEB
P10464291A0597|0 7|IL-1beta
P10464291A0597|41 50|PDGFalphaR
P10464291A0597|54 103|CCAAT/enhancer-binding protein delta (C/EBPdelta) mRNA
P10464302A1109b|68 76|mitogenic
P10464302A1109b|187 195|mitogenic
P10464310A0218|107 145|juxtamembrane tyrosine residue 463 in FGFR-1
P10464310A0218|151 162|Crk SH2 domain
P10464310A0218|175 180|FGFR-1
P10464310A0218|251 256|FGFR-1
P10466306A0000|0 8|ECG-gated
P10466306A0000|19 46|Technetium-99m sestamibi SPECT
P10466825T0000|31 48|baculovirus p10 mRNA
P10467004A0116|3 11|intron RNA
P10467004A0116|94 107|sequence motifs
P10467004A0116|110 129|subgroup-IIA1 introns
P10467004A0116|130 136|(Michel
P10467004A0683|53 61|EBS1/IBS1
P10467004A0683|68 90|EBS2/IBS2 sequence motifs
P10467403A0000|3 31|Trk/Nerve Growth Factor receptor
P10467403A0000|109 136|phosphatidylinositol 3-kinase
P10467403A0000|137 139|(PI
P10468585A0980|4 6|DNA
P10469140A0336|37 50|NF-kappaB-like
P10469140A0336|68 72|PAI-2
P10469140A0336|108 115|TNFalpha
P10469140A0336|121 164|chloramphenicol acetyl transferase reporter gene
P10469174A0678|29 31|NMR
P10469174A0678|107 110|MBF1
P10469174A0678|133 148|C-terminal domain
P10469174A0678|151 154|MBF1
P10469174A0678|152 162|BF1, MBF1CTD
P10469656T0000|36 54|immediate-early gene
P10469656T0000|88 96|MAP kinase
P10469656T0000|89 109|AP kinase cascades: MSK1
P10469656T0000|122 143|histone H3/HMG-14 kinase
P10470220A1011|105 107|RIA
P10470220A1011|164 166|LIA
P10471587A0239|58 63|RT-PCR
P10471587A0239|168 171|MICs
P10471587A0239|184 189|RT-PCR
P10471696A0734|13 16|SAS4
P10471696A0734|20 23|SAS5
P10471696A0734|65 69|HMR-E
P10471696A0734|96 98|ACS
P10471721A0141|95 97|SLG
P10471721A0141|96 101|LG, SRK
P10471721A0141|106 138|as-yet-unidentified pollen S gene(s)
P10471743A0000|1 4|cDNA
P10471743A0000|22 24|RNA
P10471743A0000|31 41|DNA helicase
P10471743A0000|61 83|Arabidopsis thaliana cDNA
P10471746A1102|7 10|MyoD
P10471746A1102|23 37|tryptophan motif
P10471746A1102|69 84|Myogenin promoter
P10471746A1102|98 105|Myogenin
P10472314A0717|0 6|RESULTS
P10472314A0717|20 22|TTP
P10472314A0717|25 28|PUNP
P10472836A0189|13 14|BW
P10472836A0189|33 34|(P
P10473589A0189|21 24|kDa)
P10473589A0189|50 64|integrase domain
P10473589A0189|90 93|kDa)
P10473598A0691|16 31|C-terminal region
P10473623A0081|37 53|growth factor-beta
P10473623A0081|127 162|omplex, activin-responsive factor (ARF)
P10474898A0629|62 70|CMT1A-REP
P10474898A0629|95 113|hybridization (FISH)
P10474898A0629|137 145|PCR-based
P10476970A0542|20 49|isoform of Rapl GTPase-activating
P10476970A0542|64 72|rap1GAPII
P10476970A0542|96 109|alpha-subunits
P10477545T0000|3 12|B-oligomer
P10477545T0000|40 58|CC chemokine receptor
P10477545T0000|76 88|M-tropic HIV-1
P10477583A0000a|16 35|B cell Ag receptor (BCR)
P10477583A0000b|16 35|B cell Ag receptor (BCR)
P10477583A0000a|16 30|B cell Ag receptor
P10477583A0000b|16 30|B cell Ag receptor
P10477583A0000b|45 55|Fc receptors
P10477583A0000a|45 55|Fc receptors
P10477583A0000a|59 61|IgG
P10477583A0000b|59 61|IgG
P10477583A0000b|62 64|(Fc
P10477583A0000a|62 64|(Fc
P10477583A0000b|80 86|G1-to-S
P10477583A0000a|80 86|G1-to-S
P10477597A0126|0 4|TRAF2
P10477597A0126|26 53|95-kDa serine/threonine kinase
P10477597A0126|68 79|center kinase
P10477597A0126|87 91|(GCKR
P10477597A0126|109 113|KHS1)
P10477597A0126|142 145|SAPK
P10477599T0000|2 29|activation-responsive element
P10477599T0000|38 66|C motif-1/lymphotactin promoter
P10477599T0000|100 110|DNA-protein
P10477620A0580|0 27|Cytokine-induced NF-kappa B DNA
P10477620A0580|1 47|ytokine-induced NF-kappa B DNA binding activity, RelA
P10477620A0580|56 80|ranslocation, I kappa B alpha
P10477620A0580|127 144|I kappa B kinase (IKK)
P10478844A1604|19 41|coactivator CREB-binding
P10478844A1604|87 97|PPARalphawt
P10478844A1604|100 110|PPARalphatr
P10478844A1604|153 163|PPARalphatr
P10478848A0331|0 3|SF-1
P10478848A0331|17 35|N-terminal AF1 domain
P10479025A0528|38 45|TF-MUSIC
P10479025A0528|69 80|target region
P10479492A0000|0 8|OBJECTIVE
P10479492A0000|43 58|End Results (SEER)
P10479492A0000|99 127|corpus uteri adenocarcinoma FIGO
P10479492A0000|133 134|II
P10480937A0000|6 22|Drosophila A kinase
P10480937A0000|47 79|A kinase anchor protein 200 (DAKAP200)
P10480937A0000|154 157|cAMP
P10480937A0000|183 185|(Li
P10482516T0000|3 5|RNA
P10482516T0000|92 122|Bacillus subtilis trpEDCFBA operon
P10482565A0469|62 88|S-induced cell-to-cell fusion
P10482620A1009|49 52|MMTV
P10482620A1009|55 57|LTR
P10482620A1009|174 180|MMTV LTR
P10483124T0000|19 29|mutagenesis
P10483124T0000|50 63|CIC5F11/CIC2B9
P10483124T0000|109 113|Ac/Ds
P10483124T0000|144 147|cDNA
P10483945A0641|0 6|RESULTS
P10483945A0641|1 12|ESULTS: CK-MB
P10484695A0791|5 10|NART-R
P10484695A0791|46 55|baseline IQ
P10485353T0000|92 115|West Africa (Burkina-Faso)
P10485470A0242|72 92|p21/WAF1/Cip1 promoter
P10485470A0242|95 98|MG63
P10485470A0242|158 160|TSA
P10486210A0126|44 64|aldehyde reductase gene
P10487040A0453|31 35|MIB-1
P10487040A0453|39 51|p53 antibodies
P10487217A0735|3 9|C2C-Prx
P10487744T0000|33 37|beta2
P10487753A0788|14 18|XDRP1
P10487759A0630|119 150|Xbra2 promoter-driven reporter gene
P10487760A0336|76 87|Xenopus MEF2D
P10487762A0252|0 3|NuA4
P10487762A0252|35 37|MDa
P10487921A0132|0 3|ATF1
P10487953A0765|37 43|S-phase
P10488087A0340|10 32|TTF-1-binding sites (TBE)
P10488087A0340|96 140|SP-A promoter-chloramphenicol acetyltransferase
P10488087A0340|161 168|SP-A gene
P10488088T0000|0 25|Insulin-like growth factor-I
P10488088T0000|33 45|bcl-2 promoter
P10488088T0000|56 102|transcription factor cAMP-response element-binding
P10488129T0058|20 22|RNA
P10488129T0058|51 62|E2F complexes
P10488147A1176|102 114|CCR3-mediated
P10488148T0000|0 11|ERK MAP kinase
P10488148T0000|52 56|HIV-1
P10488148T0000|104 107|AP-1
P10488148T0000|111 119|NF-kappaB
P10488148A0111|0 8|NF-kappaB
P10488148A0111|41 49|HIV-1 gene
P10488148A1267|23 26|MAPK
P10488148A1267|44 47|AP-1
P10488148A1267|96 99|AP-1
P10488148A1267|104 112|NF-kappaB
P10488148A1267|125 132|a complex
P10488148A1267|169 176|HIV-1 LTR
P10488337T0000|46 60|imerization, DNA
P10488337T0000|97 100|bZIP
P10488875A0000|57 65|palsy (CP)
P10488875A0000|79 93|toe walking (ITW)
P10489680A0927|0 9|Sputum IL-8
P10489680A0927|13 15|MPO
P10489680A0927|47 49|BPT
P10489680A0927|56 59|TDI-
P10489680A0927|79 80|(P
P10490604A0601|66 95|ZAP-70 block 70Z Cbl-mediated NFAT
P10490609A0413|187 189|ARS
P10490639A0000|26 30|PHO85
P10490639A0000|39 72|cyclin-dependent protein kinase (Cdk)
P10490639A0000|162 181|cyclin partners (Pcls)
P10490662A0431|15 25|lace alleles
P10490662A0819|3 9|act, SPT
P10490662A0819|67 90|epitope-specific antibody
P10490816A0000|14 20|RET gene
P10490816A0000|31 52|receptor tyrosine kinase
P10490816A0000|88 107|cancer syndromes MEN 2A
P10490816A0000|103 105|MEN
P10490816A0000|111 115|MEN 2B
P10490822A1167|31 37|Ras-GAP
P10490826T0000|0 3|EB-1
P10490826T0000|6 41|tyrosine kinase signal transduction gene
P10490826T0000|91 98|pre-B ALL
P10490826T0000|112 130|oncoprotein E2a-Pbx1
P10490835T0000|0 36|Protein kinase A-Ialpha subunit-directed
P10490835T0000|95 108|tyrosine kinase
P10490843A0159|0 3|BCL6
P10490843A0159|12 17|POZ/Zn
P10490843A0159|143 156|alignancy, PLZF
P10490955T0000|75 104|mitogen-activated protein kinase
P10490955T0000|135 158|thrombospondin-1 peptides
P10491133A0365|0 8|Optical CD
P10491133A0365|69 70|HO
P10491133A0365|83 84|NO
P10491133A0365|102 103|NO
P10491187T0000|3 31|phosphotransferase system (PTS)
P10491187T0000|94 127|a histidine phosphocarrier protein HPr
P10491187T0000|140 147|gene ptsH
P10491213A0263|33 57|alkaline phosphatase (BALP)
P10491213A0263|78 91|la protein, BGP)
P10491213A0263|108 124|pyridinoline (Pyr)
P10491213A0263|128 150|deoxypyridinoline (Dpyr)
P10491213A0263|162 175|tomography (CT)
P10492127A0914|62 86|cholecystokinin-A receptor
P10492169A0939|45 48|ESTs
P10492169A0939|56 103|enes, pregnancy-associated plasma protein-A (PAPP-A)
P10492169A0939|134 141|EST-YD1)
P10493203T0000|76 79|ST-T
P10493203T0000|102 104|ECG
P10493575T0000|34 56|Ca2+-bound rat S100B (beta
P10493575T0000|57 61|beta)
P10493575T0000|125 127|p53
P10493580A1126|118 132|esterase/lipase
P10493876A0000|65 83|fjord region (+)-(11S
P10493876A0000|66 87|jord region (+)-(11S, 12R
P10493876A0000|67 91|ord region (+)-(11S, 12R, 13R
P10493876A0000|68 96|rd region (+)-(11S, 12R, 13R, 14S)
P10493876A0000|191 198|-B[g]CDE
P10493876A0000|240 249|residue dA6
P10493876A0000|262 287|(+)- trans-anti -(B[g]C)dA6)
P10493876A0000|299 325|opposite a thymine residue dT17
P10493876A0000|331 392|DNA sequence context d(C1-T2-C3-T4-C5-(B[g]C)A6-C7-T8-T9-C10-C11)
P10493876A0000|332 442|NA sequence context d(C1-T2-C3-T4-C5-(B[g]C)A6-C7-T8-T9-C10-C11). d(G12-G13-A14-A15-G16-T17-G18-A19-G20++ +-A21-G22)
P10493876A0000|454 462|(B[g]C)dA
P10493876A0000|464 465|dT
P10493876A0000|531 533|NMR
P10493876A0000|564 575|dynamics (MD)
P10495573A0365|52 55|MUSE
P10495573A0365|124 127|MUSE
P10496161A0503|69 75|4-30 WPI
P10496161A0503|90 96|3-16 WPI
P10496284A0115|25 35|pisodes, CSF
P10496284A0115|46 65|immunoglobulin G (IgG)
P10496284A0115|102 104|IgG
P10496303A1968|0 10|CONCLUSIONS
P10496303A1968|80 97|ganciclovir (AUC24)
P10496388A1956b|9 20|nonperfusion
P10496388A1956a|9 20|nonperfusion
P10496553A1004|16 27|HIV-positive
P10497117A0358|3 7|P mRNA
P10497117A0358|26 28|ORF
P10497117A0358|79 81|ORF
P10497199A0559|82 85|GlRE
P10497199A0559|118 139|promoter-transcription
P10497199A0559|146 147|II
P10497199A0559|148 158|(COUP-TFII)
P10497262A0000|15 29|single-copy gene
P10497262A0000|36 60|trans -spliceosomal U5 snRNA
P10497262A0000|113 117|U5 RNA
P10497262A0000|138 141|cDNA
P10497800A0000|3 8|MMPI-A
P10497800A0000|9 16|(Butcher
P10497800A0000|41 44|MMPI
P10497800A0000|45 53|(Hathaway
P10497800A0000|55 62|McKinley
P10497874A0925|38 55|bisphosphate (PIP2)
P10497874A0925|117 126|PLC-gamma1
P10498616A0157|1 4|G22V
P10498616A0157|13 17|M-Ras
P10498616A0157|61 89|interleukin-3 (IL-3)-dependent
P10498616A0157|161 164|IL-3
P10498616A0157|183 186|IL-4
P10498616A1280|9 13|M-Ras
P10498706A1219|32 35|PecS
P10498706A1219|46 49|pelD
P10498706A1219|53 56|pelE
P10498706A1219|103 106|KdgR
P10498717A1048|30 33|RsmC
P10498717A1048|53 56|rsmB
P10498717A1048|90 93|RsmA
P10499357A0439|0 3|SCOB
P10499357A0439|60 69|(FR)/fixed
P10499357A0439|70 101|interval (FI) schedule (FR20:FI120)
P10501034A0839|0 11|Ribonuclease
P10501034A0839|130 142|morphogenesis
P10501936T0000|51 70|membrane protein TOM70
P10501936T0000|73 104|repeat-induced point mutation (RIP)
P10501965A0879|77 90|s6 kinase (Rsk3)
P10501965A0879|105 114|intronless
P10501965A0879|118 130|ORF-less genes
P10501965A0879|143 152|intronless
P10501969A1329|21 26|GATA-5
P10501969A1329|66 71|GATA-4
P10501969A1329|121 133|cardiogenesis
P10502216A0289|55 67|streptokinase
P10502216A0289|96 126|tissue plasminogen activator (TPA)
P10502216A0289|137 147|reperfusion
P10502216A0289|155 156|MI
P10502402A0129|9 25|cell-surface TRAIL
P10502402A0129|113 117|TRAIL
P10502402A0533|90 98|TRAIL gene
P10502434A0604|17 25|stage IBG3
P10502434A0604|32 35|ICG1
P10502434A0604|41 44|ICG2
P10502434A0604|53 63|ICG3 disease
P10504332A0701|55 84|eceptor, fluorescent-labeled RAP
P10504332A0701|158 174|wild-type receptor
P10504332A0701|159 178|ild-type receptor, RAP
P10505694A0000|0 20|Interleukin-12 (IL-12)
P10505694A0000|68 78|cells (PBMC)
P10505694A0000|89 115|interferon-gamma (IFN-gamma)
P10505694A0739|0 4|IL-12
P10506143A0610|2 5|HeLa
P10506143A0610|15 30|JNKK2-JNK1 fusion
P10506143A0610|55 57|JNK
P10506143A0610|95 98|JNK1
P10506143A0610|144 146|EGF
P10506143A0610|145 156|GF, TNF-alpha
P10506143A0610|147 170|, TNF-alpha, anisomycin, UV
P10506143A0610|148 187| TNF-alpha, anisomycin, UV irradiation, MEKK1
P10506143A0610|197 199|GTP
P10506143A0610|222 228|Cdc42Hs
P10508522A1598|19 29|TGF-beta RII
P10508522A1598|47 54|EWS-FLI1
P10510295A0606|11 87|ethanol repression autoregulation (ERA)/twelve-fold TA repeat (TAB) repressor element
P10510295A0606|110 123|promoter region
P10510295A0606|129 136|GLK1 gene
P10510379A0105|42 46|STAT6
P10510379A0105|69 78|DNA element
P10511216A0654|0 10|CONCLUSIONS
P10512699T0000|39 86|selenocysteine-containing rat thioredoxin reductase
P10512699T0000|96 106|gene fusions
P10512699T0000|121 147|bacterial-type SECIS elements
P10512699T0000|171 174|selA
P10512699T0000|172 179|elA, selB
P10512699T0000|183 191|selC genes
P10512699A0364|32 52|tructure, SECIS element
P10512699A0364|59 84|selenoprotein-encoding mRNA
P10512699A0364|135 148|opal (UGA) codon
P10512857A0000|3 26|nt signaling, beta-catenin
P10512857A0000|92 99|TCF-type
P10512882A0137|25 27|FAK
P10512882A0137|31 40|Src kinases
P10512882A0137|133 139|kinases
P10513756A0584|3 5|EPV
P10513756A0584|121 126|(alpha
P10514493A0199|0 14|Me(2)SO-induced
P10514493A0199|40 46|N1E-115
P10514493A0199|96 105|endogenous
P10514493A0199|106 114|Ntr-1 gene
P10514493A0199|118 130|reporter genes
P10514493A0199|139 151|NTR-1 promoter
P10514808T0000|9 26|ysplasias, genetics
P10514808T0000|31 45|epileptogenesis
P10516011A0471|63 86|site-directed mutagenesis
P10516011A0471|106 108|pAP
P10516026A0270|4 9|HERV-K
P10516738A0925|50 64|irbesartan/HCTZ
P10516878T0000|14 31|dopamine D2 receptor
P10516878T0000|53 70|Parkinson's disease
P10516878T0000|87 89|PET
P10517666A1069|32 33|GR
P10517666A1069|37 40|AP-1
P10517666A1069|96 99|nGRE
P10517672A1417|32 56|alpha1-globin promoter-CAT
P10517672A1417|86 90|CCAAT
P10517672A1417|111 120|(CTF1)/NF1
P10517672A1417|125 146|Drosophila Schneider SL2
P10517672A1417|168 175|NF1-like
P10517672A1417|203 205|CAT
P10517675A0809|54 65|p21WAF1/CIP1
P10517675A0809|114 135|cyclin-dependent kinase
P10518496A0952|13 27|vHnf1-deficient
P10518496A0952|196 208|organogenesis
P10518561A0261|28 43|Tec family kinases
P10518561A0885|26 30|BRDG1
P10518561A0885|47 48|PH
P10518561A0885|52 61|SH2 domains
P10518561A0885|73 84|kinase domain
P10518822A1037|0 9|CONCLUSION
P10518822A1037|120 131|CCR3 receptor
P10518937A0572|26 35|KlHIS4 gene
P10518956A0137|165 174|deiodinase
P10518956A1212|0 2|ESS
P10518956A1212|13 15|FT3
P10518956A1212|22 24|FT4
P10518956A1212|28 30|TSH
P10520800A0307|0 6|METHODS
P10520800A0307|42 45|HOCM
P10520800A0307|127 148|electrocardiogram (ECG)
P10521345A0202|213 222|NAO-driven
P10521443A0486|18 22|(i) IR
P10521443A0486|54 55|IR
P10521443A0486|89 101|(ii) NF-kappaB
P10521443A0486|149 186|dominant-negative IkappaB-alpha(A32/36)
P10521443A0486|219 239|NF-kappaB c-Rel subunit
P10521447A0606|47 60|sequence TGTGGT
P10521447A0606|63 71|core motif
P10521447A0606|96 107|AML/CBFalpha
P10521447A1190|28 41|AML3/CBFalpha1
P10521447A1190|56 63|AML1-ETO
P10521450A0437|37 53|Btk-deficient DT40
P10521509A0000|12 33|G protein signaling (RGS)
P10521509A0000|53 55|DEP
P10521509A0000|68 73|EGL-10
P10521509A0000|89 91|GGL
P10521509A0000|92 93|(G
P10521509A0000|94 125|protein gamma subunit-like) domains
P10521509A0000|164 178|RGS proteins RGS6
P10521509A0000|165 183|GS proteins RGS6, RGS7
P10521509A0000|166 188|S proteins RGS6, RGS7, RGS9
P10521509A0000|193 197|RGS11
P10521544T0000|36 55|alpha 1,2-mannosidase
P10521544T0000|65 75|Man9GlcNAc2
P10521544T0000|78 88|Man8GlcNAc2
P10521796A0872|3 5|ORs
P10521796A0872|8 9|GC
P10521796A0872|99 112|metaplasia (IM)
P10521796A0872|137 138|IM
P10521796A0872|145 158|dysplasia (DYS)
P10521796A0872|238 240|DYS
P10521796A0872|279 291|gastritis (SG)
P10521796A0872|309 322|gastritis (CAG)
P10523520A0986|8 20|nematode genes
P10523634A1404|23 39|Psi synthase domain
P10523634A1404|95 109|box H/ACA snoRNAs
P10523640A0367|11 27|Src tyrosine kinase
P10523640A0367|90 107|Stat3-mediated gene
P10523647A0000|3 25|transcription factor CHOP
P10523647A0000|26 31|(C/EBP
P10523647A0000|55 58|bZIP
P10523647A1001|5 8|CHOP
P10523647A1001|49 64|C/EBP target genes
P10523647A1001|87 90|AP-1
P10523647A1001|110 124|AP-1 target genes
P10523663A0404|40 62|homeobox activator DEAF-1
P10523674A0000|0 7|RNase MRP
P10523674A0000|11 43|ribonucleoprotein endoribonuclease
P10523674A0000|90 92|DNA
P10523674A0000|114 117|5.8S
P10523674A0000|118 121|rRNA
P10524258T0000|17 59|fibroblast growth factor receptor 1 (FGFR-1) gene
P10524258A0286|32 41|FGFR-1 gene
P10524258A0286|56 63|myogenic
P10525413A1408|53 67|CRP2(LIM2)R122A
P10525413A1408|91 113|proton-detected(15)N NMR
P10526670A0236|20 42|actin filaments (F-actin)
P10526670A0236|88 105|bisphosphate (PIP2)
P10526670A1828|17 29|ICE/caspase-1
P10526670A1828|72 81|CK-induced
P10526670A1828|105 107|PKB
P10526670A1828|131 140|CK-induced
P10527106A0384|0 8|OBJECTIVE
P10527158T0000|3 9|AL-R8 SI
P10527158T0000|18 27|generation
P10527158T0000|65 69|USDOE
P10527180A0869|0 6|RESULTS
P10527180A0869|42 48|(P<.05)
P10527180A0869|175 178|[CI]
P10527180A0869|236 237|CI
P10527180A0869|259 274|hormone receptors
P10527180A0869|284 285|CI
P10527180A0869|437 438|CI
P10527180A0869|439 460|, 1.62-2.43), metastases
P10527180A0869|524 525|CI
P10527180A0869|626 627|CI
P10527426A0521|12 19|SBEI gene
P10527426A0521|60 71|exon I+II+III
P10527426A0521|156 157|II
P10527475A0643|2 3|PC
P10527475A0643|9 13|MNGCs
P10528035A1102|46 73|serum alanine aminotransferase
P10529198A0068|60 82|homologues p140(ras-GRF)
P10529354A0375|43 54|multisubunit
P10529354A0375|69 71|20S
P10529354A0375|75 84|19S(PA700)
P10529354A0375|87 98|P28 complexes
P10529354A0375|120 122|26S
P10531334A0525|43 51|PTPS-S19A
P10531334A0525|79 110|cGMP-dependent protein kinase (cGK)
P10531334A0525|119 120|II
P10531342A0348|3 18|N-terminal domain
P10531342A0348|34 38|70 kDa
P10531342A0348|133 148|psa2/gp46 complex
P10531342A1111|59 66|ppg1 gene
P10531360A0958|101 108|VEGF mRNA
P10531446A0203|20 24|ErbB2
P10531446A0203|21 30|rbB2, ErbB3
P10531446A0203|35 39|ErbB4
P10531446A0203|53 56|ErbB
P10531446A0203|65 87|receptor tyrosine kinases
P10532354A1374|31 44|yeast homologue
P10532354A1374|56 66|epsilon-COP
P10532354A1374|96 97|ER
P10532805A0792|2 5|PC12
P10532805A1084|3 6|PC12
P10532805A1084|34 62|protein kinase A activity (AB.11)
P10532805A1084|105 126|down-regulate nrg-1 mRNA
P10533066A0758|0 3|TSC1
P10533066A1197|39 41|PTT
P10533066A1197|88 91|TSC2
P10534048A0297|9 25|lgorithm, FOREPROJ
P10534048A0297|87 124|3-D attenuation correction factors (ACF's)
P10534048A0297|138 157|two-dimensional (2-D)
P10534048A0297|235 238|a 3-D
P10534402A0126|12 15|cDNA
P10534402A0126|26 28|DNA
P10534402A0126|33 41|mouse gene
P10534402A0659|0 5|RT-PCR
P10534402A0659|123 130|Prophase
P10534402A0659|186 189|mRNA
P10535715A0268|3 5|RMR
P10535715A0268|52 59|(F(1,18)
P10535715A0268|91 95|kJ/24
P10535715A0268|115 127|kJ/24 h) phases
P10536125A0093|0 18|Oseltamivir (GS4104)
P10536125A0093|63 68|GS4071
P10536125A0093|100 127|influenzavirus neuraminidases
P10536369A0662|45 50|VDR-TR
P10536369A1280|52 75|response element-specific
P10536788A0931|29 30|PL
P10536788A0931|85 117|ontrol livers; choline-containing PL
P10536788A0931|116 117|PL
P10540015A0664|0 3|C-SP
P10540015A0664|37 39|ALS
P10540015A0664|108 110|MEP
P10540292A1179|20 36|spv virulence genes
P10540553A0980|20 22|PNA
P10540553A0980|108 110|DNA
P10540915A0697|37 51|ligation (TL&PL)
P10541432A0185|0 19|Kinase-deficient erbB
P10541432A0185|44 68|growth factor (EGF)-induced
P10541432A0185|94 103|endogenous
P10541432A0185|150 167|EGF-induced ERK MAPK
P10541432A0185|216 222|ERK MAPK
P10541550A0487|37 40|ACE3
P10541550A0487|43 62|440-bp chorion element
P10541550A0487|124 128|DmORC
P10541865A1301|34 39|CDKN2A
P10541865A1301|43 48|CDKN2B
P10542237A0357|41 54|PPARalpha-null
P10542237A0357|115 137|lipopolysaccharide (LPS)
P10542237A0357|164 167|IL-6
P10542249A0415|95 133|CAAT enhancer-binding protein (C/EBP)alpha
P10542249A0415|122 133|(C/EBP)alpha
P10542249A0415|137 145|C/EBPbeta
P10542260A0832|42 46|FVIIa
P10542260A0832|50 52|FXa
P10542260A0832|65 91|protease-activated receptors
P10542269A0000|0 25|Amyloid beta-protein (Abeta)
P10542269A0000|102 123|Alzheimer's disease (AD)
P10542269A0000|156 188|beta-amyloid precursor protein (APP)
P10542274A1376|26 44|protein kinase A (PKA)
P10542277A0000|3 20|importin alpha.beta
P10542281A0382|12 16|G1-G2
P10542281A0382|69 92|immunoglobulin-fold motif
P10542281A0382|130 137|G1 domain
P10542281A2021|70 74|G1-G2
P10543270A1054|26 32|[NOexh]
P10543727A0282|100 112|rel/NF-kappaB
P10543727A0282|148 152|H2TF1
P10543727A0282|155 169|kappaB1 element)
P10543727A0282|196 210|kappaB2 element)
P10543727A0282|252 263|H2TF1 element
P10543727A0282|286 293|p65/relA
P10543727A0282|304 306|HLA
P10543727A0282|324 331|AP-1/ATF
P10543727A0282|358 369|end (EnA-TRE)
P10543728A0358|14 16|E1A
P10543728A0358|18 24|cHa-ras
P10543728A0358|67 69|DNA
P10543728A0358|89 92|AP-1
P10543728A0358|131 133|E1A
P10543730A0000|3 31|yeast C-type cyclin Ume3p/Srb11p
P10543730A0000|38 64|cyclin-dependent kinase (Cdk)
P10544037A0617|0 3|FZD4
P10544037A0617|18 21|FZD9
P10544037A0617|25 29|FZD10
P10544037A0617|70 73|FZD4
P10544037A0617|76 79|FZD9
P10544037A0617|93 97|FZD10
P10544037A0617|105 108|FZD9
P10544088A0308|3 11|NF-kappaB
P10544088A0308|23 53|eporter construct, (PRDII)(4)-CAT
P10544088A0308|97 105|NF-kappaB
P10544089A1208|3 5|RNA
P10544089A1208|45 50|sgRNAs
P10544089A1208|53 55|TMV
P10544089A1208|61 65|crTMV
P10544089A1208|81 99|hairpin structure (H)
P10544089A1208|121 141|IRES(MP,75) (HIRES(MP)
P10544089A1208|122 162|RES(MP,75) (HIRES(MP), (75)(CR)-MP-CP-3'UTR
P10544089A1208|123 192|ES(MP,75) (HIRES(MP), (75)(CR)-MP-CP-3'UTR; HIRES(MP,75)(U1)-MP-CP-3'UTR)
P10544089A1208|214 219|MP gene
P10544113A0293|0 6|EIAV LTR
P10544113A0293|93 95|LTR
P10545192T0000|0 27|Phosphatidylinositol 3-kinase
P10545192T0000|56 74|ras/C-raf-1/MEK/ERK
P10545248A0567|73 101|homeodomain protein Tinman (Tin)
P10545281A0836|25 35|immunogenic
P10545281A0836|70 91|C-terminal coding region
P10545281A0836|114 124|bop gene mRNA
P10548434A1549|114 116|ERK
P10548434A1549|124 130|JNK/SPK
P10548622A0906|157 181|ultrasound guidance (TUGOR)
P10548722A0099|59 71|TcP2beta genes
P10548722A0099|132 135|SIRE
P10548722A0099|164 171|element)
P10549354A1782|13 15|APC
P10549354A1782|83 109|Tcf-4/beta-catenin complexes
P10549354A1782|154 165|beta-catenin
P10549354A1782|207 209|APC
P10549354A1782|208 218|PC, GSK3 beta
P10549354A1782|223 236|Axin/Conductin
P10549354A2371|40 52|Tcf target gene
P10549912A0136|138 139|ST
P10549912A0136|140 162|segment elevation (V1-V4)
P10550139A0191|0 7|PATIENTS
P10550139A0191|8 10|AND
P10550139A0191|11 17|METHODS
P10550571A0000|0 6|PURPOSE
P10550571A0000|16 22|WR-2721
P10550571A0000|145 151|WR-2721
P10550571A0000|154 163|endogenous
P10550574A1038|66 89|serum alkaline phosphatase
P10551788A0229|0 5|LHbeta
P10551788A0229|47 52|CGbeta
P10551796T0000|12 16|HIV-1
P10551816A0162|5 10|LTBP-1
P10551848A0000|16 22|(Kimura
P10551848A0000|54 62|MacLennan
P10551867A0350|43 60|9-kilobase pair mRNA
P10551867A0350|109 115|rat cDNA
P10551879T0000|6 31|AMP-dependent protein kinase
P10551879T0000|41 48|A-kinase
P10551879T0000|134 146|protein fusion
P10552357A1936|0 10|CONCLUSIONS
P10552357A1936|103 104|LV
P10552357A1936|132 135|OCTA
P10552357A1936|168 169|LV
P10552357A1936|216 227|echogenicity
P10552357A1936|232 234|AIR
P10553551A0000|0 7|Factor XI
P10554946A0082|18 22|SERMS
P10555285A1065|53 61|generated
P10555285A1065|72 85|FUT3-FUT5-FUT6
P10555285A1065|118 156|long-interspersed-nuclear-element-based
P10556028A0292|3 11|cop region
P10556028A0292|94 105|repA promoter
P10556028A0292|131 134|RepA
P10556028A0292|132 151|epA binding sites, BD-1
P10556028A0292|155 158|BD-2
P10556029A0852|0 1|WA
P10556033A0000|3 5|RFX
P10556033A0000|101 117|DNA-binding domain
P10556033A0000|131 146|C-terminal region
P10556044A0913|26 51|alpha-dystroglycan receptor
P10556044A0913|88 89|LG
P10556046A0328|33 54|BMP/ALK2/Smad-mediated
P10556063A0092|5 11|kinases
P10556089A0901|203 208|CUG-bp
P10556145A1034|17 19|DPI
P10556145A1034|23 25|SVN
P10556263A1035|0 10|CONCLUSIONS
P10556263A1035|75 76|AC
P10556595A0391|31 38|recN gene
P10556595A0391|48 50|G:C
P10556595A0391|53 55|T:A
P10556751A0758|52 54|HGV
P10556751A0758|77 91|mmunization, HGV
P10557008T0000|28 38|(Callilepis
P10557072A0127|39 43|cDNAs
P10557072A0127|52 74|UNC-51-like kinase (ULK1)
P10557072A0418|0 3|ULKs
P10557072A0418|7 12|UNC-51
P10557072A0418|45 70|amino-terminal kinase domain
P10557072A0418|98 107|(PS) domain
P10557072A0418|112 137|a carboxy-terminal (C) domain
P10557072A1218|23 26|ULK2
P10557308A0000|0 16|Connector enhancer
P10557308A0000|19 26|KSR (CNK)
P10557308A0000|30 40|multidomain
P10557308A0000|59 61|RAS
P10559207A0207|22 35|ATP sulfurylase
P10559207A0207|39 47|APS kinase
P10559207A0207|164 181|evolution generated
P10559303A0000|0 21|Epstein-Barr virus (EBV)
P10559303A0000|28 49|membrane protein 1 (LMP1)
P10559303A0000|64 75|EBV-mediated
P10559320A0080|44 53|alphavirus
P10559320A0080|67 77|protein nsP1
P10559320A0080|115 118|RNAs
P10559324A0716|33 43|Ad5 E4orf6/7
P10559324A0716|88 110|wild-type p53-expressing
P10559364A0846|2 23|HCMV(Towne)-infected HF
P10559364A0846|36 41|8 h, IE2
P10559364A0846|75 77|DNA
P10559364A0846|114 147|polymerase processivity factor (UL44)
P10559364A0846|152 169|single-stranded DNA
P10559364A0846|184 187|(SSB
P10559364A0846|189 193|UL57)
P10559364A0846|198 206|UL112-113
P10559364A0846|244 266|bromodeoxyuridine (BrdU)
P10560997A1072|0 12|CONCLUSION(S)
P10560997A1072|30 31|LH
P10561153A0225|62 64|SSc
P10561251A0000|0 6|PURPOSE
P10561251A0000|21 45|disease-free survival (DFS)
P10561251A0000|56 67|survival (OS)
P10561251A0000|127 135|stage IIIB
P10561251A0000|148 164|breast cancer (IBC)
P10561251A0000|184 203|modality therapy (CMT)
P10561251A0000|207 233|high-dose chemotherapy (HDCT)
P10561460A0615|3 5|GPI
P10561460A0615|61 71|polypeptide
P10561460A0615|88 91|cDNA
P10561460A0615|112 124|signal peptide
P10561460A0615|128 130|GPI
P10561546A0000|18 24|100-kDa
P10561546A0000|64 83|anti-peptide antibody
P10561546A0000|138 156|NF-kappaB p65 subunit
P10562456T0000|49 65|growth hormone gene
P10562495A0188|12 19|SFV genes
P10562495A0188|66 68|SFV
P10563212A0514|21 25|SF-36
P10563212A0514|47 49|QoL
P10563605A0773|40 43|IENF
P10563789A1951|26 42|F beta alpha/CG beta
P10563789A1951|78 79|CG
P10563789A1951|83 94|FSH receptors
P10563836A1234|3 14|ontrast, AP-2
P10563836A1234|55 58|T47D
P10563836A1234|98 101|AP-2
P10564280A0140|47 60|rotein, YT521-B
P10564280A0140|155 160|68-kDa
P10564472A0853|38 47|TraR fusion
P10564474T0000|0 18|PhoP-PhoQ homologues
P10564474T0000|65 89|outer-membrane protein OprH
P10564479A0384|10 13|fdsR
P10564479A0384|45 48|FdsR
P10564479A0384|54 62|fds operon
P10564495A0444|53 56|HeLa
P10564495A0444|77 80|cDNA
P10564495A0444|115 118|[CEA
P10564495A0444|119 126|(CD66e)]
P10564495A0444|120 123|CD66
P10564495A0444|176 187|CGM1- (CD66d)
P10564495A0444|191 211|NCA (CD66c)-expressing
P10564593A0428|0 3|FISH
P10564593A0428|87 99|MCF-7 AdVp3000
P10564593A0428|103 109|MCF-7 MX
P10564593A0428|116 123|S1-M1-80
P10564593A1618|3 9|MXR gene
P10564593A1618|49 59|cytogenetic
P10564593A1618|154 156|MXR
P10566630A0371|0 38|Serum insulin-like growth factor I (IGF-I) SD
P10566862A0000|0 9|BACKGROUND
P10567430A0785|35 51|brain Galpha(q/11)
P10567430A0785|90 93|GRK2
P10567430A0785|111 122|Galpha(q/11)
P10567430A0785|112 132|alpha(q/11), Galpha(s)
P10567430A0785|113 142|lpha(q/11), Galpha(s), Galpha(i)
P10567430A0785|146 158|Galpha(12/13)
P10567430A0785|183 186|GRK5
P10567430A0785|189 192|GRK6
P10567524T0000|3 12|elm1 kinase
P10567533A0818|7 27|transcription (RT)-PCR
P10567533A0818|58 67|degenerate
P10567533A0818|113 127|tyrosine kinases
P10567538A1028|14 30|acetyltransferase
P10567538A1028|114 140|CH3 domain/E1A-binding region
P10567581A0119|3 64|proliferation-specific HNF-3/fork head homolog-11B protein (HFH-11B
P10567581A0119|156 167|regenerating
P10567581A0119|225 227|DNA
P10567581A0119|239 240|(S
P10567582A1334|6 15|ouse, CtBP1
P10567582A1334|48 52|CtBP2
P10567582A1334|76 88|embryogenesis
P10568275A0679|87 92|GEOMAR
P10568455A0000|37 70|slow-release estradiol-17beta (SRE2)
P10568455A0000|114 122|PGF2alpha
P10568455A0000|138 153|corpora lutea (CL)
P10568728A1445|10 28|serum creatine kinase
P10568728A1445|59 63|ESWIB
P10568744A0728|52 70|alpha-specific genes
P10568744A0728|93 113|alpha2-Mcm1-dependent
P10570262A0000|24 26|TCR
P10570996A1213|1 12|phylogenetic
P10570996A1213|28 36|TK domains
P10570996A1213|76 87|scavenger RTK
P10570996A1213|125 126|TK
P10570996A1213|132 133|II
P10570996A1213|134 143|receptors)
P10570996A1213|193 213|insulin-like receptors
P10571047A1009|7 21|7SL RNA-encoding
P10571047A1009|88 94|HindIII
P10571474A0571|34 36|CA3
P10572087A0326|42 67|anemia group C protein (FANCC)
P10572130A1623|91 103|RNA polymerase
P10572130A1623|141 143|DNA
P10572131A0000|73 87|nasFEDCBA operon
P10572866A0481|88 112|aspartate aminotransferase
P10574913A1108|22 41|GRK-mediated receptor
P10574913A1108|23 79|RK-mediated receptor phosphorylation, beta-arrestin-mediated
P10574913A1108|164 179|GPCR-mediated ERK
P10574913A1108|224 226|ERK
P10574929A0583|35 46|47-kDa P-CIP2
P10574982A1075|0 14|Supershift EMSAs
P10574982A1075|59 66|-2 (USF-1
P10574992A0901|11 13|E1A
P10574992A0901|27 34|p300/CBP
P10574992A0901|46 59|increase in PARP
P10574992A0901|163 166|PARP
P10575231A0355|41 53|13-kb Cdc6 gene
P10575231A0355|67 73|12 exons
P10575231A0355|76 84|11 introns
P10575545A0147|15 19|CACCC
P10575545A0147|23 32|CAAT motifs
P10575642T0000|0 5|Skin pH
P10576545A0926|33 35|DNA
P10576545A0926|63 77|D1A gene promoter
P10576545A0926|125 134|transgenes
P10578528A0730|46 49|EEG)
P10579331A1225|42 68|rat HDL receptor SR-BI promoter
P10579331A1225|80 101|sterol response elements
P10579331A1225|102 106|(pSRE
P10579331A1225|110 114|dSRE)
P10579331A1225|127 134|SREBP-1a
P10579722T0000|17 42|myosin-binding subunit (MBS)
P10579722T0000|45 61|myosin phosphatase
P10579722T0000|64 73|Rho-kinase
P10580438A0508|17 40|mobility shift assay (EMSA)
P10580438A0508|46 81|GLUT4 repressor element (G4RE) generated
P10582831T0000|63 74|HIV-infected
P10584704A0913|51 56|9 cases
P10584704A0913|76 81|HMB-45
P10584704A0913|125 130|9 cases
P10585311A0494|21 23|III
P10585311A0494|24 27|MPGN
P10585311A1542|75 77|III
P10585311A1542|87 90|MPGN
P10585417A1412|86 89|PRLr
P10585417A1412|108 111|PRLr
P10585440A0204|37 48|FAK homologue
P10585440A0204|38 55|AK homologue, DFak56
P10585440A0204|68 74|band 56D
P10585453A1029|25 41|hGH-N gene promoter
P10585453A1029|158 163|hGH LCR
P10585463A0859|11 29|prenylcysteine lyase
P10585463A0859|44 58|baculovirus-Sf9
P10585480A0157|22 30|SH3 domain
P10585480A0265|24 32|SH3 domain
P10585480A0265|45 55|vinexin-Sos
P10585491A0945|45 47|CBF
P10585491A0945|53 73|wild-type AtpC promoter
P10585491A0945|129 132|AtpC
P10585491A0945|271 274|AtpC
P10586107A0160|73 92|cell surface receptors
P10586115A0477|63 71|IL-1alpha
P10586115A0477|64 80|L-1alpha, IL-1beta
P10586115A0477|65 90|-1alpha, IL-1beta, TNF-alpha
P10586115A0477|94 97|IL-6
P10586115A0477|110 118|generated
P10586115A0477|132 137|PKCeta
P10586115A0477|213 216|FCS)
P10586626A0607|130 133|ADEM
P10587460A0302|18 34|VDRE binding domain
P10587460A0302|43 51|VDR (hVDR)
P10587460A0302|83 86|hVDR
P10587460A0302|94 102|(Delta134
P10587460A0302|160 168|generated
P10587461A0341|40 48|anticodon
P10587576A0596|5 8|REPs
P10587576A0596|68 71|ESTs
P10587576A0596|86 100|SH3GL pseudogene
P10588946A0432|30 41|OSBP-related
P10588946A0432|61 65|ORP-1
P10588946A0432|68 72|ORP-6
P10589562A1208|56 57|BB
P10589562A1208|82 83|RF
P10589711A1228|3 14|ddition, narZ
P10589711A1228|72 82|Madin-Darby
P10590092A0124|28 36|HIV-1 gene
P10590092A0124|52 54|CNS
P10590368X0000|74 82|stage IA-B
P10590368X0000|97 113|cervix? BACKGROUND
P10591633A0138|101 105|SNARE
P10591633A0138|179 192|membrane fusion
P10591976A0317|17 19|LWS
P10591976A0317|19 27|S p.a. , LWS
P10591990A0178|8 15|66 DSM-IV
P10591990A0178|78 81|SAPS
P10591990A0178|79 86|APS, SANS
P10591990A0178|80 91|PS, SANS, BPRS
P10591990A0178|95 97|PAS
P10592791A0370|3 20|onclusion: (i) TECRA
P10592791A0370|55 56|SE
P10592791A0370|67 85|trains; (ii) SET-RPLA
P10592791A0370|89 98|RIDASCREEN
P10592791A0370|147 148|SE
P10592791A0370|186 188|SEE
P10592791A0370|220 227|SET-RPLA
P10592791A0370|257 266|RIDASCREEN
P10592791A0370|361 363|SEE
P10592791A0370|382 388|SET-EIA
P10592824A1157|64 74|JEV antibody
P10592824A1157|212 213|JE
P10592824A1157|235 236|(P
P10593939A0747|78 81|SR33
P10593939A0747|115 118|SR45
P10593939A0747|151 156|(SRZ21
P10593939A0747|152 153|SR
P10593939A0747|160 165|SRZ22)
P10593939A0747|208 234|Arabidopsis full-length U-70K
P10593950A1113|3 12|ummary, WT1
P10593950A1113|25 33|oligo(dT)
P10593950A1113|54 59|U2AF65
P10593950A1113|78 91|RNP-associated
P10593950A1113|106 110|hnRNP
P10594239T0000|6 35|pleckstrin homology-related gene
P10594239T0000|51 59|Ipl/Tssc3
P10594239T0000|52 66|pl/Tssc3, TDAG51
P10594903A0000|29 46|nanoparticles (RNP)
P10594903A0000|115 129|warfare agents GA
P10594903A0000|116 132|arfare agents GA, GB
P10594903A0000|117 135|rfare agents GA, GB, HD
P10594903A0000|139 140|VX
P10595315A0344|47 65|arameters, acid-base
P10595315A0344|76 85|blood gases
P10597222A1371|54 57|HMBA
P10597223A0339|82 94|GC-rich region
P10597223A0339|97 107|p21 promoter
P10597232A0000|3 10|RET/PTC3
P10597232A0000|45 48|ELE1
P10597232A0000|52 59|RET genes
P10597232A0000|83 113|radiation-induced post-Chernobyl
P10597317A1156|58 60|JBD
P10597317A1156|64 67|LMP1
P10597317A1156|94 99|HD-MyZ
P10597317A1156|179 181|JNK
P10597317A1156|204 207|LMP1
P10597317A1156|215 216|RS
P10598101A0000|15 36|bZIP protein Opaque2 (O2)
P10598101A0000|103 124|22 kDa zein gene promoters
P10598101A0754|3 9|mEmBP-1
P10598101A0754|150 166|22 kDa zein promoter
P10598316A1534|0 2|GHB
P10598316A1534|1 6|HB, 2 CB
P10598316A1534|2 10|B, 2 CB, HMB
P10599727A1567|8 9|GH
P10599727A1567|13 20|estrogen
P10599727A1567|51 52|TS
P10600171A1066|39 44|CYP3A2
P10600171A1066|79 85|COUP-TF
P10600171A1066|91 103|CYP3A2 DexRE-1
P10600171A1432|6 12|CYP3A23
P10600171A1432|51 59|3A23SiteA
P10600171A1432|77 80|USF1
P10600171A1432|93 104|bHLH/leucine
P10601280A0674|14 34|TPA-responsive element
P10601280A0674|50 69|base-line ST3 promoter
P10601290A0742|67 82|wild-type peptide
P10601290A0742|137 139|I1Y
P10601290A0742|143 145|I1F
P10601290A0742|198 217|MHC-peptide complexes
P10601335A0892|16 26|mannosidase
P10601344A1653|44 58|Rho-like GTPases
P10601344A1653|85 90|beta1A
P10601344A1653|86 97|eta1A, beta1D
P10601344A1653|101 111|IL2R-beta1A
P10601344A1653|114 117|GE11
P10601344A1653|120 123|GD25
P10601344A1653|153 156|RhoA
P10601410A0977|40 43|IVIg
P10601606A0152|3 21|rhabdomyosarcoma R1H
P10601606A0152|50 56|WAG/Rij
P10602502A0422|58 62|G0/G1
P10602502A0422|65 71|S phases
P10602507A0652|110 112|p53
P10602507A0652|132 136|CSF-1
P10602507A0652|166 185|dominant-negative p53
P10602516A0182|3 13|ddition, SLK
P10602516A0182|67 80|protein (M-NAP)
P10602516A0182|84 89|AT1-46
P10603349A1667|76 83|myogenic
P10603349A1667|84 93|progenitor
P10603349A1667|145 164|Myf5 expression domain
P10604246A0523|0 10|STUDY DESIGN
P10604246A0523|11 13|AND
P10604246A0523|14 20|METHODS
P10604246A0523|64 68|PBPCs
P10604246A0523|89 96|AutoPBSC
P10604246A0523|105 110|[V]6.0
P10604246A0523|115 122|AutoPBSC
P10604246A0523|148 150|MNC
P10604246A0523|177 181|(V4.7
P10604583T0000|63 75|Wilson disease
P10604945A0731|147 160|promoter region
P10606245A0906|16 22|CDP/cut
P10606245A0906|25 27|ROS
P10606245A0906|72 81|OC promoter
P10606245A0906|126 127|OC
P10606272A1241|11 28|double-stranded RNA
P10606272A1241|78 84|SF1 gene
P10606515A0389|34 36|DNA
P10606515A0389|49 80|beta-retinoic acid receptor element
P10606515A0389|92 96|DNase
P10607566A0880|19 37|inding, beta-catenin
P10607566A0880|63 77|RA receptor (RAR)
P10607566A0880|119 140|retinoid X receptor (RXR)
P10607566A0880|145 147|RAR
P10607566A0880|160 162|TCF
P10607566A0880|166 177|beta-catenin
P10607899A0605|21 34|promoter region
P10607899A0605|43 46|TATA
P10607899A0605|63 84|consensus binding motifs
P10607899A0605|89 95|p1, CREB
P10607899A0605|114 129|estrogen receptor
P10607900T0000|0 12|Sak kinase gene
P10608053A0923|111 120|+/- 43 IU/ml
P10608053A0923|174 176|p NS
P10608893A0727|32 34|DNA
P10608893A0727|76 108|double-stranded primer-template DNA
P10610716A1127|17 38|issense mutations, E138V
P10610716A1127|18 44|ssense mutations, E138V, R254G
P10610716A1127|49 53|P362R
P10610716A1127|79 84|AC gene
P10610716A1127|89 90|FD
P10611225A1127|37 41|eIF4A
P10611225A1127|63 68|eIF4GI
P10611225A1127|118 122|eIF4A
P10611225A1127|130 145|C-terminal region
P10611228A1388|3 10|DAP5/p86
P10611228A1388|41 48|DAP5/p97
P10611235A1927|58 61|MAPK
P10611235A1927|77 98|G(betagamma)-dependent
P10611235A1927|118 127|Ste5p-MAPK
P10611242A0541|19 38|inding, wild-type SAGA
P10611242A0541|47 49|TBP
P10611242A0541|62 73|HIS3 promoter
P10611242A0541|87 90|SAGA
P10611320A0816|65 71|CAK gene
P10611320A0816|66 76|AK gene, CAK1
P10611320A0816|90 98|monomeric
P10611320A0816|99 104|44-kDa
P10611353A0458|22 38|transcription-PCR
P10611353A0458|54 57|mRNA
P10611353A0458|80 82|RNR
P10612044A1180|42 45|AP-4
P10612044A1180|123 131|Aal-rpL34
P10612044A1180|135 147|Aal-rpL8 genes
P10612773A1210|0 10|CONCLUSIONS
P10612773A1210|25 33|S-100beta
P10613816X0000|207 218|bone diseases
P10613863T0000|3 6|VirR
P10613863T0000|115 126|pfoA promoter
P10613874A0663|41 44|pepX
P10613874A0663|69 72|ORFs
P10613874A0663|143 146|GlnR
P10613874A0663|150 153|GlnA
P10614676A0000|152 183|1 mg norethisterone acetate (E+NETA)
P10614857A0584|95 97|IFN
P10614857A0584|160 161|(P
P10614857A0584|170 210|coronavirus (P<0.001) or rhinovirus (P=0.002)
P10616948A0998|5 9|BF ECT
P10617126A1005|50 61|DHED-treated
P10617126A1005|100 108|area (CA1)
P10617126A1005|161 164|(CA1
P10617126A1005|168 171|CA3)
P10617126A1005|174 184|EC-lesioned
P10617232A0393|0 11|Serum HBV-DNA
P10618645A0750|18 21|AP-1
P10618645A0750|50 58|250 nmol/L
P10618645A0750|61 64|CalC
P10619353T0000|6 53|estrogen receptor ligand and estrogen response element
P10619353T0000|103 138|promoter transcription factor (COUP-TF)
P10620010A1155|0 9|CONCLUSION
P10620010A1155|103 108|kinase
P10620335A0749|16 18|AHR
P10620335A0749|32 38|COUP-TF
P10620335A0749|52 55|CV-1
P10620777A1399|0 7|AB004534
P10622574A0000|15 34|hepatitis C virus (HCV)
P10622574A0000|75 82|anti-HCV
P10622576A0552|132 133|IV
P10623758A0947|74 91|beta-galactosidase
P10623804A0808|83 86|SHIP
P10623804A0808|84 92|HIP, SHP-1
P10623804A0808|96 114|SHP-2 SH2-containing
P10623804A0808|130 141|Fc gamma RIIB1
P10624787A0432|62 63|(P
P10624787A0432|112 113|(P
P10624787A0432|145 151|Type 1 DM
P10624787A0432|177 178|(P
P10625494A1059|23 33|CAAT-region
P10625494A1059|61 72|MDR1 promoter
P10625494A1059|75 82|HL60/VCR
P10625683A0091|20 47|protein tyrosine kinases (PTKs)
P10625721T0101|23 34|Arrest (HACA)
P10627518A0544|112 115|UTRs
P10627532A0739|45 86|stress mitogen-activated protein (MAP) kinases
P10627532A0739|94 96|JNK
P10627532A0739|152 174|transcription factor ATF2
P10627834A0178|3 4|US
P10627834A0178|24 30|(Tehama
P10627834A0178|72 81|(Esterhazy
P10627834A0178|119 122|(Rex
P10627834A0178|126 153|blin's Glory, Meyric, McKinster
P10628748A0344|23 26|cAMP
P10628748A0344|57 68|inhibin alpha
P10628748A0344|107 110|SF-1
P10628748A0746|11 34|site-directed mutagenesis
P10628748A0746|50 53|SF-1
P10628748A0746|71 74|(TCA
P10628748A0746|75 80|GGGCCA
P10628748A0746|111 130|cAMP-response element
P10628748A0746|131 134|(CRE
P10628750T0000|11 12|II
P10628750T0000|27 52|factor (NF)-kappaB1 isoforms
P10628750T0000|62 106|angiotensinogen gene acute-phase response element
P10628750T0000|136 144|NF-kappaB
P10628750A0298|26 29|APRE
P10628750A0298|47 78|necrosis factor-alpha (TNFalpha)]-
P10628750A0298|128 158|factor-kappaB (NF-kappaB) complex
P10628750A0298|164 173|NF-kappaB1
P10628755A0000|72 73|GH
P10628755A0000|103 138|orphan GH-secretagogue receptor (GHS-R)
P10628971A0824|32 34|TGN
P10628971A0824|107 130|protein sorting genes (VPS)
P10628971A0824|144 166|dynamin family member VPS1
P10628971A1165|30 32|TGN
P10628971A1165|77 89|ollowing: RIC1
P10628971A1165|140 157|ribosome biogenesis
P10628971A1165|141 162|ibosome biogenesis; LUV1
P10628971A1165|238 242|INP53
P10628971A1165|252 303|a synaptojanin-like inositol polyphosphate 5-phosphatase
P10629035A0827|70 71|(G
P10629035A0827|105 114|telomerase
P10629176A0887|3 16|ddition, CaMig1
P10629176A0887|47 56|URS1 region
P10629176A0887|74 81|FBP1 gene
P10629938A1352|36 43|GFP-POLO
P10630471T0000|2 10|ASIC-chip
P10630630A0614|40 42|PKC
P10630630A0614|56 83|TPA-induced increase in CFI mRNA
P10633075A1111|9 11|IgG
P10633075A1111|10 21|gG, anti-GalT
P10633075A1111|56 64|monomeric
P10634007A0202|60 75|hemodialysis (HD)
P10634007A0202|79 81|NAC
P10637149A0806|15 17|G-A
P10637149A0806|33 34|RD
P10637149A0806|34 37|D, CC
P10637149A0806|85 87|REF
P10637149A0806|118 120|A-A
P10637230A0332|91 94|IFNs
P10637337A0545|15 17|DNA
P10637337A0545|36 39|TFA1
P10638607A0000|116 120|(T1-3
P10638607A0000|146 163|cell carcinoma (SCC)
P10639585A0157|9 15|MPO gene
P10640683A0204|0 11|NDRF/NeuroD2
P10640683A0204|34 36|PKN
P10640683A0204|52 56|COS-7
P10640683A0204|104 115|NDRF/NeuroD2
P10640683A0204|119 121|PKN
P10640683A0670|64 75|NDRF/NeuroD2
P10640683A0670|108 148|rat insulin promoter element 3 (RIPE3) enhancer
P10640683A0670|220 222|PKN
P10640683A0670|294 314|NDRF/NeuroD2-mediated
P10640701T0000|68 77|endogenous
P10640734A0190|32 36|ITIMs
P10640734A0190|59 90|SH2 domain-containing phosphatases
P10640734A0190|95 110|as SH2-containing
P10641037A1371|0 7|AF154055
P10642524A0156|27 31|mSTI1
P10642524A0156|95 128|tetratricopeptide repeat (TPR) motifs
P10642531A2322|76 78|RGD
P10642889A0393|29 45|5'-flanking region
P10642889A0393|59 66|ATG codon
P10642889A0393|93 96|TATA
P10643313A0345|64 91|onjunctiva, 50 micrograms rt-PA
P10643313A0345|97 103|ml (BSS)
P10643313A0345|110 114|ml SF6
P10644357A0935|23 25|VP1
P10644357A0935|118 120|VP2
P10644357A0935|124 126|VP3
P10644414T0000|57 85|mosquito ultraspiracle isoforms
P10644753A0725|28 44|anti-FLAG antibody
P10644760A0000|86 94|exogenous
P10644760A0956|42 67|N-terminal activation domain
P10644760A0956|71 97|a C-terminal repression domain
P10645921A0000|0 9|BACKGROUND
P10645921A0000|40 52|heterogeneous
P10645921A1320|46 54|(P<0.0001
P10645921A1320|105 106|SD
P10645921A1320|118 127|(P<0.0001)
P10645921A1320|149 165|circumflex disease
P10645921A1320|166 174|(P<0.0007
P10646863A0838|16 21|ICBP90
P10646863A0838|24 40|COS-1-transfected
P10646863A0838|75 84|endogenous
P10646863A0838|85 104|topoisomerase IIalpha
P10647177A0599|3 5|RNA
P10647177A0599|49 56|two-base
P10647633A1685|55 57|RSJ
P10647817T0000|11 15|cDNAs
P10647817T0000|50 78|T cell activation antigen 1 (PTA1)
P10647859A0000|66 90|pressure ventilation (IPPV)
P10647859A0000|212 224|breathing (QB)
P10647859A0000|250 267|pressure (Pappl)--6
P10647859A0000|273 279|12 cmH2O
P10647859A0000|291 307|hypocapnia (P(CO2)
P10647859A0000|295 306|capnia (P(CO2
P10648020A0151|0 6|METHODS
P10648020A0151|1 31|ETHODS: Von Willebrand factor (vWF)
P10648020A0151|50 87|factors tissue plasminogen activator (tPA)
P10648020A0151|99 101|tPA
P10648020A0151|114 150|plasminogen activator inhibitor 1 (PAI-1)
P10648020A0151|116 171|asminogen activator inhibitor 1 (PAI-1), platelets, fibrinogen
P10648020A0151|241 242|RA
P10648489A1117|62 63|ST
P10648619A0000|43 71|TATA-binding protein (TBP)-TATA
P10648619A0000|131 154|silkworm tRNA(C)(Ala) gene
P10648619A0000|241 276|a silk gland-specific tRNA(SG)(Ala) gene
P10649449A0413|41 61|squalene synthase genes
P10649456A1061|49 62|EUROFAN genetic
P10649456A1061|74 83|(EUROSCARF
P10649738A0953|55 58|CAPD
P10650938T0000|3 30|estrogen receptor (ER) isoforms
P10650938T0000|44 51|estrogen
P10650938T0000|67 75|generated
P10650938T0000|83 93|trout ER gene
P10650939A0789|36 40|A-Fos
P10650939A0789|61 64|AP-1
P10650939A1542|12 14|SMC
P10650939A1542|33 52|progesterone receptor
P10650939A1542|34 57|rogesterone receptor, PR-B
P10650939A1542|61 64|PR-A
P10650939A1542|101 114|PGDH-2368/luc3
P10650958A1315|46 66|consensus c-myb element
P10651805A1600|45 55|carrier cDNA
P10652093A0139|124 141|double-stranded DNA
P10652228A0759|25 45|c-Jun N-terminal kinase
P10652228A0759|58 77|Rho family GTP-binding
P10652362A0933|50 53|CFTR
P10652362A0933|127 144|adaptor complex AP-2
P10652362A0933|173 176|CFTR
P10652800A0984|187 189|BMI
P10653359A1297|11 18|4D1-D2.1
P10653400A0000|30 50|donor nephrectomy (LDN)
P10653693A0429|62 76|KRAB:KAP-1-RBCC
P10653693A0903|3 6|RING
P10653693A0903|23 39|coiled-coil region
P10653693A0903|54 68|oligomerization
P10653693A0903|71 80|KAP-1-RBCC
P10653693A0903|84 87|KRAB
P10653733A0596|27 56|proline-threonine-rich peptides
P10654032A1133|0 3|JPEG
P10655164A0546|106 169|imits: &amp;parl0;Li&amp;solm0;H&amp;parr0;p=1.23+0.68-0.32x10-10
P10655230A0685|29 45|mouse GCN2 isoforms
P10655230A0685|53 65|HisRS-related
P10655230A0685|90 95|kinase
P10656154A0722|30 32|PMS
P10656161A0316|0 2|MBI
P10656161A0316|6 9|MMBI
P10656161A0316|108 110|AUC
P10656802A1724|58 69|beta-hairpin
P10657238A0541|42 58|5'-flanking region
P10657238A0541|76 84|mStaf gene
P10657238A0541|106 115|mouse NMuMG
P10657658A0165|41 42|HA
P10657658A0165|63 74|I kappa B alpha
P10657658A0165|94 129|egradation, kappa B-linked reporter gene
P10657658A0165|144 157|ICAM-1 promoter
P10657658A0165|170 177|NF-kappa
P10657899A0685|61 67|PKCzeta
P10657899A0685|76 85|UV-induced
P10657899A0685|98 101|AP-1
P10657899A0685|104 106|JB6
P10657899A0685|122 136|AP-1-luciferase
P10658445A0208|0 6|METHODS
P10658445A0208|70 92|PGE1 alpha-ciclodestrina
P10658588A0304|100 101|CQ
P10658588A0304|126 129|(HB3
P10660069A0819|55 58|HOG1
P10660069A0819|61 64|PBS2
P10660069A0819|99 106|RRD genes
P10660304A0522|12 18|JAK/Tyk
P10660304A0522|27 41|tyrosine kinases
P10660304A0522|66 70|STAT3
P10660304A0522|85 88|CNTF
P10660304A0522|110 115|kinase
P10660304A0522|130 151|phosphorylation at STAT3
P10660604A0748|7 22|CARbeta/RXRalpha
P10660604A0748|51 75|HD-PPRE luciferase reporter
P10660676A0000|41 65|Growth Factor beta (TGFbeta)
P10662550A0679|5 8|SOX8
P10662550A0679|16 28|candidate gene
P10662550A0679|78 83|ATR-16
P10662614A0000|26 69|mite-transmitted wheat streak mosaic virus (WSMV)
P10662614A0972|39 54|full-length genes
P10662614A0972|57 58|CI
P10662614A0972|58 65|I, HC-Pro
P10662614A0972|76 77|CP
P10663558T0000|7 16|endogenous
P10664876A0000|218 260|pe), group B (acetonides), group C (betamethasone
P10665798A0598|41 61|aspartate transaminase
P10665798A0598|42 81|spartate transaminase, alkaline phosphatase
P10665798A0598|43 103|partate transaminase, alkaline phosphatase, creatine phosphokinase
P10665798A0598|44 124|artate transaminase, alkaline phosphatase, creatine phosphokinase, lactate dehydrogenase
P10666222A0330|31 42|survivin cDNA
P10666238A1322|19 21|E2F
P10666238A1322|34 46|E2F-1 promoter
P10666238A1322|111 123|E2F-1 promoter
P10666253A1291|53 56|tRNA
P10666253A1291|82 84|PBS
P10667597A0668|0 2|ZK7
P10667597A0668|6 15|HZF16 genes
P10668701A1311|0 9|CONCLUSION
P10668701A1311|21 24|APOE
P10668701A1311|71 72|AD
P10668701A1311|114 126|atherogenesis
P10669319A1722|84 85|II
P10669594A0000|22 33|imbrins, AgfA
P10669594A0000|37 40|SefA
P10669594A0000|67 79|fimbriae SEF17
P10669594A0000|83 87|SEF14
P10669594A0000|138 140|PT3
P10669594A0000|144 156|alpha-helical
P10669594A0000|206 220|metalloprotease
P10669594A0969|18 21|AgfA
P10669594A0969|40 43|SefA
P10669596A0430|126 146|ATP-dependent nuclease
P10669596A0430|197 223|Abc2-modified RecBCD nuclease
P10669633A0391|85 93|flt-1 gene
P10669633A0391|115 119|THP-1
P10669736A0903|29 31|CAT
P10669736A0903|62 65|HeLa
P10669736A0903|110 112|PTB
P10669751T0000|8 37|mitogen-activated protein kinase
P10669751T0000|84 96|c-jun promoter
P10671224A0254|60 64|CD95L
P10671519A0641|34 37|MAN1
P10671519A0641|110 112|LEM
P10671519A0641|136 179|membrane proteins lamina-associated polypeptide
P10671520T0000|29 50|I-mfa domain-containing
P10671520T0000|114 118|HIV-1
P10671554A0492|53 64|porcine cDNAs
P10671606A0884|57 68|out-of-phase
P10671606A0884|104 106|APA
P10671606A0884|140 142|BAH
P10672433A0199|77 84|bed (TIB)
P10672433A0199|128 143|sleep onset (WASO)
P10673426A0168|10 18|(R) domain
P10673426A0168|35 50|receptor-binding
P10673426A0168|69 87|N-terminal (T) domain
P10674395A0262|69 80|neuropeptide
P10674395A0262|70 85|europeptide, GnRH
P10674395A0262|103 121|glutamate/NO/cyclic
P10674395A0262|122 130|GMP (cGMP)
P10674395A0262|163 189|cGMP-dependent protein kinase
P10674395A0262|207 220|GnRH-secreting
P10674395A0262|229 241|cell line GT1-7
P10675331A0600|3 15|ontrast, c-Src
P10675610A0279|0 4|MSSPs
P10675610A0279|26 28|DNA
P10675610A0279|108 112|C-MYC
P10677214A1045|7 14|type MutT
P10677214A1045|21 24|E53D
P10677214A1045|28 31|E44D
P10677214A1045|64 65|pH
P10677214A1045|154 155|pH
P10677214A1045|192 196|pK(a)
P10677214A1045|307 336|MutT-Mg(2+)-dGTP-Mg(2+) complex
P10677214A2842|44 47|E44D
P10677214A2842|64 77|(1)H-(15)N HSQC
P10677214A2842|108 124|loop I-helix I motif
P10677214A2842|165 174|site region
P10679015A0216|53 59|snoRNPs
P10679065A0711|0 2|BCR
P10679065A0711|34 47|MAPK-activated
P10679065A0711|113 119|p38 MAPK
P10679065A0711|114 134|38 MAPK; MAPK-activated
P10679065A0711|209 241|CREB serine 133 phosphoacceptor motif
P10679065A1217|13 87|CRE-dependent junB promoter/chloramphenicol acetyltransferase (CAT) reporter gene
P10679065A1217|93 95|BCR
P10679065A1217|112 119|SB203580
P10679190A0693|36 53|reading frame (uORF)
P10679190A0693|101 118|reading frame (mORF)
P10679649A0311|0 6|METHODS
P10679649A0311|1 10|ETHODS: TBN
P10679649A0311|134 158|5-fluorouracil (CMF)-based
P10679781A1183|1 36|385 bp Glucocorticoid Response Unit (GRU)
P10679781A1183|91 104|dibutyryl-cAMP
P10679922A1110|59 62|ING1
P10679922A1110|69 87|tumor suppressor gene
P10681520A0525|0 7|Ras-GRF1
P10681520A0525|32 36|v-Src
P10681520A0525|83 85|GEF
P10681520A0525|157 166|Gbetagamma
P10681562A0263|12 20|PPARgamma
P10681562A0263|76 106|dominant-negative mutant receptor
P10681562A0263|116 133|wild-type PPARgamma
P10681588A0899b|0 3|EMSA
P10681588A0899a|0 3|EMSA
P10681588A0899a|33 36|PC12
P10681588A0899b|33 36|PC12
P10681588A0899a|63 65|CRE
P10681588A0899b|63 65|CRE
P10681588A0899b|96 121|transcription factor (ATF)-4
P10681588A0899a|96 121|transcription factor (ATF)-4
P10681588A0899a|125 156|CCAAT enhancer-binding protein beta
P10681588A0899b|125 156|CCAAT enhancer-binding protein beta
P10681588A0899a|125 145|CCAAT enhancer-binding
P10681588A0899b|125 129|CCAAT
P10681588A0899a|167 170|PC12
P10681588A0899b|167 170|PC12
P10681588A0899a|213 221|CCAAT-box
P10681588A0899b|213 221|CCAAT-box
P10681588A0899a|224 231|a complex
P10681588A0899b|224 231|a complex
P10681679A0220|40 53|umor, serial MRI
P10682570A0453|0 2|LPO
P10682570A0453|6 8|SOD
P10683244A0939|14 19|NBF1+R
P10683244A0939|31 34|NBF2
P10683244A0939|169 174|NBF1+R
P10683244A0939|177 180|NBF2
P10683244A1860|44 61|CFTR's NBF1+R region
P10683244A1860|68 77|NBF2 domain
P10683244A1860|210 220|exogenously
P10683259A0774|163 167|pK(a)
P10683989A0251|51 65|increases in PaO2
P10683989A0251|69 72|SaO2
P10683989A0251|73 74|(P
P10683989A0251|106 109|Qs/Q
P10683989A0251|118 119|(P
P10684069A0508|20 22|MIP
P10684069A0508|21 27|IP, MMIF
P10684069A0508|22 31|P, MMIF, FIC
P10684069A0508|46 66|minute ventilation (Vr)
P10684097A0175|15 16|SD
P10684111A1411|68 71|MAPK
P10684111A1411|78 81|MAPK
P10684265T0000|25 52|transactivator protein IE2-p86
P10684265T0000|93 126|ubiquitin-homologous proteins SUMO-1
P10684265T0000|130 135|hSMT3b
P10684304A1242|21 25|U(L)3
P10684534A0634|30 44|sum (Sigma-dose)
P10684534A0634|60 71|(Delta-dose)
P10684646A0224|70 81|FC-dependent
P10684660A1266|27 30|tRNA
P10684967A0000|0 5|NKX2.1
P10684967A0000|20 22|NK2
P10684967A0000|31 52|homeodomain-containing
P10687855T0000|93 109|zinc finger domains
P10687862A1980|3 7|CCAAT
P10687862A1980|38 41|CIII
P10687862A1980|45 50|CI/CII
P10688639A1310|31 34|PU.1
P10688639A1310|52 62|PEST domains
P10688646A0535|56 60|HS-40
P10688646A0535|85 128|alpha-globin promoter-growth hormone hybrid gene
P10688660A0992|32 34|CBP
P10688660A0992|57 60|T47D
P10688660A0992|100 111|PR-dependent
P10688660A0992|130 195| nucleosome-free, progesterone response element (PRE)-linked reporter DNA
P10688661A0237|11 33|inding protein, REST/NRSF
P10688661A0237|167 186|neuron-specific genes
P10688663A0207|12 33|core histone tail domains
P10688663A0207|139 144|TFIIIA
P10688663A0207|187 189|DNA
P10688666A1010|22 25|ASK1
P10688666A1010|48 71|art, homo-oligomerization
P10690702A0065|0 6|OUTCOME
P10690702A0065|1 28|UTCOME: Acetylcholine receptor
P10690725A1037|25 28|PRFR
P10690866A0783|41 43|TSH
P10691972T0000|21 37|5'-flanking region
P10691972T0000|57 84|resistance protein 2 (MRP2) gene
P10691972T0000|129 156|resistance protein 3 (MRP3) gene
P10692374A1873|61 63|20S
P10692374A1873|82 101|a nucleotidase complex
P10692374A1873|106 110|as PAN
P10692374A1873|216 218|PAN
P10692433A0000|3 24|transcription factor E2F
P10692433A0000|53 58|S phase
P10693314A0521|24 28|CK-MB
P10693314A0521|51 68|1 (59%) patients; ECG
P10693314A0521|77 79|AMI
P10694189A0469|11 13|MIB
P10694210A0385|21 23|H1R
P10694210A0385|181 183|H1R
P10694511A0570|18 28|yam8(+) cDNA
P10694605A1327|111 113|NS)
P10694609A0309|89 98|filtration
P10696007A1325|27 31|C2-C3
P10698516T0000|0 2|KFC
P10698516T0000|5 20|Ste20-like kinase
P10698516T0000|25 33|mitogenic
P10698516T0000|69 76|SAPK/JNK
P10698937T0000|0 4|TIP30
P10698937T0000|19 24|kinase
P10698974A0951|20 28|STAG3 gene
P10698974A0951|34 43|7q22 region
P10698974A0951|66 83|STAG3-related genes
P10698974A0951|221 248|Williams-Beuren syndrome (WBS)
P10699354A0557|0 15|Reaction time (RT)
P10699684A0661|103 104|(M
P10699896A0455|0 6|RESULTS
P10699896A0455|40 41|(P
P10702241A0357|11 19|a1 isoform
P10702253A0357|25 48|transcriptase-polymerase
P10702253A0357|72 88|HIF-1alpha subunit
P10702253A0357|103 106|cDNA
P10702253A0357|156 169|HIF-1alpha gene
P10702285A0855|30 39|G(q)/G(11)
P10702285A0855|55 82|phosphatidylinositol 3-kinase
P10702285A0855|214 244|G(q)/Q209L-stimulated GLUT4-EGFP
P10702389A1148|9 10|BL
P10702389A1148|15 26|RB2/p130 gene
P10702794A1495|26 29|ERK2
P10702794A1495|58 62|HePTP
P10702794A1495|96 100|HePTP
P10702794A1495|120 123|ERK2
P10702926T0089|46 68|alpha beta T cell receptors
P10703633A0747|136 157|24.4+/-4.1 (mean+/-SEM)
P10703633A0747|163 183|8.9+/-3.7 (mean+/-SEM)
P10704196A1051|3 16|pCMBS-reactive
P10704283A0649a|98 103|45 gene
P10704283A0649a|150 165|IL-4 cytokine gene
P10704285A0536|5 11|AP-2rep
P10704285A0536|70 86|AP-2alpha promoter
P10704285A0536|93 102|endogenous
P10704285A0536|103 115|AP-2alpha gene
P10704285A0536|152 160|AP-2alpha
P10704338A0354|42 61|amino-terminal domain
P10704338A0354|67 73|p24(CA)
P10704338A0354|172 184|alpha-helices
P10704338A0354|229 256|leucine residue (P-position-L)
P10704410T0000|0 15|Clb/Cdc28 kinases
P10704499A0682|14 20|PC12-E2
P10704499A0682|69 103|fibroblast growth factor (FGF) receptor
P10704499A0682|120 130|nonreceptor
P10704499A0682|131 144|tyrosine kinase
P10704499A0682|132 156|yrosine kinase p59(fyn), PLC
P10704499A0682|133 160|rosine kinase p59(fyn), PLC, PKC
P10704499A0682|158 160|PKC
P10704499A0682|164 166|MEK
P10704499A0682|184 222|KC, phorbol-12-myristate-13-acetate (PMA)
P10704853T0000|18 31|Bozozok/Dharma
P10704975A0479|76 80|NOC-5
P10704975A0479|122 131|NO-induced
P10705380A0629|110 123|UV-irradiation
P10705380A0629|127 131|BMP-4
P10705380A0629|149 181|ycloheximide-dependent way. genesis
P10705783A0433|123 128|mg/mL)
P10706475A0644|27 30|DSPP
P10706475A0644|44 46|DSP
P10706475A0644|50 52|DPP
P10706688A0376|11 13|TCR
P10706688A0376|30 33|AP-1
P10706688A0376|66 77|fasl promoter
P10706688A0376|105 115|on NF-kappaB
P10706736A1091|79 82|CD8+
P10706736A1091|108 128|HLA-A*0201-restricted
P10706887A0281|18 22|ALCLs
P10706887A0281|34 36|ALK
P10706887A0281|117 119|ALK
P10706887A1457|30 33|ATIC
P10706887A1457|53 71|ATIC-ALK-containing
P10708424A0800|59 63|BGLF4
P10708769A0433|42 67|ER stress-responsive element
P10711674A0000|0 6|PURPOSE
P10711674A0000|9 22|two-generation
P10711674A0000|98 101|(LCA
P10711674A0000|103 105|MIM
P10712599A0349|15 19|IRF-1
P10712618A0181|42 64|Bacillus YM55-1 aspartase
P10712618A0181|86 110|Bacillus subtilis aspartase
P10712618A0181|161 170|aspartases
P10713083A0170|32 35|TraR
P10713083A0170|80 83|TraM
P10713083A0560|37 52|AAI-dependent DNA
P10713083A0560|38 64|AI-dependent DNA binding, TraM
P10713083A0560|74 77|TraR
P10713083A0560|135 137|DNA
P10713155A0151|14 25|IIIa pre-mRNA
P10713155A0151|94 124|adenovirus-infected cells (Ad-NE)
P10713155A0151|145 148|HeLa
P10713155A0151|160 176|extracts (HeLa-NE)
P10713175A1399|34 36|ARF
P10713175A1399|113 127|ARF-Mdm2 complex
P10713175A1399|131 143|p53-dependent
P10713176A0422|46 48|E2F
P10713176A0422|120 124|v-Jun
P10713176A0422|172 210|proliferation-specific E2F-p107 complexes
P10713176A0422|225 231|mitogen
P10713176A0885|52 68|v-Jun-transformed
P10713176A0885|110 141|cdk6-specific inhibitor p16(INK4A)
P10713176A0885|154 156|DNA
P10713239A0988|0 9|CONCLUSION
P10713239A0988|79 81|IOL
P10713453A0172|76 78|57A
P10713453A0172|127 132|Hrb57A
P10714985A1057|2 4|RNA
P10714985A1057|68 74|(G/U)AG
P10714985A1057|99 115|TRAP-trp leader RNA
P10715322A0000|35 37|DNA
P10715325A0834|3 12|AtERF genes
P10715325A0834|125 161|ETHYLENE-INSENSITIVE2 (EIN2)-dependent
P10715602A0149|127 148|urfactant, Wellcome GmbH
P10715602A0149|171 176|a rSP-C
P10717612A0000|0 9|BACKGROUND
P10717612A0000|92 145|granulocyte-macrophage-colony stimulating factor (GM-CSF)
P10717612A0000|163 181|interleukin-2 (IL-2)
P10720434A0291|29 33|mRNAs
P10720434A0291|87 98|cyclin B1 mRNA
P10720434A0291|114 118|3'UTR
P10721698A1195|80 83|CSTB
P10721698A1195|156 159|CSTB
P10721704X0000|23 43|mouse Elavl1 (mHuA) gene
P10721704X0000|115 138|rganization. mHuA (Elavl1)
P10721704X0000|185 195|RNA-binding
P10721704X0000|270 273|mRNA
P10721704A1155|34 37|mHuA
P10721704A1155|95 109|promoter element
P10721714A1087|134 147|G/C-rich region
P10721717A0676|7 10|FGD1
P10721726T0000|18 43|mouse thioredoxin reductases
P10722063A0328|3 6|HPLC
P10722661A0146|0 3|CYC2
P10722661A0146|12 17|24-kDa
P10722661A0146|53 73|Neurospora crassa PREG1
P10722661A0146|92 96|PHO80
P10722661A0406|13 16|CYC2
P10722661A0406|58 93|trypanosome cdc2-related kinases (CRKs)
P10722661A0406|98 105|CYC2 gene
P10722661A0406|119 120|TY
P10722737A1726|151 161|LTC(4)S gene
P10723723A0781|16 28|mouse promoter
P10723723A0781|48 49|CT
P10724436A0085|19 22|U3O8
P10724483A0540|21 24|cAMP
P10724483A0540|44 47|SRP1
P10724483A0540|51 60|HEM13 genes
P10724483A0540|80 82|HOG
P10724519A1185|38 41|RNAs
P10725017A0673|52 57|CEN ENV
P10725017A0673|123 128|CEN ENV
P10725017A0673|134 144|'Electronic
P10725382A0398|111 114|SOS2
P10725433A0543|54 63|Wp reporter
P10725433A0543|136 156|consensus CREB-binding
P10725433A0543|174 190|wild-type promoter
P10727247A0461|97 109|TEF-1 isoforms
P10727247A0461|98 119|EF-1 isoforms, TEF-1beta
P10727247A0461|123 132|TEF-1gamma
P10727413A1244|61 73|hamster CYP7A1
P10727426A1280|3 8|kinase
P10727426A1280|19 23|PfPK6
P10727426A1280|37 39|CDK
P10727428A0000|8 43|MAP (mitogen-activated protein) kinases
P10727428A0000|119 128|MAP kinases
P10727433T0000|12 44|urokinase plasminogen activator gene
P10727433T0000|63 68|RAW264
P10727433T0000|95 135|macrophage colony-stimulating factor (CSF-1)
P10727433T0000|161 180|cell-surface receptor
P10727433A0560|17 22|CSF-1R
P10727433A0560|49 63|CSF-1-dependent
P10727433A0560|107 113|Ets/AP1
P10727433A0560|145 155|uPA promoter
P10727433A0560|195 203|oncogenic
P10727433A0560|210 222|protein kinase
P10727511A0294|64 68|GLT-1
P10727515A1202|14 23|endogenous
P10727515A1202|26 34|exogenous
P10727515A1202|35 55|G(q)-coupled receptors
P10727515A1202|63 82|delta-opioid receptor
P10727515A1202|111 117|PLCbeta
P10728945A0233|71 94|Thrombosis-II (IMPACT-II)
P10729151A1160|32 37|HPV-11
P10729151A1160|56 80|region-controlled reporter
P10729155A0653|17 20|MVMi
P10729155A0653|74 92|beta-strand I (betaI)
P10729220A0000|16 19|IGF2
P10729220A0000|50 52|II)
P10729220A0000|56 63|H19 genes
P10730292T0000|28 34|Class II
P10731411A0958|94 113|DEAD-box RNA helicases
P10731411A0958|155 157|"A"
P10731411A0958|174 179|"DEAD"
P10732669A0510|152 163|reporter gene
P10732669A0510|186 191|HD-Zip
P10732669A1336|84 89|HD-Zip
P10732669A1336|112 113|II
P10732669A1336|157 162|HD-Zip
P10733569A0364|14 17|HSFs
P10733569A0364|15 22|SFs, HSF1
P10733569A0364|66 87|heat-induced stress gene
P10733569A0364|119 122|HSF2
P10733581A1391|62 67|V12N38
P10733581A1391|100 104|TTF-1
P10733591A0146|85 97|p70(S6) kinase
P10733591A0146|101 126|c-jun N-terminal kinase (JNK)
P10733591A0533|53 61|PKClambda
P10733591A0533|102 110|PKClambda
P10734312A0503|120 147|Ras membrane localization motif
P10735272A0649|120 125|RT-PCR
P10735272A0649|181 185|ANOVA
P10735272A0649|194 231|chromosome 19q glioma tumor suppressor gene
P10735848A1440|0 3|RegA
P10735848A1440|41 48|tol-oprL
P10736161T0000|12 54|phosphoenolpyruvate:sugar phosphotransferase
P10736223A1227|46 49|prgX
P10736223A1227|68 77|Qa promoter
P10736223A1227|80 83|prgQ
P10736223A1227|88 91|PrgX
P10736223A1227|176 179|mRNA
P10737366A0280|48 51|PTFL
P10738139A0681|34 61|cytokine response pathway genes
P10738139A0681|64 67|KSHV
P10739671A0136|97 132|c-myb intron 1 transcription pause region
P10739671A0136|162 171|leukemia HL
P10739671A0136|177 188|fibroblast WI
P10739671A0136|207 239|a HL-60-specific DNA-protein complex
P10739671A0136|307 319|factors (IRFs)
P10740602A0141|0 10|STUDY DESIGN
P10740602A0141|51 57|21 cases
P10740602A0141|75 88|carcinoma (ILC)
P10741850A0452|0 34|Electrophile Response Elements (EpREs)
P10741850A0452|74 77|GCSh
P10741850A0452|81 96|GCSl subunit genes
P10741947T0000|52 54|LAD
P10742114A0486|99 100|SD
P10743608A1154|0 6|TbRAB31
P10743608A1154|40 55|ell cycle; TbRAB31
P10744026A0000|0 9|Invertases
P10744749T0000|63 76|MyoD-dependent
P10744749T0000|102 113|MyoD-binding
P10744749T0000|119 127|KIX domain
P10744749A0315|116 123|myogenic
P10744749A0315|124 127|MyoD
P10744749A0315|161 164|bHLH
P10744974T0000|73 85|protein kinase
P10747053A1102|84 91|TAF(II)s
P10747053A1102|152 156|TAF17
P10747053A1102|181 183|SBF
P10747053A1102|187 189|MBF
P10747099A0507|0 33|Extracellular-regulated kinase (ERK)
P10747099A0507|69 115|adaptor proteins p130 Crk-associated substrate (CAS)
P10747099A0507|119 130|c-CrkII (Crk)
P10747782A0390|20 43|Swi4 DNA-protein complexes
P10747782A0390|138 140|DNA
P10747782A0390|169 179|core domains
P10747879A0607|17 40|CCR5 cis-regulatory region
P10748054T0048|23 56|B lymphocyte antigen receptor-induced
P10748113A0187|20 22|RIM
P10748113A0187|37 40|RIM2
P10748113A0187|66 69|RIM1
P10748125A0000|0 15|Inhibitor-1 (I-1)
P10748125A0000|19 34|inhibitor-2 (I-2)
P10748125A0000|53 97|type 1 protein serine/threonine phosphatases (PP1)
P10748164A1284|30 31|AC
P10748164A1284|124 125|AC
P10748194T0000|34 53|density protein PSD-95
P10748672A0130|25 31|(Vipera
P10749145T0000|25 28|PCPH
P10749145T0000|50 62|diphosphatase
P10749145T0000|134 159|signal-regulated kinase ERK1
P10749166A0991|24 48|virulence-associated genes
P10749849A0000|30 47|tumor suppressor p53
P10749849A0000|120 168|cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene
P10750020A0843|29 30|ER
P10750020A0843|58 63|ER/Sp1
P10750020A0843|73 79|GC-rich
P10750020A0843|114 133|ligand-independent ER
P10750021A0728|22 46|deletion promoter-reporter
P10750524A0724|0 6|RESULTS
P10751398A1135|29 42|c-IAP2 promoter
P10751398A1135|70 73|CD40
P10751398A1135|76 87|Epstein-Barr
P10752475A1376|128 131|CD20
P10752475A1376|134 142|anti-CD20
P10752475A1376|168 189|Fc-receptor-expressing
P10752807A1598|0 9|CONCLUSION
P10752807A1598|35 75|platelet-activating factor antagonist BB-882
P10756007A0575|18 20|RBE
P10756007A1512|0 1|EM
P10756007A1512|33 46|Rep-DNA complex
P10756007A1512|58 71|ch-19 target DNA
P10756032A0599|38 52|cyclin E promoter
P10756094A0671|8 14|194 STSs
P10756100A0457|39 41|IB1
P10756225A1464|0 9|CONCLUSION
P10756225A1464|56 58|CRS
P10756225A1464|132 139|IL-5 mRNA
P10757983A0733|20 22|CRS
P10757983A0733|156 176|mouse ZBP-89 homologue)
P10758289A0141|0 6|METHODS
P10758489A0206|28 31|ICK2
P10758489A0206|59 65|Cdc2aAt
P10758489A0206|84 86|CDK
P10758489A0206|92 109|rabidopsis, Cdc2bAt
P10759693A0201|0 6|METHODS
P10759693A0201|22 34|odds ratio (OR)
P10759693A0201|121 131|H2-receptor
P10760109A1050|55 57|CVD
P10760109A1050|115 117|CVD
P10760109A1050|134 137|tHcy
P10760109A1050|135 142|Hcy, SAlb
P10760109A1050|136 154|cy, SAlb, plasma IGF-1
P10760109A1050|137 175|y, SAlb, plasma IGF-1, serum creatinine (SCr)
P10760169A1142|25 28|CreA
P10761263A1108|3 13|'Newcastle'
P10762254A0954|3 5|MMA
P10762254A0954|4 9|MA, DMA
P10762254A0954|14 34|TMA methyltransferases
P10762254A0954|65 88|MMA methyltransferase gene
P10762254A0954|109 111|DMA
P10762254A0954|115 135|TMA methyltransferases
P10762254A0954|154 171|in-frame amber codon
P10762348A0269|6 24|hosphorylation, STAT
P10763827A1158|64 74|ras oncogene
P10763827A1158|90 97|TGFbeta1
P10764150A0000|67 76|Raf kinases
P10764150A0000|110 115|FDC-P1
P10764729A1846|11 14|cDNA
P10764729A1846|30 34|betaV
P10764729A1846|58 68|GenBank(TM)
P10764760T0000|35 39|HIV-1
P10764760T0000|64 66|JNK
P10764802A1258|20 36|alpha-helix domain
P10764802A1258|39 47|p57(Kip2)
P10764802A1258|70 76|Cip/Kip
P10764802A1258|212 220|p57(Kip2)
P10764802A1258|249 256|myogenic
P10764970A1009|75 78|PCR)
P10765095A0308|31 33|PRL
P10765095A0308|113 118|L-Dopa
P10765095A0308|200 202|PRL
P10766246A0000|0 24|Integrin adhesion receptors
P10767091A0133|0 30|Intra-operative ultrasound (IOUS)
P10767251A1046|0 10|CONCLUSIONS
P10767338T0000|0 19|Hailey-Hailey disease
P10767338T0000|41 46|ATP2C1
P10767553A0100|108 128|Factor 3beta (HNF3beta)
P10767560A0105|49 59|exon-intron
P10767560A0105|77 88|mouse Pkr gene
P10767560A0105|126 147|mouse Pkr promoter region
P10767560A0105|159 171|IFN-inducible
P10769144A0000|3 5|CRE
P10769144A0000|4 20|RE, 5'-TGACGTCA-3'
P10769144A0000|66 76|cis-element
P10769144A0000|88 105|cAMP-regulated gene
P10770065A0264|20 27|(T1N0M0)
P10770065A0264|76 77|(R
P10771528T0036|18 36|alkaline phosphatase
P10771709A0291|90 93|IgM)
P10771709A0291|132 142|IgG antibody
P10772977A0222|27 31|PVX CP
P10773351A0672|11 14|CD86
P10773351A0672|53 61|IFN-gamma
P10773351A0672|96 138|GAS (gamma-interferon activation site) elements
P10773455A1268|25 38|GATA-1-binding
P10773455A1268|105 122|mouse ALAS2 promoter
P10773455A1268|204 206|MEL
P10773455A1268|273 277|ALAS2
P10773458A0000|0 6|SNAP-23
P10773667A0351|3 11|HMG domain
P10773667A0351|18 22|HMG20
P10773667A0351|52 61|yeast NHP6A
P10773951A0000|0 2|IgM
P10773951A0000|6 8|IgG
P10773951A0000|21 29|B antibody
P10775267A0363|24 29|T/T(L)
P10775267A0363|83 107|bone marrow transplant (BMT)
P10775267A0363|121 126|T/T(F)
P10775267A0363|135 156|ong-latency, pre-B-cell
P10775585A0754|0 5|Ab-MLV
P10775585A0754|23 28|P70/S2
P10775585A0754|46 51|NIH 3T3
P10775585A0754|136 183|Ras-dependent mitogen-activated protein (MAP) kinase
P10775623A0120|50 57|env genes
P10777217A0536|3 20|p53-homolog p73beta
P10777217A0536|37 48|PIG3 promoter
P10777217A0536|65 67|p53
P10777217A0536|72 89|proline-rich domain
P10777217A0536|92 98|p73beta
P10777217A0536|140 151|PIG3 promoter
P10777499A0883|56 58|DE1
P10777499A0883|133 155|light-responsive element
P10777586A1022|25 27|DNA
P10777586A1022|81 86|ZBP-89
P10777586A1022|101 115|silencer element
P10777586A1022|124 141|DNA-protein complex
P10777586A1022|193 196|HeLa
P10777669A0582|3 12|ZNF274 gene
P10777669A0582|29 36|marker RP
P10777669A0582|51 72|chromosome 19qter region
P10777669A0582|76 77|RH
P10778740A1493|142 152|pho85::HIS3
P10778757A0000|36 46|EMS-induced
P10778757A0000|90 104|Miniature1 (Mn1)
P10778757A0000|126 155|seed-specific cell wall invertase
P10778757A0000|127 161|eed-specific cell wall invertase, INCW2
P10779313A1842|41 69|enopus oocytes, beta-adrenergic
P10779313A1842|95 108|ACh-evoked GIRK
P10779313A1842|140 152|PKA-catalyzed
P10779313A1842|182 190|beta(2)AR
P10779329T0000|23 34|Src mitogenic
P10779352T0000|22 25|E2F3
P10779508T0000|0 36|Estrogen receptor-related receptor alpha
P10779508T0000|91 114|estrogen response elements
P10779508T0000|125 139|lactoferrin gene
P10779508A0452|2 6|DNase
P10779508A0452|43 46|SFRE
P10779508A0452|50 59|ERE regions
P10779508A0452|75 114|glutathione S-transferase-ERRalpha1 fusion
P10779508A0897|18 33|oactivator, SRC1a
P10779508A0897|36 40|GRIP1
P10779508A0897|57 73|ERRalpha1-induced
P10780764A0722|62 69|10 (PM10)
P10780764A0722|76 88|microm (PM2.5)
P10780883T0000|115 130|interferon-alpha
P10781109T0000|41 58|double-stranded RNA
P10781423A0993|72 136|homeodomain transcription factor thyroid transcription factor-1 (TTF-1)
P10781541A1063|61 70|3 promoters
P10781552A0000|40 49|generating
P10781604A0827|45 47|CTD
P10781604A0827|89 100|Rsp5 WW domain
P10781604A0827|101 105|(Rsp5
P10781604A0827|106 109|WW2)
P10781611A1023|45 57|LAT-deficient
P10781990A0455|0 13|T1-weighted MRI
P10782640A0444|50 61|a CM300 FEG/UT
P10782989A0575|52 81|amino-terminal DNA binding domain
P10782989A0575|115 130|DNA binding domain
P10784367A0133|0 5|METHOD
P10784393A0000|66 78|syndrome (MDS)
P10784393A0000|117 127|cytogenetic
P10785668A0000|49 57|pathogens
P10785880A0947|0 9|CONCLUSION
P10785880A0947|96 106|class 1 HELLP
P10786671A0182|23 32|telomerase
P10786671A0182|113 122|telomerase
P10786671A0182|130 153|transcriptase (hTERT) gene
P10787437A1616|69 73|SRE-1
P10787804T0000|0 3|AMDA
P10787804T0000|57 60|SNFs
P10788320A1034|23 33|TPR elements
P10788320A1034|108 112|102kD
P10788320A1034|138 146|tri-snRNP
P10788320A1034|163 173|U4/U6 snRNPs
P10788476A0891|43 48|Sec31A
P10788476A0891|78 85|ER-Golgi
P10788480T0000|25 61|single-stranded DNA-binding protein gene
P10788480T0000|100 102|DNA
P10790390X0000|110 120|E(var)3-93D
P10790390X0000|160 204|gene silencing in position effect variegation (PEV)
P10791901A0609|57 65|MRP1-PG13
P10791901A0609|98 105|MRP1 gene
P10792583A0000|21 43|vasopressin V1b receptors
P10792583A0000|102 114|hormone (ACTH)
P10792718T0000|18 36|AfsA homologue (BarX)
P10793143A1533|27 29|DNA
P10793143A1533|57 75|Abf1 ARS1 DNA-binding
P10793143A1533|106 120|Cdc6 DNA-binding
P10793143A1533|165 167|DNA
P10793991A0569|31 36|eb, TIE
P10794936A0241|22 28|MB/BacT
P10794936A0241|23 33|B/BacT, MGIT
P10794936A0241|162 181|. tuberculosis complex
P10795098A0253|29 42|Crohn's disease
P10796465A0373|0 16|SELECTION CRITERIA
P10796486A0817|0 16|SELECTION CRITERIA
P10797125A0000|23 49|progestin-mediated increases
P10797125A0000|137 144|estrogen
P10798607A1359|144 156|LCC-deficient
P10799501A1391|74 77|SPRK
P10799590A0431|0 16|Jkappa DNA-binding
P10799590A0431|65 71|EBNA-3C
P10799590A0431|134 149|wild-type EBNA-3C
P10799590A0431|143 149|EBNA-3C
P10799595A1454|9 11|YY1
P10799595A1454|15 17|CDP
P10799595A1454|51 88|differentiation-induced HPV-6 E1 promoter
P10799595A1454|102 104|HPV
P10799863T0000|20 36|metallopeptidases
P10799863T0000|73 80|HIV-1 ENV
P10799863T0000|91 100|endogenous
P10799863T0000|101 103|MHC
P10799879T0000|57 74|pleckstrin homology
P10799879T0000|78 96|Src homology 2 domains
P10801244A0578|71 76|NONMEM
P10801330A1714|133 135|FAK
P10801482A0968|118 123|kappaB
P10801809T0000|30 46|yeast PHO8 promoter
P10801809T0000|75 86|PHO5 promoter
P10802669A1434|71 73|A-T
P10802669A1434|77 79|NBS
P10802909A0478|0 9|PATIENTS OR
P10802909A0478|10 14|OTHER
P10802909A0478|15 26|PARTICIPANTS
P10804379T0001|35 47|epatitis C, HIV
P10805286A0233|33 44|cis-elements
P10805286A0233|55 61|PCI gene
P10805286A0233|89 117|epatoma-derived cell line, HepG2
P10805286A0233|140 149|rat PCI mRNA
P10805286A0233|186 193|androgen
P10805286A0914|12 18|PCI mRNA
P10805286A0914|66 75|rat PCI cDNA
P10805286A0914|103 110|androgen
P10805286A0914|116 122|PCI mRNA
P10805390A0340|60 70|GaAs/AlGaAs
P10805729A0987|81 84|DDP1
P10805729A0987|102 110|KH domains
P10805737T0000|29 62|translation initiation factor 5 (eIF5)
P10805737T0000|91 101|beta subunit
P10805737T0000|104 107|eIF2
P10805737T0000|111 114|eIF5
P10805738A0799|43 46|MyoD
P10805738A0799|44 59|yoD: (i) p38 kinase
P10805738A0799|96 115|MyoD-responsive genes
P10805738A0799|182 196|Gal4-MyoD fusion
P10805738A0799|234 262|chromatin-integrated reporters
P10805738A0799|265 268|MyoD
P10805738A0799|273 299|(iii) MyoD-dependent myogenic
P10805738A0799|357 369|p38alpha(-/-)
P10805739A0343|54 66|eIF2B subunits
P10805739A0640|57 68|eIF2Bepsilon
P10805739A0640|139 142|eIF2
P10805747A0633|40 59|Nim1p-related kinases
P10805823A1920|0 10|CONCLUSIONS
P10807903A0362|0 8|D5/D1(CT)
P10807903A0362|11 20|D5/D1D(CT)
P10807903A0362|110 133|wild-type (wt) D1 receptors
P10807903A0362|150 188|ligand binding and dopamine-stimulated cAMP
P10807903A0362|220 232|o wt D1 receptor
P10807903A0362|223 233|D1 receptors
P10810083A1283|3 28|serine-threonine kinase gene
P10810083A1283|58 72|zinc finger motif
P10810294A0730|26 27|GH
P10810294A0730|31 34|IL-6
P10810294A0730|50 61|reporter gene
P10810745A0677|0 2|HFA
P10810745A0677|67 69|HFA
P10811079A0555|0 6|RESULTS
P10811079A1277|5 8|SPP2
P10811804A0000|0 54|Mitogen-activated protein (MAP) kinase phosphatase-3 (MKP-3)
P10811804A0000|62 83|specificity phosphatase
P10811804A0000|112 148|signal-regulated kinase (ERK) MAP kinases
P10811804A0800|109 121|ERK-dependent
P10811804A0800|134 138|MKP-3
P10811908A0938|0 17|HPLC phosphopeptide
P10811908A0938|49 72|site-directed mutagenesis
P10811908A0938|87 90|NCLK
P10812294X0000|28 30|SBF
P10812294X0000|76 78|SBF
P10815410A0000|65 90|infection-induced increases
P10815410A0000|108 111|IL-1
P10815410A0000|109 116|L-1, IL-6
P10815410A0000|120 122|TNF
P10815807A1271|44 53|endogenous
P10815807A1271|54 66|c-Myb promoter
P10815807A1271|87 92|HTLV-I
P10819327T0000|1 26|. elegans KLP-11/OSM-3/KAP-1
P10819327T0000|42 60|sea urchin kinesin-II
P10819327T0000|65 100|mouse KIF3A/KIFB/KAP3 kinesin complexes
P10820904A0000|0 9|BACKGROUND
P10820904A0000|109 120|liver disease
P10823837A1213|35 41|YLL031c
P10823837A1213|85 99|alpha1-2-linked
P10823837A1213|132 134|GPI
P10823837A1213|213 221|alpha1-4-
P10823837A1213|225 239|alpha1-6-linked
P10823837A1213|253 255|GPI
P10823961A0664|14 17|TRBP
P10823961A0664|25 32|CBP/p300
P10823961A0664|36 42|DRIP130
P10823961A0664|59 78|DRIP/TRAP/ARC complex
P10823961A0664|97 100|TRBP
P10824485A0393|57 60|CD4+
P10824485A0393|95 98|AIDS
P10824958A1109|31 33|PAB
P10824958A1109|57 58|CO
P10824958A1109|69 70|PF
P10824958A1109|80 83|PSHL
P10825200T0000|11 32|protein tyrosine kinases
P10825200T0000|35 53|interleukin-2 (IL-2)
P10825200T0000|130 146|IL-2-mediated STAT
P10825293T0000|19 31|N-cadherin-Fc
P10825294A0473|11 20|OC promoter
P10825294A0473|63 65|MDR
P10825294A0473|64 69|DR, LTR
P10825294A0473|73 84|BSP promoters
P10825294A0473|156 158|AML
P10825294A0473|196 222|C-terminal pentapeptide VWRPY
P10826946A1198|89 96|gp120 SAg
P10826946A1198|130 135|V(H)3+
P10827952A0158|18 25|TAFII250
P10827952A0158|46 50|TFIID
P10827952A0158|69 79|bromodomain
P10827952A0158|126 142|histone H4 peptides
P10828591A0080|45 48|cDNA
P10828591A0080|114 128|markers D11S1765
P10831972A0744|0 6|RESULTS
P10831972A0744|15 18|CD23
P10831972A1091|0 9|CONCLUSION
P10831972A1091|62 65|CD23
P10833461A0603|32 46|chromosome (PAC)
P10833461A0603|74 85|length UGT2B7
P10833486A0598|23 26|[OR]
P10833486A0598|34 36|BMI
P10833486A0598|49 51|(OR
P10833486A0598|77 82|mmol/L
P10833486A0598|83 85|(OR
P10833486A0598|93 120|alanine aminotransferase (ALT)
P10833486A0598|124 125|2N
P10833486A0598|126 128|(OR
P10834781A0693|52 71|residence times (MRTs)
P10834781A0693|146 147|(P
P10835355A0225|77 86|rim15Delta
P10835355A0225|150 153|SSA3
P10835485A0941|12 16|"SH3"
P10835485A0941|29 40|linker domain
P10836542A0363|17 18|UV
P10836542A0363|42 45|UV-A
P10836786A0516|33 43|RNA subunits
P10836786A0516|109 116|ures (MRP
P10836786A0516|113 117|(MRP3
P10836786A0516|131 141|RNase MRP RNA
P10836786A0516|133 141|ase MRP RNA
P10837126A1004|24 34|pMesogenin1
P10837126A1004|91 101|marker genes
P10838139A1447|14 24|Ha-ras codon
P10838139A1447|49 60|EtNU-induced
P10838399A0525|13 18|PET FDG
P10838399A0525|34 58|ung infection, degenerative
P10838399A0525|59 69|bone disease
P10838531A0675|15 17|IIB
P10838531A0675|18 20|(T3
P10838531A0675|30 33|IIIA
P10838531A0675|43 46|IIIB
P10839547A0978|18 26|odel, CTCF
P10839547A0978|47 49|DNA
P10839593A0000|0 8|OBJECTIVE
P10839593A0000|60 75|suspension (ABOS)
P10839593A0000|142 144|HIV
P10840001A0188|0 8|Mucin gene
P10841537A0669|32 35|RPB5
P10841537A0669|86 113|surface-exposed alpha-helical
P10843716A0406|3 10|tryptase
P10843716A0406|39 62|tryptase-like pseudogenes
P10843716A0406|74 84|astin, a gene
P10843810A0802|80 103|tyrosine phosphatase 1 gene
P10843810A0802|165 167|LTR
P10845522A0000|0 8|OBJECTIVE
P10845522A0000|57 71|99mTc-sestamibi
P10846054A0573|71 78|RNA 2 ORFs
P10846054A0573|105 118|progeny LIYV RNA
P10846054A0573|116 118|RNA
P10846054A0573|122 124|RNA
P10846054A0573|178 184|LIYV RNA
P10846069T0000|6 11|NH(2)-
P10846069T0000|15 34|COOH-terminal domains
P10848605T0000|38 49|kinase domain
P10848605T0000|53 71|juxtamembrane region
P10848605T0000|118 129|Eph receptors
P10848848A0413|0 6|RESULTS
P10848993A0000|7 9|DNA
P10848993A0000|35 68|methylmalonyl-CoA mutase gene (mutAB)
P10848993A0000|74 94|rifamycin SV-producing
P10848993A0000|179 207|serine/threonine protein kinase
P10850329A0248|0 3|IL-2
P10850453A0713|30 35|Ha-Ras
P10850453A0713|71 79|mitogenic
P10850453A0713|88 96|TGF-beta1
P10850453A0713|99 105|TSU-Pr1
P10850453A0713|113 121|TGF-beta1
P10850453A0713|134 138|DU145
P10850453A0713|165 173|V12Ha-Ras
P10850453A1292|57 64|Ras/MAPK
P10850453A1292|127 135|TGF-beta1
P10850719A0680|0 4|Vbeta
P10850719A0680|26 31|DJbeta
P10850719A0680|67 71|Vbeta
P10850719A0680|74 78|Jbeta
P10850719A0680|114 125|Vbeta 23-RSSs
P10850719A0680|129 140|Jbeta12-RSSs
P10850849A0730|8 34|dministration, AUC0-infinity
P10850849A0730|52 70|icrog x h/ml, t1/2beta
P10850849A0730|87 117|ours, maximum concentration (Cmax)
P10850942A0989|95 97|TPN
P10850997A1016|3 14|ontrast, H-NS
P10851089A1248|5 7|SAG
P10851267A0000|0 2|E2F
P10851267A0000|64 70|S-phase
P10852460A0170|85 100|alpha-tocopherol
P10852460A0170|202 208|SENIEUR
P10852485A0477|7 16|Spring (CS)
P10852485A0477|28 32|Q gene
P10852485A0477|67 68|CS
P10852485A0477|95 97|5AL
P10852485A0477|110 114|Q gene
P10853059X0751|0 7|Karger AG
P10853850A1103|7 10|LTE4
P10854004A0788|5 7|FVR
P10854004A0788|38 40|ERT
P10854004A0788|44 46|HRT
P10854004A0788|51 53|FVR
P10854004A0788|90 91|II
P10854699A0424|5 15|FGF-AS cDNAs
P10854699A0424|32 52|full-length FGF-AS mRNA
P10854699A0424|113 118|FGF-AS
P10855690A0870|38 46|MAP kinase
P10855690A0870|60 72|hPL-B enhancer
P10855690A0870|75 93|an NF-IL-6-dependent
P10855793A1418|29 32|TNRs
P10855793A1418|149 165|neurodegenerative
P10855796A1160|14 16|RNA
P10855796A1160|67 75|EphA8 gene
P10856298A0798|14 18|cDNAs
P10856298A0798|44 52|FPGS-null
P10856298A0798|121 125|T339I
P10856491A0178|0 6|SETTING
P10856491A0178|20 46|Paris VII hospital.Patient(s)
P10857215A0000|3 24|Menopause-Rating-Scale
P10857215A0000|25 28|(MRS
P10857215A0806|3 7|MRS II
P10857262A0186|22 25|fruA
P10857262A0186|100 131|BTB protein-protein-binding domain
P10857262A0186|158 159|II
P10857751A0304|14 42|mouse ortholog (Mharp/Smarcal1)
P10857751A0304|59 95|Caenorhabditis elegans ortholog (CEHARP)
P10857751A0304|114 128|GenBank database
P10858355A0920|48 72|Enterococcus faecium SF2149
P10858355A0920|76 100|Enterococcus faecalis WH245
P10858988A0786|0 2|ECP
P10858988A0786|6 13|tryptase
P10860131A0847|74 76|(RR
P10860131A0847|84 85|CI
P10860752A1601|26 42|RNA- binding domain
P10860752A1601|91 118|bacteriophage T4 DNA polymerase
P10860752A1601|145 148|mRNA
P10860827A0399|48 69|cis-regulatory elements
P10860827A0399|101 104|CSX1
P10860846A0480|46 65|AP2 core binding region
P10860846A0480|106 108|AP2
P10860846A0480|137 139|AP2
P10860846A0480|166 180|HGF gene promoter
P10861080A0433|25 49|IkappaBalpha (IkappaBalpha
P10861080A0433|37 49|(IkappaBalpha
P10861080A0433|81 89|TNF-alpha
P10861080A0433|104 106|GBS
P10861086A0259|60 62|RAW
P10861086A0259|78 101|C-terminal Src kinase (Csk)
P10861086A0904|3 39|ontrast, c-Src-derived construct (a-Src)
P10861906A0999|58 78|meiosis-inducing genes
P10861906A0999|85 88|IME1
P10861906A0999|92 95|IME2
P10861906A0999|136 139|IME1
P10861906A0999|156 159|IME2
P10861906A0999|198 200|DNA
P10861906A1479|83 87|KIN28
P10861906A1479|91 94|CCL1
P10861909A0502|3 5|pJR
P10861909A0502|53 66|(Saccharomyces
P10861909A0502|77 84|LEU 2 gene
P10861909A0502|109 117|leu1- gene
P10861909A0502|136 146|his3+ genes)
P10861909A0502|154 185|thiamine-repressible nmt1 promoter
P10861909A0502|186 188|(3X
P10861909A0502|190 192|41X
P10861909A0502|196 198|81X
P10862289A0289|0 8|(GUT)Sera
P10862289A0289|86 88|IgG
P10863048A0000|128 131|(CRD
P10863048A0000|133 138|80 mmHg
P10864496A0401|60 63|TnrA
P10864496A0401|71 83|nrgAB promoter
P10864496A0401|98 99|nM
P10864641A1400|47 62|receptor-binding
P10864641A1400|72 73|HA
P10864989A0484|0 6|RESULTS
P10864989A0484|28 31|PAIP
P10864989A0484|87 90|WBCs
P10864989A0484|128 130|FIP
P10865422A0138|16 32|serum ferritin (SF)
P10865422A0138|17 47|erum ferritin (SF), hemoglobin (Hb)
P10865838A0000|19 36|growth factor (VEGF)
P10865940A0000|14 50|agent pyrrolidine dithiocarbamate (PDTC)
P10865940A0000|83 91|cells (EC)
P10865940A0000|123 150|pro-oxidant-induced NF-kappaB
P10866323A0666|28 57|SIE-1 hypermethylation on p21WAF1
P10866323A0666|69 72|STAT
P10866677A1839|0 33|Phd antibody-immunoreactive peptides
P10866689A0295|5 16|pRb(-) SAOS-2
P10866689A0295|81 99|al-1 binding site, pRb
P10866689A0295|136 149|tal-1-E12-Lmo2
P10866689A0295|153 180|tal-1-E12-Lmo2-Ldb1 complexes
P10866689A0295|194 202|tal-1-E12
P10866886A1277|37 45|oxycodone
P10866886A1277|48 71|morphine-like mu-receptor
P10867199A0230|107 110|EPVs
P10867199A0230|144 159|phylogenetically
P10869076A1384|83 86|tnaC
P10869076A1384|109 112|boxA
P10869465A1054|35 37|RNA
P10869465A1054|164 171|(Sertoli
P10870043A0621|22 25|GnRH
P10871045A1221|18 26|C/EBPbeta
P10871045A1221|43 54|C/EBP isoform
P10871045A1221|100 108|C/EBPbeta
P10871045A1221|119 127|C/EBPbeta
P10871045A1221|146 150|C/EBP
P10871347A0477|35 45|motif TCCCCT
P10871347A0477|59 63|PyRo1
P10871379A0261|6 9|VP16
P10871379A0261|61 63|HCF
P10871412A0369|70 84|ribozyme (Rz007)
P10872473A2286|3 7|ATR-X
P10872473A2286|41 47|XH2 gene
P10872473A2286|61 79|X chromosome (Xq13.3)
P10872535A0000|0 3|AIMS
P10872535A0000|171 196|glucose tolerance test (OGTT)
P10872756A1325|2 10|NASCIS III
P10872827A0000|0 20|Penicillin acylase (PA)
P10872827A0000|40 48|ATCC11105
P10872827A0000|87 91|24 kDa
P10872827A0000|108 112|65 kDa
P10872831A0000|16 31|sequence tag (EST)
P10872831A0000|51 78|erythropoietin receptor (EPOR)
P10872831A0000|97 107|EST database
P10872851A0714|7 9|LCx
P10872851A0714|35 44|PM-induced
P10872851A0714|75 86|AoP (P=0.045)
P10872851A0714|106 116|SV (P=0.048)
P10872851A0714|121 125|LVEDP
P10872851A0714|138 146|(P=0.002)
P10873158A0000|19 35|factor (NF)-kappaB
P10873286X0000|0 11|GAP JUNCTIONS
P10873286X0000|12 13|IN
P10873286X0000|14 16|THE
P10873286X0000|17 21|BRAIN
P10873286X0000|18 29|RAIN: PREFACE
P10873386A0000|45 53|mouse gene
P10873386A0000|60 68|C2 subunit
P10873386A0000|74 76|20S
P10873387A0816|42 52|Cacna1f gene
P10873387A0816|81 111|mouse synaptophysin gene in a region
P10873388A0623|12 23|Rhotekin cDNA
P10874044A0647|51 58|p38alpha
P10874044A0647|68 71|ERK1
P10874044A0647|69 76|RK1, ERK2
P10874044A0647|70 81|K1, ERK2, JNK1
P10874044A0647|85 88|JNK2
P10874044A0647|105 126|cadmium-induced pE1-luc
P10874151A0000|0 9|BACKGROUND
P10874151A0000|1 37|ACKGROUND: Gamma knife radiosurgery (GKR)
P10878398A0542|22 25|(Epo
P10878398A0542|29 35|Non-Epo
P10878398A0542|91 94|CAPD
P10878398A0542|103 106|(Epo
P10878398A0542|110 116|Non-Epo
P10878675A1278|0 9|CONCLUSION
P10878675A1278|14 30|alpha2-adrenergic
P10878944A0000|0 7|ID-PaGIA
P10878944A0000|67 74|DiaMed AG
P10880486A0790|18 28|EMS-induced
P10880486A0790|79 89|zipper(Ebr)
P10880486A0790|101 104|RhoA
P10881275T0000|10 17|serum IgM
P10881275T0000|27 29|GM1
P10882163A1077|154 162|aromatase
P10882850A0000|0 11|Endonuclease
P10882850A0000|12 14|III
P10882850A0000|15 19|(Nth)
P10882850A0000|40 53|DNA glycosylase
P10882850A0000|86 99|pyrimidine base
P10882850A0000|112 114|DNA
P10885750A0236|51 56|CREB-2
P10887912A0740|7 10|MVBF
P10887912A0740|17 26|maximum EMG
P10887921A0718|0 10|CONCLUSIONS
P10887921A0718|75 78|SWAP
P10889399A0243|64 66|MEK
P10890911A0470|48 59|HMG box domain
P10890911A0470|62 65|LEF1
P10890911A0470|73 79|TGFbeta
P10890911A0470|131 159|Xenopus homeobox gene twin (Xtwn)
P10891093A0000|26 48|Na(+)/H(+) exchanger NHE3
P10891093A0000|168 171|cDNA
P10891093A0000|197 200|NHE3
P10891266A0421|0 4|ACE-2
P10891286A0000|29 39|chain kinase
P10891399A1185|27 33|c-fosER
P10891399A1185|69 82|p21(Cip1/WAF1)
P10891399A1185|116 119|AP-1
P10891441A0871|13 36|pTyr317 Shc phosphopeptide
P10891441A0871|60 71|b2, Sos1, SHIP
P10891441A0871|79 88|p85 subunit
P10891441A0871|113 118|kinase
P10891489A0152|32 38|HMG-I/Y
P10891489A0152|160 171|pathogenesis
P10891632A0435|3 23|naltrexone/lofexidine
P10892823A1040|102 104|HBP
P10893243T0000|44 89|chaperonin subunit gene Ccta/t-complex polypeptide
P10893243T0000|93 114|selenocysteine tRNA gene
P10893258T0000|64 88|membrane protein biogenesis
P10894149T0000|0 3|PNRC
P10894149T0000|125 156|orphan receptors SF1 (steroidogenic
P10894149T0000|168 185|ERRalpha1 (estrogen
P10894149T0000|193 208|receptor alpha-1)
P10894816A0836|54 84|sterol-responsive element (SRE)-1
P10894816A0836|122 125|IL-6
P10895417A0000|26 30|(EPI)
P10895417A0000|86 94|(DepoFoam
P10895417A0669|9 17|EPI-C0401
P10895417A0669|33 40|DepoFoam
P10896008A0531|0 11|PARTICIPANTS
P10896859A0000|78 82|(ADX)
P10896859A0000|144 164|cortisol (ADX-constant
P10897233A1057|0 9|CONCLUSION
P10897973T0001|0 14|Antithrombin III
P10897973T0001|45 65|heparin? Thrombosis ABC
P10897973T0001|90 92|III
P10898795A0527|17 18|II
P10898795A0527|19 44|histone deacetylases (HDACs)
P10898795A0527|63 66|BCoR
P10898795A0527|82 85|BCoR
P10898795A0527|122 126|HDACs
P10899128A0661|34 59|transcription factor complex
P10899128A0661|75 82|MADS-box
P10899142A0000|35 55|Genome Project database
P10899142A0000|95 149|Leu-rich repeats-containing G protein-coupled receptor (LGR)
P10899142A0000|164 171|(DLGR-1)
P10899142A0000|209 219|LGR (DLGR-2)
P10899142A0000|232 235|cDNA
P10900129A0138|0 26|Degenerate primers homologous
P10900129A0138|58 62|CYP3A
P10900129A0138|90 96|RT-PCRs
P10900269A0396|30 33|TFOs
P10900269A0396|91 97|TK genes
P10903440A0515|26 31|TSGF-2
P10903495A0533|27 31|HepG2
P10903583T0000|42 46|OSI CA
P10903733A0540|69 72|BCMA
P10903733A0540|87 113|TNFR-associated factor (TRAF)
P10903733A0540|88 120|NFR-associated factor (TRAF) 1, TRAF2
P10903733A0540|125 129|TRAF3
P10903837A1208|8 15|RINX gene
P10903837A1208|39 54|goldfish Vsx1 gene
P10903837A1208|70 73|VSX1
P10903843A0447|119 128|Kcnq1 genes
P10903877A0879|12 14|PKA
P10903877A0879|17 33|8-bromo-cyclic AMP
P10903877A0879|61 63|PKC
P10903877A0879|110 112|3TP
P10903877A0879|136 144|ERK kinase
P10903877A0879|155 158|CRAC
P10904191A0000|66 80|AMP CT (Gen-Probe
P10904191A0000|68 104|P CT (Gen-Probe Incorporated, San Diego, CA
P10904191A0000|69 109| CT (Gen-Probe Incorporated, San Diego, CA, USA)
P10904191A0000|112 121|urogenital
P10904191A0000|169 182|void urine (FVU)
P10905349A0329|44 58|XPF endonuclease
P10905349A0609|80 103|olerance to, UV-induced DNA
P10905352A0000|9 20|plasmid pCLU1
P10905352A0000|112 123|plasmid pGKL2
P10905352A0000|138 148|protein (TP)
P10906176A0000|13 15|ETn
P10906999T0000|16 17|NO
P10907348A0508|68 70|PTH
P10907348A0508|129 130|AP
P10907971T0000|28 43|HMG-CoA reductase
P10907971T0000|81 86|CURVES
P10907971A0806|22 51|cost-effective HMG-CoA reductase
P10908317A1459|22 29|E domains
P10908317A1459|87 98|domain in rtER
P10908364A0000|0 4|G-DNA
P10908364A0000|8 23|four-stranded DNA
P10908462A3159|18 20|NRT
P10908478A0717|0 16|SELECTION CRITERIA
P10908822A0519|6 7|CI
P10909973A1508|22 26|GLP-1
P10909973A1508|32 34|CRE
P10909973A1508|68 74|M1-CREB
P10909973A1508|138 149|PKA-mediated
P10910073A0876|10 25|PDGFbetaR fusions
P10910073A0876|116 119|cDNA
P10910073A0876|124 138|PCR on patient RNA
P10910439A1196|0 10|CONCLUSIONS
P10910439A1196|71 73|GFR
P10910908A0767|27 34|PI3K-Akt
P10910908A0767|91 93|EPO
P10913094A0424|4 6|DNA
P10913094A0424|56 75|histidine-tagged AdpA
P10913094A0424|99 118|gel mobility shift-PCR
P10913172A0442|21 36|NTP-binding motif
P10913276A0510|3 37|carboxyl-terminal proline-rich domain
P10913276A0510|40 43|SOS1
P10913276A0510|77 95|PLC-gamma1 SH3 domain
P10913276A0684|56 64|SH3 domain
P10913276A0684|67 76|PLC-gamma1
P10913276A0684|109 112|SOS1
P10913304A0894|11 18|Ets mRNAs
P10913304A0894|36 52|s2, Fli1, GABPalpha
P10913304A0894|37 57|2, Fli1, GABPalpha, SAP1
P10913304A0894|67 69|PE1
P10913304A1180|59 63|57 kDa
P10913304A1180|107 125|N-terminal Ets domain
P10913304A1180|128 130|PE1
P10913304A1180|140 155|C-terminal domain
P10913304A1180|186 188|ERF
P10915728A0216|106 113|IFN-beta
P10915728A0216|155 157|IFN
P10915780A1063|50 61|cyclin D1 mRNA
P10915780A1063|140 142|ILK
P10918059A0569|13 21|RVH domain
P10918164A0878|159 161|CI]
P10918440T0000|77 86|allogeneic
P10918572A0794|0 2|VaI
P10918572A0794|6 9|VaII
P10918572A0794|35 39|ErbB2
P10918572A0794|51 55|ErbB1
P10918572A0794|52 61|rbB1, ErbB3
P10918572A0794|65 69|ErbB4
P10918572A1547|19 20|WT
P10918572A1547|31 39|TGF-alpha
P10918572A1547|47 51|ErbBs
P10918572A1547|63 67|ErbB2
P10918572A1547|146 154|TGF-alpha
P10918572A1547|187 190|ErbB
P10918596A0000|26 38|p53 C-terminus
P10918599A0071|12 27|full-length E2F-3
P10918599A0071|54 57|G1/S
P10918599A0071|55 72|1/S boundary, E2F-3B
P10918599A0071|121 122|GO
P10918612A0000|3 31|transcription factor Jun (c-Jun)
P10918943T0000|31 33|III
P10918948A0110|53 54|II
P10918948A0110|55 63|(Debridat
P10918948A0110|65 67|CAS
P10919971A0606|117 130|creatine kinase
P10920186A0528|104 106|MLL
P10920186A0528|116 127|two-sided PCR
P10920906A0759|0 9|CONCLUSION
P10920906A0759|63 65|STS
P10921197A0179|43 81|treatment planning systems--Theraplan VO5B
P10921197A0179|85 88|ADAC
P10925159A1353|7 12|MARTA1
P10925159A1353|100 113|xtracts, MARTA2
P10925207A0634|10 16|25 exons
P10925207A0634|106 118|regions (UTRs)
P10926776A0731|9 20|PDP1 isoforms
P10928179A0101|50 73|sentinel lymph nodes (SLNs)
P10928477A0764|28 34|PFA-100
P10928477A0764|62 74|vWF-dependent
P10930526A0174|40 51|PL scramblase
P10930526A0174|59 68|(HuPLSCR1)
P10931524A0313|96 106|DNA-binding
P10931927A0655|7 57|oligomer duplex 5'-A(GGGTTA)(5)-3'/5'-(TAACCC)(5)T-3'
P10931927A0655|125 137|DNA polymerase
P10931927A0655|142 144|HIV
P10931927A0655|152 164|transcriptase
P10931927A0655|176 186|telomere DNA
P10931927A0655|240 250|template DNA
P10931950A0869|7 10|MAPK
P10931950A0869|94 98|T187A
P10931960A0630|71 86|activation domain
P10931960A0630|113 128|activation domain
P10931960A0630|154 164|protein VP16
P10932196A0359|14 16|RP2
P10932196A0359|57 60|XLRP
P10932527A0947|13 14|HD
P10933728A1398|44 47|CBF2
P10933728A1398|59 63|EBNA2
P10933728A1398|95 110|hnRNP protein AUF1
P10933728A1398|130 133|CBF2
P10933728A1398|191 208|CBF1 binding element
P10933728A1398|243 247|EBNA2
P10933732A0000|19 37|herpesvirus 8 (HHV-8)
P10933732A0000|60 78|reading frames (ORFs)
P10933732A0000|165 175|factor (IRF)
P10934073A1433|26 30|CHIME
P10934310A0698|0 12|DATA SYNTHESIS
P10934310A0698|27 36|ultrasound
P10934640A1114|0 1|TB
P10934640A1114|90 94|TB BMC
P10934751T0001|0 4|CREST
P10935488A1033|25 34|endogenous
P10935488A1033|35 53|PPARgamma target gene
P10935488A1033|84 109|acid binding protein (A-FABP)
P10935880A1049|35 39|PI-3V
P10935880A1049|46 52|NCP BVDV
P10935880A1049|71 76|BVHV-1
P10935880A1049|80 83|BVDV
P10936051T0000|3 7|RS447
P10936920A0105|60 69|generation
P10938102T0000|10 39|translation initiation factor 4GI
P10938102T0000|60 62|NS1
P10938102A0265|45 47|NS1
P10938102A1359|62 64|NS1
P10938102A1359|73 78|eIF4GI
P10938102A1359|119 122|UTR)
P10938102A1359|133 136|mRNA
P10938105A0000|13 17|K-SAM
P10938105A0000|38 72|fibroblast growth factor receptor 2 gene
P10938105A0000|96 113|U-rich sequence IAS1
P10938109A1361|13 24|ells, PKCbeta
P10938109A1361|80 82|EGF
P10938109A1361|90 110|growth factor mitogenic
P10938113A0388|154 164|Vav isoforms
P10938120A1093|27 38|fbp1 promoter
P10938120A1093|63 66|UAS1
P10938120A1093|69 72|UAS2
P10938120A1093|88 90|PKA
P10938120A1093|94 97|MAPK
P10938130A0338|36 52|PLZF BTB/POZ domain
P10938135A0259|12 15|SMRT
P10938135A0259|118 131|tyrosine kinase
P10938135A0259|185 204|growth factor receptor
P10939030A0986|104 105|IV
P10939785A0540|46 48|ACE
P10940553A0912|96 104|hPer1 gene
P10940557A1687|21 27|CF1/USP
P10940557A1687|31 71|Broad Complex Z2 transcription factor elements
P10940557A1687|103 105|MIH
P10940557A1687|109 118|MO-IH genes
P10940562T0000|41 47|oas gene
P10940562T0000|62 88|O-acetylserine (thiol) lyases
P10940562A0379|45 53|oasA2 gene
P10940562A0379|65 74|pseudogene
P10940892A0573|63 77|chromosome (Chr)
P10940892A0573|81 87|D4Mit89
P10940892A0573|91 98|D4Mit147
P10940892A0573|105 113|progenies
P10942587A0981|72 79|orm. mRNA
P10942587A0981|86 98|HPV E6/E7 genes
P10942587A0981|211 217|anti-E7
P10942599A1298|38 54|Hoxa-1 target genes
P10942599A1298|150 162|embryogenesis
P10943891A1062|12 17|U6-U57
P10944466A0451|33 42|WNT-2B gene
P10945781A0412|33 47|V cholerae non-O1
P10946303A0000|0 8|TNF-alpha
P10946303A0000|25 46|time-dependent increase
P10946303A0000|49 71|cyclooxygenase-2 (COX-2)
P10946303A0000|85 88|PGE2
P10946303A0000|105 112|NCI-H292
P10947274A0839|26 28|NCS
P10947274A0839|46 57|10000 RBE-cGy
P10947274A0839|78 82|157Gd
P10947274A0839|98 100|10B
P10947840A0762|29 42|18S ribosome RNA
P10950415A0866|0 9|CONCLUSION
P10950924A0393|0 2|RNA
P10950935A0111|105 121|chromosomes (PACs)
P10950935A0111|141 157|chromosomes (YACs)
P10951579A1238|71 76|wt-p53
P10951579A1238|83 107|triggers pro-apoptotic gene
P10951579A1238|120 122|DNA
P10951848A0230|91 95|CD34+
P10952828A2638|143 144|3D
P10954093A0000|1 10|degenerate
P10954093A0000|11 13|DNA
P10954525A1161|80 84|TRE-2
P10954564A1262|42 44|ORF
P10954564A1262|57 75|immediate-early gene
P10954564A1262|104 106|ORF
P10954913A0152|1 21|2.3-kb full-length cDNA
P10954913A0152|31 51|Atlantic halibut Mx gene
P10954913A0152|68 76|liver cDNA
P10955313A0000|0 5|PLUS-3
P10955913A0827|4 8|HIT II
P10955998A1124|25 35|glycosylase
P10955998A1124|78 86|S120K MutY
P10955998A1124|96 98|DNA
P10958271A0365|0 6|METHODS
P10958271A0365|7 9|AND
P10958271A0365|10 16|RESULTS
P10958271A0365|82 103|ejection fraction (LVEF)
P10958271A0365|136 169|Technetium 99m (Tc99m) perfusion SPECT
P10958271A0365|174 219|equilibrium radionuclide angiocardiography (ERNA)
P10958456A0529|3 8|2 cDNAs
P10958456A0529|76 80|Cp.F6
P10958456A0529|90 95|Cp.F10
P10958673A0142|45 64|protein response (UPR)
P10958673A0142|81 119|cis-acting ER stress response element (ERSE)
P10958698A0280|43 53|mutagenesis
P10958698A0485|24 44|N-terminal domain (END)
P10958698A0485|58 60|HFD
P10959838A0153|65 73|nitrilase
P10961046A0342|33 42|fibrinogen
P10961046A0342|46 69|von Willebrand factor (vWF)
P10962564A0883|1 17|beta2 RARE reporter
P10962593A0580|0 19|Non-poliomyelitis AFP
P10962881A0900|51 52|CI
P10963735A0193|63 75|controls (CTL)
P10963735A0193|88 90|CRF
P10963735A0193|94 95|HD
P10963735A0193|110 117|(pre-HD)
P10963735A0193|126 134|(post-HD)
P10963735A0193|184 212|polyacrylonitrile membrane AN69
P10964833A1696|41 44|POAG
P10964833A1696|119 121|IOP
P10964833A1696|130 135|22 mmHg
P10964995A2152|55 59|ER(+)
P10964995A2152|141 145|HER-2
P10965135A0735|75 86|mos oncogenes
P10965135A0735|78 85|oncogene
P10965135A0735|172 185|th the MAP kinase
P10965135A0735|177 212|MAP kinase kinase (MKK) inhibitor PD98059
P10965135A1207|116 118|MKK
P10965135A1207|153 180|transcription factor complexes
P10965830A0305|0 12|INTERVENTIONS
P10965830A0305|26 34|tissue PO2
P10965830A0305|38 41|PCO2
P10965905T0000|0 14|Insulin receptor
P10965905T0000|48 98|growth hormone-induced mitogen-activated protein kinase
P10965905A1618|7 16|GH-induced
P10965905A1618|87 94|LY294002
P10965905A1618|154 170|IRS-1-independent
P10965905A1618|174 202|-dependent GH-induced MAP kinase
P10965905A1618|284 287|PI3K
P10965905A1618|301 319|GH-induced MAP kinase
P10967361A0000|18 39|resonance imaging (fMRI)
P10967531A1025|188 189|II
P10970048A0352|27 28|RH
P10970048A0352|142 143|RH
P10972980A0295|10 22|ell lines, mTOR
P10972980A0295|61 92|phosphatidylinositol (PI) 3-kinase
P10972980A0295|62 107|hosphatidylinositol (PI) 3-kinase; protein kinases
P10972980A0295|143 165|PD98059-sensitive kinase
P10972990A0196|3 28|tumor-suppressor protein p53
P10972990A0526|12 14|p53
P10972990A0526|99 117|thymidine kinase (TK)
P10972990A0526|144 186|hypoxanthine phosphoribosyl transferase (HPRT)
P10972990A0966|0 10|Cytogenetic
P10972990A0966|21 23|LOH
P10972990A0966|195 209|heterogeneously
P10972990A1518|32 41|p53 protein
P10973385A1423|18 19|II
P10973400A0664|0 6|RESULTS
P10974541A0389|11 18|K562 cDNA
P10974541A0389|45 60|ranscripts, MZF1B
P10974541A0389|64 68|MZF1C
P10975465A0134|8 21|cDNA clone NFBD1
P10975465A0134|43 51|KIAA0170)
P10975465A0134|140 150|BRCT domains
P10976413A0514|0 6|RESULTS
P10976413A0514|20 22|FSH
P10976413A0514|41 43|FSH
P10976413A0514|94 96|IVF
P10976413A0514|126 133|a day 3 FSH
P10976413A0514|144 149|mIU/ml
P10976413A0514|163 170|day 10 FSH
P10976413A0514|181 186|mIU/ml
P10980416T0000|30 54|bone sialoprotein (BSP) gene
P10980416T0000|86 136|pituitary-specific transcription factor-1 (Pit-1) motif
P10980416T0000|142 159|rat BSP gene promoter
P10981094A0779|6 13|target BP
P10981094A0779|75 78|(JNC
P10981094A0779|79 81|VI)
P10982076A0000|52 77|influenza-like illness (ILI)
P10982391A0425|12 14|NPF
P10982391A0425|73 92|proline-rich SH3-like
P10982391A0425|99 114|WW domain-binding
P10982391A0425|124 139|N-terminal domain
P10982825A0363|49 68|Mot3 binding site in OpA
P10983857A0923|20 27|NCX-4016
P10983857A0923|48 49|PD
P10983857A0923|150 161|STZ-diabetic
P10983979T0000|37 53|U4/U6.U5 tri-snRNP
P10983979T0000|67 79|ATP-dependent
P10984122A0911|37 39|DNA
P10984122A0911|58 77|vector mU6-C1 or mU6-C2
P10987301A0332|60 89|G protein-coupled receptor (GPCR)
P10987301A0332|139 150|(KSHV)/human
P10987301A0332|165 173|oncogenic
P10987301A0332|187 198|angiogenesis
P10987301A0332|244 261|growth factor (VEGF)
P10987301A0332|274 283|angiogenic
P10987301A0332|306 312|mitogen
P10989777A1286|44 46|URD
P10991383A0289|108 109|3D
P10992299A0745|58 70|tumorigenesis
P10992299A0745|59 75|umorigenesis, PI12
P10992299A0745|140 165|rain cancer cell lines: U-87 MG
P10993773A0717|67 78|microm/mmHg)
P10993773A0717|169 180|microm/mmHg)
P10993787A0369|11 13|MAP
P10993787A0369|17 28|MSNA increase
P10993787A0369|35 37|SHG
P10993787A0369|56 58|SHG
P10993787A0369|61 63|PHI
P10993787A0369|102 104|MAP
P10993787A0369|128 131|MSNA
P10995121A0569|95 96|(K
P10995751A0093|28 74|CCAAAT/enhancer-binding protein-beta (C/EBP-beta)
P10995751A0093|112 129|IFN response element
P10995751A0093|139 157|gamma-IFN-activated
P10997330A0361|39 47|STORP gene
P10997330A0361|99 105|PML gene
P10997863A0753|5 7|TLE
P10997863A0753|19 21|NAA
P10997863A0753|70 72|FLE
P10997904A1258|3 7|Spo0F
P10997904A1258|153 176|response regulator-kinase
P10999205A0607|98 100|VOI
P10999301A0000|99 114|microscope (SNOM)
P10999369A0192|67 71|N2/P2
P10999369A0192|99 104|microV
P10999369A0192|107 109|5 mA
P10999369A0192|122 127|microV
P10999369A0192|130 133|20 mA
P11000203A0752|16 20|K-Rev
P11000203A0752|69 83|K-Rev-dependent
P11000203A0752|91 93|RNA
P11000203A0752|108 112|K-Rev
P11000203A0752|215 217|RNA
P11000250A0200|0 4|LMP-1
P11000250A0200|47 50|TRAF
P11000250A0200|48 56|RAF, TRADD
P11000250A0200|61 63|JAK
P11000250A0200|83 92|NF-kappaB-
P11000250A0200|84 98|F-kappaB-, AP-1-
P11000250A0200|103 116|STAT-dependent
P11000250A0200|131 134|CD40
P11000266T0000|71 91|alpha-fetoprotein gene
P11000521A0588|101 106|NIH3T3
P11000521A0588|164 196|insulin receptor substrate-2 (IRS-2)
P11000521A0588|224 251|phosphatidylinositol 3-kinase
P11000521A0588|239 251|sitol 3-kinase
P11000521A0588|252 254|(PI
P11000521A0588|267 289|protein kinase B (PKB/AKT)
P11002236A0328|0 6|METHODS
P11002236A0328|45 52|PPB cases
P11003471A1149|0 11|Phylogenetic
P11003471A1149|33 37|ToLCV
P11003641A0811|11 33|Fcp1p-binding motif KEFGK
P11003641A0811|39 57|RAP74 (Tfg1p) subunit
P11003641A0811|60 64|TFIIF
P11003641A0811|67 71|EEFGE
P11003652A0961|90 92|PAK
P11003653A0198|22 32|DNA-binding
P11003653A0198|61 71|beta-globin
P11003653A0198|115 125|beta-globin
P11003653A0198|169 178|PYR complex
P11003669A0000|12 18|rat gene
P11003669A0000|38 55|ErbB-2-interacting
P11003669A0000|94 99|ErbB-2
P11003669A0000|116 128|kinase domains
P11003805A0443|21 24|DGOR
P11004369A0000|0 8|OBJECTIVE
P11004369A0000|71 92|color Doppler ultrasound
P11005808A1082|30 51|Raf-independent ERK MAPK
P11005831A0242|5 9|cDNAs
P11005831A0242|23 58|leucine zipper (bZIP)-type ABRE-binding
P11005831A0242|127 131|AREB1
P11005831A0242|128 137|REB1, AREB2
P11005831A0242|142 168|AREB3 (ABA-responsive element
P11006283A1180|11 18|AROM-p64
P11006283A1180|41 58|single-stranded DNA
P11006283A1180|62 68|poly(A)
P11006283A1180|122 125|mRNA
P11006284T0000|3 24|protein-tyrosine kinase
P11006284T0000|70 84|insulin receptor
P11006284T0000|99 126|phosphatidylinositol 3-kinase
P11007509A1271|5 7|PMR
P11007509A1271|147 161|stress perfusion
P11007777A0813|10 20|intron/exon
P11007777A0813|43 45|BAC
P11007777A0813|87 110|aspartyl beta-hydroxylase
P11007949A1395|41 44|PTEN
P11007949A1607|35 37|ILK
P11007949A1607|64 67|PTEN
P11007954A0170|3 42|growth factor receptor-bound protein 2 (Grb2)
P11007954A0170|54 62|complexed
P11007954A0170|70 73|(Son
P11007954A0170|135 166|tyrosine kinase-activated receptor
P11007961A0930|24 37|PR65/A subunits
P11007961A0930|92 95|PP2A
P11007968A0255|69 72|SAUG
P11007968A0255|73 81|1402-1 DNA
P11007968A0255|85 87|PCR
P11008420A0580|39 40|ST
P11008420A0580|67 77|ST-T complex
P11011139A0000|32 39|SIN4 gene
P11011139A0000|62 76|mediator complex
P11011139A0000|91 103|RNA polymerase
P11011139A0000|104 105|II
P11012568A0192|32 35|ACTH
P11012671A0576|24 36|C/EBP-binding
P11012671A0576|50 68|Gadd45gamma promoter
P11012671A0576|74 82|C/EBPbeta
P11012671A0576|86 95|C/EBPdelta
P11012671A0576|136 159|mobility shift assay (EMSA)
P11012671A0576|163 174|reporter gene
P11012680A0676|22 25|FGF1
P11012680A0676|41 49|SH2 domain
P11012680A0676|58 60|PP2
P11012680A1020|11 18|PLCgamma
P11012680A1020|51 73|calcium chelator BAPTA-AM
P11012680A1020|93 97|FGFR1
P11012680A1020|116 122|PDGF-BB
P11012680A1020|142 152|PDGFR-FGFR1
P11012680A1020|165 172|PLCgamma
P11012680A1020|194 197|GVBD
P11012680A1020|201 204|ERK2
P11013079A0927|73 81|mouse gene
P11013079A0927|132 148|promoter generated
P11013079A0927|193 204|SV40 promoter
P11014197A0339|83 89|kinases
P11014213A1019|46 66|hormone-binding domain
P11014213A1019|74 83|in receptor
P11014213A1019|75 99|n receptor activation, COS-1
P11014213A1019|148 162|receptors GAL-ER
P11014213A1019|180 200|hormone-binding domain
P11014213A1019|203 209|ERalpha
P11014213A1019|216 232|DNA-binding domain
P11014213A1019|238 260|transcription factor GAL4
P11014213A1019|265 295|a GAL4-responsive CAT reporter gene
P11014215A1092|49 57|248-bp DNA
P11014215A1092|118 134|5'-flanking region
P11014215A1092|145 153|GnRHR gene
P11014215A1092|177 190|GnRHa-mediated
P11014215A1092|213 225|GnRHR promoter
P11014465A0479|90 92|PVL
P11014821T0000|3 21|LAMMER protein kinase
P11015197A0310|67 74|TMS (TM4)
P11016014A0181|0 9|HYPOTHESIS
P11016724A0536|2 12|group B 37 MBq
P11016724A0536|15 23|150 microL
P11016724A0536|26 34|99mTc-HSA
P11016850A0423|9 11|DNA
P11016850A0423|94 97|LysR
P11016850A0423|121 137|regulators (LTTRs)
P11016954A0438|0 3|AGO1
P11016954A0438|15 19|QDE-2
P11016954A0438|42 46|RDE-1
P11016954A0438|58 61|RNAi
P11017876A0787|40 56|mDAP-3/EGFP fusion
P11017876A0787|85 92|protease
P11017876A0787|123 128|mDAP-3
P11018028A0263|34 65|cAMP-dependent protein kinase (PKA)
P11018028A0263|88 94|CDC25Mm
P11018028A0263|126 131|RasGEF
P11018264A0397|0 11|Reporter gene
P11018264A0397|46 58|WASP promoters
P11019257A0159|10 16|3T1-3T2
P11019257A0159|95 97|3T2
P11020375A0134|91 100|ontrol, CLI
P11020375A0134|120 140|arts per billion (ppb) AF
P11020375A0134|126 140|r billion (ppb) AF
P11020375A0134|129 140|llion (ppb) AF
P11020375A0134|134 140|(ppb) AF
P11020375A0134|153 155|CLI
P11023074A1105|32 33|CC
P11023074A1105|33 38|C, kEIA
P11023074A1105|42 46|PACE2
P11023832A1038|36 39|KG1a
P11023832A1038|37 53|G1a cells, TNFalpha
P11023832A1038|76 81|PC-PLC
P11023832A1038|85 87|PLD
P11023832A1038|117 150|turn mitogen-activated protein kinase
P11023832A1038|151 154|(MAP
P11023832A1038|165 173|NF-kappaB
P11023853A0188|139 166|time-activity laboratory (TAL)
P11023853A0188|200 203|(DEE
P11023934A0855|0 2|L/H
P11024036A0984|35 44|C/EBP alpha
P11024036A0984|36 73|/EBP alpha expression vector, reporter gene
P11024047A0626|64 81|luciferase reporter
P11024182A0781|6 26|alpha1(I) collagen mRNA
P11024182A0781|59 60|AR
P11024182A0781|63 64|IR
P11024182A0781|84 98|pHbetaAPr-1-neo
P11024182A0781|182 188|pCI.neo
P11024300A1579|74 84|polypeptide
P11024300A1579|120 142|chromatin structure (ARC)
P11024300A1579|195 203|TIG-1 mRNA
P11027027A0061|1 7|(Sunset
P11027027A0061|8 17|Yellow FCF)
P11027027A0061|43 80|chromatography/mass spectrometry (LC/MS)
P11027267A0752|11 13|40S
P11027274A1682|29 38|PI 3-kinase
P11027280A0536|0 8|Cam kinase
P11027280A0536|9 10|II
P11027289A0000|67 73|150-kDa
P11027289A0000|81 83|RNA
P11027289A0000|82 103|NA binding protein, SU(S)
P11027289A0000|128 130|RNA
P11027289A0321|26 44|arginine-rich motifs
P11027289A0321|45 49|(ARM1
P11027289A0321|53 57|ARM2)
P11027289A0321|72 74|RNA
P11027289A0321|92 96|SU(S)
P11027294A0483|26 49|histone acetyltransferase
P11027724A0335|11 17|BRI1-KD
P11027724A0335|38 48|serine (Ser)
P11027724A0335|52 65|threonine (Thr)
P11027724A0335|78 82|p-Ser
P11028131T0000|20 36|interferon beta-1b
P11028131A1374|71 72|MS
P11028131A1374|109 118|IFN beta-1b
P11028131A1374|121 124|RRMS
P11028944A1020|14 16|AUC
P11029459A0000|12 40|growth factor-beta1 (TGF-beta1)
P11029459A0000|68 80|tumor promoter
P11029467T0000|39 76|adenylate cyclase-activating polypeptide
P11029467T0000|91 117|factor-kappa B-dependent gene
P11029467T0000|163 175|cell line THP-1
P11029700A0295|5 13|Pt;cycH;1
P11029700A0295|17 25|Os;cycH;1
P11029700A0746|42 50|Os;CycH;1
P11029700A0746|85 92|rice CDKs
P11029704A0378|79 87|distB ABRE
P11029704A0378|97 119|acid-responsive element)
P11029704A0378|145 148|ABI3
P11029704A0378|152 165|ABI3-dependent
P11029704A0378|176 178|ABA
P11029704A0378|210 220|RY/G complex
P11029704A0378|263 277|ABA-independent
P11029704A0378|295 298|ABI3
P11030476A0685|65 74|spores/mL)
P11030744A0763|71 84|4-fold increase
P11030744A0763|95 105|DPM synthase
P11031252A0646|3 10|LMW FGF-2
P11031252A0646|26 28|PKC
P11031252A0646|66 75|HMW isoform
P11031252A0646|104 106|PKC
P11031252A0646|150 152|PKC
P11032677A0230|107 127|teatitis, degenerative
P11034392A1072|92 104|NF-kappaB/Rel
P11034392A1072|108 112|PI-3K
P11034392A1072|126 137|CD40-induced
P11034547A0674|15 20|NBPhox
P11034547A0674|25 39|DNA-independent
P11034547A0674|82 84|DB1
P11034547A0674|119 129|homeodomain
P11034547A1355|34 39|NBPhox
P11034547A1355|118 128|DBH promoter
P11034933A0389|0 6|METHODS
P11034933A0389|7 9|AND
P11034933A0389|10 16|RESULTS
P11034933A0389|140 148|100 nmol/L
P11035037A0183|27 46|yeast TAF145 (yTAF145)
P11035037A0183|54 56|TBP
P11035037A0183|75 77|TBP
P11035867A0000|0 8|OBJECTIVE
P11035867A0000|85 90|(Braun
P11035867A0000|91 105|PrecisionSensor
P11035867A0000|92 115|recisionSensor, Braun GmbH
P11035867A0000|148 165|ANSI/AAMI SP10-1992
P11036786A0628|63 76|"Toxicological
P11036938A1162|51 63|erbB receptors
P11037823A1134|0 10|CONCLUSIONS
P11037823A1134|1 15|ONCLUSIONS: LSCC
P11037823A1134|151 153|CHL
P11037823A1134|152 158|HL, SNHL
P11038118A0000|111 127|serum albumin (BSA)
P11038317A0000|8 16|monomeric
P11038317A0000|17 27|GTP-binding
P11038317A0000|41 43|RAB
P11038366A1322|70 87|yeast B-type subunit
P11038366A1417|49 52|PP2A
P11038366A1417|100 103|PP2A
P11039341A0180|117 119|ICA
P11040101A1180|33 40|IL-1 beta
P11040101A1180|48 55|VEGF gene
P11040101A1180|120 127|IL-1 beta
P11040101A1180|134 140|p38 MAPK
P11040101A1180|144 146|JNK
P11040101A1180|199 206|VEGF gene
P11040219A0548|9 12|NusA
P11040219A0548|15 17|RNA
P11040219A0548|51 80|amino-terminal S1 homology region
P11040219A0548|106 120|full-length NusA
P11041308A0156|36 41|DSM-IV
P11041308A0156|101 129|South Oaks Gambling Screen (SOGS)
P11042197A0386|32 44|COOH-terminal
P11042197A0386|50 51|HD
P11042199A0572|71 89|receptor-associated
P11042199A0572|73 113|ceptor-associated protein, nifedipine, MK801
P11042199A0572|217 220|CREB
P11042204A0186|24 70|phosphatidylinositol 3-kinase-dependent p38 kinase
P11042703A0875|4 7|BFDS
P11042703A0875|22 33|eference, W/A
P11043469A0440|64 72|T-regions
P11043469A0440|89 96|T-region
P11043469A0440|99 106|pTiChry5
P11043469A0440|114 124|T-right (TR)
P11044097T0000|72 79|U5 region
P11044097A0422|24 26|HMG
P11044105A0616|7 23|cis-acting element
P11044105A0616|8 30|is-acting element, exonic
P11044105A0616|31 55|splicing suppressor 1 (ESS1)
P11045180A1892|106 108|WHO
P11045607A0239|0 6|5'-RACE
P11046146A1202|65 67|NFI
P11046146A1202|150 159|TG-treated
P11046146A1202|173 179|NFI-DNA
P11046148A0716|0 4|LMP2A
P11046148A0716|133 149|Lyn tyrosine kinase
P11046517A0619|50 52|[Z]
P11049241A0659|0 6|RESULTS
P11049241A0659|22 35|roup, serum PP14
P11049241A0659|76 77|ET
P11049241A0659|174 175|ET
P11050084A0000|19 74|peroxisome proliferator-activated receptor alpha (PPARalpha)
P11050084A0888|4 21|-2485/-2458 element
P11050084A0888|27 35|PPARalpha
P11050084A0888|39 47|PPARgamma
P11050168A1185|64 88|endonuclease-mediated mRNA
P11050168A1185|133 143|RNA-binding
P11051364A0890|0 6|RESULTS
P11051364A0890|34 36|PHG
P11051364A0890|70 72|PHG
P11051370A1906|54 56|HCV
P11053009A0000|62 80|cyclooxygenase (COX)
P11053370A0708|66 69|UhpB
P11053370A0708|77 105|glutathione S-transferase (GST)
P11054011A1685|0 10|CONCLUSIONS
P11054011A1685|49 52|MSGT
P11054341A0599|0 6|RESULTS
P11054341A0599|64 67|SWAP
P11054341A0599|89 92|SWAP
P11054341A0599|128 131|SWAP
P11054539A0114|83 90|6660 base
P11054539A0114|118 128|polypeptide
P11054565A0654|7 16|p190-B exon
P11054565A0654|32 37|p190-A
P11054565A0654|85 90|GTPase
P11054565A0654|142 150|GAP domain
P11054565A0654|207 215|p190 genes
P11054571A0230|14 33|teneurin-1 (TEN1) gene
P11054571A0230|52 54|PAC
P11054970A0282|76 78|NF1
P11056007A0224|33 39|FVVLNLQ
P11056007A0224|115 126|SET (Suvar3-9
P11056007A0224|167 177|domain (SID)
P11056007A0224|180 183|rMTM
P11056019A0926|0 3|MED1
P11056019A0926|12 22|glycosylase
P11056019A0926|45 71|adduct 3,N(4)-ethenocytosine
P11058119A0957|23 26|XAB1
P11058119A0957|46 51|GTPase
P11058119A0957|83 85|XPA
P11058120A0256|11 22|actors, IRF-2
P11058120A0256|71 75|IRF-1
P11058120A0256|80 88|oncogenic
P11058132A0264|13 16|CDSs
P11058406A0447|0 19|Tobramycin-loaded SLN
P11059777A0813|100 103|PAX3
P11059777A0813|174 181|BCL-X(L)
P11059786T0000|9 28|growth factor receptor
P11059786T0000|143 171|phosphatidylinositol 3'-kinase
P11059786A0682|0 11|VEGF promoter
P11059786A0682|100 103|EGFR
P11059786A0682|111 139|phosphatidylinositol 3'-kinase
P11059786A0682|140 145|[PI(3)
P11062047A1208|5 9|IHHNV
P11062047A1208|122 163|virus Penaeus stylirostris densovirus (PstDNV)
P11062067A0000|0 36|Stress-activated protein kinase 1 (SAPK1)
P11062067A0000|48 73|c-Jun N-terminal kinase (JNK)
P11062068T0000|21 55|mitogen-activated protein (MAP) kinase
P11062068T0000|80 91|p38 MAP kinase
P11062068T0000|110 128|p38 C-terminal domain
P11062257A0977|8 24|class C-Vps complex
P11062274T0000|47 63|tissue plasminogen
P11062705A0658|43 47|ATF-2
P11063127A0000|74 95|protein phosphatase (PP)
P11063127A0000|103 106|PP2A
P11063127A0000|134 150|acid (OA)-mediated
P11063252A0437|37 39|HSL
P11063742A0000|0 8|NF-kappaB
P11066245T0000|59 62|SNFs
P11067797A1306|0 10|CONCLUSIONS
P11067797A1306|1 15|ONCLUSIONS: EBCT
P11067797A1306|135 136|BV
P11067928A0532|8 11|mAbs
P11067928A0532|23 26|V(H)
P11067928A0532|30 37|J(H) gene
P11067928A0532|71 81|Jkappa genes
P11069011A0224|0 2|SSF
P11069075T0000|19 51|Xenopus laevis CXC chemokine receptor
P11069307A0546|12 15|RNA2
P11069307A0546|95 109|BMV RNA1-encoded
P11069307A0546|174 177|DED1
P11069756A2618|1 16|bbreviations: CAS
P11069756A2618|2 31|breviations: CAS, CRK-associated
P11069756A2618|3 43|reviations: CAS, CRK-associated substrate; CH
P11069756A2618|4 67|eviations: CAS, CRK-associated substrate; CH, calponin-homology domain
P11069756A2618|5 71|viations: CAS, CRK-associated substrate; CH, calponin-homology domain; CSK
P11069756A2618|6 91|iations: CAS, CRK-associated substrate; CH, calponin-homology domain; CSK, C-terminal SRC kinase
P11069756A2618|9 122|ions: CAS, CRK-associated substrate; CH, calponin-homology domain; CSK, C-terminal SRC kinase; E6, Papillomavirus E6 protein; FAK
P11069756A2618|102 243|omavirus E6 protein; FAK, focal adhesion kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor; GRK, G-protein-coupled-receptor kinase
P11069756A2618|129 142|adhesion kinase
P11069756A2618|130 146|dhesion kinase; GIT
P11069756A2618|131 150|hesion kinase; GIT, GRK
P11069756A2618|132 165|esion kinase; GIT, GRK interacter; GPCR
P11069756A2618|133 206|sion kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor
P11069756A2618|134 210|ion kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor; GRK
P11069756A2618|135 243|on kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor; GRK, G-protein-coupled-receptor kinase
P11069756A2618|136 248|n kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor; GRK, G-protein-coupled-receptor kinase; MAPK
P11069756A2618|137 266| kinase; GIT, GRK interacter; GPCR, heterotrimeric-G-protein-coupled receptor; GRK, G-protein-coupled-receptor kinase; MAPK, mitogen-activated
P11069756A2618|250 279| mitogen-activated protein kinase
P11069756A2618|280 283|(ERK
P11069756A2618|286 292|38, JNK)
P11069756A2618|287 296|8, JNK); PAK
P11069756A2618|289 346|JNK); PAK, p21-activated kinase; PBS, paxillin-binding subdomain
P11069756A2618|290 350|NK); PAK, p21-activated kinase; PBS, paxillin-binding subdomain; PIX
P11069756A2618|291 366|K); PAK, p21-activated kinase; PBS, paxillin-binding subdomain; PIX, PAK-interacting
P11069756A2618|292 384|); PAK, p21-activated kinase; PBS, paxillin-binding subdomain; PIX, PAK-interacting exchange factor; PKL
P11069756A2618|394 399|kinase
P11069756A2618|395 410|inase linker; POR1
P11069756A2618|422 426|ac; PS
P11069756A2618|424 443|; PS, phosphoserine; PT
P11069756A2618|425 463|PS, phosphoserine; PT, phosphothreonine; PY
P11069756A2618|427 483|, phosphoserine; PT, phosphothreonine; PY, phosphotyrosine; RTK
P11069756A2618|428 521|phosphoserine; PT, phosphothreonine; PY, phosphotyrosine; RTK, growth factor receptor tyrosine kinase; SH
P11069756A2618|429 540|hosphoserine; PT, phosphothreonine; PY, phosphotyrosine; RTK, growth factor receptor tyrosine kinase; SH, SRC-homology domain
P11069788A0531|3 26|5 ventilator-dependent, SB
P11069788A0531|70 90|difference PEEP(i),dyn
P11069788A0531|111 115|+/- SD
P11069788A0531|126 133|cm H(2)O)
P11069788A0531|151 161|PEEP(i),dyn
P11069788A0531|175 182|cm H(2)O)
P11069791A0226|42 44|IPT
P11069791A0226|76 83|(Regimen
P11069791A0226|109 111|IPT
P11069791A0226|134 141|(Regimen
P11069791A0226|170 172|IPT
P11069791A0226|189 196|(Regimen
P11069825A0530|9 16|122 cases
P11069897A1112|25 30|BACH1t
P11069897A1112|39 43|BACH1
P11069897A1112|63 80|BTB domain-mediated
P11069999A1602|3 9|U17/U16
P11069999A1602|16 23|U16+ gene
P11069999A1602|49 54|HIV LTR
P11070007A0136|21 29|EBNA genes
P11070007A0136|50 65|EBV-immortalized
P11070056A0704|40 51|RNaseH domain
P11070056A0704|54 61|Lian-Aa1
P11070056A0704|55 78|ian-Aa1, a mosquito non-LTR
P11070078A1153|42 44|p53
P11070078A1153|84 87|HeLa
P11070078A1153|112 114|HPV
P11071651A1308|16 32|RARalpha-specific
P11071651A1308|111 117|FR-beta
P11071789T0000|30 32|ACE
P11071852A0297|18 23|SOCS-3
P11071852A0297|38 42|IGFIR
P11071852A0297|57 62|SOCS-3
P11071852A0297|72 95|transcription-polymerase
P11071852A0297|126 135|muscle mRNA
P11071924A0588|18 20|SH2
P11071924A0588|24 40|RING finger domains
P11071924A0588|81 83|SH2
P11071924A0588|87 103|RING finger domains
P11071924A0588|106 110|SLI-1
P11071924A0588|143 147|c-Cbl
P11071974A0155|22 24|HRT
P11071974A0155|55 67|disease (ESRD)
P11072155A0764|42 48|TGF beta
P11072155A0764|96 99|SF2)
P11073218A0800|51 53|U.G
P11073539A0866|29 40|desmin in SW13
P11073870A0375|31 33|PRC
P11073870A0375|47 49|PHC
P11073870A0375|86 88|PRC
P11073870A0375|92 94|PHC
P11073919A0631|166 168|ODC
P11073919A0631|231 253|phosphate-binding domain
P11073919A0631|323 326|ODCs
P11073919A0631|348 362|. ruminantium LDC
P11073954A0337|3 10|Psc2 cDNA
P11073954A0337|26 47|reading frame homologous
P11073954A0337|50 52|CP2
P11074003A0741|73 77|CGNPs
P11074210A0623|3 4|QT
P11074210A0623|82 83|BP
P11075678A0298|76 93|DFT (B3LYP/6-31G**)
P11075929A1657|32 35|ThlA
P11075929A1657|124 127|ThlB
P11075944A0691|51 54|MMTV
P11075944A0691|85 93|androgens
P11075944A0691|96 99|SC-3
P11076860A0872|45 49|UEV1A
P11076860A0872|85 91|Kua-UEV
P11076860A0872|141 149|Kua domain
P11076860A0872|188 194|Kua-UEV
P11078726X0000|31 38|human p53
P11078726X0000|57 69|p53-dependent
P11078726X0000|84 93|p53 protein
P11078726X0000|277 293|p53-dependent gene
P11080796A0883|52 54|IKK
P11080796A0883|66 80|rotein, IKKgamma
P11080796A1277|3 14|Tax/IKKgamma
P11080796A1277|49 51|IKK
P11080796A1277|62 77|ubunits, IKKalpha
P11080796A1277|81 87|IKKbeta
P11080796A1277|171 173|IKK
P11081962T0000|10 14|AFLP-
P11082185A0415|80 84|IRF-1
P11082587X0000|146 174|Brillouin backscattering (SBBS)
P11082715X0001|58 62|HPLC]
P11082715X0001|85 104|chromatography (HPLC)
P11083154A0881|38 52|oxygen uptake VO2
P11083154A0881|40 82|ygen uptake VO2, heart rate, minute ventilation VE
P11083358A1071|0 9|CONCLUSION
P11083358A1071|1 13|ONCLUSION: SPT
P11083358A1071|30 32|WST
P11083432A0332|40 48|2; (2) FK-1
P11083432A0332|53 60|; (3) FK-3
P11083868A0386|0 2|DNA
P11083868A0386|13 36|glutathione S-transferase
P11083868A0386|103 133|C-terminal transactivation domain
P11084022A1178|13 16|ALK7
P11084334A0590|3 14|swa2-1 allele
P11084334A0590|71 104|tetratricopeptide repeat (TPR) domain
P11084334A0590|72 111|etratricopeptide repeat (TPR) domain, a motif
P11084556T0000|85 94|progenitor
P11085267A0562|19 24|sconC3
P11085267A0562|35 40|sconB+
P11086872A0000|85 91|(Citrus
P11087141A0977|18 27|alpha1,3GT
P11087141A0977|87 115|5'-untranslated region (5'-UTR)
P11088635A0200|8 28|Kubo-Martin-Schwinger
P11089911A1267|3 16|non-homologous
P11089911A1267|118 129|ATLN elements
P11090172A0612|15 18|RNA1
P11090172A0612|33 36|RNA3
P11090172A0612|55 69|yeast paralleled
P11090172A0612|103 114|FHV virion RNA
P11090272A1240|45 48|ORL1
P11090272A1240|52 55|GAIP
P11090762A0527|0 6|RESULTS
P11090762A0527|85 104|long-lasting increase
P11090762A0527|129 156|alpha-1 (9-11 Hz) power increase
P11092770A0238|43 60|'difficult'.Taking
P11092770A0238|61 72|Pell-Gregory
P11092809A0823|29 32|ERKs
P11092809A0823|36 40|PI3Ks
P11092850A1023|7 17|16S rRNA gene
P11092850A1023|56 63|tuf genes
P11092886A0341|13 25|protein kinase
P11092886A0341|45 53|CREMalpha
P11092886A0341|93 135|phosphoenolpyruvate carboxykinase (PEPCK) gene
P11093745A0563|15 18|HNF3
P11093745A0563|43 49|NF1/CTF
P11093745A0563|79 98|silencer-like element
P11094066A0505|57 90|forkhead transcription factor FKHR-L1
P11094066A0505|95 98|IL-3
P11094066A0505|108 114|FKHR-L1
P11094066A0505|125 139|a PI3K-dependent
P11094066A1194|55 63|p27(KIP1)
P11094066A1194|84 102|PI3K-induced FKHR-L1
P11094072A0842|0 4|DNase
P11094072A0842|40 44|c-Myb
P11094072A1234|14 18|c-Myb
P11094072A1234|31 43|RAG-2 promoter
P11094072A1234|67 80|consensus c-Myb
P11094073A0000|73 110|Ros receptor protein tyrosine kinase (RPTK)
P11094075A0257|43 54|r-PTPeta gene
P11094075A0257|131 147|v-ras-Ki oncogenes
P11094087T0000|84 126|Raf-MEK-extracellular signal-regulated kinase
P11094091A0000|16 38|transcription factor CREB
P11094109A0600|0 6|RESULTS
P11094590A0617|116 118|VAP
P11094590A0617|123 125|PSB
P11094590A0617|129 131|PTC
P11095248A0423|19 31|roteins, XFGF3
P11095248A0423|126 139|NH2-terminally
P11095248A1523|0 11|NH2-terminal
P11095248A1523|41 45|FGF3s
P11095981A0254|22 33|cis-elements
P11095981A0254|65 77|200 bp promoter
P11096662T0000|31 43|Artery Disease
P11097040A0000|70 82|TRIS-extender
P11097079A0525|64 73|NIMH-LCM-p
P11098217A0674|23 43|mouse chromosome 7A2-A3
P11099377T0000|36 96|UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase
P11099377T0000|108 119|isoform XT-II
P11101008A0649|0 14|Chaperones/HSPs
P11101847A0159|0 8|Oncogenic
P11101847A0159|21 24|E2F1
P11101847A0159|85 97|suppressor p53
P11102458A0000|56 94|eurobeachin, a neuron-specific multidomain
P11102458A0000|104 109|327 kDa
P11102458A0000|135 143|site (K(d)
P11102458A0000|160 161|II
P11102458A0000|181 193|protein kinase
P11102458A0000|195 198|(PKA
P11102458A0000|199 202|RII)
P11103472A0802|12 14|ADD
P11103472A0802|40 44|CNV-1
P11103472A0802|79 83|CNV-1
P11103472A0802|87 91|CNV-2
P11103601T0025|5 9|UMDNJ
P11103792A0755|16 20|c-Myc
P11103792A0755|121 161|rowth factor-containing serum. c-Myc-induced
P11105129T0000|49 94|Producing Extended-Spectrum beta-lactamase (ESBL)
P11105716A0782|0 9|CONCLUSION
P11105716A0782|32 34|AIF
P11105716A0782|103 105|CBV
P11105716A0782|109 111|CBF
P11105716A0782|165 192|contrast-enhanced MR perfusion
P11105717A0123|0 6|METHODS
P11106216A0918|5 8|COPD
P11106216A0918|72 74|FOT
P11106428A0635|71 86|FAP-1 (C-terminal
P11106428A0635|114 132|form (Cys2408-->Ser)
P11106428A0635|140 169|glutathione-S-transferase (GST)
P11106668A0875|38 54|spacer-RING domain
P11106668A0875|99 117|N-terminal BIR domain
P11106668A0875|120 125|c-IAP1
P11107637X0001|251 262|heart disease
P11108151A0560|0 27|Ang II-induced fibronectin mRNA
P11108151A0560|44 61|PKC inhibitors or PKC
P11108151A0560|99 103|EGF-R
P11108151A0560|131 135|EGF-R
P11108151A0560|145 160|tyrphostin AG1478
P11108151A0560|181 195|fibronectin mRNA
P11108523A0326|124 127|(I11
P11108548A0710|0 1|MS
P11108548A0710|150 153|APcI
P11108616A0000|9 20|(Oreochromis
P11108616A0000|84 102|space missions STS-55
P11108616A0000|106 111|STS-84
P11108720A0124|0 3|S6K2
P11108720A0124|24 27|S6K1
P11108720A0124|33 42|core kinase
P11108720A0124|83 86|S6K1
P11108720A0124|97 113|C-terminal regions
P11108720A0124|213 216|S6K2
P11108720A1130|21 85|th the mitogen-activated protein-extracellular signal-regulated kinase
P11108720A1130|26 96|mitogen-activated protein-extracellular signal-regulated kinase kinase (MEK)
P11108720A1130|120 123|S6K2
P11108720A1130|154 157|S6K1
P11108839A0401|32 36|70 kDa
P11108839A0401|48 53|kinase
P11108839A0401|59 70|85 kDa isoform
P11110040A0000|31 43|5-HT2 receptor
P11110528A0414|19 20|2D
P11111051A0051|34 62|histone acetyltransferase (HAT)
P11112417A1126|23 27|MLSN1
P11112417A1126|137 141|MLSN1
P11112417A1126|198 201|mRNA
P11112700T0000|21 44|microtubule binding domain
P11112700T0000|47 86|microtubule actin crosslinking factor (MACF)
P11112700A1936|25 45|GSR-containing domains
P11112700A1936|92 111|GSR-containing domain
P11112700A1936|149 151|MTs
P11112790A0989|62 64|UPR
P11113179A0541|22 25|SRC1
P11113179A0541|42 44|CBP
P11113179A0541|50 65|estrogen receptor
P11113179A0541|87 90|SRC1
P11113179A0541|129 131|CBP
P11113179A1020|73 83|LXXLL motifs
P11113179A1020|90 98|AD1 region
P11113179A1020|101 104|SRC1
P11113199A0800|5 7|MEK
P11113199A0800|38 41|ERKs
P11113199A0800|52 55|a MEK
P11113199A0800|109 123|ERK2-Delta19-25
P11113692A0169|66 81|retinopathy (BDR)
P11113692A0169|85 87|PDR
P11114294A0075|31 79|pro-inflammatory cytokines tumor necrosis factor alpha
P11114294A0075|119 174| the cystic fibrosis transmembrane conductance regulator (CFTR)
P11114294A0075|128 178|fibrosis transmembrane conductance regulator (CFTR) gene
P11114294A0075|187 191|HT-29
P11114521A0282|12 15|RhoA
P11114718A0349|47 51|v-Src
P11114718A0349|56 59|mRNA
P11114718A0349|78 91|p21 (WAF1/CIP1)
P11114924A0808|0 3|ORFA
P11114924A0808|7 10|ccdA
P11116131A0863|18 28|P2Y(11) mRNA
P11116148A0741|41 43|PKB
P11116148A0741|69 77|C/EBPbeta
P11116148A0741|85 94|C/EBPalpha
P11116148A0741|103 145|N-terminal transactivation domains in C/EBPbeta
P11117263A0570|131 155|2'-deoxymugineic acid (DMA)
P11117263A0570|172 179|acid (MA)
P11117263A0570|207 213|(epiHMA
P11117263A0570|250 253|(HMA
P11117523A0650|15 22|COUP-TFI
P11117523A0650|87 88|RA
P11117826A0788|7 9|PET
P11117826A0788|83 85|PET
P11117826A0788|132 140|PET-based
P11117826A0788|158 165|MR-based
P11118062A1691|61 69|K-ras gene
P11118438A0411|29 34|MdPin1
P11118438A0411|37 49|Pin1 homologue
P11118438A0411|74 79|(Malus
P11118440T0000|62 89|candidate tumor suppressor ING1
P11118440T0000|97 107|mSin3/HDAC1
P11118440T0000|123 140|corepressor complex
P11118619A0835|37 39|TAg
P11118712A1296|175 188|within-herd PTB
P11118712A1296|206 212|low.For
P11119611A0428|0 7|ORFK10.5
P11119611A0428|49 63|antigen 2 (LANA2)
P11119611A0428|83 95|KSHV-infected
P11119611A0428|126 128|PEL
P11119611A0428|132 133|CD
P11119611A0428|140 141|KS
P11121043A0074|3 13|enopus, BMPs
P11121043A0074|65 76|neurogenesis
P11121118T0000|29 55|phosphodiesterase PDE11A gene
P11121118A0075|43 45|GAF
P11121118A0075|60 75|N-terminal region
P11121397A0587|55 94|alpha1,4-N-acetylglucosaminyltransferase
P11121434A0915|15 21|Mek/Erk
P11121434A0915|54 72|ek inhibitor, PD98059
P11121434A0915|147 150|HR12
P11121490A0000|3 37|transcription factor CHOP/GADD153 gene
P11122381A0908|19 49|tyrosine-phosphorylated peptides
P11122381A0908|61 65|betac
P11122381A0908|93 98|GM-CSF
P11122381A0908|141 145|STAT5
P11122588A0549|0 18|MAIN OUTCOME MEASURES
P11122588A0549|60 63|(AHI
P11122588A0549|125 145|moderate-to-severe SDB
P11122588A0549|158 160|AHI
P11123089A0362|77 86|pathogenic
P11123089A0362|154 167|tissue diseases
P11123316T0000|0 8|Tec kinase
P11123316T0000|39 66|phosphatidylinositol 3-kinase
P11123316T0000|73 99|Tec pleckstrin homology domain
P11123701A0442|28 30|DNA
P11123701A0442|142 144|DNA
P11123701A0442|171 190|transcription complex
P11123701A0442|225 227|DNA
P11123701A0442|255 263|diffusion
P11123701A0442|277 279|DNA
P11123912A0306|21 29|SH2 domain
P11123912A0306|56 67|SH2 complexed
P11123912A0306|129 140|T antigen (MT)
P11124024A1098|36 51|protein complexes
P11124024A1098|82 85|a C+T
P11124024A1098|116 125|GAGA motifs
P11125151T0000|40 51|phylogenetic
P11125872A0133|33 42|compound RP
P11125872A0133|58 74|phosphodiesterase
P11125872A0133|75 76|IV
P11126353A0582|0 6|RESULTS
P11126353A0582|27 30|(BMI
P11126353A0582|31 38|SDS>2.0)
P11127200A1024|32 35|AP-1
P11127200A1024|61 63|ROS
P11127200A1024|92 95|AP-1
P11127200A1024|124 133|TGF-beta1-
P11127200A1024|137 151|BMP-2-regulated
P11127200A1024|167 187|(alpha1) collagen I gene
P11127200A1024|196 214|TGF-beta1-regulated
P11127200A1024|241 286|hormone (PTH)/PTH-related peptide (PTHrP) receptor
P11127250A1111|0 1|PM
P11127250A1111|37 38|SB
P11127250A1111|81 82|SB
P11127250A1111|119 120|VL
P11128312A1238|87 94|femur BMD
P11128312A1238|111 113|BMD
P11128312A1238|163 178|radiographs (FD2)
P11128925A0000|0 9|BACKGROUND
P11128925A0000|52 70|interleukin-6 (IL-6)
P11128925A0000|97 106|fluid (GCF)
P11128925A0000|161 173|arthritis (RA)
P11128925A0000|182 198|periodontitis (AP)
P11129515A0000|106 131|pre-menstrual syndrome (PMS)
P11129724A0904|69 85|MRSA-contaminated
P11129724A0904|109 112|MRSA
P11131634A0955|0 1|NF
P11131634A0955|58 59|WT
P11132148A0162|54 67|promoter region
P11132148A0162|98 100|HLA
P11132790A0609|53 55|S-B
P11132790A0609|56 57|IV
P11133741A0617|0 19|NiCl(2)-induced MCP-1
P11133741A0617|49 57|NF-kappaB
P11133741A0617|73 89|NF-kappaB-binding
P11133830A0174|17 19|CD2
P11133830A0174|22 30|mitogenic
P11133830A0174|38 48|anti-CD2 mAb
P11133830A0174|121 126|120 kDa
P11133830A0174|160 178|proto-oncogene c-Cbl
P11133927T0000|10 12|NIR
P11133986A0350|81 84|PU.1
P11133986A0350|88 114|PU.1 interaction partner (PIP)
P11133986A0350|142 146|c-Fos
P11133986A0350|151 155|c-Jun
P11133986A0350|170 186|kappaE3'-enhancer
P11133986A0350|189 191|3T3
P11134033A0000|93 110|48-kDa eIF3e subunit
P11134033A0000|113 143|translation initiation factor eIF3
P11134033A0639|2 24|int6 deletion (int6Delta)
P11134351A1405|13 18|MIP-2A
P11134351A1405|56 60|MBP-1
P11134508A0317|48 71|Arabidopsis HD (AtHD1) gene
P11137296A0923|52 65|full-length RNA
P11137296A0923|101 118|cDNA ends (RLM-RACE)
P11137296A0923|144 194|translation initiation codon.Reverse transcription-PCR
P11137296A0923|215 219|PFK-A
P11137296A0923|216 225|FK-A, PFK-B
P11137296A0923|229 238|PFK-C genes
P11137296A1216|0 8|PFK-A mRNA
P11137296A1216|58 62|PFK-B
P11137296A1216|66 75|PFK-C genes
P11137367A0297|9 19|Toshiba IIDR
P11137367A0297|46 52|X-ray TV
P11138009A1032|49 60|IVS51+5G-->A
P11138009A1032|71 74|USH1
P11138694A0000|0 37|[18F](+)-4-fluorobenzyltrozamicol (FBT)
P11138694A0000|231 233|PET
P11139148A0421|36 44|homologue
P11139148A0421|47 51|SAF-A
P11139148A0421|88 91|MARs
P11139148A0421|114 126|satMa-binding
P11139336A0257|33 38|INCENP
P11139469A0402|0 4|Ang II
P11139469A0402|25 32|Ang2 mRNA
P11139469A0402|102 114|protein kinase
P11139473A0696|54 89|consensus cAMP-responsive element (CRE)
P11139473A0696|108 120|SMemb promoter
P11139567A1440|0 12|LH/CG receptor
P11139567A1440|25 28|ARNO
P11139567A1440|56 83|phosphatidylinositol 3-kinase
P11139567A1440|84 86|(PI
P11139567A1440|100 124|G protein beta gamma subunits
P11139605A0811|177 182|C/EBPs
P11139974A0762|20 21|VT
P11139974A0762|56 57|BV
P11139974A0762|77 78|RV
P11142380A0389|0 7|Nuclease
P11142380A0389|18 46|structure-directed mutagenesis
P11142380A0389|62 76|105-nt TE (TE105)
P11142380A0389|142 163|single-stranded regions
P11143384A0267|0 8|Tele-Talk
P11145562A0000|20 69|type 1 insulin-like growth factor (IGF) receptor (IGF-IR)
P11145563A0202|27 38|StAR promoter
P11145563A0202|69 99|element-binding proteins (SREBPs)
P11145563A0303|12 19|SREBP-1a
P11145563A0303|30 41|StAR promoter
P11145563A0303|64 68|COS-1
P11145566A0000|10 47|high-density lipoprotein receptor (HDL-R)
P11145566A0000|161 165|HDL-R
P11145571A0788|0 17|IFN-stimulated gene
P11145571A0788|29 33|STAT1
P11145571A0788|60 94|IFN-stimulated response element (ISRE)
P11145571A0788|98 132|gamma-activated sequence (GAS) element
P11145590A0217|46 83|TGF-beta1 action on thyroglobulin (TG) gene
P11145590A0217|107 126|attention on TGF-beta1
P11145717A0936|3 28|epitope-protected lysine (K)
P11145717A0936|42 49|30-aa TPO
P11145743A0170|72 105|thyroid transcription factor 1 (TTF-1)
P11145743A0170|118 149|domain-containing protein 8 (Pax-8)
P11145743A0170|183 201|deiodinase promoters
P11145887A1393|35 38|AP-1
P11145887A1393|58 61|JunD
P11145887A1393|81 85|c-Jun
P11145887A1393|82 90|-Jun, JunB
P11145887A1393|95 99|c-Fos
P11145955A0189|14 69|ligand-activated estrogen receptor alpha (ERalpha)-dependent
P11145955A0189|106 108|SRE
P11145955A0189|166 201|mitogen-activated protein kinase (MAPK)
P11145955A0189|239 266|growth factor alpha (TGF-alpha)
P11146961T0000|0 8|Perfusion
P11146961T0000|21 38|perfusion-assisted
P11146961T0000|53 72|artery bypass (PADCAB)
P11148042A1258|17 24|(LA)(12)
P11148042A1258|38 45|chain PEs
P11148589A1124|0 10|CONCLUSIONS
P11148589A1124|161 163|HBV
P11149472A1257|10 20|NP/NMP4/CIZ
P11150315A0226|83 95|NGF-activated
P11150315A0226|103 115|EGF-activated
P11150315A0226|164 166|DNA
P11150315A0226|202 204|DNA
P11150315A0226|224 227|PC12
P11150315A0844|0 2|NGF
P11150315A0844|34 36|ERK
P11150315A0844|56 58|EGF
P11150315A1126|0 2|NGF
P11150315A1126|10 12|EGF
P11150439A0701|41 54|3-hour infusion
P11150439A0701|57 69|NaH(13)CO(3')
P11150439A0701|58 85|aH(13)CO(3'), breath (13)CO(2)
P11151826T0000|1 12|orkload, UAPs
P11152070A0573|3 10|actA gene
P11152070A0573|47 58|. chrysogenum
P11152070A0573|92 95|pcbC
P11152070A0573|99 103|cefEF
P11152081A0413|6 16|10 mmol SDS/l
P11152283A0223|27 29|NGF
P11152283A0223|61 64|PC12
P11152283A0223|68 72|INS-1
P11152283A0223|104 121|NGF-regulated genes
P11152344A0416|79 83|C1-C2
P11152451A0529|3 38|Schistosoma mansoni homologue (SmSmad2)
P11152451A0529|67 81|a Sj26-GST fusion
P11152451A1580|24 30|SmSmad2
P11152451A1580|44 51|TGF-beta
P11152451A1580|165 174|target gene
P11152451A1580|218 225|TGF-beta
P11152521A0181|94 101|ORF40/41
P11152521A0181|120 136|a primase-helicase
P11152521A0181|168 179|127-bp intron
P11152963A0000|15 40|src homology 3 (SH3)-encoding
P11152963A0000|64 83|astrocytes (SETA) gene
P11153302A0000|0 9|Naltrexone
P11153302A0000|35 48|opioid receptor
P11154491A0322|0 6|METHODS
P11154491A0322|97 98|CT
P11154491A0322|109 115|EUS-FNA
P11155096A0222|0 6|METHODS
P11155096A0222|88 112|thyroid peroxidase (TPO-Abs
P11155096A0222|126 131|IU/ml)
P11155096A0222|127 140|U/ml), serum TSH
P11155096A0222|138 140|TSH
P11155096A0222|180 184|mU/l)
P11155096A0222|181 208|U/l), serum thyroxin levels (T4)
P11156484A0223|0 4|TBARS
P11156484A0223|51 60|AFR release
P11156484A0223|91 104|resonance (EPR)
P11156618T0000|30 37|mouse SCL
P11156618T0000|74 97|restriction endonucleases
P11156789A1669|63 65|CSF
P11156789A1669|227 229|CSF
P11156789A1669|290 292|CSF
P11157035A1405|107 117|IFN alpha-2b
P11157334A1107|0 7|Serum PTH
P11157334A1107|29 30|WL
P11157334A1107|47 48|WM
P11157334A1107|54 55|(P
P11157763T0000|14 25|EMAPII domain
P11157763T0000|33 63|aminoacyl-tRNA synthetase complex
P11157774A0789|11 22|dSLBP alleles
P11157784A0141|11 19|DGCR6 gene
P11157784A0141|102 111|ene, DGCR6L
P11157879A0192|0 6|METHODS
P11157879A0192|59 61|BRB
P11158236A0000|0 21|Nerve growth factor (NGF)
P11158236A0000|33 40|acid (RA)
P11158236A0000|55 67|actions on PC12
P11158288T0000|15 27|RNA polymerase
P11158288T0000|28 29|II
P11158288T0000|64 85|activation domain in CREB
P11158288T0000|102 105|CREB
P11158290A0728|73 84|IkappaBalpha
P11158290A0728|74 90|kappaBalpha, -beta
P11158295A0158|30 41|kinase domain
P11158295A0158|58 74|Src homology 3 (SH3)
P11158295A0158|78 87|SH2 regions
P11158310A0993|24 27|ERSF
P11158310A0993|37 40|NF-Y
P11158310A0993|44 52|ATF6alpha
P11158310A0993|84 87|ERSE
P11158310A0993|117 119|UPR
P11158324A1073|166 206|riglyceride transfer protein, (ii) an increase
P11158324A1073|252 297|ssion of the major high-density lipoprotein receptor
P11158324A1073|267 297|high-density lipoprotein receptor
P11158324A1073|268 317|igh-density lipoprotein receptor, scavenger receptor BI
P11158324A1073|322 335|(iii) a decrease
P11158326A1032|27 31|SHIP2
P11158326A1032|56 70|SH2 domain (R47G)
P11158337A0000|50 73|GnRH receptor (GnRH-R) gene
P11158337A0000|146 151|GnRH-R
P11158337A0000|162 175|sequence (GRAS)
P11158337A0000|180 210|activator protein-1 (AP-1) element
P11158337A0000|218 230|steroidogenic
P11158337A0000|231 244|factor-1 (SF-1)
P11158456A0223|0 6|METHODS
P11158456A0223|116 118|BHS
P11159081A1155|23 24|MR
P11159363A1251|38 68|E2F element ((m)CG(m)CG) generated
P11159363A1251|73 113|methylcytosine-specific DNA-protein complex
P11160096A1067|28 40|wild-type fliF
P11160280A1275|7 23|IFN-gamma-induced
P11160280A1275|36 40|IRF-1
P11160280A1275|59 68|IRF element
P11160307A0394|5 21|olecule, wH22xeGFP
P11160307A0394|51 67|anti-FcgammaRI mAb
P11160307A0394|75 89|eGFP genetically
P11160307A0394|119 127|CH3 domain
P11160307A0394|120 137|H3 domain. wH22xeGFP
P11160307A0394|152 171|ligand-binding region
P11160307A0394|201 220|ligand-binding region
P11160307A0394|241 262|cross-linking FcgammaRI
P11160656A0000|20 40|cytomegalovirus (HCMV)
P11160656A0000|71 83|region (MIERR)
P11160656A0000|103 118|romoter, enhancer
P11160656A0000|162 165|HCMV
P11160656A0000|256 275|NTera2 carcinoma (NT2)
P11160683A1220|33 37|C/EBP
P11160683A1220|59 63|C/EBP
P11160683A1220|83 88|CREB-1
P11160683A1220|102 109|ATF/CREB
P11160683A1220|135 138|CREB
P11160688A1726|91 94|ICP0
P11160721A0932|39 52|mutation (556M)
P11160721A0932|62 73|TBLV enhancer
P11160732A0464|56 61|SIVmac
P11160732A0464|76 114|SIVmac239 (T-lymphocyte tropic [T-tropic])
P11160732A0464|77 124|IVmac239 (T-lymphocyte tropic [T-tropic]), SIVmac316
P11160732A0464|136 152|tropic [M-tropic])
P11160732A0464|157 178|SIVmac1A11 (dualtropic)
P11160732A1199|12 14|PCR
P11160732A1199|58 66|vector DNA
P11160732A1199|178 186|SIVmac239
P11160732A1199|246 248|DNA
P11160738A1414|34 39|vIRF-2
P11160742A0696|29 31|PML
P11160742A0696|44 55|EBV-positive
P11160860A0662|27 49|IkappaB kinase (IKK-beta)
P11160860A0662|78 86|NF-kappaB
P11160860A0662|104 110|IkappaB
P11160860A0662|181 192|IkappaBalpha
P11160896A0713|27 31|C2C12
P11160896A0713|56 60|MEF2A
P11160902A0962|13 16|TFOs
P11160902A0962|84 109|c-sis/PDGF-B proto-oncogene
P11160929T0000|19 29|DNA-binding
P11160929T0000|36 44|LAGLIDADG
P11160929T0000|51 63|endonucleases
P11161455A1286|29 31|DNA
P11161455A1286|64 91|endothelial-TACC-related cDNA
P11161793A1033|22 37|receptor isoforms
P11161793A1033|122 125|EGFR
P11161816A0851|81 86|SH3GLB
P11162576A0213|77 84|intronic
P11162576A0213|103 111|PDE5A gene
P11162936A2727|56 64|estrogens
P11162936A2727|67 79|antiestrogens
P11162936A2727|83 89|ERalpha
P11162936A2727|92 97|ERbeta
P11163968A0152|202 237|restriction-modification gene homologs
P11164078A0833|44 46|NAD
P11166863A0167|19 20|CI
P11166863A0167|63 76|toxicity (RTOG)
P11167019A1249|2 7|'TATA'
P11167019A1249|39 47|GABPalpha
P11167019A1249|50 58|ATPsynCF6
P11167111A0957|76 78|LPD
P11167111A0957|105 106|TX
P11168366A0569|85 91|GGT mRNA
P11168366A0569|94 98|HepG2
P11168422A0248|84 94|ATP-binding
P11168446T0000|46 49|COLD
P11168588T0000|12 37|herpes simplex virus type 2 US3
P11168588T0000|48 56|Cdc42/Rac
P11168588T0000|77 97|c-Jun N-terminal kinase
P11169080T0000|21 50|expensive--try ignorance--Bok's
P11169149A0097|15 28|nowledge, SNTCS
P11170476A1546|27 48|peptide--gp96 complexes
P11170476A1546|70 84|peptide-binding
P11170476A1546|133 135|MHC
P11171118A0836|22 25|NF-1
P11171118A0836|28 32|PSE-B
P11171118A0836|42 46|PSE-A
P11171118A0836|75 85|DNA-protein
P11171118A0836|105 119|NF-1 DNA elements
P11171320A0894|197 208|in an increase
P11171320A0894|227 245|v-Src-transformed EL
P11171320A0894|249 256|EalphaCL
P11172944A0548|0 6|RESULTS
P11172944A0826|55 68|plasma TNFalpha
P11176098A0342|0 6|METHODS
P11176290T0000|90 92|MRI
P11177538A0655|28 30|MOI
P11178696A0301|6 7|US
P11178696A0301|148 151|PD US
P11178765A0642|25 33|exogenous
P11179272T0000|39 59|Helicobacter pylori IgG
P11179272T0000|136 145|ultrasound
P11179400T0000|11 46|single-unit carotid body chemoreceptors
P11179664T0000|55 102|leukemia-associated transcription factor RUNX1/AML1
P11179668A0869|53 56|PLTP
P11179687A0280|50 83|protein-tyrosine phosphatases (PTPs)
P11179687A0280|134 144| soluble PTPs
P11179687A0280|141 144|PTPs
P11179687A0280|151 169|receptor PTPs (RPTPs)
P11179687A1118|95 106|phylogenetic
P11179689A0000|3 9|Sox gene
P11179689A0000|16 19|(Sry
P11179689A0000|24 34|HMG box gene)
P11179689A0000|62 64|DNA
P11179689A0000|152 154|DNA
P11179956A1818|64 79|C-terminal domain
P11179956A1818|142 158|N-terminal domains
P11180027A1306|34 36|M6G
P11180255A0776|69 71|UHF
P11180688A0000|30 34|(V'O2
P11180688A0000|139 154|Fitness Test (MFT)
P11181516A0119|11 45|5'-deletion insulin promoter-reporter
P11181516A0119|88 102|INS-1 beta-cells
P11181516A0119|123 142|Hh-responsive regions
P11181516A0119|152 170|rat insulin I promoter
P11181516A0119|185 208|glucose-response elements
P11181516A0119|212 215|(E2)
P11181516A0119|219 229|Flat (A2/A3)
P11181525T0000|3 22|androgen receptor (AR)
P11181525T0000|44 60|androgen-specific
P11181525T0000|73 78|AR gene
P11181525T0000|94 99|exonic
P11181531A0464|22 30|estrogens
P11181531A0464|86 105|NF-kappa B target genes
P11181548A0214|22 28|cis-DNA
P11181548A0214|39 48|element(s)
P11181548A0214|63 76|issue-, region-
P11181548A0214|109 119|mE-RABP gene
P11181548A0214|124 130|5-kb DNA
P11181564A0733|39 47|region 8E1
P11187016T0000|56 67|carcinogenic
P11188971A0000|29 50|Parkinson's disease (PD)
P11188993A0298|94 104|acid-Schiff
P11189314A1000|24 27|BACM
P11189314A1000|78 81|GLCM
P11191208A0000|143 145|ABC
P11191208A0000|229 232|PDR1
P11191208A0000|236 244|PDR3 genes
P11191365A0682|112 126|tachycardia (VT)
P11191365A0682|162 177|fibrillation (VF)
P11191365A0682|175 176|VF
P11191365A0682|190 191|VT
P11191365A0682|199 200|VF
P11191365A0682|234 254|non-diabetics (P<0.05)
P11193045A1193|49 57|p53, p73, p
P11194101A0532|0 10|Baseline BMD
P11194147A1496|64 67|HIDD
P11194183A0866|275 285|+/- SD)/0.25
P11195338A0494|36 44|Lg3 allele
P11195401A1030|4 12|plasma AVP
P11195401A1030|51 55|SSRIs
P11195401A1030|65 67|AVP
P11195401A1030|92 96|SIADH
P11196191A1789|7 10|T47D
P11196191A1789|8 35|47D breast carcinoma cells, IL-6
P11196191A1789|53 63|EGF receptor
P11196191A1789|99 107|MAPK/PI3K
P11196199T0000|5 13|homologue
P11196199T0000|58 99|AMP-responsive element binding (CREB)-binding
P11196199T0000|147 149|p53
P11197328T0000|46 62|5'-flanking region
P11197328T0000|65 105|maize C4 phosphoenolpyruvate carboxylase gene
P11197549A0748|0 6|RESULTS
P11197549A0748|18 41|tabilization period, PaCO2
P11197549A0748|47 52|+/- SD)
P11197926A0000|0 9|BACKGROUND
P11197926A0000|80 110|General Health Questionnaire (GHQ)
P11198053T0000|14 15|LI
P11198424T0000|37 41|OsPSK
P11198424T0000|69 88|phytosulfokine-alpha
P11200568A0830|78 80|IgM
P11200568A0830|84 86|IgG
P11201250A0849|0 8|Plasma DHE
P11201250A0849|69 71|PSA
P11202434T0000|33 54|acyl-CoA-binding domain
P11202434T0000|64 81|14[C]palmitoyl-CoA
P11202434T0000|91 95|ACBP2
P11202434T0000|99 125|Arabidopsis acyl-CoA-binding
P11203702A1307|33 61|tyrosine-rich activation domain
P11203702A1307|96 112|domain in CT239-403
P11207216A0296|9 18|PGHS-2 cDNA
P11207216A0296|51 74|transcription-polymerase
P11207216A0296|91 94|cDNA
P11207216A0719|15 24|PGHS-2 mRNA
P11207216A0719|132 135|(PMA
P11207216A0719|137 142|100 nM)
P11207261A1421|27 43|PTP-deficient DT40
P11207261A1421|87 114|Fc gamma RIIB1-PECAM-1 receptor
P11207261A1421|139 180|Src homology 2-domain-containing phosphatases
P11207261A1421|140 186|rc homology 2-domain-containing phosphatases, SHP-1
P11207261A1421|190 194|SHP-2
P11207261A1421|279 288|BCR complex
P11207269A0745|0 16|Anti-nucleolin mAb
P11207282A0729|117 126|surface IgM
P11207282A0729|172 178|IgH gene
P11207288A0897|18 41|YFV Ag-binding region (ABR)
P11207288A0897|114 123|peptide-Ag
P11207308A0999|73 91|OSM-stimulated STAT1
P11207308A0999|74 118|SM-stimulated STAT1 phosphorylation, DNA-binding
P11207308A0999|129 133|STAT1
P11207308A0999|138 158|c-Jun N-terminal kinase
P11207308A0999|185 188|JAK1
P11207308A0999|186 193|AK1, JAK2
P11207308A0999|187 198|K1, JAK2, JAK3
P11207308A0999|188 205|1, JAK2, JAK3, ERK1/2
P11207609A0994|26 34|QKTT motif
P11207609A0994|38 42|TGN46
P11207609A0994|66 79|steady-state ER
P11207609A0994|103 149|stomatitis virus glycoprotein (VSVG) chimeras in HeLa
P11207609A0994|153 155|NRK
P11208017A0070|1 4|cDNA
P11208017A0070|18 26|C2H2-type
P11208017A0070|19 50|2H2-type zinc finger protein, SCOF-1
P11208814A0673|55 65|DmCKIIalpha
P11208814A0673|75 78|bHLH
P11208814A0673|173 176|CKII
P11208814A0673|183 192|a subdomain
P11209100A0069|55 57|PMN
P11209100A0069|107 113|release
P11209100A0069|141 179|interleukin-1 receptor antagonist (IL-1ra)
P11209814A0243|125 155|aluminum calcium phosphate (ALCAP)
P11209814A0243|159 176|hydroxyapetite (HA)
P11210401A0000|0 30|Sevelamer hydrochloride (Renagel)
P11210839A0282|6 8|PO3
P11211759A0165|148 161|ANAMED HUMITUBE
P11211936A1490|65 72|JNK/SAPK
P11211936A1490|85 92|JNK/ SAPK
P11211936A1490|129 138|RA-induced
P11212249A0993|65 87|activator protein 1 (AP-1)
P11212327A1564|63 65|PIG
P11212327A1564|82 87|IRS1/3
P11212327A1564|113 124|p59Lyn kinase
P11212327A1564|223 225|PIG
P11213342A0492|0 6|RESULTS
P11213342A0492|11 23|parameters SF2
P11214177A1125|41 48|22 nt RNAs
P11214177A1125|64 69|satRNA
P11214354A1104|0 5|VE-DEF
P11214354A1104|116 118|I-R
P11214354A1104|132 134|CON
P11218739A0811|22 27|H-BPPV
P11218739A0811|38 43|6 cases
P11220166A0616|169 190|brain dopamine receptors
P11220306A0911|0 5|HexA71
P11220306A0911|23 26|RpoS
P11220306A0911|81 85|HexA-
P11220306A0911|101 105|HexA+
P11220306A1753|16 23|rsmB+ DNA
P11220306A1753|117 121|hexA+
P11220486A0686|6 10|IL-12
P11220857T0000|0 3|CHAP
P11221845A0295|74 77|SV40
P11221845A0295|98 107|mice (MT-D2
P11221845A0295|155 173|Methylation (RLGS-M)
P11221845A0800|54 68|intron-less gene
P11221845A0800|143 160|SNAG repressor motif
P11221845A0800|166 183|NH2-terminal region
P11221845A0800|191 215|C2H2-type zinc finger motifs
P11221845A0800|221 233|COOH-terminal
P11221845A1713|11 17|N18TG-2
P11221845A1713|173 182|target gene
P11221845A1713|216 233|liver tumorigenesis
P11221845A1713|245 248|SV40
P11222387A1497|65 81|ABL tyrosine kinase
P11222387A1497|66 103|BL tyrosine kinase inhibition, FTI SCH66336
P11222387A1497|133 147|BCR/ABL-induced
P11222720A1699|14 17|RPMS
P11222720A1699|44 48|EBNA2
P11222720A1699|94 126|CBF1-associated corepressor complex
P11223153A0533|3 5|BFA
P11223186A1095|17 40|oIFNtau enhancer-reporter
P11223186A1095|96 99|AP-1
P11223186A1095|97 108|P-1 site, GATA
P11223199A0751|57 58|WB
P11223240A0655|10 19|Menin1 gene
P11223240A0655|82 93|5-kb messages
P11223246A0359|29 47|RBP21 shares homology
P11223246A0359|92 112|pRb-binding motif LxCxE
P11223246A0359|118 133|C-terminal region
P11223255A1034|14 36|consensus amino acid motif
P11223255A1034|40 69|serine threonine receptor kinases
P11223256A1212|53 64|pea 33RNP gene
P11223257A0404|0 5|OsBBPI
P11223257A0404|66 74|exogenous
P11223257A0404|83 90|acid (JA)
P11223257A0404|104 129|protein phosphatase 2A (PP2A)
P11223257A0404|105 155|rotein phosphatase 2A (PP2A) inhibitors, cantharidin (CN)
P11223257A0404|159 171|endothall (EN)
P11223257A0404|254 271|cycloheximide (CHX)
P11224226A0000|49 70|benzodiazepine receptor
P11224226A0000|116 137|benzodiazepine receptor
P11226228A0899|32 36|TyrRS
P11226752A0750|58 76|mouse deltex homologs
P11226752A0750|125 146|helix-loop-helix (bHLH)
P11226752A0750|221 224|DTX1
P11227039A0953|31 33|BMI
P11227039A0953|34 35|(P
P11227039A0953|45 47|PBF
P11227039A0953|48 49|(P
P11227484T0000|44 65|ion-association complex
P11230145A0732|40 60|Notch-CBF1/RBP-Jkappa
P11230145A0732|147 155|oncogenic
P11230169A0480|100 128|460-kb CENP-A-binding DNA domain
P11230169A0480|159 169|20p12 region
P11230534A0688|18 32|39 DEAH helicases
P11230889A1151|124 127|HBO2
P11231287A0158|21 45|neuroblastoma cells SK-N-SH
P11233643A0000|26 51|5-aminolaevulinic acid (ALA)
P11233643A0000|73 74|IX
P11233643A0000|75 80|(PPIX)
P11233643A0000|96 107|therapy (PDT)
P11233643A0000|142 144|ALA
P11234223A1451|143 145|AMK
P11234223A1451|144 149|MK, IPM
P11234223A1451|153 156|PAPM
P11234223A1451|168 170|CAZ
P11234223A1451|169 175|AZ, MEPM
P11235335T0000|8 10|HIV
P11235777A0878|2 29|Klinefelter's syndrome (47XXY)
P11235817A0000|3 21|histamine H1 receptor
P11237038A0889|96 99|HIFU
P11237491A0000|0 3|AIMS
P11237491A0000|60 75|tumour markers CEA
P11237491A0000|61 78|umour markers CEA, CA
P11237491A0000|77 78|CA
P11238105A0959|15 27|alpha subunits
P11238105A0959|87 93|alpha-2
P11238105A0959|195 209|up-regulate CD86
P11238375A0617|11 14|RhoA
P11238375A0617|33 38|kinase
P11238375A0617|70 73|ERK6
P11238375A0617|126 130|MAPKs
P11238402A0191|59 69|DAN/TIR gene
P11238405A0817|95 103|fbp1-lacZ
P11238405A0817|123 130|spc1 MAPK
P11238447A0524|36 41|eIF-5A
P11238447A0524|77 83|Rev-NES
P11238447A0524|88 101|CRM1/exportin1
P11238447A0524|109 114|eIF-5A
P11238447A0524|131 152|nucleoporins CAN/nup214
P11238586A0000|41 127|histocompatibility complex (MHC)-restricted peptide-specific T cell receptor (TCR)-alpha/betas
P11238586A0000|155 160|alpha1
P11238586A0000|164 169|alpha2
P11238586A0000|182 184|MHC
P11238882A0157|26 29|eIF6
P11238916A0838|27 29|PTP
P11238916A0838|47 79|paxillin-associated tyrosine kinase
P11238916A0838|154 156|PTP
P11238947A0636|7 21|base change (A8G)
P11238947A0636|45 49|hnRNP
P11238947A0636|74 79|A2RE-2
P11238947A0636|89 91|RNA
P11239184A1340|31 32|CD
P11239184A1340|101 102|CT
P11239529A0981|0 7|IL-1beta
P11240600A0523|64 66|VGB
P11241166A0677|0 5|TaqMan
P11241166A0677|46 47|FA
P11241166A0677|92 115|leptin receptor (Ob-R) mRNA
P11241166A0677|155 158|STAT
P11241166A0677|156 174|TAT signalling, SOCS3
P11241166A0677|227 239|sequence (CIS)
P11241215A0566|27 34|sBMPR-IA
P11241215A0566|147 169|chromatography (RP-HPLC)
P11241215A0566|188 199|enterokinase
P11241243A0693|113 116|PSC)
P11241243A0693|120 122|p53
P11241356T0000|82 93|collagen gene
P11241672T0000|31 63|murine beta(3) integrin gene promoter
P11241672T0000|128 133|STAT-6
P11243306A0961|0 10|CONCLUSIONS
P11243306A0961|31 35|oxLDL
P11243306A0961|101 113|artery disease
P11243306A0961|164 173|anti-oxLDL
P11243336A0000|0 9|GafChromic
P11243336A0000|10 18|(MD-55-2)
P11243494A0833|0 6|RESULTS
P11243494A0833|64 66|CRF
P11243777A0000|0 22|Cis-acting CCAAT elements
P11243777A0000|53 67|promoter regions
P11243980A0510|31 33|PET
P11244568A0506|3 8|Gap69C
P11244568A0506|12 26|single-copy gene
P11244568A0506|42 51|2.1-kb mRNA
P11244733A0782|0 4|Cases
P11245986T0000|50 73|rat aldolase B gene promoter
P11246679A0000|0 8|OBJECTIVE
P11246679A0000|62 77|heart block (CCHB)
P11246887A0000|26 54|cholesteryl ester transfer (CET)
P11246887A0000|27 92|holesteryl ester transfer (CET), cholesteryl ester transfer protein (CETP)
P11246887A0000|117 137|transfer protein (PLTP)
P11246887A0000|180 203|artery calcification (CAC)
P11246887A0000|285 287|CAC
P11247663A1447|38 49|DNAH9 alleles
P11248626T0000|10 25|first-generation
P11250196A0455|3 19|(two-motif) domain
P11250196A0455|84 93|two-domain
P11250196A0455|105 124|betagamma-crystallin
P11250942A0626|20 22|VDR
P11250942A0626|36 40|GRIP1
P11250942A0626|44 47|RAC3
P11250942A0626|64 96|VDR activation function (AF-2) domain
P11250942A0626|161 163|VDR
P11251083T0000|50 55|S phase
P11251083T0000|100 106|MEK/ERK
P11251104A0526|15 27|alpha-amylase
P11251104A0526|52 75|transcription factor GAMyb
P11251104A0526|99 100|GA
P11251252A0494|0 1|3D
P11251252A0494|34 43|ultrasound
P11251252A0494|110 111|3D
P11251951A0000|0 9|BACKGROUND
P11251951A0000|171 176|(CMIS)
P11254134A0648|9 12|PTax
P11254134A0648|52 54|PTF
P11254504A0766|11 24|promoter region
P11254504A0766|49 70|cis-regulatory elements
P11254504A0766|88 125|owth response-1, activator protein-2, MyoD
P11254504A0766|139 151|factor-kappaB
P11254504A0766|161 210|inc finger protein-1, caudal-related homeobox (Cdx) gene
P11254713A1029|47 53|rel/AP1
P11254713A1029|180 187|IL-2 gene
P11255035A0331|11 20|progenitor
P11255035A0331|32 50|rain, SVZa progenitor
P11255252A0961|8 10|ER3
P11255252A0961|21 23|DNA
P11255252A0961|59 64|FXR HRE
P11255252A0961|85 98|FXR-expressing
P11255423A0211|0 8|OBJECTIVE
P11255423A0211|59 69|HIV-related
P11255423A0211|82 93|decline in CD4
P11255423A0211|124 126|HIV
P11256845A0340|29 68|Scotland Coronary Prevention Study (WOSCOPS)
P11256845A0340|177 183|WOSCOPS
P11256944A1144|29 32|ATF6
P11256944A1144|39 45|G13 gene
P11256944A1144|94 126|cis-acting ER stress response element
P11256944A1144|153 154|ER
P11256962A0233|69 83|beta subunit gene
P11256962A0233|125 145|GlyR alpha subunit genes
P11256962A0233|169 177|exon (exon
P11256962A0233|227 238|GlyR beta mRNA
P11257870A0000|93 102|filter (TF)
P11257870A0000|115 132|sludge process (ASP)
P11257870A0000|161 182|trichloroethylene (TCE)
P11257870A0000|223 240|retention time (HRT)
P11258906A0743|2 4|DNA
P11258906A0743|106 109|RecA
P11259503A0212|21 27|microM)
P11259503A0212|73 82|luciferase
P11259593A1094|10 18|ace2Delta
P11260468A1179|31 33|AR1
P11260468A1179|39 65|promoter-proximal CAP subunit
P11260468A1179|80 84|papBA
P11260468A1179|119 141|histone-like protein H-NS
P11263622A0683|0 6|RESULTS
P11263622A0683|95 97|MRI
P11263664T0000|0 3|SIP1
P11263664T0000|4 8|(Smad
P11263664T0000|32 64|deltaEF1 (delta-crystallin enhancer
P11263664A1085|19 22|SIP1
P11263664A1085|42 49|XBra gene
P11264176A0181|19 22|G1/S
P11264176A0181|71 90|cyclin A2/cdk2 complex
P11264182A0000|29 36|(HTLV-I)
P11264182A0000|154 167|leukemogenesis
P11264375A0000|8 28|cytomegalovirus (HCMV)
P11264375A0000|34 58|immediate-early protein IE2
P11264561A0167|0 8|OBJECTIVE
P11264561A0167|28 31|RSTD
P11265853A0000|25 42|Assist System (LVAS)
P11265853A0000|43 50|(Novacor
P11265853A0000|53 66|rp, Oakland, CA)
P11266184A0000|46 77|2-dimensional time-of-flight (TOF)
P11266184A0000|86 98|resonance (MR)
P11266184A0000|152 164|spin-echo (SE)
P11266227A0295|39 40|pH
P11266540A0328|103 109|Tcf/Lef
P11266558A1470|88 103|initiator element
P11266558A1470|127 149|recruiting RNA polymerase
P11266558A1470|135 139|ng RNA
P11266558A1470|150 151|II
P11266558A1470|157 173|SL RNA gene promoter
P11266615A0258|60 71|linker region
P11267679A0102|3 12|438 bp EcoRI
P11268459A0167|60 81|DOX binding ability (%DB)
P11268887A1174|100 102|FVC
P11268887A1174|106 109|FEV1
P11271297T0000|66 67|FK
P11273995A1148|37 41|74 TOF
P11274149A0625|44 47|RING
P11274179A0610|21 33|Rac/Cdc42/Pak
P11274184A0000|65 86|heme oxygenase-1 (HO-1))
P11274184A1068|24 27|ATF4
P11274184A1068|45 59|CdCl(2)-induced
P11274184A1068|75 82|ho-1 gene
P11274357A0724|84 89|nm23H1
P11274357A0724|103 111|GDP-bound
P11274357A0724|133 136|RhoA
P11274357A0724|144 152|GTP-bound
P11274357A0724|170 196|nucleoside diphosphate kinase
P11274357A0724|209 214|nm23H1
P11274357A0724|246 254|GTP-bound
P11274357A0724|266 272|GTPases
P11274368A0469|76 93|histone deacetylase
P11274368A0818|22 37|initiator element
P11274368A0818|66 76|p21 promoter
P11274368A0818|79 83|c-Myc
P11274563T0000|28 29|MR
P11275986A0091|41 65|p53 tumor suppressor protein
P11276426A0501|13 16|(Mad
P11277913T0000|45 53|Hsp70 mRNA
P11277913T0000|83 86|mRNA
P11278286A0456|2 6|SN-48
P11278286A0456|31 32|MR
P11278286A0456|32 35|R, GR
P11278286A0456|40 54|5-HT1A receptors
P11278286A0456|83 86|nGRE
P11278286A0456|96 99|GRE)
P11278286A0456|133 141|rat 5-HT1A
P11278286A1083|61 65|MR/GR
P11278286A1083|86 87|MR
P11278286A1083|90 91|GR
P11278290A1220|38 45|TGF-beta
P11278310A1516|47 62|2-MeSADP-induced
P11278390A0632|7 30|transcriptase-polymerase
P11278390A0632|60 69|PKRDeltaE7
P11278400A0668|63 65|POU
P11278400A0668|66 69|(OCT
P11278400A0668|70 88|binding) homeodomain
P11278440A0095|0 2|SV1
P11278440A0095|30 50|S1 transmembrane domain
P11278440A0095|102 106|S0-S1
P11278461A0637|103 124|rainbow trout HIF-1alpha
P11278461A0637|157 179|chinook salmon HIF-1alpha
P11278488T0000|3 16|v-Src SH3 domain
P11278488T0000|73 86|adhesion kinase
P11278521A0849|1 7|20-base
P11278521A0849|157 168|lacZ reporter
P11278563A0917|82 90|tankyrase
P11278583A0873|0 10|Mutagenesis
P11278583A0873|13 23|SNT1(IRS)CX
P11278583A0873|48 61|effector motifs
P11278583A0873|68 70|SNT
P11278583A0873|95 97|ERK
P11278583A0873|141 161|phosphotyrosine motifs
P11278583A0873|196 216|phosphotyrosine motifs
P11278583A0873|252 266|C-terminal motif
P11278594A0618|18 27|propeptide
P11278594A0618|60 64|MIC-1
P11278594A0618|67 85|TGF-beta1 propeptide
P11278594A0618|122 130|monomeric
P11278594A0618|184 198|MIC-1 propeptide
P11278604A0300|45 56|Pro(-)5Lec20
P11278604A0300|121 123|CHO
P11278604A0300|191 208|GlcNAc-terminating
P11278610A0902|14 17|SOCS
P11278610A0902|70 77|TEL-JAK2
P11278671T0000|0 39|Neuron-specific Bcl-2 homology 3 domain-only
P11278713A1054|8 26|10-nucleotide region
P11278713A1054|76 94|instability elements
P11278713A1054|143 154|coding region
P11278819A0565|40 56|18-bp MOK2-binding
P11278819A0565|96 109|mouse IRBP genes
P11278819A0565|150 160|core element
P11278819A0565|164 167|MOK2
P11278848A1316|12 19|SB203580
P11278848A1316|29 39|LPS-induced
P11278855A0205|32 34|TLS
P11278870A0123|45 72|ctr4(+) copper transporter gene
P11278870A0123|141 169|copper-signaling element (CuSE)
P11278928A1634|32 35|mRNA
P11278928A1634|76 79|mRNA
P11278928A1634|115 134|C/EBPepsilon isoforms
P11279038A0194|0 10|WRN helicase
P11279038A0194|28 30|DNA
P11279038A0194|69 71|DNA
P11279086A1350|20 28|ADAM-TS12
P11279108T0000|9 33|serum response factor to CArG
P11279207A0904|29 32|HPK1
P11279207A0904|50 52|TCR
P11279324A0710|40 53|creatine kinase
P11279385A3917|75 76|2D
P11279720A0844|0 16|SELECTION CRITERIA
P11279720A0844|114 131|Parkinson's disease
P11280495A1330|0 10|CONCLUSIONS
P11280495A1330|42 56|glucose-based PD
P11280495A1330|110 113|AGEs
P11280799A1025|3 19|ontrast, exogenous
P11280799A1025|20 28|PTHrP1-34
P11280799A1025|32 43|1-86 peptides
P11280799A1025|69 72|IL-8
P11280799A1025|93 110|PTHrP-neutralizing
P11280799A1025|149 152|IL-8
P11280799A1025|166 170|PTHrP
P11281268A0000|7 36|two-domain arginine kinases (AKs)
P11281268A0000|96 112|phosphagen kinases
P11281268A0000|97 116|hosphagen kinases: AKs
P11282029A0075|3 62|mouse platelet-derived growth factor (PDGF) beta-receptor promoter
P11282029A0075|72 81|CCAAT motif
P11282029A0075|86 89|NF-Y
P11282088A0837|0 10|Baseline MBF
P11282088A0837|36 44|(P<0.001)
P11282394A0841|14 25|VH/VL-chains
P11282394A0841|86 89|mAbs
P11282395A0530|31 36|RAG1/2
P11282395A0530|54 56|DNA
P11282395A0530|111 124|protein complex
P11282395A0530|130 162|DNA repair proteins Nbs1/Mre11/Rad50
P11282395A1073|49 52|CDR3
P11282395A1073|64 73|endogenous
P11282395A1073|74 82|Ig lambdaL
P11282395A1073|86 100|kappaL chain gene
P11282395A1073|145 147|NBS
P11282433T0000|0 4|Phase
P11282433T0000|5 6|II
P11282761A0531|99 100|NO
P11283010A0701|30 38|CGS 12066A
P11283014A0921|21 24|WASP
P11283014A0921|56 58|TCR
P11283168A0738|70 76|Gus gene
P11283256A0258|27 30|MRCK
P11283256A0258|39 68|high-molecular-weight complexes
P11283354A0548|107 116|epigenetic
P11285054A0781|28 33|SOREMP
P11285054A0781|87 89|REM
P11285054A0781|101 105|NREMP
P11285054A0781|147 150|NREM
P11285235A0466|8 12|TRPS1
P11285235A0466|85 88|GATA
P11285329A0682|7 8|CI
P11285329A0682|8 27|I: 9.6-9.7) micromol/L
P11285329A0682|38 39|(P
P11286833A0959|68 98|maintenance chemotherapy.RESULTS
P11287555A1057|3 11|Delta6CCI
P11287555A1057|88 94|CEMx174
P11287555A1057|98 100|MT4
P11287578A1311|12 30|nterleukin-8, RANTES
P11287578A1311|54 66|protein 1alpha
P11287578A1311|71 99|10-kappaDa IFN-gamma-inducible
P11287579A1084|8 18|utant, T255A
P11287579A1084|40 45|E4orf6
P11287579A1084|68 76|late-gene
P11287611A0802|6 14|PPARgamma
P11287611A0802|39 49|(15d-PGJ(2)
P11287611A0802|53 59|PGD(2))
P11287611A0802|78 86|(BRL49653
P11287611A0802|139 150|cyclin D1 gene
P11287623A0286|24 84|Ras-activated Raf-MEK-extracellular signal-regulated kinase (ERK)
P11287623A0286|148 163|integrin subunits
P11287654A0150|0 3|PABP
P11287654A0150|30 57|N-terminal RNA-binding domains
P11288208A0712|53 55|PCP
P11288208A0712|84 86|CD4
P11288930A0000|43 82|4-chloro-2-methylphenoxyacetic acid (MCPA)
P11288930A0000|112 122|generations
P11289135A0975|12 13|FP
P11289135A0975|70 99|mitogen-activated protein kinase
P11289135A0975|120 148|signal-regulated protein kinase
P11289135A0975|161 163|PMA
P11289135A0975|205 239|by the mitogen-activated protein kinase
P11289135A0975|210 239|mitogen-activated protein kinase
P11289149A0658|8 10|EWS
P11289149A0658|54 87|COOH-terminal transactivation domain
P11289149A0658|93 124|cofactor CREB-binding protein (CBP)
P11290415A0288|37 46|ICBP90 gene
P11290415A0288|100 102|PCR
P11290906T0000|24 34|Tl-201 SPECT
P11291552A0156|0 6|METHODS
P11291552A0156|46 48|MFH
P11292335A0852|18 24|dnaE173
P11292335A0852|87 97|single-base
P11292839A0531|28 30|III
P11292839A0531|58 63|U6 gene
P11292839A0531|100 107|TATA-box
P11292839A0531|141 179|TATA-binding protein (TBP) mutant (TBP-DR2)
P11292839A0531|161 163|TBP
P11292839A0531|190 208|TBP wild-type (TBPwt)
P11292844A0081|0 2|HSF
P11292844A0081|8 10|DNA
P11292844A0081|48 50|DNA
P11294895A0292|24 35|spo20(+) gene
P11295470A0954|107 109|UTR
P11296288A1107|30 54|pCMVJS21 (pCMVJS21DeltaGP)
P11296288A1107|76 81|orf-x)
P11297419A0894|2 15|F222W:W21F rGST
P11297514A0218|52 54|CBF
P11297514A0218|116 135|cold-responsive genes
P11297545A0948|25 32|CHOP cDNA
P11297545A0948|74 77|CHOP
P11297545A0948|104 128|hGH-stimulated mitogenesis
P11297545A0948|182 184|hGH
P11297545A0948|187 204|a p38 MAPK-dependent
P11297866A0484|60 61|BF
P11298326A0677|26 36|Vkappa genes
P11298326A0677|67 100|complementarity-determining regions
P11301189A1396|36 45|p19(INK4d)
P11302566A1318|48 63|dopamine receptor
P11302704T0000|0 19|Homo-oligomerisation
P11302704T0000|44 66|mouse histone deacetylase
P11303027A0954|51 57|GTPases
P11303027A0954|63 65|ARF
P11303638A0559|4 6|NEU
P11306101A0000|5 8|RACE
P11306101A0000|51 98|hamster liver 3-hydroxy-hexobarbital dehydrogenases
P11306101A0000|140 162|17beta-hydroxy-steroids
P11306101A0000|166 187|3alpha-hydroxysteroids
P11306463A0383|14 20|C domain
P11306463A0383|24 30|b, L901Q
P11306463A0383|72 78|cdk4/D1
P11306463A0383|107 113|C domain
P11306511A1476|86 94|mdm2 mRNAs
P11306511A1476|105 124|progesterone receptor
P11308851A0333|52 55|GSER
P11308877A0213|70 80|input phases
P11309077A0953|55 56|II
P11309373A0783|10 18|mCTR mRNAs
P11309373A0783|84 95|mCTR isoforms
P11309373A0783|129 150|5'-untranslated regions
P11309389A0273|64 109|phorbol ester phorbol 12-myristate 13-acetate (PMA)
P11309389A0273|122 136|metalloprotease
P11309389A0273|148 156|generates
P11309389A0273|165 168|GHBP
P11309389A0273|173 194|membrane-associated GHR
P11309389A0273|265 267|GHR
P11309400T0000|11 37|terminus modifications on mRNA
P11309677A0000|70 88|Gulf War Illness (GWI)
P11309677A0000|110 122|fatigue (GV-F)
P11309677A0000|135 148|veterans (GV-H)
P11309678A0489|7 23|transcription-PCR
P11309678A0489|34 37|mRNA
P11310937A0548|0 6|RESULTS
P11310937A0548|100 102|CRP
P11310937A0548|106 109|IL-6
P11310937A0548|149 158|fibrinogen
P11310937A0548|162 170|TNF-alpha
P11311480A0079|88 103|cell infiltration
P11311550A0253|39 50|rat eIF4E gene
P11311550A0253|55 56|kB
P11311550A0253|62 83|rat eIF4E promoter region
P11311550A0253|212 220|C(2)C(12)
P11311563A0423|8 12|CCAAT
P11311563A0423|45 63|romoter construct, OA
P11311563A0423|95 99|CCAAT
P11311687A0231|3 8|JHRLSS
P11311687A0231|42 44|RLS
P11311687A0231|140 142|RLS
P11311980A1049|0 9|GABA(B)R1g
P11312120A1311|0 8|NF-kappaB
P11312120A1311|79 87|oncogenes
P11312120A1311|98 104|Bcr/Abl
P11312326A0169|14 41|RRE-defective HIV type 1 (HIV-1)
P11313249T0000|6 54|myeloid-restricted zebrafish CCAAT/enhancer-binding
P11313249T0000|88 103|activation domain
P11313342A0224|140 142|PAP
P11313386A0704|0 5|SH2D1A
P11313386A0704|36 39|CD40
P11313386A0704|72 84|B cell receptor
P11313398A0687|0 20|Cross-linking FcalphaR
P11313398A0687|23 29|wt-ITAM
P11313398A0687|32 39|IIA-ITAM
P11313398A0687|64 65|PI
P11313398A0687|96 103|PKBalpha
P11313946T0000|25 29|M-Ras
P11313946T0000|58 76|p21 Ras-mediated gene
P11313946A0449|0 7|RPM/RGL3
P11313946A0449|17 20|AF-6
P11313946A0449|74 78|M-Ras
P11313961A1323|96 103|(p53(-/-
P11313961A1323|127 133|p53 gene
P11314030A1264|24 39|C-terminal region
P11314030A1264|101 103|FAK
P11314030A1264|158 178|ibitory region in the SH3
P11314030A1264|176 204|SH3 linker/C-terminal SH3 domain
P11314428A0651|152 154|LHS
P11314428A0651|167 170|RHS)
P11315633A0920|22 24|VPg
P11315633A0920|28 30|RNA
P11315633A0920|40 52|RNA polymerase
P11315633A0920|69 77|E445-T446
P11316127A0485|3 8|%SVend
P11316127A0485|11 15|HCM-I
P11316127A0485|65 70|HCM-II
P11318363A0085|0 5|DESIGN
P11318608A0669|5 13|brain cDNA
P11318608A0669|55 58|cDNA
P11318608A0669|70 89|full-length DENTT cDNA
P11318608A0669|188 212|localization signals (NLSs)
P11318608A0669|219 236|coiled-coil regions
P11318608A1155|14 32|EGFP-tagged DENTT NLS
P11318608A1155|70 74|NLS-1
P11319098A0164|17 32|tryptophanyl tRNA
P11319098A0164|37 67|protein translocase component SecE
P11319098A0164|86 96|protein NusG
P11319098A0164|141 144|PkwR
P11319098A0164|177 185|LacI-GalR
P11319880A1108|9 18|(FRAP/mTOR
P11319880A1108|36 41|4E-BP1
P11321187A0355|26 27|MS
P11321187A0355|72 94|. pneumoniae-specific IgG
P11323411A0505|44 53|SH2 domains
P11323411A0505|56 59|SHP2
P11323411A0505|103 113|N-SH2 domain
P11323411A0505|121 147|phosphotyrosine (Tyr(P))-627
P11323411A0505|154 164|C-SH2 domain
P11323411A0505|172 181|Tyr(P)-659
P11323419T0000|58 95|blood group alpha (1,2)fucosyltransferase
P11323419T0000|73 95|(1,2)fucosyltransferase
P11323716A0413|3 12|UBA domains
P11323716A0413|15 19|RAD23
P11323716A0413|23 26|DDI1
P11324516A0159|47 71|D2 receptor agonist LY171555
P11324516A0159|74 86|D1/D2 receptor
P11324516A0159|154 155|AA
P11325195A0661|12 14|MFI
P11325944A0511|20 34|full-length UhpB
P11325944A0511|48 66|ybrid protein, GST-Bc
P11325944A0511|75 103|glutathione S-transferase (GST)
P11325944A0511|144 147|UhpB
P11325944A0511|176 179|uhpT
P11327698A0191|14 16|PKC
P11327698A0191|20 30|p44/p42MAPK
P11327698A0191|58 86|HBx-induced Sp1-mediated IGF-II
P11327698A0191|117 122|(i) PKC
P11327698A0191|120 122|PKC
P11327698A0191|135 137|PMA
P11327698A0191|201 220|HBx-transfected HepG2
P11327698A0191|202 233|Bx-transfected HepG2 cells; (ii) PKC
P11327698A0191|231 233|PKC
P11327698A0191|304 313|IGF-II mRNA
P11327698A0191|316 335|HBx-transfected HepG2
P11327698A0191|365 367|MEK
P11327698A0191|424 433|IGF-II mRNA
P11327698A0191|436 455|HBx-transfected HepG2
P11327858A0087|76 78|p53
P11328853A0644|56 59|SF-1
P11328853A0644|82 95|promoter region
P11331589A0113|3 12|MSL complex
P11331596A0710|27 36|EVH1 domain
P11331613A0827|19 22|pVHL
P11333263A0240|12 18|476 base
P11333268A1521|70 83|switch 2 regions
P11333268A1521|259 261|GDP
P11334124A0903|48 61|increase in FEV1
P11334124A0903|66 74|6 h (AUC0-6
P11334124A0903|84 87|FEV1
P11335116A1099|35 40|BmHR3A
P11335116A1099|60 63|RORE
P11335116A1099|64 72|(Retinoic
P11335116A1099|73 98|acid-related Orphan receptor
P11335116A1099|183 188|BmHR3A
P11335116A1099|216 225|BmGATAbeta
P11335116A1099|229 236|ESP genes
P11335116A1099|243 256|vitellogenesis
P11336211A0132|37 41|[Appl
P11336698A0075|58 81|yeast remodeler RSC complex
P11337859A0651|3 5|COD
P11337859A0651|45 49|FeCl3
P11337859A0651|119 123|mol/L
P11337859A0651|150 193|hydrogen peroxide oxidation pretreatment at a H2O2
P11337859A0651|206 210|mol/L
P11340085A0211|146 155|C/EBPalpha
P11340085A0211|221 236|regions (CR1-CR4)
P11340085A0211|246 266|transactivation domain
P11340516A0509|11 16|ADAL-2
P11340516A0509|50 66|tolerance to ADAL-2
P11341405A0146|0 5|SAMPLE
P11341405A0146|6 15|POPULATION
P11341405A0146|7 19|OPULATION: MCB
P11341405A0146|74 76|MCB
P11341405A1154|0 10|CONCLUSIONS
P11341405A1154|11 13|AND
P11341405A1154|14 21|CLINICAL
P11341405A1154|22 30|RELEVANCE
P11341405A1154|86 91|MCB-IV
P11341405A1154|95 96|-V
P11341405A1154|186 188|MCB
P11341828A0744|14 35|nine-residue D-peptides
P11341828A0744|50 69|pocket-binding domain
P11342479A0430|0 6|METHODS
P11342479A0430|7 9|AND
P11342479A0430|10 16|RESULTS
P11342479A0430|11 30|ESULTS: Palmaz-Schatz
P11345435A0199|17 29|RNA subdomains
P11345445A0533|2 14|Cd-spiked OECD
P11347201X0001|53 67|diet] BACKGROUND
P11349796A0950|49 60|exposure (D0)
P11349796A0950|85 99|measurement (D3)
P11349796A0950|120 124|(D30)
P11350038A0459|38 42|(Stem
P11350038A0459|93 98|hY RNAs
P11350165A1606|12 13|DB
P11350175A0173|65 73|isomerase
P11350812A0829|15 39|Raf-1 target ERK kinase (MEK)
P11350812A0829|67 75|Rp-cAMPS-
P11350812A0829|79 92|PKI-induced ERK
P11350957A0457|0 8|PACAP mRNA
P11350957A0457|60 69|ells, PACAP
P11350982A0560|48 56|GCN1-GCN2
P11350982A0560|82 85|GCN2
P11352663A0138|84 90|COUP-TF
P11352663A0138|109 117|NF-kappaB
P11352671A0492|64 67|(UCU
P11352671A0492|70 73|ACU)
P11352671A0492|100 110|RNA-editing
P11352671A0492|120 124|V gene
P11352671A0492|130 149|full-length hPIV2 cDNA
P11352671A0492|179 196|viruses [rPIV2V(-)]
P11352671A0492|204 207|cDNA
P11353392A1127|24 28|ADEx2
P11353392A1127|80 99|loss-of-function ASIP
P11353770A0085|65 77|N-glycosylase
P11353770A0085|101 125|8-oxoguanine residues in DNA
P11353774A0255|48 64|forkhead homologue
P11353774A0255|67 88|rhabdomyosarcoma (FKHR)
P11353774A0255|181 199|hormone receptor (NR)
P11354406A1373|11 13|CSF
P11354406A1373|97 99|ICP
P11355576A1125|30 32|CDK
P11355576A1125|83 110|he tumor suppressor protein, pRb
P11355576A1125|86 110|umor suppressor protein, pRb
P11355576A1125|154 159|S phase
P11355576A1125|202 204|E2F
P11356716A0372|54 58|GHS-R
P11356835A0000|56 63|"general
P11356853A0429|3 18|a13 cells, CoCl(2)
P11356853A0429|42 63|luciferase reporter gene
P11356853A0429|82 123|15-kilobase pair mouse ho-1 promoter (pHO15luc)
P11356853A0554|60 89|stress-response elements (StREs)
P11356853A0873|12 15|AP-1
P11356853A0873|64 67|StRE
P11357063A0138|98 115|species' homologous
P11357063A0138|148 160|LH/CGbeta gene
P11357063A0138|174 190|LHbeta-CGbeta gene
P11357063A1053|25 34|LHbeta gene
P11357063A1053|39 55|5'-flanking region
P11357063A1053|61 75|gpLH/CGbeta gene
P11357063A1053|91 94|TATA
P11357063A1053|120 140|translation start codon
P11358801A1046|37 46|reaks, NHEJ
P11358958A0878|17 21|RACK1
P11358958A0878|41 52|E1A-mediated
P11358958A0878|71 74|HF7c
P11358958A0878|105 115|E1A-induced
P11359568T0000|22 43|pRA2 partitioning region
P11359568T0000|23 48|RA2 partitioning region: ParB
P11359568T0000|62 66|parAB
P11359568T0000|89 108|nucleoprotein complex
P11359568T0000|117 140|lasmid partition site, parS
P11359827T0000|58 66|pyrogenic
P11359827T0000|80 86|J (SPE-I
P11359827T0000|90 95|SPE-J)
P11359827T0000|113 120|pyogenes
P11359907A0099|7 16|dozen HIF-1
P11359907A0099|76 93|growth factor (VEGF)
P11360190A0178|58 67|G0/G1 phase
P11360190A0178|74 83|G2/M phases
P11361338A0093|42 56|type 1C-terminal
P11361338A0093|68 88|targeting signal (PTS1)
P11361338A0093|104 116|tripeptide SKL
P11361338A0447|8 22|PEX5-TPR domains
P11361338A0447|69 76|TPR-less
P11361493T0000|0 4|HIV-1
P11367523A1684|27 29|C4A
P11367523A1684|33 35|C4B
P11367523A2624|8 10|C4B
P11367523A2624|103 110|C4A genes
P11368363A0129|70 97|myeloperoxidase (MPO) promoter
P11368363A0129|139 142|cDNA
P11368363A0129|140 142|DNA
P11368363A0129|164 175|HBP1 (HMG-Box
P11368363A1103|40 56|DNA-binding domain
P11368363A1103|76 82|rat HBP1
P11368363A1103|119 134|repressor domains
P11368787A0180|71 83|annexin A5 gene
P11368901A0327|26 29|BCNT
P11368901A0327|68 80|RTE-1-derived
P11368911T0000|42 45|mRNA
P11368914T0071|33 48|complement C3 gene
P11368914T0071|87 89|ORF
P11369066A1210|0 10|CONCLUSIONS
P11369066A1210|18 20|MMF
P11369700A0074|0 2|CSR
P11369700A0074|115 126|germline (GL)
P11369700A0074|116 142|ermline (GL), C(H) region genes
P11369700A0616|55 74|mouse GL alpha promoter
P11369700A0616|110 113|PU.1
P11369700A0616|158 179|luciferase reporter gene
P11369700A0616|191 205|GL alpha promoter
P11370174A0447|77 79|MMF
P11371115A0962|50 52|HBs
P11371115A0962|89 91|MGN
P11371115A0962|94 97|MPGN
P11371160A0193|39 53|base-pair C1-G72
P11371160A0193|57 73|discriminator base
P11371160A0854|29 37|anticodon
P11371160A0854|47 63|tyrosine anticodon
P11371160A0854|81 85|TyrRS
P11371343A0125|16 32|ell cycle, separase
P11371417A0744|58 82|hord compliance, an increase
P11371417A0744|103 132|tumor necrosis factor (TNF)-alpha
P11371417A0744|138 170|/- 306 pg/ml), interleukin (IL)-1beta
P11371417A0744|213 228|protein-2 (MIP-2)
P11371417A0744|348 361|aggregates (LA)
P11372882A1143|8 14|p,p'DDE
P11372882A1143|18 25|beta-HCH
P11372882A1143|79 82|PCBs
P11372959A1447|126 128|(R2
P11373277A0812|37 50|oncoprotein E1A
P11373277A0812|80 89|endogenous
P11373277A0812|90 102|AP-2alpha gene
P11373277A0812|156 172|AP-2alpha promoter
P11373277A0812|188 190|E1A
P11373277A0812|198 220|AP-2rep corepressor CtBP1
P11374051A0437|109 125|co-morbid diseases
P11374559A0103|0 3|SERS
P11374559A0103|54 58|p-NTP
P11375392T0000|3 14|core promoter
P11375392T0000|22 41|thioredoxin reductase
P11375392T0000|109 133|housekeeping-type promoter
P11375392T0000|140 167|AU-rich element-regulated gene
P11376007A0584|46 58|protein kinase
P11376007A0584|69 74|DNA-PK
P11376007A0584|135 152|protein phosphatase
P11376007A0584|156 181|protein phosphatase 2A (PP2A)
P11376007A0584|225 242|protein phosphatase
P11376119A0346|8 16|exon (exon
P11376119A0346|17 19|1A)
P11376119A0346|41 61|5'-untranslated region
P11376119A0346|67 75|GHR 1A mRNA
P11376119A0346|109 115|GHR gene
P11376165T0000|0 2|FLP
P11376165T0000|6 19|Cre recombinase
P11376279A0000|47 59|resonance (MR)
P11376687A0344|7 33|nucleotide polymorphism (SNP)
P11376687A0344|70 85|SNP (GTG83/ATG83)
P11376687A0344|117 127|in-frame AUG
P11376687A0344|130 144|B-type MTH1 mRNAs
P11376687A0344|136 139|MTH1
P11376687A0344|162 176|MTH1 polypeptide
P11376946A0000|31 35|SHP-1
P11376946A0000|38 84|SH2 domain-containing protein-tyrosine phosphatase
P11376946A0000|200 222|tissue-specific promoter
P11377975A0898|13 31|Arg1-expressing COS1
P11377975A0898|56 65|proteinase
P11378898A0164|0 3|ORF1
P11378898A0164|10 15|p; EMBL
P11380028A0000|66 97|Technetium Tc 99m (99mTc)-pentetate
P11380028A0000|120 132|131 (131I-OIH)
P11380370A0000|44 62|Kaposi's sarcoma (KS)
P11381094A0797|28 37|C2B domains
P11381094A0797|58 59|II
P11382948A0793|3 29|onclusion, USPIO-enhanced MRI
P11382948A0793|150 155|USPIO)
P11383860A0661|52 56|99mTc
P11384225A0634|69 80|protein (GFP)
P11384225A0634|100 111|EAV-specific
P11384229A1669|11 14|N63S
P11384229A1669|28 39|wild-type VP5
P11384229A1669|87 104|beta-galactosidase
P11384229A1669|143 145|PR7
P11384880A0719|28 45|3beta-HSD type 1 gene
P11384880A0719|81 87|ZR-75-1
P11385840A1684|12 14|RTC
P11387208T0000|0 21|SKP1-SnRK protein kinase
P11387208T0000|62 84|plant SCF ubiquitin ligase
P11387351A0092|0 7|PATIENTS
P11387351A0092|8 10|AND
P11387351A0092|11 17|METHODS
P11387351A0092|77 111|analog 2-chlorodeoxyadenosine (2-CDA)
P11387351A0092|135 137|AML
P11387351A0092|164 166|AML
P11387351A0092|184 196|syndrome (MDS)
P11387950X0001|175 198|tumor necrosis factor (TNF)
P11387950X0001|232 248|pancreatitis (ANP)
P11387950X0001|304 306|ANP
P11387950X0001|388 390|TNF
P11389077A0000|10 26|receptor-mediated
P11389085A0290|0 1|TT
P11389085A0290|14 16|MTC
P11389085A0290|35 46|MEN 2A type RET
P11389085A0290|78 86|RelA(p65)
P11389085A1032|24 32|NF-kappaB
P11389085A1032|61 62|TT
P11389085A1032|100 108|oncogenic
P11389085A1032|116 118|RET
P11389085A1032|121 126|NIH 3T3
P11390395A1018|13 18|HMGI-C
P11390395A1018|53 66|PIAS3-mediated
P11390395A1018|79 93|STAT3-dependent
P11390581A1203|37 43|GC-rich
P11390581A1203|57 71|-99/-91 Cp region
P11390581A1203|90 112|oriPI-EBNA1-independent
P11390581A1203|121 141|oriPI-EBNA1-dependent
P11390650A0562|78 95|proline-rich region
P11390650A0562|98 103|SLP-76
P11390650A0562|125 133|P-1 domain
P11390663A1400|20 28|gcn4Delta
P11390663A1400|88 103|Gcn4p target genes
P11390684A1170|47 50|jadM
P11391303A0807|5 14|LHR (R-LHR)
P11391303A1023|0 10|CONCLUSIONS
P11391303A1023|28 30|LHR
P11391531A1157|13 21|NF-kappaB
P11391531A1157|31 43|Mdr1b promoter
P11391531A1157|66 74|TNF-alpha
P11391793A0856|99 101|SRO
P11391793A0856|160 174|chromosome (PAC)
P11393463A0274|84 91|NEO-PI-R
P11393791A1153|22 25|RNAs
P11393791A1153|147 198|reverse-transcription polymerase chain reaction (RT-PCR)
P11396685A0477|27 29|DTD
P11398899A1183|91 93|PH3
P11399064T0000|47 78|CCAAT/enhancer binding protein beta
P11399064T0000|79 84|(C/EBP
P11399064T0000|85 89|beta)
P11399834T0000|14 16|HCV
P11399834T0000|63 68|HCV NAT
P11400644A0435|83 96|PCDD/F releases
P11400644A0435|118 124|I-TEQ/y
P11401611A1703|0 10|CONCLUSIONS
P11401611A1703|58 60|HRT
P11402674T0000|0 23|Newcastle disease antibody
P11403663A0359|90 94|on 2-D
P11404016A1922|17 25|TE domains
P11404016A1922|39 42|PKSs
P11404016A1922|86 88|TEs
P11404016A1922|89 91|(TE
P11404016A1922|92 95|IIs)
P11404016A1922|143 177|non-ribosomal peptide synthases (NRPS)
P11404019A0532|26 31|mGSTM2
P11404019A0532|73 86|promoter region
P11406007A0292|0 16|SELECTION CRITERIA
P11406007A0292|56 59|IUSs
P11406025A0204|0 9|OBJECTIVES
P11406277A0598|167 183|parent Hlx promoter
P11407289A1507|0 10|CONCLUSIONS
P11407289A1507|78 80|BIS
P11407650A0661|35 42|serum PTH
P11407650A0661|102 104|7 BC
P11408338A1686|21 23|PSP
P11408575A0000|65 86|cyclin-dependent kinase
P11408575A0000|97 119|cyclin B (Clb)-associated
P11408591A0000|29 42|hyaluronan (HA)
P11408604A1440|29 42|D(2L) receptors
P11408604A1440|54 62|ERK kinase
P11408604A1440|101 112|PDGF receptor
P11408604A1440|149 154|ERK1/2
P11408604A1440|183 204|receptor tyrosine kinase
P11408774X0893|0 7|Karger AG
P11409425A0000|76 83|Diseases
P11409425A0000|87 131|Stroke (NINDS) tissue plasminogen activator (t-PA)
P11409425A0000|176 194|apolipoprotein (Apo)
P11409425A0000|314 317|t-PA
P11410110A0190|0 3|NIRS
P11410110A0190|42 71|muscle O(2) consumption (mV.O(2))
P11410110A0190|75 95|forearm blood flow (FBF)
P11410563A0363|168 170|OSF
P11410664A0963|42 65|breast carcinoma MDA-MB231
P11410664A0963|90 92|MPG
P11410664A0963|146 148|BER
P11410664A0963|181 183|BER
P11410664A0963|184 189|(hOGG1
P11410664A0963|193 202|APE/ref-1)
P11410664A0963|211 224|reversal (MGMT)
P11410679A0000|38 51|Cre recombinase
P11410679A0000|92 94|LOX
P11410679A0000|233 235|LOX
P11411198A0711|136 148|non-Hodgkin's
P11411961A0735|79 81|JRA
P11413148A0573|0 5|STAT5A
P11413148A0573|20 36|Src homology 2 (SH2)
P11413148A0573|40 49|SH3 domains
P11413148A0573|64 75|BTK-mediated
P11413277A1121|43 49|dose MTX
P11413277A1121|53 57|ara-C
P11413277A1121|77 81|PCNSL
P11413310A0148|0 5|RANTES
P11413310A0148|79 89|CC chemokine
P11413310A0148|192 201|infiltrate
P11413310A0148|211 213|RSV
P11413319A0000|0 12|Reovirus mRNAs
P11413760A0000|85 96|ACh receptors
P11415633A1253|38 40|3-D
P11415952A0369|0 8|Angina (Q)
P11415952A0369|145 156|heart disease
P11416012T0000|42 71|density lipoprotein receptor gene
P11416012T0000|162 174|protein kinase
P11416012T0000|163 204|rotein kinase a, phosphatidylinositol 3-kinase
P11416012T0000|209 238|mitogen-activated protein kinase
P11416012A1982|20 32|PKA-dependent
P11416012A1982|44 47|LH's
P11416012A1982|87 97|LDL receptor
P11416012A1982|109 119|bp) reporter
P11416012A1982|148 207|full-sequence rabbit muscle protein kinase inhibitor (PKI) minigene
P11416012A1982|235 254|sarcoma virus promoter
P11416012A2511|35 47|insulin/IGF-I
P11416012A2511|95 113|LDL receptor promoter
P11416012A2511|206 232|phophatidylinositol 3-kinase
P11416012A2511|248 250|nM)
P11416012A2511|254 255|LY
P11416012A2511|265 271|microM)
P11416012A2511|273 306| or of mitogen-activated protein kinase
P11416012A2511|277 306|mitogen-activated protein kinase
P11416012A2511|278 315|itogen-activated protein kinase kinase, PD
P11416012A2511|324 330|microM)
P11416012A2511|340 346|microM)
P11416132A1351|56 61|bxd PRE
P11416132A1351|64 71|d(GA)(n)
P11416132A1351|103 115|PcG-dependent
P11416144A1324|39 44|ZBP-89
P11416144A1324|106 115|p53 protein
P11416737T0000|43 59|lasmacytoma: a case
P11418130A0499|21 24|loxP
P11418662A0917|22 30|Notch(IC)
P11418662A0917|40 45|p50 DNA
P11418662A0917|82 91|p50 subunit
P11418662A0917|101 109|NF-kappaB
P11419938T0000|77 79|DNA
P11422200A0000|0 41|Granulocyte colony-stimulating factor (G-CSF)
P11422757A0737|58 60|ACR
P11423991A1393|22 31|p53 mutants
P11423991A1393|55 57|p53
P11423991A1393|93 95|p53
P11423991A1393|137 145|p53-based
P11425877A1026|116 125|fluid phase
P11427329A1077|16 20|FPS-R
P11427329A1077|75 77|VAS
P11427329A1077|97 99|CAS
P11427611A0000|151 181|Laboratory Standards (NCCLS) M38-P
P11427611A0000|152 291|aboratory Standards (NCCLS) M38-P method, a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based
P11428435A0446|0 5|DESIGN
P11428897A0318|35 38|CopG
P11428897A0318|68 76|target DNA
P11428897A0318|82 92|protein:DNA
P11428897A0318|220 223|CopG
P11429702A0917|25 53|erum-starved conditions, KMS-11
P11429702A0917|57 61|OPM-2
P11429702A0917|107 111|FGFR3
P11429702A0917|157 161|Y373C
P11429702A0917|165 178|K650E receptors
P11429702A0917|196 199|aFGF
P11430042A0000|103 107|(BMIM
P11430042A0000|108 111|BF4)
P11430042A0000|135 146|liquid (RTIL)
P11431348A0000|22 46|checkpoint abrogator UCN-01
P11431348A0000|76 116|bitors of the mitogen-activated protein kinase
P11431348A0000|87 122|mitogen-activated protein kinase (MAPK)
P11431348A0000|129 138|(MEK)/MAPK
P11431472A0540|20 28|Rab6A-GTP
P11431472A0540|44 48|(K(d)
P11431472A0540|67 71|Rab1B
P11431472A0540|84 87|-11A
P11432112A0000|0 6|PURPOSE
P11432112A0000|47 65|embryo cleavage (FEC)
P11432112A0000|93 112|sperm injection (ICSI)
P11432748T0000|12 32|laminin beta2 chain gene
P11433014A0683|45 58|core histone H2A
P11433014A0683|61 63|H2B
P11433014A0683|90 92|MCB
P11433014A0683|124 133|endogenous
P11433018A0756|48 59|H/ACA snoRNAs
P11433018A0756|86 97|H/ACA snoRNPs
P11433024A0260|0 9|Telomerase
P11433024A0260|13 36|ribonucleoprotein complex
P11433024A0260|61 63|DNA
P11433024A0260|87 89|RNA
P11433379A0000|0 19|SIT (SHP2-interacting
P11434084A0508|11 20|patients DD
P11434084A0508|40 65|microlatex tests--Tinaquant
P11434084A0508|69 70|BC
P11435428A0000|9 36|acetyl-CoA synthetase (AceCS1)
P11435428A0000|73 82|acetyl-CoA
P11435517A0396|22 23|DM
P11435517A0396|23 26|M, OM
P11435517A0396|24 29|, OM, CP
P11435517A0396|43 52|fiber (TDF)
P11435517A0396|65 74|energy (GE)
P11435517A0396|84 85|(P
P11435560A1322|29 38|HFV R region
P11435560A1322|83 95|target HFV mRNA
P11435578A0760|5 8|TxRE
P11435578A0760|22 48|AMP-responsive elements (CRE)
P11435578A0760|68 77|"TGACGTCA"
P11435578A0760|127 140|(e.g.,AGACGTCA
P11435578A0760|142 149|TGACGGCA
P11435578A0760|143 159|GACGGCA, TGACCTCA)
P11435578A2231|37 48|consensus CRE
P11435578A2231|59 72|21-bp enhancers
P11435578A2231|91 98|CREB/ATF
P11435578A2231|136 147|LTR-directed
P11435605A0587|0 23|Site-directed mutagenesis
P11435605A0587|26 28|CAR
P11435605A0587|41 43|CAR
P11435605A0587|193 197|Ad41L
P11435688A0262|34 50|ATP-binding domain
P11435983T0000|36 45|allogeneic
P11438651A1365|32 34|HML
P11438654A1237|49 53|c-Met
P11438654A1237|70 73|PI3K
P11438654A1237|83 92|c-Akt/Pak1
P11438666A0555|19 40|ouse protein, TAF(II)140
P11438666A0555|54 56|HFD
P11438666A0555|61 81|plant homeodomain (PHD)
P11438666A0555|143 147|TFIID
P11438838A0788|27 29|TAR
P11438838A0788|61 77|RNA promoter (U6-P)
P11439343A0785|12 15|MPc3
P11439343A0785|67 69|AF9
P11441311X0001|20 26|MACOP-B
P11441311X0001|59 78|lymphomas] BACKGROUND
P11441311X0001|157 183|non-Hodgkin's lymphomas (NHL)
P11441952A0414|2 10|20 days (D)
P11441952A0414|16 30|3 months post-TBI
P11441952A0414|137 151|5 months post-TBI
P11441952A0414|205 207|TBI
P11441974A0320|40 51|hemolymph PO2
P11441974A0320|63 70|1-2.5 kPa
P11441974A0320|149 151|(O2
P11443509A0293|0 5|DESIGN
P11443509A0293|95 101|(NHANES
P11443509A0293|117 137|Follow-up Study (NHEFS)
P11443999A0573|84 85|(P
P11445008A0816|52 55|FGFR
P11445008A0816|90 92|RNA
P11445008A0816|113 115|RNA
P11447490A0598|18 25|effusion
P11448051A0093|154 158|(NaCl
P11448051A0093|195 203|(Eudragit
P11448051A0093|204 209|RS100)
P11449014A0000|0 13|STUDY OBJECTIVE
P11449014A0000|108 119|trials (CCTs)
P11449014A0000|152 186|epidemiologist/biostatistician (E/B)
P11450490A0565|174 175|(P
P11451682A0190|24 25|AE
P11451995T0000|83 124|isoprenylcysteine carboxyl methyltransferase
P11454004T0000|58 94|glycerol-3-phosphate dehydrogenase gene
P11454004T0000|112 119|a complex
P11454004T0000|120 142|hormone-response element
P11454190A0000|0 14|BACKGROUND/AIMS
P11454190A0000|41 63|fatty liver disease (NAFL)
P11454190A0000|90 101|liver disease
P11454239A0478|27 31|ANOVA
P11454239A0478|156 184|Cronbach's alpha (alpha) RESULTS
P11454239A0478|234 249|Chronbach's alpha
P11454703A0000|3 30|telomerase RNA-protein complex
P11454703A0000|67 69|DNA
P11454703A0000|196 208|tumorigenesis
P11456259A0142|10 48|TSH binding inhibitor immunoglobulin (TBII)
P11457139A0604|18 20|CVN
P11457139A0604|56 78|affinity Man(9)GlcNAc(2)
P11457139A0604|85 88|D1D3
P11457139A0604|97 111|Man(8)GlcNAc(2)
P11459794A1172|0 5|TE-671
P11459794A1172|34 52|cAMP response element
P11459794A1172|110 124|GnRH-II promoter
P11461595A0000|94 108|eaction, B+B-->B
P11462004A0886|12 17|Vp1 DBD
P11462004A0886|67 69|NLS
P11462004A0886|95 96|(N
P11462004A1500|114 117|NLS1
P11462952A1040|28 43|ange: 25-110 mU/L)
P11462952A1040|59 69|mU/L-168.20
P11462952A1040|81 85|mU/L)
P11463359A0167|18 32|phorbol ester PMA
P11463359A0167|54 79|dexamethasone/cAMP-induced
P11463359A0167|93 106|luciferase gene
P11463359A0167|127 140|G6Pase promoter
P11463359A0167|165 169|H4IIE
P11463834A0606|7 25|deletion mutagenesis
P11463834A0606|59 61|CBP
P11463834A0606|74 101|carboxy-terminal region 2 (CR2)
P11465518A0000|0 9|BACKGROUND
P11465655A0439|17 31|beta-adrenergic
P11466227A1665|13 20|AS-oligo
P11466227A1665|44 55|FSH-mediated
P11466227A1665|71 81|EB*-mTf-CAT
P11466227A1665|101 113|cAMP-mediated
P11467349A0452|47 49|ISF
P11468958A0122|52 63|2 CJD-related
P11468958A0122|113 115|CJD
P11468958A0122|195 196|UK
P11468958A0122|244 246|CJD
P11469701A0377|76 96|insulin therapy (CIIIT)
P11469853A0702|60 68|C1 domains
P11469853A0702|78 86|Raf kinase
P11469853A0702|90 95|rat PKC
P11469853A1053|62 67|GTPase
P11469853A1053|100 107|C1 domain
P11469970A0873|16 18|III
P11469970A0873|19 21|SOD
P11470914A0305|24 28|STAT3
P11470914A0305|68 86|STAT3-dependent gene
P11471077A0382|0 6|RESULTS
P11471077A0382|64 67|TRA1
P11471077A0382|71 74|TRA2
P11471077A0382|101 105|TRA's
P11472523A0535|0 9|CONCLUSION
P11472523A0535|58 60|DON
P11472523A0535|83 86|AFB1
P11472696A0387|19 23|CPIgG
P11472696A0387|20 27|PIgG, CRP
P11472696A0387|32 41|fibrinogen
P11472696A0387|78 80|ACS
P11472696A0387|102 110|(non-ACS)
P11473254A0000|0 3|NaeI
P11473254A0000|11 25|DNA endonuclease
P11473254A0000|32 44|topoisomerase
P11473254A0000|48 58|recombinase
P11473261A0587|36 71|guanine nucleotide exchange factor (GEF)
P11478627A0573|58 59|[D
P11478627A0573|62 64|(Y1
P11479104A0446|29 52|anti-cardiolipin antibody
P11479104A0446|97 124|upus erythematosis. CONCLUSION
P11479104A0446|173 175|POF
P11479501A0744|0 6|RESULTS
P11479501A0744|69 76|(SD/mean
P11480490A0443|68 72|I(Kr)
P11480497T0000|9 25|aerosol-vapor JP-8
P11481625A0202|57 79|three-times-weekly (TIW)
P11481625A0202|103 106|MIU)
P11481625A0202|112 126|once-weekly (QW)
P11484578A1132|0 9|CONCLUSION
P11486032A1261|74 78|RUNX1
P11486032A1261|108 114|E2A-HLF
P11486399A0000|40 53|etoposide (IEV)
P11486476A0147|137 141|CK-MB
P11486476A0147|223 225|ACS
P11486476A1512|8 28|arkers troponin T, CK-MB
P11486476A1512|105 107|ECG
P11490862A0141|57 70|Stamey-Pereyra
P11494391A0579|41 55|artery-alone ALT
P11495920A0504|1 6|1-base
P11495920A0504|52 61|CYP3A4 gene
P11496617A0301|0 6|METHODS
P11496617A0301|293 295|II)
P11496617A0301|301 305|mg DHB
P11496617A0301|358 361|III)
P11496617A0301|377 379|IV)
P11498795A0716|34 41|G1-phase
P11498795A0716|81 82|RB
P11498795A0716|115 120|S phase
P11500512A0000|8 16|ABCG1 gene
P11500512A0000|36 59|ATP-binding cassette (ABC)
P11500571A0976|27 33|NtmybAS
P11500571A0976|54 64|ollen, gPAL1
P11500913A1238|0 11|C/EBPbeta LIP
P11500913A1238|26 29|HC11
P11500913A1238|48 62|beta-casein mRNA
P11500913A1238|119 128|lactogenic
P11502738A1457|92 99|bp region
P11502738A1457|105 120|cyclin D1 promoter
P11502758A0869|52 56|LAD-1
P11502758A0869|66 69|FGFR
P11504545A0393|72 74|NF1
P11504545A0393|108 111|HeLa
P11504545A0393|115 118|CV-1
P11504545A0393|133 139|BKV-MLP
P11504709A0981|62 64|PMA
P11504709A0981|67 69|TPO
P11504709A0981|120 123|GPIX
P11504709A0981|165 182|MAPK/extracellular
P11504709A0981|183 204|signal-regulated kinase
P11505407A0461|0 6|RESULTS
P11505407A0461|51 55|EpCAM
P11505407A0461|98 131|tumor necrosis factor alpha (TNFalpha)
P11509266A0955|17 56|hazards regression adenocarcinoma (P=0.006)
P11509266A0955|74 85|BPF (P=0.003)
P11509266A0955|92 102|age (P=0.03)
P11509266A0955|124 136|stage (P=0.02)
P11509615T0000|0 27|Phosphatidylinositol 3-kinase
P11509615T0000|89 100|IL-2 receptor
P11509673A0574|24 27|(BM3
P11509673A0574|60 76|P450 AA epoxygenase
P11509673A0574|61 84|450 AA epoxygenase, F87V BM3
P11509673A0574|148 156|14,15-EET
P11509673A0574|149 159|4,15-EET, AA
P11511544T0000|3 12|loop domain
P11511544T0000|52 62|DNA-binding
P11512925A0000|0 4|EXAFS
P11512925A0000|26 29|Ge-K
P11512925A0000|61 65|Ge-Si
P11513121T0000|35 38|QSAR
P11513121T0000|89 91|BCF
P11513121T0000|124 139|compounds (PCOCs)
P11513180A1257|57 58|CT
P11513579A0372|75 81|Rho-GDI
P11516890A0236|24 43|cytochrome P-450 (CYP)
P11516890A0236|70 75|CYP 2D6
P11516890A0236|79 81|3A4
P11516890A0236|109 113|SSRIs
P11517190T0000|5 12|intronic
P11517190T0000|26 39|rat ER alpha gene
P11517190A0352|91 94|TATA
P11517190A0352|170 188|E-responsive element
P11517269A0472|15 23|GABAergic
P11517399A0858|18 21|mRNA
P11517399A0858|173 182|generation
P11517445A0221|0 13|Sixty-one cases
P11520436A0705|5 10|BALB/c
P11521191A0000|38 43|12S E1A
P11522431A0673|55 60|ICD-10
P11522584A0882|58 60|MMF
P11522584A0882|88 89|(P
P11522626A1374|32 39|G(1) gene
P11522626A1374|97 106|Mek-Erk1/2
P11522626A1374|116 132|estrogen receptors
P11522658A0086|25 35|ErbB1/ErbB2
P11522658A0086|79 126|ErbB kinase inhibitor AG1478in ErbB2-dependent BT-474
P11522658A0086|130 135|SKBR-3
P11522658A0870|40 43|MAPK
P11522658A0870|132 137|kinase
P11523446A0523|0 2|ICA
P11523446A0523|43 44|LC
P11523446A0523|48 68|time-of-flight (TOF) MS
P11523446A0523|84 85|LC
P11523446A0523|102 127|nitrogen detection (LC-CLND)
P11524015A0937|18 23|BZAP45
P11524015A0937|42 51|H4 promoter
P11524015A0937|61 79|-1)/CAT reporter gene
P11524815A0753|81 92|1, 2N0M0 cases
P11524823X0001|9 11|OAE
P11524823X0001|20 23|(GSI
P11524823X0001|135 148|OAE screener GSI
P11525102A0970|40 42|ACP
P11525102A0970|65 70|PubMed
P11525102A0970|104 106|(CI
P11525486A0350|14 25|CaCO3-CO2/N2
P11525486A0350|65 66|pH
P11525640A0560|12 15|JNK1
P11525640A0560|19 27|ERK kinase
P11525640A0560|83 86|JNK1
P11525640A0560|133 145|ERK (PD098059)
P11525640A0560|171 172|UV
P11525640A0560|187 200|GADD45 promoter
P11528127A1402|5 6|GC
P11528127A1402|83 84|GC
P11528127A1402|117 122|L1/L2"
P11528500A0571|15 21|NRL gene
P11529914T0000|0 8|NF-kappaB
P11529914T0000|36 40|CD154
P11529914T0000|41 45|(CD40
P11530684A0667|88 104|drive NK1-receptor
P11530684A0667|182 183|II
P11530684A0667|217 244|drive NMDA receptor-mechanisms
P11530684A0667|255 257|III
P11530684A0667|313 330|drive NMDA-receptor
P11530829A0000|45 47|ECG
P11532556A0000|20 44|angioencephalopathy (SDAE)
P11532856A1175|75 77|HGF
P11532856A1175|80 91|stress kinase
P11532856A1175|108 120|p42/44 mitogen
P11532856A1175|130 141|kinase (MAPK)
P11532856A1175|181 207|c-Jun-N-terminal kinase (JNK)
P11532856A1175|211 217|p38 MAPK
P11532856A1175|220 224|HIF-1
P11533238A1137|13 26|octamer element
P11533238A1137|63 67|HDAC1
P11533238A1137|97 111|HLA-DRA promoter
P11533340A1285|74 76|PDF
P11534900A0000|100 116|synergists MGK-264
P11534900A0000|101 138|ynergists MGK-264, piperonyl butoxide (PB)
P11535014A1157|52 54|TLE
P11535532A0189|19 29|enzyme DUB-2
P11535532A0189|51 54|IL-2
P11535832A0586|21 26|HDAC9a
P11535832A0586|60 64|HDAC9
P11538437A0568|61 65|N2(A)
P11538437A0568|67 84|N2(A) --> N2(C,B,V')
P11538437A0568|86 90|N2(X)
P11538437A0568|87 96|2(X), N2(A)
P11538437A0568|98 114|N2(X,V>5) --> N2(X)
P11538437A0568|116 123|N2(B,V')
P11538437A0568|150 154|N2(A)
P11538437A0568|156 158|CH4
P11538437A0568|175 187|M2 --> CN(B,V')
P11538437A0568|180 181|CN
P11538437A0568|190 200|2, N2(X,V>4)
P11538437A0568|202 211|CN --> N2(X)
P11538437A0568|213 222|CN(B,A,V')
P11538437A0568|226 233|N2-1% CH4
P11539522A0612|3 10|NAUSICAA
P11539522A0612|38 40|LET
P11540991A0127|53 60|NASA MSFC
P11540991A0127|91 100|NASA KC-135
P11540991A0127|136 139|EASE
P11540991A0127|156 181|Shuttle Atlantis mission 61-B
P11542780A0086|26 39|detectors (TLD)
P11542780A0086|113 116|(LET
P11542780A0086|118 134|10 keV/micrometer)
P11542780A0086|152 171|track detectors (PNTD)
P11542780A0086|188 205|energy tranfer (LET)
P11543154T0000|11 23|TLD Mg2SiO4:Tb
P11543317A0203|94 100|Mg2SiO4
P11543317A0203|95 109|g2SiO4: Tb (TDMS)
P11543317A0203|127 145|track detector (PNTD)
P11543662A0562|8 12|gstC'
P11545594A1556|23 32|Myb domains
P11545594A1556|75 83|Myb domain
P11547819A0532|0 6|METHODS
P11547819A0532|164 179|matter generation
P11550795A2583|16 23|RORgamma
P11550795A2583|45 66|T cell receptor-mediated
P11552058A0235|4 6|ICP
P11552058A0833|51 102|aline solution, THAM (Tris-hydroxy-methyl-aminomethane)
P11552724A0527|0 10|CONCLUSIONS
P11552724A0527|1 33|ONCLUSIONS: ChromaFlo-enhanced IVUS
P11552922A0361|0 6|CYP2C19
P11552922A0361|33 42|polymerase
P11553091A1472|122 123|II
P11553704A0674|53 62|EGFR-CD533
P11553704A0674|102 105|MAPK
P11554469A1386|44 52|CesA genes
P11554469A1386|59 76|cellulose synthases
P11554469A1386|125 165|non-cellulosic (1-->4)beta-glycan synthases
P11554727A0890|73 75|PTH
P11554727A0890|79 96|5'-GGGGGAGGGGAG-3'
P11554727A0890|108 112|PTHSR
P11555516A0639|24 38|threshold (COAT)
P11555516A0639|105 117|artery disease
P11556809A2085|17 32|CYP71D20-encoded
P11557127A0991|3 16|onclusion, NF-Y
P11557127A0991|77 87|rat mrp2 gene
P11557127A0991|102 109|MRP2 gene
P11559366T0000|0 12|E2F1-mediated
P11559366T0000|43 80|plasminogen activator inhibitor type 1 gene
P11559547T0000|30 72|estrogen-inducible pS2 breast cancer marker gene
P11559547T0000|78 80|ERR
P11559564A0459|0 5|NB-506
P11559564A0459|37 49|topoisomerase
P11559564A0459|110 132|splicing factor (SF2/ASF)
P11559789A0314|65 71|ASF/SF2
P11559789A0314|90 126|a progesterone antagonist-inducible gene
P11559789A0314|152 158|ASF/SF2
P11559821A1315|0 2|DNA
P11559821A1315|42 48|p30(II)
P11559821A1315|66 82|CREB-Tax-p300/CBP
P11560292A0557|51 62|prototype DSS
P11560509T0000|0 2|DNA
P11560509T0000|16 28|F factor TraI36
P11560509T0000|62 79|single-stranded DNA
P11560992A0000|7 66|specificity kinases mitogen-activated protein kinase (MAPK) kinase
P11560992A0000|67 72|(MKK)7
P11560992A0000|76 79|MKK4
P11560992A0000|125 203|stress kinases stress-activated protein kinases (SAPKs)/c-Jun N-terminal kinases (JNKs)
P11560992A0000|231 239|mitogenic
P11560992A0651|0 7|SAPK/JNK
P11560992A0651|54 57|MKK7
P11560992A0651|81 84|MKK4
P11560992A0651|152 155|MKK4
P11560992A1184|5 8|MKK7
P11560992A1184|44 65|stress-induced SAPK/JNK
P11560992A1184|90 93|MKK7
P11560992A1184|128 149|antigen receptor-driven
P11561626A0197|31 36|TMT-55
P11561626A0197|121 128|"Zn-TMT"
P11561626A0197|152 159|"Cd-TMT"
P11561626A0197|171 178|"Pb-TMT"
P11561626A0197|179 195|(M3[S3C3N3]2.nH2O
P11561626A0197|202 207|M=Cd2+
P11562278A0169|110 118|oncogenic
P11564871A1184|33 44|TATA-unified
P11564871A1184|128 130|TBP
P11564871A1184|176 187|TATA elements
P11564893A1068|48 50|6RG
P11564893A1068|49 61|RG lesion, MGMT
P11564893A1068|75 122|DNA repair factor to a transcription regulator (R-MGMT)
P11565747A1020|16 31|plicing assays, UV
P11565747A1020|47 57|RNA-binding
P11565747A1020|136 138|PSI
P11565747A1020|145 149|SELEX
P11565747A1020|194 205|P element IVS3
P11566874T0000|6 16|motor domain
P11566948A1217|49 52|ACEI
P11566996A1391|17 20|uvrA
P11566996A1391|82 96|acid-induced DNA
P11566996A1391|158 159|pH
P11568988A0960|47 50|WCXR
P11568988A0960|104 113|Pa elastase
P11569900A0660|0 13|APC-resistance
P11570735A1097|0 6|RESULTS
P11570735A1097|246 247|II
P11570820T0000|4 15|casein kinase
P11572388A0000|68 102|solvation energy relationships (LSERs)
P11572388A0000|147 160|reversed-phase
P11572388A0000|182 187|(RPLC)
P11572467T0000|56 87|tissue plasminogen activator (t-PA)
P11572467A0658|67 70|t-PA
P11572467A0658|81 91|plasminogen
P11573891A0525|0 6|RESULTS
P11573891A0525|71 73|TST
P11574088A1687|61 63|SPK
P11574088A1687|77 79|PAK
P11574088A1687|90 91|(P
P11574105A0727|51 68|increase in antibody
P11574105A0727|121 123|GBS
P11574105A0727|174 176|GBS
P11574105A0727|194 212|outcome (anti-GM1 IgG
P11574105A0727|210 235|IgG and anti-GD1a IgM antibody
P11574105A0727|216 235|anti-GD1a IgM antibody
P11574105A0727|251 266|damage (anti-GD1a
P11574105A0727|267 277| IgM antibody
P11576158A1371|5 16|TVD-patients
P11577094A1226|39 48|WT-1/HSAL2
P11578685A0077|0 5|ICAM-1
P11578685A0077|44 45|GO
P11579100T0000|0 21|Phosphotyrosyl peptides
P11579100T0000|27 43|Stat3-mediated DNA
P11579100T0000|28 63|tat3-mediated DNA binding activity, gene
P11580301A1161|14 16|HCV
P11580757A0304|0 6|METHODS
P11580757A0304|33 38|13 TFCD
P11580757A0304|119 142|resonance (MR)-detectable
P11580757A0304|158 170|epileptogenic
P11580941A0815|0 6|RESULTS
P11580941A0815|32 38|UPDRS II
P11580941A0815|42 44|III
P11583621A0301|80 89|hTAF(II)80
P11583621A0301|81 105|TAF(II)80 delta. hTAF(II)80
P11583621A0301|118 127|hTAF(II)80
P11583621A0301|135 151|TFIID-like complex
P11583621A0301|159 168|hTAF(II)31
P11583880T0000|33 38|AneuRx
P11584328A0532|59 64|CYP450
P11585856A0285|0 6|METHODS
P11585856A0285|37 53|depth-dependent RR
P11585856A0285|65 66|AC
P11585856A0285|133 138|[PER])
P11587514A0758|11 20|abi1-1 gene
P11587514A0758|44 46|ABA
P11587514A0758|61 90|GA-responsive alpha-amylase gene
P11587980A1039|57 59|FOT
P11589779T0000|0 5|HTLV-1
P11590364A1056|11 16|beta5L
P11592315A0325|0 8|PROCEDURE
P11592532A0188|0 6|METHODS
P11592532A0188|37 40|(HFA
P11593394A0000|12 38|growth factor-beta (TGF-beta)
P11593394A0000|109 135|E-type cyclin kinase complexes
P11593394A0000|181 190|p15(Ink4b)
P11593394A0000|194 214|p27(Kip1) cyclin kinase
P11595170A0582|20 24|cDNAs
P11595170A0582|30 44|NR5A2 (hB1F) gene
P11595176T0000|29 37|SPEC1 gene
P11595176T0000|63 75|close promoter
P11595176T0000|90 110|AF1q translocation gene
P11595813A0633|22 30|androgens
P11595813A0633|128 136|aromatase
P11595813A0633|129 153|romatase, 5alpha-reductase
P11595813A0633|180 196|androgen receptors
P11595840A0000|11 48|fluorine-18 fluorodeoxyglucose (F-18 FDG)
P11596104A0614|32 37|PARNAs
P11596104A0614|85 93|kilobases
P11596838A1357|139 163|short-acting beta2-agonist
P11597936A0570|5 7|CAD
P11597936A0570|79 107|density lipoprotein (+/-5 mg/dL)
P11597936A0570|112 136|triglycerides (+/-50 mg/dL)
P11599079A1040|66 69|(API
P11599079A1040|85 88|(API
P11599079A1040|107 110|(API
P11599797A0732|0 6|RESULTS
P11599840A0813|48 59|3.4+/-1.4 kPa
P11599840A0813|89 100|3.4+/-0.9 kPa
P11599840A0813|112 128|ection, 3+/-0.3 kPa
P11599840A0813|118 128|, 3+/-0.3 kPa
P11599840A0813|167 178|3.5+/-0.9 kPa
P11600252A0795|3 4|LA
P11602353A0770|13 21|HNF-3 beta
P11602353A0770|14 27|NF-3 beta, HFH-1
P11602353A0770|15 33|F-3 beta, HFH-1, HFH-2
P11602353A0770|16 39|-3 beta, HFH-1, HFH-2, HFH-3
P11602353A0770|17 45|3 beta, HFH-1, HFH-2, HFH-3, C/EBP
P11602353A0770|41 45|C/EBP
P11602353A0770|50 58|C/EBP beta
P11604152A0526|3 6|MABP
P11604152A0526|10 14|MCBFV
P11604152A0526|69 72|(VLF
P11604152A0526|106 108|(LF
P11604152A0526|144 146|(HF
P11604152A0526|174 176|CCF
P11604152A0526|244 251|mean CCFs
P11605207T0001|19 30|heart disease
P11605598A0785|92 93|US
P11606538A1002|54 75|receptor tyrosine kinase
P11606538A1002|97 110|neuropeptidase
P11642687T0000|39 44|QWB-SA
P11642687T0000|48 52|SF-36
P11642687T0000|86 100|prostate disease
P11653491T0000|21 23|DNA
P11669476A0346|1 60|ro-inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha)
P11676899A0704|43 54|Epstein-Barr
P11677363A0775|39 41|IMT
P11677363A0775|66 68|SBP
P11677363A0775|71 72|PP
P11677363A0775|90 91|(P
P11677363A0775|117 119|SBP
P11677363A0775|122 123|PP
P11678437A0000|72 75|(Zea
P11679441A0429|0 1|NO
P11679441A0429|60 63|(NOx
P11679441A0429|120 124|(cGMP
P11680835A0756|5 13|base-case
P11684665A0000|1 21|. elegans embryogenesis
P11685047A0301|9 19|chromogenic
P11685284X0000|0 12|[Diabetologia
P11685284X0000|21 26|[Suppl
P11685284X0000|30 37|B37-B44]
P11686239A0464|26 31|3B gene
P11686239A0464|65 67|G/C
P11686239A0464|195 212|Dictyostelium genes
P11686378A0326|68 71|LD50
P11686378A0326|147 161|E coli/cfu mL(-1)
P11686378A0326|330 332|EHD
P11687083A0218|0 9|OBJECTIVES
P11687180A3209|46 63|pre-dialysis rHu EPO
P11687352A0215|0 6|METHODS
P11687352A0215|55 59|LASIK
P11687517A1619|2 6|ISREs
P11687517A1619|29 41|mouse promoter
P11687737A0000|0 9|BACKGROUND
P11687737A0000|19 30|heart disease
P11691585T0000|3 12|hcKrox gene
P11691585T0000|49 59|matrix genes
P11691585A1174|115 119|cKrox
P11692004A1200|110 112|NF1
P11693461A1649|52 54|$US
P11693461A1649|64 66|$US
P11693461A1649|79 81|TNF
P11693461A1649|96 97|RA
P11695481A0310|22 37|combination O3/UV
P11697760A0000|57 76|17beta-estradiol (E2)
P11697760A0000|90 101|hormone (PTH)
P11697760A0000|138 140|OVX
P11703464A0560|19 30|subjects rCBF
P11703558A0000|0 15|Doxorubicin (DOX)
P11704380A1608|33 40|Irr-rMFP
P11704380A1608|43 50|Un-nrMFP
P11704380A1608|88 95|Rev-rMFP
P11704380A1608|98 106|Sta-nrMFP
P11704829A0312|67 72|gene-7
P11704829A0312|83 87|a gene
P11706949T0000|16 49|insulin-like growth factor I receptors
P11708032A0183|35 56|intra-arterial infusion
P11708032A0183|59 76|levoforinate (l-LV)
P11708032A0183|85 104|5-fluorouracil (5-FU)
P11708032A0183|136 145|metastases
P11708761A1388|58 60|ACE
P11709561T0000|0 4|Phase
P11709561T0000|5 6|II
P11709561T0000|17 26|anti-G(D2)
P11709561T0000|37 47|antibody 3F8
P11710685A0994b|22 26|ASCUS
P11710685A0994a|22 26|ASCUS
P11710685A0994a|37 45|ASCUS/SIL
P11710685A0994b|37 45|ASCUS/SIL
P11711701A0602|95 104|Tc-99m MIBI
P11716043A0380|56 58|PTC
P11716441A0585|0 2|ISS
P11716441A0585|50 56|(APACHE
P11716441A0585|57 59|II)
P11723500X0000|0 8|[Clinical
P11723500X0000|82 97|women] BACKGROUND
P11723500X0000|107 124|cell carcinoma (SCC)
P11723675A1022|48 51|SOFA
P11723675A1022|128 135|APACHE II
P11726262A0692|53 56|(HMB
P11726262A0692|67 68|mM
P11726262A0692|68 72|M; LEU
P11726262A0692|83 84|mM
P11726262A0692|84 88|M; CON
P11726262A0692|99 101|mM)
P11727073A0842|0 9|CONCLUSION
P11727073A0842|36 42|MIST-VR
P11730182A0984|117 121|(Acer
P11730712A0416|75 94|MCA occlusion (P<0.01)
P11732088A0471|120 136|ultrasound (SSEUS)
P11732417A0571|169 173|ELISA
P11736792A0204|60 63|(G1)
P11736792A0204|79 82|(G2)
P11737056A0680|35 36|ME
P11737056A0680|40 41|ET
P11737056A0680|63 66|BrdU
P11737158A1517|47 68|usiform gyrus, Broca BA44
P11737900A0700|27 35|plasma COP
P11738404A0120|39 135|1 alpha,2 alpha-diacetoxy-8 beta-isobutanoyloxy- 9 alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4 beta
P11738404A0120|40 273|alpha,2 alpha-diacetoxy-8 beta-isobutanoyloxy- 9 alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4 beta, 6 beta-dihydroxy-beta-dihydroagarofuran (1), 1 alpha,2 alpha-diacetoxy-8 beta-(beta- furancarbonyloxy)-9 alpha-benzoyloxy-13-isobutanoyloxy-4 beta
P11738404A0120|41 312|lpha,2 alpha-diacetoxy-8 beta-isobutanoyloxy- 9 alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4 beta, 6 beta-dihydroxy-beta-dihydroagarofuran (1), 1 alpha,2 alpha-diacetoxy-8 beta-(beta- furancarbonyloxy)-9 alpha-benzoyloxy-13-isobutanoyloxy-4 beta, 6 beta-dihydroxy-beta-dihydroagarofuran
P11738404A0120|319 324|1 alpha
P11738404A0120|320 409|alpha, 6 beta, 8 alpha,13-tetraacetoxy-9 alpha-benzoyloxy-2 alpha-hydroxy-beta-dihydroagarofuran
P11738404A0120|421 431|analyses NMR
P11738404A0120|435 436|MS
P11740571A0114|87 107|glutathione peroxidase
P11741259A1233|16 27|pH-sensitive
P11741259A1233|65 71|release
P11741554T0000|87 99|artery disease
P11741554T0000|120 132|artery disease
P11742432A0798|73 75|MAC
P11742432A0798|299 302|AIDS
P11742432A0798|316 318|CD4
P11742432A0798|339 353|100 cells/microL
P11743360A2491|46 49|IL-6
P11743612A1179|12 13|CF
P11743612A1179|113 114|CF
P11744290T0045|0 10|(Cactaceae)
P11752821A1365|0 9|CONCLUSION
P11752821A1365|1 13|ONCLUSION: MMF
P11752821A1365|64 91|Adamantiades-Behcet's disease
P11755894A0466|89 91|ADL
P11755894A0466|141 150|ileus (POI)
P11760398A0553|0 6|METHODS
P11760398A0553|34 35|BS
P11760398A0553|134 135|BS
P11760398A0553|189 191|ISG
P11760796A0698|20 25|PHACES
P11761601A0133|2 26|omputer program, ACCESS-IAQ
P11764062A0000|33 48|Children (PSWQ-C)
P11764062A0000|144 154|generalized
P11764062A0000|178 186|(Chorpita
P11764226A0798|28 31|ILAR
P11764226A0798|79 86|a disease
P11764226A0798|137 141|EULAR
P11771979A1141|42 44|LDF
P11771979A1141|129 137|rgans, LDF
P11771979A1141|200 212|heterogeneity
P11773168A0915|16 27|survival (OS)
P11773168A0915|31 59|progression-free survival (PFS)
P11773168A0915|112 113|(P
P11773921A0397|0 6|METHODS
P11773921A0397|46 59|ADP-stimulated
P11773921A0397|174 186|artery disease
P11776922A0830|0 1|IV
P11776922A0830|38 46|skull base
P11776922A0830|78 79|II
P11777575A0363|27 28|(L
P11777575A0363|85 88|PyMS
P11777575A0363|130 143|networks (ANNs)
P11777632A1678|0 1|AF
P11777632A1678|158 159|AF
P11778804A0179|60 62|FDT
P11781615A0000|7 37|graft-versus-host disease (cGVHD)
P11781615A0000|60 69|allogeneic
P11782218A0349|10 28|white-on-white (W-W)
P11782218A0349|11 42|hite-on-white (W-W) perimetry, SWAP
P11785085X0001|149 173|vacuum aspiration (Introl-4
P11785085X0001|193 220|pneumovibromassage (PVM-R-01)
P11786248A1162|61 64|PPTg
P11787322X0001|78 79|IV
P11787720A1313|53 60|(C18:2n6
P11787720A1313|102 109|(C20:4n6
P11789206A1182|0 10|CONCLUSIONS
P11789206A1182|26 29|MIRI
P11789206A1182|60 62|TCM
P11790897T0000|49 57|SELDI-TOF
P11791853A0532|106 108|COD
P11793172A0545|29 30|PE
P11793172A0545|62 64|THA
P11793172A0545|134 135|PE
P11793614A0000|0 8|OBJECTIVE
P11793614A0000|85 101|phosphodiesterase
P11800586A1090|10 17|DPPD gene
P11800878T0000|40 51|ultrashort UV
P11802580A0000|3 39|General Practice Research Database (GPRD)
P11802580A0000|59 78|computerized database
P11803325A0868|7 8|DC
P11803325A0868|38 40|HBS
P11803325A0868|54 56|2 DC
P11803325A0868|62 64|CBC
P11803325A0868|78 80|7 DC
P11803325A0868|86 88|GIK
P11804081A0552|19 22|ENRP
P11804081A0552|50 51|TP
P11804100A0365b|32 35|BOD5
P11804100A0365a|32 35|BOD5
P11804100A0365b|39 43|NH3-N
P11804100A0365a|39 43|NH3-N
P11804100A0365a|104 105|TP
P11804100A0365b|104 105|TP
P11804510A0730|187 195|cryogenic
P11806132A0253|3 4|TB
P11806132A0253|19 25|"AIRIN"
P11806132A0253|44 45|TB
P11810685A0147|50 59|q-space MRI
P11810685A0147|148 149|3D
P11810685A0147|191 196|DT-MRI
P11811743A0800|58 67|Class III FI
P11816458A0319|10 18|"Examples
P11816458A0319|36 38|APA
P11818675X0897|0 7|Karger AG
P11819326A0000|0 5|AIM:To
P11819326A0000|76 126|porto-systemic encephalopathy (PSE).METHODS:Fifty-one
P11819326A0000|168 170|PSE
P11821098A0269|0 20|MAIN OUTCOME MEASURE(S)
P11821098A0269|35 37|FSH
P11821098A0269|36 40|SH, LH
P11822790A0907|18 20|SIP
P11822811A0319|94 97|VMTH
P11828186A0239|78 89|heart disease
P11828186A0239|97 99|CRP
P11828186A0239|165 171|(NHANES
P11828186A0239|172 175|III)
P11830544A0335|28 36|HER-2/neu
P11830544A0335|69 85|G6-(1B4M-Gd)(256)
P11830544A0335|118 123|WIBC-9
P11830544A0335|150 160|control MC-5
P11830544A0335|189 200|angiogenesis
P11831512A0468|163 165|CSS
P11831512A0468|175 192|equivalent [DE]-20)
P11831512A0468|218 222|DE-42
P11832019A0668|0 10|CONCLUSIONS
P11832019A0668|1 15|ONCLUSIONS: AMVT
P11832019A0668|43 58|emergency disease
P11834476A1187|60 70|transfusion
P11834476A1187|106 138|cross-linked hemoglobin transfusion
P11835109A0000|100 109|life (HRQL)
P11836046A0549|196 203|estrogen
P11836303A0518|0 7|TNFalpha
P11836303A0518|11 14|IL-6
P11838058A0084|0 6|METHODS
P11838058A0084|1 13|ETHODS: 9 cases
P11838058A0084|40 60|tissue expansion (CITE)
P11838058A0084|64 69|9 cases
P11838058A0084|82 121|pressure-controlled tissue expansion (CPTE)
P11838102T0001|0 8|Wegener's
P11840365A0949|66 70|SF-36
P11840365A0949|71 72|(P
P11843252A0907|51 53|CI)
P11844591A0329|44 58|peak torque (APT)
P11844812A0915|11 16|4 ng/mL
P11844812A0915|26 28|AUC
P11844812A0915|34 39|ANN ROC
P11844812A0915|74 77|AUCs
P11844812A0915|97 99|PSA
P11844812A0915|100 101|(P
P11844812A0915|110 115|PSA-TZ
P11844812A0915|161 162|(P
P11845547A0449|27 40|obutamine, KATP
P11846187A0894|3 21|GT-foreign-pictures
P11849417A0900|53 63|75+.RESULTS
P11849417A0900|82 91|dialysis PD
P11849417A0900|130 131|(P
P11849417A0900|144 145|HD
P11849796A0452|0 6|RESULTS
P11849796A0452|39 44|3D-CRT
P11849796A0452|48 51|IMRT
P11849796A0452|102 105|IMRT
P11851941A0372|165 187|hydroxyethyl starch (HES)
P11852907A0871|3 36|equilibrium phosphorus content (EPC0)
P11852907A0871|75 77|SRP
P11853943A0122|45 47|R-R
P11858548A0241|64 66|NMR
P11858635A0896|37 40|QSAR
P11858635A0896|61 63|LOO
P11859400A0229|55 57|HSV
P11859400A0229|75 77|HSV
P11859400A0229|100 134|progenitor cell transplantation (APCT)
P11859400A0229|195 197|HSV
P11860876A0409|0 4|HIV-1
P11860876A0409|15 18|IDUs
P11861092A0730|128 137|scale (FGS)
P11861092A0730|150 167|colour Doppler (FCD)
P11861092A0730|180 196|power Doppler (FPD)
P11861092A0730|216 225|scale (HGS)
P11861092A0730|235 252|inversion mode (Pim)
P11861092A0730|260 266|HDI5000
P11861092A0730|286 289|(ATL
P11861092A0730|292 301|othell, WA)
P11862350T0000|50 61|NMDA receptor
P11864173T0000|16 24|pathogens
P11866130A0419|88 92|MS222
P11867388A0502|3 8|EC(50)
P11867388A0502|144 147|SEM)
P11867388A0502|201 202|(P
P11872359A0000|21 41|insulin resistance (IR)
P11872359A0000|75 86|disease (CVD)
P11872359A0000|121 133|syndrome." CVD
P11872570T0000|24 26|NHS
P11873003X0000|0 4|HIV-1
P11873003X0000|60 63|AIDS
P11873003X0000|107 126|countries? OBJECTIVES
P11873003X0000|159 163|HIV-1
P11873003X0000|193 196|AIDS
P11873003X0000|234 237|AIDS
P11874637A0212|34 47|therapy (HAART)
P11874637A0212|100 102|HIV
P11874637A0212|179 210|deficiency syndrome (AIDS)-related
P11875695A0718|88 89|CI
P11879108A0719|0 17|MAIN OUTCOME MEASURE
P11879108A0719|77 82|ligase
P11879108A0719|155 180|immunodeficiency virus (HIV)
P11881923A1256|48 50|CBG
P11881923A1256|68 69|(P
P11881923A1256|85 91|INITIAL
P11881923A1256|111 113|PRE
P11881923A1256|116 119|POST
P11882054A0568|52 64|tructures, FMZ
P11882054A0568|106 116|9-mm regions
P11882054A0568|119 132|interest (ROIs)
P11882054A0568|212 223|mirror region
P11882054A1250|50 52|FMZ
P11882054A1250|133 148|peri-lesional FMZ
P11882054A1250|192 206|epileptogenesis
P11882747A0354|0 1|CD
P11883763A1062|16 24|239+240Pu
P11883763A1062|167 175|239+240Pu
P11884014A0665|44 56|EEN-related GI
P11885053A1897|29 38|(Volkan's)
P11886473A0796|37 46|nod-/CagA-
P11886473A0796|61 70|nod+/CagA-
P11886473A0796|80 89|nod-/CagA+
P11886473A0796|101 110|nod+/CagA+
P11887803A1455|148 153|to CAPD
P11887803A1455|187 190|CAPD
P11888867A0000|0 9|BACKGROUND
P11888867A0000|57 63|TA90-IC
P11888867A0000|83 88|90-kDa
P11890354A0000|40 57|oprelvekin (rhIL-11
P11890354A0000|91 95|IL-11
P11893767A0356|23 42|minute ventilation (E)
P11893767A0356|60 80|equivalent (VE/(O(2)))
P11894605A1429|0 13|INTERPRETATION
P11895024A1054|11 13|GBS
P11895024A1054|23 24|TM
P11895024A1054|44 46|AFP
P11897449A0566|91 93|RFA
P11897449A0566|92 101|FA. RESULTS
P11897950A0617|0 10|CONCLUSIONS
P11898797A0124|39 62|choline acetyltransferase
P11899479A0122|157 165|CHROMagar
P11899479A0122|276 287|kit AuxaColor
P11900770T0000|67 82|dopamine receptor
P11902068T0000|3 5|CKD
P11902738A0185|0 7|PATIENTS
P11902738A0185|8 10|AND
P11902738A0185|11 17|METHODS
P11902781A0550|16 23|N(O3-)-N
P11902781A0550|27 34|N(H3-)-N
P11902781A0550|79 82|mg/L
P11908529A0553|100 103|AgCl
P11908529A0553|101 116|gCl crystals, LiF)
P11910310A0279|0 5|DESIGN
P11910344A1119|0 10|CONCLUSIONS
P11910344A1119|69 76|type 1 HRS
P11912261A0284|33 35|PTH
P11912261A0284|60 82|calcium-sensing receptor
P11920455X1195|0 37|Copyright 2002 American Cancer Society.DOI
P11920896A0298|30 31|DR
P11920896A0298|109 131|false-positive rate (FPR)
P11921126A1196|15 20|PDQ-39
P11921126A1196|16 28|DQ-39, STN-DBS
P11921126A1196|68 70|QoL
P11921126A1196|93 94|PD
